Shortage reports,DISCLAIMER: The information found within this file is presented in the language in which it was written and submitted.,,,,,,,,,,,,,,,,,,,,
Report ID,Drug Identification Number,Report Type,Brand name,Company Name,Common or Proper name,Ingredients,Strength(s),Packaging size,Route of administration,Shortage status,Dosage form(s),ATC Code,ATC description,Anticipated start date,Actual start date,Estimated end date,Actual end date,Reason,Date Created,Date Updated,Tier 3
28240,1963937,Shortage,0.9% SODIUM CHLORIDE IRRIGATION USP,B. BRAUN MEDICAL INC,Sodium Chloride,SODIUM CHLORIDE,0.90%,"500mL, 1000mL, 2000mL, 4000mL",IRRIGATION,Actual shortage,SOLUTION,B05CB,IRRIGATING SOLUTIONS,,2017/11/3,,,Requirements related to complying with good manufacturing practices.,2017/11/6,2019/4/4,No
24792,2141450,Shortage,20% PROSOL,BAXTER CORPORATION,20% PROSOL,PHENYLALANINE HISTIDINE TRYPTOPHAN LEUCINE ARGININE THREONINE ALANINE DL-METHIONINE GLYCINE GLUTAMIC ACID PROLINE L-ASPARTIC ACID TYROSINE LYSINE SERINE VALINE ISOLEUCINE,1G 1.18G 0.32G 1.08G 1.96G 0.98G 2.76G 0.76G 2.06G 1.02G 1.34G 0.6G 0.05G 1.35G 1.02G 1.44G 1.08G,2000 mL,INTRAVENOUS,Resolved,LIQUID,B05BA,I.V. SOLUTIONS,2017/11/15,2017/11/15,2017/12/15,2017/11/21,Disruption of the manufacture of the drug.,2017/10/10,2017/11/22,No
27274,2248489,Shortage,"4% ASTRACAINE DENTAL WITH EPINEPHRINE 1:200,000 (0.005MG/ML)",DENTSPLY CANADA LIMITED,"Articaine Hydrochloride 40 mg/mL and Epinephrine Injection 1:200,000",ARTICAINE HYDROCHLORIDE EPINEPHRINE,40MG 0.005MG,100 1.8 mL cartridges/box,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018/3/1,2018/3/1,2018/4/30,2018/3/29,Disruption of the manufacture of the drug.,2017/10/27,2018/3/30,No
26870,2299135,Shortage,40 (MEQ)MMOL/L POTASSIUM CHLORIDE PLUS 5% DEXTROSE & 0.9% CHLORURE DE SODIUM/SODIUM CHLORIDE INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Injection USP 079109254,DEXTROSE POTASSIUM CHLORIDE SODIUM CHLORIDE,5.0G 0.3G 0.9G,1000ML,INTRAVENOUS,Resolved,SOLUTION,B05BB,I.V. SOLUTIONS,2017/10/17,,2017/11/30,2017/11/30,Other (Please describe in comments),2017/10/24,2018/12/28,No
30198,37974,Shortage,50% DEXTROSE INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,50% DEXTROSE,DEXTROSE,500MG,25x50mL GVL,INTRAVENOUS,Resolved,SOLUTION,B05BA,I.V. SOLUTIONS,,2018/1/19,,2018/3/2,Disruption of the manufacture of the drug.,2017/11/22,2018/3/5,No
10415,2364182,Shortage,ABSTRAL,PALADIN LABS INC,FENTANYL,FENTANYL,200MCG,10 Tabs,SUBLINGUAL,Resolved,TABLET,N02AB,OPIOIDS,,2015/11/27,,2015/11/27,Disruption of the manufacture of the drug.,2017/5/16,2017/11/30,No
29649,2303450,Shortage,ACCEL PIOGLITAZONE,ACCEL PHARMA INC,ACCEL PIOGLITAZONE,PIOGLITAZONE,30MG,100 tablets,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017/11/17,2017/11/17,2018/1/10,2018/3/19,Disruption of the manufacture of the drug.,2017/11/17,2018/3/20,No
14434,2236606,Shortage,ACCOLATE TAB 20 MG,ASTRAZENECA CANADA INC,zafirlukast tablets,ZAFIRLUKAST,20MG,60,ORAL,Avoided shortage,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017/12/31,,,2017/8/15,Disruption of the manufacture of the drug.,2017/6/30,2017/8/15,No
22073,2164418,Shortage,ACEBUTOLOL-200 - TAB 200MG,PRO DOC LIMITEE,ACEBUTOLOL-200,ACEBUTOLOL,200MG,100-500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/9/13,,2018/11/15,Delay in shipping of the drug.,2017/9/13,2018/11/16,No
17195,2362244,Shortage,ACETAMINOPHEN TABLETS USP 500 MG,APOTEX INC,ACETAMINOPHEN,ACETAMINOPHEN,500MG,30 BTL,ORAL,Resolved,TABLET,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,2017/8/18,,2017/9/29,2017/10/2,Disruption of the manufacture of the drug.,2017/7/26,2017/10/5,No
32028,2028174,Shortage,"ACETAMINOPHEN, CAFFEINE & CODEINE",PHARMASCIENCE INC,ACET CODEINE,ACETAMINOPHEN CODEINE PHOSPHATE CAFFEINE,300MG 8MG 15MG,200,ORAL,Resolved,TABLET,N02AJ,OPIOIDS,,2017/12/7,,2020/6/5,Disruption of the manufacture of the drug.,2017/12/7,2020/6/9,No
4161,2025337,Shortage,"ACETAMINOPHEN, CAFFEINE & CODEINE",PHARMASCIENCE INC,ANALGESICS C.L.,ACETAMINOPHEN CODEINE PHOSPHATE CAFFEINE,300MG 8MG 15MG,200,ORAL,Resolved,TABLET,N02AJ,,,2017/3/23,,2020/6/5,Disruption of the manufacture of the drug.,2017/3/24,2020/6/9,No
13688,2025337,Shortage,"ACETAMINOPHEN, CAFFEINE & CODEINE",PHARMASCIENCE INC,ACETOMINOPHEN,ACETAMINOPHEN CODEINE PHOSPHATE CAFFEINE,300MG 8MG 15MG,100,ORAL,Resolved,TABLET,N02AJ,OPIOIDS,2017/8/21,2017/8/21,,2020/6/5,Disruption of the manufacture of the drug.,2017/6/23,2020/6/9,No
23251,2017431,Shortage,ACETAMINOPHENE 160MGCO.CROQUABLE POUR ENFANT,LABORATOIRE RIVA INC,Acetaminophene 160mgco. Croquable pour enfant,ACETAMINOPHEN,160MG,20,ORAL,Resolved,TABLET,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,2017/9/25,2017/9/25,2017/9/29,2017/10/13,Disruption of the manufacture of the drug.,2017/9/25,2017/10/24,No
5652,386626,Shortage,ACETAMINOPHENE 500TAB,PRO DOC LIMITEE,ACETAMINOPHENE,ACETAMINOPHEN,500MG,1000,ORAL,Avoided shortage,TABLET,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,2018/9/12,,,2018/6/20,Delay in shipping of the drug.,2017/4/5,2018/9/11,No
14896,545015,Shortage,ACETAZOLAMIDE,AA PHARMA INC,ACETAZOLAMIDE,ACETAZOLAMIDE,250MG,100 Bottle,ORAL,Resolved,TABLET,S01EC,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2017/7/6,2017/7/17,2017/7/12,Disruption of the manufacture of the drug.,2017/7/7,2017/7/13,No
2482,2243098,Shortage,ACETYLCYSTEINE SOLUTION,SANDOZ CANADA INCORPORATED,ACETYLCYSTEINE,ACETYLCYSTEINE,200MG,10ML,"INHALATION
INTRAVENOUS
ORAL",Resolved,SOLUTION,R05CB,"EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.",2017/3/14,,2017/4/14,2017/4/24,Disruption of the manufacture of the drug.,2017/3/14,2017/6/26,No
2486,2243098,Shortage,ACETYLCYSTEINE SOLUTION,SANDOZ CANADA INCORPORATED,ACETYLCYSTEINE,ACETYLCYSTEINE,200MG,30ML,"INHALATION
INTRAVENOUS
ORAL",Resolved,SOLUTION,R05CB,"EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.",2017/3/14,,2017/7/28,2017/7/28,Disruption of the manufacture of the drug.,2017/3/14,2017/8/2,No
5804,2381486,Shortage,ACH-ALENDRONATE,ACCORD HEALTHCARE INC,ALENDRONATE,ALENDRONIC ACID,10MG,28 tabs in blister pack per box  |  28 comprimés en plaquette thermoformée par boîte,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017/4/1,2017/4/1,2017/4/1,2017/4/1,Disruption of the manufacture of the drug.,2017/4/6,2017/5/9,No
5806,2381486,Shortage,ACH-ALENDRONATE,ACCORD HEALTHCARE INC,ALENDRONATE,ALENDRONIC ACID,10MG,28 TABS PER BOX     |     BOÎTE DE 28 COMPRIMÉS,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017/4/1,2017/4/1,2017/10/20,2017/9/25,Disruption of the manufacture of the drug.,2017/4/6,2017/9/29,No
5817,2381494,Shortage,ACH-ALENDRONATE,ACCORD HEALTHCARE INC,ALENDRONATE,ALENDRONIC ACID,70MG,4 TABS PER BOX     |     BOÎTE DE 4 COMPRIMÉS,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017/3/1,2017/3/1,2017/7/28,2017/7/7,Disruption of the manufacture of the drug.,2017/4/6,2017/7/8,No
33986,2381486,Shortage,ACH-ALENDRONATE,ACCORD HEALTHCARE INC,ALENDRONATE,ALENDRONIC ACID,10MG,28 tabs (blister) per box  | 28 comprimés en plaquette par boîte,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/12/11,2018/2/9,2018/2/12,Disruption of the manufacture of the drug.,2017/12/20,2018/2/15,No
5820,2325985,Shortage,ACH-BICALUTAMIDE,ACCORD HEALTHCARE INC,BICALUTAMIDE,BICALUTAMIDE,50MG,100 TABS PER BOTTLE     |     BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,2017/4/1,2017/4/1,2017/7/14,2017/7/5,Disruption of the manufacture of the drug.,2017/4/6,2017/7/13,No
16461,2426757,Shortage,ACH-CAPECITABINE,ACCORD HEALTHCARE INC,CAPECITABINE,CAPECITABINE,150MG,60 Tabs Blister Pack/Box     |     60 comprimés en plaquette alvéolées /Boîte,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,2017/7/19,2017/7/19,,2017/12/8,Other (Please describe in comments),2017/7/19,2017/12/20,No
16466,2426765,Shortage,ACH-CAPECITABINE,ACCORD HEALTHCARE INC,CAPECITABINE,CAPECITABINE,500MG,120 Tabs Blister Pack / Box     |     120 comprimés en plaquettes alvéolées / Boîte,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,2017/7/19,2017/7/19,,2017/12/8,Other (Please describe in comments),2017/7/19,2017/12/20,No
22174,2426757,Shortage,ACH-CAPECITABINE,ACCORD HEALTHCARE INC,CAPECITABINE,CAPECITABINE,150MG,60 TABLETS PER BOTTLE  |  60 COMPRIMÉS PAR BOUTEILLE,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,2017/9/13,2017/9/13,2017/10/20,2017/10/16,Disruption of the manufacture of the drug.,2017/9/15,2017/10/20,No
26463,2434652,Shortage,ACH-ESCITALOPRAM,ACCORD HEALTHCARE INC,ESCITALOPRAM,ESCITALOPRAM,10MG,6 BLISTERS PACKS/BOX (60 TABS/BOX)  |  6 PLAQUETTES ALVÉOLÉES/BOÎTE (60 COMPRIMÉS/BOÎTES),ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/9/25,2017/9/25,2017/12/1,2017/12/15,Disruption of the manufacture of the drug.,2017/10/20,2017/12/20,No
26466,2434660,Shortage,ACH-ESCITALOPRAM,ACCORD HEALTHCARE INC,ESCITALOPRAM,ESCITALOPRAM,20MG,3 BLISTER PACKS/BOX (30 TABS/BOX)  | 3 PLAQUETTES ALVÉOLÉES/BOÎTE (30 COMPRIMÉS/BOÎTES),ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/9/26,2017/9/26,2017/11/17,2017/12/8,Disruption of the manufacture of the drug.,2017/10/20,2017/12/20,No
9673,2434652,Shortage,ACH-ESCITALOPRAM,ACCORD HEALTHCARE INC,ESCITALOPRAM,ESCITALOPRAM,10MG,100 TABS PER BOTTLE   |   BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/5/9,2017/5/9,2017/11/3,2017/10/16,Disruption of the manufacture of the drug.,2017/5/9,2017/10/27,No
34007,2434652,Shortage,ACH-ESCITALOPRAM,ACCORD HEALTHCARE INC,ESCITALOPRAM,ESCITALOPRAM,10MG,"10 TABS PER BLISTER PACK, 3 BLISTER PACKS PER BOX   | 10 COMPRIMÉS PAR PLAQUETTE, 3 PLAQUETTES PAR BOÎTE",ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/12/15,2017/12/15,2018/2/9,2018/2/12,Disruption of the manufacture of the drug.,2017/12/20,2018/2/15,No
9695,2355043,Shortage,ACH-FINASTERIDE,ACCORD HEALTHCARE INC,FINASTERIDE,FINASTERIDE,5MG,100 TABS PER BOTTLE     |     BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2017/5/8,2017/5/8,2017/6/16,2017/7/10,Disruption of the manufacture of the drug.,2017/5/9,2017/7/19,No
34002,2339595,Shortage,ACH-PIOGLITAZONE,ACCORD HEALTHCARE INC,PIOGLITAZONE,PIOGLITAZONE,45MG,90 tabs per bottle   |   90 comprimés par bouteille,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/12/18,2018/2/23,2018/2/12,Disruption of the manufacture of the drug.,2017/12/20,2018/2/15,No
18283,2389819,Shortage,ACH-TEMOZOLOMIDE,ACCORD HEALTHCARE INC,TEMOZOLOMIDE,TEMOZOLOMIDE,20MG,5 CAPSULES / BOTTLE     |     5 CAPSULES / BOUTEILLE,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/7/4,2017/7/4,2017/9/22,2017/9/20,Disruption of the manufacture of the drug.,2017/8/4,2017/9/22,No
19042,2230507,Shortage,ACID REDUCER,APOTEX INC,RANITIDINE,RANITIDINE,75MG,6/10 BLS,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
3348,2297477,Shortage,ACT AMLODIPINE,ACTAVIS PHARMA COMPANY,AMLODIPINE,AMLODIPINE,2.5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/3/17,2017/7/31,2017/9/1,Disruption of the manufacture of the drug.,2017/3/17,2017/9/19,No
8767,2301407,Shortage,ACT CABERGOLINE,ACTAVIS PHARMA COMPANY,CABERGOLINE,CABERGOLINE,0.5MG,8,ORAL,Actual shortage,TABLET,G02CB,OTHER GYNECOLOGICALS,,2015/1/1,,,Requirements related to complying with good manufacturing practices.,2017/5/3,2017/10/5,No
3390,2420155,Shortage,ACT CELECOXIB,ACTAVIS PHARMA COMPANY,CELECOXIB,CELECOXIB,100MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/9/30,2018/2/5,2018/2/15,Disruption of the manufacture of the drug.,2017/3/17,2018/10/11,No
9901,2370638,Shortage,ACT DILTIAZEM CD,ACTAVIS PHARMA COMPANY,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/5/4,2017/5/31,2017/8/30,Demand increase for the drug.,2017/5/10,2017/9/19,No
3362,2370522,Shortage,ACT DILTIAZEM T,ACTAVIS PHARMA COMPANY,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,360MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/6/30,2018/9/20,2018/9/30,Disruption of the manufacture of the drug.,2017/3/17,2018/10/11,No
20315,2291886,Shortage,ACT ENALAPRIL,ACTAVIS PHARMA COMPANY,ENALAPRIL,ENALAPRIL SODIUM,4MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/8/18,2017/9/15,2017/10/6,Disruption of the manufacture of the drug.,2017/8/24,2017/10/10,No
20326,2291908,Shortage,ACT ENALAPRIL,ACTAVIS PHARMA COMPANY,ENALAPRIL,ENALAPRIL SODIUM,16MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/8/20,2017/9/15,2017/10/6,Disruption of the manufacture of the drug.,2017/8/24,2017/10/10,No
9912,2423863,Shortage,ACT ESOMEPRAZOLE,ACTAVIS PHARMA COMPANY,ESOMEPRAZOLE,ESOMEPRAZOLE,40MG,30,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/8/1,2018/6/30,2018/6/30,Disruption of the manufacture of the drug.,2017/5/10,2018/7/30,No
9917,2414716,Shortage,ACT EZETIMIBE,ACTAVIS PHARMA COMPANY,EZETIMIBE,EZETIMIBE,10MG,100,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017/5/4,2017/5/30,2017/5/17,Disruption of the manufacture of the drug.,2017/5/10,2017/5/24,No
20300,2256142,Shortage,ACT GABAPENTIN,ACTAVIS PHARMA COMPANY,GABAPENTIN,GABAPENTIN,100MG,500,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/8/18,,,Disruption of the manufacture of the drug.,2017/8/24,2018/10/11,No
9922,2274191,Shortage,ACT LEVETIRACETAM,ACTAVIS PHARMA COMPANY,LEVETIRACETAM,LEVETIRACETAM,500MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/5/4,2018/9/1,2018/9/15,Disruption of the manufacture of the drug.,2017/5/10,2018/10/11,No
9939,2274205,Shortage,ACT LEVETIRACETAM,ACTAVIS PHARMA COMPANY,LEVETIRACETAM,LEVETIRACETAM,750MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/5/4,2018/9/30,2018/9/30,Disruption of the manufacture of the drug.,2017/5/10,2018/10/11,No
3357,2327589,Shortage,ACT OLANZAPINE ODT,ACTAVIS PHARMA COMPANY,OLANZAPINE ODT,OLANZAPINE,15MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017/3/17,2018/6/1,2018/6/1,Disruption of the manufacture of the drug.,2017/3/17,2018/6/15,No
10972,2327570,Shortage,ACT OLANZAPINE ODT,ACTAVIS PHARMA COMPANY,OLANZAPINE,OLANZAPINE,10MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017/5/17,2018/6/1,2018/6/1,Disruption of the manufacture of the drug.,2017/5/24,2018/6/15,No
10975,2327597,Shortage,ACT OLANZAPINE ODT,ACTAVIS PHARMA COMPANY,OLANZAPINE,OLANZAPINE,20MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017/5/17,2018/9/30,2018/9/30,Disruption of the manufacture of the drug.,2017/5/24,2018/10/11,No
3366,2394170,Shortage,ACT OXYCODONE CR,ACTAVIS PHARMA COMPANY,OXYCODONE,OXYCODONE HYDROCHLORIDE,5MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017/3/17,2017/6/30,2017/7/30,Requirements related to complying with good manufacturing practices.,2017/3/17,2017/9/19,No
3377,2394189,Shortage,ACT OXYCODONE CR,ACTAVIS PHARMA COMPANY,OXYCODONE,OXYCODONE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017/3/17,2017/6/30,2017/7/30,Requirements related to complying with good manufacturing practices.,2017/3/17,2017/9/19,No
3381,2394197,Shortage,ACT OXYCODONE CR,ACTAVIS PHARMA COMPANY,OXYCODONE,OXYCODONE HYDROCHLORIDE,20MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017/3/17,,2017/6/30,Requirements related to complying with good manufacturing practices.,2017/3/17,2017/7/1,No
3384,2394219,Shortage,ACT OXYCODONE CR,ACTAVIS PHARMA COMPANY,OXYCODONE,OXYCODONE HYDROCHLORIDE,80MG,500,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017/3/17,2017/6/30,2017/7/30,Requirements related to complying with good manufacturing practices.,2017/3/17,2017/9/19,No
10978,2394200,Shortage,ACT OXYCODONE CR,ACTAVIS PHARMA COMPANY,OXYCODONE,OXYCODONE HYDROCHLORIDE,40MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017/5/17,2017/6/30,2017/7/30,Disruption of the manufacture of the drug.,2017/5/24,2017/9/19,No
3310,2248182,Shortage,ACT PRAVASTATIN,ACTAVIS PHARMA COMPANY,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/3/17,,,Disruption of the manufacture of the drug.,2017/3/17,2018/12/20,No
3314,2248184,Shortage,ACT PRAVASTATIN,ACTAVIS PHARMA COMPANY,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/3/17,,,Disruption of the manufacture of the drug.,2017/3/17,2018/12/20,No
3394,2402955,Shortage,ACT PREGABALIN,ACTAVIS PHARMA COMPANY,PREGABALIN,PREGABALIN,150MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/3/17,2017/6/1,2017/8/1,Disruption of the manufacture of the drug.,2017/3/17,2017/9/19,No
20303,2402920,Shortage,ACT PREGABALIN,ACTAVIS PHARMA COMPANY,PREGABALIN,PREGABALIN,50MG,500,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/8/20,,,Disruption of the manufacture of the drug.,2017/8/24,2018/12/20,No
10981,2402920,Shortage,ACT PREGABALIN,ACTAVIS PHARMA COMPANY,PREGABALIN,PREGABALIN,50MG,100,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/5/17,,,Disruption of the manufacture of the drug.,2017/5/24,2017/10/10,No
10991,2295482,Shortage,ACT RAMIPRIL,ACTAVIS PHARMA COMPANY,RAMIPRIL,RAMIPRIL,1.25MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/5/17,2017/7/31,2017/8/20,Disruption of the manufacture of the drug.,2017/5/24,2017/9/19,No
3320,2248571,Shortage,ACT RANITIDINE,ACTAVIS PHARMA COMPANY,RANITIDINE,RANITIDINE,300MG,100,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/3/17,2017/6/15,2017/9/1,Disruption of the manufacture of the drug.,2017/3/17,2017/9/19,No
3330,2282607,Shortage,ACT RISPERIDONE,ACTAVIS PHARMA COMPANY,ACT  RISPERIDONE,RISPERIDONE,1MG,60,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017/3/17,2017/6/5,2017/8/1,Disruption of the manufacture of the drug.,2017/3/17,2017/9/19,No
3337,2282623,Shortage,ACT RISPERIDONE,ACTAVIS PHARMA COMPANY,RISPERIDONE,RISPERIDONE,3MG,60,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017/3/17,2017/6/7,2017/8/1,Disruption of the manufacture of the drug.,2017/3/17,2017/9/19,No
10984,2282615,Shortage,ACT RISPERIDONE,ACTAVIS PHARMA COMPANY,RISPERIDONE,RISPERIDONE,2MG,60,ORAL,Actual shortage,TABLET,N05AX,ANTIPSYCHOTICS,,2017/5/17,,,Disruption of the manufacture of the drug.,2017/5/24,2018/10/11,No
10988,2381702,Shortage,ACT RIZATRIPTAN,ACTAVIS PHARMA COMPANY,RIZATRIPTAN,RIZATRIPTAN,10MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/5/17,2017/7/18,2017/8/15,Disruption of the manufacture of the drug.,2017/5/24,2017/9/19,No
3343,2287390,Shortage,ACT SERTRALINE,ACTAVIS PHARMA COMPANY,SERTRALINE,SERTRALINE,25MG,100,ORAL,Actual shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017/3/17,,,Disruption of the manufacture of the drug.,2017/3/17,2018/12/20,No
4464,1959034,Shortage,ACT-HIB,SANOFI PASTEUR LIMITED,Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate),HAEMOPHILUS INFLUENZAE TYPE B-PRP TETANUS PROTEIN,10 μG 30 μG,"5 x 0.5 mL vials / 5 fioles de 0,5 mL",INTRAMUSCULAR,Resolved,Powder For Solution,J07AG,BACTERIAL VACCINES,2017/3/28,2017/3/28,2017/11/15,2018/1/18,Delay in shipping of the drug.,2017/3/28,2018/1/22,No
5831,2242518,Shortage,ACTONEL,ALLERGAN PHARMA CO.,ACTONEL 5MG,RISEDRONATE SODIUM,5MG,28 COUNT,ORAL,Actual shortage,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2018/8/1,,,,Other (Please describe in comments),2017/4/6,2018/12/20,No
5854,2239146,Shortage,ACTONEL,ALLERGAN PHARMA CO.,ACTONEL 30mg,RISEDRONATE SODIUM,30MG,30mg tablets,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017/1/23,2017/1/23,2017/1/23,2017/1/23,Other (Please describe in comments),2017/4/6,2017/10/4,No
1181,2352044,Shortage,ADACEL-POLIO,SANOFI PASTEUR LIMITED,"Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine",INACTIVATED POLIOMYELITIS VACCINE PERTACTIN FILAMENTOUS HAEMAGGLUTININ PERTUSSIS TOXOID FIMBRIAE TYPES 2 AND 3 INACTIVATED POLIOMYELITIS VACCINE INACTIVATED POLIOMYELITIS VACCINE TETANUS TOXOID DIPHTHERIA TOXOID,8UNIT 3MCG 5MCG 2.5MCG 5MCG 32UNIT 40UNIT 5LF 2LF,"10 x 0.5 mL syringes / 10 seringues de 0,5 mL",INTRAMUSCULAR,Resolved,SUSPENSION,J07CA,"BACTERIAL AND VIRAL VACCINES, COMBINED",2016/6/22,2016/6/22,,2018/2/1,Disruption of the manufacture of the drug.,2017/3/13,2018/2/11,No
907,326577,Shortage,ADASEPT ACNE GEL,ODAN LABORATORIES LTD,Acne Treatment Gel,TRICLOSAN SODIUM THIOSULFATE SALICYLIC ACID,0.5% 8% 2%,15 g,TOPICAL,Actual shortage,LOTION,D02,EMOLLIENTS AND PROTECTIVES,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
29048,2267659,Shortage,ADENOSINE INJECTION,FRESENIUS KABI CANADA LTD,Adenosine Injection,ADENOSINE,3MG,3mg/mL 2mL,INTRAVENOUS,Resolved,SOLUTION,C01EB,OTHER CARDIAC PREPARATIONS,,2017/11/10,2018/1/5,2017/12/21,Disruption of the manufacture of the drug.,2017/11/13,2018/2/1,No
32385,155357,Shortage,ADRENALIN CHLORIDE SOL 1:1000 AMP,ERFA CANADA 2012 INC,EPINEPHRINE,EPINEPHRINE,1MG,30 ml,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2018/12/12,2018/12/6,2019/2/15,2019/2/11,Other (Please describe in comments),2017/12/11,2019/2/12,No
17440,2240836,Shortage,ADVAIR 250 DISKUS,GLAXOSMITHKLINE INC,fluticasone propionate and salmeterol inhalation powder,SALMETEROL FLUTICASONE PROPIONATE,50MCG 250MCG,1x60 doses,INHALATION,Resolved,POWDER,R03AK,"ADRENERGICS, INHALANTS",,2017/8/8,2017/8/28,2017/8/14,Delay in shipping of the drug.,2017/7/28,2017/8/16,No
11909,2240836,Shortage,ADVAIR 250 DISKUS,GLAXOSMITHKLINE INC,Fluticasone propionate and salmeterol inhalation powder,SALMETEROL FLUTICASONE PROPIONATE,50MCG 250MCG,1x28 doses,INHALATION,Resolved,POWDER,R03AK,"ADRENERGICS, INHALANTS",,2017/5/31,2017/7/11,2017/7/6,Disruption of the manufacture of the drug.,2017/6/5,2017/7/7,No
16538,2240837,Shortage,ADVAIR 500 DISKUS,GLAXOSMITHKLINE INC,fluticasone propionate and salmeterol inhalation powder,SALMETEROL FLUTICASONE PROPIONATE,50MCG 500MCG,1x28 doses,INHALATION,Resolved,POWDER,R03AK,"ADRENERGICS, INHALANTS",,2017/7/17,2017/8/14,2017/8/3,Delay in shipping of the drug.,2017/7/20,2017/8/4,No
20982,35076,Shortage,ALCAINE,NOVARTIS PHARMACEUTICALS CANADA INC,ALCAINE 0.5 SOLN 15ML,PROXYMETACAINE HYDROCHLORIDE,0.50%,15ML,OPHTHALMIC,Resolved,DROPS,S01HA,LOCAL ANESTHETICS,,2017/8/25,2017/10/4,2017/10/10,Delay in shipping of the drug.,2017/9/5,2017/11/28,No
1416,180408,Shortage,ALDACTAZIDE 25,PFIZER CANADA INC,ALDACTAZIDE 25,HYDROCHLOROTHIAZIDE SPIRONOLACTONE,25MG 25MG,BOTTLE/BOUTEILLE (100),ORAL,Resolved,TABLET,C03EA,DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB,,2017/7/28,,2018/3/13,Other (Please describe in comments),2017/3/13,2018/3/14,No
27679,594377,Shortage,ALDACTAZIDE 50,PFIZER CANADA INC,ALDACTAZIDE,HYDROCHLOROTHIAZIDE SPIRONOLACTONE,50MG 50MG,100 TAB/BTL,ORAL,Resolved,TABLET,C03EA,DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB,,2017/11/8,,2018/3/21,Disruption of the manufacture of the drug.,2017/11/1,2018/3/23,No
21750,285455,Shortage,ALDACTONE 100 MG,PFIZER CANADA INC,ALDACTONE,SPIRONOLACTONE,100MG,100 tabs BTL,ORAL,Resolved,TABLET,C03DA,POTASSIUM-SPARING AGENTS,,2017/10/9,,2018/7/27,Demand increase for the drug.,2017/9/8,2018/7/30,No
24674,28606,Shortage,ALDACTONE 25 MG,PFIZER CANADA INC,ALDACTONE,SPIRONOLACTONE,25MG,100's,ORAL,Resolved,TABLET,C03DA,POTASSIUM-SPARING AGENTS,,2017/10/16,,2018/9/6,Demand increase for the drug.,2017/10/6,2018/9/7,No
1637,2239505,Shortage,ALDARA P,VALEANT CANADA LP/VALEANT CANADA S.E.C.,IMIQUIMOD Cream,IMIQUIMOD,5%,5.075g,Topical,Avoided shortage,Cream,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,2017/3/16,2017/2/16,2017/3/16,2017/3/15,Disruption of the manufacture of the drug.,2017/3/13,2017/3/16,No
7593,2239505,Shortage,ALDARA P,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALDARA P,IMIQUIMOD,5%,CREAM,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,,2017/4/20,2017/5/12,2017/8/24,Delay in shipping of the drug.,2017/4/21,2017/8/25,No
24052,2239505,Shortage,ALDARA P,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALDARA P,IMIQUIMOD,5%,N/A,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,2017/10/27,,2017/11/3,2018/1/1,Other (Please describe in comments),2017/10/2,2018/1/17,No
28166,2299712,Shortage,ALENDRONATE,SIVEM PHARMACEUTICALS ULC,ALENDRONATE,ALENDRONIC ACID,70MG,4,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/7/3,,2018/7/23,Other (Please describe in comments),2017/11/6,2018/7/24,No
28174,2299712,Shortage,ALENDRONATE,SIVEM PHARMACEUTICALS ULC,ALENDRONATE,ALENDRONIC ACID,70MG,100,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/7/3,,2018/7/23,Other (Please describe in comments),2017/11/6,2018/7/24,No
12091,2352966,Shortage,ALENDRONATE,SANIS HEALTH INC,ALENDRONATE TABS,ALENDRONIC ACID,70MG,4's and 100's,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017/6/12,2017/6/15,2018/5/31,2018/5/25,Disruption of the manufacture of the drug.,2017/6/6,2018/5/26,No
21985,2352966,Shortage,ALENDRONATE,SANIS HEALTH INC,ALENDRONATE TABS,ALENDRONIC ACID,70MG,"4, 100",ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017/6/12,2017/6/15,2018/5/31,2018/5/25,Disruption of the manufacture of the drug.,2017/9/13,2018/5/26,No
8996,2087286,Shortage,ALKERAN,ASPEN PHARMACARE CANADA INC.,Alkeran Injection / Melphalan,MELPHALAN BUFFER SOLUTION,50MG 10ML,1 vial,"INTRAVENOUS
INTRA-ARTERIAL",Resolved,"KIT
POWDER FOR SOLUTION
SOLUTION",L01AA,ALKYLATINGAGENTS,2017/6/1,,2017/6/19,2017/6/16,Delay in shipping of the drug.,2017/5/4,2017/6/17,No
4023,2382067,Shortage,ALLERJECT,KALEO INC,EPINEPHRINE SOLUTION FOR INJECTION USP,EPINEPHRINE,0.3MG,1 UNITS/1 CARTON,INTRAMUSCULAR,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2017/3/23,2017/3/23,,2020/5/19,Disruption of the manufacture of the drug.,2017/3/23,2020/5/29,No
4027,2382059,Shortage,ALLERJECT,KALEO INC,"EPINEPHRINE SOLUTION FOR INJECTION, USP",EPINEPHRINE,0.15MG,1 UNITS/1 CARTON,INTRAMUSCULAR,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2017/3/23,2017/3/23,2020/5/19,2020/5/19,Disruption of the manufacture of the drug.,2017/3/23,2020/5/29,No
14180,2424029,Shortage,ALMOTRIPTAN,PRO DOC LIMITEE,ALMOTRIPTAN,ALMOTRIPTAN,12.5MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018/11/23,,2018/12/21,Delay in shipping of the drug.,2017/6/28,2018/12/22,No
22982,2381710,Shortage,ALOXI,PURDUE PHARMA,Aloxi Injection,,,0.25 mg/5 mL,,Resolved,,,,2017/9/21,2017/9/21,2017/10/30,2017/10/23,Disruption of the manufacture of the drug.,2017/9/21,2017/10/24,No
21851,1908189,Shortage,ALPRAZOLAM-0.25,PRO DOC LIMITEE,ALPRAZOLAM,ALPRAZOLAM,.25MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/9/11,,2017/11/2,Delay in shipping of the drug.,2017/9/11,2017/11/3,No
6454,2320924,Shortage,ALREX,BAUSCH & LOMB INC,ALREX,LOTEPREDNOL ETABONATE,0.20%,-,OPHTHALMIC,Resolved,SUSPENSION,S01BA,ANTIINFLAMMATORY AGENTS,2017/5/31,,2017/6/7,2017/7/14,Other (Please describe in comments),2017/4/11,2017/7/15,No
19723,2283158,Shortage,ALTACE HCT,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE HCT,HYDROCHLOROTHIAZIDE RAMIPRIL,12.5MG 5MG,NA,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017/8/17,2017/10/31,2017/11/23,Other (Please describe in comments),2017/8/17,2017/11/24,No
19730,2283182,Shortage,ALTACE HCT,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE HCT,HYDROCHLOROTHIAZIDE RAMIPRIL,25.0MG 10.0MG,na,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",2017/8/16,,2017/10/31,2017/9/6,Other (Please describe in comments),2017/8/17,2017/9/7,No
19733,2283166,Shortage,ALTACE HCT,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE HCT,HYDROCHLOROTHIAZIDE RAMIPRIL,12.5MG 10.0MG,na,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017/8/16,2017/10/31,2017/11/21,Other (Please describe in comments),2017/8/17,2017/11/22,No
19736,2283131,Shortage,ALTACE HCT,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE HCT,HYDROCHLOROTHIAZIDE RAMIPRIL,12.5MG 2.5MG,na,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017/11/30,,2018/5/15,Other (Please describe in comments),2017/8/17,2018/5/16,No
11351,2283174,Shortage,ALTACE HCT,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE HCT,HYDROCHLOROTHIAZIDE RAMIPRIL,25.0MG 5.0MG,NA,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017/5/26,2017/7/15,2017/9/1,Demand increase for the drug.,2017/5/26,2017/9/2,No
26483,2283174,Shortage,ALTACE HCT,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE HCT,HYDROCHLOROTHIAZIDE RAMIPRIL,25.0MG 5.0MG,na,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017/10/20,2018/2/15,2018/3/16,Other (Please describe in comments),2017/10/20,2018/3/17,No
32249,2283166,Shortage,ALTACE HCT,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE HCT,HYDROCHLOROTHIAZIDE RAMIPRIL,12.5MG 10.0MG,na,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017/12/7,,2018/5/3,Other (Please describe in comments),2017/12/8,2018/5/11,No
22634,2285614,Shortage,ALVESCO,ASTRAZENECA CANADA INC,ciclesonide,CICLESONIDE,200MCG,120 doses,INHALATION,Avoided shortage,"AEROSOL, METERED DOSE",R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2017/10/6,,2017/10/20,2017/10/2,Disruption of the manufacture of the drug.,2017/9/19,2017/10/2,No
31479,2245272,Shortage,AMARYL,SANOFI-AVENTIS CANADA INC,Amaryl 1mg,GLIMEPIRIDE,1MG,30.s,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/11/28,2017/12/8,2017/12/15,Other (Please describe in comments),2017/12/1,2017/12/18,No
12800,2237820,Shortage,AMERGE,GLAXOSMITHKLINE INC,naratriptan hydrochloride tablets,NARATRIPTAN,1MG,2's,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/6/26,2017/8/23,2017/8/17,Demand increase for the drug.,2017/6/15,2017/8/18,No
2581,2237821,Shortage,AMERGE,GLAXOSMITHKLINE INC,Naratriptan hydrochloride tablet,NARATRIPTAN,2.5MG,6's,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/3/2,2017/5/15,2017/5/11,Disruption of the manufacture of the drug.,2017/3/14,2017/5/12,No
18730,2237821,Shortage,AMERGE,GLAXOSMITHKLINE INC,naratriptan hydrochloride tablets,NARATRIPTAN,2.5MG,6's,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/9/15,2017/11/22,2017/11/14,Shortage of an active ingredient.,2017/8/10,2017/11/16,No
30577,2237820,Shortage,AMERGE,GLAXOSMITHKLINE INC,naratriptan hydrochloride tablets,NARATRIPTAN,1MG,2's,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018/1/4,2018/5/9,2018/5/9,Demand increase for the drug.,2017/11/24,2018/5/10,No
19872,582662,Shortage,AMINOPHYLLINE INJ 25MG/ML,OMEGA LABORATORIES LTD,AMINOPHYLLINE INJ 25MG/ML,AMINOPHYLLINE,25MG,10 X 10mL vial,INTRAVENOUS,Resolved,SOLUTION,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017/6/25,2017/6/25,2018/1/31,2018/2/16,Disruption of the manufacture of the drug.,2017/8/18,2018/6/14,No
19903,582654,Shortage,AMINOPHYLLINE INJ 50MG/ML,OMEGA LABORATORIES LTD,AMINOPHYLLINE INJECTION,AMINOPHYLLINE,50MG,10ML,INTRAVENOUS,Actual shortage,SOLUTION,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017/10/31,2017/6/28,,,Disruption of the manufacture of the drug.,2017/8/19,2018/6/14,No
7647,497193,Shortage,AMINOPHYLLINE INJECTION 25MG/ML,HOSPIRA HEALTHCARE CORPORATION,AMINOPHYLLINE,AMINOPHYLLINE,25MG,25x10mL,INTRAVENOUS,Resolved,SOLUTION,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017/5/29,,2017/7/11,2017/7/11,Disruption of the manufacture of the drug.,2017/4/24,2017/7/14,No
34014,497193,Shortage,AMINOPHYLLINE INJECTION USP,PFIZER CANADA INC,Aminophylline,AMINOPHYLLINE,25MG,25x10mL,INTRAVENOUS,Resolved,SOLUTION,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2018/4/12,,2018/12/18,Disruption of the manufacture of the drug.,2017/12/20,2018/12/19,No
15451,2242325,Shortage,AMIODARONE HYDROCHLORIDE FOR INJECTION,SANDOZ CANADA INCORPORATED,AMIODARONE,AMIODARONE HYDROCHLORIDE,50MG,9ML VIAL,INTRAVENOUS,Resolved,LIQUID,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",2017/8/1,,2017/8/18,2017/8/18,Delay in shipping of the drug.,2017/7/11,2017/10/18,No
2515,2242325,Shortage,AMIODARONE HYDROCHLORIDE FOR INJECTION,SANDOZ CANADA INCORPORATED,AMIODARONE,AMIODARONE HYDROCHLORIDE,50MG,18ML,INTRAVENOUS,Resolved,LIQUID,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",2017/3/14,,2017/9/21,2017/10/16,Disruption of the manufacture of the drug.,2017/3/14,2017/10/18,No
2315,2326817,Shortage,AMLODIPINE,PRO DOC LIMITEE,AMLODIPINE,AMLODIPINE,10.0MG,500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/3/14,,2017/5/24,Delay in shipping of the drug.,2017/3/14,2017/5/29,No
2336,2326795,Shortage,AMLODIPINE,PRO DOC LIMITEE,AMLODIPINE,AMLODIPINE,2.5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/3/29,,2017/5/24,Delay in shipping of the drug.,2017/3/14,2017/5/29,No
2354,2331292,Shortage,AMLODIPINE,SANIS HEALTH INC,AMLODIPINE TABS,AMLODIPINE,10MG,250,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/2/23,2017/8/31,2017/8/11,Shortage of an active ingredient.,2017/3/14,2017/8/18,No
2367,2331284,Shortage,AMLODIPINE,SANIS HEALTH INC,AMLODIPINE TABS,AMLODIPINE,5MG,500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/2/23,2017/8/31,2017/8/18,Shortage of an active ingredient.,2017/3/14,2017/8/19,No
4693,2326809,Shortage,AMLODIPINE,PRO DOC LIMITEE,AMLODIPINE,AMLODIPINE,5.0MG,500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/3/29,,2017/6/9,Other (Please describe in comments),2017/3/29,2017/6/12,No
13144,2401509,Shortage,AMOXICILLIN CAPSULES,SIVEM PHARMACEUTICALS ULC,AMOXICILLIN,AMOXICILLIN,500MG,500,ORAL,Resolved,CAPSULE,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",2017/6/16,,2017/7/3,2017/7/16,Delay in shipping of the drug.,2017/6/16,2017/11/3,No
2473,582212,Shortage,AMSA PD INJ 50MG/ML,ERFA CANADA 2012 INC,Amsa PD INJ,Amsacrine,50 mg,Vial,Injection,Actual shortage,Liquid,L01XX,OTHER ANTINEOPLASTIC AGENTS,2014/7/21,2014/7/21,,,Requirements related to complying with good manufacturing practices.,2017/3/14,2018/3/14,No
13478,2221861,Shortage,ANANDRON,SANOFI-AVENTIS CANADA INC,Nilutamide,NILUTAMIDE,50MG,90,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,2017/6/20,2017/6/20,2017/6/26,2017/6/29,Other (Please describe in comments),2017/6/21,2017/7/6,No
22286,2245346,Shortage,ANDROGEL,BGP PHARMA ULC,ANDROGEL,TESTOSTERONE,1%,30,TOPICAL,Resolved,GEL,G03BA,ANDROGENS,,2017/11/3,,2017/11/17,Delay in shipping of the drug.,2017/9/18,2017/11/20,No
13912,2245345,Shortage,ANDROGEL,BGP PHARMA ULC,ANDROGEL,TESTOSTERONE,1%,30,TOPICAL,Resolved,GEL,G03BA,ANDROGENS,,2017/7/12,,2017/7/14,Disruption of the manufacture of the drug.,2017/6/26,2017/7/17,No
15737,2245345,Shortage,ANDROGEL,BGP PHARMA ULC,ANDROGEL,TESTOSTERONE,1%,30,TOPICAL,Resolved,GEL,G03BA,ANDROGENS,2017/8/1,2017/8/8,,2017/8/18,Disruption of the manufacture of the drug.,2017/7/14,2017/9/18,No
32424,2245346,Shortage,ANDROGEL,BGP PHARMA ULC,ANDROGEL,TESTOSTERONE,1%,"5g sachet, 30 units",TOPICAL,Resolved,GEL,G03BA,ANDROGENS,,2018/7/9,2018/7/19,2018/7/20,Delay in shipping of the drug.,2017/12/11,2018/7/21,No
28364,2245345,Shortage,ANDROGEL,BGP PHARMA ULC,ANDROGEL,TESTOSTERONE,1%,"2.5 g, 30 sachet",TOPICAL,Resolved,GEL,G03BA,ANDROGENS,2018/11/22,2018/11/30,2018/12/17,2018/12/12,Delay in shipping of the drug.,2017/11/6,2018/12/13,No
31812,544981,Shortage,APO ACETAMINOPHEN TAB 325MG,APOTEX INC,ACETAMINOPHEN,ACETAMINOPHEN,325MG,100 BTL,ORAL,Resolved,TABLET,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,,2017/12/4,2018/6/29,2018/6/29,Disruption of the manufacture of the drug.,2017/12/5,2018/7/3,No
701,545007,Shortage,APO ACETAMINOPHEN TAB 500MG,APOTEX INC,ACETAMINOPHEN,ACETAMINOPHEN,500MG,100 BLS,ORAL,Resolved,TABLET,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,2017/6/30,2017/6/23,2017/9/29,2017/10/6,Disruption of the manufacture of the drug.,2017/3/13,2017/10/10,No
19582,603279,Shortage,APO AMPI CAPSULES 250MG,APOTEX INC,AMPICILLIN,AMPICILLIN,250MG,100 BTL & 1000 BTL,ORAL,Actual shortage,CAPSULE,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/16,2017/10/5,No
19589,603295,Shortage,APO AMPI CAPSULES 500MG,APOTEX INC,AMPICILLIN,AMPICILLIN,500MG,100 BTL & 500 BTL,ORAL,Actual shortage,CAPSULE,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/16,2017/10/5,No
19578,603260,Shortage,APO AMPI LIQ 125MG/5ML,APOTEX INC,AMPICILLIN,AMPICILLIN,125MG,60/100/150 ML,ORAL,Actual shortage,LIQUID,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/16,2017/10/5,No
19586,603287,Shortage,APO AMPI LIQ 250MG/5ML,APOTEX INC,AMPICILLIN,AMPICILLIN,250MG,60/100/150 ML,ORAL,Actual shortage,LIQUID,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/16,2017/10/5,No
18948,472468,Shortage,APO ASA TAB 325MG,APOTEX INC,ASA,ACETYLSALICYLIC ACID,325MG,100 BTL & 500 BTL & 1000 BTL,ORAL,Actual shortage,TABLET,N02BA,OTHER ANALGESICS AND ANTIPYRETICS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
18766,402699,Shortage,APO CARBAMAZEPINE TAB 200MG,APOTEX INC,CARBAMAZEPINE,CARBAMAZEPINE,200MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,N03AF,ANTIEPILEPTICS,,2017/3/10,,2017/3/10,Disruption of the manufacture of the drug.,2017/8/11,2020/2/19,No
18757,360287,Shortage,APO CHLORTHALIDONE TAB 100MG,APOTEX INC,CHLORTHALIDONE,CHLORTHALIDONE,100MG,100 BTL,ORAL,Actual shortage,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/11,2017/10/5,No
14163,487872,Shortage,APO CIMETIDINE TAB 300MG,APOTEX INC,CIMETIDINE,CIMETIDINE,300MG,100 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/8/15,2017/7/17,2017/8/31,2017/8/18,Disruption of the manufacture of the drug.,2017/6/28,2017/8/21,No
93,487872,Shortage,APO CIMETIDINE TAB 300MG,APOTEX INC,CIMETIDINE,CIMETIDINE,300MG,1000 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/3/1,2017/6/9,2017/6/7,Disruption of the manufacture of the drug.,2017/3/10,2017/6/8,No
99,600059,Shortage,APO CIMETIDINE TAB 400MG,APOTEX INC,CIMETIDINE,CIMETIDINE,400MG,100 BTL & 500 BTL,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2015/1/23,,,Disruption of the manufacture of the drug.,2017/3/10,2017/10/5,No
104,600067,Shortage,APO CIMETIDINE TAB 600MG,APOTEX INC,CIMETIDINE,CIMETIDINE,600MG,100 BTL,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2016/8/23,,,Disruption of the manufacture of the drug.,2017/3/10,2018/9/8,No
18970,618292,Shortage,APO CLOXI CAP 250MG,APOTEX INC,CLOXACILLIN,CLOXACILLIN SODIUM,250MG,100 BTL & 1000 BTL,ORAL,Actual shortage,CAPSULE,J01CF,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
18967,618284,Shortage,APO CLOXI CAP 500MG,APOTEX INC,CLOXACILLIN,CLOXACILLIN SODIUM,500MG,100 BTL & 500 BTL,ORAL,Actual shortage,CAPSULE,J01CF,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
18973,644633,Shortage,APO CLOXI FOR ORAL SOLN 125MG/5ML,APOTEX INC,CLOXACILLIN,CLOXACILLIN SODIUM,125MG,100 ML/200 ML/60ML,ORAL,Actual shortage,POWDER FOR SOLUTION,J01CF,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
20866,362158,Shortage,APO DIAZEPAM TAB 5MG,APOTEX INC,DIAZEPAM,DIAZEPAM,5MG,1000 BTL,ORAL,Avoided shortage,TABLET,N05BA,ANXIOLYTICS,2017/10/31,2017/10/25,2017/11/30,2017/10/25,Disruption of the manufacture of the drug.,2017/9/5,2017/10/31,No
8587,362158,Shortage,APO DIAZEPAM TAB 5MG,APOTEX INC,DIAZEPAM,DIAZEPAM,5MG,100 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/5/1,2017/6/26,2017/6/12,Disruption of the manufacture of the drug.,2017/5/2,2017/6/13,No
15252,771376,Shortage,APO DILTIAZ TAB 30MG,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,30MG,100 BTL,ORAL,Resolved,TABLET,C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/7/10,2018/10/19,2018/9/24,Disruption of the manufacture of the drug.,2017/7/11,2018/9/28,No
11066,771384,Shortage,APO DILTIAZ TAB 60MG,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,60MG,100 BTL,ORAL,Resolved,TABLET,C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2017/7/31,2017/7/31,2018/10/19,2018/10/15,Disruption of the manufacture of the drug.,2017/5/24,2018/10/17,No
3622,363766,Shortage,APO DIMENHYDRINATE TAB 50MG,APOTEX INC,DIMENHYDRINATE,DIMENHYDRINATE,50MG,1000 BTL,ORAL,Resolved,TABLET,R06AA,ANTIHISTAMINES FOR SYSTEMIC USE,,2017/3/20,2017/4/28,2017/4/28,Disruption of the manufacture of the drug.,2017/3/20,2017/5/2,No
327,707570,Shortage,APO FUROSEMIDE TAB 80MG,APOTEX INC,FUROSEMIDE,FUROSEMIDE,80MG,100 BTL,ORAL,Resolved,TABLET,C03CA,HIGH-CEILING DIURETICS,,2017/2/27,2017/5/31,2017/5/31,Disruption of the manufacture of the drug.,2017/3/11,2017/6/5,No
17237,1913662,Shortage,APO GLYBURIDE TAB 5MG,APOTEX INC,GLYBURIDE,GLYBURIDE,5MG,100 BTL,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017/9/15,,2017/10/31,2017/10/2,Disruption of the manufacture of the drug.,2017/7/26,2017/10/5,No
18957,587702,Shortage,APO HALOPERIDOL LIQ 2MG/ML,APOTEX INC,HALOPERIDOL,HALOPERIDOL,2MG,100 ML & 500 ML & 15 ML,ORAL,Actual shortage,SOLUTION,N05AD,ANTIPSYCHOTICS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
18760,396796,Shortage,APO HALOPERIDOL TAB 0.5MG,APOTEX INC,HALOPERIDOL,HALOPERIDOL,.5MG,100 BTL & 1000 BTL,ORAL,Actual shortage,TABLET,N05AD,ANTIPSYCHOTICS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/11,2017/10/5,No
18763,396818,Shortage,APO HALOPERIDOL TAB 1MG,APOTEX INC,HALOPERIDOL,HALOPERIDOL,1MG,100 BTL & 1000 BTL,ORAL,Actual shortage,TABLET,N05AD,ANTIPSYCHOTICS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/11,2017/10/5,No
330,644552,Shortage,APO HYDRO TAB 100MG,APOTEX INC,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,100MG,100 BTL,ORAL,Resolved,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",,2014/4/17,,2019/5/6,Disruption of the manufacture of the drug.,2017/3/11,2019/11/26,No
11069,646059,Shortage,APO HYDROXYZINE CAP 10MG,APOTEX INC,HYDROXYZINE,HYDROXYZINE HYDROCHLORIDE,10MG,100 BTL,ORAL,Resolved,CAPSULE,N05BB,ANXIOLYTICS,2017/6/9,2017/6/5,2017/8/31,2017/8/9,Disruption of the manufacture of the drug.,2017/5/24,2017/8/10,No
12289,646024,Shortage,APO HYDROXYZINE CAP 25MG,APOTEX INC,HYDROXYZINE,HYDROXYZINE HYDROCHLORIDE,25MG,100 BTL,ORAL,Resolved,CAPSULE,N05BB,ANXIOLYTICS,2017/7/21,,2017/8/31,2017/9/15,Disruption of the manufacture of the drug.,2017/6/8,2017/9/22,No
5900,646024,Shortage,APO HYDROXYZINE CAP 25MG,APOTEX INC,HYDROXYZINE,HYDROXYZINE HYDROCHLORIDE,25MG,100 BTL,ORAL,Resolved,CAPSULE,N05BB,ANXIOLYTICS,2017/4/21,,2017/6/7,2017/6/2,Disruption of the manufacture of the drug.,2017/4/7,2017/6/5,No
11072,646016,Shortage,APO HYDROXYZINE CAP 50MG,APOTEX INC,HYDROXYZINE,HYDROXYZINE HYDROCHLORIDE,50MG,100 BTL,ORAL,Resolved,CAPSULE,N05BB,ANXIOLYTICS,2017/6/26,2017/6/12,2017/8/31,2017/9/15,Disruption of the manufacture of the drug.,2017/5/24,2017/9/22,No
18961,611158,Shortage,APO INDOMETHACIN CAP 25MG,APOTEX INC,INDOMETHACIN,INDOMETHACIN,25MG,100 BTL & 1000 BTL,ORAL,Actual shortage,CAPSULE,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
18964,611166,Shortage,APO INDOMETHACIN CAP 50MG,APOTEX INC,INDOMETHACIN,INDOMETHACIN,50MG,100 BTL & 500 BTL,ORAL,Actual shortage,CAPSULE,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
18916,441708,Shortage,APO METHAZIDE 15,APOTEX INC,METHAZIDE,HYDROCHLOROTHIAZIDE METHYLDOPA,15MG 250MG,100 BTL,ORAL,Actual shortage,TABLET,C02LB,ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/11,2017/10/5,No
18936,441716,Shortage,APO METHAZIDE 25,APOTEX INC,METHAZIDE,HYDROCHLOROTHIAZIDE METHYLDOPA,25MG 250MG,100 BTL,ORAL,Actual shortage,TABLET,C02LB,ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
16879,592277,Shortage,APO NAPROXEN TAB 500MG,APOTEX INC,NAPROXEN,NAPROXEN,500MG,500 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/7/24,2017/8/11,2017/8/11,Disruption of the manufacture of the drug.,2017/7/25,2017/9/22,No
16881,592277,Shortage,APO NAPROXEN TAB 500MG,APOTEX INC,NAPROXEN,NAPROXEN,500MG,500 BTL,ORAL,Avoided shortage,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/12/18,,,2017/11/8,Disruption of the manufacture of the drug.,2017/7/25,2017/11/9,No
18939,441724,Shortage,APO OXTRIPHYLLINE TAB 100MG,APOTEX INC,OXTRIPHYLLINE,OXTRIPHYLLINE,100MG,100 BTL,ORAL,Actual shortage,TABLET,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
18942,441732,Shortage,APO OXTRIPHYLLINE TAB 200MG,APOTEX INC,OXTRIPHYLLINE,OXTRIPHYLLINE,200MG,100 BTL & 500 BTL,ORAL,Actual shortage,TABLET,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
18954,511692,Shortage,APO OXTRIPHYLLINE TAB 300MG,APOTEX INC,OXTRIPHYLLINE,OXTRIPHYLLINE,300MG,100 BTL,ORAL,Actual shortage,TABLET,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
429,642223,Shortage,APO PEN VK,APOTEX INC,PENICILLIN,PENICILLIN V POTASSIUM,200000UNIT,100 ML,ORAL,Resolved,POWDER FOR SOLUTION,J01CE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2014/8/5,,2019/3/8,Disruption of the manufacture of the drug.,2017/3/11,2019/3/9,No
432,642231,Shortage,APO PEN VK,APOTEX INC,PENICILLIN,PENICILLIN V POTASSIUM,480000UNIT,100 ML,ORAL,Resolved,POWDER FOR SOLUTION,J01CE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2014/10/9,,2019/3/4,Disruption of the manufacture of the drug.,2017/3/11,2019/3/8,No
12692,550957,Shortage,APO PREDNISONE TAB 50MG,APOTEX INC,PREDNISONE,PREDNISONE,50MG,100 BTL,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017/6/12,2017/7/14,2017/7/28,Disruption of the manufacture of the drug.,2017/6/13,2017/7/31,No
26629,312770,Shortage,APO PREDNISONE TAB 5MG,APOTEX INC,PREDNISONE,PREDNISONE,5MG,100 BTL,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017/10/23,2017/11/30,2017/11/17,Disruption of the manufacture of the drug.,2017/10/23,2017/11/20,No
7234,312770,Shortage,APO PREDNISONE TAB 5MG,APOTEX INC,PREDNISONE,PREDNISONE,5MG,100 BTL,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017/4/19,2017/4/28,2017/4/28,Disruption of the manufacture of the drug.,2017/4/19,2017/5/1,No
14003,312770,Shortage,APO PREDNISONE TAB 5MG,APOTEX INC,PREDNISONE,PREDNISONE,5MG,100 BTL,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017/6/26,2017/8/8,2017/7/27,Disruption of the manufacture of the drug.,2017/6/27,2017/7/28,No
18913,402788,Shortage,APO PROPRANOLOL TAB 10MG,APOTEX INC,PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,10MG,100 BTL & 1000 BTL,ORAL,Actual shortage,TABLET,C07AA,BETA BLOCKING AGENTS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/11,2017/10/5,No
18951,504335,Shortage,APO PROPRANOLOL TAB 120MG,APOTEX INC,PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,120MG,100 BTL,ORAL,Actual shortage,TABLET,C07AA,BETA BLOCKING AGENTS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
18769,402753,Shortage,APO PROPRANOLOL TAB 40MG,APOTEX INC,PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,40MG,100 BTL & 1000 BTL,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2017/3/10,,2018/9/28,Disruption of the manufacture of the drug.,2017/8/11,2020/2/13,No
18910,402761,Shortage,APO PROPRANOLOL TAB 80MG,APOTEX INC,PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,80MG,100 BTL & 1000 BTL,ORAL,Actual shortage,TABLET,C07AA,BETA BLOCKING AGENTS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/11,2017/10/5,No
30971,445282,Shortage,APO SULFATRIM DS TAB,APOTEX INC,SULFATRIM,SULFAMETHOXAZOLE TRIMETHOPRIM,800MG 160MG,100 BTL,ORAL,Resolved,TABLET,J01EE,SULFONAMIDES AND TRIMETHOPRIM,,2018/1/1,2018/1/8,2018/1/8,Disruption of the manufacture of the drug.,2017/11/28,2018/1/10,No
27741,445274,Shortage,APO SULFATRIM TAB,APOTEX INC,SULFATRIM,SULFAMETHOXAZOLE TRIMETHOPRIM,400MG 80MG,100 BTL,ORAL,Resolved,TABLET,J01EE,SULFONAMIDES AND TRIMETHOPRIM,2018/1/31,2018/1/15,2018/4/2,2018/3/14,Disruption of the manufacture of the drug.,2017/11/1,2018/3/15,No
27770,441775,Shortage,APO TRIAZIDE,APOTEX INC,TRIAZIDE,TRIAMTERENE HYDROCHLOROTHIAZIDE,50MG 25MG,100 BTL & 1000 BTL,ORAL,Resolved,TABLET,C03EA,DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB,,2017/10/30,2018/3/2,2018/2/16,Disruption of the manufacture of the drug.,2017/11/1,2018/2/17,No
10439,441775,Shortage,APO TRIAZIDE,APOTEX INC,TRIAZIDE,TRIAMTERENE HYDROCHLOROTHIAZIDE,50MG 25MG,100 BTL & 1000 BTL,ORAL,Resolved,TABLET,C03EA,DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB,,2017/5/15,2017/8/4,2017/7/19,Disruption of the manufacture of the drug.,2017/5/16,2017/7/20,No
8,2396769,Shortage,APO-ABACAVIR,APOTEX INC,Abacavir,ABACAVIR,300MG,60 BTL,ORAL,Resolved,TABLET,J05AF,DIRECT ACTING ANTIVIRALS,,2017/1/31,2017/5/15,2017/4/27,Disruption of the manufacture of the drug.,2017/3/10,2017/4/28,No
14,2416255,Shortage,APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE,APOTEX INC,Abacavir-Lamivudine-Zidovudine,ZIDOVUDINE ABACAVIR LAMIVUDINE,300MG 300MG 150MG,60 BTL,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2017/2/27,2017/5/31,2017/5/19,Disruption of the manufacture of the drug.,2017/3/10,2017/5/23,No
20846,2147602,Shortage,APO-ACEBUTOLOL,APOTEX INC,ACEBUTOLOL,ACEBUTOLOL,100MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/10/6,2017/9/22,2018/11/30,2018/11/7,Disruption of the manufacture of the drug.,2017/9/4,2018/11/9,No
20849,2147610,Shortage,APO-ACEBUTOLOL,APOTEX INC,ACEBUTOLOL,ACEBUTOLOL,200MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/9/22,2018/11/30,2018/11/8,Disruption of the manufacture of the drug.,2017/9/4,2018/11/9,No
20854,2147629,Shortage,APO-ACEBUTOLOL,APOTEX INC,ACEBUTOLOL,ACEBUTOLOL,400MG,100 BTL,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/9/29,2017/9/22,2018/11/30,2018/11/7,Disruption of the manufacture of the drug.,2017/9/5,2018/11/9,No
17198,2207656,Shortage,APO-ACYCLOVIR,APOTEX INC,ACYCLOVIR,ACYCLOVIR,800MG,100 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017/8/31,2017/8/7,2018/1/5,2017/12/29,Disruption of the manufacture of the drug.,2017/7/26,2017/12/31,No
630,2207621,Shortage,APO-ACYCLOVIR - TAB 200MG,APOTEX INC,ACYCLOVIR,ACYCLOVIR,200MG,100 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017/4/9,2017/3/20,2017/5/1,2017/4/20,Disruption of the manufacture of the drug.,2017/3/12,2017/4/21,No
20857,2207621,Shortage,APO-ACYCLOVIR - TAB 200MG,APOTEX INC,ACYCLOVIR,ACYCLOVIR,200MG,100 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017/10/31,2017/10/2,2018/1/5,2017/12/29,Disruption of the manufacture of the drug.,2017/9/5,2017/12/31,No
18,2207648,Shortage,APO-ACYCLOVIR - TAB 400MG,APOTEX INC,ACYCLOVIR,ACYCLOVIR,400MG,100 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/9/4,2018/2/19,2018/1/30,Disruption of the manufacture of the drug.,2017/3/10,2018/1/31,No
21,2207656,Shortage,APO-ACYCLOVIR - TAB 800MG,APOTEX INC,ACYCLOVIR,ACYCLOVIR,800MG,100 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/2/27,2017/5/1,2017/4/20,Disruption of the manufacture of the drug.,2017/3/10,2017/4/21,No
18512,2248730,Shortage,APO-ALENDRONATE,APOTEX INC,ALENDRONATE,ALENDRONIC ACID,70MG,4 BLS,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/8/4,2017/12/29,2017/12/29,Disruption of the manufacture of the drug.,2017/8/8,2017/12/31,No
25204,2248727,Shortage,APO-ALENDRONATE,APOTEX INC,ALENDRONATE,ALENDRONIC ACID,5MG,30 BLS,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/10/9,2018/3/30,2018/3/26,Disruption of the manufacture of the drug.,2017/10/11,2018/3/27,No
633,2248730,Shortage,APO-ALENDRONATE,APOTEX INC,ALENDRONATE,ALENDRONIC ACID,70MG,100 BTL,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017/4/29,2017/3/28,2017/6/6,2017/6/4,Disruption of the manufacture of the drug.,2017/3/12,2017/6/5,No
9849,2248730,Shortage,APO-ALENDRONATE,APOTEX INC,ALENDRONATE,ALENDRONIC ACID,70MG,4 BLS,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/5/8,2017/7/20,2017/7/18,Disruption of the manufacture of the drug.,2017/5/10,2017/7/19,No
13300,2248730,Shortage,APO-ALENDRONATE,APOTEX INC,ALENDRONATE,ALENDRONIC ACID,70MG,100 BTL,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/6/19,2017/9/20,2017/9/1,Disruption of the manufacture of the drug.,2017/6/19,2017/9/3,No
30793,2454475,Shortage,APO-ALENDRONATE/VITAMIN D3,APOTEX INC,ALENDRONATE,ALENDRONIC ACID VITAMIN D3,70MG 5600UNIT,4 BLS,ORAL,Resolved,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/11/27,2018/6/29,2018/6/29,Disruption of the manufacture of the drug.,2017/11/27,2018/7/3,No
15962,2454467,Shortage,APO-ALENDRONATE/VITAMIN D3,APOTEX INC,ALENDRONATE,ALENDRONIC ACID VITAMIN D3,70MG 2800UNIT,4 BLS,ORAL,Resolved,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/11/13,2018/5/31,2018/4/5,Disruption of the manufacture of the drug.,2017/7/17,2018/4/6,No
28534,2315866,Shortage,APO-ALFUZOSIN,APOTEX INC,ALFUZOSIN,ALFUZOSIN HYDROCHLORIDE,10MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/11/6,2018/1/31,2018/1/17,Disruption of the manufacture of the drug.,2017/11/7,2018/1/18,No
24,2405806,Shortage,APO-ALMOTRIPTAN,APOTEX INC,ALMOTRIPTAN,ALMOTRIPTAN,12.5MG,6 BLS,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2014/10/1,,2019/5/13,Disruption of the manufacture of the drug.,2017/3/10,2019/5/14,No
27,2405792,Shortage,APO-ALMOTRIPTAN,APOTEX INC,ALMOTRIPTAN,ALMOTRIPTAN,6.25MG,6 BLS,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2014/10/1,,2019/5/13,Disruption of the manufacture of the drug.,2017/3/10,2019/5/14,No
12241,2243612,Shortage,APO-ALPRAZ TS,APOTEX INC,ALPRAZOLAM,ALPRAZOLAM,2MG,100 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,2017/7/17,2017/6/19,2017/10/25,2017/10/20,Disruption of the manufacture of the drug.,2017/6/7,2017/10/24,No
11956,784400,Shortage,APO-AMILZIDE TAB,APOTEX INC,AMILZIDE,HYDROCHLOROTHIAZIDE AMILORIDE HYDROCHLORIDE,50MG 5MG,100 BTL,ORAL,Resolved,TABLET,C03EA,DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB,,2017/6/5,2017/8/31,2017/6/12,Disruption of the manufacture of the drug.,2017/6/6,2017/6/14,No
26557,784400,Shortage,APO-AMILZIDE TAB,APOTEX INC,AMILZIDE,HYDROCHLOROTHIAZIDE AMILORIDE HYDROCHLORIDE,50MG 5MG,100 BTL & 1000 BTL,ORAL,Resolved,TABLET,C03EA,DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB,,2017/10/23,2018/8/10,2018/7/10,Disruption of the manufacture of the drug.,2017/10/23,2018/7/11,No
23533,2273373,Shortage,APO-AMLODIPINE,APOTEX INC,AMLODIPINE,AMLODIPINE,5.0MG,500 BTL,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/9/25,2017/10/31,2017/9/29,Disruption of the manufacture of the drug.,2017/9/26,2017/10/3,No
32511,2273381,Shortage,APO-AMLODIPINE,APOTEX INC,AMLODIPINE,AMLODIPINE,10.0MG,500 BTL,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/12/11,2018/2/14,2018/1/23,Disruption of the manufacture of the drug.,2017/12/12,2018/1/24,No
19213,2411296,Shortage,APO-AMLODIPINE-ATORVASTATIN,APOTEX INC,AMLODIPINE - ATORVASTATIN,AMLODIPINE ATORVASTATIN,5MG 80MG,100 BTL,ORAL,Resolved,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",,2017/8/14,2017/10/23,2017/10/23,Disruption of the manufacture of the drug.,2017/8/14,2017/10/24,No
33,2411288,Shortage,APO-AMLODIPINE-ATORVASTATIN,APOTEX INC,AMLODIPINE - ATORVASTATIN,AMLODIPINE ATORVASTATIN,5MG 40MG,100 BTL,ORAL,Resolved,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",,2017/2/14,2017/3/15,2017/3/16,Disruption of the manufacture of the drug.,2017/3/10,2017/4/4,No
15420,2411261,Shortage,APO-AMLODIPINE-ATORVASTATIN,APOTEX INC,AMLODIPINE - ATORVASTATIN,AMLODIPINE ATORVASTATIN,5MG 20MG,100 BTL,ORAL,Resolved,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",,2017/7/10,2017/8/25,2017/8/4,Disruption of the manufacture of the drug.,2017/7/11,2017/8/8,No
12278,2411318,Shortage,APO-AMLODIPINE-ATORVASTATIN,APOTEX INC,AMLODIPINE - ATORVASTATIN,AMLODIPINE ATORVASTATIN,10MG 10MG,100 BTL,ORAL,Resolved,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",2017/6/23,2017/6/12,2017/8/31,2017/8/7,Disruption of the manufacture of the drug.,2017/6/8,2017/8/8,No
41,2288559,Shortage,APO-AMOXI CLAV,APOTEX INC,AMOXI CLAV,AMOXICILLIN CLAVULANIC ACID,400MG 57MG,70 ml,ORAL,Resolved,POWDER FOR SUSPENSION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2014/10/9,,2019/5/17,Other (Please describe in comments),2017/3/10,2019/5/18,No
44,2243986,Shortage,APO-AMOXI CLAV 125MG/31.25MG PER 5ML,APOTEX INC,AMOXI CLAV,AMOXICILLIN CLAVULANIC ACID,125MG 31.25MG,100 ml,ORAL,Resolved,POWDER FOR SUSPENSION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2014/10/9,,2018/9/8,Disruption of the manufacture of the drug.,2017/3/10,2018/9/9,No
49,2243987,Shortage,APO-AMOXI CLAV 250MG/62.5MG PER 5ML,APOTEX INC,AMOXI CLAV,AMOXICILLIN CLAVULANIC ACID,250MG 62.5MG,100 ml,ORAL,Resolved,POWDER FOR SUSPENSION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2014/10/9,,2019/5/6,Disruption of the manufacture of the drug.,2017/3/10,2019/5/13,No
636,2245623,Shortage,APO-AMOXI CLAV 875/125,APOTEX INC,AMOXICILLIN,AMOXICILLIN CLAVULANIC ACID,875MG 125MG,100 BTL,ORAL,Resolved,TABLET,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",2017/3/20,2017/3/20,2017/4/24,2017/4/24,Disruption of the manufacture of the drug.,2017/3/12,2017/4/25,No
11959,2245623,Shortage,APO-AMOXI CLAV 875/125,APOTEX INC,AMOXICILLIN,AMOXICILLIN CLAVULANIC ACID,875MG 125MG,100 BTL,ORAL,Resolved,TABLET,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017/7/31,2017/9/8,2017/9/4,Disruption of the manufacture of the drug.,2017/6/6,2017/9/5,No
13967,628131,Shortage,APO-AMOXI PWR FOR SUSP 125MG/5ML,APOTEX INC,AMOXICILLIN,AMOXICILLIN,125MG,100 ML  &   150 ML,ORAL,Resolved,POWDER FOR SUSPENSION,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017/6/23,,2018/9/8,Disruption of the manufacture of the drug.,2017/6/26,2018/9/9,No
29028,628158,Shortage,APO-AMOXI PWR FOR SUSP 250MG/5ML,APOTEX INC,AMOXICILLIN,AMOXICILLIN,250MG,100 ML & 500 ML,ORAL,Resolved,POWDER FOR SUSPENSION,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017/11/13,2018/2/12,2018/1/30,Disruption of the manufacture of the drug.,2017/11/13,2018/1/31,No
5888,2374420,Shortage,APO-ANASTROZOLE,APOTEX INC,ANASTROZOLE,ANASTROZOLE,1MG,30 BLS,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017/10/2,2017/12/29,2017/12/10,Disruption of the manufacture of the drug.,2017/4/7,2017/12/11,No
55,2374420,Shortage,APO-ANASTROZOLE,APOTEX INC,ANASTROZOLE,ANASTROZOLE,1MG,30 BLS,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017/3/10,2017/3/15,2017/3/13,Disruption of the manufacture of the drug.,2017/3/10,2017/4/4,No
12668,773697,Shortage,APO-ATENOL TAB 100MG,APOTEX INC,ATENOLOL,ATENOLOL,100MG,30 BLS,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/6/12,2017/7/14,2017/7/14,Disruption of the manufacture of the drug.,2017/6/13,2017/7/17,No
23536,773697,Shortage,APO-ATENOL TAB 100MG,APOTEX INC,ATENOLOL,ATENOLOL,100MG,30 BLS,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/9/22,2017/11/10,2017/11/6,Disruption of the manufacture of the drug.,2017/9/26,2017/11/7,No
33783,773697,Shortage,APO-ATENOL TAB 100MG,APOTEX INC,ATENOLOL,ATENOLOL,100MG,30 BLS,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/12/18,2018/7/6,2018/6/29,Disruption of the manufacture of the drug.,2017/12/19,2018/7/3,No
17202,773689,Shortage,APO-ATENOL TAB 50MG,APOTEX INC,ATENOLOL,ATENOLOL,50MG,30 BLS,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/8/7,2017/8/18,2017/11/15,2017/11/6,Disruption of the manufacture of the drug.,2017/7/26,2017/11/7,No
17205,773689,Shortage,APO-ATENOL TAB 50MG,APOTEX INC,ATENOLOL,ATENOLOL,50MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/8/31,2017/8/14,2017/10/31,2017/10/20,Disruption of the manufacture of the drug.,2017/7/26,2017/10/24,No
13970,773689,Shortage,APO-ATENOL TAB 50MG,APOTEX INC,ATENOLOL,ATENOLOL,50MG,30 BLS,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/6/26,2017/7/21,2017/7/14,Disruption of the manufacture of the drug.,2017/6/26,2017/7/17,No
33780,773689,Shortage,APO-ATENOL TAB 50MG,APOTEX INC,ATENOLOL,ATENOLOL,50MG,30 BLS,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/12/18,2018/7/6,2018/7/3,Disruption of the manufacture of the drug.,2017/12/19,2018/7/4,No
61,2318059,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOMOXETINE HCL,ATOMOXETINE,40MG,30 BLS,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/2/14,2017/7/24,2017/7/19,Disruption of the manufacture of the drug.,2017/3/10,2017/7/20,No
64,2318067,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOMOXETINE HCL,ATOMOXETINE,60MG,30 BLS,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2016/11/8,2017/7/24,2017/7/19,Disruption of the manufacture of the drug.,2017/3/10,2017/7/20,No
30796,2318059,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOMOXETINE,ATOMOXETINE,40MG,100 BTL,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/11/27,2018/6/6,2018/5/23,Disruption of the manufacture of the drug.,2017/11/27,2018/5/24,No
3160,2318032,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOMOXETINE,ATOMOXETINE,18MG,30 BLS,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2017/5/31,2017/6/5,2017/7/24,2017/7/14,Disruption of the manufacture of the drug.,2017/3/17,2017/7/17,No
5891,2295318,Shortage,APO-ATORVASTATIN,APOTEX INC,ATORVASTATIN,ATORVASTATIN,80MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/4/24,2017/4/24,2017/7/10,2017/6/26,Disruption of the manufacture of the drug.,2017/4/7,2017/6/27,No
709,2295261,Shortage,APO-ATORVASTATIN,APOTEX INC,ATORVASTATIN,ATORVASTATIN,10MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/3/10,2017/3/24,2017/3/22,Disruption of the manufacture of the drug.,2017/3/13,2017/4/4,No
712,2295318,Shortage,APO-ATORVASTATIN,APOTEX INC,ATORVASTATIN,ATORVASTATIN,80MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/3/10,2017/3/31,2017/4/3,Disruption of the manufacture of the drug.,2017/3/13,2017/4/4,No
16861,2295261,Shortage,APO-ATORVASTATIN,APOTEX INC,ATORVASTATIN,ATORVASTATIN,10MG,500 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/7/24,2017/8/31,2017/9/11,Disruption of the manufacture of the drug.,2017/7/25,2017/9/22,No
13305,2295288,Shortage,APO-ATORVASTATIN,APOTEX INC,ATORVASTATIN,ATORVASTATIN,20MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/6/19,2017/8/15,2017/8/4,Disruption of the manufacture of the drug.,2017/6/19,2017/8/8,No
19126,2247423,Shortage,APO-AZITHROMYCIN,APOTEX INC,AZITHROMYCIN,AZITHROMYCIN,250MG,100 BTL & 6 BLS,ORAL,Actual shortage,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
3083,2415542,Shortage,APO-AZITHROMYCIN Z,APOTEX INC,AZITHROMYCIN,AZITHROMYCIN,250MG,6 BLS,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/7/31,2017/9/29,2017/9/29,Disruption of the manufacture of the drug.,2017/3/16,2017/10/3,No
30799,2415542,Shortage,APO-AZITHROMYCIN Z,APOTEX INC,AZITHROMYCIN,AZITHROMYCIN,250MG,6 BLS,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/11/27,2018/4/24,2018/4/16,Disruption of the manufacture of the drug.,2017/11/27,2018/4/17,No
24328,2139332,Shortage,APO-BACLOFEN TABLETS - 10MG,APOTEX INC,BACLOFEN,BACLOFEN,10MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2017/10/2,2017/12/29,2017/12/6,Disruption of the manufacture of the drug.,2017/10/4,2017/12/7,No
14154,2139332,Shortage,APO-BACLOFEN TABLETS - 10MG,APOTEX INC,BACLOFEN,BACLOFEN,10MG,500 BTL,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",2017/8/4,2017/7/24,2017/8/16,2017/8/16,Disruption of the manufacture of the drug.,2017/6/28,2017/8/17,No
19087,2239044,Shortage,APO-BENZYDAMINE ORAL RINSE,APOTEX INC,BENZYDAMINE,BENZYDAMINE HYDROCHLORIDE,0.15%,100/250 ML,BUCCAL,Actual shortage,LIQUID,A01AD,STOMATOLOGICAL PREPARATIONS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
67,2296063,Shortage,APO-BICALUTAMIDE,APOTEX INC,BICALUTAMIDE30,BICALUTAMIDE,50MG,30 BLS,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017/1/11,2017/4/5,2017/3/31,Disruption of the manufacture of the drug.,2017/3/10,2017/4/3,No
20860,2296063,Shortage,APO-BICALUTAMIDE,APOTEX INC,BICLUTAMIDE,BICALUTAMIDE,50MG,30 BLS,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,2017/10/20,2017/9/22,2018/9/14,2018/8/22,Disruption of the manufacture of the drug.,2017/9/5,2018/8/23,No
18985,754595,Shortage,APO-BISACODYL SUP 10MG,APOTEX INC,BISACODYL,BISACODYL,10MG,100 BLS/6 BLS,RECTAL,Actual shortage,SUPPOSITORY,A06AB,DRUGS FOR CONSTIPATION,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
26154,2256177,Shortage,APO-BISOPROLOL,APOTEX INC,BISOPROLOL,BISOPROLOL FUMARATE,10MG,100 BTL,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/10/16,2017/12/14,2017/11/30,Disruption of the manufacture of the drug.,2017/10/17,2017/12/4,No
17208,2256134,Shortage,APO-BISOPROLOL,APOTEX INC,BISOPROLOL,BISOPROLOL FUMARATE,5MG,100 BTL,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/9/18,2017/9/22,2017/12/15,2017/12/13,Disruption of the manufacture of the drug.,2017/7/26,2017/12/14,No
11056,2211076,Shortage,APO-BUSPIRONE - TAB 10MG,APOTEX INC,BUPIRONE,BUSPIRONE HYDROCHLORIDE,10MG,100 BTL,ORAL,Resolved,TABLET,N05BE,ANXIOLYTICS,2017/6/12,2017/5/29,2017/6/30,2017/6/26,Disruption of the manufacture of the drug.,2017/5/24,2017/6/27,No
26564,2211076,Shortage,APO-BUSPIRONE - TAB 10MG,APOTEX INC,BUSPIRONE,BUSPIRONE HYDROCHLORIDE,10MG,100 BTL,ORAL,Resolved,TABLET,N05BE,ANXIOLYTICS,,2017/10/23,2018/1/5,2017/11/17,Disruption of the manufacture of the drug.,2017/10/23,2017/11/20,No
18517,2365340,Shortage,APO-CANDESARTAN,APOTEX INC,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,100 BTL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/8/7,2020/2/28,2020/2/21,Disruption of the manufacture of the drug.,2017/8/8,2020/2/25,No
18520,2365359,Shortage,APO-CANDESARTAN,APOTEX INC,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,100 BTL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/8/4,2020/2/28,2020/2/21,Disruption of the manufacture of the drug.,2017/8/8,2020/2/25,No
639,2365367,Shortage,APO-CANDESARTAN,APOTEX INC,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,500 BTL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017/3/26,2017/3/14,2017/6/19,2017/6/22,Disruption of the manufacture of the drug.,2017/3/12,2017/6/27,No
3516,2399105,Shortage,APO-CANDESARTAN,APOTEX INC,CANDESARTAN,CANDESARTAN CILEXETIL,32MG,100 BTL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/3/20,2020/2/28,2020/2/21,Disruption of the manufacture of the drug.,2017/3/20,2020/2/25,No
706,2365340,Shortage,APO-CANDESARTAN,APOTEX INC,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,30 BLS,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/3/10,,2018/9/8,Disruption of the manufacture of the drug.,2017/3/13,2018/9/9,No
32772,2395134,Shortage,APO-CANDESARTAN/HCTZ,APOTEX INC,CANDESARTAN + HCTZ,HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL,25MG 32MG,100 BTL,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/12/11,,2018/2/23,Disruption of the manufacture of the drug.,2017/12/14,2018/2/26,No
28539,2395126,Shortage,APO-CANDESARTAN/HCTZ,APOTEX INC,CANDESARTAN + HCTZ,HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL,12.5MG 32MG,100 BTL,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/11/6,,2018/2/23,Disruption of the manufacture of the drug.,2017/11/7,2018/2/26,No
21199,2367866,Shortage,APO-CANDESARTAN/HCTZ,APOTEX INC,CANDESARTAN + HCTZ,HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL,12.5MG 16.0MG,100 BTL & 30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/9/4,,2018/2/23,Disruption of the manufacture of the drug.,2017/9/7,2018/2/26,No
30992,2247935,Shortage,APO-CARVEDILOL,APOTEX INC,CARVEDILOL,CARVEDILOL,12.5MG,100 BTL,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,2017/12/15,2017/12/12,2018/6/29,2018/5/26,Disruption of the manufacture of the drug.,2017/11/29,2018/5/27,No
30802,2247936,Shortage,APO-CARVEDILOL,APOTEX INC,CARVEDILOL,CARVEDILOL,25MG,100 BTL,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2017/11/27,2018/7/31,2018/5/26,Delay in shipping of the drug.,2017/11/27,2018/5/27,No
29031,2247934,Shortage,APO-CARVEDILOL,APOTEX INC,CARVEDILOL,CARVEDILOL,6.25MG,100 BTL,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2017/11/13,2018/6/29,2018/5/26,Disruption of the manufacture of the drug.,2017/11/13,2018/5/27,No
19036,2230263,Shortage,APO-CEFACLOR,APOTEX INC,CEFACLOR,CEFACLOR,250MG,100 BTL & 500 BTL,ORAL,Actual shortage,CAPSULE,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
19039,2230264,Shortage,APO-CEFACLOR,APOTEX INC,CEFACLOR,CEFACLOR,500MG,100 BTL,ORAL,Actual shortage,CAPSULE,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
19066,2237500,Shortage,APO-CEFACLOR,APOTEX INC,CEFACLOR,CEFACLOR,125MG,100/150 ML,ORAL,Actual shortage,POWDER,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
19069,2237501,Shortage,APO-CEFACLOR,APOTEX INC,CEFACLOR,CEFACLOR,250MG,100/150 ML,ORAL,Actual shortage,POWDER,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
19072,2237502,Shortage,APO-CEFACLOR,APOTEX INC,CEFACLOR,CEFACLOR,375MG,100/70 ML,ORAL,Actual shortage,POWDER,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
7102,2240774,Shortage,APO-CEFADROXIL,APOTEX INC,CEFADROXIL,CEFADROXIL,500MG,100 BTL,ORAL,Resolved,CAPSULE,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/4/14,2017/5/2,2017/4/24,Disruption of the manufacture of the drug.,2017/4/17,2017/4/25,No
71,2292998,Shortage,APO-CEFPROZIL,APOTEX INC,CEFPROZIL,CEFPROZIL,250MG,100 BTL,ORAL,Resolved,TABLET,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2016/3/31,,2017/9/29,Disruption of the manufacture of the drug.,2017/3/10,2017/10/3,No
74,2293005,Shortage,APO-CEFPROZIL,APOTEX INC,CEFPROZIL,CEFPROZIL,500MG,100 BTL,ORAL,Resolved,TABLET,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2016/3/31,,2017/9/29,Disruption of the manufacture of the drug.,2017/3/10,2017/10/3,No
3163,2244394,Shortage,APO-CEFUROXIME,APOTEX INC,CEFUROXIME,CEFUROXIME,500MG,100 BTL,ORAL,Resolved,TABLET,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,2017/3/31,2017/3/27,2017/6/15,2017/6/9,Disruption of the manufacture of the drug.,2017/3/17,2017/6/12,No
9951,2418932,Shortage,APO-CELECOXIB,APOTEX INC,CELECOXIB,CELECOXIB,100MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/10/2,2017/12/4,2017/11/17,Disruption of the manufacture of the drug.,2017/5/10,2017/11/20,No
23546,2418940,Shortage,APO-CELECOXIB,APOTEX INC,CELECOXIB,CELECOXIB,200MG,100 BTL,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/9/22,2018/2/28,2018/2/23,Disruption of the manufacture of the drug.,2017/9/26,2018/2/26,No
19090,2240910,Shortage,APO-CETIRIZINE,APOTEX INC,CETIRIZINE,CETIRIZINE HYDROCHLORIDE,5MG,10/15 BLS,ORAL,Resolved,TABLET,R06AE,ANTIHISTAMINES FOR SYSTEMIC USE,,2017/3/10,,2018/5/30,Disruption of the manufacture of the drug.,2017/8/14,2018/5/31,No
19099,2242329,Shortage,APO-CHLORHEXIDINE ORAL RINSE,APOTEX INC,CHLORHEXIDINE,CHLORHEXIDINE GLUCONATE,0.12%,475 ML,ORAL,Actual shortage,LIQUID,A01AB,STOMATOLOGICAL PREPARATIONS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
6414,2417316,Shortage,APO-CICLESONIDE,APOTEX INC,CICLESONIDE,CICLESONIDE,50MCG,120 doses,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,2017/4/30,2017/3/20,,2018/12/17,Disruption of the manufacture of the drug.,2017/4/11,2018/12/20,No
3520,2417316,Shortage,APO-CICLESONIDE,APOTEX INC,CICLESONIDE,CICLESONIDE,50MCG,120 doses,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2017/3/20,,2018/12/17,Disruption of the manufacture of the drug.,2017/3/20,2019/1/3,No
80,2291134,Shortage,APO-CILAZAPRIL,APOTEX INC,CILAZAPRIL,CILAZAPRIL,1MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/3/10,2017/3/17,2017/3/17,Disruption of the manufacture of the drug.,2017/3/10,2017/4/4,No
16853,2291150,Shortage,APO-CILAZAPRIL,APOTEX INC,CILAZAPRIL,CILAZAPRIL,5MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/7/24,2017/8/18,2017/8/14,Disruption of the manufacture of the drug.,2017/7/25,2017/8/15,No
14068,2291134,Shortage,APO-CILAZAPRIL,APOTEX INC,CILAZAPRIL,CILAZAPRIL,1MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/6/26,2017/10/31,2017/7/21,Disruption of the manufacture of the drug.,2017/6/27,2017/7/24,No
83,2284987,Shortage,APO-CILAZAPRIL/HCTZ,APOTEX INC,CILAZAPRIL HCTZ,HYDROCHLOROTHIAZIDE CILAZAPRIL,12.5MG 5MG,100 BTL,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017/2/22,2017/3/20,2017/3/16,Disruption of the manufacture of the drug.,2017/3/10,2017/4/4,No
19102,2243085,Shortage,APO-CIMETIDINE ORAL SOLUTION,APOTEX INC,CIMETIDINE,CIMETIDINE,300MG,250 ML,ORAL,Actual shortage,LIQUID,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
86,2452693,Shortage,APO-CINACALCET,APOTEX INC,CINACALCET,CINACALCET,30MG,30 BTL,ORAL,Resolved,TABLET,H05BX,ANTI-PARATHYROID HORMONES,,2017/1/17,2017/3/31,2017/3/22,Disruption of the manufacture of the drug.,2017/3/10,2017/4/4,No
3619,2229522,Shortage,APO-CIPROFLOX,APOTEX INC,CIPROFLOX,CIPROFLOXACIN,500MG,500 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2017/3/20,2017/6/14,2017/6/12,Disruption of the manufacture of the drug.,2017/3/20,2017/6/12,No
107,2229522,Shortage,APO-CIPROFLOX,APOTEX INC,CIPROFLOX,CIPROFLOXACIN,500MG,100 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2017/1/3,2017/6/14,2017/6/12,Disruption of the manufacture of the drug.,2017/3/10,2017/6/12,No
110,2263130,Shortage,APO-CIPROFLOX,APOTEX INC,CIPROFLOX,CIPROFLOXACIN,0.30%,5 ml,OPHTHALMIC,Resolved,SOLUTION,S01AE,ANTIINFECTIVES,,2014/10/9,,2019/6/3,Disruption of the manufacture of the drug.,2017/3/10,2019/6/12,No
21061,2246057,Shortage,APO-CITALOPRAM,APOTEX INC,CITALORPAM,CITALOPRAM,40MG,100 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/9/4,2018/4/30,2018/3/7,Disruption of the manufacture of the drug.,2017/9/6,2018/3/8,No
113,2246057,Shortage,APO-CITALOPRAM,APOTEX INC,CITALOPRAM,CITALOPRAM,40MG,30 BLS,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/2/1,2017/5/8,2017/4/6,Disruption of the manufacture of the drug.,2017/3/10,2017/4/7,No
12281,2246056,Shortage,APO-CITALOPRAM,APOTEX INC,CITALOPRAM,CITALOPRAM,20MG,30 BLS,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/6/30,,2017/8/31,2017/8/31,Disruption of the manufacture of the drug.,2017/6/8,2017/11/20,No
12283,2246056,Shortage,APO-CITALOPRAM,APOTEX INC,CITALOPRAM,CITALOPRAM,20MG,30 BLS,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/6/30,2017/6/12,2017/10/11,2017/10/11,Disruption of the manufacture of the drug.,2017/6/8,2017/10/12,No
9925,2274752,Shortage,APO-CLARITHROMYCIN,APOTEX INC,CLARITHROMYCIN,CLARITHROMYCIN,500MG,100 BTL,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/5/8,2017/6/27,2017/6/22,Disruption of the manufacture of the drug.,2017/5/10,2017/6/23,No
116,2413345,Shortage,APO-CLARITHROMYCIN XL,APOTEX INC,CLARITHROMYCIN,CLARITHROMYCIN,500MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2016/5/31,2017/5/31,2017/5/4,Disruption of the manufacture of the drug.,2017/3/10,2017/5/5,No
32520,2245233,Shortage,APO-CLINDAMYCIN,APOTEX INC,CLINDAMYCIN,CLINDAMYCIN,300MG,100 BTL,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/12/11,2018/2/15,2018/1/25,Disruption of the manufacture of the drug.,2017/12/12,2018/1/26,No
119,2245232,Shortage,APO-CLINDAMYCIN,APOTEX INC,CLINDAMYCIN,CLINDAMYCIN,150MG,100 BTL,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2016/10/3,2017/5/31,2017/5/26,Disruption of the manufacture of the drug.,2017/3/10,2017/5/27,No
122,2245233,Shortage,APO-CLINDAMYCIN,APOTEX INC,CLINDAMYCIN,CLINDAMYCIN,300MG,100 BTL,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2016/11/14,2017/10/31,2017/10/27,Disruption of the manufacture of the drug.,2017/3/10,2017/10/30,No
23550,2245232,Shortage,APO-CLINDAMYCIN,APOTEX INC,CLINDAMYCIN,CLINDAMYCIN,150MG,100 BTL,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/9/22,2017/10/13,2017/10/11,Disruption of the manufacture of the drug.,2017/9/26,2017/10/12,No
22870,2177889,Shortage,APO-CLONAZEPAM - TAB 0.5MG,APOTEX INC,Clonazepam - Tab 0.5mg,CLONAZEPAM,.5MG,100 BTL,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2017/9/22,2017/9/20,2018/10/1,2018/9/8,Disruption of the manufacture of the drug.,2017/9/20,2018/9/9,No
22970,2177889,Shortage,APO-CLONAZEPAM - TAB 0.5MG,APOTEX INC,CLONAZEPAM,CLONAZEPAM,.5MG,500 BTL,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2017/10/2,2017/9/29,2018/10/1,2018/10/3,Disruption of the manufacture of the drug.,2017/9/21,2018/10/5,No
19136,2248732,Shortage,APO-CLONIDINE,APOTEX INC,CLONIDINE,CLONIDINE HYDROCHLORIDE,0.025MG,100 BTL,ORAL,Actual shortage,TABLET,C02AC,"ANTIADRENERGIC AGENTS, CENTRALLY ACTING",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
18994,868949,Shortage,APO-CLONIDINE TAB 0.1MG,APOTEX INC,CLONIDINE,CLONIDINE HYDROCHLORIDE,.1MG,100 BTL & 500 BTL,ORAL,Actual shortage,TABLET,C02AC,"ANTIADRENERGIC AGENTS, CENTRALLY ACTING",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
18997,868957,Shortage,APO-CLONIDINE TAB 0.2MG,APOTEX INC,CLONIDINE,CLONIDINE HYDROCHLORIDE,.2MG,100 BTL & 500 BTL,ORAL,Actual shortage,TABLET,C02AC,"ANTIADRENERGIC AGENTS, CENTRALLY ACTING",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
8859,2252767,Shortage,APO-CLOPIDOGREL,APOTEX INC,CLOPIDOGREL,CLOPIDOGREL,75MG,30 BLS,ORAL,Resolved,TABLET,B01AC,ANTITHROMBOTIC AGENTS,2017/5/16,2017/5/22,2017/7/21,2017/7/21,Disruption of the manufacture of the drug.,2017/5/4,2017/7/22,No
19051,2231390,Shortage,APO-CROMOLYN NASAL SPRAY,APOTEX INC,CROMOLYN,CROMOLYN SODIUM,2%,26 ML,NASAL,Actual shortage,"SOLUTION
SPRAY",R01AC,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
19054,2231431,Shortage,APO-CROMOLYN STERULES,APOTEX INC,CROMOLYN,CROMOLYN SODIUM,1%,2ML,INHALATION,Actual shortage,SOLUTION,R03BC,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
241,2244324,Shortage,APO-CYCLOSPORINE ORAL SOLUTION,APOTEX INC,CYCLOSPORINE,CYCLOSPORIN,100MG,50 ml,ORAL,Resolved,SOLUTION,L04AD,IMMUNOSUPPRESSANTS,,2014/7/1,,2018/9/8,Disruption of the manufacture of the drug.,2017/3/10,2018/9/9,No
20281,2461560,Shortage,APO-DEFERASIROX,APOTEX INC,DEFERASIROX,DEFERASIROX,500MG,30 BLS,ORAL,Resolved,TABLET FOR SUSPENSION,V03AC,ALL OTHER THERAPEUTIC PRODUCTS,,2017/8/18,2017/9/15,2017/9/15,Disruption of the manufacture of the drug.,2017/8/24,2017/9/22,No
275,2284030,Shortage,APO-DESMOPRESSIN,APOTEX INC,DESMOPRESSIN,DESMOPRESSIN ACETATE,0.1MG,100 BTL,ORAL,Resolved,TABLET,H01BA,POSTERIOR PITUITARY LOBE HORMONES,,2016/11/30,2017/5/12,2017/5/12,Disruption of the manufacture of the drug.,2017/3/10,2017/5/13,No
278,2284049,Shortage,APO-DESMOPRESSIN,APOTEX INC,DESMOPRESSIN,DESMOPRESSIN ACETATE,0.2MG,100 BTL,ORAL,Resolved,TABLET,H01BA,POSTERIOR PITUITARY LOBE HORMONES,,2017/2/20,2017/6/27,2017/6/20,Disruption of the manufacture of the drug.,2017/3/10,2017/6/21,No
16680,2284030,Shortage,APO-DESMOPRESSIN,APOTEX INC,DESMOPRESSIN,DESMOPRESSIN ACETATE,0.1MG,100 BTL,ORAL,Resolved,TABLET,H01BA,POSTERIOR PITUITARY LOBE HORMONES,,2017/7/24,2018/1/10,2017/12/19,Disruption of the manufacture of the drug.,2017/7/24,2017/12/20,No
16683,2284049,Shortage,APO-DESMOPRESSIN,APOTEX INC,DESMOPRESSIN,DESMOPRESSIN ACETATE,0.2MG,100 BTL,ORAL,Resolved,TABLET,H01BA,POSTERIOR PITUITARY LOBE HORMONES,,2017/7/24,2018/7/6,2018/8/14,Disruption of the manufacture of the drug.,2017/7/24,2018/8/15,No
11059,2284030,Shortage,APO-DESMOPRESSIN,APOTEX INC,DESMOPRESSIN,DESMOPRESSIN ACETATE,0.1MG,100 BTL,ORAL,Resolved,TABLET,H01BA,POSTERIOR PITUITARY LOBE HORMONES,2017/5/31,2017/5/29,2017/6/27,2017/6/20,Disruption of the manufacture of the drug.,2017/5/24,2017/6/21,No
20863,2250055,Shortage,APO-DEXAMETHASONE,APOTEX INC,DEXAMETHASONE,DEXAMETHASONE,4MG,100 BTL,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",2017/10/16,2017/10/13,2017/12/29,2017/12/1,Disruption of the manufacture of the drug.,2017/9/5,2017/12/4,No
24257,2261081,Shortage,APO-DEXAMETHASONE,APOTEX INC,DEXAMETHASONE,DEXAMETHASONE,0.5MG,100 BTL,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017/10/2,2017/12/29,2017/11/27,Disruption of the manufacture of the drug.,2017/10/4,2017/11/28,No
25207,2243433,Shortage,APO-DICLO RAPIDE 50 MG TABLETS,APOTEX INC,DICLOFENAC,DICLOFENAC POTASSIUM,50MG,100 BTL,ORAL,Resolved,TABLET,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/10/9,2017/12/29,2017/11/21,Disruption of the manufacture of the drug.,2017/10/11,2017/11/22,No
11062,2162814,Shortage,APO-DICLO SR,APOTEX INC,DICLOFENAC,DICLOFENAC SODIUM,75MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/6/19,2017/6/12,2017/10/10,2017/9/21,Disruption of the manufacture of the drug.,2017/5/24,2017/9/22,No
30805,2162814,Shortage,APO-DICLO SR,APOTEX INC,DICLOFENAC,DICLOFENAC SODIUM,75MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/11/27,2018/5/7,2018/4/16,Disruption of the manufacture of the drug.,2017/11/27,2018/4/17,No
16856,2441020,Shortage,APO-DICLOFENAC OPHTHALMIC,APOTEX INC,DICLOFENAC,DICLOFENAC SODIUM,0.10%,10 mL,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,,2017/7/24,2017/8/28,2017/9/15,Disruption of the manufacture of the drug.,2017/7/25,2017/9/22,No
19326,2281201,Shortage,APO-DIGOXIN,APOTEX INC,DIGOXIN,DIGOXIN,0.25MG,100 BTL & 500 BTL,ORAL,Actual shortage,TABLET,C01AA,CARDIAC GLYCOSIDES,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
19329,2281228,Shortage,APO-DIGOXIN,APOTEX INC,DIGOXIN,DIGOXIN,0.125MG,100 BTL & 500 BTL,ORAL,Actual shortage,TABLET,C01AA,CARDIAC GLYCOSIDES,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
19332,2281236,Shortage,APO-DIGOXIN,APOTEX INC,DIGOXIN,DIGOXIN,0.0625MG,100 BTL,ORAL,Actual shortage,TABLET,C01AA,CARDIAC GLYCOSIDES,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
281,2230997,Shortage,APO-DILTIAZ CD,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,120MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2016/4/19,,2018/12/17,Disruption of the manufacture of the drug.,2017/3/10,2018/12/18,No
284,2230998,Shortage,APO-DILTIAZ CD,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,180MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2016/5/25,,2018/12/17,Disruption of the manufacture of the drug.,2017/3/10,2018/12/18,No
14168,2230999,Shortage,APO-DILTIAZ CD,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,240MG,100 BTL,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2017/9/22,2017/9/29,,2018/12/17,Disruption of the manufacture of the drug.,2017/6/28,2018/12/18,No
716,2230999,Shortage,APO-DILTIAZ CD,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,240MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2016/11/8,,2018/12/17,Disruption of the manufacture of the drug.,2017/3/13,2018/12/18,No
287,2229526,Shortage,APO-DILTIAZ CD - CAP 300MG,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,300MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/2/6,,2018/12/17,Disruption of the manufacture of the drug.,2017/3/10,2018/12/18,No
19030,2222965,Shortage,APO-DILTIAZ SR - 90MG/SRC,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,90MG,100 BTL & 500 BTL,ORAL,Actual shortage,CAPSULE (SUSTAINED-RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
19033,2222973,Shortage,APO-DILTIAZ SR - SRC 120MG,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,120MG,100 BTL & 500 BTL,ORAL,Actual shortage,CAPSULE (SUSTAINED-RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
19027,2222957,Shortage,APO-DILTIAZ SR - SRC 60MG,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,60MG,100 BTL & 500 BTL,ORAL,Actual shortage,CAPSULE (SUSTAINED-RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
19598,2242232,Shortage,APO-DIPIVEFRIN,APOTEX INC,DIPIVEFRIN,DIPIVEFRIN HYDROCHLORIDE,0.10%,5/10/15 ML,OPHTHALMIC,Actual shortage,LIQUID,S01EA,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2017/3/10,,,Other (Please describe in comments),2017/8/16,2017/10/5,No
12805,2239699,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,250MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,2017/6/23,2017/6/19,2017/7/31,2017/7/25,Disruption of the manufacture of the drug.,2017/6/15,2017/7/26,No
12059,2239700,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,500MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2017/6/6,2017/7/14,2017/7/14,Disruption of the manufacture of the drug.,2017/6/6,2017/7/17,No
19120,2245080,Shortage,APO-DOCUSATE CALCIUM,APOTEX INC,DOCUSATE,DOCUSATE CALCIUM,240MG,100 BTL,ORAL,Actual shortage,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
16867,2103613,Shortage,APO-DOMPERIDONE - TAB 10MG,APOTEX INC,DOMPERIDONE,DOMPERIDONE,10MG,500 BTL,ORAL,Resolved,TABLET,A03FA,PROPULSIVES,,2017/7/24,2017/8/10,2017/8/7,Disruption of the manufacture of the drug.,2017/7/25,2017/8/8,No
5402,2362260,Shortage,APO-DONEPEZIL,APOTEX INC,DONEPEZIL,DONEPEZIL HYDROCHLORIDE,5MG,"100 BTL, 500 BTL & 30 BLS",ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2017/4/3,2017/7/21,2017/7/21,Disruption of the manufacture of the drug.,2017/4/4,2017/7/24,No
9928,2362279,Shortage,APO-DONEPEZIL,APOTEX INC,DONEPEZIL,DONEPEZIL HYDROCHLORIDE,10MG,30 BLS,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2017/8/7,2017/9/27,2017/9/29,Disruption of the manufacture of the drug.,2017/5/10,2017/10/4,No
290,2299615,Shortage,APO-DORZO-TIMOP,APOTEX INC,DORZOLAMIDE-TIMOLOL,TIMOLOL DORZOLAMIDE,5MG 20MG,10 mL,OPHTHALMIC,Resolved,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2015/10/6,2019/7/12,2019/7/12,Disruption of the manufacture of the drug.,2017/3/10,2019/7/13,No
13312,2049996,Shortage,APO-DOXEPIN,APOTEX INC,DOXEPIN,DOXEPIN,10MG,100 BTL,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2017/6/19,2017/6/30,2017/6/30,Disruption of the manufacture of the drug.,2017/6/19,2017/7/4,No
29957,2050005,Shortage,APO-DOXEPIN,APOTEX INC,DOXEPIN,DOXEPIN,25MG,100 BTL,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2017/11/20,2018/1/2,2017/12/7,Disruption of the manufacture of the drug.,2017/11/21,2017/12/8,No
4389,2050013,Shortage,APO-DOXEPIN,APOTEX INC,DOXEPIN,DOXEPIN,50MG,100 BTL,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2017/3/27,2017/4/10,2017/3/31,Disruption of the manufacture of the drug.,2017/3/27,2017/4/3,No
294,2049996,Shortage,APO-DOXEPIN,APOTEX INC,DOXEPIN,DOXEPIN,10MG,100 BTL,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2016/12/13,2017/4/10,2017/3/31,Disruption of the manufacture of the drug.,2017/3/10,2017/4/3,No
298,2050048,Shortage,APO-DOXEPIN,APOTEX INC,DOXEPIN,DOXEPIN,100MG,100 BTL,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2017/2/14,2017/4/10,2017/3/31,Disruption of the manufacture of the drug.,2017/3/10,2017/4/3,No
302,2050005,Shortage,APO-DOXEPIN,APOTEX INC,DOXEPIN,DOXEPIN,25MG,100 BTL,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2017/1/24,2017/4/10,2017/4/7,Disruption of the manufacture of the drug.,2017/3/10,2017/4/10,No
19003,2050056,Shortage,APO-DOXEPIN,APOTEX INC,DOXEPIN,DOXEPIN,150MG,100 BTL,ORAL,Actual shortage,CAPSULE,N06AA,ANTIDEPRESSANTS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
28546,2049996,Shortage,APO-DOXEPIN,APOTEX INC,DOXEPIN,DOXEPIN,10MG,100 BTL,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2017/11/6,2017/12/22,2017/12/7,Disruption of the manufacture of the drug.,2017/11/7,2017/12/8,No
20869,740713,Shortage,APO-DOXY CAP 100MG,APOTEX INC,DOXYCYCLINE,DOXYCYCLINE,100MG,250 BTL,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,2017/10/20,2017/10/16,2017/11/30,2017/11/15,Disruption of the manufacture of the drug.,2017/9/5,2017/11/16,No
26569,874256,Shortage,APO-DOXY TABS 100MG,APOTEX INC,DOXYCYCLINE,DOXYCYCLINE,100MG,100 BTL,ORAL,Resolved,TABLET,J01AA,TETRACYCLINES,,2017/12/18,2018/2/19,2018/2/19,Disruption of the manufacture of the drug.,2017/10/23,2018/2/21,No
33576,2413248,Shortage,APO-DOXYLAMINE/B6,APOTEX INC,DOXYLAMINE,DOXYLAMINE SUCCINATE PYRIDOXINE HYDROCHLORIDE,10MG 10MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET (DELAYED-RELEASE),R06AA,ANTIHISTAMINES FOR SYSTEMIC USE,,2017/12/11,2018/7/20,2018/6/29,Disruption of the manufacture of the drug.,2017/12/18,2018/7/3,No
642,2440431,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,60MG,30 BLS,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017/5/1,2017/5/8,2017/6/9,2017/6/2,Disruption of the manufacture of the drug.,2017/3/12,2017/6/5,No
645,2440431,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,60MG,100 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017/4/20,,2017/6/12,2017/5/30,Disruption of the manufacture of the drug.,2017/3/12,2017/5/31,No
648,2440431,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,60MG,30 BLS,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017/4/13,2017/4/3,2017/4/28,2017/4/21,Disruption of the manufacture of the drug.,2017/3/12,2018/4/2,No
651,2440423,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,30MG,30 BLS,ORAL,Avoided shortage,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017/4/11,2017/4/3,2017/6/20,2017/4/5,Disruption of the manufacture of the drug.,2017/3/12,2017/10/5,No
20640,2440423,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,30MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2017/8/28,2017/11/15,2017/10/19,Disruption of the manufacture of the drug.,2017/8/30,2017/10/20,No
12286,2440431,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,60MG,100 BTL,ORAL,Avoided shortage,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017/10/20,2017/10/2,2017/11/15,2017/10/19,Disruption of the manufacture of the drug.,2017/6/8,2017/10/20,No
305,2386054,Shortage,APO-ELETRIPTAN,APOTEX INC,ELETRIPTAN,ELETRIPTAN,20MG,6 BLS,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2014/10/1,2020/1/10,2019/12/31,Disruption of the manufacture of the drug.,2017/3/11,2020/1/7,No
308,2386062,Shortage,APO-ELETRIPTAN,APOTEX INC,ELETRIPTAN,ELETRIPTAN,40MG,6 BLS,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2014/10/1,2020/1/10,2019/12/31,Disruption of the manufacture of the drug.,2017/3/11,2020/1/7,No
23663,2452006,Shortage,APO-EMTRICITABINE-TENOFOVIR,APOTEX INC,EMTRICITABINE-TENOFOVIR,TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE,300MG 200MG,30 BTL,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2017/9/22,2017/10/20,2017/9/29,Disruption of the manufacture of the drug.,2017/9/27,2017/10/2,No
27703,2019892,Shortage,APO-ENALAPRIL TAB 10MG,APOTEX INC,ENALAPRIL,ENALAPRIL MALEATE,10MG,500 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/10/30,2018/1/12,2018/1/2,Disruption of the manufacture of the drug.,2017/11/1,2018/1/3,No
27707,2019906,Shortage,APO-ENALAPRIL TAB 20MG,APOTEX INC,ENALAPRIL,ENALAPRIL MALEATE,20MG,500 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/10/30,2018/4/30,2018/4/6,Disruption of the manufacture of the drug.,2017/11/1,2018/4/7,No
27710,2019884,Shortage,APO-ENALAPRIL TAB 5MG,APOTEX INC,ENALAPRIL,ENALAPRIL MALEATE,5MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/10/30,2018/1/12,2017/12/19,Disruption of the manufacture of the drug.,2017/11/1,2017/12/20,No
311,2396955,Shortage,APO-ENTECAVIR,APOTEX INC,ENTECAVIR,ENTECAVIR,0.5MG,30 BTL,ORAL,Resolved,TABLET,J05AF,DIRECT ACTING ANTIVIRALS,,2016/10/18,2017/10/31,2017/10/10,Disruption of the manufacture of the drug.,2017/3/11,2017/10/11,No
742,2295016,Shortage,APO-ESCITALOPRAM,APOTEX INC,ESCITALOPRAM,ESCITALOPRAM,10MG,500 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/2/6,2017/3/28,2017/3/28,Disruption of the manufacture of the drug.,2017/3/13,2017/3/29,No
745,2295024,Shortage,APO-ESCITALOPRAM,APOTEX INC,ESCITALOPRAM,ESCITALOPRAM,20MG,500 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/2/14,2017/4/30,2017/4/19,Disruption of the manufacture of the drug.,2017/3/13,2017/4/20,No
314,2419726,Shortage,APO-EXEMESTANE,APOTEX INC,EXEMESTANE,EXEMESTANE,25MG,30 BLS,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2014/10/2,,2019/6/3,Disruption of the manufacture of the drug.,2017/3/11,2019/6/12,No
318,2427826,Shortage,APO-EZETIMIBE,APOTEX INC,EZETIMIBE,EZETIMIBE,10MG,100 BTL,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017/3/1,2017/3/17,2017/3/14,Disruption of the manufacture of the drug.,2017/3/11,2017/3/15,No
655,2427826,Shortage,APO-EZETIMIBE,APOTEX INC,EZETIMIBE,EZETIMIBE,10MG,30 BLS,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2017/3/25,,2017/4/28,2017/4/24,Disruption of the manufacture of the drug.,2017/3/12,2017/4/25,No
8862,2427826,Shortage,APO-EZETIMIBE,APOTEX INC,EZETIMIBE,EZETIMIBE,10MG,30 BLS,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2017/5/23,2017/6/5,2017/7/28,2017/7/17,Disruption of the manufacture of the drug.,2017/5/4,2017/7/18,No
10400,2427826,Shortage,APO-EZETIMIBE,APOTEX INC,EZETIMIBE,EZETIMIBE,10MG,100 BTL,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017/5/15,2017/7/20,2017/7/17,Disruption of the manufacture of the drug.,2017/5/16,2017/7/18,No
5366,2427826,Shortage,APO-EZETIMIBE,APOTEX INC,EZETIMIBE,EZETIMIBE,10MG,100 BTL,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017/3/31,2017/4/28,2017/4/24,Disruption of the manufacture of the drug.,2017/4/4,2017/4/25,No
23553,2292041,Shortage,APO-FAMCICLOVIR,APOTEX INC,FAMCICLOVIR,FAMCICLOVIR,250MG,30 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/9/22,2018/4/10,2018/1/17,Disruption of the manufacture of the drug.,2017/9/26,2018/1/18,No
17234,2292068,Shortage,APO-FAMCICLOVIR,APOTEX INC,FAMCICLOVIR,FAMCICLOVIR,500MG,30 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017/9/22,2017/8/28,2018/4/10,2018/1/17,Disruption of the manufacture of the drug.,2017/7/26,2018/1/18,No
20872,2292041,Shortage,APO-FAMCICLOVIR,APOTEX INC,FAMCICLOVIR,FAMCICLOVIR,250MG,30 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017/10/13,2017/10/9,2018/4/10,2018/1/17,Disruption of the manufacture of the drug.,2017/9/5,2018/1/18,No
26572,2292025,Shortage,APO-FAMCICLOVIR,APOTEX INC,FAMCICLOVIR,FAMCICLOVIR,125MG,30 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/10/23,2018/1/22,2018/1/18,Disruption of the manufacture of the drug.,2017/10/23,2018/1/19,No
719,2292068,Shortage,APO-FAMCICLOVIR,APOTEX INC,FAMCICLOVIR,FAMCICLOVIR,500MG,30 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/3/10,2017/5/24,2017/4/14,Disruption of the manufacture of the drug.,2017/3/13,2017/4/17,No
19048,2231119,Shortage,APO-FAMOTIDINE,APOTEX INC,FAMOTIDINE,FAMOTIDINE,10MG,10/12/6 BLS,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
619,1953842,Shortage,APO-FAMOTIDINE TAB 20MG USP,APOTEX INC,FAMOTIDINE,FAMOTIDINE,20 MG,100 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2014/10/1,,2018/9/8,Disruption of the manufacture of the drug.,2017/3/11,2018/9/9,No
616,1953834,Shortage,APO-FAMOTIDINE TAB 40MG USP,APOTEX INC,FAMOTIDINE,FAMOTIDINE,40MG,100 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2014/10/1,,2018/9/8,Disruption of the manufacture of the drug.,2017/3/11,2018/9/9,No
18543,2452367,Shortage,APO-FELODIPINE,APOTEX INC,FELODIPINE,FELODIPINE,2.5MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/8/7,2017/9/15,2017/9/15,Disruption of the manufacture of the drug.,2017/8/9,2017/9/22,No
5894,2239864,Shortage,APO-FENO-MICRO,APOTEX INC,FENOFIBRATE,FENOFIBRATE,200MG,30 BLS,ORAL,Resolved,CAPSULE,C10AB,"LIPID MODIFYING AGENTS, PLAIN",2017/4/14,,2017/6/15,2017/5/25,Disruption of the manufacture of the drug.,2017/4/7,2017/5/26,No
30995,2239864,Shortage,APO-FENO-MICRO,APOTEX INC,FENOFIBRATE,FENOFIBRATE,200MG,30 BLS,ORAL,Resolved,CAPSULE,C10AB,"LIPID MODIFYING AGENTS, PLAIN",2017/12/5,2017/12/8,2018/7/27,2018/7/13,Disruption of the manufacture of the drug.,2017/11/29,2018/7/17,No
17228,2239864,Shortage,APO-FENO-MICRO,APOTEX INC,FENOFIBRATE,FENOFIBRATE,200MG,30 BLS,ORAL,Resolved,CAPSULE,C10AB,"LIPID MODIFYING AGENTS, PLAIN",2017/8/21,,2017/10/13,2017/10/2,Disruption of the manufacture of the drug.,2017/7/26,2017/10/5,No
3749,2239864,Shortage,APO-FENO-MICRO,APOTEX INC,FENOFIBRATE,FENOFIBRATE,200MG,100 BTL,ORAL,Resolved,CAPSULE,C10AB,"LIPID MODIFYING AGENTS, PLAIN",2017/4/2,,2017/5/31,2017/6/1,Disruption of the manufacture of the drug.,2017/3/21,2017/6/5,No
2295,2239864,Shortage,APO-FENO-MICRO,APOTEX INC,FENOFIBRATE,FENOFIBRATE,200MG,100 BTL,ORAL,Resolved,CAPSULE,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2017/3/13,2017/5/31,2017/5/11,Disruption of the manufacture of the drug.,2017/3/14,2017/5/12,No
321,2246859,Shortage,APO-FENO-SUPER,APOTEX INC,FENOFIBRATE,FENOFIBRATE,100MG,30 BLS,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2017/1/31,,2017/5/31,Disruption of the manufacture of the drug.,2017/3/11,2019/11/26,No
8593,2246860,Shortage,APO-FENO-SUPER,APOTEX INC,FENOFIBRATE,FENOFIBRATE,160MG,30 BLS,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2017/8/8,2017/9/15,2017/8/1,Disruption of the manufacture of the drug.,2017/5/2,2017/8/29,No
6551,2246859,Shortage,APO-FENO-SUPER,APOTEX INC,FENOFIBRATE,FENOFIBRATE,100MG,100 BTL,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2017/4/7,2017/5/31,2017/4/27,Disruption of the manufacture of the drug.,2017/4/12,2017/4/28,No
15268,2246859,Shortage,APO-FENO-SUPER,APOTEX INC,FENOFIBRATE,FENOFIBRATE,100MG,100 BTL,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2018/7/16,2019/5/24,2019/5/24,Disruption of the manufacture of the drug.,2017/7/11,2019/5/25,No
3524,2246860,Shortage,APO-FENO-SUPER,APOTEX INC,FENOFIBRATE,FENOFIBRATE,160MG,30 BLS,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2017/10/18,2018/6/22,2018/5/11,Disruption of the manufacture of the drug.,2017/3/20,2018/5/15,No
622,2225980,Shortage,APO-FENOFIBRATE,APOTEX INC,FENOFIBRATE,FENOFIBRATE,100 MG,100 BTL,ORAL,Resolved,CAPSULE,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2016/2/2,,2018/8/24,Disruption of the manufacture of the drug.,2017/3/11,2019/11/26,No
13317,2365383,Shortage,APO-FINASTERIDE,APOTEX INC,FINASTERIDE,FINASTERIDE,5MG,30 BLS,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/6/19,2017/7/24,2017/7/18,Disruption of the manufacture of the drug.,2017/6/19,2017/7/19,No
19117,2244842,Shortage,APO-FLAVOXATE,APOTEX INC,FLAVOXATE,FLAVOXATE HYDROCHLORIDE,200MG,100 BTL,ORAL,Actual shortage,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
32525,2239288,Shortage,APO-FLUNISOLIDE NASAL SPRAY,APOTEX INC,FLUNISOLIDE,FLUNISOLIDE,0.25MG,25 ML,NASAL,Resolved,METERED-DOSE PUMP,R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2017/12/11,,2018/2/23,Disruption of the manufacture of the drug.,2017/12/12,2018/2/26,No
30928,1912038,Shortage,APO-FLURBIPROFEN FC TABLETS 100MG,APOTEX INC,FLURBIPROFEN,FLURBIPROFEN,100MG,100 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/11/27,,2018/9/6,Disruption of the manufacture of the drug.,2017/11/28,2018/9/7,No
14171,2231330,Shortage,APO-FLUVOXAMINE TABLETS,APOTEX INC,FLUVOXAMINE,FLUVOXAMINE MALEATE,100MG,100 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/8/31,2017/8/9,2018/3/9,2018/3/2,Disruption of the manufacture of the drug.,2017/6/28,2018/3/4,No
14174,2231329,Shortage,APO-FLUVOXAMINE TABLETS,APOTEX INC,FLUVOXAMINE,FLUVOXAMINE MALEATE,50MG,100 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/8/14,2017/7/31,2018/3/9,2018/3/2,Disruption of the manufacture of the drug.,2017/6/28,2018/3/4,No
324,2266016,Shortage,APO-FOSINOPRIL,APOTEX INC,FOSINOPRIL,FOSINOPRIL SODIUM,20MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/2/14,2017/4/17,2017/4/7,Disruption of the manufacture of the drug.,2017/3/11,2017/4/10,No
658,2266008,Shortage,APO-FOSINOPRIL,APOTEX INC,FOSINOPRIL,FOSINOPRIL SODIUM,10MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017/3/17,2017/3/14,2017/4/15,2017/4/7,Disruption of the manufacture of the drug.,2017/3/12,2017/4/10,No
21082,2426471,Shortage,APO-FROVATRIPTAN,APOTEX INC,FROVATRIPTAN,FROVATRIPTAN,2.5MG,6 BLS,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/9/4,2017/10/6,2017/10/9,Disruption of the manufacture of the drug.,2017/9/6,2017/10/10,No
23558,2293366,Shortage,APO-GABAPENTIN,APOTEX INC,GABAPENTIN,GABAPENTIN,800MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/9/22,2017/11/17,2017/10/27,Disruption of the manufacture of the drug.,2017/9/26,2017/10/31,No
31001,2293358,Shortage,APO-GABAPENTIN,APOTEX INC,GABAPENTIN,GABAPENTIN,600MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017/12/28,2017/12/11,2018/4/13,2018/3/21,Disruption of the manufacture of the drug.,2017/11/29,2018/3/22,No
31004,2293366,Shortage,APO-GABAPENTIN,APOTEX INC,GABAPENTIN,GABAPENTIN,800MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017/12/28,2017/12/11,2018/4/13,2018/3/21,Disruption of the manufacture of the drug.,2017/11/29,2018/3/22,No
5897,2244306,Shortage,APO-GABAPENTIN CAPSULES,APOTEX INC,GABAPENTIN,GABAPENTIN,400MG,100 BTL  &  500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/5/1,2017/4/14,2017/9/11,2017/9/14,Disruption of the manufacture of the drug.,2017/4/7,2017/9/15,No
30998,2244304,Shortage,APO-GABAPENTIN CAPSULES,APOTEX INC,GABAPENTIN,GABAPENTIN,100MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/12/29,2017/12/11,2018/2/23,2018/2/20,Disruption of the manufacture of the drug.,2017/11/29,2018/2/21,No
12064,2244305,Shortage,APO-GABAPENTIN CAPSULES,APOTEX INC,GABAPENTIN,GABAPENTIN,300MG,100 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/7/20,2017/8/16,2017/8/15,Disruption of the manufacture of the drug.,2017/6/6,2017/8/16,No
20000,2244304,Shortage,APO-GABAPENTIN CAPSULES,APOTEX INC,GABAPENTIN,GABAPENTIN,100MG,100 & 500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/8/21,2017/9/29,2017/9/29,Disruption of the manufacture of the drug.,2017/8/21,2017/10/4,No
28726,2244305,Shortage,APO-GABAPENTIN CAPSULES,APOTEX INC,GABAPENTIN,GABAPENTIN,300MG,100 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/11/6,2017/12/18,2017/12/18,Disruption of the manufacture of the drug.,2017/11/9,2017/12/19,No
604,2244306,Shortage,APO-GABAPENTIN CAPSULES,APOTEX INC,GABAPENTIN,GABAPENTIN,400MG,100 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/3/10,2017/3/28,2017/3/28,Disruption of the manufacture of the drug.,2017/3/11,2017/3/29,No
661,2244305,Shortage,APO-GABAPENTIN CAPSULES,APOTEX INC,GABAPENTIN,GABAPENTIN,300MG,500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/6/1,2017/7/31,2017/7/12,Disruption of the manufacture of the drug.,2017/3/12,2017/7/13,No
6554,885754,Shortage,APO-GAIN LIQ 20MG/ML,APOTEX INC,MINOXIDIL,MINOXIDIL,20MG,60 ML,TOPICAL,Resolved,LIQUID,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,,2017/4/7,,2018/2/23,Disruption of the manufacture of the drug.,2017/4/12,2018/2/26,No
610,1979582,Shortage,APO-GEMFIBROZIL,APOTEX INC,GEMFIBROZIL,GEMFIBROZIL,600MG,100 BTL,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2014/10/9,,2019/5/6,Disruption of the manufacture of the drug.,2017/3/11,2019/11/26,No
607,1979574,Shortage,APO-GEMFIBROZIL CAP 300MG USP,APOTEX INC,GEMFIBROZIL,GEMFIBROZIL,300 MG,100 BTL,ORAL,Resolved,CAPSULE,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2014/10/9,,2019/6/3,Disruption of the manufacture of the drug.,2017/3/11,2019/6/12,No
26159,2245247,Shortage,APO-GLICLAZIDE,APOTEX INC,GLICLAZIDE,GLICLAZIDE,80MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/10/16,2018/6/22,2018/5/21,Disruption of the manufacture of the drug.,2017/10/17,2018/5/22,No
29960,2407124,Shortage,APO-GLICLAZIDE MR,APOTEX INC,GLICLAZIDE,GLICLAZIDE,60MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/11/20,2018/4/30,2018/3/20,Disruption of the manufacture of the drug.,2017/11/21,2018/3/21,No
32536,2295377,Shortage,APO-GLIMEPIRIDE,APOTEX INC,GLIMEPIRIDE,GLIMEPIRIDE,1MG,100 BTL,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/12/11,,2019/9/20,Disruption of the manufacture of the drug.,2017/12/12,2019/9/21,No
31007,2295393,Shortage,APO-GLIMEPIRIDE,APOTEX INC,GLIMEPIRIDE,GLIMEPIRIDE,4MG,100 BTL,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017/12/15,2017/12/11,,2019/9/20,Shortage of an inactive ingredient or component.,2017/11/29,2019/9/21,No
18945,463698,Shortage,APO-HALOPERIDOL TAB 10MG,APOTEX INC,HALOPERIDOL,HALOPERIDOL,10MG,100 BTL & 500 BTL,ORAL,Actual shortage,TABLET,N05AD,ANTIPSYCHOTICS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
18184,441627,Shortage,APO-HYDRALAZINE,APOTEX INC,HYDRALAZINE,HYDRALAZINE HYDROCHLORIDE,25MG,100 BTL,ORAL,Resolved,TABLET,C02DB,"ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",,2017/7/31,2017/8/4,2017/10/2,Other (Please describe in comments),2017/8/3,2017/10/10,No
18187,441635,Shortage,APO-HYDRALAZINE,APOTEX INC,HYDRALAZINE,HYDRALAZINE HYDROCHLORIDE,50MG,100 BTL,ORAL,Resolved,TABLET,C02DB,"ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",,2017/7/31,2017/8/4,2017/10/2,Other (Please describe in comments),2017/8/3,2017/10/10,No
18190,441619,Shortage,APO-HYDRALAZINE,APOTEX INC,HYDRALAZINE,HYDRALAZINE HYDROCHLORIDE,10MG,100 BTL,ORAL,Resolved,TABLET,C02DB,"ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",,2017/7/31,2017/8/7,2017/10/2,Other (Please describe in comments),2017/8/3,2017/10/10,No
16931,2327856,Shortage,APO-HYDRO,APOTEX INC,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,12.5MG,500 BTL,ORAL,Resolved,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",,2017/7/17,2017/9/29,2017/9/11,Disruption of the manufacture of the drug.,2017/7/25,2017/9/15,No
25210,2327856,Shortage,APO-HYDRO,APOTEX INC,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,12.5MG,500 BTL,ORAL,Resolved,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",,2017/10/9,2018/3/16,2018/3/2,Disruption of the manufacture of the drug.,2017/10/11,2018/3/6,No
26163,2364123,Shortage,APO-HYDROMORPHONE,APOTEX INC,HYDROMORPHONE HCL,HYDROMORPHONE HYDROCHLORIDE,2MG,100 BTL,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017/10/16,2018/1/5,2017/12/14,Disruption of the manufacture of the drug.,2017/10/17,2017/12/15,No
25214,2364115,Shortage,APO-HYDROMORPHONE,APOTEX INC,HYDROMORPHONE HCL,HYDROMORPHONE HYDROCHLORIDE,1MG,100 BTL,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017/10/9,2018/1/31,2018/1/19,Disruption of the manufacture of the drug.,2017/10/11,2018/1/22,No
20105,2364115,Shortage,APO-HYDROMORPHONE,APOTEX INC,HYDROMORPHONE HCL,HYDROMORPHONE HYDROCHLORIDE,1MG,100 BTL,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017/8/21,2017/9/5,2017/8/31,Disruption of the manufacture of the drug.,2017/8/23,2017/9/1,No
27809,2364131,Shortage,APO-HYDROMORPHONE,APOTEX INC,HYDROMORPHONE HCL,HYDROMORPHONE HYDROCHLORIDE,4MG,100 BTL,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017/11/1,2017/12/29,2017/12/29,Disruption of the manufacture of the drug.,2017/11/2,2017/12/31,No
17605,2364158,Shortage,APO-HYDROMORPHONE,APOTEX INC,HYDROMORPHONE HCL,HYDROMORPHONE HYDROCHLORIDE,8MG,100 BTL,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017/7/31,2017/9/5,2017/9/5,Disruption of the manufacture of the drug.,2017/8/1,2017/9/6,No
20875,2246691,Shortage,APO-HYDROXYQUINE,APOTEX INC,HYDROXYQUINE,HYDROXYCHLOROQUINE SULFATE,200MG,100 BTL,ORAL,Resolved,TABLET,P01BA,ANTIMALARIALS,2017/10/31,2017/11/7,2017/11/30,2017/11/17,Disruption of the manufacture of the drug.,2017/9/5,2017/11/20,No
19129,2247937,Shortage,APO-HYDROXYUREA,APOTEX INC,HYDROXYUREA,HYDROXYUREA,500MG,100 BTL,ORAL,Resolved,CAPSULE,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2017/3/10,,2017/12/5,Disruption of the manufacture of the drug.,2017/8/14,2017/12/7,No
31010,2355345,Shortage,APO-IMATINIB,APOTEX INC,IMATINIB,IMATINIB,400MG,30 BLS,ORAL,Resolved,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,2018/3/26,2018/3/28,2018/4/27,2018/4/17,Disruption of the manufacture of the drug.,2017/11/29,2018/4/18,No
17609,2355345,Shortage,APO-IMATINIB,APOTEX INC,IMATINIB,IMATINIB,400MG,30 BLS,ORAL,Resolved,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,,2017/7/31,2017/9/5,2017/9/5,Disruption of the manufacture of the drug.,2017/8/1,2017/9/6,No
333,2407825,Shortage,APO-IMIQUIMOD,APOTEX INC,IMIQUIMOD,IMIQUIMOD,5%,24 x 250mg packet,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,,2015/9/24,,2019/5/3,Disruption of the manufacture of the drug.,2017/3/11,2019/11/26,No
15973,2245246,Shortage,APO-INDAPAMIDE 1.25 MG TABLETS,APOTEX INC,INDAPAMIDE,INDAPAMIDE,1.25MG,100 BTL,ORAL,Resolved,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",,2017/7/17,2017/12/20,2017/12/11,Disruption of the manufacture of the drug.,2017/7/17,2017/12/14,No
8865,2245246,Shortage,APO-INDAPAMIDE 1.25 MG TABLETS,APOTEX INC,INDAPAMIDE,INDAPAMIDE,1.25MG,100 BTL,ORAL,Resolved,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",2017/6/12,2017/7/17,2017/12/20,2017/12/11,Disruption of the manufacture of the drug.,2017/5/4,2017/12/14,No
613,2126222,Shortage,APO-IPRAVENT SOLUTION - INH 250MCG/ML,APOTEX INC,IPRATROPIUM,IPRATROPIUM BROMIDE,250µG,20 ML,INHALATION,Resolved,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017/1/24,2017/4/13,2017/4/10,Disruption of the manufacture of the drug.,2017/3/11,2017/4/11,No
19060,2231494,Shortage,APO-IPRAVENT STERULES,APOTEX INC,IPRATROPIUM,IPRATROPIUM BROMIDE,0.03%,2ML,INHALATION,Actual shortage,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
19111,2243827,Shortage,APO-IPRAVENT STERULES,APOTEX INC,IPRATROPIUM,IPRATROPIUM BROMIDE,125MCG,2ML,INHALATION,Actual shortage,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
336,2386976,Shortage,APO-IRBESARTAN,APOTEX INC,IRBESARTAN,IRBESARTAN,150MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2016/6/8,2017/12/18,2017/12/11,Disruption of the manufacture of the drug.,2017/3/11,2017/12/14,No
339,2386984,Shortage,APO-IRBESARTAN,APOTEX INC,IRBESARTAN,IRBESARTAN,300MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2014/6/17,2017/12/18,2017/12/11,Disruption of the manufacture of the drug.,2017/3/11,2017/12/14,No
342,2386968,Shortage,APO-IRBESARTAN,APOTEX INC,IRBESARTAN,IRBESARTAN,75MG,100 BTL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2016/2/2,2017/12/18,2017/12/11,Disruption of the manufacture of the drug.,2017/3/11,2017/12/14,No
345,2387646,Shortage,APO-IRBESARTAN/HCTZ,APOTEX INC,IRBESARTAN/HCTZ,HYDROCHLOROTHIAZIDE IRBESARTAN,12.5MG 150MG,500 BTL,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2014/10/1,2017/4/30,2017/4/21,Disruption of the manufacture of the drug.,2017/3/11,2017/4/24,No
351,2387654,Shortage,APO-IRBESARTAN/HCTZ,APOTEX INC,IRBESARTAN/HCTZ,HYDROCHLOROTHIAZIDE IRBESARTAN,12.5MG 300MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2014/10/1,2017/4/30,2017/4/21,Disruption of the manufacture of the drug.,2017/3/11,2017/4/24,No
25287,2387662,Shortage,APO-IRBESARTAN/HCTZ,APOTEX INC,IRBESARTAN/HCTZ,HYDROCHLOROTHIAZIDE IRBESARTAN,25MG 300MG,100 BTL,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/10/9,2017/12/15,2017/11/10,Disruption of the manufacture of the drug.,2017/10/11,2017/11/15,No
354,2272830,Shortage,APO-ISMN,APOTEX INC,ISMN,ISOSORBIDE-5-MONONITRATE,60MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2017/3/10,2017/4/12,2017/4/7,Disruption of the manufacture of the drug.,2017/3/11,2017/4/10,No
8602,2272830,Shortage,APO-ISMN,APOTEX INC,ISMN,ISOSORBIDE-5-MONONITRATE,60MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2017/5/1,2017/7/14,2017/6/26,Disruption of the manufacture of the drug.,2017/5/2,2017/6/27,No
16871,2272830,Shortage,APO-ISMN,APOTEX INC,ISMN,ISOSORBIDE-5-MONONITRATE,60MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2018/1/12,2018/3/19,2018/2/22,Disruption of the manufacture of the drug.,2017/7/25,2018/2/23,No
16874,2272830,Shortage,APO-ISMN,APOTEX INC,ISMN,ISOSORBIDE-5-MONONITRATE,60MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2017/7/24,2017/9/29,2017/9/22,Demand increase for the drug.,2017/7/25,2017/9/25,No
19595,2243989,Shortage,APO-KETOROLAC INJECTABLE,APOTEX INC,KETOROLAC,KETOROLAC TROMETHAMINE,30MG,1 ML,INTRAMUSCULAR,Actual shortage,SOLUTION,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/3/10,,,Other (Please describe in comments),2017/8/16,2017/10/5,No
19024,2221330,Shortage,APO-KETOTIFEN - SYR 1MG/5ML,APOTEX INC,KETOTIFEN,KETOTIFEN FUMARATE,1MG,250 ML,ORAL,Actual shortage,SYRUP,R06AX,ANTIHISTAMINES FOR SYSTEMIC USE,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
19105,2243538,Shortage,APO-LABETALOL TABLETS,APOTEX INC,LABETALOL,LABETALOL HYDROCHLORIDE,100MG,100 BTL,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2020/11/2,2021/1/28,2021/1/8,Disruption of the manufacture of the drug.,2017/8/14,2021/1/11,No
19108,2243539,Shortage,APO-LABETALOL TABLETS,APOTEX INC,LABETALOL,LABETALOL HYDROCHLORIDE,200MG,100 BTL,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2020/11/2,2021/1/28,2021/1/8,Disruption of the manufacture of the drug.,2017/8/14,2021/1/11,No
357,2242814,Shortage,APO-LACTULOSE,APOTEX INC,LACTULOSE,LACTULOSE,667MG,1 L,ORAL,Resolved,LIQUID,A06AD,DRUGS FOR CONSTIPATION,,2017/1/13,,2017/10/4,Disruption of the manufacture of the drug.,2017/3/11,2017/10/5,No
360,2242814,Shortage,APO-LACTULOSE,APOTEX INC,LACTULOSE,LACTULOSE,667MG,500 ml,ORAL,Resolved,LIQUID,A06AD,DRUGS FOR CONSTIPATION,,2017/3/10,2017/8/8,2017/7/31,Disruption of the manufacture of the drug.,2017/3/11,2017/7/31,No
664,2369052,Shortage,APO-LAMIVUDINE,APOTEX INC,LAMIVUDINE,LAMIVUDINE,150MG,100 BTL,ORAL,Resolved,TABLET,J05AF,DIRECT ACTING ANTIVIRALS,2017/5/8,2017/5/8,2017/5/19,2017/5/15,Disruption of the manufacture of the drug.,2017/3/12,2017/5/16,No
15271,2369060,Shortage,APO-LAMIVUDINE,APOTEX INC,LAMIVUDINE,LAMIVUDINE,300MG,100 BTL,ORAL,Resolved,TABLET,J05AF,DIRECT ACTING ANTIVIRALS,,2017/7/10,2017/9/15,2017/8/30,Disruption of the manufacture of the drug.,2017/7/11,2017/8/31,No
31907,2375540,Shortage,APO-LAMIVUDINE-ZIDOVUDINE,APOTEX INC,LAMIVUDINE-ZIDOVUDINE,ZIDOVUDINE LAMIVUDINE,300MG 150MG,100 BTL,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2017/12/4,2018/7/31,2018/6/29,Disruption of the manufacture of the drug.,2017/12/6,2018/7/3,No
14177,2293811,Shortage,APO-LANSOPRAZOLE,APOTEX INC,LANSOPRAZOLE,LANSOPRAZOLE,15MG,100 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/7/21,,2017/10/10,2017/9/29,Disruption of the manufacture of the drug.,2017/6/28,2017/10/3,No
10403,2293838,Shortage,APO-LANSOPRAZOLE,APOTEX INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,100 BTl & 500 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/5/15,2017/10/10,2017/10/4,Disruption of the manufacture of the drug.,2017/5/16,2017/10/5,No
363,2296527,Shortage,APO-LATANOPROST,APOTEX INC,LATANOPROST,LATANOPROST,50MCG,2.5 ml,OPHTHALMIC,Resolved,SOLUTION,S01EE,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2016/4/5,,2018/6/27,Disruption of the manufacture of the drug.,2017/3/11,2020/2/13,No
739,2414155,Shortage,APO-LATANOPROST-TIMOP,APOTEX INC,LATANOPROST-TIMOLOL MALEATE,TIMOLOL LATANOPROST,5MG 50MCG,2.5 ml,OPHTHALMIC,Resolved,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2015/6/8,2018/9/10,2018/9/10,Disruption of the manufacture of the drug.,2017/3/13,2018/9/11,No
667,2256495,Shortage,APO-LEFLUNOMIDE,APOTEX INC,LEFLUNOMIDE,LEFLUNOMIDE,10MG,30 BTL,ORAL,Resolved,TABLET,L04AA,IMMUNOSUPPRESSANTS,2017/5/2,2017/4/14,2017/5/31,2017/5/19,Disruption of the manufacture of the drug.,2017/3/12,2017/5/23,No
3169,2358514,Shortage,APO-LETROZOLE,APOTEX INC,LETROZOLE,LETROZOLE,2.5MG,30 BLS,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,2017/5/23,2017/5/29,2017/7/21,2017/7/19,Disruption of the manufacture of the drug.,2017/3/17,2017/7/20,No
17251,2285932,Shortage,APO-LEVETIRACETAM,APOTEX INC,LEVETIRACETAM,LEVETIRACETAM,500MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017/12/22,2017/12/18,2018/4/6,2018/3/14,Disruption of the manufacture of the drug.,2017/7/26,2018/3/15,No
24262,2285940,Shortage,APO-LEVETIRACETAM,APOTEX INC,LEVETIRACETAM,LEVETIRACETAM,750MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2018/1/12,2018/1/5,2018/3/14,2018/3/14,Disruption of the manufacture of the drug.,2017/10/4,2018/3/15,No
19096,2241575,Shortage,APO-LEVOBUNOLOL OPHTHALMIC SOLUTION USP 0.25%,APOTEX INC,LEVOBUNOLOL,LEVOBUNOLOL HYDROCHLORIDE,0.25%,5/10 ML,OPHTHALMIC,Actual shortage,LIQUID,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2017/3/10,,,Other (Please describe in comments),2017/8/14,2017/10/5,No
19093,2241574,Shortage,APO-LEVOBUNOLOL OPHTHALMIC SOLUTION USP 0.5%,APOTEX INC,LEVOBUNOLOL,LEVOBUNOLOL HYDROCHLORIDE,0.50%,5/10/15 ML,OPHTHALMIC,Actual shortage,LIQUID,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
20108,2195968,Shortage,APO-LEVOCARB - TAB 25MG/250MG,APOTEX INC,LEVOCARB,CARBIDOPA LEVODOPA,25MG 250MG,500 BTL,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,,2017/8/21,2017/11/17,2017/11/8,Disruption of the manufacture of the drug.,2017/8/23,2017/11/9,No
24265,2195968,Shortage,APO-LEVOCARB - TAB 25MG/250MG,APOTEX INC,LEVOCArB,CARBIDOPA LEVODOPA,25MG 250MG,100 BTL,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,,2017/10/2,2017/11/10,2017/11/8,Disruption of the manufacture of the drug.,2017/10/4,2017/11/9,No
23561,2245211,Shortage,APO-LEVOCARB CR,APOTEX INC,LEVOCARB,CARBIDOPA LEVODOPA,50MG 200MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2017/9/22,2017/10/20,2017/10/23,Disruption of the manufacture of the drug.,2017/9/26,2017/10/24,No
20879,2245211,Shortage,APO-LEVOCARB CR,APOTEX INC,LEVOCARB,CARBIDOPA LEVODOPA,50MG 200MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2017/10/13,2017/10/31,2017/10/23,Disruption of the manufacture of the drug.,2017/9/5,2017/10/24,No
8348,2272873,Shortage,APO-LEVOCARB CR,APOTEX INC,LEVOCARB,CARBIDOPA LEVODOPA,25MG 100MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2017/4/25,2017/5/31,2017/5/30,Disruption of the manufacture of the drug.,2017/4/28,2017/5/31,No
10406,2245211,Shortage,APO-LEVOCARB CR,APOTEX INC,LEVOCARB,CARBIDOPA LEVODOPA,50MG 200MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2017/5/15,2017/6/7,2017/6/1,Disruption of the manufacture of the drug.,2017/5/16,2017/6/2,No
366,2284707,Shortage,APO-LEVOFLOXACIN,APOTEX INC,LEVOFLOXACIN,LEVOFLOXACIN,250MG,100 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2017/1/3,2017/4/24,2017/3/15,Disruption of the manufacture of the drug.,2017/3/11,2017/3/16,No
369,2284715,Shortage,APO-LEVOFLOXACIN,APOTEX INC,LEVOFLOXACIN,LEVOFLOXACIN,500MG,100 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2017/3/10,2017/4/24,2017/3/15,Disruption of the manufacture of the drug.,2017/3/11,2017/3/16,No
670,2325942,Shortage,APO-LEVOFLOXACIN,APOTEX INC,LEVOFLOXACIN,LEVOFLOXACIN,750MG,100 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,2017/3/24,2017/3/13,2017/7/26,2017/7/12,Disruption of the manufacture of the drug.,2017/3/12,2017/7/13,No
11077,2217503,Shortage,APO-LISINOPRIL TABLET 10 MG,APOTEX INC,LISINOPRIL,LISINOPRIL,10MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017/6/5,2017/5/29,2017/7/7,2017/6/22,Disruption of the manufacture of the drug.,2017/5/24,2017/6/23,No
8868,2217503,Shortage,APO-LISINOPRIL TABLET 10 MG,APOTEX INC,LISINOPRIL,LISINOPRIL,10MG,500 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017/5/15,2017/5/8,2017/6/30,2017/6/22,Disruption of the manufacture of the drug.,2017/5/4,2017/6/23,No
17150,2217503,Shortage,APO-LISINOPRIL TABLET 10 MG,APOTEX INC,LISINOPRIL,LISINOPRIL,10MG,500 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017/10/31,2017/10/23,2018/6/29,2018/2/5,Disruption of the manufacture of the drug.,2017/7/25,2018/2/9,No
26166,2217511,Shortage,APO-LISINOPRIL TABLET 20 MG,APOTEX INC,LISINOPRIL,LISINOPRIL,20MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/10/16,2018/2/9,2018/1/25,Disruption of the manufacture of the drug.,2017/10/17,2018/1/26,No
21085,2217481,Shortage,APO-LISINOPRIL TABLET 5 MG,APOTEX INC,LISINOPRIL,LISINOPRIL,5MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/9/4,2018/1/22,2017/12/29,Disruption of the manufacture of the drug.,2017/9/6,2017/12/31,No
17254,2242838,Shortage,APO-LITHIUM CARBONATE,APOTEX INC,LITHIUM CARBONATE,LITHIUM CARBONATE,300MG,100 BTL,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,2017/9/8,2017/8/15,2017/11/6,2017/10/30,Disruption of the manufacture of the drug.,2017/7/26,2017/10/31,No
30935,2242837,Shortage,APO-LITHIUM CARBONATE,APOTEX INC,LITHIUM CARBONATE,LITHIUM CARBONATE,150MG,100 BTL,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2017/11/27,2018/1/31,2018/1/9,Disruption of the manufacture of the drug.,2017/11/28,2018/1/10,No
30938,2242838,Shortage,APO-LITHIUM CARBONATE,APOTEX INC,LITHIUM CARBONATE,LITHIUM CARBONATE,300MG,100 BTL,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2017/11/27,2018/1/31,2018/1/9,Disruption of the manufacture of the drug.,2017/11/28,2018/1/10,No
372,2212005,Shortage,APO-LOPERAMIDE - TAB 2MG,APOTEX INC,LOPERAMIDE,LOPERAMIDE HYDROCHLORIDE,2MG,100 BTL,ORAL,Actual shortage,TABLET,A07DA,ANTIPROPULSIVES,,2014/10/9,,,Disruption of the manufacture of the drug.,2017/3/11,2017/10/5,No
13975,2410753,Shortage,APO-LORAZEPAM SUBLINGUAL,APOTEX INC,LORAZEPAM,LORAZEPAM,1MG,100 BTL,SUBLINGUAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/6/26,2017/8/9,2017/8/15,Disruption of the manufacture of the drug.,2017/6/26,2017/8/18,No
375,655740,Shortage,APO-LORAZEPAM TAB 0.5MG,APOTEX INC,LORAZEPAM,LORAZEPAM,0.5MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2016/9/27,2017/8/31,2017/8/7,Disruption of the manufacture of the drug.,2017/3/11,2017/8/8,No
26594,655759,Shortage,APO-LORAZEPAM TAB 1MG,APOTEX INC,LORAZEPAM,LORAZEPAM,1MG,100 BTL & 1000 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/10/23,2018/1/19,2018/1/19,Disruption of the manufacture of the drug.,2017/10/23,2018/1/22,No
722,2353504,Shortage,APO-LOSARTAN,APOTEX INC,LOSARTAN,LOSARTAN POTASSIUM,50MG,100 BTL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/2/1,2017/3/12,2017/3/15,Disruption of the manufacture of the drug.,2017/3/13,2017/3/16,No
26827,2371243,Shortage,APO-LOSARTAN/HCTZ,APOTEX INC,LOSARTAN/HCTZ,HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM,12.5MG 100MG,30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/10/23,2018/11/30,2018/9/10,Disruption of the manufacture of the drug.,2017/10/24,2018/9/11,No
13322,2220172,Shortage,APO-LOVASTATIN - TAB 20MG,APOTEX INC,LOVASTATIN,LOVASTATIN,20MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/6/19,2017/7/20,2017/7/18,Disruption of the manufacture of the drug.,2017/6/19,2017/7/19,No
30941,2220172,Shortage,APO-LOVASTATIN - TAB 20MG,APOTEX INC,LOVASTATIN,LOVASTATIN,20MG,500 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/11/27,2018/9/10,2018/9/10,Disruption of the manufacture of the drug.,2017/11/28,2018/9/11,No
19075,2237651,Shortage,APO-LOXAPINE,APOTEX INC,LOXAPINE,LOXAPINE,5MG,100 BTL,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
19078,2237652,Shortage,APO-LOXAPINE,APOTEX INC,LOXAPINE,LOXAPINE,10MG,100 BTL,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
19081,2237653,Shortage,APO-LOXAPINE,APOTEX INC,LOXAPINE,LOXAPINE,25MG,100 BTL,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
19084,2237654,Shortage,APO-LOXAPINE,APOTEX INC,LOXAPINE,LOXAPINE,50MG,100 BTL,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
14186,2277298,Shortage,APO-MEDROXY,APOTEX INC,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,10MG,100 BTL,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,2017/8/31,2017/8/15,2017/11/17,2017/10/26,Disruption of the manufacture of the drug.,2017/6/28,2017/10/27,No
5997,2277298,Shortage,APO-MEDROXY,APOTEX INC,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,10MG,100 BTL,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,2017/4/28,,2017/5/25,2017/5/17,Disruption of the manufacture of the drug.,2017/4/7,2017/5/18,No
24268,2267640,Shortage,APO-MEDROXY,APOTEX INC,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,100MG,100 BTL,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,,2017/10/2,2017/11/15,2017/11/1,Disruption of the manufacture of the drug.,2017/10/4,2017/11/2,No
14183,2244726,Shortage,APO-MEDROXY TABLETS,APOTEX INC,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,2.5MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,2017/9/8,2017/9/4,2017/11/17,2017/10/25,Disruption of the manufacture of the drug.,2017/6/28,2017/10/26,No
586,2396467,Shortage,APO-MELOXICAM,APOTEX INC,MELOXICAM,MELOXICAM,1.5G,32 ML & 10 ML,ORAL,Resolved,SUSPENSION,,,,2017/3/10,,2019/11/22,Disruption of the manufacture of the drug.,2017/3/11,2019/11/25,No
589,2396467,Shortage,APO-MELOXICAM,APOTEX INC,MELOXICAM,MELOXICAM,1.5G,100 ML & 180 ML,ORAL,Resolved,SUSPENSION,,,,2017/3/10,,2018/5/1,Disruption of the manufacture of the drug.,2017/3/11,2018/5/2,No
378,2248974,Shortage,APO-MELOXICAM,APOTEX INC,MELOXICAM,MELOXICAM,15MG,100 BTL,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/3/10,2017/7/28,2017/7/12,Disruption of the manufacture of the drug.,2017/3/11,2017/7/13,No
8871,2248973,Shortage,APO-MELOXICAM,APOTEX INC,MELOXICAM,MELOXICAM,7.5MG,500 BTL,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/9/18,,,2017/10/2,Disruption of the manufacture of the drug.,2017/5/4,2017/10/5,No
10424,2248973,Shortage,APO-MELOXICAM,APOTEX INC,MELOXICAM,MELOXICAM,7.5MG,500 BTL,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/5/15,2017/7/31,2017/7/12,Disruption of the manufacture of the drug.,2017/5/16,2017/7/13,No
14191,2366487,Shortage,APO-MEMANTINE,APOTEX INC,MEMANTINE,MEMANTINE HYDROCHLORIDE,10MG,100 BTL,ORAL,Resolved,TABLET,N06DX,ANTI-DEMENTIA DRUGS,2017/8/31,2017/8/18,2020/6/5,2020/5/29,Disruption of the manufacture of the drug.,2017/6/28,2020/6/3,No
381,2366487,Shortage,APO-MEMANTINE,APOTEX INC,MEMANTINE,MEMANTINE HYDROCHLORIDE,10MG,30 BLS,ORAL,Resolved,TABLET,N06DX,ANTI-DEMENTIA DRUGS,,2017/2/6,2017/3/24,2017/3/20,Disruption of the manufacture of the drug.,2017/3/11,2017/4/4,No
19320,2258935,Shortage,APO-METHIMAZOLE,APOTEX INC,METHIMAZOLE,THIAMAZOLE,5MG,100 BTL,ORAL,Actual shortage,TABLET,H03BB,ANTITHYROID PREPARATIONS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
592,2249324,Shortage,APO-METHYLPHENIDATE,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,10MG,100 BTL,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/3/10,2017/4/4,2017/4/3,Disruption of the manufacture of the drug.,2017/3/11,2017/4/4,No
30084,2249332,Shortage,APO-METHYLPHENIDATE,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,20MG,100 BTL,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/11/21,2018/2/2,2018/1/24,Disruption of the manufacture of the drug.,2017/11/22,2018/1/25,No
16938,2452758,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,27MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/7/24,2017/11/16,2017/11/2,Disruption of the manufacture of the drug.,2017/7/25,2017/11/3,No
16942,2452766,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,36MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/7/24,2017/9/8,2017/8/30,Disruption of the manufacture of the drug.,2017/7/25,2017/8/31,No
384,2452766,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,36MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/1/31,2017/4/16,2017/3/31,Disruption of the manufacture of the drug.,2017/3/11,2017/4/1,No
387,2330377,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,54MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2016/12/20,2017/4/16,2017/3/31,Disruption of the manufacture of the drug.,2017/3/11,2017/4/1,No
28553,2452766,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,36MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/11/6,2018/1/12,2018/1/8,Disruption of the manufacture of the drug.,2017/11/7,2018/1/10,No
25292,2330377,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,54MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/10/9,2018/1/31,2018/1/22,Disruption of the manufacture of the drug.,2017/10/11,2018/1/23,No
390,2285177,Shortage,APO-METOPROLOL SR,APOTEX INC,METOPROLOL,METOPROLOL TARTRATE,200MG,100 BTL,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C07AB,BETA BLOCKING AGENTS,,2015/8/7,,,Disruption of the manufacture of the drug.,2017/3/11,2017/10/5,No
29969,2084104,Shortage,APO-MINOCYCLINE CAP 100MG,APOTEX INC,MINOCYCLINE,MINOCYCLINE,100MG,100 BTL,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,,2017/11/20,2018/2/2,2018/2/2,Disruption of the manufacture of the drug.,2017/11/21,2018/2/6,No
12680,2084104,Shortage,APO-MINOCYCLINE CAP 100MG,APOTEX INC,MINOCYCLINE,MINOCYCLINE,100MG,100 BTL,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,,2017/6/12,2017/7/24,2017/7/18,Disruption of the manufacture of the drug.,2017/6/13,2017/7/19,No
8612,2084104,Shortage,APO-MINOCYCLINE CAP 100MG,APOTEX INC,MINOCYCLINE,MINOCYCLINE,100MG,100 BTL,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,,2017/5/1,2017/6/2,2017/6/5,Disruption of the manufacture of the drug.,2017/5/2,2017/6/5,No
31013,2084090,Shortage,APO-MINOCYCLINE CAP 50MG,APOTEX INC,MINOCYCLINE,MINOCYCLINE,50MG,100 BTL,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,2017/12/28,2017/12/11,2018/2/23,2018/1/19,Disruption of the manufacture of the drug.,2017/11/29,2018/1/22,No
12355,2084090,Shortage,APO-MINOCYCLINE CAP 50MG,APOTEX INC,MINOCYCLINE,MINOCYCLINE,50MG,100 BTL,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,2017/6/30,2017/6/19,2017/7/24,2017/7/18,Disruption of the manufacture of the drug.,2017/6/9,2017/7/19,No
15370,2286629,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,30MG,100 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017/7/10,2017/10/20,2017/10/16,Disruption of the manufacture of the drug.,2017/7/11,2017/10/17,No
19226,2286610,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,15MG,30 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017/8/14,2017/9/27,2017/9/29,Disruption of the manufacture of the drug.,2017/8/14,2017/10/3,No
3909,2286610,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,15MG,30 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2017/4/5,2017/3/27,2017/5/12,2017/4/19,Disruption of the manufacture of the drug.,2017/3/22,2017/5/2,No
12358,2286637,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,45MG,30 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2017/6/26,2017/6/12,2017/8/31,2017/8/7,Disruption of the manufacture of the drug.,2017/6/9,2017/8/8,No
393,2286629,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,30MG,100 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017/2/6,2017/4/28,2017/5/4,Disruption of the manufacture of the drug.,2017/3/11,2017/5/10,No
396,2286637,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,45MG,30 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017/2/22,2017/3/27,2017/3/22,Disruption of the manufacture of the drug.,2017/3/11,2017/3/23,No
8874,2286610,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,15MG,30 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2017/5/26,2017/5/15,2017/6/27,2017/6/14,Disruption of the manufacture of the drug.,2017/5/4,2017/6/15,No
10429,2286629,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,30MG,100 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017/5/15,2017/6/23,2017/6/12,Disruption of the manufacture of the drug.,2017/5/16,2017/6/15,No
24271,2286637,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,45MG,30 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017/10/2,2017/10/25,2017/10/16,Disruption of the manufacture of the drug.,2017/10/4,2017/10/17,No
15959,2403587,Shortage,APO-MOMETASONE,APOTEX INC,MOMETASONE,MOMETASONE FUROATE,50MCG,50MCG/SPRY 140MS,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2017/7/17,2017/8/18,2017/8/17,Disruption of the manufacture of the drug.,2017/7/17,2017/8/18,No
32813,2374609,Shortage,APO-MONTELUKAST,APOTEX INC,MONTELUKAST,MONTELUKAST,10MG,100 BTL,ORAL,Resolved,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2017/12/11,2018/3/9,2018/2/14,Disruption of the manufacture of the drug.,2017/12/14,2018/2/15,No
28556,2404923,Shortage,APO-MOXIFLOXACIN,APOTEX INC,MOXIFLOXACIN,MOXIFLOXACIN,400MG,30 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2017/11/6,2018/3/30,2018/3/26,Disruption of the manufacture of the drug.,2017/11/7,2018/3/27,No
399,2404923,Shortage,APO-MOXIFLOXACIN,APOTEX INC,MOXIFLOXACIN,MOXIFLOXACIN,400MG,30 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2017/2/16,2017/5/8,2017/4/26,Disruption of the manufacture of the drug.,2017/3/11,2017/4/27,No
8877,2352567,Shortage,APO-MYCOPHENOLATE,APOTEX INC,MYCOPHENOLATE,MYCOPHENOLATE MOFETIL,500MG,50 BLS,ORAL,Resolved,TABLET,L04AA,IMMUNOSUPPRESSANTS,2017/6/8,,2017/6/28,2017/6/28,Disruption of the manufacture of the drug.,2017/5/4,2017/7/4,No
20927,2352567,Shortage,APO-MYCOPHENOLATE,APOTEX INC,MYCOPHENOLATE,MYCOPHENOLATE MOFETIL,500MG,50 BLS,ORAL,Resolved,TABLET,L04AA,IMMUNOSUPPRESSANTS,2017/9/29,2017/10/2,2017/10/20,2017/10/13,Disruption of the manufacture of the drug.,2017/9/5,2017/10/16,No
25296,2238639,Shortage,APO-NABUMETONE,APOTEX INC,NABUMETONE,NABUMETONE,500MG,100 BTL,ORAL,Resolved,TABLET,M01AX,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/10/9,2018/8/15,2018/8/21,Disruption of the manufacture of the drug.,2017/10/11,2018/8/22,No
31016,2444275,Shortage,APO-NALTREXONE,APOTEX INC,NALTREXONE,NALTREXONE HYDROCHLORIDE,50MG,30 BTL,ORAL,Resolved,TABLET,N07BB,DRUGS USED IN ADDICTIVE DISORDERS,2017/12/15,2017/12/12,2018/3/2,2018/1/15,Disruption of the manufacture of the drug.,2017/11/29,2018/1/16,No
25299,2444275,Shortage,APO-NALTREXONE,APOTEX INC,NALTREXONE,NALTREXONE HYDROCHLORIDE,50MG,30 BTL,ORAL,Resolved,TABLET,N07BB,DRUGS USED IN ADDICTIVE DISORDERS,,2017/10/9,2017/11/30,2017/10/24,Disruption of the manufacture of the drug.,2017/10/11,2017/10/25,No
11082,1940309,Shortage,APO-NAPRO-NA DS TAB 550MG,APOTEX INC,NAPROXEN,NAPROXEN SODIUM,550MG,100 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/11/30,2017/11/1,2018/10/31,2018/10/4,Disruption of the manufacture of the drug.,2017/5/24,2018/10/5,No
24274,592277,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN,NAPROXEN,500MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/12/13,2018/2/28,2018/2/28,Disruption of the manufacture of the drug.,2017/10/4,2018/3/1,No
20882,2246701,Shortage,APO-NAPROXEN EC TABLETS,APOTEX INC,NAPROXEN,NAPROXEN,500MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/10/2,2017/9/22,2018/8/8,2018/7/30,Disruption of the manufacture of the drug.,2017/9/5,2018/7/31,No
19015,2177072,Shortage,APO-NAPROXEN SR TABLETS 750MG,APOTEX INC,NAPROXEN,NAPROXEN,750MG,100 BTL,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
12069,2427931,Shortage,APO-NEVIRAPINE XR,APOTEX INC,NEVIRAPINE,NEVIRAPINE,400MG,30 BLS,ORAL,Resolved,TABLET (EXTENDED-RELEASE),J05AG,DIRECT ACTING ANTIVIRALS,,2017/6/5,,2017/8/29,Disruption of the manufacture of the drug.,2017/6/6,2017/8/30,No
19018,2181525,Shortage,APO-NIFED PA - SRT 20MG,APOTEX INC,NIFEDIPINE,NIFEDIPINE,20MG,100 BTL & 500 BTL/60 BLS,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
19021,2197448,Shortage,APO-NIFED PA - TAB 10MG,APOTEX INC,NIFEDIPINE,NIFEDIPINE,10MG,100 BTL & 500 BTL/60 BLS,ORAL,Actual shortage,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
402,2393433,Shortage,APO-NITROGLYCERIN,APOTEX INC,NITROGLYCERIN,NITROGLYCERIN,0.4MG,200 METERED DOSES,SUBLINGUAL,Resolved,METERED-DOSE PUMP,C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2017/6/12,,2018/2/23,Other (Please describe in comments),2017/3/11,2018/2/26,No
405,2248398,Shortage,APO-OFLOXACIN,APOTEX INC,OFLOXACIN,OFLOXACIN,0.30%,5 ML,OPHTHALMIC,Resolved,SOLUTION,S01AE,ANTIINFECTIVES,,2014/5/8,,2019/1/7,Disruption of the manufacture of the drug.,2017/3/11,2019/1/8,No
26625,2281791,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,2.5MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017/10/23,2018/1/15,2017/12/19,Disruption of the manufacture of the drug.,2017/10/23,2017/12/20,No
28689,2281813,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,7.5MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017/11/6,2018/1/31,2018/1/9,Disruption of the manufacture of the drug.,2017/11/9,2018/1/10,No
32818,2281848,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,15.0MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017/12/11,2018/4/27,2018/4/4,Disruption of the manufacture of the drug.,2017/12/14,2018/4/5,No
17257,2281813,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,7.5MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2017/8/18,2017/7/31,2017/10/6,2017/10/2,Disruption of the manufacture of the drug.,2017/7/26,2017/10/5,No
20113,2281821,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,10.0MG,500 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017/8/22,2017/10/4,2017/9/29,Disruption of the manufacture of the drug.,2017/8/23,2017/10/3,No
28564,2281821,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,10.0MG,500 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017/11/6,2018/1/15,2018/1/10,Disruption of the manufacture of the drug.,2017/11/7,2018/1/11,No
677,2281848,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,15.0MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2017/4/24,2017/4/25,2017/6/3,2017/6/3,Disruption of the manufacture of the drug.,2017/3/12,2017/6/5,No
9933,2281813,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,7.5MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017/5/8,2017/6/12,2017/6/9,Disruption of the manufacture of the drug.,2017/5/10,2017/6/13,No
9954,2333015,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,20.0MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017/5/5,2017/6/3,2017/6/3,Disruption of the manufacture of the drug.,2017/5/10,2017/6/5,No
29036,2360624,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,10MG,30 BLS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017/11/13,2018/8/20,2018/8/14,Disruption of the manufacture of the drug.,2017/11/13,2018/8/15,No
18546,2360632,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,15MG,30 BLS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017/8/7,2017/8/31,2017/8/21,Disruption of the manufacture of the drug.,2017/8/9,2017/8/23,No
12689,2360640,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,20MG,30 BLS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017/6/12,2017/7/21,2017/7/31,Disruption of the manufacture of the drug.,2017/6/13,2017/7/31,No
29348,2360632,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,15MG,100 BTL,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017/11/10,2018/2/28,2018/1/30,Disruption of the manufacture of the drug.,2017/11/16,2018/1/31,No
24277,2360640,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,20MG,30 BLS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017/10/2,2018/2/28,2018/1/26,Disruption of the manufacture of the drug.,2017/10/4,2018/1/29,No
19231,2453452,Shortage,APO-OLMESARTAN,APOTEX INC,OLMESARTAN MEDOXOMIL,OLMESARTAN MEDOXOMIL,20MG,30 BLS,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/8/10,2018/1/29,2018/1/18,Disruption of the manufacture of the drug.,2017/8/14,2018/1/19,No
17614,2453460,Shortage,APO-OLMESARTAN,APOTEX INC,OLMESARTAN MEDOXOMIL,OLMESARTAN MEDOXOMIL,40MG,100 BTL & 30 BLS,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/7/31,2018/1/22,2018/1/19,Disruption of the manufacture of the drug.,2017/8/1,2018/1/20,No
16900,2453606,Shortage,APO-OLMESARTAN/HCTZ,APOTEX INC,OLMESARTAN-HCTZ,HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL,12.5MG 20MG,100 BTL & 30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/12/11,2018/4/30,2018/4/20,Disruption of the manufacture of the drug.,2017/7/25,2018/4/23,No
16905,2453614,Shortage,APO-OLMESARTAN/HCTZ,APOTEX INC,OLMESARTAN-HCTZ,HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL,12.5MG 40MG,100 BTL & 30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/12/18,2018/4/30,2018/4/20,Disruption of the manufacture of the drug.,2017/7/25,2018/4/23,No
16895,2453622,Shortage,APO-OLMESARTAN/HCTZ,APOTEX INC,OLMESARTAN-HCTZ,HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL,25MG 40MG,30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/7/21,2017/12/29,2017/11/16,Disruption of the manufacture of the drug.,2017/7/25,2017/11/17,No
11567,2402823,Shortage,APO-OLOPATADINE,APOTEX INC,OLOPATADINE,OLOPATADINE,0.20%,2.5 ML,OPHTHALMIC,Resolved,SOLUTION,S01GX,DECONGESTANTS AND ANTIALLERGICS,,2017/5/29,2017/6/30,2017/6/29,Disruption of the manufacture of the drug.,2017/5/30,2017/6/30,No
408,2245058,Shortage,APO-OMEPRAZOLE,APOTEX INC,OMEPRAZOLE,OMEPRAZOLE,20MG,100 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/3/10,2017/4/4,2017/4/3,Disruption of the manufacture of the drug.,2017/3/11,2017/4/4,No
674,2245058,Shortage,APO-OMEPRAZOLE,APOTEX INC,OMEPRAZOLE,OMEPRAZOLE,20MG,500 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/3/26,,2017/4/4,2017/4/3,Disruption of the manufacture of the drug.,2017/3/12,2017/4/4,No
32822,2288184,Shortage,APO-ONDANSETRON,APOTEX INC,ONDANSETRON,ONDANSETRON,4MG,10 BLS,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017/12/8,2018/9/21,2018/9/25,Disruption of the manufacture of the drug.,2017/12/14,2018/9/28,No
411,2243661,Shortage,APO-OXAPROZIN,APOTEX INC,OXAPROZIN,OXAPROZIN,600MG,100 BTL,ORAL,Actual shortage,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2012/3/23,,,Disruption of the manufacture of the drug.,2017/3/11,2017/10/5,No
19045,2231089,Shortage,APO-OXYBUTYNIN,APOTEX INC,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,1MG,473 ML,ORAL,Actual shortage,SYRUP,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
14201,2163543,Shortage,APO-OXYBUTYNIN - TAB 5MG,APOTEX INC,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,5MG,100 BTL,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/7/31,2017/7/10,2018/12/21,2018/11/29,Disruption of the manufacture of the drug.,2017/6/28,2018/11/30,No
414,2163543,Shortage,APO-OXYBUTYNIN - TAB 5MG,APOTEX INC,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,5 MG,500 BTL,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/2/22,2017/5/10,2017/3/31,Disruption of the manufacture of the drug.,2017/3/11,2017/4/3,No
5865,2163543,Shortage,APO-OXYBUTYNIN - TAB 5MG,APOTEX INC,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,5MG,500 BTL,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",0017-04-24,2017/4/21,2018/12/21,2018/11/29,Disruption of the manufacture of the drug.,2017/4/7,2018/11/30,No
16912,2366746,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,5.0MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017/7/21,2017/9/29,2017/9/29,Disruption of the manufacture of the drug.,2017/7/25,2017/10/3,No
33867,2306530,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,40MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017/12/18,2018/3/30,2018/3/20,Disruption of the manufacture of the drug.,2017/12/20,2018/3/21,No
17260,2306530,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,40MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,2017/8/1,2017/7/31,2017/11/3,2017/10/23,Disruption of the manufacture of the drug.,2017/7/26,2017/10/24,No
17263,2366789,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,80.0MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,2017/8/8,2017/7/31,2017/9/18,2017/9/20,Disruption of the manufacture of the drug.,2017/7/26,2017/9/22,No
417,2366754,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,10.0MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2014/3/27,,2018/5/15,Disruption of the manufacture of the drug.,2017/3/11,2018/5/16,No
420,2394774,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,30MG,30 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2014/3/27,,2018/9/3,Disruption of the manufacture of the drug.,2017/3/11,2018/9/19,No
423,2366762,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,20.0MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017/3/10,2017/5/26,2017/5/23,Disruption of the manufacture of the drug.,2017/3/11,2017/5/24,No
8615,2306530,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,40MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017/5/1,2017/5/31,2017/6/2,Disruption of the manufacture of the drug.,2017/5/2,2017/6/5,No
25304,2366762,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,20.0MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017/10/9,2018/3/30,2018/3/12,Disruption of the manufacture of the drug.,2017/10/11,2018/3/13,No
17266,2324628,Shortage,APO-OXYCODONE/ACET,APOTEX INC,OXYCODONE+ACETAMINOPHEN,ACETAMINOPHEN OXYCODONE HYDROCHLORIDE,325MG 5MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,N02AJ,OPIOIDS,,2017/12/18,2018/3/30,2018/3/16,Disruption of the manufacture of the drug.,2017/7/26,2018/3/17,No
426,2324628,Shortage,APO-OXYCODONE/ACET,APOTEX INC,OXYCODONE/ACET,ACETAMINOPHEN OXYCODONE HYDROCHLORIDE,325MG 5MG,500 BTL,ORAL,Resolved,TABLET,N02AJ,,,2017/3/10,2017/4/12,2017/4/6,Disruption of the manufacture of the drug.,2017/3/11,2017/4/7,No
9936,2324628,Shortage,APO-OXYCODONE/ACET,APOTEX INC,OXYCODONE+ACETAMINOPHEN,ACETAMINOPHEN OXYCODONE HYDROCHLORIDE,325MG 5MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,N02AJ,,,2017/6/1,2017/6/30,2017/6/30,Disruption of the manufacture of the drug.,2017/5/10,2017/7/4,No
19133,2248844,Shortage,APO-PACLITAXEL INJECTABLE,APOTEX INC,PACLITAXEL,PACLITAXEL,6MG,5/25/50 ML,INTRAVENOUS,Actual shortage,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
21090,2292920,Shortage,APO-PANTOPRAZOLE,APOTEX INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,100 BTL,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/9/4,2017/9/27,2017/9/29,Disruption of the manufacture of the drug.,2017/9/6,2017/10/3,No
17296,2292920,Shortage,APO-PANTOPRAZOLE,APOTEX INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500 BTL,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/7/31,2017/7/31,2017/9/15,2017/8/25,Disruption of the manufacture of the drug.,2017/7/26,2017/8/28,No
8723,2240908,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE,PAROXETINE,20MG,100 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/5/2,2017/7/14,2017/6/27,Disruption of the manufacture of the drug.,2017/5/2,2017/6/28,No
3175,2240907,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE,PAROXETINE,10MG,100 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/4/30,2017/5/1,2017/7/10,2017/6/22,Disruption of the manufacture of the drug.,2017/3/17,2017/6/23,No
29039,2240908,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE,PAROXETINE,20MG,30 BLS,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/11/13,2018/5/15,2018/4/5,Disruption of the manufacture of the drug.,2017/11/13,2018/4/6,No
31910,2240909,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE,PAROXETINE,30MG,100 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/12/4,2018/3/30,2018/3/8,Disruption of the manufacture of the drug.,2017/12/6,2018/3/8,No
10434,2240909,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE,PAROXETINE,30MG,100 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/8/21,2017/10/31,2017/10/25,Disruption of the manufacture of the drug.,2017/5/16,2017/10/27,No
3529,2240908,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE,PAROXETINE,20MG,30 BLS,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/3/20,2017/7/21,2017/7/10,Disruption of the manufacture of the drug.,2017/3/20,2017/7/11,No
30954,2240907,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE,PAROXETINE,10MG,100 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/11/27,2018/3/30,2018/3/2,Disruption of the manufacture of the drug.,2017/11/28,2018/3/5,No
31913,2460912,Shortage,APO-PHENYTOIN SODIUM,APOTEX INC,PHENYTOIN,PHENYTOIN SODIUM,100MG,100 BTL,ORAL,Resolved,CAPSULE,N03AB,ANTIEPILEPTICS,,2018/1/22,2018/4/30,2018/4/25,Disruption of the manufacture of the drug.,2017/12/6,2018/4/26,No
7231,2292378,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100 BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2017/4/19,2017/5/26,2017/5/19,Disruption of the manufacture of the drug.,2017/4/19,2017/5/24,No
27721,2292378,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100 BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2017/10/30,2018/1/12,2017/12/18,Disruption of the manufacture of the drug.,2017/11/1,2017/12/19,No
17309,2292386,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,100 BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017/8/1,2017/7/31,2017/10/31,2017/10/19,Disruption of the manufacture of the drug.,2017/7/26,2017/10/20,No
17312,2292394,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.0MG,100 BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017/8/18,2017/9/4,2017/10/31,2017/10/19,Disruption of the manufacture of the drug.,2017/7/26,2017/10/20,No
680,2292386,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,100 BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017/3/24,2017/4/10,2017/6/2,2017/5/30,Disruption of the manufacture of the drug.,2017/3/12,2017/5/31,No
683,2292394,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.0MG,100 BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017/3/24,2017/3/24,2017/6/2,2017/6/3,Disruption of the manufacture of the drug.,2017/3/12,2017/6/5,No
11038,2243506,Shortage,APO-PRAVASTATIN,APOTEX INC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/5/22,2017/12/22,2017/12/18,Disruption of the manufacture of the drug.,2017/5/24,2017/12/20,No
23619,2243508,Shortage,APO-PRAVASTATIN,APOTEX INC,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/9/25,2017/12/15,2017/11/22,Disruption of the manufacture of the drug.,2017/9/27,2017/11/23,No
12361,2243506,Shortage,APO-PRAVASTATIN,APOTEX INC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/7/14,2017/6/26,2017/8/31,2017/8/23,Disruption of the manufacture of the drug.,2017/6/9,2017/9/22,No
595,2243507,Shortage,APO-PRAVASTATIN,APOTEX INC,PRAVASTATIN,PRAVASTATIN SODIUM,20MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/8/7,2017/8/28,2017/8/28,Disruption of the manufacture of the drug.,2017/3/11,2017/8/31,No
444,2243508,Shortage,APO-PRAVASTATIN,APOTEX INC,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/7/31,2017/9/5,2017/8/24,Disruption of the manufacture of the drug.,2017/3/11,2017/8/25,No
3533,2243506,Shortage,APO-PRAVASTATIN,APOTEX INC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/3/20,2017/4/30,2017/4/21,Disruption of the manufacture of the drug.,2017/3/20,2017/4/24,No
24280,2243506,Shortage,APO-PRAVASTATIN,APOTEX INC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/10/2,2017/12/22,2017/11/6,Disruption of the manufacture of the drug.,2017/10/4,2017/11/7,No
24283,2243507,Shortage,APO-PRAVASTATIN,APOTEX INC,PRAVASTATIN,PRAVASTATIN SODIUM,20MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/10/2,2017/12/22,2017/11/6,Disruption of the manufacture of the drug.,2017/10/4,2017/11/7,No
31019,882828,Shortage,APO-PRAZO TAB 2MG,APOTEX INC,PRAZOSIN,PRAZOSIN,2MG,100 BTL,ORAL,Resolved,TABLET,C02CA,"ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",2017/12/20,2017/12/19,2018/3/2,2018/1/26,Disruption of the manufacture of the drug.,2017/11/29,2018/1/29,No
7704,2394251,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,75MG,100 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/4/21,2017/5/8,2017/5/8,Disruption of the manufacture of the drug.,2017/4/24,2017/5/10,No
11041,2394294,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,300MG,100 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/5/22,2017/9/15,2017/9/15,Disruption of the manufacture of the drug.,2017/5/24,2017/9/22,No
23623,2394278,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,150MG,500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/9/25,2017/12/8,2017/10/27,Disruption of the manufacture of the drug.,2017/9/27,2017/10/30,No
23626,2394235,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,25MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/9/25,2018/2/15,2018/1/18,Disruption of the manufacture of the drug.,2017/9/27,2018/1/19,No
23629,2394243,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,50MG,100 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/9/25,2018/2/5,2018/1/18,Disruption of the manufacture of the drug.,2017/9/27,2018/1/19,No
18553,2394286,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,225MG,100 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/8/7,2017/9/15,2017/9/15,Disruption of the manufacture of the drug.,2017/8/9,2017/9/22,No
12695,2394243,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,50MG,500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/6/12,2018/2/5,2018/1/18,Disruption of the manufacture of the drug.,2017/6/13,2018/1/19,No
447,2394278,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,150MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2016/9/7,2017/6/9,2017/5/8,Disruption of the manufacture of the drug.,2017/3/11,2017/5/10,No
450,2394243,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,50MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/2/14,2017/6/9,2017/5/8,Disruption of the manufacture of the drug.,2017/3/11,2017/5/10,No
456,2394251,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,75MG,500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2016/9/7,2017/6/9,2017/5/8,Disruption of the manufacture of the drug.,2017/3/11,2017/5/10,No
728,2394235,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,25MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/2/1,2017/6/9,2017/5/8,Disruption of the manufacture of the drug.,2017/3/13,2017/10/10,No
18976,713325,Shortage,APO-PROCAINAMIDE CAP 250MG,APOTEX INC,PROCAINAMIDE,PROCAINAMIDE HYDROCHLORIDE,250MG,100 BTL,ORAL,Actual shortage,CAPSULE,C01BA,"ANTIARRHYTHMICS, CLASS I AND III",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
18979,713333,Shortage,APO-PROCAINAMIDE CAP 375MG,APOTEX INC,PROCAINAMIDE,PROCAINAMIDE HYDROCHLORIDE,375G,100 BTL,ORAL,Actual shortage,CAPSULE,C01BA,"ANTIARRHYTHMICS, CLASS I AND III",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
18982,713341,Shortage,APO-PROCAINAMIDE CAP 500MG,APOTEX INC,PROCAINAMIDE,PROCAINAMIDE HYDROCHLORIDE,500MG,100 BTL,ORAL,Actual shortage,CAPSULE,C01BA,"ANTIARRHYTHMICS, CLASS I AND III",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
23632,2243324,Shortage,APO-PROPAFENONE,APOTEX INC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,150MG,100 BTL,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",,2017/9/22,2018/9/28,2018/8/29,Disruption of the manufacture of the drug.,2017/9/27,2018/8/30,No
20885,2243324,Shortage,APO-PROPAFENONE,APOTEX INC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,150MG,100 BTL,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",2017/10/10,2017/10/2,2017/11/30,2017/10/26,Disruption of the manufacture of the drug.,2017/9/5,2017/10/27,No
8880,2243324,Shortage,APO-PROPAFENONE,APOTEX INC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,150MG,100 BTL,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",2017/6/23,2017/6/5,2017/7/31,2017/7/12,Disruption of the manufacture of the drug.,2017/5/4,2017/7/13,No
460,2243325,Shortage,APO-PROPAFENONE,APOTEX INC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,300MG,100 BTL,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",,2017/12/18,2018/9/28,2018/8/29,Disruption of the manufacture of the drug.,2017/3/11,2018/8/30,No
23635,2313901,Shortage,APO-QUETIAPINE,APOTEX INC,QUETIAPINE,QUETIAPINE,25MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017/9/22,2018/1/22,2018/1/2,Disruption of the manufacture of the drug.,2017/9/27,2018/1/3,No
26195,2313928,Shortage,APO-QUETIAPINE,APOTEX INC,QUETIAPINE,QUETIAPINE,100MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017/10/16,2018/1/25,2018/1/12,Disruption of the manufacture of the drug.,2017/10/18,2018/1/13,No
27735,2313944,Shortage,APO-QUETIAPINE,APOTEX INC,QUETIAPINE,QUETIAPINE,300MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017/10/30,2018/1/31,2018/1/12,Disruption of the manufacture of the drug.,2017/11/1,2018/1/13,No
20888,2313936,Shortage,APO-QUETIAPINE,APOTEX INC,QUETIAPINE,QUETIAPINE,200MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2017/10/31,2017/10/16,2018/2/2,2018/1/19,Disruption of the manufacture of the drug.,2017/9/5,2018/1/24,No
8883,2313936,Shortage,APO-QUETIAPINE,APOTEX INC,QUETIAPINE,QUETIAPINE,200MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2017/5/22,2017/5/15,2017/7/7,2017/6/30,Disruption of the manufacture of the drug.,2017/5/4,2017/7/4,No
8702,2313928,Shortage,APO-QUETIAPINE,APOTEX INC,QUETIAPINE,QUETIAPINE,100MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017/5/1,2017/7/10,2017/6/26,Disruption of the manufacture of the drug.,2017/5/2,2017/6/27,No
17315,2248500,Shortage,APO-QUINAPRIL,APOTEX INC,QUINAPRIL,QUINAPRIL,10MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017/8/31,2017/8/7,2017/10/20,2017/10/16,Disruption of the manufacture of the drug.,2017/7/26,2017/10/18,No
453,2248500,Shortage,APO-QUINAPRIL,APOTEX INC,QUINAPRIL,QUINAPRIL,10MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/3/10,2017/5/1,2017/5/1,Disruption of the manufacture of the drug.,2017/3/11,2017/5/2,No
463,2248500,Shortage,APO-QUINAPRIL,APOTEX INC,QUINAPRIL,QUINAPRIL,10MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2016/11/1,2017/5/1,2017/5/31,Disruption of the manufacture of the drug.,2017/3/11,2017/6/5,No
31022,2408767,Shortage,APO-QUINAPRIL/HCTZ,APOTEX INC,QUINAPRIL - HCTZ,HYDROCHLOROTHIAZIDE QUINAPRIL,12.5MG 10MG,100 BTL & 30 BLS,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",2017/12/15,2017/12/11,2018/5/31,2018/4/17,Disruption of the manufacture of the drug.,2017/11/29,2018/4/18,No
31025,2408783,Shortage,APO-QUINAPRIL/HCTZ,APOTEX INC,QUINAPRIL/HCTZ,HYDROCHLOROTHIAZIDE QUINAPRIL,25MG 20MG,100 BTL & 30 BLS,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",2017/12/27,2017/12/11,2018/11/2,2018/11/1,Disruption of the manufacture of the drug.,2017/11/29,2018/11/2,No
23638,2408775,Shortage,APO-QUINAPRIL/HCTZ,APOTEX INC,QUINAPRIL - HCTZ,HYDROCHLOROTHIAZIDE QUINAPRIL,12.5MG 20MG,100 BTL,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017/9/22,2018/5/4,2018/3/28,Disruption of the manufacture of the drug.,2017/9/27,2018/3/29,No
20891,2408775,Shortage,APO-QUINAPRIL/HCTZ,APOTEX INC,QUINAPRIL - HCTZ,HYDROCHLOROTHIAZIDE QUINAPRIL,12.5MG 20MG,30 BLS,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017/12/18,2018/6/8,2018/4/13,Disruption of the manufacture of the drug.,2017/9/5,2018/4/15,No
32809,2254514,Shortage,APO-QUININE CAPSULES,APOTEX INC,QUININE,QUININE SULFATE,200MG,100 BTL,ORAL,Resolved,CAPSULE,P01BC,ANTIMALARIALS,,2017/12/11,2018/5/4,2018/4/16,Disruption of the manufacture of the drug.,2017/12/14,2018/4/17,No
20894,2254522,Shortage,APO-QUININE CAPSULES,APOTEX INC,QUININE,QUININE SULFATE,300MG,100 BTL,ORAL,Resolved,CAPSULE,P01BC,ANTIMALARIALS,2017/10/31,2017/10/2,2018/5/4,2018/4/16,Disruption of the manufacture of the drug.,2017/9/5,2018/4/17,No
15375,2345587,Shortage,APO-RABEPRAZOLE,APOTEX INC,RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/7/10,2017/7/31,2017/7/26,Disruption of the manufacture of the drug.,2017/7/11,2017/7/27,No
6516,2345579,Shortage,APO-RABEPRAZOLE,APOTEX INC,RABEPRAZOLE,RABEPRAZOLE SODIUM,10MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/4/10,2017/5/29,2017/5/24,Disruption of the manufacture of the drug.,2017/4/11,2017/5/25,No
466,2345587,Shortage,APO-RABEPRAZOLE,APOTEX INC,RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2016/12/20,2017/5/19,2017/5/19,Disruption of the manufacture of the drug.,2017/3/11,2017/5/23,No
8705,2251515,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,1.25MG,100 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/5/1,2017/5/31,2017/6/8,Disruption of the manufacture of the drug.,2017/5/2,2017/6/9,No
8707,2251515,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,1.25MG,30 BLS,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/5/1,2017/6/15,2017/6/8,Disruption of the manufacture of the drug.,2017/5/2,2017/6/8,No
12074,2251582,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,10MG,100 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/7/7,2017/7/10,2017/9/5,2017/8/28,Disruption of the manufacture of the drug.,2017/6/6,2017/8/28,No
31028,2251582,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,10MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/12/18,2017/12/11,2018/3/5,2018/2/19,Disruption of the manufacture of the drug.,2017/11/29,2018/2/21,No
11087,2251531,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,2.5MG,30 BLS,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/5/31,2017/6/5,2017/6/22,2017/6/20,Disruption of the manufacture of the drug.,2017/5/24,2017/6/21,No
23641,2251582,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,10MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/12/11,2018/2/28,2017/10/23,Disruption of the manufacture of the drug.,2017/9/27,2017/12/14,No
23644,2251515,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,1.25MG,100 BTL & 30 BLS,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/9/22,2017/11/20,2017/11/6,Disruption of the manufacture of the drug.,2017/9/27,2017/11/9,No
6000,2251515,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,1.25MG,100 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/5/10,2017/5/3,2017/6/12,2017/6/8,Disruption of the manufacture of the drug.,2017/4/7,2017/6/9,No
14204,2251582,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,10MG,30 BLS,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/7/24,2017/7/10,2017/11/21,2017/11/17,Disruption of the manufacture of the drug.,2017/6/28,2017/11/20,No
14207,2251574,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,5MG,100 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/7/21,2017/10/2,2017/12/15,2017/11/6,Disruption of the manufacture of the drug.,2017/6/28,2017/11/9,No
14210,2251574,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,5MG,30 BLS,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2018/1/2,2018/4/9,2018/3/28,Disruption of the manufacture of the drug.,2017/6/28,2018/3/29,No
14213,2251574,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,5MG,100BTL & 500 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/7/31,2017/7/14,2017/11/10,2017/11/6,Disruption of the manufacture of the drug.,2017/6/28,2017/11/9,No
20897,2251515,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,1.25MG,100 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/10/20,2017/10/16,2017/11/20,2017/11/6,Disruption of the manufacture of the drug.,2017/9/5,2017/11/9,No
13475,2251531,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,2.5MG,30 BLS,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/6/21,2017/11/17,2017/11/17,Disruption of the manufacture of the drug.,2017/6/21,2017/11/21,No
731,2251515,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,1.25MG,100 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/3/10,2017/3/20,2017/3/15,Disruption of the manufacture of the drug.,2017/3/13,2017/3/16,No
734,2251582,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,10MG,500 BTL & 30 BLS,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/3/10,2017/3/20,2017/3/15,Disruption of the manufacture of the drug.,2017/3/13,2017/3/16,No
30957,2251531,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,2.5MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/11/27,2018/3/26,2018/3/7,Disruption of the manufacture of the drug.,2017/11/28,2018/3/8,No
29983,733059,Shortage,APO-RANITIDINE TABLET 150MG,APOTEX INC,RANITIDINE,RANITIDINE,150MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/11/20,2018/10/1,2018/9/28,Disruption of the manufacture of the drug.,2017/11/21,2018/9/29,No
11044,733059,Shortage,APO-RANITIDINE TABLET 150MG,APOTEX INC,RANITIDINE,RANITIDINE,150MG,60 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/5/22,2017/8/8,2017/7/25,Disruption of the manufacture of the drug.,2017/5/24,2017/7/26,No
3180,733059,Shortage,APO-RANITIDINE TABLET 150MG,APOTEX INC,RANITIDINE,RANITIDINE,150MG,60 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/4/10,,2017/8/8,2017/7/24,Disruption of the manufacture of the drug.,2017/3/17,2017/7/26,No
686,733059,Shortage,APO-RANITIDINE TABLET 150MG,APOTEX INC,RANITIDINE,RANITIDINE,150MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/4/20,2017/3/17,2017/5/1,2017/4/20,Disruption of the manufacture of the drug.,2017/3/12,2017/4/21,No
8886,733059,Shortage,APO-RANITIDINE TABLET 150MG,APOTEX INC,RANITIDINE,RANITIDINE,150MG,500 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/6/19,2017/5/29,2017/8/8,2017/7/25,Disruption of the manufacture of the drug.,2017/5/4,2017/7/26,No
8938,733059,Shortage,APO-RANITIDINE TABLET 150MG,APOTEX INC,RANITIDINE,RANITIDINE,150MG,100 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/6/30,2017/6/15,2017/8/8,2017/7/28,Disruption of the manufacture of the drug.,2017/5/4,2017/7/31,No
12364,733067,Shortage,APO-RANITIDINE TABLET 300MG,APOTEX INC,RANITIDINE,RANITIDINE,300MG,30 BLS,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/6/30,2017/6/12,2017/7/31,2017/7/24,Disruption of the manufacture of the drug.,2017/6/9,2017/7/26,No
20645,733067,Shortage,APO-RANITIDINE TABLET 300MG,APOTEX INC,RANITIDINE,RANITIDINE,300MG,500 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/8/28,2017/10/31,2017/10/27,Disruption of the manufacture of the drug.,2017/8/30,2017/10/31,No
8889,733067,Shortage,APO-RANITIDINE TABLET 300MG,APOTEX INC,RANITIDINE,RANITIDINE,300MG,100 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/6/12,2017/5/15,2017/8/8,2017/7/21,Disruption of the manufacture of the drug.,2017/5/4,2017/7/22,No
438,2404680,Shortage,APO-RASAGILINE,APOTEX INC,RASAGILINE,RASAGILINE,0.5MG,100 BTL,ORAL,Resolved,TABLET,N04BD,DOPAMINERGIC AGENTS,,2017/2/6,2017/4/30,2017/3/27,Disruption of the manufacture of the drug.,2017/3/11,2017/3/28,No
441,2404680,Shortage,APO-RASAGILINE,APOTEX INC,RASAGILINE,RASAGILINE,0.5MG,100 BTL,ORAL,Resolved,TABLET,N04BD,DOPAMINERGIC AGENTS,,2016/9/14,2017/4/30,2017/3/27,Disruption of the manufacture of the drug.,2017/3/11,2017/3/28,No
14011,2404680,Shortage,APO-RASAGILINE,APOTEX INC,RASAGILINE,RASAGILINE,0.5MG,100 BTL,ORAL,Resolved,TABLET,N04BD,DOPAMINERGIC AGENTS,,2017/6/26,2017/11/15,2017/11/10,Disruption of the manufacture of the drug.,2017/6/27,2017/11/13,No
8892,2404699,Shortage,APO-RASAGILINE,APOTEX INC,RASAGILINE,RASAGILINE,1MG,100 BTL,ORAL,Resolved,TABLET,N04BD,DOPAMINERGIC AGENTS,2017/5/26,2017/6/15,2018/4/27,2018/4/4,Disruption of the manufacture of the drug.,2017/5/4,2018/4/5,No
469,2404680,Shortage,APO-RASAGILINE,APOTEX INC,RASAGILINE,RASAGILINE,0.5MG,100 BTL,ORAL,Resolved,TABLET,N04BD,DOPAMINERGIC AGENTS,,2017/2/6,2017/4/30,2017/3/27,Disruption of the manufacture of the drug.,2017/3/11,2017/3/28,No
472,2404699,Shortage,APO-RASAGILINE,APOTEX INC,RASAGILINE,RASAGILINE,1MG,100 BTL,ORAL,Resolved,TABLET,N04BD,DOPAMINERGIC AGENTS,,2016/9/14,2017/4/30,2017/3/27,Disruption of the manufacture of the drug.,2017/3/11,2017/3/28,No
475,2355663,Shortage,APO-REPAGLINIDE,APOTEX INC,REPAGLINIDE,REPAGLINIDE,0.5MG,100 BTL,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2014/10/9,,2018/9/10,Disruption of the manufacture of the drug.,2017/3/11,2018/9/11,No
478,2355671,Shortage,APO-REPAGLINIDE,APOTEX INC,REPAGLINIDE,REPAGLINIDE,1.0MG,100 BTL,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2014/10/9,,2018/9/10,Disruption of the manufacture of the drug.,2017/3/11,2018/9/11,No
481,2355698,Shortage,APO-REPAGLINIDE,APOTEX INC,REPAGLINIDE,REPAGLINIDE,2.0MG,100 BTL,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2014/9/9,,2018/9/10,Disruption of the manufacture of the drug.,2017/3/11,2018/9/11,No
20648,2352583,Shortage,APO-RILUZOLE,APOTEX INC,RILUZOLE,RILUZOLE,50MG,60 BTL,ORAL,Resolved,TABLET,N07XX,OTHER NERVOUS SYSTEM DRUGS,,2017/8/28,2018/3/30,2018/2/27,Disruption of the manufacture of the drug.,2017/8/30,2018/2/28,No
26643,2377721,Shortage,APO-RISEDRONATE,APOTEX INC,RISEDRONATE,RISEDRONATE SODIUM,150MG,1 BLS,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/10/23,2017/11/27,2017/11/10,Disruption of the manufacture of the drug.,2017/10/23,2017/11/15,No
598,2353687,Shortage,APO-RISEDRONATE,APOTEX INC,RISEDRONATE,RISEDRONATE SODIUM,35MG,100 BTL,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/2/14,2017/4/30,2017/4/28,Disruption of the manufacture of the drug.,2017/3/11,2017/5/2,No
20704,2377721,Shortage,APO-RISEDRONATE,APOTEX INC,RISEDRONATE,RISEDRONATE SODIUM,150MG,30 BTL,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/8/28,2017/11/10,2017/10/19,Disruption of the manufacture of the drug.,2017/8/31,2017/10/20,No
484,2377721,Shortage,APO-RISEDRONATE,APOTEX INC,RISEDRONATE,RISEDRONATE SODIUM,150MG,1 BLS,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/2/14,2017/3/15,2017/3/14,Disruption of the manufacture of the drug.,2017/3/11,2017/3/15,No
32827,2282127,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,0.50MG,500 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017/12/11,2018/6/15,2018/5/11,Disruption of the manufacture of the drug.,2017/12/14,2018/5/14,No
32834,2280396,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,1MG,30 ML,ORAL,Resolved,SOLUTION,N05AX,ANTIPSYCHOTICS,,2017/12/11,2018/2/23,2018/2/13,Disruption of the manufacture of the drug.,2017/12/14,2018/2/14,No
601,2282127,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,0.50MG,500 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017/3/10,2017/6/2,2017/5/31,Disruption of the manufacture of the drug.,2017/3/11,2017/6/1,No
3183,2282119,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,0.25MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2017/4/20,2017/4/14,2017/6/2,2017/5/31,Disruption of the manufacture of the drug.,2017/3/17,2017/6/1,No
14216,2282135,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,1.0MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2017/7/31,2017/7/17,2017/12/15,2017/11/30,Disruption of the manufacture of the drug.,2017/6/28,2017/12/1,No
14219,2282143,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,2.0MG,500 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2017/9/8,2017/8/15,2017/12/15,2017/11/29,Disruption of the manufacture of the drug.,2017/6/28,2017/11/30,No
20122,2282119,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,0.25MG,500 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017/8/21,2017/12/15,2017/11/28,Disruption of the manufacture of the drug.,2017/8/23,2017/11/29,No
17319,2282127,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,0.50MG,500 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2017/9/22,2017/8/15,2017/12/15,2017/11/28,Disruption of the manufacture of the drug.,2017/7/26,2017/11/29,No
9906,2282127,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,0.50MG,100 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017/5/8,2017/6/7,2017/5/31,Demand increase for the drug.,2017/5/10,2017/6/1,No
20707,2282119,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,0.25MG,100 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017/8/28,2017/12/15,2017/11/29,Disruption of the manufacture of the drug.,2017/8/31,2017/11/30,No
20900,2336715,Shortage,APO-RIVASTIGMINE,APOTEX INC,RIVASTIGMINE,RIVASTIGMINE,1.5MG,100 BTL,ORAL,Resolved,CAPSULE,N06DA,ANTI-DEMENTIA DRUGS,2017/10/20,2017/10/16,2019/10/18,2019/10/11,Disruption of the manufacture of the drug.,2017/9/5,2019/10/15,No
17322,2336758,Shortage,APO-RIVASTIGMINE,APOTEX INC,RIVASTIGMINE,RIVASTIGMINE,6MG,100 BTL,ORAL,Resolved,CAPSULE,N06DA,ANTI-DEMENTIA DRUGS,2017/9/18,2017/8/28,2018/3/30,2018/3/26,Disruption of the manufacture of the drug.,2017/7/26,2018/3/27,No
487,2336731,Shortage,APO-RIVASTIGMINE,APOTEX INC,RIVASTIGMINE,RIVASTIGMINE,4.5MG,100 BTL,ORAL,Resolved,CAPSULE,N06DA,ANTI-DEMENTIA DRUGS,,2017/3/10,2017/5/23,2017/5/17,Disruption of the manufacture of the drug.,2017/3/11,2017/5/18,No
14560,2393468,Shortage,APO-RIZATRIPTAN,APOTEX INC,RIZATRIPTAN,RIZATRIPTAN,5MG,6 BLS,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/6/29,,2018/1/5,Disruption of the manufacture of the drug.,2017/7/4,2018/1/10,No
504,2393476,Shortage,APO-RIZATRIPTAN,APOTEX INC,RIZATRIPTAN,RIZATRIPTAN,10MG,6 BLS,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/1/31,2017/8/31,2017/8/17,Disruption of the manufacture of the drug.,2017/3/11,2017/8/18,No
490,2393492,Shortage,APO-RIZATRIPTAN RPD,APOTEX INC,RIZATRIPTAN,RIZATRIPTAN,10MG,6 BLS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2014/10/1,2020/7/3,2019/4/5,Disruption of the manufacture of the drug.,2017/3/11,2020/7/6,No
493,2393484,Shortage,APO-RIZATRIPTAN RPD,APOTEX INC,RIZATRIPTAN,RIZATRIPTAN,5MG,6 BLS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2014/10/1,,2018/9/10,Disruption of the manufacture of the drug.,2017/3/11,2018/9/11,No
17325,2403366,Shortage,APO-ROSIGLITAZONE,APOTEX INC,ROSIGLITAZONE,ROSIGLITAZONE,2MG,100 BTL,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017/7/31,2017/7/31,2017/10/16,2017/10/13,Disruption of the manufacture of the drug.,2017/7/26,2017/10/16,No
20214,2403374,Shortage,APO-ROSIGLITAZONE,APOTEX INC,ROSIGLITAZONE,ROSIGLITAZONE,4MG,100 BTL,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/8/21,2017/10/16,2017/10/13,Disruption of the manufacture of the drug.,2017/8/24,2017/10/16,No
8710,2337983,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,10MG,500 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/5/1,2017/8/31,2017/8/15,Disruption of the manufacture of the drug.,2017/5/2,2017/8/16,No
8713,2338009,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,40MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/5/1,2017/8/31,2017/8/16,Disruption of the manufacture of the drug.,2017/5/2,2017/8/17,No
28440,2338009,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,40MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/12/22,2017/12/11,2018/3/26,2018/3/19,Disruption of the manufacture of the drug.,2017/11/7,2018/3/20,No
7716,2337991,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,20MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/4/21,2017/6/7,2017/6/9,Disruption of the manufacture of the drug.,2017/4/24,2017/6/13,No
31031,2337983,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,10MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/12/15,2017/12/11,2018/4/4,2018/3/12,Disruption of the manufacture of the drug.,2017/11/29,2018/3/13,No
31034,2337991,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,20MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/12/15,2017/12/11,2018/3/26,2018/3/19,Disruption of the manufacture of the drug.,2017/11/29,2018/3/20,No
18560,2338009,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,40MG,100 BTL & 500 BTL & 30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/8/7,2017/11/30,2017/11/6,Disruption of the manufacture of the drug.,2017/8/9,2017/11/7,No
14223,2337991,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,20MG,500 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/7/24,2017/7/24,2017/10/10,2017/9/29,Disruption of the manufacture of the drug.,2017/6/28,2017/10/3,No
20623,2337991,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,20MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/8/28,2017/11/10,2017/10/27,Disruption of the manufacture of the drug.,2017/8/29,2017/10/30,No
20626,2337983,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,10MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/8/28,2017/11/10,2017/11/2,Disruption of the manufacture of the drug.,2017/8/29,2017/11/3,No
14227,2337975,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,5MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/8/21,2017/10/31,2017/11/2,Disruption of the manufacture of the drug.,2017/6/28,2017/11/3,No
725,2337991,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,20MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/3/10,2017/3/30,2017/3/30,Disruption of the manufacture of the drug.,2017/3/13,2017/3/31,No
30960,2337975,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,5MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/11/27,2018/3/5,2018/2/26,Disruption of the manufacture of the drug.,2017/11/28,2018/2/27,No
19000,2046741,Shortage,APO-SALVENT 5MG/ML,APOTEX INC,SALBUTAMOL,SALBUTAMOL,5MG,10ML,"INHALATION
ORAL",Actual shortage,SOLUTION,R03AC,"ADRENERGICS, INHALANTS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
18988,790419,Shortage,APO-SALVENT AEM 100MCG,APOTEX INC,SALBUTAMOL,SALBUTAMOL,100MCG,INHALER 15,INHALATION,Actual shortage,METERED-DOSE AEROSOL,R03AC,"ADRENERGICS, INHALANTS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
19057,2231488,Shortage,APO-SALVENT STERULES,APOTEX INC,SALBUTAMOL,SALBUTAMOL,1MG,2.5 ml,INHALATION,Actual shortage,SOLUTION,R03AC,"ADRENERGICS, INHALANTS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
19063,2231678,Shortage,APO-SALVENT STERULES,APOTEX INC,SALBUTAMOL,SALBUTAMOL,2MG,2.5 ml,INHALATION,Actual shortage,SOLUTION,R03AC,"ADRENERGICS, INHALANTS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
19114,2243828,Shortage,APO-SALVENT STERULES,APOTEX INC,SALBUTAMOL,SALBUTAMOL,0.5MG,5 ML,INHALATION,Actual shortage,SOLUTION,R03AC,"ADRENERGICS, INHALANTS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
689,2146851,Shortage,APO-SALVENT TABLETS - 4MG,APOTEX INC,SALBUTAMOL,SALBUTAMOL,4MG,100 BTL,ORAL,Resolved,TABLET,R03CC,ADRENERGICS FOR SYSTEMIC USE,2017/4/19,2017/4/14,2017/5/20,2017/5/8,Disruption of the manufacture of the drug.,2017/3/12,2017/5/10,No
19323,2266393,Shortage,APO-SALVENT-IPRAVENT STERULES,APOTEX INC,SALBUTAMOL,IPRATROPIUM BROMIDE SALBUTAMOL,0.5MG 2.5MG,5 ML,INHALATION,Actual shortage,SOLUTION,R03AL,"ADRENERGICS, INHALANTS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
17328,2230641,Shortage,APO-SELEGILINE,APOTEX INC,SELEGILINE,SELEGILINE HYDROCHLORIDE,5MG,100 BTL,ORAL,Resolved,TABLET,N04BD,DOPAMINERGIC AGENTS,2017/8/31,2017/8/7,2018/3/30,2018/3/23,Disruption of the manufacture of the drug.,2017/7/26,2018/3/27,No
13334,2238281,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,50MG,250 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017/6/19,2017/9/29,2017/9/29,Disruption of the manufacture of the drug.,2017/6/19,2017/10/4,No
28709,2238282,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,100MG,100 BTL & 250 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017/11/6,2018/2/28,2018/1/30,Disruption of the manufacture of the drug.,2017/11/9,2018/1/31,No
11090,2238281,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,50MG,100 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017/6/26,2017/6/5,2017/9/29,2017/9/29,Disruption of the manufacture of the drug.,2017/5/24,2017/10/4,No
3186,2238282,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,100MG,250 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017/3/31,2017/3/27,2017/5/2,2017/4/28,Disruption of the manufacture of the drug.,2017/3/17,2017/5/1,No
14233,2238282,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,100MG,250 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017/7/31,2017/7/10,2017/9/29,2017/9/29,Disruption of the manufacture of the drug.,2017/6/28,2017/10/4,No
12698,2238280,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,25MG,100 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017/6/12,2017/10/11,2017/10/11,Disruption of the manufacture of the drug.,2017/6/13,2017/10/12,No
20903,2238282,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,100MG,100 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017/9/22,,2017/10/31,2017/10/2,Disruption of the manufacture of the drug.,2017/9/5,2017/10/5,No
30963,2238280,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,25MG,100 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017/11/27,2018/3/14,2018/2/22,Disruption of the manufacture of the drug.,2017/11/28,2018/2/23,No
30967,2238281,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,50MG,100 BTL & 250 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017/11/27,2018/2/9,2018/1/17,Disruption of the manufacture of the drug.,2017/11/28,2018/1/18,No
28700,2248203,Shortage,APO-SILDENAFIL,APOTEX INC,SILDENAFIL,SILDENAFIL,100MG,4 BLS,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/11/6,2017/12/29,2017/12/29,Disruption of the manufacture of the drug.,2017/11/9,2018/1/3,No
507,2418118,Shortage,APO-SILDENAFIL R,APOTEX INC,SILDENAFIL,SILDENAFIL,20MG,100 BTL,ORAL,Resolved,TABLET,C02,OTHER ANTIHYPERTENSIVES,,2014/11/6,,2017/8/22,Disruption of the manufacture of the drug.,2017/3/11,2017/8/24,No
14244,2247014,Shortage,APO-SIMVASTATIN,APOTEX INC,SIMVASTATIN,SIMVASTATIN,40MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/7/31,2017/7/24,2017/11/17,2017/10/27,Disruption of the manufacture of the drug.,2017/6/28,2017/10/30,No
14065,2247015,Shortage,APO-SIMVASTATIN,APOTEX INC,SIMVASTATIN,SIMVASTATIN,80MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/6/26,2017/11/17,2017/10/26,Disruption of the manufacture of the drug.,2017/6/27,2017/10/27,No
25636,2167794,Shortage,APO-SOTALOL - TAB 160MG,APOTEX INC,SOTALOL,SOTALOL HYDROCHLORIDE,160MG,100 BTL,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2017/10/9,2018/1/31,2018/1/18,Disruption of the manufacture of the drug.,2017/10/12,2018/1/19,No
20906,2210428,Shortage,APO-SOTALOL 80MG TABLETS,APOTEX INC,SOTALOL,SOTALOL HYDROCHLORIDE,80MG,100 BTL,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,2017/9/29,2017/9/25,2018/1/31,2018/1/18,Disruption of the manufacture of the drug.,2017/9/5,2018/1/19,No
21096,2125250,Shortage,APO-SUCRALFATE - TAB 1G,APOTEX INC,SUCRALFATE,SUCRALFATE,1G,500 BTL,ORAL,Resolved,TABLET,A02BX,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/9/4,,2018/9/10,Disruption of the manufacture of the drug.,2017/9/6,2018/9/11,No
18991,846465,Shortage,APO-SULFATRIM ORAL SUSPENSION,APOTEX INC,SULFATRIM,SULFAMETHOXAZOLE TRIMETHOPRIM,40MG 8MG,100/400/800 ML,ORAL,Actual shortage,SUSPENSION,J01EE,SULFONAMIDES AND TRIMETHOPRIM,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
14247,2268388,Shortage,APO-SUMATRIPTAN,APOTEX INC,SUMATRIPTAN,SUMATRIPTAN,50MG,6 BLS,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2017/8/1,2017/8/7,2017/9/20,2017/8/29,Disruption of the manufacture of the drug.,2017/6/28,2017/8/30,No
20245,2422115,Shortage,APO-TADALAFIL,APOTEX INC,TADALAFIL,TADALAFIL,20MG,4 BLS,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/8/18,2017/10/20,2017/10/10,Disruption of the manufacture of the drug.,2017/8/24,2017/10/11,No
26646,2422093,Shortage,APO-TADALAFIL,APOTEX INC,TADALAFIL,TADALAFIL,5MG,30 BLS,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/10/23,2017/12/18,2017/11/27,Disruption of the manufacture of the drug.,2017/10/23,2017/11/29,No
15409,2422085,Shortage,APO-TADALAFIL,APOTEX INC,TADALAFIL,TADALAFIL,2.5MG,30 BLS,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/7/10,2017/12/28,2017/12/6,Disruption of the manufacture of the drug.,2017/7/11,2017/12/7,No
29949,2422115,Shortage,APO-TADALAFIL,APOTEX INC,TADALAFIL,TADALAFIL,20MG,4 BLS,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/11/20,2018/1/19,2018/1/8,Disruption of the manufacture of the drug.,2017/11/21,2018/1/8,No
20909,812390,Shortage,APO-TAMOX TAB 20MG,APOTEX INC,TAMOXIFEN,TAMOXIFEN,20MG,100 BTL & 250 BTL,ORAL,Resolved,TABLET,L02BA,HORMONE ANTAGONISTS AND RELATED AGENTS,2017/9/25,2017/9/25,2017/12/22,2017/11/24,Disruption of the manufacture of the drug.,2017/9/5,2017/11/27,No
31039,2362406,Shortage,APO-TAMSULOSIN CR,APOTEX INC,TAMSULOSIN,TAMSULOSIN HYDROCHLORIDE,0.4MG,30 BLS,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2017/12/29,2018/1/2,2018/2/28,2018/1/19,Disruption of the manufacture of the drug.,2017/11/29,2018/1/22,No
15995,2362406,Shortage,APO-TAMSULOSIN CR,APOTEX INC,TAMSULOSIN,TAMSULOSIN HYDROCHLORIDE,0.4MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/7/17,2017/11/10,2017/10/23,Disruption of the manufacture of the drug.,2017/7/17,2017/10/24,No
17331,2362406,Shortage,APO-TAMSULOSIN CR,APOTEX INC,TAMSULOSIN,TAMSULOSIN HYDROCHLORIDE,0.4MG,30 BLS,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2017/8/4,2017/8/1,2017/11/14,2017/11/10,Disruption of the manufacture of the drug.,2017/7/26,2017/11/13,No
9946,2362406,Shortage,APO-TAMSULOSIN CR,APOTEX INC,TAMSULOSIN,TAMSULOSIN HYDROCHLORIDE,0.4MG,30 BLS,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/5/8,2017/5/29,2017/5/12,Disruption of the manufacture of the drug.,2017/5/10,2017/5/13,No
11047,2420090,Shortage,APO-TELMISARTAN,APOTEX INC,TELMISARTAN,TELMISARTAN,80MG,100 BTL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/5/22,2017/9/29,2017/9/29,Disruption of the manufacture of the drug.,2017/5/24,2017/10/3,No
12080,2420082,Shortage,APO-TELMISARTAN,APOTEX INC,TELMISARTAN,TELMISARTAN,40MG,100 BTL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/6/5,2017/9/29,2017/9/29,Disruption of the manufacture of the drug.,2017/6/6,2017/10/3,No
11050,2420031,Shortage,APO-TELMISARTAN/HCTZ,APOTEX INC,TELMISARTAN/HCTZ,HYDROCHLOROTHIAZIDE TELMISARTAN,25MG 80MG,100 BTL,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/5/22,,,Disruption of the manufacture of the drug.,2017/5/24,2018/12/20,No
6524,2420023,Shortage,APO-TELMISARTAN/HCTZ,APOTEX INC,TELMISARTAN/HCTZ,HYDROCHLOROTHIAZIDE TELMISARTAN,12.5MG 80MG,30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/4/10,,2018/9/11,Disruption of the manufacture of the drug.,2017/4/11,2018/9/12,No
8922,2420023,Shortage,APO-TELMISARTAN/HCTZ,APOTEX INC,TELMISARTAN/HCTZ,HYDROCHLOROTHIAZIDE TELMISARTAN,12.5MG 80MG,100 BTL,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2017/7/17,2017/6/26,,2018/9/11,Disruption of the manufacture of the drug.,2017/5/4,2018/9/12,No
748,2420023,Shortage,APO-TELMISARTAN/HCTZ,APOTEX INC,TELMISARTAN/HCTZ,HYDROCHLOROTHIAZIDE TELMISARTAN,12.5MG 80MG,30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/3/10,2017/3/31,2017/3/30,Disruption of the manufacture of the drug.,2017/3/13,2017/3/31,No
23655,2234504,Shortage,APO-TERAZOSIN,APOTEX INC,TERAZOSIN,TERAZOSIN,5MG,100 BTL,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/9/25,2017/10/16,2017/10/16,Disruption of the manufacture of the drug.,2017/9/27,2017/10/24,No
14250,2234502,Shortage,APO-TERAZOSIN,APOTEX INC,TERAZOSIN,TERAZOSIN,1MG,100 BTL,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2017/8/18,2017/7/31,2017/11/15,2017/10/16,Disruption of the manufacture of the drug.,2017/6/28,2017/10/17,No
11053,2239893,Shortage,APO-TERBINAFINE,APOTEX INC,TERBINAFINE,TERBINAFINE,250MG,100 BTL,ORAL,Resolved,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,,2017/5/22,2017/7/25,2017/7/18,Disruption of the manufacture of the drug.,2017/5/24,2017/7/19,No
27773,2239893,Shortage,APO-TERBINAFINE,APOTEX INC,TERBINAFINE,TERBINAFINE,250MG,100 BTL,ORAL,Resolved,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,,2017/10/30,2017/11/30,2017/11/22,Disruption of the manufacture of the drug.,2017/11/1,2017/11/23,No
18567,2239893,Shortage,APO-TERBINAFINE,APOTEX INC,TERBINAFINE,TERBINAFINE,250MG,500 BTL,ORAL,Resolved,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,,2017/8/7,2017/9/15,2017/9/15,Disruption of the manufacture of the drug.,2017/8/9,2017/9/22,No
21209,2407590,Shortage,APO-TETRABENAZINE,APOTEX INC,TETRABENZAPINE,TETRABENAZINE,25MG,100 BTL,ORAL,Resolved,TABLET,N07XX,OTHER NERVOUS SYSTEM DRUGS,,2017/9/4,2017/12/15,2017/11/21,Disruption of the manufacture of the drug.,2017/9/7,2017/11/22,No
19010,2136120,Shortage,APO-TIAPROFENIC TABLETS -300MG,APOTEX INC,TIAPROFENIC,TIAPROFENIC ACID,300MG,100 BTL & 500 BTL,ORAL,Actual shortage,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
19007,2136112,Shortage,APO-TIAPROFENIC TABLETS-200MG,APOTEX INC,TIAPROFENIC,TIAPROFENIC ACID,200MG,100 BTL,ORAL,Actual shortage,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/13,2017/10/5,No
510,2290812,Shortage,APO-TIMOP GEL,APOTEX INC,TIMOLOL MALEATE,TIMOLOL,0.50%,5 ML,OPHTHALMIC,Resolved,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2014/10/9,,2019/2/4,Other (Please describe in comments),2017/3/11,2019/2/5,No
513,755826,Shortage,APO-TIMOP OPH SOLN 0.25%,APOTEX INC,TIMOLOL MALEATE,TIMOLOL,0.25%,5 ML & 10 ML,OPHTHALMIC,Resolved,LIQUID,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2015/3/18,,2017/8/24,Disruption of the manufacture of the drug.,2017/3/11,2019/1/3,No
19123,2245698,Shortage,APO-TOBRAMYCIN,APOTEX INC,TOBRAMYCIN,TOBRAMYCIN,0.30%,5 ML,OPHTHALMIC,Actual shortage,SOLUTION,S01AA,ANTIINFECTIVES,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
516,2369680,Shortage,APO-TOLTERODINE,APOTEX INC,TOLTERODINE,TOLTERODINE TARTRATE,1MG,100 BTL,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/2/8,2017/11/24,2017/11/7,Disruption of the manufacture of the drug.,2017/3/11,2017/11/8,No
519,2369699,Shortage,APO-TOLTERODINE,APOTEX INC,TOLTERODINE,TOLTERODINE TARTRATE,2MG,100 BTL,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/2/8,2017/11/24,2017/11/6,Disruption of the manufacture of the drug.,2017/3/11,2017/11/7,No
523,2369699,Shortage,APO-TOLTERODINE,APOTEX INC,TOLTERODINE,TOLTERODINE TARTRATE,2MG,500 BTL,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/2/8,2018/2/28,2018/2/27,Disruption of the manufacture of the drug.,2017/3/11,2018/2/28,No
7728,2279614,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,25MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/4/21,2017/7/7,2017/7/4,Disruption of the manufacture of the drug.,2017/4/24,2017/7/5,No
32839,2279614,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,25MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/12/11,2018/3/12,2018/3/2,Disruption of the manufacture of the drug.,2017/12/14,2018/3/6,No
27767,2279630,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,100MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/10/30,2018/1/19,2018/1/2,Disruption of the manufacture of the drug.,2017/11/1,2018/1/3,No
12701,2279630,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,100MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/6/12,2017/7/10,2017/7/7,Disruption of the manufacture of the drug.,2017/6/13,2017/7/11,No
3746,2279630,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,100MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/4/30,2017/5/25,2017/3/20,Disruption of the manufacture of the drug.,2017/3/21,2017/3/21,No
21216,2279649,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,200MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/9/4,2017/10/16,2017/10/13,Disruption of the manufacture of the drug.,2017/9/7,2017/10/16,No
9957,2279630,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,100MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/5/5,2017/5/26,2017/5/24,Disruption of the manufacture of the drug.,2017/5/10,2017/5/25,No
692,2426153,Shortage,APO-TRAMADOL,APOTEX INC,TRAMADOL,TRAMADOL HYDROCHLORIDE,50MG,100 BTL,ORAL,Resolved,TABLET,N02AX,OPIOIDS,2017/3/29,2017/3/13,2017/4/20,2017/4/14,Disruption of the manufacture of the drug.,2017/3/12,2017/4/17,No
528,2415739,Shortage,APO-TRAVOPROST Z,APOTEX INC,TRAVOPROST,TRAVOPROST,0.00%,5ml,OPHTHALMIC,Resolved,SOLUTION,S01EE,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2015/12/17,2019/1/30,2019/1/2,Disruption of the manufacture of the drug.,2017/3/11,2019/1/3,No
6521,2147645,Shortage,APO-TRAZODONE TABLETS 100MG,APOTEX INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,100MG,500 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017/4/10,2017/7/10,2017/7/4,Disruption of the manufacture of the drug.,2017/4/11,2017/7/5,No
21219,2147645,Shortage,APO-TRAZODONE TABLETS 100MG,APOTEX INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,100MG,100 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017/9/4,2018/10/15,2018/9/28,Disruption of the manufacture of the drug.,2017/9/7,2018/9/29,No
531,2147637,Shortage,APO-TRAZODONE TABLETS 50MG,APOTEX INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,50MG,250 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017/3/10,2017/7/24,2017/7/4,Disruption of the manufacture of the drug.,2017/3/11,2017/7/5,No
26652,2147637,Shortage,APO-TRAZODONE TABLETS 50MG,APOTEX INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,50MG,100 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017/10/23,2018/10/29,2018/9/27,Disruption of the manufacture of the drug.,2017/10/23,2018/9/28,No
12085,2437635,Shortage,APO-TRIAMCINOLONE AQ,APOTEX INC,TRIAMCINOLONE,TRIAMCINOLONE ACETONIDE,55MCG,30 BTL,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2017/6/5,2017/11/17,2017/11/17,Disruption of the manufacture of the drug.,2017/6/6,2017/11/20,No
8716,2248540,Shortage,APO-TRYPTOPHAN,APOTEX INC,TRYPTOPHAN,TRYPTOPHAN,500MG,100 BTL,ORAL,Resolved,CAPSULE,N06AX,ANTIDEPRESSANTS,,2017/5/1,2017/7/24,2017/7/25,Disruption of the manufacture of the drug.,2017/5/2,2017/7/31,No
534,2248540,Shortage,APO-TRYPTOPHAN,APOTEX INC,TRYPTOPHAN,TRYPTOPHAN,500MG,100 BTL,ORAL,Resolved,CAPSULE,N06AX,ANTIDEPRESSANTS,,2016/2/2,2017/5/31,2017/4/11,Disruption of the manufacture of the drug.,2017/3/11,2017/4/12,No
17335,2248538,Shortage,APO-TRYPTOPHAN,APOTEX INC,TRYPTOPHAN,TRYPTOPHAN,500MG,100 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2017/9/28,2017/8/14,2018/3/23,2018/3/23,Disruption of the manufacture of the drug.,2017/7/26,2018/3/25,No
26662,2354705,Shortage,APO-VALACYCLOVIR,APOTEX INC,VALACYCLOVIR,VALACYCLOVIR,1000MG,21 BLS,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/10/23,2018/2/14,2018/1/30,Disruption of the manufacture of the drug.,2017/10/23,2018/1/31,No
26224,2295822,Shortage,APO-VALACYCLOVIR,APOTEX INC,VALACYCLOVIR,VALACYCLOVIR,500MG,30 BLS,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/10/16,2018/2/12,2018/1/30,Disruption of the manufacture of the drug.,2017/10/18,2018/1/31,No
3539,2295822,Shortage,APO-VALACYCLOVIR,APOTEX INC,VALACYCLOVIR,VALACYCLOVIR,500MG,30 BLS,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/3/20,2017/3/23,2017/3/23,Disruption of the manufacture of the drug.,2017/3/20,2017/3/24,No
537,2393824,Shortage,APO-VALGANCICLOVIR,APOTEX INC,VALGANCICLOVIR,VALGANCICLOVIR,450MG,60 BTL,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2016/11/14,,,Disruption of the manufacture of the drug.,2017/3/11,2018/2/21,No
15412,2238370,Shortage,APO-VALPROIC SYRUP,APOTEX INC,VALPROIC ACID,VALPROIC ACID,50MG,450 ml,ORAL,Resolved,SYRUP,N03AG,ANTIEPILEPTICS,,2017/7/10,2017/8/25,2017/8/17,Disruption of the manufacture of the drug.,2017/7/11,2017/8/18,No
272,2371529,Shortage,APO-VALSARTAN,APOTEX INC,VALSARTAN,VALSARTAN,80MG,100 BTL & 500 BTL & 30 BLS,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2014/10/1,,2018/12/27,Disruption of the manufacture of the drug.,2017/3/10,2019/3/8,No
549,2371537,Shortage,APO-VALSARTAN,APOTEX INC,VALSARTAN,VALSARTAN,160MG,100 BTL & 500 BTL & 30 BLS,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2014/10/1,,2018/12/27,Disruption of the manufacture of the drug.,2017/3/11,2019/3/8,No
570,2371545,Shortage,APO-VALSARTAN,APOTEX INC,VALSARTAN,VALSARTAN,320MG,30 BLS,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2014/10/1,,2018/12/27,Disruption of the manufacture of the drug.,2017/3/11,2019/3/11,No
573,2371510,Shortage,APO-VALSARTAN,APOTEX INC,VALSARTAN,VALSARTAN,40MG,30 BLS,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2014/10/1,,2018/12/28,Disruption of the manufacture of the drug.,2017/3/11,2019/3/11,No
263,2382555,Shortage,APO-VALSARTAN/HCTZ,APOTEX INC,VALSARTAN/HCTZ,HYDROCHLOROTHIAZIDE VALSARTAN,12.5MG 160MG,100 BTL & 30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2016/1/4,,2018/12/28,Disruption of the manufacture of the drug.,2017/3/10,2019/3/21,No
266,2382547,Shortage,APO-VALSARTAN/HCTZ,APOTEX INC,VALSARTAN/HCTZ,HYDROCHLOROTHIAZIDE VALSARTAN,12.5MG 80MG,100 BTL & 500 BTL & 30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2016/1/4,,2018/12/28,Disruption of the manufacture of the drug.,2017/3/10,2019/3/21,No
269,2382555,Shortage,APO-VALSARTAN/HCTZ,APOTEX INC,VALSARTAN/HCTZ,HYDROCHLOROTHIAZIDE VALSARTAN,12.5MG 160MG,500 BTL,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2016/1/4,,2018/12/28,Disruption of the manufacture of the drug.,2017/3/10,2019/3/21,No
546,2382563,Shortage,APO-VALSARTAN/HCTZ,APOTEX INC,VALSARTAN/HCTZ,HYDROCHLOROTHIAZIDE VALSARTAN,25MG 160MG,100 BTL & 500 BTL & 30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2016/1/4,,2018/12/28,Disruption of the manufacture of the drug.,2017/3/11,2019/3/21,No
564,2382571,Shortage,APO-VALSARTAN/HCTZ,APOTEX INC,VALSARTAN/HCTZ,HYDROCHLOROTHIAZIDE VALSARTAN,12.5MG 320MG,30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2014/10/1,,2018/12/28,Disruption of the manufacture of the drug.,2017/3/11,2019/3/21,No
567,2382598,Shortage,APO-VALSARTAN/HCTZ,APOTEX INC,VALSARTAN/HCTZ,HYDROCHLOROTHIAZIDE VALSARTAN,25MG 320MG,30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2014/10/1,,2018/12/28,Disruption of the manufacture of the drug.,2017/3/11,2019/3/21,No
23658,2331705,Shortage,APO-VENLAFAXINE XR,APOTEX INC,VENLAFAXINE,VENLAFAXINE,150.0MG,500 BTL,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017/9/25,2018/3/7,2018/3/7,Disruption of the manufacture of the drug.,2017/9/27,2018/3/8,No
10442,2331691,Shortage,APO-VENLAFAXINE XR,APOTEX INC,VENLAFAXINE,VENLAFAXINE,75.0MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017/5/15,2018/3/23,2018/3/7,Disruption of the manufacture of the drug.,2017/5/16,2018/3/8,No
16886,2331683,Shortage,APO-VENLAFAXINE XR,APOTEX INC,VENLAFAXINE,VENLAFAXINE,37.5MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017/7/24,2018/3/23,2018/3/7,Disruption of the manufacture of the drug.,2017/7/25,2018/3/8,No
260,2246894,Shortage,APO-VERAP SR,APOTEX INC,VERAPAMIL,VERAPAMIL HYDROCHLORIDE,180MG,100 BTL and 500 BTL,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2015/4/17,,,Disruption of the manufacture of the drug.,2017/3/10,2019/12/4,No
552,2246893,Shortage,APO-VERAP SR,APOTEX INC,VERAPAMIL,VERAPAMIL HYDROCHLORIDE,120MG,100 BTL,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2015/4/17,,,Disruption of the manufacture of the drug.,2017/3/11,2019/12/4,No
255,2246895,Shortage,APO-VERAP SR,APOTEX INC,VERAPAMIL SR,VERAPAMIL HYDROCHLORIDE,240MG,100 BTL and 500 BTL,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2014/3/19,,,Disruption of the manufacture of the drug.,2017/3/10,2019/12/4,No
12088,2409674,Shortage,APO-VORICONAZOLE,APOTEX INC,VORICONAZOLE,VORICONAZOLE,50MG,30 BTL,ORAL,Resolved,TABLET,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2017/6/5,2017/8/31,2017/8/14,Disruption of the manufacture of the drug.,2017/6/6,2017/8/15,No
14073,2409682,Shortage,APO-VORICONAZOLE,APOTEX INC,VORICONAZOLE,VORICONAZOLE,200MG,30 BTL,ORAL,Resolved,TABLET,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2017/6/26,2017/8/31,2017/8/14,Disruption of the manufacture of the drug.,2017/6/27,2017/8/15,No
252,2409682,Shortage,APO-VORICONAZOLE,APOTEX INC,VORICONAZOLE,VORICONAZOLE,200MG,30 BTL,ORAL,Resolved,TABLET,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2014/10/1,2017/3/16,2017/3/14,Disruption of the manufacture of the drug.,2017/3/10,2017/3/15,No
695,2242927,Shortage,APO-WARFARIN,APOTEX INC,WARFARIN,WARFARIN SODIUM,4MG,100 BTL,ORAL,Resolved,TABLET,B01AA,ANTITHROMBOTIC AGENTS,2017/3/22,2017/3/27,2017/6/12,2017/6/8,Disruption of the manufacture of the drug.,2017/3/12,2017/6/8,No
25646,2380951,Shortage,APO-ZOLMITRIPTAN,APOTEX INC,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,6 BLS,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/10/9,,2018/2/23,Disruption of the manufacture of the drug.,2017/10/12,2018/2/26,No
25649,2381575,Shortage,APO-ZOLMITRIPTAN RAPID,APOTEX INC,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,6 BLS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2017/10/9,,2018/9/11,Disruption of the manufacture of the drug.,2017/10/12,2018/9/12,No
245,2436159,Shortage,APO-ZOLPIDEM ODT,APOTEX INC,Zolpidem,ZOLPIDEM TARTRATE,5MG,30 BLS,SUBLINGUAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05CF,HYPNOTICS AND SEDATIVES,,2017/1/27,2017/4/10,2017/4/7,Disruption of the manufacture of the drug.,2017/3/10,2017/4/10,No
249,2434946,Shortage,APO-ZOLPIDEM ODT,APOTEX INC,ZOLPIDEM ODT,ZOLPIDEM TARTRATE,10MG,30 BLS,SUBLINGUAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05CF,HYPNOTICS AND SEDATIVES,,2017/1/31,2017/4/14,2017/4/14,Disruption of the manufacture of the drug.,2017/3/10,2017/4/17,No
20915,2245077,Shortage,APO-ZOPICLONE,APOTEX INC,ZOPICLONE,ZOPICLONE,5MG,100 BTL,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,2017/10/27,2017/10/2,2018/2/12,2018/1/18,Disruption of the manufacture of the drug.,2017/9/5,2018/1/19,No
19558,2218313,Shortage,APO-ZOPICLONE - TAB 7.5MG,APOTEX INC,ZOPICLONE,ZOPICLONE,7.5MG,100 BTL,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,,2017/8/16,2017/11/30,2017/10/18,Disruption of the manufacture of the drug.,2017/8/16,2017/10/19,No
20912,2218313,Shortage,APO-ZOPICLONE - TAB 7.5MG,APOTEX INC,ZOPICLONE,ZOPICLONE,7.5MG,500 BTL,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,2017/10/13,2017/9/25,2017/11/30,2017/10/17,Disruption of the manufacture of the drug.,2017/9/5,2017/10/18,No
10868,2317192,Shortage,APRI 21,TEVA CANADA LIMITED,DESOGESTREL ETHINYL ESTRADIOL,DESOGESTREL ETHINYL ESTRADIOL,0.15MG 0.03MG,6,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2017/5/15,2017/8/18,2017/9/15,Shortage of an inactive ingredient or component.,2017/5/23,2017/9/19,No
10871,2317206,Shortage,APRI 28,TEVA CANADA LIMITED,DESOGESTREL ETHINYL ESTRADIOL,DESOGESTREL ETHINYL ESTRADIOL,0.15MG 0.03MG,6,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2017/5/15,2017/8/4,2017/9/15,Shortage of an inactive ingredient or component.,2017/5/23,2017/9/19,No
29518,2194031,Shortage,ARISTOCORT R,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ARISTOCORT R,TRIAMCINOLONE ACETONIDE,0.10%,na,TOPICAL,Resolved,OINTMENT,D07AB,"CORTICOSTEROIDS, PLAIN",,2017/11/17,2017/11/24,2017/11/30,Other (Please describe in comments),2017/11/17,2017/12/1,No
5,2194155,Shortage,ARISTOSPAN,VALEO PHARMA INC,Triamcinolone Hexacetonide Suspension,TRIAMCINOLONE HEXACETONIDE,20 mg / mL,1 mL / vial,Intra-Articular,Resolved,Suspension,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2014/4/25,,2018/5/31,Disruption of the manufacture of the drug.,2017/3/10,2018/6/5,No
29404,2245531,Shortage,ARIXTRA,ASPEN PHARMACARE CANADA INC.,Arixtra® 2.5mg,FONDAPARINUX SODIUM,2.5MG,10 PF syringes,"INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,B01AX,ANTITHROMBOTIC AGENTS,2018/3/31,2018/3/31,2018/7/23,2018/7/13,Delay in shipping of the drug.,2017/11/16,2018/7/14,No
29407,2258056,Shortage,ARIXTRA,ASPEN PHARMACARE CANADA INC.,Arixtra® 7.5mg,FONDAPARINUX SODIUM,12.5MG,10 PF syringes,SUBCUTANEOUS,Resolved,SOLUTION,B01AX,ANTITHROMBOTIC AGENTS,2017/12/31,2017/12/31,2018/7/23,2018/7/20,Delay in shipping of the drug.,2017/11/16,2018/7/21,No
2443,1926713,Shortage,ARLIDIN TABLETS 6MG,ERFA CANADA 2012 INC,Nylidrin,Nylidrin Hydrochloride,6 mg,bottle,oral,Resolved,tablet,C04AA,PERIPHERALVASODILATORS,2015/1/19,2015/1/19,,2018/3/14,Disruption of the manufacture of the drug.,2017/3/14,2018/12/11,No
4096,2381559,Shortage,ARZERRA,NOVARTIS PHARMACEUTICALS CANADA INC,ARZERRA 100MG VIALS,Ofatumumab,100MG,5ML X 3,INTRAVENOUS,Resolved,SOLUTION,L01XC,OTHER ANTINEOPLASTIC AGENTS,2017/8/1,2017/9/21,,2018/9/26,Other (Please describe in comments),2017/3/23,2018/10/17,No
4093,2381567,Shortage,ARZERRA,NOVARTIS PHARMACEUTICALS CANADA INC,Arzerra 1000MG VIALS,Ofatumumab,1000MG,50ML X 1,INTRAVENOUS,Resolved,SOLUTION,L01XC,OTHER ANTINEOPLASTIC AGENTS,,2017/2/28,,2018/9/26,Other (Please describe in comments),2017/3/23,2018/9/27,No
11291,2009013,Shortage,ASAPHEN,PHARMASCIENCE INC,ASAPHEN,ACETYLSALICYLIC ACID,80MG,500,ORAL,Resolved,TABLET (CHEWABLE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,2017/9/2,,2017/9/29,2017/9/15,Disruption of the manufacture of the drug.,2017/5/25,2017/9/19,No
7328,2009013,Shortage,ASAPHEN,PHARMASCIENCE INC,ASAPHEN 80 MG,ACETYLSALICYLIC ACID,80MG,100,ORAL,Resolved,TABLET (CHEWABLE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,2017/8/24,2017/8/24,2017/11/30,2017/10/25,Disruption of the manufacture of the drug.,2017/4/20,2017/10/26,No
13093,2238545,Shortage,ASAPHEN E.C.,PHARMASCIENCE INC,ASAPHEN 80MG,ACETYLSALICYLIC ACID,80MG,1000,ORAL,Avoided shortage,TABLET (DELAYED-RELEASE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,2017/9/4,2017/9/4,,2017/6/21,Disruption of the manufacture of the drug.,2017/6/16,2017/10/12,No
8528,2238545,Shortage,ASAPHEN E.C.,PHARMASCIENCE INC,ASAPHEN,ACETYLSALICYLIC ACID,80MG,500,ORAL,Avoided shortage,TABLET (DELAYED-RELEASE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,2017/7/7,2017/7/7,2017/8/21,2017/5/17,Demand increase for the drug.,2017/5/2,2017/10/12,No
13691,2238545,Shortage,ASAPHEN E.C.,PHARMASCIENCE INC,ASAPHEN EC,ACETYLSALICYLIC ACID,80MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,2017/7/11,2017/7/11,,2018/5/4,Disruption of the manufacture of the drug.,2017/6/23,2018/5/5,No
21898,2280167,Shortage,ASATAB 80 MG CHEWABLE TABLETS,ODAN LABORATORIES LTD,Acetylsalicylic Acid Chewable Tablets,ACETYLSALICYLIC ACID,80MG,100,ORAL,Resolved,TABLET (CHEWABLE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,,2017/9/12,2017/10/20,2017/10/20,Demand increase for the drug.,2017/9/12,2017/10/21,No
1390,2352427,Shortage,ASATAB EC 325MG,ODAN LABORATORIES LTD,"Acetylsalicylic Acid Delayed Release Tablets, USP",ACETYLSALICYLIC ACID,325MG,100; 1000,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1407,2352435,Shortage,ASATAB EC 650MG,ODAN LABORATORIES LTD,"Acetylsalicylic Acid Delayed Release Tablets, USP",ACETYLSALICYLIC ACID,650MG,100; 1000,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
24866,2243596,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,400MCG,30DOSE,INHALATION,Avoided shortage,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2017/10/30,,2017/11/17,2017/10/20,Delay in shipping of the drug.,2017/10/10,2017/10/20,No
31778,2438690,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,ASMANEX TWISTHALER,MOMETASONE FUROATE,100MCG,30DOSE,INHALATION,Resolved,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2018/1/15,2018/1/2,2018/6/1,2018/5/31,Disruption of the manufacture of the drug.,2017/12/5,2018/6/1,No
18787,2243596,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,400MCG,60 dose,INHALATION,Avoided shortage,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2017/9/6,,2017/9/21,2017/9/5,Disruption of the manufacture of the drug.,2017/8/11,2017/10/11,No
14711,2243596,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,400MCG,60dose,INHALATION,Resolved,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017/7/5,2017/7/14,2017/7/7,Delay in shipping of the drug.,2017/7/5,2017/7/8,No
29052,2438690,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,100MCG,30DOSE,INHALATION,Resolved,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017/11/24,2017/12/4,2017/12/1,Delay in shipping of the drug.,2017/11/13,2017/12/2,No
24803,2243595,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,200MCG,60 DOSE,INHALATION,Resolved,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2017/11/2,2017/11/1,2017/11/17,2017/11/13,Delay in shipping of the drug.,2017/10/10,2017/11/14,No
28205,2238316,Shortage,ATENOLOL,SIVEM PHARMACEUTICALS ULC,ATENOLOL,ATENOLOL,50MG,30,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/9/25,,2018/7/23,Other (Please describe in comments),2017/11/6,2018/7/24,No
28209,2238316,Shortage,ATENOLOL,SIVEM PHARMACEUTICALS ULC,ATENOLOL,ATENOLOL,50MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/11/15,2017/11/27,,2018/7/23,Other (Please describe in comments),2017/11/6,2018/7/24,No
28212,2238316,Shortage,ATENOLOL,SIVEM PHARMACEUTICALS ULC,ATENOLOL,ATENOLOL,50MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/7/24,,2018/7/23,Other (Please describe in comments),2017/11/6,2018/7/24,No
28215,2238318,Shortage,ATENOLOL,SIVEM PHARMACEUTICALS ULC,ATENOLOL,ATENOLOL,100MG,30,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/11/1,,2018/7/23,Other (Please describe in comments),2017/11/6,2018/7/24,No
28218,2238318,Shortage,ATENOLOL,SIVEM PHARMACEUTICALS ULC,ATENOLOL,ATENOLOL,100MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/9/15,,2018/7/23,Other (Please describe in comments),2017/11/6,2018/7/24,No
14152,828807,Shortage,ATENOLOL,PRO DOC LIMITEE,ATENOLOL,ATENOLOL,50MG,30-500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/10/17,,2018/3/9,Delay in shipping of the drug.,2017/6/28,2018/3/10,No
14161,828793,Shortage,ATENOLOL,PRO DOC LIMITEE,ATENOLOL,ATENOLOL,100MG,30-100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/10/19,,2018/3/9,Delay in shipping of the drug.,2017/6/28,2018/3/10,No
31935,2041464,Shortage,ATIVAN,PFIZER CANADA INC,ATIVAN,LORAZEPAM,1MG,1X100 TAB/BTL,SUBLINGUAL,Avoided shortage,TABLET,N05BA,ANXIOLYTICS,2017/12/14,,2017/12/18,2017/12/12,Disruption of the manufacture of the drug.,2017/12/6,2017/12/13,No
28375,2041448,Shortage,ATIVAN,PFIZER CANADA INC,ATIVAN,LORAZEPAM,2MG,100 TAB/BTL,ORAL,Avoided shortage,TABLET,N05BA,ANXIOLYTICS,2017/12/14,,2017/12/6,2017/12/6,Delay in shipping of the drug.,2017/11/6,2017/12/6,No
6457,2396912,Shortage,ATOMOXETINE,PRO DOC LIMITEE,ATOMOXETINE,ATOMOXETINE,18MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/4/11,,2017/5/4,Delay in shipping of the drug.,2017/4/11,2017/5/5,No
6207,2396939,Shortage,ATOMOXETINE,PRO DOC LIMITEE,ATOMOXETINE,ATOMOXETINE,40MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018/4/20,,2018/5/10,Delay in shipping of the drug.,2017/4/7,2018/5/11,No
4507,2396920,Shortage,ATOMOXETINE,PRO DOC LIMITEE,ATOMOXETINE,ATOMOXETINE,25MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/3/28,,2017/4/24,Delay in shipping of the drug.,2017/3/28,2017/4/25,No
9702,2396947,Shortage,ATOMOXETINE,PRO DOC LIMITEE,ATOMOXETINE,ATOMOXETINE,60MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/5/30,,2017/7/18,Delay in shipping of the drug.,2017/5/9,2017/7/19,No
21037,2449153,Shortage,AURO-BETAHISTINE,AURO PHARMA INC,Betahistine,BETAHISTINE HYDROCHLORIDE,16MG,100,ORAL,Resolved,TABLET,N07CA,ANTIVERTIGO PREPARATIONS,,2017/8/28,2017/10/16,2018/4/30,Demand increase for the drug.,2017/9/5,2018/5/1,No
21040,2421046,Shortage,AURO-CANDESARTAN HCT,AURO PHARMA INC,Candesartan HCT,HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL,12.5MG 32MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/8/8,2017/12/15,2018/5/2,Other (Please describe in comments),2017/9/5,2018/5/3,No
8822,2436914,Shortage,AURO-CLINDAMYCIN,AURO PHARMA INC,Clindamycin,CLINDAMYCIN HYDROCHLORIDE,300MG,100 bottle,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2017/5/4,,2017/8/15,2017/9/1,Other (Please describe in comments),2017/5/3,2017/9/5,No
3624,2394472,Shortage,AURO-LISINOPRIL,AURO PHARMA INC,Lisinopril,LISINOPRIL,5MG,100 and 500 bottle,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/3/16,,2018/11/12,Disruption of the manufacture of the drug.,2017/3/20,2018/11/13,No
3644,2394480,Shortage,AURO-LISINOPRIL,AURO PHARMA INC,LISINOPRIL,LISINOPRIL,10MG,100 and 500 bottle,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/3/16,,2018/5/2,Disruption of the manufacture of the drug.,2017/3/20,2018/5/3,No
3655,2430487,Shortage,AURO-MODAFINIL,AURO PHARMA INC,MODAFINIL,MODAFINIL,100MG,30,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/3/16,2017/4/7,2017/9/1,Delay in shipping of the drug.,2017/3/20,2018/4/30,No
21034,2433877,Shortage,AURO-PREGABALIN,AURO PHARMA INC,Pregabalin,PREGABALIN,50MG,100 bottle,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/8/28,2017/10/31,2018/4/30,Demand increase for the drug.,2017/9/5,2018/5/1,No
3665,2442590,Shortage,AURO-ROSUVASTATIN,AURO PHARMA INC,ROSUVASTATIN,ROSUVASTATIN,20MG,90 and 500 bottle,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/3/16,2017/4/7,2017/9/1,Delay in shipping of the drug.,2017/3/20,2017/9/5,No
2267,2247086,Shortage,AVANDAMET,GLAXOSMITHKLINE INC,Rosiglitazone maleate and metformin hydrochloride tablet,METFORMIN HYDROCHLORIDE ROSIGLITAZONE,500MG 2MG,100's,ORAL,Resolved,TABLET,A10BD,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2016/7/7,,2017/4/20,Other (Please describe in comments),2017/3/14,2020/2/27,No
2271,2248440,Shortage,AVANDAMET,GLAXOSMITHKLINE INC,Rosiglitazone maleate and metformin hydrochloride tablet,METFORMIN HYDROCHLORIDE ROSIGLITAZONE,1000MG 2.00MG,100's,ORAL,Resolved,TABLET,A10BD,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2016/7/20,,2017/4/20,Other (Please describe in comments),2017/3/14,2020/2/27,No
2274,2248441,Shortage,AVANDAMET,GLAXOSMITHKLINE INC,Rosiglitazone maleate and metformin hydrochloride tablet,METFORMIN HYDROCHLORIDE ROSIGLITAZONE,1000MG 4.00MG,100's,ORAL,Resolved,TABLET,A10BD,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2016/3/28,,2017/4/20,Other (Please describe in comments),2017/3/14,2020/2/27,No
5838,2241112,Shortage,AVANDIA,GLAXOSMITHKLINE INC,Rosiglitazone maleate tablet,ROSIGLITAZONE,2MG,60's,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017/6/5,,2017/6/12,2017/6/13,Disruption of the manufacture of the drug.,2017/4/6,2017/6/14,No
18205,2237792,Shortage,AVAXIM,SANOFI PASTEUR LIMITED,Hepatitis A Vaccine Inactivated,"HEPATITIS A VACCINE, INACTIVATED",160UNIT,1 x 0.5 mL (single dose) syringe,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,2017/11/1,,2018/1/31,2018/2/1,Disruption of the manufacture of the drug.,2017/8/3,2018/2/2,No
1222,2243741,Shortage,AVAXIM - PEDIATRIC       -(SYRINGE),SANOFI PASTEUR LIMITED,Hepatitis A Vaccine Inactivated,"HEPATITIS A VACCINE, INACTIVATED",80UNIT,"1 x 0.5 mL (single dose) syringe / 1 seringue de 0,5 mL (dose unique)",INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,2015/11/2,2015/11/2,2018/1/31,2018/2/1,Disruption of the manufacture of the drug.,2017/3/13,2018/2/2,No
12543,2246414,Shortage,AVELOX I.V.,BAYER INC,moxifloxacin injection,MOXIFLOXACIN,400MG,250 mL Ready-to-use minibag,INTRAVENOUS,Resolved,SOLUTION,J01MA,QUINOLONE ANTIBACTERIALS,2017/6/30,,2018/3/29,2018/2/23,Disruption of the manufacture of the drug.,2017/6/12,2018/2/27,No
17802,778338,Shortage,AXID,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,AXID 150mg CAPS 100,NIZATIDINE,150MG,100,ORAL,Resolved,CAPSULE,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/8/9,2017/8/9,2018/10/12,2018/10/25,Disruption of the manufacture of the drug.,2017/8/1,2018/10/29,No
14721,2334844,Shortage,"AZITHROMYCIN FOR INJECTION, USP",HOSPIRA HEALTHCARE CORPORATION,AZITHROMYCIN,AZITHROMYCIN,500MG,10x500mg,INTRAVENOUS,Avoided shortage,POWDER FOR SOLUTION,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2018/3/6,,,2017/9/30,Other (Please describe in comments),2017/7/5,2017/11/24,No
29307,37818,Shortage,BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP,PFIZER CANADA INC,SODIUM CHLORIDE,SODIUM CHLORIDE,9MG,25x10mL PVL MD,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,B05CB,IRRIGATING SOLUTIONS,,2018/1/31,,2018/3/6,Disruption of the manufacture of the drug.,2017/11/15,2018/3/7,No
16200,2282224,Shortage,BARACLUDE,BRISTOL-MYERS SQUIBB CANADA,entecavir,ENTECAVIR,0.5MG,1 BTL X 30,ORAL,Avoided shortage,TABLET,J05AF,DIRECT ACTING ANTIVIRALS,2017/9/11,,2017/9/8,2017/9/8,Demand increase for the drug.,2017/7/18,2017/9/21,No
5282,2102978,Shortage,BENTYLOL,APTALIS PHARMA CANADA ULC,BENTYLOL 2 mg/ml Syrup,DICYCLOMINE HYDROCHLORIDE,10MG,250 mL bottle,ORAL,Resolved,SYRUP,A03AA,DRUGS FOR FUNCTIONAL BOWEL DISORDERS,2017/5/31,,,2018/11/19,Other (Please describe in comments),2017/4/4,2018/11/26,No
5465,2103087,Shortage,BENTYLOL TABLET 10MG,APTALIS PHARMA CANADA ULC,Bentylol,DICYCLOMINE HYDROCHLORIDE,10MG,bottle 100 tabs,ORAL,Resolved,TABLET,A03AA,DRUGS FOR FUNCTIONAL BOWEL DISORDERS,2017/12/20,,2017/7/12,2018/11/19,Other (Please describe in comments),2017/4/4,2018/11/26,No
34019,2103095,Shortage,BENTYLOL TABLET 20MG,APTALIS PHARMA CANADA ULC,Bentylol,DICYCLOMINE HYDROCHLORIDE,20MG,bottle,ORAL,Resolved,TABLET,A03AA,DRUGS FOR FUNCTIONAL BOWEL DISORDERS,2017/9/1,,,2018/11/19,Other (Please describe in comments),2017/12/20,2018/11/26,No
29526,2336847,Shortage,BESIVANCE,BAUSCH & LOMB INC,BESIVANCE,BESIFLOXACIN,0.60%,N/A,OPHTHALMIC,Resolved,SUSPENSION,S01AE,ANTIINFECTIVES,,2017/10/31,,2018/7/6,Other (Please describe in comments),2017/11/17,2018/7/9,No
24121,716618,Shortage,BETADERM CRM 0.05%,TARO PHARMACEUTICALS INC,BETADERM CRM 0.05%,BETAMETHASONE,0.05%,454G,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2018/10/15,2018/10/26,2018/10/29,Disruption of the manufacture of the drug.,2017/10/2,2018/10/30,No
16650,716626,Shortage,BETADERM CRM 0.1%,TARO PHARMACEUTICALS INC,BETADERM CRM 0.1%,BETAMETHASONE VALERATE,0.10%,454G,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2018/2/22,2018/3/30,2018/3/28,Disruption of the manufacture of the drug.,2017/7/21,2018/3/29,No
18094,716634,Shortage,BETADERM LOTION 0.1%,TARO PHARMACEUTICALS INC,BETADERM LOTION,BETAMETHASONE,0.10%,75ML,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2018/5/23,2018/7/16,2018/8/2,Disruption of the manufacture of the drug.,2017/8/2,2018/8/3,No
22255,716642,Shortage,BETADERM ONT 0.05%,TARO PHARMACEUTICALS INC,BETADERM ONT 0.05%,BETAMETHASONE,0.5MG,454G,TOPICAL,Resolved,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",,2018/3/28,2018/4/27,2018/4/26,Disruption of the manufacture of the drug.,2017/9/18,2018/4/27,No
5781,751286,Shortage,BETAGAN OPH SOLN 0.25%,ALLERGAN INC,"Betagan 0,25% 10 mL C Cap",LEVOBUNOLOL HYDROCHLORIDE,0.25%,10ML,OPHTHALMIC,Resolved,LIQUID,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2002/1/1,,2017/7/26,Other (Please describe in comments),2017/4/6,2017/8/4,No
3978,2244756,Shortage,BIAXIN XL,BGP PHARMA ULC,Biaxin,CLARITHROMYCIN,500MG,60s,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2016/12/8,,,Disruption of the manufacture of the drug.,2017/3/22,2020/7/24,No
27657,2247167,Shortage,BIO-AMITRIPTYLINE,BIOMED PHARMA,Amytriptyline hydrochloride Tablets 25 mg,,,500,,Actual shortage,,,,,2011/4/20,,,Other (Please describe in comments),2017/11/1,2018/2/20,No
27660,2247168,Shortage,BIO-AMITRIPTYLINE,BIOMED PHARMA,Amitriptyline Hydrochloride 50mg,,,100,,Actual shortage,,,,,2011/4/20,,,Other (Please describe in comments),2017/11/1,2017/11/1,No
22951,2247166,Shortage,BIO-AMITRIPTYLINE,BIOMED PHARMA,Amytriptyline hydrochloride Tablets 10 mg,AMITRIPTYLINE HYDROCHLORIDE,10MG,500,,Actual shortage,,,,2011/4/20,2011/4/20,,,Other (Please describe in comments),2017/9/21,2017/10/26,No
7710,2392127,Shortage,BIO-AMLODIPINE,BIOMED PHARMA,AMLODIPINE,AMLODIPINE,2.5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017/4/24,2017/4/24,2017/6/21,2017/7/7,Demand increase for the drug.,2017/4/24,2017/10/26,No
31547,2392127,Shortage,BIO-AMLODIPINE,BIOMED PHARMA,AMLODIPINE 2.5 MG,AMLODIPINE,2.5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017/11/29,2017/11/29,,2019/1/30,Demand increase for the drug.,2017/12/1,2019/1/31,No
22886,2392488,Shortage,BIO-ANASTROZOLE,BIOMED PHARMA,ANASTROZOLE,ANASTROZOLE,1MG,100,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,2016/1/1,2016/1/1,,2019/5/9,Delay in shipping of the drug.,2017/9/20,2019/5/10,No
27663,2392194,Shortage,BIO-ATENOLOL,BIOMED PHARMA,Atenolol Tablets 25 mg,,,100,,Actual shortage,,,,,2015/1/1,,,Other (Please describe in comments),2017/11/1,2017/11/1,No
27667,2392178,Shortage,BIO-ATENOLOL,BIOMED PHARMA,Atenolol Tablets 50 mg,,,100,,Actual shortage,,,,,2015/1/1,,,Other (Please describe in comments),2017/11/1,2017/11/1,No
27670,2392186,Shortage,BIO-ATENOLOL,BIOMED PHARMA,Atenolol Tablets 100 mg,,,100,,Actual shortage,,,,,2015/1/1,,,Other (Please describe in comments),2017/11/1,2017/11/1,No
22889,2448491,Shortage,BIO-CITALOPRAM,BIOMED PHARMA,CITALOPRAM,CITALOPRAM,20MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/6/20,2017/6/20,,2018/6/28,Delay in shipping of the drug.,2017/9/20,2018/9/19,No
27675,2247173,Shortage,BIO-DIAZEPAM,BIOMED PHARMA,Diazepam Tablets 2 mg,,,100,,Actual shortage,,,,,2012/2/28,,,Other (Please describe in comments),2017/11/1,2017/11/1,No
27681,2247174,Shortage,BIO-DIAZEPAM,BIOMED PHARMA,Diazepam Tablets 5 mg,,,500,,Actual shortage,,,,,2012/2/28,,,Other (Please describe in comments),2017/11/1,2017/11/1,No
27686,2247176,Shortage,BIO-DIAZEPAM,BIOMED PHARMA,Diazepam Tablets 10 mg,,,500,,Actual shortage,,,,,2012/2/27,,,Other (Please describe in comments),2017/11/1,2017/11/1,No
7702,2425211,Shortage,BIO-EZETIMIBE,BIOMED PHARMA,EZETIMIBE,EZETIMIBE,10MG,30,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2017/4/24,2017/4/24,2017/5/2,2017/5/11,Disruption of the manufacture of the drug.,2017/4/24,2017/5/12,No
27689,2248126,Shortage,BIO-FLURAZEPAM,BIOMED PHARMA,Flurazepam Hydrochloride Capsules 15 mg,,,120,,Actual shortage,,,,,2012/5/30,,,Other (Please describe in comments),2017/11/1,2017/11/1,No
27692,2248127,Shortage,BIO-FLURAZEPAM,BIOMED PHARMA,Flurazepam Hydrochloride Capsules 30 mg,,,120,,Actual shortage,,,,,2012/5/30,,,Other (Please describe in comments),2017/11/1,2017/11/1,No
27695,2247371,Shortage,BIO-FUROSEMIDE,BIOMED PHARMA,Furosemide Tablets 20 mg,FUROSEMIDE,20MG,500,ORAL,Actual shortage,TABLET,C03CA,HIGH-CEILING DIURETICS,,2016/10/2,,,Other (Please describe in comments),2017/11/1,2017/11/2,No
18772,2247372,Shortage,BIO-FUROSEMIDE,BIOMED PHARMA,FUROSEMIDE,FUROSEMIDE,40MG,500,ORAL,Actual shortage,TABLET,C03CA,HIGH-CEILING DIURETICS,,2015/10/1,,,Requirements related to complying with good manufacturing practices.,2017/8/11,2017/10/5,No
18775,2247170,Shortage,BIO-HYDROCHLOROTHIAZIDE,BIOMED PHARMA,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,25MG,100,ORAL,Actual shortage,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",2016/3/22,2016/3/22,,,Disruption of the manufacture of the drug.,2017/8/11,2017/10/26,No
26815,2247171,Shortage,BIO-HYDROCHLOROTHIAZIDE,BIOMED PHARMA,Hydrochlorothiazide,HYDROCHLOROTHIAZIDE,50MG,100,ORAL,Actual shortage,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",2015/8/1,2015/8/1,,,Other (Please describe in comments),2017/10/24,2017/10/26,No
18781,2392496,Shortage,BIO-LETROZOLE,BIOMED PHARMA,LETROZOLE,LETROZOLE,2.5MG,100,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,2019/6/1,2019/6/1,,2021/10/20,Disruption of the manufacture of the drug.,2017/8/11,2021/10/21,No
27935,2445964,Shortage,BIO-LOSARTAN,BIOMED PHARMA,Bio-LOSARTAN 25mg-100,LOSARTAN POTASSIUM,25MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/11/1,,2018/6/15,Other (Please describe in comments),2017/11/2,2018/6/18,No
7713,2442078,Shortage,BIO-MODAFINIL,BIOMED PHARMA,MODAFINIL,MODAFINIL,100MG,100,ORAL,Actual shortage,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2017/4/1,2017/4/1,,,Delay in shipping of the drug.,2017/4/24,2017/10/26,No
27698,2247177,Shortage,BIO-OXAZEPAM,BIOMED PHARMA,Oxazepam Tablets 10 mg,,,100,,Actual shortage,,,,,2012/2/28,,,Other (Please describe in comments),2017/11/1,2017/11/1,No
27701,2247178,Shortage,BIO-OXAZEPAM,BIOMED PHARMA,Oxazepam Tablets 15 mg,,,500,,Actual shortage,,,,,2012/2/28,,,Other (Please describe in comments),2017/11/1,2017/11/1,No
27712,2247179,Shortage,BIO-OXAZEPAM,BIOMED PHARMA,Oxazepam Tablets 30 mg,,,500,,Actual shortage,,,,,2012/2/27,,,Other (Please describe in comments),2017/11/1,2017/11/1,No
22877,2445867,Shortage,BIO-PANTOPRAZOLE,BIOMED PHARMA,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/7/1,2017/7/1,,2018/8/24,Delay in shipping of the drug.,2017/9/20,2018/8/25,No
22874,2447193,Shortage,BIO-QUETIAPINE,BIOMED PHARMA,QUETIAPINE,QUETIAPINE,25MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2017/9/12,2017/9/12,,2017/12/1,Delay in shipping of the drug.,2017/9/20,2018/9/19,No
22880,2444860,Shortage,BIO-VALACYCLOVIR,BIOMED PHARMA,VALACYCLOVIR,VALACYCLOVIR,500MG,100,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2016/12/15,2016/12/15,,,Delay in shipping of the drug.,2017/9/20,2018/2/20,No
19888,2312557,Shortage,BOOSTRIX-POLIO,GLAXOSMITHKLINE INC,"Combined diphtheria, tetanus, acellular pertussis  and inactivated poliomyelitis vaccine",INACTIVATED POLIOVIRUS TYPE I INACTIVATED POLIOVIRUS TYPE II INACTIVATED POLIOVIRUS TYPE III TETANUS TOXOID ADSORBED DIPHTHERIA TOXOID ADSORBED PERTUSSIS TOXOID ADSORBED FILAMENTOUS HAEMAGGLUTININ ADSORBED PERTACTIN ADSORBED,40D 8D 32D 5.0LF 2.5LF 8MCG 8MCG 2.5MCG,10's,INTRAMUSCULAR,Resolved,SUSPENSION,J07CA,"BACTERIAL AND VIRAL VACCINES, COMBINED",,2017/11/8,2017/12/7,2017/12/6,Delay in shipping of the drug.,2017/8/18,2017/12/7,No
802,2268140,Shortage,BRAVELLE,FERRING INC,BRAVELLE,Urofollitropin for injection,75 IU's per vial,5 vials,Subcutaneous,Resolved,Powder for Injection,G03GA,GONADOTROPHINS AND OTHER OVULATION STIMULANTS,2015/9/9,2015/10/1,,2019/7/18,Disruption of the manufacture of the drug.,2017/3/13,2019/7/29,No
14644,2185377,Shortage,BRETYLIUM TOSYLATE INJECTION USP,SANDOZ CANADA INCORPORATED,BRETYLIUM,BRETYLIUM TOSYLATE,50MG,5 X 10ML VIALS,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",,2017/7/3,2017/7/28,2017/7/28,Requirements related to complying with good manufacturing practices.,2017/7/5,2017/10/18,No
18340,2185377,Shortage,BRETYLIUM TOSYLATE INJECTION USP,SANDOZ CANADA INCORPORATED,BRETYLIUM,BRETYLIUM TOSYLATE,50MG,5 X 10ML VIALS,"INTRAMUSCULAR
INTRAVENOUS",Actual shortage,SOLUTION,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",,2017/8/1,,,Delay in shipping of the drug.,2017/8/7,2017/12/4,No
17549,2309238,Shortage,BREVIBLOC PREMIXED INJECTION,BAXTER CORPORATION,Brevibloc Premixed Injection,ESMOLOL HYDROCHLORIDE,10MG,250mL Intravia Container,INTRAVENOUS,Resolved,SOLUTION,C07AB,BETA BLOCKING AGENTS,2017/7/27,2017/7/27,2017/8/8,2017/8/8,Delay in shipping of the drug.,2017/7/31,2017/8/9,No
31826,363812,Shortage,BUSCOPAN,SANOFI-AVENTIS CANADA INC,Buscopan 10mg,HYOSCINE BUTYLBROMIDE,10MG,100,ORAL,Resolved,TABLET,A03BB,"BELLADONNAAND DERIVATIVES, PLAIN",2018/1/15,2018/1/15,2019/6/1,2019/3/14,Other (Please describe in comments),2017/12/5,2019/3/15,No
3682,363812,Shortage,BUSCOPAN,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Buscopan Tabs,HYOSCINE BUTYLBROMIDE,10MG,100,ORAL,Resolved,TABLET,A03BB,"BELLADONNAAND DERIVATIVES, PLAIN",,2017/2/3,,2017/7/18,Disruption of the manufacture of the drug.,2017/3/20,2017/7/19,No
15779,2242504,Shortage,BUTORPHANOL NASAL SPRAY,AA PHARMA INC,Butorphanol Nasal Spray,BUTORPHANOL TARTRATE,10MG,2.5 ml,NASAL,Resolved,SOLUTION,N02AF,OPIOIDS,,2017/7/14,2017/9/15,2017/9/14,Disruption of the manufacture of the drug.,2017/7/14,2017/9/15,No
18193,2361817,Shortage,BYETTA,ASTRAZENECA CANADA INC,exenatide injection,EXENATIDE,250MCG,2.4 mL prefilled pen,SUBCUTANEOUS,Resolved,SOLUTION,A10BJ,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017/8/14,,2017/9/4,2017/9/6,Demand increase for the drug.,2017/8/3,2017/9/7,No
10355,2361817,Shortage,BYETTA,ASTRAZENECA CANADA INC,exenatide injection,EXENATIDE,250MCG,2.4 mL prefilled pen,SUBCUTANEOUS,Resolved,SOLUTION,A10BJ,,2017/6/12,,2017/6/20,2017/6/20,Delay in shipping of the drug.,2017/5/15,2017/6/21,No
8288,2399342,Shortage,CALCITRIOL INJECTION USP,STERIMAX INC,CALCITRIOL INJECTION USP,CALCITRIOL,2MCG,10 AMPOULES,INTRAVENOUS,Resolved,SOLUTION,A11CC,"VIT A AND D, INCL COMBINATIONS OF THE TWO",,2016/10/17,2016/10/17,2017/10/18,Other (Please describe in comments),2017/4/27,2021/8/11,No
28074,294748,Shortage,CALCIUM CHLORIDE INJECTION USP,PFIZER CANADA INC,Calcium Chloride LifeShield,CALCIUM CHLORIDE,100MG,10x10mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2017/11/17,,2017/12/29,Disruption of the manufacture of the drug.,2017/11/4,2018/1/2,No
26810,294748,Shortage,CALCIUM CHLORIDE INJECTION USP,PFIZER CANADA INC,CALCIUM CHLORIDE ANSYR,CALCIUM CHLORIDE,100MG,10x10mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2017/11/10,,2018/1/26,Disruption of the manufacture of the drug.,2017/10/24,2018/2/7,No
13187,2293269,Shortage,CAMPRAL,MYLAN PHARMACEUTICALS ULC,CAMPRAL,ACAMPROSATE CALCIUM,333MG,84BL,ORAL,Resolved,TABLET (DELAYED-RELEASE),N07BB,DRUGS USED IN ADDICTIVE DISORDERS,2018/7/17,2018/7/3,2018/10/9,2018/10/9,Delay in shipping of the drug.,2017/6/16,2018/10/10,No
13149,2388707,Shortage,CANDESARTAN,SIVEM PHARMACEUTICALS ULC,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017/6/16,,2017/7/3,2017/7/30,Demand increase for the drug.,2017/6/16,2017/11/3,No
6263,2388901,Shortage,CANDESARTAN,SANIS HEALTH INC,CANDESARTAN TABS,CANDESARTAN CILEXETIL,4MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/4/14,2017/5/19,2017/5/8,Other (Please describe in comments),2017/4/10,2017/5/10,No
12745,2388901,Shortage,CANDESARTAN,SANIS HEALTH INC,CANDESARTAN TABS,CANDESARTAN CILEXETIL,4MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017/6/15,,2017/6/30,2017/6/21,Delay in shipping of the drug.,2017/6/14,2017/6/22,No
7008,2413604,Shortage,CARBAMAZEPINE CR,PRO DOC LIMITEE,CARBAMAZEPINE CR,CARBAMAZEPINE,400MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N03AF,ANTIEPILEPTICS,,2017/4/24,2017/5/9,2017/5/9,Delay in shipping of the drug.,2017/4/13,2017/5/10,No
14724,2241999,Shortage,CARBOCAINE 1%,HOSPIRA HEALTHCARE CORPORATION,CARBOCAINE,MEPIVACAINE HYDROCHLORIDE,1%,10x30ml,"EPIDURAL
INTRACAUDAL",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017/9/28,,,2017/9/30,Other (Please describe in comments),2017/7/5,2017/11/23,No
14728,2242000,Shortage,CARBOCAINE 1%,HOSPIRA HEALTHCARE CORPORATION,CARBOCAINE,MEPIVACAINE HYDROCHLORIDE,1%,5x50ml,BLOCK/INFILTRATION,Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018/3/11,,,2017/9/30,Other (Please describe in comments),2017/7/5,2017/11/23,No
34273,2241999,Shortage,CARBOCAINE 1%,PFIZER CANADA INC,CARBOCAINE,MEPIVACAINE HYDROCHLORIDE,1%,10X30mL GVL,"EPIDURAL
INTRACAUDAL",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018/3/9,,2018/5/2,Disruption of the manufacture of the drug.,2017/12/22,2018/5/3,No
14731,2242001,Shortage,CARBOCAINE 2%,HOSPIRA HEALTHCARE CORPORATION,CARBOCAINE,MEPIVACAINE HYDROCHLORIDE,20MG,10x20ml,"INTRACAUDAL
EPIDURAL",Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017/10/31,,,2017/9/30,Other (Please describe in comments),2017/7/5,2017/11/23,No
34267,2242001,Shortage,CARBOCAINE 2%,PFIZER CANADA INC,Carbocaine,MEPIVACAINE HYDROCHLORIDE,20MG,10x20mL GVL,"INTRACAUDAL
EPIDURAL",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018/1/19,,2018/4/2,Disruption of the manufacture of the drug.,2017/12/22,2018/4/3,No
26486,2011239,Shortage,CARBOLITH CAPSULES 600MG,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CARBOLITH CAPSULES 600MG,LITHIUM CARBONATE,600MG,na,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2017/10/20,2017/11/3,2017/10/25,Other (Please describe in comments),2017/10/20,2017/11/3,No
31468,2011239,Shortage,CARBOLITH CAPSULES 600MG,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CARBOLITH CAPSULES 600MG,LITHIUM CARBONATE,600MG,na,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2017/12/1,2017/12/20,2018/1/19,Other (Please describe in comments),2017/12/1,2018/1/23,No
10874,2125439,Shortage,CARBOPLATIN INJECTION,TEVA CANADA LIMITED,CARBOPLATIN,CARBOPLATIN,10MG,45ML,INTRAVENOUS,Resolved,LIQUID,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2017/5/18,2017/7/27,2017/8/1,Disruption of the manufacture of the drug.,2017/5/23,2017/9/19,No
5825,2320371,Shortage,CARBOPLATIN INJECTION,ACCORD HEALTHCARE INC,CARBOPLATIN,CARBOPLATIN,10MG,"10 MG/ML, 5 ML/VIAL (50 MG/VIAL)     |     10 MG/ML, 5 ML/FLACON (50 MG/FLACON)",INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,2017/1/31,2017/1/31,2017/5/24,2017/5/9,Disruption of the manufacture of the drug.,2017/4/6,2017/5/10,No
3281,2320371,Shortage,CARBOPLATIN INJECTION,ACCORD HEALTHCARE INC,CARBOPLATIN,CARBOPLATIN,10MG,45 ML VIAL OF 450 MG     |     FLACON DE 45 ML DE 450 MG,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,2017/2/14,2017/2/14,2017/3/20,2017/3/20,Disruption of the manufacture of the drug.,2017/3/17,2017/4/6,No
3295,2320371,Shortage,CARBOPLATIN INJECTION,ACCORD HEALTHCARE INC,CARBOPLATIN,CARBOPLATIN,10MG,60 ML VIAL OF 600 MG     |     FLACON DE 60 ML DE 600 MG,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,2017/3/7,2017/3/7,2017/4/5,2017/3/31,Disruption of the manufacture of the drug.,2017/3/17,2017/4/6,No
31955,2126680,Shortage,CARBOPLATIN INJECTION BP,PFIZER CANADA INC,CARBOPLATIN,CARBOPLATIN,10MG,15mL,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,2018/4/16,,,2018/4/19,Disruption of the manufacture of the drug.,2017/12/6,2018/4/20,No
21747,2126680,Shortage,CARBOPLATIN INJECTION BP,PFIZER CANADA INC,CARBOPLATIN,CARBOPLATIN,10MG,1x60mL,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,2017/10/26,,2017/12/15,2017/11/9,Disruption of the manufacture of the drug.,2017/9/8,2017/11/14,No
161,2144328,Shortage,CARNITOR -TAB 330MG,SIGMA-TAU PHARMACEUTICALS INC,levocarnitine,LEVOCARNITINE,330MG,90 tablets,ORAL,Resolved,TABLET,A16AA,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,,2016/4/1,2017/6/2,2017/6/2,Disruption of the manufacture of the drug.,2017/3/10,2017/6/3,No
28179,2248755,Shortage,CARVEDILOL,SIVEM PHARMACEUTICALS ULC,CARVEDILOL,CARVEDILOL,25MG,100,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2017/10/13,2018/8/31,2018/9/3,Requirements related to complying with good manufacturing practices.,2017/11/6,2018/9/10,No
32560,2248752,Shortage,CARVEDILOL,SIVEM PHARMACEUTICALS ULC,CARVEDILOL,CARVEDILOL,3.125MG,100,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,2018/2/19,2018/2/15,2018/11/7,2018/11/7,Other (Please describe in comments),2017/12/12,2018/11/8,No
33371,2437120,Shortage,CEFAZOLIN FOR INJECTION,STERIMAX INC,CEFAZOLIN FOR INJECTION,CEFAZOLIN,10G,10 vials,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/12/18,2018/3/26,2018/3/12,Delay in shipping of the drug.,2017/12/18,2018/6/5,No
21857,2437120,Shortage,CEFAZOLIN FOR INJECTION,STERIMAX INC,CEFAZOLIN FOR INJECTION,CEFAZOLIN,10G,PACK OF 10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/9/11,2017/11/13,2017/11/8,Other (Please describe in comments),2017/9/11,2017/11/9,No
21860,2437112,Shortage,CEFAZOLIN FOR INJECTION,STERIMAX INC,CEFAZOLIN FOR INJECTION,CEFAZOLIN,1G,PACK OF 25 VIALS,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/9/11,2017/11/20,2017/11/16,Other (Please describe in comments),2017/9/11,2017/11/17,No
8815,2437120,Shortage,CEFAZOLIN FOR INJECTION,STERIMAX INC,CEFAZOLIN FOR INJECTION,CEFAZOLIN,10G,PACK OF 10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/5/1,,2017/6/5,Other (Please describe in comments),2017/5/3,2017/6/7,No
10877,2108119,Shortage,CEFAZOLIN FOR INJECTION,TEVA CANADA LIMITED,CEFAZOLIN,CEFAZOLIN,0.5G,10,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/5/17,2017/7/30,2017/9/1,Disruption of the manufacture of the drug.,2017/5/23,2017/9/19,No
17865,2108135,Shortage,CEFAZOLIN FOR INJECTION,TEVA CANADA LIMITED,CEFAZOLIN,CEFAZOLIN,10G,10G,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/8/1,2017/10/15,2017/10/20,Disruption of the manufacture of the drug.,2017/8/1,2017/10/24,No
12782,2452162,Shortage,CEFAZOLIN FOR INJECTION,FRESENIUS KABI CANADA LTD,Cefazolin for Injection,CEFAZOLIN,10G,10g Vial,INTRAVENOUS,Avoided shortage,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,2017/7/3,,2017/4/13,2017/6/7,Disruption of the manufacture of the drug.,2017/6/15,2020/1/16,No
33327,2308959,Shortage,CEFAZOLIN FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFAZOLIN,CEFAZOLIN,1G,10 VIALS,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/12/12,2018/5/4,2018/4/30,Demand increase for the drug.,2017/12/15,2018/5/3,No
2520,2308959,Shortage,CEFAZOLIN FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFAZOLIN,CEFAZOLIN,1G,1G,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,2017/3/14,,2017/5/31,2017/5/5,Disruption of the manufacture of the drug.,2017/3/14,2017/7/5,No
2533,2308932,Shortage,CEFAZOLIN FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFAZOLIN,CEFAZOLIN,500MG,10 X 500MG,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,2017/3/14,,2017/4/28,2017/5/5,Demand increase for the drug.,2017/3/14,2017/7/5,No
2536,2308932,Shortage,CEFAZOLIN FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFAZOLIN,CEFAZOLIN,500MG,10 X 500MG,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/3/14,2017/4/14,2017/5/5,Demand increase for the drug.,2017/3/14,2017/7/5,No
12777,2237140,Shortage,"CEFAZOLIN FOR INJECTION, USP",FRESENIUS KABI CANADA LTD,Cefazolin for Injection,CEFAZOLIN,10G,10g Vial,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2019/7/4,2019/9/6,2019/9/6,Disruption of the manufacture of the drug.,2017/6/15,2019/9/13,No
698,2319039,Shortage,CEFEPIME FOR INJECTION,APOTEX INC,CEFEPIME,CEFEPIME (CEFEPIME HYDROCHLORIDE),2G,20 ML,INJECTION,Actual shortage,POWDER FOR SOLUTION,J01DE,OTHER BETA-LACTAM ANTIBACTERIALS,,2012/8/23,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
3140,2128195,Shortage,CEFOXITIN FOR INJECTION,TEVA CANADA LIMITED,CEFOXITIN,CEFOXITIN,2G,10,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/3/17,2017/6/9,2017/6/30,Disruption of the manufacture of the drug.,2017/3/17,2017/9/5,No
17868,2240773,Shortage,CEFOXITIN FOR INJECTION,TEVA CANADA LIMITED,CEFOXITIN,CEFOXITIN,10G,10G,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/8/1,2017/11/30,2017/12/15,Demand increase for the drug.,2017/8/1,2018/1/3,No
8810,2437864,Shortage,CEFTAZIDIME FOR INJECTION BP,STERIMAX INC,CEFTAZIDIME FOR INJECTION BP,CEFTAZIDIME,6G,1 VIAL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/5/1,2017/5/19,2017/5/24,Delay in shipping of the drug.,2017/5/3,2017/5/25,No
15628,2409968,Shortage,CEFTRIAXONE FOR INJECTION,FRESENIUS KABI CANADA LTD,Ceftriaxone for Injection 100g SmartPak,CEFTRIAXONE,100G,100g SmartPak,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/12/11,2018/5/18,2018/5/23,Disruption of the manufacture of the drug.,2017/7/12,2018/5/24,No
6467,2292297,Shortage,CEFTRIAXONE FOR INJECTION USP,SANDOZ CANADA INCORPORATED,ROCEPHIN,CEFTRIAXONE,10.0G,10g VIAL,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/4/11,2017/4/28,2017/5/5,Demand increase for the drug.,2017/4/11,2017/8/2,No
31046,2292297,Shortage,CEFTRIAXONE FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFTRIxone,CEFTRIAXONE,10.0G,1 VIAL,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/11/20,2017/12/15,2017/12/12,Requirements related to complying with good manufacturing practices.,2017/11/29,2017/12/15,No
21365,2292289,Shortage,CEFTRIAXONE FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFTRIAXONE,CEFTRIAXONE,2.0G,10X2gV,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/9/1,2017/10/10,2017/10/9,Delay in shipping of the drug.,2017/9/7,2017/10/18,No
9644,2292262,Shortage,CEFTRIAXONE FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFTRIAXONE,CEFTRIAXONE,0.25G,10 VIALS/FIOLES,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/5/9,2017/8/18,2017/8/28,Delay in shipping of the drug.,2017/5/9,2017/10/18,No
18143,2292289,Shortage,CEFTRIAXONE FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFTRIAXONE,CEFTRIAXONE,2.0G,10 VIALS,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,2017/8/10,,2017/8/31,2017/10/9,Delay in shipping of the drug.,2017/8/3,2017/10/18,No
3832,2292289,Shortage,CEFTRIAXONE FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFTRIAXONE,CEFTRIAXONE,2.0G,10 X 2G VIALS,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/3/21,2017/3/31,2017/3/24,Requirements related to complying with good manufacturing practices.,2017/3/22,2017/3/28,No
32244,2325594,Shortage,CEFTRIAXONE SODIUM FOR INJECTION BP,STERIMAX INC,CEFTRIAXONE SODIUM FOR INJECTION BP,CEFTRIAXONE,250MG,10 VIALS,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/12/8,2018/1/8,2017/12/22,Delay in shipping of the drug.,2017/12/8,2017/12/23,No
29312,2250276,Shortage,"CEFTRIAXONE SODIUM FOR INJECTION, BP",HOSPIRA HEALTHCARE CORPORATION,Ceftriaxone sodium,CEFTRIAXONE,250MG,10x250mg vial,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/11/13,,2017/12/20,Disruption of the manufacture of the drug.,2017/11/15,2017/12/21,No
29321,2250306,Shortage,"CEFTRIAXONE SODIUM FOR INJECTION, BP",HOSPIRA HEALTHCARE CORPORATION,Ceftriaxone sodium,CEFTRIAXONE,2G,10x2g vial,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/11/21,,2018/2/12,Disruption of the manufacture of the drug.,2017/11/15,2018/7/26,No
7489,2239941,Shortage,CELEBREX,PFIZER CANADA INC,CELEBREX,CELECOXIB,100MG,100's,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/4/28,,2017/5/31,2017/6/1,Disruption of the manufacture of the drug.,2017/4/20,2017/6/28,No
26143,2424398,Shortage,CELECOXIB,PRO DOC LIMITEE,CELECOXIB,CELECOXIB,200MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/10/17,,2017/10/17,Delay in shipping of the drug.,2017/10/17,2017/11/29,No
5679,2429675,Shortage,CELECOXIB,SIVEM PHARMACEUTICALS ULC,CELECOXIB,CELECOXIB,100MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/4/4,,2018/7/23,Other (Please describe in comments),2017/4/5,2018/7/24,No
5682,2429683,Shortage,CELECOXIB,SIVEM PHARMACEUTICALS ULC,CELECOXIB,CELECOXIB,200MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/4/4,,2018/7/23,Other (Please describe in comments),2017/4/5,2018/7/24,No
22070,2424398,Shortage,CELECOXIB,PRO DOC LIMITEE,CELECOXIB,CELECOXIB,200MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/9/13,,2017/9/21,Delay in shipping of the drug.,2017/9/13,2017/9/22,No
5719,2429683,Shortage,CELECOXIB,SIVEM PHARMACEUTICALS ULC,CELECOXIB,CELECOXIB,200MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/4/4,,2018/7/23,Other (Please describe in comments),2017/4/5,2018/7/24,No
7806,28096,Shortage,CELESTONE SOLUSPAN,MERCK CANADA INC,BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID,BETAMETHASONE ACETATE BETAMETHASONE,3MG 3MG,1mL,"INTRA-ARTICULAR
INTRABURSAL
INTRADERMAL
INTRAMUSCULAR",Resolved,SUSPENSION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",2017/5/1,2017/5/1,2017/5/24,2017/5/23,Delay in shipping of the drug.,2017/4/24,2017/5/24,No
16797,28096,Shortage,CELESTONE SOLUSPAN,MERCK CANADA INC,BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID,BETAMETHASONE ACETATE BETAMETHASONE,3MG 3MG,1mL,"INTRA-ARTICULAR
INTRABURSAL
INTRADERMAL
INTRAMUSCULAR",Resolved,SUSPENSION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",2017/9/13,2017/9/15,2017/9/29,2017/9/28,Delay in shipping of the drug.,2017/7/24,2017/9/29,No
20078,548375,Shortage,CESAMET,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CESAMET,NABILONE,1MG,NA,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2017/4/15,,2017/11/21,Other (Please describe in comments),2017/8/22,2017/11/22,No
3308,2312263,Shortage,CESAMET,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CESAMET,NABILONE,0.25MG,50,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,2018/2/15,,2018/5/15,2018/2/15,Shortage of an active ingredient.,2017/3/17,2018/2/16,No
3317,2256193,Shortage,CESAMET,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CESAMET,NABILONE,0.5MG,50,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,2017/4/10,,2018/1/22,2017/11/21,Shortage of an active ingredient.,2017/3/17,2017/11/22,No
25863,2247766,Shortage,CETROTIDE,EMD SERONO A DIVISION OF EMD INC CANADA,cetrorelix acetate,CETRORELIX,0.25MG,1 vial / flacon,SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,H01CC,HYPOTHALAMIC HORMONES,,2017/10/12,2017/12/31,2017/12/1,Demand increase for the drug.,2017/10/13,2017/12/2,No
2128,2056429,Shortage,CHARAC-25,OMEGA LABORATORIES LTD,Charac-25,CHARCOAL ACTIVATED,222MG,112.5mL bottle,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2016/9/28,2017/5/31,2017/5/30,Disruption of the manufacture of the drug.,2017/3/14,2017/6/19,No
19841,2056429,Shortage,CHARAC-25,OMEGA LABORATORIES LTD,Charac-25,CHARCOAL ACTIVATED,222MG,112.5mL bottle,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,2017/6/12,2017/6/12,2017/8/31,2017/8/31,Disruption of the manufacture of the drug.,2017/8/18,2017/9/1,No
2116,637955,Shortage,CHARAC-50,OMEGA LABORATORIES LTD,Charac-50,CHARCOAL ACTIVATED,50G,225mL bottle,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2017/1/23,2017/3/31,2017/5/30,Disruption of the manufacture of the drug.,2017/3/14,2017/8/18,No
19822,637955,Shortage,CHARAC-50,OMEGA LABORATORIES LTD,CHARAC-50,CHARCOAL ACTIVATED,50G,225mL botle,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,2017/6/14,2017/6/14,2017/9/15,2017/9/9,Disruption of the manufacture of the drug.,2017/8/18,2017/9/18,No
2125,2060205,Shortage,CHARACTOL-25,OMEGA LABORATORIES LTD,Charactol-25,CHARCOAL ACTIVATED,200MG,125mL bottle,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2016/10/19,2017/5/31,2017/5/30,Disruption of the manufacture of the drug.,2017/3/14,2017/6/19,No
2122,649236,Shortage,CHARACTOL-50,OMEGA LABORATORIES LTD,Charactol-50,CHARCOAL ACTIVATED,50G,250mL bottle,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2016/7/28,2017/3/31,2017/5/30,Disruption of the manufacture of the drug.,2017/3/14,2017/6/19,No
19817,649236,Shortage,CHARACTOL-50,OMEGA LABORATORIES LTD,Charactol-50,CHARCOAL ACTIVATED,50G,250mL bottle,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,2017/6/14,2017/6/14,2017/9/15,2017/9/9,Disruption of the manufacture of the drug.,2017/8/18,2017/9/18,No
1794,632333,Shortage,CHARCODOTE SUSP 200MG/ML,PHARMASCIENCE INC,Charcodote,CHARCOAL ACTIVATED,200MG,250 ml,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2015/11/3,,2020/4/1,Disruption of the manufacture of the drug.,2017/3/13,2020/4/2,No
4175,632333,Shortage,CHARCODOTE SUSP 200MG/ML,PHARMASCIENCE INC,CHARCODOTE,CHARCOAL ACTIVATED,200MG,250ml,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2017/3/23,2017/4/12,2017/4/12,Disruption of the manufacture of the drug.,2017/3/24,2017/10/11,No
5460,632333,Shortage,CHARCODOTE SUSP 200MG/ML,PHARMASCIENCE INC,CHARCODOTE,CHARCOAL ACTIVATED,200MG,250ml,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2017/3/23,2017/4/12,2017/4/12,Disruption of the manufacture of the drug.,2017/4/4,2017/10/11,No
6019,632333,Shortage,CHARCODOTE SUSP 200MG/ML,PHARMASCIENCE INC,CHARCODOTE,CHARCOAL ACTIVATED,200MG,250 mL,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2017/4/5,2017/4/12,2017/4/12,Disruption of the manufacture of the drug.,2017/4/7,2017/10/11,No
7341,632333,Shortage,CHARCODOTE SUSP 200MG/ML,PHARMASCIENCE INC,CHARCODOTE,CHARCOAL ACTIVATED,200MG,250 ML,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2017/4/19,,2020/6/5,Disruption of the manufacture of the drug.,2017/4/20,2020/6/9,No
1805,2105470,Shortage,CHARCODOTE-AQUEOUS SUS 200MG/ML,PHARMASCIENCE INC,Charcodote,CHARCOAL ACTIVATED,200MG,250 ml,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2015/11/3,,2020/4/1,Disruption of the manufacture of the drug.,2017/3/13,2020/4/2,No
1851,618454,Shortage,CHLORAX,AA PHARMA INC,CHLORAX 5/2.5MG CAP 100 BTL,CHLORDIAZEPOXIDE HYDROCHLORIDE CLIDINIUM BROMIDE,5/2.5MG,100 Bottle,Oral,Resolved,Capsule,A03CA,ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS,2017/1/18,2017/1/18,2017/9/4,2017/7/25,Shortage of an active ingredient.,2017/3/13,2017/7/26,No
5730,522988,Shortage,CHLORDIAZEPOXIDE,AA PHARMA INC,CHLORDIAZEPOXIDE,CHLORDIAZEPOXIDE HYDROCHLORIDE,10MG,100 Bottle,ORAL,Resolved,CAPSULE,N05BA,ANXIOLYTICS,,2017/4/5,2017/9/8,2017/9/8,Shortage of an active ingredient.,2017/4/5,2017/9/9,No
5733,522996,Shortage,CHLORDIAZEPOXIDE,AA PHARMA INC,CHLORDIAZEPOXIDE,CHLORDIAZEPOXIDE HYDROCHLORIDE,25MG,100 Bottle,ORAL,Resolved,CAPSULE,N05BA,ANXIOLYTICS,,2017/4/5,2017/10/20,2017/10/17,Shortage of an active ingredient.,2017/4/5,2017/10/18,No
1977,522724,Shortage,CHLORDIAZEPOXIDE,AA PHARMA INC,CHLORDIAZEPOXIDE HYDROCHLORIDE,CHLORDIAZEPOXIDE HYDROCHLORIDE,5 MG,100 Bottle,Oral,Resolved,Capsule,N05BA,ANXIOLYTICS,2016/6/9,2016/6/9,2017/9/4,2017/8/11,Shortage of an active ingredient.,2017/3/13,2017/8/12,No
2425,476366,Shortage,CHOLEDYL ELIXIR 100MG/5ML,ERFA CANADA 2012 INC,"Oxtriphylline Oral Solution, USP",Oxtriphylline,100 mg,bottle,Oral,Resolved,Elixir,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017/1/19,2017/1/19,,2017/12/12,Disruption of the manufacture of the drug.,2017/3/14,2018/3/14,No
6396,476374,Shortage,CHOLEDYL EXPECTORANT ELIXIR,ERFA CANADA 2012 INC,Oxtriphylline Guaifenesin,OXTRIPHYLLINE GUAIFENESIN,100MG 50MG,bottle,ORAL,Resolved,ELIXIR,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2017/4/14,2017/5/23,2017/5/30,Other (Please describe in comments),2017/4/11,2018/3/14,No
19488,,Shortage,Choletec,,MEBROFENIN powder for solution,MEBROFENIN,45mg/vial,kit of 10 vials,Intravenous,Resolved,powder for solution,V09DA,Hepatic and reticulo endothelial system,,2017/6/1,2018/4/9,2018/3/30,Disruption of the manufacture of the drug.,2017/8/15,2018/9/28,No
8489,2228556,Shortage,CHOLOGRAFIN MEGLUMINE INJ. - LIQ IV,BRACCO IMAGING CANADA,Cholografin,MEGLUMINE IODIPAMIDE,52%,10X20ml,INTRAVENOUS,Actual shortage,LIQUID,V08AC,"X-RAY CONTRAST MEDIA, IODINATED",,2017/5/1,,,Disruption of the manufacture of the drug.,2017/5/1,2018/12/20,No
8306,2410346,Shortage,CICLOPIROX TOPICAL SOLUTION,STERIMAX INC,CICLOPIROX TOPICAL SOLUTION,CICLOPIROX,8%,1 BOTTLE,TOPICAL,Actual shortage,SOLUTION,D01AE,ANTIFUNGALS FOR TOPICAL USE,,2017/4/7,,,Other (Please describe in comments),2017/4/27,2017/10/5,No
6940,2155974,Shortage,CIPRO 750 - TAB 750MG,BAYER INC,ciprofloxacin tablet USP,CIPROFLOXACIN,750MG,50s,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,2017/4/28,,2017/5/31,2017/5/31,Disruption of the manufacture of the drug.,2017/4/13,2017/6/1,No
30093,2251787,Shortage,CIPRO XL,BAYER INC,Ciprofloxacin Hydrochloride and Ciprofloxacin Extended Release,CIPROFLOXACIN,1000MG,50,ORAL,Resolved,TABLET (EXTENDED-RELEASE),J01MA,QUINOLONE ANTIBACTERIALS,2017/11/27,,2018/4/16,2018/4/9,Disruption of the manufacture of the drug.,2017/11/22,2018/4/10,No
19335,2304546,Shortage,"CIPROFLOXACIN INTRAVENOUS INFUSION, BP",APOTEX INC,CIPROFLOX,CIPROFLOXACIN,2MG,100/200 ML,INTRAVENOUS,Actual shortage,SOLUTION,J01MA,QUINOLONE ANTIBACTERIALS,,2017/3/10,,,Disruption of the manufacture of the drug.,2017/8/14,2017/10/5,No
1428,2425718,Shortage,CISATRACURIUM BESYLATE INJECTION,HOSPIRA HEALTHCARE CORPORATION,Cisatracurium Besylate,CISATRACURIUM,2MG,20 mg/10 mL x 10,INTRAVENOUS,Resolved,SOLUTION,M03AC,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",,2015/7/30,,2019/3/25,Requirements related to complying with good manufacturing practices.,2017/3/13,2019/3/28,No
3275,2355183,Shortage,"CISPLATIN INJECTION, BP",ACCORD HEALTHCARE INC,CISPLATIN,CISPLATIN,1MG,100 ML VIAL OF 100 MG     |     FLACON DE 100 ML DE 100 MG,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,2017/3/6,2017/3/6,2017/4/12,2017/3/30,Disruption of the manufacture of the drug.,2017/3/17,2017/4/6,No
33689,2445719,Shortage,CITALOPRAM,SANIS HEALTH INC,CITALOPRAM TAB,CITALOPRAM,10MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/12/18,2018/1/19,2018/1/17,Other (Please describe in comments),2017/12/19,2018/1/18,No
5591,2442469,Shortage,CLARITHROMYCIN,SIVEM PHARMACEUTICALS ULC,CLARITHROMYCIN,CLARITHROMYCIN,250MG,100,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/4/4,2017/4/11,2017/4/10,Demand increase for the drug.,2017/4/5,2017/4/11,No
143,2257955,Shortage,CLARUS,MYLAN PHARMACEUTICALS ULC,Isotretinoin,ISOTRETINOIN,10MG,30,ORAL,Resolved,CAPSULE,D10BA,ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,2016/1/4,2016/1/4,,2017/3/20,Requirements related to complying with good manufacturing practices.,2017/3/10,2017/3/22,No
148,2257963,Shortage,CLARUS,MYLAN PHARMACEUTICALS ULC,Isotretinoin,ISOTRETINOIN,40MG,30,ORAL,Resolved,CAPSULE,D10BA,ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,,2016/1/4,,2017/3/20,Requirements related to complying with good manufacturing practices.,2017/3/10,2017/3/22,No
5039,2257963,Shortage,CLARUS,MYLAN PHARMACEUTICALS ULC,Clarus,ISOTRETINOIN,40MG,30BL,ORAL,Avoided shortage,CAPSULE,D10BA,ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,2017/6/29,,,2017/6/27,Disruption of the manufacture of the drug.,2017/3/31,2017/6/28,No
29071,2243659,Shortage,CLINDA-T,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CLINDA-T,CLINDAMYCIN,1%,na,TOPICAL,Actual shortage,SOLUTION,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2017/11/9,,,Disruption of the manufacture of the drug.,2017/11/13,2019/6/12,No
17933,2400529,Shortage,CLINDAMYCIN,SANIS HEALTH INC,CLINDAMYCIN CAPS,CLINDAMYCIN,150MG,100,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2013/5/14,,2018/3/23,Disruption of the manufacture of the drug.,2017/8/2,2020/2/27,No
17938,2400537,Shortage,CLINDAMYCIN,SANIS HEALTH INC,CLINDAMYCIN CAPS,CLINDAMYCIN,300MG,100,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2013/5/14,,2018/3/23,Disruption of the manufacture of the drug.,2017/8/2,2020/2/27,No
18146,2408511,Shortage,CLINDAMYCIN IV INFUSION,SANDOZ CANADA INCORPORATED,CLINDAMYCIN,CLINDAMYCIN,12MG,10 X 50ML MINIBAGS,INTRAVENOUS,Resolved,SOLUTION,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/7/21,2017/8/18,2017/8/14,Delay in shipping of the drug.,2017/8/3,2017/10/10,No
18149,2408538,Shortage,CLINDAMYCIN IV INFUSION,SANDOZ CANADA INCORPORATED,CLINDAMYCIN,CLINDAMYCIN,18MG,10 X 50ML MINIBAGS,INTRAVENOUS,Resolved,SOLUTION,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/7/21,2017/8/18,2017/8/14,Delay in shipping of the drug.,2017/8/3,2017/10/10,No
8380,2248525,Shortage,CLINDAMYCINE-150,PRO DOC LIMITEE,CLINDAMYCINE,CLINDAMYCIN,150MG,100,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/4/28,,2017/10/24,Delay in shipping of the drug.,2017/4/28,2017/10/25,No
6192,2248526,Shortage,CLINDAMYCINE-300,PRO DOC LIMITEE,CLINDAMYCINE,CLINDAMYCIN,300MG,100,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/4/11,,2017/10/25,Delay in shipping of the drug.,2017/4/7,2017/10/26,No
2635,2243050,Shortage,CLINDETS,GLAXOSMITHKLINE INC,Clindamycin phosphate solution in pledget,CLINDAMYCIN,1%,60's,TOPICAL,Resolved,PAD,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2017/2/8,,2017/5/2,Disruption of the manufacture of the drug.,2017/3/14,2017/5/3,No
11231,2243050,Shortage,CLINDETS,GLAXOSMITHKLINE INC,Clindamycin phosphate solution in pledget,CLINDAMYCIN,1%,60's,TOPICAL,Resolved,PAD,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2017/6/2,,2017/9/14,Disruption of the manufacture of the drug.,2017/5/25,2020/2/27,No
17444,2382822,Shortage,CLINDOXYL ADV GEL,GLAXOSMITHKLINE INC,clindamycin and benzoyl peroxide gel,BENZOYL PEROXIDE CLINDAMYCIN,3% 1%,45g,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2017/7/26,2017/10/9,2017/9/26,Disruption of the manufacture of the drug.,2017/7/28,2017/9/27,No
24666,2382822,Shortage,CLINDOXYL ADV GEL,GLAXOSMITHKLINE INC,clindamycin and benzoyl peroxide gel,BENZOYL PEROXIDE CLINDAMYCIN,3% 1%,45g,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2017/11/8,2017/11/24,2017/11/20,Disruption of the manufacture of the drug.,2017/10/6,2017/11/22,No
12148,2243158,Shortage,CLINDOXYL GEL,GLAXOSMITHKLINE INC,Clindamycin and benzoyl peroxide gel,BENZOYL PEROXIDE CLINDAMYCIN,50MG 10MG,45g,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2017/6/12,2017/10/3,2017/9/26,Disruption of the manufacture of the drug.,2017/6/6,2017/9/27,No
3063,2330407,Shortage,CLOLAR,SANOFI-AVENTIS CANADA INC,CLOLAR,CLOFARABINE,1MG,20 MG/20 ML UNIDOSE VIAL,INTRAVENOUS,Resolved,SOLUTION,L01BB,ANTIMETABOLITES,,2016/12/20,2017/4/14,2017/4/19,Other (Please describe in comments),2017/3/16,2017/4/20,No
13141,2442035,Shortage,CLONAZEPAM,SIVEM PHARMACEUTICALS ULC,CLONAZEPAM,CLONAZEPAM,0.5MG,100,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2017/6/16,,2017/6/26,2017/7/23,Demand increase for the drug.,2017/6/16,2017/11/6,No
27985,812382,Shortage,CLOTRIMADERM CREAM 1%,TARO PHARMACEUTICALS INC,CLOTRIMADERM CREAM 1%,CLOTRIMAZOLE,1%,500G,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,,2018/12/10,2019/2/1,2019/1/28,Disruption of the manufacture of the drug.,2017/11/3,2019/2/4,No
22258,812382,Shortage,CLOTRIMADERM CREAM 1%,TARO PHARMACEUTICALS INC,CLOTRIMADERM CREAM 1%,CLOTRIMAZOLE,1%,30 G,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,2017/9/15,,2017/9/22,2017/10/1,Disruption of the manufacture of the drug.,2017/9/18,2017/10/2,No
34379,812366,Shortage,CLOTRIMADERM VAG CREAM 1%,TARO PHARMACEUTICALS INC,CLOTRIMADERM VAG CREAM 1%,CLOTRIMAZOLE,1%,50G,VAGINAL,Resolved,CREAM,G01AF,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",,2017/12/19,2018/1/30,2018/2/1,Disruption of the manufacture of the drug.,2017/12/25,2018/2/2,No
2671,68594,Shortage,COACTIFED,GLAXOSMITHKLINE INC,Triprolidine hydrochloride/pseudoephedrine hydrocholride/codeine phosphate syrup,PSEUDOEPHEDRINE HYDROCHLORIDE TRIPROLIDINE HYDROCHLORIDE CODEINE PHOSPHATE,30MG 2MG 10MG,100 mL,ORAL,Resolved,SYRUP,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,,2016/9/14,,2018/5/28,Disruption of the manufacture of the drug.,2017/3/14,2020/2/27,No
13399,2230302,Shortage,CODEINE CONTIN 50MG CONTROLLED RELEASE TAB,PURDUE PHARMA,codeine controlled release tablets,CODEINE,50MG,60s,ORAL,Resolved,TABLET (EXTENDED-RELEASE),R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,2017/6/20,2017/6/20,2017/6/30,2017/7/12,Requirements related to complying with good manufacturing practices.,2017/6/20,2017/7/13,No
8036,642975,Shortage,COLESTID GRANULES,PFIZER CANADA INC,COLESTID,COLESTIPOL HYDROCHLORIDE,5G,30's,ORAL,Resolved,GRANULES,C10AC,"LIPID MODIFYING AGENTS, PLAIN",,2017/4/21,2017/5/11,2017/5/11,Disruption of the manufacture of the drug.,2017/4/25,2017/5/12,No
17518,642975,Shortage,COLESTID GRANULES,PFIZER CANADA INC,Colestid,COLESTIPOL HYDROCHLORIDE,5G,30's,ORAL,Resolved,GRANULES,C10AC,"LIPID MODIFYING AGENTS, PLAIN",2017/7/28,,2017/8/21,2017/8/21,Delay in shipping of the drug.,2017/7/31,2017/8/22,No
2178,2231675,Shortage,COMBIVENT UDV,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,COMBIVENT UDV,IPRATROPIUM BROMIDE SALBUTAMOL,0.2MG 1.0MG,20 x 2.5ml,INHALATION,Resolved,SOLUTION,R03AL,"ADRENERGICS, INHALANTS",,2017/1/11,2017/4/24,2017/4/5,Disruption of the manufacture of the drug.,2017/3/14,2017/4/6,No
3593,223107,Shortage,CONRAY 30,LIEBEL-FLARSHEIM CANADA INC,Iothalamate Meglumine Injection 30%,IOTHALAMATE MEGLUMINE,300MG,100 mL,INTRAVASCULAR,Resolved,SOLUTION,V08AA,"X-RAY CONTRAST MEDIA, IODINATED",,2017/7/21,,2018/3/14,Shortage of an active ingredient.,2017/3/20,2018/5/3,No
3597,223107,Shortage,CONRAY 30,LIEBEL-FLARSHEIM CANADA INC,Iothalamate Meglumine Injection 30 %,IOTHALAMATE MEGLUMINE,300MG,250 mL,INTRAVASCULAR,Resolved,SOLUTION,V08AA,"X-RAY CONTRAST MEDIA, IODINATED",2017/5/1,2017/7/21,,2018/3/14,Shortage of an active ingredient.,2017/3/20,2018/5/3,No
3661,477095,Shortage,CONRAY 43,LIEBEL-FLARSHEIM CANADA INC,Iothalamate Meglumine Injection 43%,IOTHALAMATE MEGLUMINE,430MG,"50, 100 and 200 mL",INTRAVASCULAR,Resolved,SOLUTION,V08AA,"X-RAY CONTRAST MEDIA, IODINATED",2016/1/1,,,2018/4/5,Shortage of an active ingredient.,2017/3/20,2018/5/3,No
3587,131237,Shortage,CONRAY 60,LIEBEL-FLARSHEIM CANADA INC,Iothalamate Meglumine Injection 60 %,IOTHALAMATE MEGLUMINE,600MG,50 mL,INTRAVASCULAR,Resolved,SOLUTION,V08AA,"X-RAY CONTRAST MEDIA, IODINATED",2016/12/1,,2017/3/31,2017/3/31,Shortage of an active ingredient.,2017/3/20,2018/1/23,No
3608,131237,Shortage,CONRAY 60,LIEBEL-FLARSHEIM CANADA INC,Iothalamate Meglumine 60 %,IOTHALAMATE MEGLUMINE,600MG,200 mL,INTRAVASCULAR,Resolved,SOLUTION,V08AA,"X-RAY CONTRAST MEDIA, IODINATED",2016/6/1,2016/6/1,,2019/2/18,Shortage of an active ingredient.,2017/3/20,2019/2/19,No
3575,131237,Shortage,CONRAY 60,LIEBEL-FLARSHEIM CANADA INC,Iothalamate Meglumine Injection 60 %,IOTHALAMATE MEGLUMINE,600MG,20 mL Bottle,INTRAVASCULAR,Resolved,SOLUTION,V08AA,"X-RAY CONTRAST MEDIA, IODINATED",2016/11/30,2016/11/30,,2019/2/18,Shortage of an active ingredient.,2017/3/20,2019/2/19,No
3583,131237,Shortage,CONRAY 60,LIEBEL-FLARSHEIM CANADA INC,Iothalamate Meglumine Injection 60 %,IOTHALAMATE MEGLUMINE,600MG,30 mL,INTRAVASCULAR,Resolved,SOLUTION,V08AA,"X-RAY CONTRAST MEDIA, IODINATED",2017/1/31,2017/1/31,,2019/2/18,Shortage of an active ingredient.,2017/3/20,2019/3/14,No
28619,2425009,Shortage,CONTINGENCY ONE,MYLAN PHARMACEUTICALS ULC,CONTINGENCY ONE,LEVONORGESTREL,1.5MG,1BL,ORAL,Resolved,TABLET,G03AD,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2018/1/31,2018/2/2,2018/5/14,2018/5/11,Delay in shipping of the drug.,2017/11/8,2018/5/31,No
5960,2224577,Shortage,COPHYLAC DROPS,VALEANT CANADA LP/VALEANT CANADA S.E.C.,COPHYLAC DROPS,NORMETHADONE HYDROCHLORIDE P-HYDROXYEPHEDRINE HYDROCHLORIDE,10MG 20MG,ORAL,ORAL,Resolved,DROPS,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,2017/6/30,,,2018/4/3,Other (Please describe in comments),2017/4/7,2018/4/4,No
32433,1985205,Shortage,CREON MINIMICROSPHERES 25,BGP PHARMA ULC,CREON 25,AMYLASE PROTEASE LIPASE,25500UNIT 1600UNIT 25000UNIT,100,ORAL,Resolved,CAPSULE,A09AA,"DIGESTIVES, INCL ENZYMES",2018/11/8,2018/11/12,2019/3/19,2019/3/15,Delay in shipping of the drug.,2017/12/11,2019/3/16,No
2263,16055,Shortage,CUPRIMINE,VALEANT CANADA LP/VALEANT CANADA S.E.C.,D-PENICILLAMINE capsule,D-PENICILLAMINE,250mg,100,Oral,Resolved,Capsule,M01CC,SPECIFIC ANTIRHEUMATIC AGENTS,2017/3/14,,2017/4/17,2017/8/16,Disruption of the manufacture of the drug.,2017/3/14,2017/8/17,No
21228,2220644,Shortage,CYCLOBENZAPRINE-10  -  TAB 10MG,PRO DOC LIMITEE,CYCLOBENZAPRINE,CYCLOBENZAPRINE HYDROCHLORIDE,10MG,500,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2017/9/5,,2017/9/19,Delay in shipping of the drug.,2017/9/7,2017/9/20,No
18225,2192276,Shortage,CYCLOCORT,GLAXOSMITHKLINE INC,amcinonide lotion,AMCINONIDE,0.10%,60 mL,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2017/7/28,,2017/9/14,Disruption of the manufacture of the drug.,2017/8/3,2020/2/27,No
27654,2018152,Shortage,CYCLOMEN,SANOFI-AVENTIS CANADA INC,Cyclome,DANAZOL,100MG,100,ORAL,Resolved,CAPSULE,G03XA,OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM,2017/12/15,,2018/5/16,2018/6/6,Other (Please describe in comments),2017/11/1,2018/6/7,No
6879,2290308,Shortage,CYESTRA-35,PALADIN LABS INC,Ethinyl Estradiol Cyproterone Acetate,ETHINYL ESTRADIOL CYPROTERONE ACETATE,0.035MG 2MG,21 Tablets,ORAL,Resolved,TABLET,G03HB,ANTIANDROGENS,2017/4/13,2017/4/13,2017/5/23,2017/5/19,Delay in shipping of the drug.,2017/4/13,2017/5/20,No
1992,2245898,Shortage,CYPROTERONE,AA PHARMA INC,CYPROTERONE ACETATE,CYPROTERONE ACETATE,50MG,100 Bottle,ORAL,Resolved,TABLET,G03HA,ANTIANDROGENS,2017/3/7,2017/3/7,2017/3/28,2017/3/29,Other (Please describe in comments),2017/3/13,2017/3/31,No
8941,397466,Shortage,CYSTO-CONRAY II,LIEBEL-FLARSHEIM CANADA INC,Iothalamate Meglumine Injection USP 17.2%,IOTHALAMATE MEGLUMINE,172MG,"250 mL, 500 mL",URETHRAL,Resolved,SOLUTION,V08AA,"X-RAY CONTRAST MEDIA, IODINATED",,2017/5/3,2018/10/22,2018/10/22,Shortage of an active ingredient.,2017/5/4,2018/10/23,No
1059,2126656,Shortage,CYTARABINE INJECTION,HOSPIRA HEALTHCARE CORPORATION,CYTARABINE,CYTARABINE,100MG,1g/mL X 10,"INTRATHECAL
INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,L01BC,ANTIMETABOLITES,2013/6/15,2013/6/15,,2017/9/20,Disruption of the manufacture of the drug.,2017/3/13,2017/10/13,No
14419,582301,Shortage,DALACIN T 1%,PFIZER CANADA INC,Dalacin T,CLINDAMYCIN,1%,30mL,TOPICAL,Actual shortage,SOLUTION,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2018/1/26,,,Disruption of the manufacture of the drug.,2017/6/29,2019/3/11,No
14425,582301,Shortage,DALACIN T 1%,PFIZER CANADA INC,Dalacin T,CLINDAMYCIN,1%,60mL,TOPICAL,Actual shortage,SOLUTION,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2018/1/26,,,Disruption of the manufacture of the drug.,2017/6/30,2019/3/11,No
1733,2230769,Shortage,DALMACOL,LABORATOIRE RIVA INC,Dalmacol,DOXYLAMINE SUCCINATE SODIUM CITRATE HYDROCODONE BITARTRATE ALCOHOL ANHYDROUS ETAFEDRIN HYDROCHLORIDE,1.2MG 40MG .33MG .05ML 3.33MG,500ml & 2L,ORAL,Resolved,LIQUID,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,2017/3/13,2017/3/13,2017/5/12,2017/5/9,Shortage of an active ingredient.,2017/3/13,2017/7/4,No
3045,1997602,Shortage,DANTRIUM CAPSULES,PAR PHARMACEUTICAL COMPANIES,Dantrolene Sodium Capsules,DANTROLENE SODIUM,25MG,100 capsules/bottle,ORAL,Resolved,CAPSULE,M03CA,"MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS",,2017/1/10,,2017/4/20,Other (Please describe in comments),2017/3/16,2017/4/21,No
33830,2241600,Shortage,DEFEROXAMINE MESYLATE FOR INJECTION,PFIZER CANADA INC,DEFEROXAMINE,DEFEROXAMINE MESYLATE,500MG,10 x 500mg,"INTRAMUSCULAR
INTRAPERITONEAL
INTRAVENOUS
SUBCUTANEOUS",Avoided shortage,POWDER FOR SOLUTION,V03AC,ALL OTHER THERAPEUTIC PRODUCTS,2018/5/12,,2018/5/14,2018/5/8,Disruption of the manufacture of the drug.,2017/12/19,2018/5/9,No
6772,2247022,Shortage,DEFEROXAMINE MESYLATE FOR INJECTION,HOSPIRA HEALTHCARE CORPORATION,DEFEROXAMINE,DEFEROXAMINE MESYLATE,2G,1x2g,"INTRAMUSCULAR
INTRAPERITONEAL
INTRAVENOUS
SUBCUTANEOUS",Resolved,POWDER FOR SOLUTION,V03AC,ALL OTHER THERAPEUTIC PRODUCTS,,2017/4/13,2017/7/7,2017/7/7,Disruption of the manufacture of the drug.,2017/4/13,2017/7/11,No
11690,2241600,Shortage,DEFEROXAMINE MESYLATE FOR INJECTION,HOSPIRA HEALTHCARE CORPORATION,Deferoxamine,DEFEROXAMINE MESYLATE,500MG,10 x 500mg,"INTRAMUSCULAR
INTRAPERITONEAL
INTRAVENOUS
SUBCUTANEOUS",Resolved,POWDER FOR SOLUTION,V03AC,ALL OTHER THERAPEUTIC PRODUCTS,2017/6/2,,2017/7/11,2017/7/11,Demand increase for the drug.,2017/6/1,2017/7/12,No
12960,29246,Shortage,DELATESTRYL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,DELATESTRYL,TESTOSTERONE ENANTHATE,200MG,na,INTRAMUSCULAR,Resolved,SOLUTION,G03BA,ANDROGENS,,2017/6/15,,2017/6/23,Other (Please describe in comments),2017/6/16,2017/6/24,No
23236,29246,Shortage,DELATESTRYL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,DELATESTRYL,TESTOSTERONE ENANTHATE,200MG,5ML,INTRAMUSCULAR,Resolved,SOLUTION,G03BA,ANDROGENS,2017/12/20,,2018/1/4,2018/1/2,Other (Please describe in comments),2017/9/25,2018/1/23,No
22959,469327,Shortage,DEMULEN 30 (21 DAY PACK),PFIZER CANADA INC,DEMULEN,ETHYNODIOL DIACETATE ETHINYL ESTRADIOL,2MG 30MCG,21's,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2018/1/3,,2018/4/11,Disruption of the manufacture of the drug.,2017/9/21,2018/4/12,No
29300,471526,Shortage,DEMULEN 30 (28 DAY PACK),PFIZER CANADA INC,DEMULEN,ETHINYL ESTRADIOL ETHYNODIOL DIACETATE,30MCG 2MG,28's,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2018/2/28,,2018/4/9,Disruption of the manufacture of the drug.,2017/11/15,2018/4/10,No
7165,443840,Shortage,DEPAKENE,BGP PHARMA ULC,Depakene,VALPROIC ACID,250MG,100,ORAL,Resolved,CAPSULE,N03AG,ANTIEPILEPTICS,,2017/1/25,,2017/4/24,Disruption of the manufacture of the drug.,2017/4/18,2017/6/8,No
24055,2230642,Shortage,DERMATOP EMOLLIENT CREAM,VALEANT CANADA LP/VALEANT CANADA S.E.C.,DERMATOP EMOLLIENT CREAM,PREDNICARBATE,0.10%,N/A,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2017/10/12,,,2017/10/24,Other (Please describe in comments),2017/10/2,2017/10/25,No
22963,2239064,Shortage,DETROL,PFIZER CANADA INC,DETROL,TOLTERODINE TARTRATE,1MG,60's,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/9/19,2017/11/1,2017/11/1,Other (Please describe in comments),2017/9/21,2017/11/2,No
18152,664227,Shortage,DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML,SANDOZ CANADA INCORPORATED,DEXAMETHASONE10,DEXAMETHASONE PHOSPHATE,4MG,10 X 5ML VIALS,"INTRAMUSCULAR
INTRASYNOVIAL
INTRAVENOUS",Resolved,SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017/7/21,2017/8/18,2017/8/7,Delay in shipping of the drug.,2017/8/3,2017/10/18,No
2964,2205963,Shortage,DEXIRON,LUITPOLD PHARMACEUTICALS INC,Iron Dextran,IRON,50MG,2 ml single dose vials supplied in cartons of 10 vials,"INTRAMUSCULAR
INTRAVENOUS",Resolved,LIQUID,B03,IRON PREPARATIONS,2017/11/13,2017/11/30,2018/2/22,2018/2/28,Disruption of the manufacture of the drug.,2017/3/15,2018/3/1,No
23829,39551,Shortage,DEXTROSE 5% IN LACTATED RINGERS,HOSPIRA HEALTHCARE CORPORATION,Dextrose 5% in lactated ringers,SODIUM LACTATE DEXTROSE CALCIUM CHLORIDE POTASSIUM CHLORIDE SODIUM CHLORIDE,3.1MG 50.0MG 0.2MG 0.3MG 6.0MG,24,INTRAVENOUS,Resolved,SOLUTION,B05BB,I.V. SOLUTIONS,,2017/9/28,2017/12/31,2017/12/31,Disruption of the manufacture of the drug.,2017/9/28,2018/1/1,No
26118,60348,Shortage,DEXTROSE 5% INJ 5GM/100ML USP,BAXTER CORPORATION,Dextrose 5% Inj - AVIVA,DEXTROSE,5G,250mL AVIVA,INTRAVENOUS,Resolved,LIQUID,B05BA,I.V. SOLUTIONS,2018/1/4,2018/1/4,2018/11/27,2018/11/27,Disruption of the manufacture of the drug.,2017/10/17,2018/11/27,No
32181,60348,Shortage,DEXTROSE 5% INJ 5GM/100ML USP,BAXTER CORPORATION,Dextrose 5% Inj – AVIVA,DEXTROSE,5G,500mL AVIVA,INTRAVENOUS,Resolved,LIQUID,B05BA,I.V. SOLUTIONS,2018/1/4,2018/1/4,2018/11/27,2018/11/27,Disruption of the manufacture of the drug.,2017/12/8,2018/11/27,No
19398,60348,Shortage,DEXTROSE 5% INJ 5GM/100ML USP,BAXTER CORPORATION,"5% Dextrose Injection, USP",DEXTROSE,5G,50mL,INTRAVENOUS,Resolved,LIQUID,B05BA,I.V. SOLUTIONS,2017/8/15,2017/8/15,2018/2/28,2018/2/28,Disruption of the manufacture of the drug.,2017/8/15,2018/3/1,No
3322,2398982,Shortage,DIACOMIT,BIOCODEX SA,Diacomit,Stiripentol,500MG,package of 60 sachets,ORAL,Actual shortage,POWDER FOR SUSPENSION,N03AX,ANTIEPILEPTICS,2017/3/17,2017/3/17,2017/8/31,,Disruption of the manufacture of the drug.,2017/3/17,2018/12/20,No
15021,865095,Shortage,DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM,BAXTER CORPORATION,"DIANEAL,PD4 1.5% 1.5L TWIN BAG",SODIUM LACTATE DEXTROSE MAGNESIUM CHLORIDE CALCIUM CHLORIDE SODIUM CHLORIDE,448MG 1.5G 5.08MG 18.3MG 538MG,"1.5L BAGS, 6/box",DIALYSIS,Resolved,SOLUTION,B05,HEMODIALYTICS AND HEMOFILTRATES,2017/7/21,2017/7/21,2017/7/28,2017/7/31,Disruption of the manufacture of the drug.,2017/7/10,2017/8/1,No
18608,865117,Shortage,DIANEAL PD4 CAPD SOLUTION WITH 4.25% DEXTROSE AND 2.5MEQ/L CALCIUM,BAXTER CORPORATION,"DIANEAL, PD4 4.25% 2.5L TB",SODIUM LACTATE DEXTROSE MAGNESIUM CHLORIDE CALCIUM CHLORIDE SODIUM CHLORIDE,448MG 4.25G 5.08MG 18.3MG 538MG,"2.5L bags,  4/box",DIALYSIS,Resolved,SOLUTION,B05,HEMODIALYTICS AND HEMOFILTRATES,2017/8/22,,2017/8/22,2017/8/22,Demand increase for the drug.,2017/8/9,2017/8/23,No
6274,2352397,Shortage,DICLOFENAC EC,SANIS HEALTH INC,DICLOFENAC EC TABS,DICLOFENAC SODIUM,50MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/4/14,,2017/5/19,2017/4/26,Other (Please describe in comments),2017/4/10,2017/4/27,No
7210,2024152,Shortage,DIFLUCAN PWS 50MG/5ML,PFIZER CANADA INC,DIFLUCAN,FLUCONAZOLE,50MG,100ML VIAL,ORAL,Resolved,POWDER FOR SOLUTION,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2017/4/18,2017/4/21,2017/4/20,Disruption of the manufacture of the drug.,2017/4/18,2017/4/25,No
12597,627100,Shortage,DILAUDID,PURDUE PHARMA,"Hydromorphone Hydrochloride, 2mg/mL",HYDROMORPHONE HYDROCHLORIDE,2MG,25 x 1 mL ampoules,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,LIQUID,N02AA,OPIOIDS,2017/6/12,2017/6/12,2017/12/31,2017/12/31,Other (Please describe in comments),2017/6/12,2020/3/23,No
23095,125083,Shortage,DILAUDID,PURDUE PHARMA,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,2MG,100,ORAL,Resolved,TABLET,N02AA,OPIOIDS,2017/9/22,2017/9/22,2017/10/2,2017/10/23,Demand increase for the drug.,2017/9/22,2017/10/24,No
12825,622133,Shortage,DILAUDID HP,PURDUE PHARMA,Hydromorphone,HYDROMORPHONE HYDROCHLORIDE,10MG,10 x 5 mL ampoules,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,LIQUID,N02AA,OPIOIDS,2017/6/15,2017/6/15,2017/12/31,2017/12/31,Other (Please describe in comments),2017/6/15,2020/3/23,No
12828,622133,Shortage,DILAUDID HP,PURDUE PHARMA,Hydromorphone,HYDROMORPHONE HYDROCHLORIDE,10MG,10 x 1 mL ampoules,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,LIQUID,N02AA,OPIOIDS,2017/6/15,2017/6/15,2017/12/31,2017/12/31,Other (Please describe in comments),2017/6/15,2020/3/23,No
12731,622133,Shortage,DILAUDID HP,PURDUE PHARMA,"Hydromorphone Hydrochloride, 10mg/mL",HYDROMORPHONE HYDROCHLORIDE,10MG,10 x 1 mL ampoules,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,LIQUID,N02AA,OPIOIDS,2017/6/13,2017/6/13,2017/12/31,2017/12/31,Other (Please describe in comments),2017/6/13,2020/3/23,No
17941,2400421,Shortage,DILTIAZEM CD,SANIS HEALTH INC,DILTIAZEM CD CAPS,DILTIAZEM HYDROCHLORIDE,120MG,100,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2016/6/22,,2017/8/3,Disruption of the manufacture of the drug.,2017/8/2,2020/2/27,No
17945,2400448,Shortage,DILTIAZEM CD,SANIS HEALTH INC,DILTIAZEM CD CAPS,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2016/6/13,,2017/8/3,Disruption of the manufacture of the drug.,2017/8/2,2020/2/27,No
17949,2400456,Shortage,DILTIAZEM CD,SANIS HEALTH INC,DILTIAZEM CD CAPS,DILTIAZEM HYDROCHLORIDE,240MG,100,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2016/8/25,,2017/8/2,Disruption of the manufacture of the drug.,2017/8/2,2020/2/27,No
17952,2400464,Shortage,DILTIAZEM CD,SANIS HEALTH INC,DILTIAZEM CD CAPS,DILTIAZEM HYDROCHLORIDE,300MG,100,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2016/8/2,,2019/9/27,Disruption of the manufacture of the drug.,2017/8/2,2020/2/27,No
11479,2160773,Shortage,DIOFLUOR STRIPS,DIOPTIC PHARMACEUTICALS INC,FLUORESCEIN SODIUM OPHTHALMIC STRIPS,FLUORESCEIN SODIUM,1MG,100 strips/box,TOPICAL,Resolved,STRIP,S01JA,DIAGNOSTICAGENTS,2017/6/19,,,2019/5/30,Requirements related to complying with good manufacturing practices.,2017/5/30,2019/6/25,No
2541,596612,Shortage,DIPHENHYDRAMINE HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,DIPHENHYDRAMINE,DIPHENHYDRAMINE HYDROCHLORIDE,50MG,10 X 1ML,"INTRAMUSCULAR
INTRAVENOUS",Resolved,LIQUID,R06AA,ANTIHISTAMINES FOR SYSTEMIC USE,,2017/3/14,2018/6/29,2018/5/18,Disruption of the manufacture of the drug.,2017/3/14,2018/5/23,No
9567,578428,Shortage,DIPROSALIC,MERCK CANADA INC,Betamethasone Dipropionate and Salicylic Acid Lotion,BETAMETHASONE SALICYLIC ACID,0.5MG 20MG,60mL,TOPICAL,Resolved,LOTION,D07XC,"CORTICOSTEROIDS, OTHER COMBINATIONS",2017/5/12,2017/5/11,2017/7/14,2017/7/7,Delay in shipping of the drug.,2017/5/8,2017/7/8,No
19673,578428,Shortage,DIPROSALIC,MERCK CANADA INC,Betamethasone Dipropionate and Salicylic Acid Lotion,BETAMETHASONE SALICYLIC ACID,0.5MG 20MG,60mL,TOPICAL,Resolved,LOTION,D07XC,"CORTICOSTEROIDS, OTHER COMBINATIONS",2017/8/22,2017/8/22,2017/9/8,2017/9/6,Delay in shipping of the drug.,2017/8/17,2017/9/7,No
24126,417246,Shortage,DIPROSONE LOTION,MERCK CANADA INC,Betamethasone Dipropionate Lotion,BETAMETHASONE,0.05%,75mL,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",2017/10/16,2017/10/4,2017/11/10,2017/11/10,Demand increase for the drug.,2017/10/2,2017/11/11,No
33935,2243960,Shortage,DITROPAN XL  -(5MG),JANSSEN INC,oxybutynin chloride,OXYBUTYNIN CHLORIDE,5MG,5mg bottle,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/12/21,2017/12/21,2018/1/16,2018/1/16,Disruption of the manufacture of the drug.,2017/12/20,2018/1/17,No
17955,2400499,Shortage,DIVALPROEX,SANIS HEALTH INC,DIVALPROEX TABS,VALPROIC ACID,125MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2016/2/19,,2017/8/3,Disruption of the manufacture of the drug.,2017/8/2,2020/2/27,No
17958,2400502,Shortage,DIVALPROEX,SANIS HEALTH INC,DIVALPROEX TABS,VALPROIC ACID,250MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2015/9/1,,2017/7/31,Disruption of the manufacture of the drug.,2017/8/2,2020/2/27,No
17961,2400510,Shortage,DIVALPROEX,SANIS HEALTH INC,DIVALPROEX TABS,VALPROIC ACID,500MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2015/9/1,,2017/7/31,Disruption of the manufacture of the drug.,2017/8/2,2020/2/27,No
18904,2424835,Shortage,DIVIGEL,TEVA CANADA LIMITED,DIVIGEL,ESTRADIOL,0.10%,30,TRANSDERMAL,Resolved,GEL,G03CA,ESTROGENS,,2017/8/11,2017/11/9,2017/12/29,Disruption of the manufacture of the drug.,2017/8/11,2018/1/3,No
25930,2210401,Shortage,DOBUTAMINE INJECTION USP,PFIZER CANADA INC,DOBUTAMINE,DOBUTAMINE,12.5MG,10x20mL,INTRAVENOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017/11/15,,2018/9/7,Disruption of the manufacture of the drug.,2017/10/13,2018/9/8,No
1680,2412225,Shortage,DOCETAXEL INJECTION,TEVA CANADA LIMITED,DOCETAXEL,DOCETAXEL,20MG,0.72ML,INTRAVENOUS,Actual shortage,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2016/2/29,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1688,2412233,Shortage,DOCETAXEL INJECTION,TEVA CANADA LIMITED,DOCETAXEL,DOCETAXEL,80MG,2.88ML,INTRAVENOUS,Actual shortage,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2016/2/29,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
2556,2439336,Shortage,DOCETAXEL INJECTION,SANDOZ CANADA INCORPORATED,DOCETAXEL,DOCETAXEL,10MG,16ML,INTRAVENOUS,Resolved,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2017/3/14,2017/5/19,2017/5/15,Demand increase for the drug.,2017/3/14,2017/5/17,No
24907,2426838,Shortage,DOCUSATE SODIUM,SANIS HEALTH INC,DOCUSATE SODIUM CAPS,DOCUSATE SODIUM,100MG,100,ORAL,Resolved,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,2017/10/10,,2017/10/27,2017/11/15,Other (Please describe in comments),2017/10/10,2017/11/16,No
9689,2402653,Shortage,DONEPEZIL HYDROCHLORIDE TABLETS,ACCORD HEALTHCARE INC,DONEPEZIL,DONEPEZIL HYDROCHLORIDE,10MG,100 TABS PER BOTTLE     |     BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,2017/4/21,2017/4/21,2017/8/4,2017/7/21,Disruption of the manufacture of the drug.,2017/5/9,2017/7/22,No
25661,761850,Shortage,DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP,BAXTER CORPORATION,DOPAMINE 0.8MG/ML,DOPAMINE HYDROCHLORIDE DEXTROSE,.8MG 50MG,250mL,INTRAVENOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2017/10/12,2017/10/12,2018/3/1,2018/3/5,Disruption of the manufacture of the drug.,2017/10/12,2018/3/7,No
25606,761826,Shortage,DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP,BAXTER CORPORATION,DOPAMINE HCL 1.6MG/ML,DOPAMINE HYDROCHLORIDE DEXTROSE,1.6MG 50MG,250mL,INTRAVENOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2017/10/12,2017/10/12,2018/3/1,2018/3/5,Disruption of the manufacture of the drug.,2017/10/11,2018/3/7,No
25658,761834,Shortage,DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP,BAXTER CORPORATION,DOPAMINE HCL 3.2MG/ML,DEXTROSE DOPAMINE HYDROCHLORIDE,50MG 3.2MG,250mL,INTRAVENOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2017/10/12,2017/10/12,2018/2/6,2018/2/6,Disruption of the manufacture of the drug.,2017/10/12,2018/2/7,No
2039,2242471,Shortage,DOSTINEX,PFIZER CANADA INC,DOSTINEX,CABERGOLINE,0.5MG,BOTTLE 8's,ORAL,Resolved,TABLET / TABLETTE,G02CB,OTHER GYNECOLOGICALS,,2017/4/13,2017/4/24,2017/4/27,Demand increase for the drug.,2017/3/14,2017/4/28,No
20248,2452650,Shortage,DULOXETINE,PRO DOC LIMITEE,DULOXETINE,DULOXETINE,30MG,30-100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2017/11/29,,2017/12/7,Delay in shipping of the drug.,2017/8/24,2017/12/8,No
8299,2453649,Shortage,DULOXETINE,SIVEM PHARMACEUTICALS ULC,DULOXETINE,DULOXETINE,60MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017/5/3,,2017/5/12,2017/5/12,Demand increase for the drug.,2017/4/27,2017/5/18,No
28079,2453649,Shortage,DULOXETINE,SIVEM PHARMACEUTICALS ULC,DULOXETINE,DULOXETINE,60MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2017/10/26,2017/12/4,2017/12/6,Delay in shipping of the drug.,2017/11/5,2017/12/12,No
5595,2453630,Shortage,DULOXETINE,SIVEM PHARMACEUTICALS ULC,DULOXETINE,DULOXETINE,30MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2017/4/27,2017/5/31,2017/6/4,Demand increase for the drug.,2017/4/5,2017/11/3,No
28882,2429012,Shortage,DUTASTERIDE,SIVEM PHARMACEUTICALS ULC,DUTASTERIDE,DUTASTERIDE,0.5MG,30,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2017/12/4,2017/12/8,2018/1/29,2018/1/25,Disruption of the manufacture of the drug.,2017/11/10,2018/1/30,No
19704,2421712,Shortage,DUTASTERIDE,PRO DOC LIMITEE,DUTASTERIDE,DUTASTERIDE,0.5MG,30,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/8/17,,2019/11/26,Delay in shipping of the drug.,2017/8/17,2019/11/27,No
10471,2432889,Shortage,DYMISTA,MEDA PHARMACEUTICALS LTD,Dymista,FLUTICASONE PROPIONATE azelastine hydrochloride,50MCG 137MCG,25ML,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2017/5/15,,2017/8/11,Disruption of the manufacture of the drug.,2017/5/16,2017/8/14,No
27184,2237280,Shortage,EFFEXOR XR,PFIZER CANADA INC,EFFEXOR,VENLAFAXINE,75MG,90s,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017/12/20,,2018/1/19,Disruption of the manufacture of the drug.,2017/10/26,2018/1/20,No
10091,2209764,Shortage,EGOZINC-HC,PHARMASCIENCE INC,EGOZING,HYDROCORTISONE ACETATE ZINC SULFATE,0.5% 0.5%,15g,"RECTAL
TOPICAL",Resolved,OINTMENT,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,,2017/5/1,,2020/6/5,Shortage of an inactive ingredient or component.,2017/5/11,2020/6/8,No
3710,335088,Shortage,ELAVIL,AA PHARMA INC,ELAVIL,AMITRIPTYLINE HYDROCHLORIDE,50MG,100 Bottle,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017/3/24,,2017/4/17,2017/4/11,Demand increase for the drug.,2017/3/20,2017/4/12,No
625,851744,Shortage,ELOCOM CREAM,MERCK CANADA INC,mometasone furoate cream,MOMETASONE FUROATE,0.10%,50g,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2017/3/2,2017/3/3,2017/3/10,2017/3/9,Other (Please describe in comments),2017/3/11,2017/3/13,No
13234,851744,Shortage,ELOCOM CREAM,MERCK CANADA INC,Mometasone Furoate Cream,MOMETASONE FUROATE,0.10%,15g,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2017/6/26,2017/7/5,2017/7/14,2017/7/7,Delay in shipping of the drug.,2017/6/19,2017/7/8,No
1019,851744,Shortage,ELOCOM CREAM,MERCK CANADA INC,"Mometasone Furoate Cream, BP",MOMETASONE FUROATE,0.10%,15g,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2017/3/14,2017/3/14,2017/3/17,2017/3/16,Demand increase for the drug.,2017/3/13,2017/3/17,No
17246,2213222,Shortage,ELTROXIN,ASPEN PHARMACARE CANADA INC.,levothyroxine sodium,LEVOTHYROXINE SODIUM,200MCG,500 tablets,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,,2017/7/26,2017/10/17,2017/10/23,Delay in shipping of the drug.,2017/7/26,2017/10/24,No
12809,595799,Shortage,EMO CORT CREAM 2.5%,GLAXOSMITHKLINE INC,Hydrocortisone cream,HYDROCORTISONE,2.50%,45 g,TOPICAL,Resolved,CREAM,D07AA,"CORTICOSTEROIDS, PLAIN",,2017/6/16,,2017/9/14,Disruption of the manufacture of the drug.,2017/6/15,2020/2/27,No
3254,595799,Shortage,EMO CORT CREAM 2.5%,GLAXOSMITHKLINE INC,Hydrocortisone cream,HYDROCORTISONE,2.50%,225 g,TOPICAL,Resolved,CREAM,D07AA,"CORTICOSTEROIDS, PLAIN",,2017/3/27,,2017/9/14,Disruption of the manufacture of the drug.,2017/3/17,2020/2/27,No
2720,595802,Shortage,EMO CORT LOTION 2.5%,GLAXOSMITHKLINE INC,Hydrocortisone lotion,HYDROCORTISONE,2.50%,60 mL,TOPICAL,Resolved,LOTION,D07AA,"CORTICOSTEROIDS, PLAIN",,2016/3/7,,2017/4/28,Other (Please describe in comments),2017/3/14,2020/2/27,No
3487,2273217,Shortage,ENABLEX,MERUS LABS LUXCO S. A R.L.,Darifenacin,DARIFENACIN,7.5MG,28,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/8/1,,,2017/10/6,Other (Please describe in comments),2017/3/20,2017/10/10,No
3498,2273225,Shortage,ENABLEX,MERUS LABS LUXCO S. A R.L.,Darifenacin,DARIFENACIN,15MG,28,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/10/1,,,2017/10/6,Other (Please describe in comments),2017/3/20,2017/10/10,No
17559,2388499,Shortage,ENALAPRILAT INJECTION USP,STERIMAX INC,VASOTEC IV,ENALAPRILAT,1.25MG,10 VIALS,INTRAVENOUS,Resolved,SOLUTION,C09AA,"ACE INHIBITORS, PLAIN",,2017/7/31,2017/9/11,2017/9/12,Other (Please describe in comments),2017/7/31,2017/9/13,No
10357,1916548,Shortage,ENDOCET,BRISTOL-MYERS SQUIBB CANADA,Oxycocet (Oxycodone and Acetaminophen),ACETAMINOPHEN OXYCODONE HYDROCHLORIDE,325MG 5MG,Bottles of 100's and 500's,ORAL,Avoided shortage,TABLET,N02AJ,,2017/7/5,,,2017/7/4,Demand increase for the drug.,2017/5/15,2017/7/4,No
6511,1919431,Shortage,ENGERIX B INJ SUS 20MCG/ML,GLAXOSMITHKLINE INC,Hepatitis B vaccine (recombinant),HEPATITIS B SURFACE ANTIGEN,20MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2017/4/6,,2019/12/9,Demand increase for the drug.,2017/4/11,2019/12/10,No
3112,2052431,Shortage,ENTOCORT ENEMA,TILLOTTS PHARMA GMBH,Entocort Enema,SODIUM CHLORIDE BUDESONIDE,115ML 2.3MG,7 solutions,RECTAL,Resolved,"KIT
TABLET
ENEMA",A07EA,INTESTINALANTIINFLAMMATORY AGENTS,2017/4/3,2017/4/3,2017/7/14,2017/7/10,Delay in shipping of the drug.,2017/3/17,2017/7/19,No
1218,38121,Shortage,EPHEDRINE SULFATE INJECTION,HOSPIRA HEALTHCARE CORPORATION,Ephedrine,EPHEDRINE SULFATE,50MG,50mg/1mL x 50,"INTRAMUSCULAR
SUBCUTANEOUS",Resolved,SOLUTION,R03CA,ADRENERGICS FOR SYSTEMIC USE,,2015/7/24,,2019/3/29,Shortage of an active ingredient.,2017/3/13,2019/3/30,No
34254,2435810,Shortage,EPINEPHRINE INJECTION,TELIGENT OU,EPINEPHRINE INJECTION,EPINEPHRINE,1MG,1 mL,"INTRACARDIAC
INTRAMUSCULAR
INTRATRACHEAL
INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017/11/15,2018/6/29,2018/6/29,Disruption of the manufacture of the drug.,2017/12/22,2018/7/9,No
20797,509558,Shortage,EPIPEN,MYLAN SPECIALTY LP,EPIPEN,EPINEPHRINE,1MG,Each (0.3MG/0.3ML AUTO-INJECTOR),INTRAMUSCULAR,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2017/9/27,,,2017/10/6,Disruption of the manufacture of the drug.,2017/9/1,2017/10/10,No
26964,509558,Shortage,EPIPEN,MYLAN SPECIALTY LP,EPIPEN,EPINEPHRINE,1MG,Each (0.3MG/0.3ML AUTO-INJECTOR),INTRAMUSCULAR,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017/10/30,,2017/11/15,Disruption of the manufacture of the drug.,2017/10/25,2017/11/16,No
31606,509558,Shortage,EPIPEN,MYLAN SPECIALTY LP,EPIPEN,EPINEPHRINE,1MG,Each (0.3MG/0.3ML AUTO-INJECTOR),INTRAMUSCULAR,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017/12/4,2018/3/23,2018/3/9,Disruption of the manufacture of the drug.,2017/12/4,2018/3/10,No
5774,509558,Shortage,EPIPEN,MYLAN SPECIALTY LP,EPIPEN Auto-Injector,EPINEPHRINE,1MG,Each (0.3MG/0.3ML AUTO-INJECTOR),INTRAMUSCULAR,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017/4/5,,2017/4/24,Disruption of the manufacture of the drug.,2017/4/6,2017/4/25,No
5794,578657,Shortage,EPIPEN JR,MYLAN SPECIALTY LP,EpiPen Junior Auto-Injector,EPINEPHRINE,0.5MG,Each (0.15MG/0.3ML AUTO-INJECTOR),INTRAMUSCULAR,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017/4/5,2017/4/26,2017/5/1,Disruption of the manufacture of the drug.,2017/4/6,2017/5/2,No
1081,2264927,Shortage,EPIRUBICIN HYDROCHLORIDE INJECTION,HOSPIRA HEALTHCARE CORPORATION,EPIRUBICIN,EPIRUBICIN HYDROCHLORIDE,2MG,10mg/5mL x 1,INTRAVENOUS,Resolved,SOLUTION,L01DB,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,2014/10/14,2014/11/29,,2017/9/4,Disruption of the manufacture of the drug.,2017/3/13,2018/7/26,No
1691,2405083,Shortage,EPTIFIBATIDE INJECTION,TEVA CANADA LIMITED,EPTIFIBATIDE,EPTIFIBATIDE,0.75MG,100ML,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,,2016/11/1,,2017/3/3,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
1694,2367858,Shortage,EPTIFIBATIDE INJECTION,TEVA CANADA LIMITED,EFTIFIBATIDE,EPTIFIBATIDE,2MG,10ML,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,,2016/11/1,,2017/3/3,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
12379,2457431,Shortage,ERFA-TRANEXAMIC,,TRANEXAMIC ACID IV,TRANEXAMIC ACID,100 mg/mL,vial,Intravenous,Actual shortage,Solution,B02AA,Antifibrinolytics,,2018/4/25,,,Other (Please describe in comments),2017/6/9,2023/3/2,No
22112,2237815,Shortage,ERWINASE,JAZZ PHARMACEUTICALS FRANCE SAS,Erwina L-asparaginase,ASPARAGINASE,10000UNIT,"3 mL vials, 5 vials per carton","INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,POWDER FOR SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,2017/9/14,,,2021/3/10,Other (Please describe in comments),2017/9/14,2021/3/16,No
2952,2237815,Shortage,ERWINASE,JAZZ PHARMACEUTICALS FRANCE SAS,Erwinia L-asparaginase,ASPARAGINASE,10000UNIT,3 mL vials,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,POWDER FOR SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,2017/3/14,,2017/6/30,2017/6/30,Other (Please describe in comments),2017/3/15,2018/3/7,No
30979,682020,Shortage,ERYTHRO-BASE,AA PHARMA INC,ERYTHRO-BASE,ERYTHROMYCIN,250MG,100 BTL,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/11/28,2017/12/11,2017/12/12,Disruption of the manufacture of the drug.,2017/11/28,2018/4/23,No
4144,682020,Shortage,ERYTHRO-BASE,AA PHARMA INC,ERYTHRO-BASE,ERYTHROMYCIN,250MG,1000 BOTTLE,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2016/10/28,,,2016/10/28,Disruption of the manufacture of the drug.,2017/3/24,2017/3/28,No
3752,637416,Shortage,ERYTHRO-ES,AA PHARMA INC,ERYTHRO-ES,ERYTHROMYCIN,600MG,100 Bottle,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2015/6/24,,,2019/1/15,Disruption of the manufacture of the drug.,2017/3/21,2020/8/6,No
3795,688568,Shortage,ERYTHRO-S,AA PHARMA INC,ERYTHRO-S,ERYTHROMYCIN,500MG,100 Bottle,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2016/10/31,,2017/3/31,Disruption of the manufacture of the drug.,2017/3/21,2017/4/2,No
5599,2429039,Shortage,ESCITALOPRAM,SIVEM PHARMACEUTICALS ULC,ESCITALOPRAM,ESCITALOPRAM,10MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/4/4,2017/4/14,2017/4/10,Disruption of the manufacture of the drug.,2017/4/5,2017/4/11,No
5602,2429039,Shortage,ESCITALOPRAM,SIVEM PHARMACEUTICALS ULC,ESCITALOPRAM,ESCITALOPRAM,10MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/4/4,2017/4/14,2017/4/11,Disruption of the manufacture of the drug.,2017/4/5,2017/4/12,No
5609,2429047,Shortage,ESCITALOPRAM,SIVEM PHARMACEUTICALS ULC,ESCITALOPRAM,ESCITALOPRAM,20MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/4/4,2017/4/12,2017/4/11,Requirements related to complying with good manufacturing practices.,2017/4/5,2017/4/12,No
4504,2394839,Shortage,ESOMEPRAZOLE,PRO DOC LIMITEE,ESOMEPRAZOLE,ESOMEPRAZOLE,20MG,30,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/3/28,,2017/4/26,Delay in shipping of the drug.,2017/3/28,2017/4/27,No
4100,2241835,Shortage,ESTALIS 140/50 MCG,NOVARTIS PHARMACEUTICALS CANADA INC,ESTALIS 140/50UG 8'S,ESTRADIOL NORETHINDRONE ACETATE,0.62MG 2.7MG,8's,TRANSDERMAL,Resolved,PATCH,G03FA,PROGESTOGENS AND ESTROGENS IN COMBINATION,,2017/3/3,2017/6/9,2017/6/8,Delay in shipping of the drug.,2017/3/23,2017/6/9,No
14305,2241835,Shortage,ESTALIS 140/50 MCG,NOVARTIS PHARMACEUTICALS CANADA INC,ESTALIS 140/50UG 8'S,ESTRADIOL NORETHINDRONE ACETATE,0.62MG 2.7MG,8's,TRANSDERMAL,Resolved,PATCH,G03FA,PROGESTOGENS AND ESTROGENS IN COMBINATION,,2017/6/28,2017/11/1,2017/10/24,Delay in shipping of the drug.,2017/6/28,2017/10/27,No
15049,2241837,Shortage,ESTALIS 250/50 MCG,NOVARTIS PHARMACEUTICALS CANADA INC,ESTALIS 250/50UG 8'S,ESTRADIOL NORETHINDRONE ACETATE,0.51MG 4.8MG,8'S,TRANSDERMAL,Resolved,PATCH,G03FA,PROGESTOGENS AND ESTROGENS IN COMBINATION,2017/8/28,2017/8/23,2018/1/17,2018/1/17,Delay in shipping of the drug.,2017/7/10,2018/1/18,No
2001,2232317,Shortage,ETODOLAC,AA PHARMA INC,ETODOLAC,ETODOLAC,200 MG,100 Bottle,Oral,Resolved,Capsule,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2016/4/13,2017/8/9,2017/6/12,Shortage of an active ingredient.,2017/3/13,2017/9/5,No
2004,2232318,Shortage,ETODOLAC,AA PHARMA INC,ETODOLAC,ETODOLAC,300MG,100 Bottle,ORAL,Resolved,CAPSULE,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/2/2,2017/8/9,2017/6/12,Shortage of an active ingredient.,2017/3/13,2017/9/5,No
2567,2380935,Shortage,ETOPOSIDE INJECTION USP,SANDOZ CANADA INCORPORATED,ETOPOSIDE,ETOPOSIDE,20MG,10ML,INTRAVENOUS,Resolved,SOLUTION,L01CB,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2017/3/14,2017/7/28,2017/7/28,Delay in shipping of the drug.,2017/3/14,2017/8/2,No
33330,2380935,Shortage,ETOPOSIDE INJECTION USP,SANDOZ CANADA INCORPORATED,ETOPOSIDE,ETOPOSIDE,20MG,25ML VIAL,INTRAVENOUS,Resolved,SOLUTION,L01CB,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2017/12/22,2017/12/18,2018/1/29,2018/1/26,Delay in shipping of the drug.,2017/12/16,2018/1/29,No
14647,2380935,Shortage,ETOPOSIDE INJECTION USP,SANDOZ CANADA INCORPORATED,ETOPOSIDE,ETOPOSIDE,20MG,25ML VIAL,INTRAVENOUS,Resolved,SOLUTION,L01CB,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2017/7/3,2017/7/28,2017/7/28,Delay in shipping of the drug.,2017/7/5,2017/8/2,No
16287,2380935,Shortage,ETOPOSIDE INJECTION USP,SANDOZ CANADA INCORPORATED,ETOPOSIDE,ETOPOSIDE,20MG,5ML VIAL,INTRAVENOUS,Resolved,SOLUTION,L01CB,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2017/7/3,,2017/7/31,Delay in shipping of the drug.,2017/7/18,2017/8/1,No
14354,2422549,Shortage,EZETIMIBE,PRO DOC LIMITEE,EZETIMIBE,EZETIMIBE,10MG,30-100,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017/6/21,,2017/8/10,Delay in shipping of the drug.,2017/6/29,2017/8/17,No
31781,2247521,Shortage,EZETROL,MERCK CANADA INC,ezetimibe tablets,EZETIMIBE,10MG,30TAB BLIS,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2018/1/24,2018/1/23,2018/3/16,2018/3/15,Delay in shipping of the drug.,2017/12/5,2018/3/16,No
27626,2247521,Shortage,EZETROL,MERCK CANADA INC,ezetimibe tablets,EZETIMIBE,10MG,30TAB,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2017/11/1,2017/11/1,2017/11/6,2017/11/6,Delay in shipping of the drug.,2017/10/31,2017/11/7,No
16581,2248416,Shortage,FASTURTEC,SANOFI-AVENTIS CANADA INC,Fasturtec 1.5mg vial powder plus 1.0mL solvent,RASBURICASE,1.5MG,3 vials,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,V03AF,ALL OTHER THERAPEUTIC PRODUCTS,,2017/7/17,2017/9/4,2017/8/16,Other (Please describe in comments),2017/7/21,2017/8/17,No
16562,2243333,Shortage,FERRLECIT,SANOFI-AVENTIS CANADA INC,Sodium Ferric Gluconate,IRON,12.5MG,10,INTRAVENOUS,Resolved,LIQUID,B03,IRON PREPARATIONS,,2017/7/17,,2017/7/17,Other (Please describe in comments),2017/7/20,2017/7/21,No
11094,2445085,Shortage,FINASTERIDE,SANIS HEALTH INC,FINASTERIDE TABS,FINASTERIDE,1MG,30,ORAL,Resolved,TABLET,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,,2017/5/23,2017/7/28,2017/9/21,Other (Please describe in comments),2017/5/24,2017/9/22,No
10850,2350270,Shortage,FINASTERIDE,PRO DOC LIMITEE,FINASTERIDE,FINASTERIDE,5MG,30,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/5/15,,2017/7/13,Delay in shipping of the drug.,2017/5/23,2017/7/14,No
30104,2445085,Shortage,FINASTERIDE,SANIS HEALTH INC,FINASTERIDE TAB,FINASTERIDE,1MG,100,ORAL,Resolved,TABLET,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,2017/11/22,2017/11/6,2018/1/31,2018/1/15,Delay in shipping of the drug.,2017/11/22,2018/1/16,No
30107,2445077,Shortage,FINASTERIDE,SANIS HEALTH INC,FINASTERIDE TABS,FINASTERIDE,5MG,30,ORAL,Avoided shortage,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2018/1/31,,2018/1/31,2018/1/29,Delay in shipping of the drug.,2017/11/22,2018/1/29,No
10955,2445077,Shortage,FINASTERIDE,SANIS HEALTH INC,FINASTERIDE TABS,FINASTERIDE,5MG,30's,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/5/23,2017/7/28,2017/8/18,Other (Please describe in comments),2017/5/23,2017/9/21,No
3070,1926845,Shortage,FLAGYSTATIN CREAM,SANOFI-AVENTIS CANADA INC,FLAGYSTATIN CREAM 500MG  55G,NYSTATIN METRONIDAZOLE,100000UNIT 500MG,55G,VAGINAL,Resolved,CREAM,G01AA,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",,2017/1/13,2018/7/31,2017/8/16,Other (Please describe in comments),2017/3/16,2017/8/22,No
15722,756784,Shortage,FLAREX,NOVARTIS PHARMACEUTICALS CANADA INC,FLAREX 0.1% SUSP 5ML,FLUOROMETHOLONE ACETATE,0.10%,5 ml,OPHTHALMIC,Resolved,SUSPENSION,S01BA,ANTIINFLAMMATORY AGENTS,,2017/6/15,2017/7/17,2017/7/17,Delay in shipping of the drug.,2017/7/13,2017/7/27,No
26394,2230845,Shortage,FLOLAN,GLAXOSMITHKLINE INC,Epoprostenol Powder for Injection,EPOPROSTENOL,0.5MG,vial,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,,2017/10/16,2017/11/9,2017/11/8,Delay in shipping of the drug.,2017/10/19,2017/11/9,No
2725,2213672,Shortage,FLONASE - AEM-SUS NAS  50MCG/MD,GLAXOSMITHKLINE INC,Fluticasone propionate aqueous nasal spray,Fluticasone propionate,50 µg,120's,Intranasal,Resolved,Nasal spray,R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2017/1/11,,2017/8/1,Other (Please describe in comments),2017/3/14,2020/2/27,No
9053,2261472,Shortage,FLUCONAZOLE  IN SODIUM CHLORIDE INJECTION USP,BAXTER CORPORATION,"Fluconazole Injection, USP 200 mg/ 100 mL",FLUCONAZOLE,2MG,"1000mL, 2mg/mL",INTRAVENOUS,Resolved,SOLUTION,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,2017/5/1,,2017/6/30,2017/9/14,Disruption of the manufacture of the drug.,2017/5/4,2017/9/15,No
24222,2420783,Shortage,FLULAVAL TETRA,ID BIOMEDICAL CORPORATION OF QUEBEC,"Quadrivalent Influenza Vaccine (Split Virion, Inactivated)",HAEMAGGLUTININ-STRAIN B HAEMAGGLUTININ-STRAIN B HAEMAGGLUTININ-STRAIN A HAEMAGGLUTININ-STRAIN A,15MCG 15MCG 15MCG 15MCG,1 vial X 10 doses,INTRAMUSCULAR,Resolved,SUSPENSION,J07BB,VIRAL VACCINES,2017/9/27,2017/9/27,2018/3/30,2018/3/30,Other (Please describe in comments),2017/10/3,2018/3/31,No
21779,2266342,Shortage,FLUMAZENIL INJECTION,FRESENIUS KABI CANADA LTD,"Flumazenil Injection, USP 0.1mg/mL MD Vial",FLUMAZENIL,0.1MG,5mL,INTRAVENOUS,Resolved,SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,2017/10/10,2017/10/10,2017/11/15,2017/11/17,Demand increase for the drug.,2017/9/8,2017/11/18,No
11758,2237775,Shortage,"FLUORESCEIN SODIUM & BENOXINATE HYDROCHLORIDE OPHTALMIC SOLUTION, USP",BAUSCH & LOMB INC,"FLUORESCEIN SODIUM & BENOXINATE HYDROCHLORIDE OPHTALMIC SOLUTION, USP",FLUORESCEIN SODIUM BENOXINATE HYDROCHLORIDE,0.25% 0.4%,n/a,OPHTHALMIC,Actual shortage,SOLUTION,S01JA,DIAGNOSTICAGENTS,,2018/5/1,,,Other (Please describe in comments),2017/6/2,2018/5/4,No
16061,505005,Shortage,FLUORESCITE,NOVARTIS PHARMACEUTICALS CANADA INC,FLUORESCITE 10% 5mg vial (1x12),FLUORESCEIN SODIUM,10%,1 x 12,INTRAVENOUS,Resolved,SOLUTION,V04,OTHER DIAGNOSTIC AGENTS,,2017/7/17,2017/8/23,2017/8/28,Delay in shipping of the drug.,2017/7/17,2017/8/31,No
3092,2413450,Shortage,FLUOROURACIL INJECTION,ACCORD HEALTHCARE INC,FLUOROURACIL,FLUOROURACIL,5G,1 VIAL OF 100 ML,INTRAVENOUS,Resolved,SOLUTION,L01BC,ANTIMETABOLITES,2016/12/23,2016/12/23,2017/3/22,2017/3/22,Other (Please describe in comments),2017/3/16,2017/3/23,No
12837,2413450,Shortage,FLUOROURACIL INJECTION,ACCORD HEALTHCARE INC,FLUOROURACIL,FLUOROURACIL,5G,"50 MG/ML, 100 ML/VIAL (5 G/VIAL)     |     50 MG/ML, 100 ML/FLACON (5 G/FLACON)",INTRAVENOUS,Resolved,SOLUTION,L01BC,ANTIMETABOLITES,2017/6/23,,2017/8/14,2017/7/7,Other (Please describe in comments),2017/6/15,2017/7/13,No
1405,2182742,Shortage,FLUOROURACIL INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,Fluorouracil (5FU),FLUOROURACIL,50MG,5 g/100 mL x 1,INTRAVENOUS,Resolved,SOLUTION,L01BC,ANTIMETABOLITES,,2017/3/2,2017/3/20,2017/3/20,Other (Please describe in comments),2017/3/13,2017/3/21,No
16495,2374455,Shortage,FLUOXETINE,SIVEM PHARMACEUTICALS ULC,FLUOXETINE,FLUOXETINE,20MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017/7/5,,2017/11/4,Demand increase for the drug.,2017/7/19,2017/11/5,No
13172,2374455,Shortage,FLUOXETINE,SIVEM PHARMACEUTICALS ULC,FLUOXETINE,FLUOXETINE,20MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017/6/26,2017/7/5,2018/4/3,2018/4/2,Disruption of the manufacture of the drug.,2017/6/16,2018/4/3,No
13175,2374455,Shortage,FLUOXETINE,SIVEM PHARMACEUTICALS ULC,FLUOXETINE,FLUOXETINE,20MG,500,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017/6/26,2018/4/3,2018/4/2,Disruption of the manufacture of the drug.,2017/6/16,2018/4/3,No
28686,405345,Shortage,FLUPHENAZINE,AA PHARMA INC,FLUPHENAZINE,FLUPHENAZINE HYDROCHLORIDE,1MG,100 Bottle,ORAL,Resolved,TABLET,N05AB,ANTIPSYCHOTICS,,2017/11/6,2018/3/9,2018/3/8,Disruption of the manufacture of the drug.,2017/11/9,2018/3/9,No
24232,2420686,Shortage,FLUVIRAL,ID BIOMEDICAL CORPORATION OF QUEBEC,"Trivalent Influenza Vaccine (Split Virion, Inactivated)",HAEMAGGLUTININ-STRAIN B HAEMAGGLUTININ-STRAIN A HAEMAGGLUTININ-STRAIN A,15MCG 15MCG 15MCG,1 vial X 10 doses,INTRAMUSCULAR,Resolved,SUSPENSION,J07BB,VIRAL VACCINES,2017/9/27,2017/9/27,2018/3/30,2018/3/30,Other (Please describe in comments),2017/10/3,2018/7/13,No
24150,2236754,Shortage,FLUVOXAMINE-100,PRO DOC LIMITEE,FLUVOXAMINE,FLUVOXAMINE MALEATE,100MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/10/2,,2018/3/8,Delay in shipping of the drug.,2017/10/2,2018/3/9,No
26046,2236753,Shortage,FLUVOXAMINE-50,PRO DOC LIMITEE,FLUVOXAMINE,FLUVOXAMINE MALEATE,50MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/10/16,,2018/3/13,Delay in shipping of the drug.,2017/10/16,2018/3/14,No
22207,2139480,Shortage,FOLIC ACID INJECTION,FRESENIUS KABI CANADA LTD,Folic Acid Injection 5 mg/mL MD Vial,FOLIC ACID,5MG,10mL,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,B03BB,VITAMIN B12 AND FOLIC ACID,2017/9/29,,2017/12/12,2017/11/20,Disruption of the manufacture of the drug.,2017/9/15,2018/2/1,No
4301,2212234,Shortage,FORTAZ - INJ 6G/VIAL,GLAXOSMITHKLINE INC,Ceftazidime for injection,CEFTAZIDIME,6G,6's,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/7/20,,2020/12/21,Shortage of an active ingredient.,2017/3/24,2020/12/22,No
23505,2276429,Shortage,FOSAVANCE,MERCK CANADA INC,Alendronate Sodium / Cholecalciferol tablets,ALENDRONIC ACID VITAMIN D3,70MG 2800UNIT,4TAB BLIS,ORAL,Resolved,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017/10/11,2017/9/27,2018/1/5,2018/1/2,Delay in shipping of the drug.,2017/9/26,2018/1/3,No
33516,2314940,Shortage,FOSAVANCE,MERCK CANADA INC,Alendronate Sodium / Cholecalciferol Tablets,ALENDRONIC ACID VITAMIN D3,70MG 5600UNIT,4's,ORAL,Resolved,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2018/1/2,2018/1/2,2018/2/9,2018/1/26,Delay in shipping of the drug.,2017/12/18,2018/1/27,No
31799,2303019,Shortage,FOSINOPRIL-20,PRO DOC LIMITEE,FOSINOPRIL,FOSINOPRIL SODIUM,20MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/12/5,,2017/12/14,Delay in shipping of the drug.,2017/12/5,2017/12/15,No
28041,2396610,Shortage,FREYA 28,MYLAN PHARMACEUTICALS ULC,FREYA 28,DESOGESTREL ETHINYL ESTRADIOL,0.15MG 0.03MG,28BL,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2019/2/1,2019/2/1,2019/3/20,2019/3/20,Delay in shipping of the drug.,2017/11/3,2019/3/21,No
16534,29149,Shortage,FUNGIZONE INTRAVENOUS INJECTION 50MG,BRISTOL-MYERS SQUIBB CANADA,Amphotericin B,AMPHOTERICIN B,50MG,(1 VL) 15 ML,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J02AA,ANTIMYCOTICS FOR SYSTEMIC USE,2018/5/22,2018/4/20,2019/5/22,2019/5/22,Other (Please describe in comments),2017/7/20,2019/5/23,No
2574,527033,Shortage,FUROSEMIDE INJ USP,SANDOZ CANADA INCORPORATED,FUROSEMIDE,FUROSEMIDE,10MG,10 X 4ML,"INTRAMUSCULAR
INTRAVENOUS",Resolved,LIQUID,C03CA,HIGH-CEILING DIURETICS,,2017/3/14,2017/6/30,2017/4/18,Demand increase for the drug.,2017/3/14,2017/4/19,No
18388,527033,Shortage,FUROSEMIDE INJ USP,SANDOZ CANADA INCORPORATED,FUROSEMIDE,FUROSEMIDE,10MG,10 X 4ML VIALS,"INTRAMUSCULAR
INTRAVENOUS",Resolved,LIQUID,C03CA,HIGH-CEILING DIURETICS,2017/8/11,2017/10/2,2017/10/27,2017/10/25,Demand increase for the drug.,2017/8/7,2017/10/26,No
2181,2360365,Shortage,FUROSEMIDE INJECTION,OMEGA LABORATORIES LTD,Furosemide Injection,FUROSEMIDE,10MG,2mL vial,"INTRAMUSCULAR
INTRAVENOUS",Actual shortage,LIQUID,C03CA,HIGH-CEILING DIURETICS,,2016/12/23,,,Disruption of the manufacture of the drug.,2017/3/14,2017/11/13,No
2186,2360365,Shortage,FUROSEMIDE INJECTION,OMEGA LABORATORIES LTD,Furosemide Injection,FUROSEMIDE,10MG,4mL vial,"INTRAMUSCULAR
INTRAVENOUS",Actual shortage,LIQUID,C03CA,HIGH-CEILING DIURETICS,,2016/12/9,,,Disruption of the manufacture of the drug.,2017/3/14,2017/11/13,No
18391,2382539,Shortage,FUROSEMIDE INJECTION SDZ,SANDOZ CANADA INCORPORATED,FUROSEMIDE,FUROSEMIDE,10MG,10 X 2ML AMPS,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,C03CA,HIGH-CEILING DIURETICS,,2017/8/1,2017/8/31,2017/8/18,Demand increase for the drug.,2017/8/7,2017/10/18,No
3829,2382539,Shortage,FUROSEMIDE INJECTION SDZ,SANDOZ CANADA INCORPORATED,FUROSEMIDE,FUROSEMIDE,10MG,10 X 4ML AMPOULES,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,C03CA,HIGH-CEILING DIURETICS,,2017/3/21,2017/6/26,2017/4/18,Demand increase for the drug.,2017/3/22,2017/4/19,No
26269,2461404,Shortage,FUROSEMIDE INJECTION USP,STERIMAX INC,FUROSEMIDE INJECTION USP,FUROSEMIDE,10MG,25 VIALS,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,C03CA,HIGH-CEILING DIURETICS,,2017/10/18,2018/3/5,2018/3/2,Other (Please describe in comments),2017/10/18,2018/3/3,No
34270,2384094,Shortage,FUROSEMIDE INJECTION USP,TELIGENT OU,FUROSEMIDE INJECTION,FUROSEMIDE,10MG,2 ML,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,C03CA,HIGH-CEILING DIURETICS,,2017/10/31,2018/4/24,2018/4/26,Disruption of the manufacture of the drug.,2017/12/22,2018/4/27,No
2584,401633,Shortage,FUROSEMIDE SPECIAL,SANDOZ CANADA INCORPORATED,FUROSEMIDE,FUROSEMIDE,10MG/ML,10 X 25ML,INJECTABLE,Resolved,LIQUID IN VIAL,C03CA,HIGH-CEILING DIURETICS,2017/3/23,,2017/5/31,2017/7/28,Demand increase for the drug.,2017/3/14,2017/10/18,No
31051,401633,Shortage,FUROSEMIDE SPECIAL,SANDOZ CANADA INCORPORATED,FUROSEMIDE,FUROSEMIDE,10MG,10 VIALS,INTRAVENOUS,Resolved,SOLUTION,C03CA,HIGH-CEILING DIURETICS,2017/12/4,,2017/12/15,2017/12/12,Delay in shipping of the drug.,2017/11/29,2017/12/15,No
18155,401633,Shortage,FUROSEMIDE SPECIAL,SANDOZ CANADA INCORPORATED,FUROSEMIDE,FUROSEMIDE,10MG,10 X 25ML VIALS,INTRAVENOUS,Resolved,SOLUTION,C03CA,HIGH-CEILING DIURETICS,2017/8/3,2017/8/18,2017/11/17,2017/10/24,Demand increase for the drug.,2017/8/3,2017/10/27,No
2189,2360446,Shortage,FUROSEMIDE SPECIAL INJECTION,OMEGA LABORATORIES LTD,Furosemide Special Injection,FUROSEMIDE,10MG,25mL vial,INTRAVENOUS,Actual shortage,LIQUID,C03CA,HIGH-CEILING DIURETICS,,2016/12/13,,,Disruption of the manufacture of the drug.,2017/3/14,2017/10/5,No
24913,2353261,Shortage,GABAPENTIN,SANIS HEALTH INC,GABAPENTIN CAPS,GABAPENTIN,400MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/10/16,,2017/11/10,2017/10/26,Other (Please describe in comments),2017/10/10,2017/10/27,No
33110,2353245,Shortage,GABAPENTIN,SANIS HEALTH INC,GABAPENTIN CAP,GABAPENTIN,100MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/12/11,2017/12/29,2017/12/21,Disruption of the manufacture of the drug.,2017/12/15,2017/12/22,No
16498,2246314,Shortage,GABAPENTIN,SIVEM PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,100MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/6/15,2018/4/27,2018/4/27,Other (Please describe in comments),2017/7/19,2018/4/30,No
16501,2246314,Shortage,GABAPENTIN,SIVEM PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,100MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/6/15,2018/4/27,2018/4/27,Other (Please describe in comments),2017/7/19,2018/4/30,No
16504,2246316,Shortage,GABAPENTIN,SIVEM PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,400MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/7/17,,2017/8/9,Demand increase for the drug.,2017/7/19,2017/8/10,No
16507,2246316,Shortage,GABAPENTIN,SIVEM PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,400MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/7/17,2018/4/27,2018/4/27,Other (Please describe in comments),2017/7/19,2018/4/30,No
30110,2353261,Shortage,GABAPENTIN,SANIS HEALTH INC,GABAPENTIN CAP,GABAPENTIN,400MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/11/29,2017/11/22,2017/12/29,2017/12/21,Other (Please describe in comments),2017/11/22,2017/12/22,No
28134,2246315,Shortage,GABAPENTIN,SIVEM PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/6/15,2018/4/27,2018/4/27,Other (Please describe in comments),2017/11/6,2018/4/30,No
28137,2246315,Shortage,GABAPENTIN,SIVEM PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,300MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/6/15,2018/4/27,2018/4/27,Other (Please describe in comments),2017/11/6,2018/4/30,No
28140,2246316,Shortage,GABAPENTIN,SIVEM PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,400MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/6/15,2018/4/27,2018/4/27,Other (Please describe in comments),2017/11/6,2018/4/30,No
3233,2392534,Shortage,GABAPENTIN TABLETS USP,ACCORD HEALTHCARE INC,GABAPENTIN,GABAPENTIN,800MG,BOTTLE OF 100 TABS   |    BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2016/12/6,2016/12/6,2017/11/3,2017/11/8,Disruption of the manufacture of the drug.,2017/3/17,2017/11/13,No
25684,2416603,Shortage,GALANTAMINE ER,PRO DOC LIMITEE,GALANTAMINE ER,GALANTAMINE,24MG,30,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2017/10/11,,2018/1/10,Delay in shipping of the drug.,2017/10/12,2018/1/11,No
21233,2416573,Shortage,GALANTAMINE ER,PRO DOC LIMITEE,GALANTAMINE,GALANTAMINE,8MG,30,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2017/9/5,,2018/1/16,Delay in shipping of the drug.,2017/9/7,2018/1/17,No
14330,2416581,Shortage,GALANTAMINE ER,PRO DOC LIMITEE,GALATAMINE ER,GALANTAMINE,16MG,30,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2017/8/1,,2018/1/5,Delay in shipping of the drug.,2017/6/29,2018/1/5,No
16832,2362759,Shortage,GD-AMLODIPINE/ATORVASTATIN,GENMED A DIVISION OF PFIZER CANADA INC,GD-Amlodipine/Atorvastatin,AMLODIPINE ATORVASTATIN,5MG 10MG,90s,ORAL,Resolved,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",2017/7/19,,2017/8/3,2017/8/3,Delay in shipping of the drug.,2017/7/24,2017/8/4,No
8733,2274574,Shortage,GD-AZITHROMYCIN,GENMED A DIVISION OF PFIZER CANADA INC,GD-AZITHROMYCIN,AZITHROMYCIN,200MG,600mg/15mL,ORAL,Resolved,POWDER FOR SUSPENSION,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/4/21,2017/5/16,2017/5/5,Disruption of the manufacture of the drug.,2017/5/2,2017/5/6,No
27753,2274566,Shortage,GD-AZITHROMYCIN,GENMED A DIVISION OF PFIZER CANADA INC,AZITHROMYCIN,AZITHROMYCIN,100MG,300mg/15mL,ORAL,Resolved,POWDER FOR SUSPENSION,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2018/1/17,,2018/8/14,Disruption of the manufacture of the drug.,2017/11/1,2018/8/15,No
7589,2291975,Shortage,GD-CELECOXIB,GENMED A DIVISION OF PFIZER CANADA INC,GD-CELECOXIB,CELECOXIB,100MG,100's,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/4/28,,2017/5/31,2017/6/1,Disruption of the manufacture of the drug.,2017/4/21,2017/6/28,No
33910,2285843,Shortage,GD-GABAPENTIN,GENMED A DIVISION OF PFIZER CANADA INC,GD-GABAPENTIN,GABAPENTIN,600MG,100's,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018/1/2,,2018/2/5,Disruption of the manufacture of the drug.,2017/12/20,2018/2/7,No
12112,2291010,Shortage,GD-QUINAPRIL,GENMED A DIVISION OF PFIZER CANADA INC,GD-Quinapril,QUINAPRIL,40MG,90,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/7/7,,2018/9/25,Shortage of an active ingredient.,2017/6/6,2018/9/26,No
27249,2360039,Shortage,GD-VENLAFAXINE XR,GENMED A DIVISION OF PFIZER CANADA INC,VENLAFAXINE,VENLAFAXINE,75MG,90s,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017/12/18,,2018/1/24,Disruption of the manufacture of the drug.,2017/10/27,2018/1/25,No
14909,2324210,Shortage,GEMCITABINE FOR INJECTION,ACCORD HEALTHCARE INC,GEMCITABINE,GEMCITABINE,1G,1 G POWDER IN A VIAL     |     1 G DE POUDRE DANS UN FLACON,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L01BC,ANTIMETABOLITES,2017/7/5,2017/7/5,2017/9/29,2017/9/20,Demand increase for the drug.,2017/7/7,2017/11/24,No
1697,2305534,Shortage,GEMCITABINE FOR INJECTION,TEVA CANADA LIMITED,GEMCITABINE,GEMCITABINE,1G,1000MG,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L01BC,ANTIMETABOLITES,,2016/11/1,,2018/6/30,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
9700,2370034,Shortage,GEMCITABINE FOR INJECTION,ACCORD HEALTHCARE INC,GEMCITABINE,GEMCITABINE,2G,2 G (POWDER) PER VIAL   |   FLACON DE 2 G (POUDRE),INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L01BC,ANTIMETABOLITES,2017/5/9,2017/5/9,2017/7/7,2017/7/6,Disruption of the manufacture of the drug.,2017/5/9,2017/7/13,No
18317,2412292,Shortage,GEMCITABINE INJECTION,SANDOZ CANADA INCORPORATED,GEMCITABINE,GEMCITABINE,40MG,50  ML VIAL,INTRAVENOUS,Resolved,SOLUTION,L01BC,ANTIMETABOLITES,,2017/7/21,2017/8/18,2017/8/18,Delay in shipping of the drug.,2017/8/7,2017/10/18,No
11695,2402831,Shortage,GEMCITABINE INJECTION,HOSPIRA HEALTHCARE CORPORATION,Gemcitabine,GEMCITABINE,38MG,1 x 52.6mL,INTRAVENOUS,Resolved,SOLUTION,L01BC,ANTIMETABOLITES,,2017/6/1,2017/7/3,2017/7/3,Delay in shipping of the drug.,2017/6/1,2017/7/4,No
24836,2305003,Shortage,GEN-CLOZAPINE,MYLAN PHARMACEUTICALS ULC,CLOZAPINE,CLOZAPINE,50MG,100BT,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2017/10/18,2017/10/19,2017/10/31,2017/10/20,Delay in shipping of the drug.,2017/10/10,2017/10/21,No
28038,2247244,Shortage,GEN-CLOZAPINE,MYLAN PHARMACEUTICALS ULC,CLOZAPINE,CLOZAPINE,100MG,100BT,ORAL,Avoided shortage,TABLET,N05AH,ANTIPSYCHOTICS,2017/12/19,,,2017/11/23,Delay in shipping of the drug.,2017/11/3,2017/11/23,No
4063,2305011,Shortage,GEN-CLOZAPINE,MYLAN PHARMACEUTICALS ULC,CLOZAPINE,CLOZAPINE,200MG,100BT,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017/11/7,2017/11/14,2017/11/14,Delay in shipping of the drug.,2017/3/23,2017/11/15,No
18394,2268531,Shortage,GENTAMICIN INJECTION USP,SANDOZ CANADA INCORPORATED,GENTAMICIN,GENTAMICIN,10MG,10 X 2ML VIALS,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,,2017/8/1,2017/11/30,2017/11/17,Requirements related to complying with good manufacturing practices.,2017/8/7,2017/11/28,No
18397,2242652,Shortage,GENTAMICIN INJECTION USP,SANDOZ CANADA INCORPORATED,GENTAMICIN,GENTAMICIN,40MG,20ML VIAL,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,,2017/8/1,2017/12/15,2017/12/12,Requirements related to complying with good manufacturing practices.,2017/8/7,2017/12/15,No
16068,2190885,Shortage,GLUCOBAY,BAYER INC,Acarbose,ACARBOSE,50MG,120,ORAL,Resolved,TABLET,A10BF,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017/7/13,2017/7/13,2017/9/15,2017/9/14,Disruption of the manufacture of the drug.,2017/7/17,2017/9/15,No
16073,2190893,Shortage,GLUCOBAY,BAYER INC,Acarbose,ACARBOSE,100MG,120 Tablets,ORAL,Resolved,TABLET,A10BF,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017/7/13,2017/7/13,2017/8/25,2017/8/24,Disruption of the manufacture of the drug.,2017/7/17,2017/8/25,No
2494,2099233,Shortage,GLUCOPHAGE,SANOFI-AVENTIS CANADA INC,Glucophage 500mg,METFORMIN HYDROCHLORIDE,500MG,100 and 500,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/3/3,2017/3/17,2017/3/16,Other (Please describe in comments),2017/3/14,2017/3/20,No
18724,2187078,Shortage,HAVRIX - SUS IM 1440 ELISA UNITS/ML,GLAXOSMITHKLINE INC,"hepatitis A vaccine, inactivated","HEPATITIS A VACCINE, INACTIVATED",1440UNIT,1's (prefilled syringe),INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2017/8/8,2018/2/28,2018/2/23,Demand increase for the drug.,2017/8/10,2018/2/26,No
14833,2187078,Shortage,HAVRIX - SUS IM 1440 ELISA UNITS/ML,GLAXOSMITHKLINE INC,"Hepatitis A vaccine, inactivated","HEPATITIS A VACCINE, INACTIVATED",1440UNIT,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2017/7/5,2017/7/10,2017/7/10,Delay in shipping of the drug.,2017/7/6,2017/7/11,No
18721,2231056,Shortage,HAVRIX 720 JUNIOR,GLAXOSMITHKLINE INC,"hepatitis A vaccine, inactivated","HEPATITIS A VACCINE, INACTIVATED",720UNIT,1's (prefilled syringe),INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2017/8/8,2018/2/28,2018/2/21,Delay in shipping of the drug.,2017/8/10,2018/2/22,No
28221,2209713,Shortage,HEPARIN SODIUM 20000UNITS IN 5% DEXTROSE INJ,B. BRAUN MEDICAL INC,Heparin Sodium in Dextrose,DEXTROSE HEPARIN SODIUM,5G 4000UNIT,500mL,INTRAVENOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,,2019/11/9,2019/12/16,2019/12/18,Disruption of the manufacture of the drug.,2017/11/6,2019/12/19,No
28224,2209713,Shortage,HEPARIN SODIUM 20000UNITS IN 5% DEXTROSE INJ,B. BRAUN MEDICAL INC,Heparin Sodium in Dextrose,DEXTROSE HEPARIN SODIUM,5G 4000UNIT,500mL,INTRAVENOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,2018/1/2,2018/1/2,,2019/2/28,Disruption of the manufacture of the drug.,2017/11/6,2019/3/18,No
28235,2209721,Shortage,HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ,B. BRAUN MEDICAL INC,Heparin Sodium in Dextrose,DEXTROSE HEPARIN SODIUM,5G 10000UNIT,250mL,INTRAVENOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,,2017/11/3,,2017/11/15,Requirements related to complying with good manufacturing practices.,2017/11/6,2017/11/15,No
32666,2209721,Shortage,HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ,B. BRAUN MEDICAL INC,Heparin Sodium in Dextrose,DEXTROSE HEPARIN SODIUM,5G 10000UNIT,250mL,INTRAVENOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,2017/12/12,2017/12/12,,2019/2/28,Delay in shipping of the drug.,2017/12/12,2019/3/18,No
28238,1935941,Shortage,"HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML",B. BRAUN MEDICAL INC,Heparin Sodium in Dextrose,CITRIC ACID DEXTROSE SODIUM PHOSPHATE DIBASIC HEPARIN SODIUM,93MG 5G 410MG 5000UNIT,500mL,INTRAVENOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,2018/1/2,2018/1/2,,2019/2/28,Disruption of the manufacture of the drug.,2017/11/6,2019/3/18,No
18727,2239194,Shortage,HEPTOVIR,GLAXOSMITHKLINE INC,lamivudine oral solution,LAMIVUDINE,5MG,240 mL,ORAL,Resolved,SOLUTION,J05AF,DIRECT ACTING ANTIVIRALS,,2017/8/2,2017/9/22,2017/9/12,Demand increase for the drug.,2017/8/10,2017/9/13,No
29521,2239200,Shortage,HIBERIX,GLAXOSMITHKLINE INC,Haemophilus influenzae type b (Hib) conjugate vaccine,HAEMOPHILUS INFLUENZAE TYPE B-PRP AND TETANUS TOXOID CONJUGATE,10MCG,1's,INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,J07AG,BACTERIAL VACCINES,,2017/11/16,2017/12/7,2017/12/4,Demand increase for the drug.,2017/11/17,2017/12/6,No
38,575186,Shortage,HISTANTIL TAB 50MG,PHARMASCIENCE INC,PROMETHAZINE HYDROCHLORIDE,PROMETHAZINE HYDROCHLORIDE,50MG,100 CAPS,ORAL,Resolved,TABLET,R06AD,ANTIHISTAMINES FOR SYSTEMIC USE,2017/1/10,2017/1/10,2018/5/3,2018/5/1,Disruption of the manufacture of the drug.,2017/3/10,2018/5/2,No
17360,2238525,Shortage,HP-PAC,TAKEDA PHARMACEUTICALS AMERICA INC,"Lansoprazole, Clarithromycin, Amoxicillin",AMOXICILLIN LANSOPRAZOLE CLARITHROMYCIN,500MG 30MG 500MG,HP-PAC 7-Day,ORAL,Resolved,"KIT
CAPSULE
CAPSULE (SUSTAINED-RELEASE)
TABLET",A02BD,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/9/21,2017/10/13,2017/10/16,Requirements related to complying with good manufacturing practices.,2017/7/26,2017/10/17,No
32477,2238525,Shortage,HP-PAC,TAKEDA PHARMACEUTICALS AMERICA INC,"LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN",AMOXICILLIN LANSOPRAZOLE CLARITHROMYCIN,500MG 30MG 500MG,Blister pack,ORAL,Resolved,"KIT
CAPSULE
CAPSULE (SUSTAINED-RELEASE)
TABLET",A02BD,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018/5/7,,2018/6/25,Delay in shipping of the drug.,2017/12/11,2018/6/26,No
32737,465283,Shortage,HYDREA CAP 500MG,BRISTOL-MYERS SQUIBB CANADA,Hydroxyurea,HYDROXYUREA,500MG,1BTL x 100,ORAL,Resolved,CAPSULE,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2018/2/26,,2018/4/18,Demand increase for the drug.,2017/12/13,2018/4/19,No
1700,872520,Shortage,HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION,TEVA CANADA LIMITED,HYDROCORTISONE SODIUM SUCCINATE,HYDROCORTISONE,100MG,10,"INTRAMUSCULAR
INTRAVENOUS",Actual shortage,POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2016/2/29,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1703,872539,Shortage,HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION,TEVA CANADA LIMITED,HYDROCORTISONE SODIUM SUCCINATE,HYDROCORTISONE,250MG,10,"INTRAMUSCULAR
INTRAVENOUS",Actual shortage,POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2016/2/29,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1706,878618,Shortage,HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION,TEVA CANADA LIMITED,HYDROCORTISONE SODIUM SUCCINATE,HYDROCORTISONE,500MG,10,"INTRAMUSCULAR
INTRAVENOUS",Actual shortage,POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2016/2/29,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
13885,2145928,Shortage,HYDROMORPHONE HP 10,SANDOZ CANADA INCORPORATED,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,10MG,10 X 5ML VIALS,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,N02AA,OPIOIDS,2017/6/28,,2017/7/17,2017/6/30,Demand increase for the drug.,2017/6/26,2017/7/5,No
2616,2244797,Shortage,HYDROMORPHONE HP FORTE INJECTION,SANDOZ CANADA INCORPORATED,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,100MG,10ML,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,N02AA,OPIOIDS,,2017/3/14,2017/12/22,2017/11/17,Disruption of the manufacture of the drug.,2017/3/14,2017/11/28,No
14734,2382636,Shortage,HYDROMORPHONE HYDROCHLORIDE INJECTION USP HP 10,HOSPIRA HEALTHCARE CORPORATION,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,10MG,10X1ML,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,N02AA,OPIOIDS,,2017/11/8,,2017/12/29,Other (Please describe in comments),2017/7/5,2018/1/9,No
14737,2382636,Shortage,HYDROMORPHONE HYDROCHLORIDE INJECTION USP HP 10,HOSPIRA HEALTHCARE CORPORATION,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,10MG,10X5ML,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Avoided shortage,SOLUTION,N02AA,OPIOIDS,2018/6/24,,,2017/12/21,Other (Please describe in comments),2017/7/5,2017/12/22,No
8426,2382636,Shortage,HYDROMORPHONE HYDROCHLORIDE INJECTION USP HP 10,HOSPIRA HEALTHCARE CORPORATION,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,10MG,1x50mL,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,N02AA,OPIOIDS,,2017/5/24,,2017/12/29,Other (Please describe in comments),2017/4/28,2018/1/9,No
22273,2242984,Shortage,HYDROVAL CREAM 0.2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Hydroval Cream 0.2%,HYDROCORTISONE VALERATE,0.20%,60 g,TOPICAL,Resolved,CREAM,D07AA,"CORTICOSTEROIDS, PLAIN",2017/9/15,2017/9/15,2017/10/31,2017/11/2,Requirements related to complying with good manufacturing practices.,2017/9/18,2017/11/3,No
7298,2242984,Shortage,HYDROVAL CREAM 0.2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",HYDRO VAL 0.2%,HYDROCORTISONE VALERATE,0.20%,45 gram,TOPICAL,Resolved,CREAM,D07AA,"CORTICOSTEROIDS, PLAIN",,2017/4/11,2017/9/1,2017/9/1,Disruption of the manufacture of the drug.,2017/4/19,2017/9/8,No
7302,2242984,Shortage,HYDROVAL CREAM 0.2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",HYDRO VAL 0.2%,HYDROCORTISONE VALERATE,0.20%,15 gram,TOPICAL,Resolved,CREAM,D07AA,"CORTICOSTEROIDS, PLAIN",2017/4/29,,2017/5/8,2017/5/8,Disruption of the manufacture of the drug.,2017/4/19,2017/6/6,No
24212,2242984,Shortage,HYDROVAL CREAM 0.2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Hydroval Cream 0.2%,HYDROCORTISONE VALERATE,0.20%,500 g,TOPICAL,Resolved,CREAM,D07AA,"CORTICOSTEROIDS, PLAIN",,2018/6/15,2018/7/6,2018/8/2,Disruption of the manufacture of the drug.,2017/10/3,2018/8/3,No
22276,2242985,Shortage,HYDROVAL OINTMENT 0.2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Hydroval Ointment 0.2%,HYDROCORTISONE VALERATE,0.20%,60 g,TOPICAL,Resolved,OINTMENT,D07AA,"CORTICOSTEROIDS, PLAIN",,2018/6/15,2018/7/6,2018/8/2,Disruption of the manufacture of the drug.,2017/9/18,2018/8/3,No
34391,2242985,Shortage,HYDROVAL OINTMENT 0.2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Taro Pharmaceuticals Hydroval Ointment,HYDROCORTISONE VALERATE,0.20%,15 g,TOPICAL,Resolved,OINTMENT,D07AA,"CORTICOSTEROIDS, PLAIN",2017/12/27,2017/12/27,2018/2/6,2018/2/6,Disruption of the manufacture of the drug.,2017/12/27,2018/2/7,No
12803,2014793,Shortage,IC-GREEN,AKORN INC,indocyanine green,INDOCYANINE GREEN,25MG,6 vials with 6 vials of diluent,INTRAVENOUS,Resolved,POWDER,V04,OTHER DIAGNOSTIC AGENTS,2017/6/8,2017/6/8,2017/9/4,2017/8/31,Disruption of the manufacture of the drug.,2017/6/15,2017/9/1,No
27651,2014793,Shortage,IC-GREEN,AKORN INC,indocyanine green,INDOCYANINE GREEN,25MG,6 vials with 6 vials of diluent,INTRAVENOUS,Resolved,POWDER,V04CX,OTHER DIAGNOSTIC AGENTS,2017/11/1,2017/11/6,2018/2/8,2018/2/5,Disruption of the manufacture of the drug.,2017/11/1,2018/2/8,No
11683,2241357,Shortage,IFEX (IFOSFAMIDE) 1 G/VIAL,BAXTER CORPORATION,IFOSFAMIDE,IFOSFAMIDE,1G,1g Vial,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L01AA,ALKYLATINGAGENTS,2017/6/1,,2017/6/12,2017/6/12,Demand increase for the drug.,2017/6/1,2017/8/28,No
20433,2241357,Shortage,IFEX (IFOSFAMIDE) 1 G/VIAL,BAXTER CORPORATION,IFEX,IFOSFAMIDE,1G,1g Vial,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L01AA,ALKYLATINGAGENTS,2017/8/28,2017/8/28,2017/11/6,2017/10/5,Demand increase for the drug.,2017/8/28,2017/10/6,No
26411,2126559,Shortage,IMDUR - EXTENDED RELEASE TABLETS 60 MG,ASTRAZENECA CANADA INC,isosorbide-5-mononitrate extended release tablets,ISOSORBIDE-5-MONONITRATE,60MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2017/10/19,2017/10/19,2018/2/8,2018/2/21,Demand increase for the drug.,2017/10/20,2018/2/22,No
26414,2126559,Shortage,IMDUR - EXTENDED RELEASE TABLETS 60 MG,ASTRAZENECA CANADA INC,isosorbide-5-mononitrate extended release tablets,ISOSORBIDE-5-MONONITRATE,60MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2017/10/19,2017/10/19,2017/12/15,2017/12/8,Demand increase for the drug.,2017/10/20,2017/12/9,No
21890,2126559,Shortage,IMDUR - EXTENDED RELEASE TABLETS 60 MG,ASTRAZENECA CANADA INC,isosorbide-5-mononitrate extended release tablets,ISOSORBIDE-5-MONONITRATE,60MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2017/8/18,2017/8/18,2017/10/2,2017/10/6,Demand increase for the drug.,2017/9/12,2017/10/8,No
21895,2126559,Shortage,IMDUR - EXTENDED RELEASE TABLETS 60 MG,ASTRAZENECA CANADA INC,isosorbide-5-mononitrate extended release tablets,ISOSORBIDE-5-MONONITRATE,60MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2017/7/28,2017/7/28,2017/10/9,2017/10/6,Demand increase for the drug.,2017/9/12,2017/10/8,No
2148,2357437,Shortage,IMIPENEM AND CILASTATIN FOR INJECTION,HOSPIRA HEALTHCARE CORPORATION,Imipenem and Cilastatin,CILASTATIN IMIPENEM,500MG 500MG,500mg x 10,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DH,OTHER BETA-LACTAM ANTIBACTERIALS,,2016/4/2,,2018/8/14,Other (Please describe in comments),2017/3/14,2018/8/15,No
4140,326852,Shortage,IMIPRAMINE,AA PHARMA INC,IMIPRAMINE,IMIPRAMINE HYDROCHLORIDE,50MG,1000 BOTTLE,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2016/5/27,,2016/5/27,Disruption of the manufacture of the drug.,2017/3/24,2017/3/28,No
11250,2212161,Shortage,IMITREX DF - TAB 100MG,GLAXOSMITHKLINE INC,Sumatriptan succinate tablets,SUMATRIPTAN,100MG,6's,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018/1/11,2018/7/6,2018/6/21,Shortage of an active ingredient.,2017/5/25,2018/6/22,No
11245,2212153,Shortage,IMITREX DF - TAB 50MG,GLAXOSMITHKLINE INC,Sumatriptan succinate tablets,SUMATRIPTAN,50MG,6's,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/9/20,2018/6/7,2018/6/6,Shortage of an active ingredient.,2017/5/25,2018/6/8,No
3259,2212188,Shortage,IMITREX INJECTION 12MG/ML,GLAXOSMITHKLINE INC,Sumatriptan succinate injection,SUMATRIPTAN,12MG,2's,SUBCUTANEOUS,Avoided shortage,LIQUID,N02CC,ANTIMIGRAINE PREPARATIONS,2017/3/27,,,2017/3/23,Disruption of the manufacture of the drug.,2017/3/17,2017/3/29,No
11234,2212188,Shortage,IMITREX INJECTION 12MG/ML,GLAXOSMITHKLINE INC,Sumatriptan succinate injection,SUMATRIPTAN,12MG,5x0.5mL,SUBCUTANEOUS,Resolved,LIQUID,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/6/26,2018/6/29,2018/6/26,Shortage of an active ingredient.,2017/5/25,2018/6/27,No
11237,2212188,Shortage,IMITREX INJECTION 12MG/ML,GLAXOSMITHKLINE INC,Sumatriptan succinate injection,SUMATRIPTAN,12MG,2x0.5mL,SUBCUTANEOUS,Resolved,LIQUID,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/6/12,2018/3/23,2018/3/15,Shortage of an active ingredient.,2017/5/25,2018/3/16,No
11253,2212188,Shortage,IMITREX INJECTION 12MG/ML,GLAXOSMITHKLINE INC,Sumatriptan succinate injection,SUMATRIPTAN,12MG,2x0.5mL (Refill pack/L’emballage de recharge),SUBCUTANEOUS,Resolved,LIQUID,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/6/29,2018/2/28,2018/2/7,Shortage of an active ingredient.,2017/5/25,2018/2/8,No
12156,2230420,Shortage,IMITREX NASAL SPRAY,GLAXOSMITHKLINE INC,Sumatriptan nasal spray,SUMATRIPTAN,20MG,2's,NASAL,Resolved,SPRAY,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/8/9,2018/2/28,2018/2/22,Shortage of an active ingredient.,2017/6/6,2018/2/23,No
5841,2230420,Shortage,IMITREX NASAL SPRAY,GLAXOSMITHKLINE INC,Sumatriptan nasal spray,SUMATRIPTAN,20MG,2's,NASAL,Resolved,SPRAY,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/5/16,2017/5/26,2017/5/25,Disruption of the manufacture of the drug.,2017/4/6,2017/5/26,No
10741,2230418,Shortage,IMITREX NASAL SPRAY,GLAXOSMITHKLINE INC,Sumatriptan nasal spray,SUMATRIPTAN,5MG,2's,NASAL,Resolved,SPRAY,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/6/12,2018/2/9,2018/2/7,Shortage of an active ingredient.,2017/5/19,2018/2/8,No
31856,1959042,Shortage,IMOVAX POLIO,SANOFI PASTEUR LIMITED,Inactivated Poliomyelitis Vaccine (Vero Cell Origin),INACTIVATED POLIOMYELITIS VACCINE INACTIVATED POLIOMYELITIS VACCINE INACTIVATED POLIOMYELITIS VACCINE,32UNIT 8UNIT 40UNIT,1 x 0.5 mL (single dose) syringe,SUBCUTANEOUS,Resolved,SUSPENSION,J07BF,VIRAL VACCINES,2017/11/28,2017/11/28,2018/2/1,2018/2/1,Requirements related to complying with good manufacturing practices.,2017/12/6,2018/4/26,No
3035,1908286,Shortage,IMOVAX RABIES RABIES VACCINE INACTIVATED (DCO),SANOFI PASTEUR LIMITED,Rabies Vaccine Inactivated (DCO),RABIES VACCINE INACTIVATED,2.5UNIT,"1.0 mL single dose vial with 1 mL diluent / Fiole de 1,0 mL à dose unique avec 1 mL de diluant",INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,J07BG,VIRAL VACCINES,2017/11/22,2017/11/22,2017/12/15,2017/12/1,Requirements related to complying with good manufacturing practices.,2017/3/16,2017/12/2,No
27093,2398869,Shortage,INDAYO,MYLAN PHARMACEUTICALS ULC,INDAYO,ETHINYL ESTRADIOL LEVONORGESTREL,0.03MG 0.15MG,91BL,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2018/5/11,2018/5/14,2018/8/23,2018/8/22,Delay in shipping of the drug.,2017/10/26,2018/8/23,No
16559,2323052,Shortage,INSPRA,PFIZER CANADA INC,Inspra,EPLERENONE,25MG,3 x 10 TABS,ORAL,Resolved,TABLET,C03DA,POTASSIUM-SPARING AGENTS,2017/7/20,,2017/8/10,2017/8/10,Disruption of the manufacture of the drug.,2017/7/20,2017/8/11,No
27636,2323052,Shortage,INSPRA,PFIZER CANADA INC,INSPRA,EPLERENONE,25MG,3x10 Tabs,ORAL,Resolved,TABLET,C03DA,POTASSIUM-SPARING AGENTS,,2017/12/15,,2018/4/16,Disruption of the manufacture of the drug.,2017/11/1,2018/4/17,No
5429,2294990,Shortage,INSTILLAGEL,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,INSTILLAGEL LIDO2%CHLORHEX 0.05%10X11mL,LIDOCAINE HYDROCHLORIDE CHLORHEXIDINE GLUCONATE,2% 0.05%,10x11mL,TOPICAL,Resolved,GEL,N01BB,"ANESTHETICS, LOCAL",2017/6/14,2017/6/15,2017/7/24,2017/7/17,Disruption of the manufacture of the drug.,2017/4/4,2017/7/18,No
14814,2294990,Shortage,INSTILLAGEL,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,INSTILLAGEL LIDO2% CHLORHEX 0.05%,LIDOCAINE HYDROCHLORIDE CHLORHEXIDINE GLUCONATE,2% 0.05%,10X6mL,TOPICAL,Resolved,GEL,N01BB,"ANESTHETICS, LOCAL",2017/7/17,2017/7/10,2017/7/18,2017/7/17,Disruption of the manufacture of the drug.,2017/7/6,2017/7/18,No
16762,2240351,Shortage,INTEGRILIN,MERCK CANADA INC,Eptifibatide Injection,EPTIFIBATIDE,0.75MG,100ML VIAL,INTRAVENOUS,Avoided shortage,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,2017/8/21,,2017/8/31,2017/8/14,Delay in shipping of the drug.,2017/7/24,2017/8/14,No
2210,2240351,Shortage,INTEGRILIN,MERCK CANADA INC,eptifibatide injection Solution for Intravenous Infusion,EPTIFIBATIDE,"0,75 mg/mL",75 mg/100 mL infusion vial - Fiole de 75 mg/100 mL pour perfusion,Intravenous,Resolved,Solution,B01AC,ANTITHROMBOTIC AGENTS,2016/6/27,2016/6/27,2017/4/14,2017/4/10,Delay in shipping of the drug.,2017/3/14,2017/4/11,No
9382,2240352,Shortage,INTEGRILIN,MERCK CANADA INC,Eptifibatide Injection,EPTIFIBATIDE,2MG,20MG/10ML vial,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,,2017/7/5,2017/8/11,2017/8/9,Delay in shipping of the drug.,2017/5/8,2017/8/10,No
18477,2223406,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b  lyophilized powder,WATER INTERFERON ALFA-2B,1ML 10000000UNIT,1X10MIU PWDER & DIL VIAL,"INTRALESIONAL
INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,"LIQUID
POWDER FOR SOLUTION",L03AB,IMMUNOSTIMULANTS,,2017/8/4,2017/8/25,2017/8/22,Demand increase for the drug.,2017/8/8,2017/8/23,No
8757,2223406,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b  lyophilized powder,WATER INTERFERON ALFA-2B,1ML 10000000UNIT,1X10 MIU,"INTRALESIONAL
INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,"LIQUID
POWDER FOR SOLUTION",L03AB,IMMUNOSTIMULANTS,2017/5/3,2017/5/3,2017/7/21,2017/7/14,Demand increase for the drug.,2017/5/3,2017/7/15,No
20821,2240695,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection (multi-dose pen),INTERFERON ALFA-2B,50000000UNIT,60MIU PEN,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2017/10/2,2017/10/2,2017/12/4,2017/12/1,Delay in shipping of the drug.,2017/9/1,2017/12/2,No
11883,2238675,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection,INTERFERON ALFA-2B,10000000UNIT,1X10MIU HSA FREE VIAL,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,L03AB,IMMUNOSTIMULANTS,,2017/7/11,2017/8/4,2017/8/4,Delay in shipping of the drug.,2017/6/5,2017/8/5,No
2168,2240694,Shortage,INTRON A,MERCK CANADA INC,INTERFERON ALFA-2b solution for injection,INTERFERON ALFA-2B,25000000UNIT,1.2 mL - 30 x 10 6 IU/pen - 30 x 10 6 UI/stylo,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2017/2/13,2017/2/13,2017/3/17,2017/3/20,Delay in shipping of the drug.,2017/3/14,2017/3/21,No
6265,2240693,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection (multi-dose pen),INTERFERON ALFA-2B,15000000UNIT,18 MIU Pen,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2017/5/1,2017/5/2,2017/7/31,2017/7/19,Demand increase for the drug.,2017/4/10,2017/7/20,No
6269,2240695,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection (multi-dose pen),INTERFERON ALFA-2B,50000000UNIT,60 MIU pen,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2017/5/1,2017/4/24,2017/6/16,2017/6/16,Delay in shipping of the drug.,2017/4/10,2017/6/17,No
18059,2240694,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection,INTERFERON ALFA-2B,25000000UNIT,1X25MIU HSA FREE VIAL,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,,2017/7/11,2017/8/4,2017/8/4,Delay in shipping of the drug.,2017/8/2,2017/8/5,No
2194,2240695,Shortage,INTRON A,MERCK CANADA INC,INTERFERON ALFA-2b solution pour injection,INTERFERON ALFA-2B,50000000UNIT,1.2 mL - 60 x 10 6 IU/pen - 60 x 10 6 UI/stylo,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2017/2/9,2017/3/9,2017/3/17,2017/3/20,Delay in shipping of the drug.,2017/3/14,2017/3/21,No
26524,2240694,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection (multi-dose pen),INTERFERON ALFA-2B,25000000UNIT,30MIU PEN,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2017/10/23,2017/10/23,2017/11/24,2017/11/17,Delay in shipping of the drug.,2017/10/23,2017/11/18,No
15541,2238675,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection,INTERFERON ALFA-2B,10000000UNIT,1X10MIU HSA FREE VIAL,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Avoided shortage,SOLUTION,L03AB,IMMUNOSTIMULANTS,2017/8/3,,2017/8/4,2017/8/2,Delay in shipping of the drug.,2017/7/12,2017/10/10,No
18925,2240693,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection (multi-dose pen),INTERFERON ALFA-2B,15000000UNIT,18MIU PEN,SUBCUTANEOUS,Avoided shortage,LIQUID,L03AB,IMMUNOSTIMULANTS,2017/9/7,,2017/9/18,2017/9/6,Demand increase for the drug.,2017/8/12,2017/10/11,No
19449,2238675,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection,INTERFERON ALFA-2B,10000000UNIT,1X25MIU HSA FREE VIAL,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,L03AB,IMMUNOSTIMULANTS,,2017/8/14,2017/9/15,2017/9/12,Demand increase for the drug.,2017/8/15,2017/9/13,No
3653,2245568,Shortage,IODOVET TOPICAL SOLUTION,LABORATOIRE RIVA INC,Iodovet topical solution,POVIDONE-IODINE,10%,5L & 450ml,TOPICAL,Resolved,SOLUTION,,,2017/3/20,2017/3/20,,2017/3/24,Disruption of the manufacture of the drug.,2017/3/20,2017/3/25,No
24465,888354,Shortage,IOPIDINE OPH SOL 1%,ALCON CANADA INC,APRACLONIDINE HCL,APRACLONIDINE,1%,(2 x 0.1mL)  x 12,OPHTHALMIC,Resolved,LIQUID,S01EA,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2017/10/3,2018/1/24,2018/1/8,Disruption of the manufacture of the drug.,2017/10/5,2018/1/9,No
2199,2246083,Shortage,IPRAVENT,AA PHARMA INC,IPRAVENT,IPRATROPIUM BROMIDE,0.03%,15 ML,NASAL,Resolved,SOLUTION,R01AX,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2015/4/15,,2017/7/28,Disruption of the manufacture of the drug.,2017/3/14,2020/8/6,No
2304,2365162,Shortage,IRBESARTAN-HCTZ,PRO DOC LIMITEE,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE IRBESARTAN,12.5MG 150MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/3/14,,2017/4/11,Delay in shipping of the drug.,2017/3/14,2017/4/18,No
14365,2365189,Shortage,IRBESARTAN-HCTZ,PRO DOC LIMITEE,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE IRBESARTAN,25MG 300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/8/30,,2018/5/8,Delay in shipping of the drug.,2017/6/29,2018/5/9,No
15521,2365170,Shortage,IRBESARTAN-HCTZ,PRO DOC LIMITEE,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE IRBESARTAN,12.5MG 300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018/4/5,,2018/5/8,Delay in shipping of the drug.,2017/7/12,2018/5/9,No
9705,2365162,Shortage,IRBESARTAN-HCTZ,PRO DOC LIMITEE,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE IRBESARTAN,12.5MG 150MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/6/1,,2017/11/21,Delay in shipping of the drug.,2017/5/9,2017/11/22,No
3937,2410419,Shortage,IRINOTECAN,PFIZER CANADA INC,IRINOTECAN,IRINOTECAN HYDROCHLORIDE,20MG,1 x 5mL,INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2017/3/22,2017/6/21,2017/6/21,Demand increase for the drug.,2017/3/22,2017/6/22,No
34022,2410419,Shortage,IRINOTECAN,PFIZER CANADA INC,Irinotecan,IRINOTECAN HYDROCHLORIDE,20MG,1x15mL,INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2018/3/26,,2018/7/12,Demand increase for the drug.,2017/12/20,2018/7/13,No
2042,2410419,Shortage,IRINOTECAN,PFIZER CANADA INC,IRINOTECAN,IRINOTECAN HYDROCHLORIDE,20MG,1x15ML,INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2016/12/21,2017/8/29,2017/8/29,Other (Please describe in comments),2017/3/14,2017/8/30,No
32661,2258218,Shortage,IRINOTECAN HYDROCHLORIDE INJECTION,HOSPIRA HEALTHCARE CORPORATION,IRINOTECAN,IRINOTECAN HYDROCHLORIDE,20MG,1 x 2mL,INTRAVENOUS,Avoided shortage,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,2018/4/9,,,2018/2/26,Demand increase for the drug.,2017/12/12,2018/2/26,No
25312,2258218,Shortage,IRINOTECAN HYDROCHLORIDE INJECTION,HOSPIRA HEALTHCARE CORPORATION,IRINOTECAN,IRINOTECAN HYDROCHLORIDE,20MG,1x5mL,INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2017/10/31,,2018/1/18,Disruption of the manufacture of the drug.,2017/10/11,2018/1/19,No
22186,2357585,Shortage,IRINOTECAN HYDROCHLORIDE TRIHYDRATE FOR INJECTION,ACCORD HEALTHCARE INC,IRINOTECAN,IRINOTECAN HYDROCHLORIDE,20MG,"2 mL vial, 10 vials per box  |  Flacon de 2 ml, Boîte de 10 flacons",INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,2017/9/13,2017/9/13,2017/10/13,2017/10/16,Disruption of the manufacture of the drug.,2017/9/15,2017/10/20,No
3252,2357585,Shortage,IRINOTECAN HYDROCHLORIDE TRIHYDRATE FOR INJECTION,ACCORD HEALTHCARE INC,IRINOTECAN,IRINOTECAN HYDROCHLORIDE,20MG,5 ML VIAL OF 100 MG   |   FLACON DE 5 ML DE 100 MG,INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,2016/12/27,2016/12/27,2017/3/22,2017/3/22,Disruption of the manufacture of the drug.,2017/3/17,2017/3/23,No
32906,2392429,Shortage,ISENTRESS,MERCK CANADA INC,raltegravir chewable tablets,RALTEGRAVIR,25MG,60TAB,ORAL,Resolved,TABLET (CHEWABLE),J05AX,DIRECT ACTING ANTIVIRALS,,2017/12/13,2018/2/23,2018/2/23,Demand increase for the drug.,2017/12/14,2018/2/24,No
5614,2446073,Shortage,ISMN,SIVEM PHARMACEUTICALS ULC,ISMN,ISOSORBIDE-5-MONONITRATE,60MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2017/4/25,,,2017/6/27,Demand increase for the drug.,2017/4/5,2017/11/3,No
5617,2446073,Shortage,ISMN,SIVEM PHARMACEUTICALS ULC,ISMN,ISOSORBIDE-5-MONONITRATE,60MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2017/4/25,,,2017/6/27,Demand increase for the drug.,2017/4/5,2017/11/3,No
6358,2354926,Shortage,JAMP REPAGLINIDE,JAMP PHARMA CORPORATION,REPAGLINIDE,REPAGLINIDE,0.5MG,100,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/4/9,,2020/3/31,Disruption of the manufacture of the drug.,2017/4/10,2020/4/29,No
6361,2354934,Shortage,JAMP REPAGLINIDE,JAMP PHARMA CORPORATION,REPAGLINIDE,REPAGLINIDE,1.0MG,100,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/4/9,,2020/3/31,Disruption of the manufacture of the drug.,2017/4/10,2020/4/29,No
6364,2354942,Shortage,JAMP REPAGLINIDE,JAMP PHARMA CORPORATION,REPAGLINIDE,REPAGLINIDE,2.0MG,100,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/4/9,,2020/3/31,Disruption of the manufacture of the drug.,2017/4/10,2020/4/29,No
3375,2435551,Shortage,JAMP-AMITRIPTYLINE TABLETS,JAMP PHARMA CORPORATION,Amitriptyline Hydrochloride Tablets,AMITRIPTYLINE HYDROCHLORIDE,75MG,100,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2016/11/7,2017/7/31,2017/8/8,Disruption of the manufacture of the drug.,2017/3/17,2017/8/9,No
3396,2435543,Shortage,JAMP-AMITRIPTYLINE TABLETS,JAMP PHARMA CORPORATION,Amitriptyline Hydrochloride Tablets,AMITRIPTYLINE HYDROCHLORIDE,50MG,100,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2016/11/7,2017/8/31,2017/8/31,Disruption of the manufacture of the drug.,2017/3/17,2017/9/27,No
3402,2435543,Shortage,JAMP-AMITRIPTYLINE TABLETS,JAMP PHARMA CORPORATION,Amitriptyline Hydrochloride Tablets,AMITRIPTYLINE HYDROCHLORIDE,50MG,1000,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2016/11/7,2017/8/31,2017/9/26,Disruption of the manufacture of the drug.,2017/3/17,2017/9/27,No
3405,2435535,Shortage,JAMP-AMITRIPTYLINE TABLETS,JAMP PHARMA CORPORATION,Amitriptyline Hydrochloride tablets,AMITRIPTYLINE HYDROCHLORIDE,25MG,1000,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2016/11/7,2017/7/31,2017/8/3,Disruption of the manufacture of the drug.,2017/3/17,2017/8/8,No
3409,2435535,Shortage,JAMP-AMITRIPTYLINE TABLETS,JAMP PHARMA CORPORATION,Amitriptyline Hydrochloride Tablets,AMITRIPTYLINE HYDROCHLORIDE,25MG,100,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2016/11/7,,2017/8/3,Disruption of the manufacture of the drug.,2017/3/17,2017/8/8,No
3481,2435527,Shortage,JAMP-AMITRIPTYLINE TABLETS,JAMP PHARMA CORPORATION,Amitriptyline hydrochloride,AMITRIPTYLINE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2016/11/7,2016/11/7,2017/11/15,2017/11/8,Disruption of the manufacture of the drug.,2017/3/20,2017/11/9,No
3484,2435527,Shortage,JAMP-AMITRIPTYLINE TABLETS,JAMP PHARMA CORPORATION,Amitriptyline hydrochloride,AMITRIPTYLINE HYDROCHLORIDE,10MG,1000,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2016/11/7,2017/11/15,2017/11/8,Disruption of the manufacture of the drug.,2017/3/20,2017/11/9,No
3489,2357186,Shortage,JAMP-AMLODIPINE,JAMP PHARMA CORPORATION,Amlodipine besilate,AMLODIPINE,2.5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/3/1,,2021/4/21,Disruption of the manufacture of the drug.,2017/3/20,2021/7/30,No
3501,2433060,Shortage,JAMP-AMOXICILLIN,JAMP PHARMA CORPORATION,Amoxicillan trihydrate,AMOXICILLIN,250MG,100,ORAL,Resolved,CAPSULE,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2016/11/14,,2018/5/1,Demand increase for the drug.,2017/3/20,2018/5/2,No
3508,2433060,Shortage,JAMP-AMOXICILLIN,JAMP PHARMA CORPORATION,Amoxicillan trihydrate,AMOXICILLIN,250MG,1000,ORAL,Resolved,CAPSULE,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2016/11/11,,2018/5/1,Disruption of the manufacture of the drug.,2017/3/20,2018/5/2,No
3511,2433079,Shortage,JAMP-AMOXICILLIN,JAMP PHARMA CORPORATION,Amoxicillan trihydrate,AMOXICILLIN,500MG,100,ORAL,Resolved,CAPSULE,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2016/11/14,,2018/5/1,Disruption of the manufacture of the drug.,2017/3/20,2018/5/2,No
3514,2433079,Shortage,JAMP-AMOXICILLIN,JAMP PHARMA CORPORATION,Amoxicillan trihydrate,AMOXICILLIN,500MG,500,ORAL,Resolved,CAPSULE,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2016/11/14,,2018/5/1,Disruption of the manufacture of the drug.,2017/3/20,2018/5/2,No
3527,2367564,Shortage,JAMP-ATENOLOL,JAMP PHARMA CORPORATION,Atenolol,ATENOLOL,50MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2016/9/22,2017/8/31,2017/9/26,Disruption of the manufacture of the drug.,2017/3/20,2017/9/27,No
3536,2367564,Shortage,JAMP-ATENOLOL,JAMP PHARMA CORPORATION,Atenolol,ATENOLOL,50MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2016/9/22,2017/8/31,2017/9/26,Disruption of the manufacture of the drug.,2017/3/20,2017/9/27,No
3544,2367572,Shortage,JAMP-ATENOLOL,JAMP PHARMA CORPORATION,Atenolol,ATENOLOL,100MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/2/22,2017/8/31,2017/9/26,Disruption of the manufacture of the drug.,2017/3/20,2017/9/27,No
3551,2367572,Shortage,JAMP-ATENOLOL,JAMP PHARMA CORPORATION,Atenolol,ATENOLOL,100MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/2/22,2017/8/31,2017/9/26,Disruption of the manufacture of the drug.,2017/3/20,2017/9/27,No
3554,2367572,Shortage,JAMP-ATENOLOL,JAMP PHARMA CORPORATION,Atenolol,ATENOLOL,100MG,30,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/2/22,2017/7/31,2017/9/26,Disruption of the manufacture of the drug.,2017/3/20,2017/9/27,No
3558,2367564,Shortage,JAMP-ATENOLOL,JAMP PHARMA CORPORATION,Atenolol,ATENOLOL,50MG,30,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2016/9/22,2017/8/31,2017/9/26,Disruption of the manufacture of the drug.,2017/3/20,2017/9/27,No
34184,2357216,Shortage,JAMP-BICALUTAMIDE,JAMP PHARMA CORPORATION,Bicalutamide,BICALUTAMIDE,50MG,30,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017/12/22,,2018/5/1,Disruption of the manufacture of the drug.,2017/12/22,2018/5/2,No
3561,2386518,Shortage,JAMP-CANDESARTAN,JAMP PHARMA CORPORATION,Candesartan,CANDESARTAN CILEXETIL,8MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2016/9/21,2017/7/31,2017/8/3,Disruption of the manufacture of the drug.,2017/3/20,2017/8/8,No
3564,2386534,Shortage,JAMP-CANDESARTAN,JAMP PHARMA CORPORATION,Candesartan,CANDESARTAN CILEXETIL,32MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/2/28,2017/7/31,2017/8/3,Disruption of the manufacture of the drug.,2017/3/20,2017/8/8,No
3567,2386496,Shortage,JAMP-CANDESARTAN,JAMP PHARMA CORPORATION,Candesartan,CANDESARTAN CILEXETIL,4MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2016/9/15,2020/12/31,,Disruption of the manufacture of the drug.,2017/3/20,2020/2/18,No
4828,2420147,Shortage,JAMP-CYANOCOBALAMIN,JAMP PHARMA CORPORATION,Cyanocobalamin Injection,VITAMIN B12,1000MCG,30,"INTRAMUSCULAR
SUBCUTANEOUS",Actual shortage,SOLUTION,B03BA,VITAMIN B12 AND FOLIC ACID,,2016/9/15,2020/6/30,,Disruption of the manufacture of the drug.,2017/3/30,2020/2/18,No
4831,2420147,Shortage,JAMP-CYANOCOBALAMIN,JAMP PHARMA CORPORATION,Cyanocobalamin Injection,VITAMIN B12,1000MCG,10,"INTRAMUSCULAR
SUBCUTANEOUS",Actual shortage,SOLUTION,B03BA,VITAMIN B12 AND FOLIC ACID,,2016/12/13,2020/6/30,,Disruption of the manufacture of the drug.,2017/3/30,2020/2/18,No
23888,2361469,Shortage,JAMP-GABAPENTIN,JAMP PHARMA CORPORATION,Gabarentin,GABAPENTIN,100MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/9/1,,2017/11/23,Disruption of the manufacture of the drug.,2017/9/29,2017/11/24,No
23892,2361493,Shortage,JAMP-GABAPENTIN,JAMP PHARMA CORPORATION,Gabarentin,GABAPENTIN,400MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/9/1,,2017/11/23,Disruption of the manufacture of the drug.,2017/9/29,2017/11/24,No
23895,2361493,Shortage,JAMP-GABAPENTIN,JAMP PHARMA CORPORATION,Gabapentin,GABAPENTIN,400MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/9/1,,2017/11/23,Disruption of the manufacture of the drug.,2017/9/29,2017/11/24,No
23898,2361485,Shortage,JAMP-GABAPENTIN,JAMP PHARMA CORPORATION,GABAPENTIN,GABAPENTIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/9/1,,2017/11/23,Disruption of the manufacture of the drug.,2017/9/29,2017/11/24,No
3570,2402289,Shortage,JAMP-GABAPENTIN TABLETS,JAMP PHARMA CORPORATION,Gabapentin,GABAPENTIN,600MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2016/9/15,2017/5/8,2017/7/5,Disruption of the manufacture of the drug.,2017/3/20,2017/8/8,No
3573,2402297,Shortage,JAMP-GABAPENTIN TABLETS,JAMP PHARMA CORPORATION,Gabarentin,GABAPENTIN,800MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2016/9/15,2017/9/30,2017/10/9,Disruption of the manufacture of the drug.,2017/3/20,2017/10/10,No
3805,2373912,Shortage,JAMP-INDAPAMIDE,JAMP PHARMA CORPORATION,Indapamide,INDAPAMIDE,2.5MG,100,ORAL,Actual shortage,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",,2016/9/15,2020/12/31,,Other (Please describe in comments),2017/3/21,2018/12/19,No
3810,2373912,Shortage,JAMP-INDAPAMIDE,JAMP PHARMA CORPORATION,Indapamide,INDAPAMIDE,2.5MG,30,ORAL,Actual shortage,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",,2016/9/15,2020/12/31,,Other (Please describe in comments),2017/3/21,2018/12/19,No
3813,2373912,Shortage,JAMP-INDAPAMIDE,JAMP PHARMA CORPORATION,Indapamide,INDAPAMIDE,2.5MG,30,ORAL,Actual shortage,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",,2016/9/15,2020/12/31,,Other (Please describe in comments),2017/3/21,2018/12/19,No
3580,2373904,Shortage,JAMP-INDAPAMIDE,JAMP PHARMA CORPORATION,Indapamide,INDAPAMIDE,1.25MG,100,ORAL,Actual shortage,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",,2016/9/15,2020/12/31,,Other (Please describe in comments),2017/3/20,2020/2/18,No
4427,2418215,Shortage,JAMP-IRBESARTAN,JAMP PHARMA CORPORATION,Irbesartan Tablets,IRBESARTAN,300MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2016/9/15,2017/6/30,2017/7/5,Disruption of the manufacture of the drug.,2017/3/27,2017/8/8,No
4430,2418231,Shortage,JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE,JAMP PHARMA CORPORATION,Irbesartan Hydrochlorothiazide Tablets,HYDROCHLOROTHIAZIDE IRBESARTAN,12.5MG 300MG,28,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2016/9/15,2017/8/31,2017/9/26,Disruption of the manufacture of the drug.,2017/3/27,2017/9/27,No
4434,2418258,Shortage,JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE,JAMP PHARMA CORPORATION,Irbesartan Hydrochlorothiazide Tablets,HYDROCHLOROTHIAZIDE IRBESARTAN,25MG 300MG,28,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2016/9/15,2017/8/31,2017/4/28,Disruption of the manufacture of the drug.,2017/3/27,2017/8/8,No
4437,2418223,Shortage,JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE,JAMP PHARMA CORPORATION,Irbesartan Hydrochlorothiazide Tablets,HYDROCHLOROTHIAZIDE IRBESARTAN,12.5MG 150MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2016/9/15,,2017/8/31,2017/9/26,Disruption of the manufacture of the drug.,2017/3/27,2017/9/27,No
4441,2418231,Shortage,JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE,JAMP PHARMA CORPORATION,Irbesartan Hydrochlorothiazide Tablets,HYDROCHLOROTHIAZIDE IRBESARTAN,12.5MG 300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2016/9/15,2017/8/31,2017/9/26,Disruption of the manufacture of the drug.,2017/3/27,2017/9/27,No
4444,2418258,Shortage,JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE,JAMP PHARMA CORPORATION,Irbesartan Hydrochlorothiazide Tablets,HYDROCHLOROTHIAZIDE IRBESARTAN,25MG 300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2016/9/15,2017/8/31,2017/4/28,Disruption of the manufacture of the drug.,2017/3/27,2017/8/8,No
23901,2408244,Shortage,JAMP-LOSARTAN HCTZ,JAMP PHARMA CORPORATION,Losartan HCTZ,HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM,12.5MG 50MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/9/1,,2018/5/18,Disruption of the manufacture of the drug.,2017/9/29,2018/5/19,No
23905,2408252,Shortage,JAMP-LOSARTAN HCTZ,JAMP PHARMA CORPORATION,Losartan HCTZ,HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM,25MG 100MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/9/1,,2018/5/1,Disruption of the manufacture of the drug.,2017/9/29,2018/5/2,No
23908,2408244,Shortage,JAMP-LOSARTAN HCTZ,JAMP PHARMA CORPORATION,Losartan HCTZ,HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM,12.5MG 50MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/9/1,,2018/5/18,Disruption of the manufacture of the drug.,2017/9/29,2018/5/19,No
23918,2408252,Shortage,JAMP-LOSARTAN HCTZ,JAMP PHARMA CORPORATION,Losartan HCTZ,HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM,25MG 100MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/9/1,,2018/5/18,Disruption of the manufacture of the drug.,2017/9/29,2018/5/19,No
4836,2419173,Shortage,JAMP-METHOTREXATE,JAMP PHARMA CORPORATION,Methotrexate Solution,METHOTREXATE,25MG,5x2,"INTRA-ARTERIAL
INTRAMUSCULAR
INTRATHECAL
INTRAVENOUS",Resolved,SOLUTION,L01BA,ANTIMETABOLITES,,2016/9/15,,2020/9/4,Disruption of the manufacture of the drug.,2017/3/30,2020/10/9,No
29952,2356813,Shortage,JAMP-METOPROLOL-L,JAMP PHARMA CORPORATION,Metoprolol-l,METOPROLOL TARTRATE,25MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/11/20,,2018/5/29,Disruption of the manufacture of the drug.,2017/11/21,2018/5/30,No
29937,2356848,Shortage,JAMP-METOPROLOL-L,JAMP PHARMA CORPORATION,Metoprolol-l 100mg,METOPROLOL TARTRATE,100MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/11/20,,2018/1/29,Disruption of the manufacture of the drug.,2017/11/21,2018/1/30,No
29941,2356848,Shortage,JAMP-METOPROLOL-L,JAMP PHARMA CORPORATION,Metoprolol-l,METOPROLOL TARTRATE,100MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/11/20,,2018/1/29,Disruption of the manufacture of the drug.,2017/11/21,2018/1/30,No
29946,2356813,Shortage,JAMP-METOPROLOL-L,JAMP PHARMA CORPORATION,Metoprolol-l,METOPROLOL TARTRATE,25MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/11/20,,2018/5/29,Disruption of the manufacture of the drug.,2017/11/21,2018/5/30,No
34187,2313685,Shortage,JAMP-ONDANSETRON,JAMP PHARMA CORPORATION,Ondansetron,ONDANSETRON,4MG,10,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017/12/22,,2018/4/27,Disruption of the manufacture of the drug.,2017/12/22,2018/4/28,No
34192,2313693,Shortage,JAMP-ONDANSETRON,JAMP PHARMA CORPORATION,Ondansetron,ONDANSETRON,8MG,10,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017/12/22,,2018/4/27,Disruption of the manufacture of the drug.,2017/12/22,2018/4/28,No
4839,2420422,Shortage,JAMP-ONDANSETRON,JAMP PHARMA CORPORATION,Ondansetron,ONDANSETRON,2MG,20ml,INTRAVENOUS,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2016/9/21,,2018/7/4,Disruption of the manufacture of the drug.,2017/3/30,2018/7/5,No
4842,2420414,Shortage,JAMP-ONDANSETRON,JAMP PHARMA CORPORATION,Ondansetron,ONDANSETRON,2MG,5x2ml,INTRAVENOUS,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2016/12/2,,2018/7/31,Disruption of the manufacture of the drug.,2017/3/30,2018/8/1,No
34198,2440717,Shortage,JAMP-OXCARBAZEPINE,JAMP PHARMA CORPORATION,Oxcarbazepine,OXCARBAZEPINE,150MG,100,ORAL,Resolved,TABLET,N03AF,ANTIEPILEPTICS,,2017/12/22,,2018/5/18,Disruption of the manufacture of the drug.,2017/12/22,2018/5/19,No
34206,2440725,Shortage,JAMP-OXCARBAZEPINE,JAMP PHARMA CORPORATION,Oxcarbazepine,OXCARBAZEPINE,300MG,100,ORAL,Resolved,TABLET,N03AF,ANTIEPILEPTICS,,2017/12/22,,2018/5/18,Disruption of the manufacture of the drug.,2017/12/22,2018/5/19,No
30028,2365529,Shortage,JAMP-PIOGLITAZONE,JAMP PHARMA CORPORATION,Pioglitazone 30mg,PIOGLITAZONE,30MG,90,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/11/20,,2019/6/28,Disruption of the manufacture of the drug.,2017/11/21,2019/7/8,No
30031,2365537,Shortage,JAMP-PIOGLITAZONE,JAMP PHARMA CORPORATION,Pioglitazone 45mg,PIOGLITAZONE,45MG,90,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/11/20,,2019/6/28,Disruption of the manufacture of the drug.,2017/11/21,2019/7/8,No
4741,2330970,Shortage,JAMP-PRAVASTATIN,JAMP PHARMA CORPORATION,Pravastatin Sodium  Tablets,PRAVASTATIN SODIUM,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2016/12/20,2017/6/30,2017/7/5,Shortage of an active ingredient.,2017/3/30,2017/8/8,No
4761,2330954,Shortage,JAMP-PRAVASTATIN,JAMP PHARMA CORPORATION,Pravastatin Sodium Tablets,PRAVASTATIN SODIUM,10MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/1/31,2017/6/30,2017/7/5,Shortage of an active ingredient.,2017/3/30,2017/8/8,No
4768,2330962,Shortage,JAMP-PRAVASTATIN,JAMP PHARMA CORPORATION,Pravastatin Sodium Tablets,PRAVASTATIN SODIUM,20MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/1/26,2017/6/30,2017/7/5,Shortage of an active ingredient.,2017/3/30,2017/8/8,No
29963,2445190,Shortage,JAMP-QUININE,JAMP PHARMA CORPORATION,Quinine 200mg,QUININE SULFATE,200MG,100,ORAL,Resolved,CAPSULE,P01BC,ANTIMALARIALS,,2017/11/20,,2018/2/19,Disruption of the manufacture of the drug.,2017/11/21,2018/2/20,No
29966,2445190,Shortage,JAMP-QUININE,JAMP PHARMA CORPORATION,Quinine 200mg,QUININE SULFATE,200MG,500,ORAL,Resolved,CAPSULE,P01BC,ANTIMALARIALS,,2017/11/20,,2018/8/6,Disruption of the manufacture of the drug.,2017/11/21,2018/8/7,No
29975,2445204,Shortage,JAMP-QUININE,JAMP PHARMA CORPORATION,Quinine 300mg,QUININE SULFATE,300MG,500,ORAL,Resolved,CAPSULE,P01BC,ANTIMALARIALS,,2017/11/20,,2018/2/19,Disruption of the manufacture of the drug.,2017/11/21,2018/2/20,No
29978,2445204,Shortage,JAMP-QUININE,JAMP PHARMA CORPORATION,Quinine 300mg,QUININE SULFATE,300MG,100,ORAL,Resolved,CAPSULE,P01BC,ANTIMALARIALS,,2017/11/20,,2018/2/19,Disruption of the manufacture of the drug.,2017/11/21,2018/2/20,No
6664,2440334,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril,RAMIPRIL,15MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/4/1,,2018/8/6,Disruption of the manufacture of the drug.,2017/4/12,2018/8/7,No
23927,2331128,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril Capsule,RAMIPRIL,2.5MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/9/1,2017/11/15,2017/11/8,Disruption of the manufacture of the drug.,2017/9/29,2017/11/9,No
23931,2331136,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril Capsule,RAMIPRIL,5MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/9/1,2017/11/15,2017/11/15,Disruption of the manufacture of the drug.,2017/9/29,2017/11/16,No
23937,2331144,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril Capsule,RAMIPRIL,10MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/9/1,2017/11/15,2017/11/15,Disruption of the manufacture of the drug.,2017/9/29,2017/11/16,No
23944,2331144,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril Capsule,RAMIPRIL,10MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/9/1,2017/11/15,2017/11/15,Disruption of the manufacture of the drug.,2017/9/29,2017/11/16,No
23950,2331136,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril Capsule,RAMIPRIL,5MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/9/1,2017/11/15,2017/11/15,Disruption of the manufacture of the drug.,2017/9/29,2017/11/16,No
23958,2331128,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril Capsule,RAMIPRIL,2.5MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/9/1,2017/11/15,2017/11/8,Disruption of the manufacture of the drug.,2017/9/29,2017/11/9,No
23964,2331136,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril Capsule - Blister,RAMIPRIL,5MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/9/1,2017/11/15,2017/11/15,Disruption of the manufacture of the drug.,2017/9/29,2017/11/16,No
23970,2331144,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril Capsule - Blister,RAMIPRIL,10MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/9/1,2017/11/15,2017/11/15,Disruption of the manufacture of the drug.,2017/9/29,2017/11/16,No
4771,2331101,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril Capsules,RAMIPRIL,1.25MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2016/9/8,,2018/11/19,Disruption of the manufacture of the drug.,2017/3/30,2018/11/27,No
23973,2331128,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril Capsule - Blister,RAMIPRIL,2.5MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/9/1,2017/11/15,2017/11/8,Disruption of the manufacture of the drug.,2017/9/29,2017/11/9,No
4777,2359529,Shortage,JAMP-RISPERIDONE,JAMP PHARMA CORPORATION,Risperidone Tablets,RISPERIDONE,0.25MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2016/9/15,2017/8/31,2017/10/2,Disruption of the manufacture of the drug.,2017/3/30,2017/10/3,No
4782,2359537,Shortage,JAMP-RISPERIDONE,JAMP PHARMA CORPORATION,Risperidone Tablets,RISPERIDONE,0.50MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2016/9/15,2017/8/31,2017/10/2,Disruption of the manufacture of the drug.,2017/3/30,2017/10/3,No
4786,2359553,Shortage,JAMP-RISPERIDONE,JAMP PHARMA CORPORATION,Risperidone Tablets,RISPERIDONE,2.0MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2016/9/15,2017/8/31,2017/9/26,Disruption of the manufacture of the drug.,2017/3/30,2017/9/27,No
4789,2359553,Shortage,JAMP-RISPERIDONE,JAMP PHARMA CORPORATION,Risperidone Tablets,RISPERIDONE,2.0MG,60,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2016/9/15,2018/1/1,2017/9/26,Disruption of the manufacture of the drug.,2017/3/30,2017/9/27,No
4791,2359588,Shortage,JAMP-RISPERIDONE,JAMP PHARMA CORPORATION,Risperidone Tablets,RISPERIDONE,4.0MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2016/9/15,2017/8/31,2017/9/26,Disruption of the manufacture of the drug.,2017/3/30,2017/9/27,No
4796,2359545,Shortage,JAMP-RISPERIDONE,JAMP PHARMA CORPORATION,Risperidone Tablets,RISPERIDONE,1.0MG,60,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2016/9/15,2018/1/1,2017/9/26,Disruption of the manufacture of the drug.,2017/3/30,2017/9/27,No
4800,2359588,Shortage,JAMP-RISPERIDONE,JAMP PHARMA CORPORATION,Risperidone Tablets,RISPERIDONE,4.0MG,60,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2016/11/15,2018/1/1,2017/9/26,Disruption of the manufacture of the drug.,2017/3/30,2017/9/27,No
4803,2359561,Shortage,JAMP-RISPERIDONE,JAMP PHARMA CORPORATION,Risperidone Tablets,RISPERIDONE,3.0MG,60,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2014/9/15,2018/1/1,2017/9/26,Disruption of the manufacture of the drug.,2017/3/30,2017/9/27,No
30025,2352362,Shortage,JAMP-ROPINIROLE,JAMP PHARMA CORPORATION,Ropinirole 5mg,ROPINIROLE,5.0MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2017/11/20,,2019/7/2,Disruption of the manufacture of the drug.,2017/11/21,2019/7/8,No
4806,2352362,Shortage,JAMP-ROPINIROLE,JAMP PHARMA CORPORATION,Ropinole Tablets,ROPINIROLE,5.0MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2016/9/15,2017/5/8,2017/7/5,Disruption of the manufacture of the drug.,2017/3/30,2017/8/8,No
4809,2352346,Shortage,JAMP-ROPINIROLE,JAMP PHARMA CORPORATION,Ropinirole Tablets,ROPINIROLE,1.0MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2016/9/15,2017/6/30,2017/7/5,Disruption of the manufacture of the drug.,2017/3/30,2017/7/12,No
23976,2391287,Shortage,JAMP-ROSUVASTATIN,JAMP PHARMA CORPORATION,Rosuvastatin,ROSUVASTATIN,40.0MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/9/1,,2018/2/19,Disruption of the manufacture of the drug.,2017/9/29,2018/2/20,No
23980,2391287,Shortage,JAMP-ROSUVASTATIN,JAMP PHARMA CORPORATION,Rosuvastatin,ROSUVASTATIN,40.0MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/9/1,,2018/2/19,Disruption of the manufacture of the drug.,2017/9/29,2018/2/20,No
34221,2391260,Shortage,JAMP-ROSUVASTATIN,JAMP PHARMA CORPORATION,Rosuvastatin,ROSUVASTATIN,10.0MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/12/22,,2018/2/19,Disruption of the manufacture of the drug.,2017/12/22,2018/2/20,No
23983,2391279,Shortage,JAMP-ROSUVASTATIN,JAMP PHARMA CORPORATION,Rosuvastatin,ROSUVASTATIN,20.0MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/9/1,,2018/2/19,Disruption of the manufacture of the drug.,2017/9/29,2018/2/20,No
23988,2391252,Shortage,JAMP-ROSUVASTATIN,JAMP PHARMA CORPORATION,Rosuvastatin,ROSUVASTATIN,5MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/9/1,,2018/2/19,Disruption of the manufacture of the drug.,2017/9/29,2018/2/20,No
34235,2391260,Shortage,JAMP-ROSUVASTATIN,JAMP PHARMA CORPORATION,Rosuvastatin,ROSUVASTATIN,10.0MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/12/22,,2018/2/19,Disruption of the manufacture of the drug.,2017/12/22,2018/2/20,No
34239,2391279,Shortage,JAMP-ROSUVASTATIN,JAMP PHARMA CORPORATION,Rosuvastatin,ROSUVASTATIN,20.0MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/12/22,,2018/2/19,Disruption of the manufacture of the drug.,2017/12/22,2018/2/20,No
34242,2391252,Shortage,JAMP-ROSUVASTATIN,JAMP PHARMA CORPORATION,Rosuvastatin,ROSUVASTATIN,5MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/12/22,,2018/2/19,Disruption of the manufacture of the drug.,2017/12/22,2018/2/20,No
4812,2375591,Shortage,JAMP-SIMVASTATIN,JAMP PHARMA CORPORATION,Simvastatin Tablets,SIMVASTATIN,5MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/9/15,,2018/10/15,Disruption of the manufacture of the drug.,2017/3/30,2018/10/16,No
4815,2375648,Shortage,JAMP-SIMVASTATIN,JAMP PHARMA CORPORATION,Simvastatin Tablets,SIMVASTATIN,80MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2016/9/15,,2018/10/15,Disruption of the manufacture of the drug.,2017/3/30,2018/10/16,No
30034,2368617,Shortage,JAMP-SOTALOL,JAMP PHARMA CORPORATION,Sotalol 80mg,SOTALOL HYDROCHLORIDE,80MG,100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2017/11/20,,2018/4/16,Disruption of the manufacture of the drug.,2017/11/21,2018/4/17,No
30037,2368617,Shortage,JAMP-SOTALOL,JAMP PHARMA CORPORATION,Sotalol,SOTALOL HYDROCHLORIDE,80MG,500,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2017/11/20,,2018/8/6,Disruption of the manufacture of the drug.,2017/11/21,2018/8/7,No
30040,2368625,Shortage,JAMP-SOTALOL,JAMP PHARMA CORPORATION,Sotalol,SOTALOL HYDROCHLORIDE,160MG,100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2017/11/20,,2018/7/4,Disruption of the manufacture of the drug.,2017/11/21,2018/7/5,No
30011,2451824,Shortage,JAMP-TADALAFIL,JAMP PHARMA CORPORATION,Tadalafil 2.5mg,TADALAFIL,2.5MG,7 x 4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/11/20,,2018/8/6,Disruption of the manufacture of the drug.,2017/11/21,2018/8/7,No
30014,2451832,Shortage,JAMP-TADALAFIL,JAMP PHARMA CORPORATION,Jamp-Tadalafil,TADALAFIL,5MG,7 x 4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/11/20,,2018/2/19,Disruption of the manufacture of the drug.,2017/11/21,2018/2/20,No
30017,2451840,Shortage,JAMP-TADALAFIL,JAMP PHARMA CORPORATION,Tadalafil 10mg,TADALAFIL,10MG,1 x 4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/11/20,,2018/2/12,Disruption of the manufacture of the drug.,2017/11/21,2018/2/13,No
34247,2451859,Shortage,JAMP-TADALAFIL,JAMP PHARMA CORPORATION,Tadalafil,TADALAFIL,20MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/12/22,,2018/2/12,Disruption of the manufacture of the drug.,2017/12/22,2018/2/13,No
4818,2357070,Shortage,JAMP-TERBINAFINE,JAMP PHARMA CORPORATION,Terbinafine Tablets,TERBINAFINE,250MG,30,ORAL,Actual shortage,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,,2016/9/15,2020/12/31,,Disruption of the manufacture of the drug.,2017/3/30,2020/2/18,No
4821,2357070,Shortage,JAMP-TERBINAFINE,JAMP PHARMA CORPORATION,Terbinafine Tablets,TERBINAFINE,250MG,100,ORAL,Actual shortage,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,,2017/9/15,2020/12/31,,Disruption of the manufacture of the drug.,2017/3/30,2018/12/19,No
4845,2420287,Shortage,JAMP-TOBRAMYCIN,JAMP PHARMA CORPORATION,Tobramycin,TOBRAMYCIN,40MG,10x2,"INTRAMUSCULAR
INTRAVENOUS",Actual shortage,LIQUID,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,,2016/9/21,2020/12/31,,Disruption of the manufacture of the drug.,2017/3/30,2018/12/19,No
4848,2420287,Shortage,JAMP-TOBRAMYCIN,JAMP PHARMA CORPORATION,Tobramycin,TOBRAMYCIN,40MG,1x30,"INTRAMUSCULAR
INTRAVENOUS",Actual shortage,LIQUID,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,,2016/10/31,2020/12/31,,Disruption of the manufacture of the drug.,2017/3/30,2018/12/19,No
23993,2435608,Shortage,JAMP-TOPIRAMATE,JAMP PHARMA CORPORATION,Topiramate,TOPIRAMATE,25MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/9/25,,2017/11/27,Disruption of the manufacture of the drug.,2017/9/29,2017/11/28,No
23996,2441454,Shortage,JAMP-VALACYCLOVIR,JAMP PHARMA CORPORATION,Valacyclovir,VALACYCLOVIR,500MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/9/15,,2018/10/12,Disruption of the manufacture of the drug.,2017/9/29,2018/10/15,No
30022,2449110,Shortage,JAMP-VITAMIN D,JAMP PHARMA CORPORATION,Vitamine D 50000 UI,VITAMIN D3,50000UNIT,100,ORAL,Resolved,CAPSULE,A11CC,"VIT A AND D, INCL COMBINATIONS OF THE TWO",,2017/11/20,,2018/4/16,Disruption of the manufacture of the drug.,2017/11/21,2018/4/17,No
4447,2387239,Shortage,JAMPZINC-HC,JAMP PHARMA CORPORATION,Zinc Sulfate Monohydrate + Hydrocortisone Acetate ointment,Zinc sulfate monohydrate HYDROCORTISONE ACETATE,0.5% 0.5%,30g,"RECTAL
TOPICAL",Resolved,OINTMENT,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,,2016/11/22,2017/5/12,2017/6/9,Disruption of the manufacture of the drug.,2017/3/27,2017/6/10,No
14703,2303922,Shortage,JANUVIA,MERCK CANADA INC,sitagliptin tablets (as sitagliptin phosphate monohydrate),SITAGLIPTIN,100MG,100 tab,ORAL,Resolved,TABLET,A10BH,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017/7/5,2017/7/5,2017/7/14,2017/7/14,Delay in shipping of the drug.,2017/7/5,2017/7/15,No
15836,2303922,Shortage,JANUVIA,MERCK CANADA INC,sitagliptin tablets (as sitagliptin phosphate monohydrate),SITAGLIPTIN,100MG,100 tab,ORAL,Resolved,TABLET,A10BH,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017/7/18,2017/7/6,2017/7/20,2017/7/24,Delay in shipping of the drug.,2017/7/17,2017/10/11,No
29207,2441306,Shortage,JENCYCLA,SANDOZ CANADA INCORPORATED,JENCYCLA,NORETHINDRONE,0.35MG,BLISTERS 28'S,ORAL,Resolved,TABLET,G03AC,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2017/11/13,2017/12/4,2017/12/11,Demand increase for the drug.,2017/11/14,2017/12/15,No
16744,2441306,Shortage,JENCYCLA,SANDOZ CANADA INCORPORATED,JENCYCLA,NORETHINDRONE,0.35MG,28,ORAL,Resolved,TABLET,G03AC,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2017/7/7,2017/10/27,2017/10/27,Delay in shipping of the drug.,2017/7/24,2017/10/28,No
19958,2410818,Shortage,JETREA,ALCON CANADA INC,solution for intravitreal injection,OCRIPLASMIN,2.5MG,0.2mL,INTRAVITREAL,Resolved,SOLUTION,S01XA,OTHER OPHTHALMOLOGICALS,2017/8/21,2017/8/21,,2017/8/31,Delay in shipping of the drug.,2017/8/21,2017/9/1,No
32010,2242163,Shortage,KADIAN,BGP PHARMA ULC,KADIAN,MORPHINE SULFATE,10MG,100,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),N02AA,OPIOIDS,,2017/12/7,,2017/12/7,Requirements related to complying with good manufacturing practices.,2017/12/7,2017/12/8,No
33593,2242163,Shortage,KADIAN,BGP PHARMA ULC,KADIAN,MORPHINE SULFATE,10MG,100,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),N02AA,OPIOIDS,2017/12/29,,2018/1/5,2017/12/29,Delay in shipping of the drug.,2017/12/18,2018/1/3,No
20585,2242163,Shortage,KADIAN,BGP PHARMA ULC,Morphine ER,MORPHINE SULFATE,10MG,100,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),N02AA,OPIOIDS,,2017/10/2,,2017/10/3,Delay in shipping of the drug.,2017/8/29,2017/10/4,No
20588,2184435,Shortage,KADIAN,BGP PHARMA ULC,Morphine ER,MORPHINE SULFATE,20MG,100,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),N02AA,OPIOIDS,2018/4/6,2018/4/6,2018/5/9,2018/5/9,Demand increase for the drug.,2017/8/29,2018/5/10,No
3704,2184435,Shortage,KADIAN,BGP PHARMA ULC,Kadian,MORPHINE SULFATE,20MG,100s,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),N02AA,OPIOIDS,2017/4/11,,,2017/4/11,Requirements related to complying with good manufacturing practices.,2017/3/20,2017/4/12,No
30923,2184451,Shortage,KADIAN,BGP PHARMA ULC,KADIAN,MORPHINE SULFATE,100MG,50,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),N02AA,OPIOIDS,2018/4/3,2018/3/29,2018/4/6,2018/4/3,Demand increase for the drug.,2017/11/28,2018/4/4,No
28368,2184443,Shortage,KADIAN,BGP PHARMA ULC,KADIAN,MORPHINE SULFATE,50MG,100,ORAL,Avoided shortage,CAPSULE (SUSTAINED-RELEASE),N02AA,OPIOIDS,2017/11/22,,,2017/11/20,Delay in shipping of the drug.,2017/11/6,2017/11/20,No
31054,2246795,Shortage,KETAMINE HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,KETAMINE,KETAMINE,10MG,1 VIAL,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,N01AX,"ANESTHETICS, GENERAL",,2017/11/13,2017/12/4,2017/12/11,Requirements related to complying with good manufacturing practices.,2017/11/29,2017/12/15,No
34394,2245662,Shortage,KETODERM CREAM 2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Taro Pharmaceuticals Ketoderm Cream,KETOCONAZOLE,2%,30,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,,2018/8/2,2018/8/17,2018/8/30,Disruption of the manufacture of the drug.,2017/12/27,2018/9/7,No
3758,790427,Shortage,KETOPROFEN,AA PHARMA INC,KETOPROFEN,KETOPROFEN,50MG,100 Bottle,ORAL,Resolved,CAPSULE,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2016/9/13,,,2019/7/31,Disruption of the manufacture of the drug.,2017/3/21,2020/8/6,No
2621,2239944,Shortage,KETOROLAC TROMETHAMINE INJECTION USP,SANDOZ CANADA INCORPORATED,KETOROLAC Trometh,KETOROLAC TROMETHAMINE,30MG,10x1mL fiole/vial,INTRAMUSCULAR,Resolved,LIQUID,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2015/10/30,2017/4/17,2017/4/11,Requirements related to complying with good manufacturing practices.,2017/3/14,2017/4/12,No
12797,2400871,Shortage,KETOTIFEN OPHTHALMIC SOLUTION,STERIMAX INC,KETOTIFEN OPHTHALMIC SOLUTION,KETOTIFEN,0.25MG,1 BOTTLE,OPHTHALMIC,Resolved,SOLUTION,S01GX,DECONGESTANTS AND ANTIALLERGICS,,2017/6/13,,2017/8/14,Other (Please describe in comments),2017/6/15,2017/8/15,No
27239,2231689,Shortage,LABETALOL HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,LABETALOL,LABETALOL HYDROCHLORIDE,5MG,10 X 25ml VIALS,INTRAVENOUS,Resolved,LIQUID,C07AG,BETA BLOCKING AGENTS,,2017/10/20,2017/11/17,2017/11/13,Requirements related to complying with good manufacturing practices.,2017/10/27,2017/11/19,No
14740,2391090,Shortage,LABETALOL HYDROCHLORIDE INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,LABETALOL HYDROCHLORIDE,LABETALOL HYDROCHLORIDE,5MG,1X20ML,INTRAVENOUS,Resolved,SOLUTION,C07AG,BETA BLOCKING AGENTS,,2017/10/5,,2017/11/13,Other (Please describe in comments),2017/7/5,2017/12/15,No
10718,2387468,Shortage,"LABETALOL HYDROCHLORIDE INJECTION, USP",MYLAN PHARMACEUTICALS ULC,"LABETALOL HYDROCHLORIDE INJECTION, USP",LABETALOL HYDROCHLORIDE,5MG,20ML 1VL,INTRAVENOUS,Resolved,SOLUTION,C07AG,BETA BLOCKING AGENTS,2017/5/1,2018/5/5,,2019/3/8,Disruption of the manufacture of the drug.,2017/5/19,2019/3/9,No
24738,39470,Shortage,LACTATED RINGER'S INJECTION,HOSPIRA HEALTHCARE CORPORATION,Lactated Ringer’s Injection USP,SODIUM LACTATE CALCIUM CHLORIDE POTASSIUM CHLORIDE SODIUM CHLORIDE,3.1MG 0.2MG 0.3MG 6MG,1000ml,INTRAVENOUS,Resolved,SOLUTION,B05BB,I.V. SOLUTIONS,2017/10/6,,2017/11/11,2017/10/30,Demand increase for the drug.,2017/10/6,2017/10/31,No
22120,2142082,Shortage,LAMICTAL,GLAXOSMITHKLINE INC,Lamotrigine tablets,LAMOTRIGINE,25MG,100's,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018/1/11,2018/2/26,2018/2/15,Shortage of an active ingredient.,2017/9/14,2018/2/16,No
20136,2142112,Shortage,LAMICTAL,GLAXOSMITHKLINE INC,Lamotrigine tablets,LAMOTRIGINE,150MG,60's,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/10/26,2018/3/20,2018/3/15,Shortage of an active ingredient.,2017/8/23,2018/3/16,No
12467,2240115,Shortage,LAMICTAL,GLAXOSMITHKLINE INC,Lamotrigine chewable/dispersible tablets,LAMOTRIGINE,5MG,28's,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/7/17,2017/9/7,2017/9/8,Shortage of an active ingredient.,2017/6/9,2017/9/13,No
8275,2385767,Shortage,LANSOPRAZOLE,SIVEM PHARMACEUTICALS ULC,LANSOPRAZOLE,LANSOPRAZOLE,15MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/5/3,,2017/5/15,2017/5/15,Demand increase for the drug.,2017/4/27,2017/5/18,No
14792,2366282,Shortage,LANSOPRAZOLE,PRO DOC LIMITEE,LANSOPRAZOLE,LANSOPRAZOLE,30MG,100-500,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/7/17,2017/10/17,2017/10/18,Delay in shipping of the drug.,2017/7/5,2017/10/19,No
22773,2433028,Shortage,LANSOPRAZOLE,PHARMASCIENCE INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/9/15,2017/9/25,2017/10/9,Disruption of the manufacture of the drug.,2017/9/19,2017/10/11,No
14489,2183005,Shortage,LEUCOVORIN CALCIUM INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,Levoleucovorin Calcium,LEUCOVORIN,10MG,1x 5mL VIAL / AMPOULE,"INTRAMUSCULAR
INTRAVENOUS",Resolved,LIQUID,V03AF,ALL OTHER THERAPEUTIC PRODUCTS,2017/7/10,,2017/10/18,2017/10/17,Disruption of the manufacture of the drug.,2017/7/3,2017/10/18,No
2522,2182998,Shortage,LEUCOVORIN CALCIUM INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,Levoleucovorin Calcium,LEUCOVORIN,10MG,1 x 50mL,INTRAVENOUS,Resolved,LIQUID,V03AF,ALL OTHER THERAPEUTIC PRODUCTS,2017/3/14,2017/4/5,2017/7/6,2017/7/6,Disruption of the manufacture of the drug.,2017/3/14,2017/7/11,No
22279,4626,Shortage,LEUKERAN,ASPEN PHARMACARE CANADA INC.,Leukeran®,CHLORAMBUCIL,2MG,25 tablets,ORAL,Resolved,TABLET,L01AA,ALKYLATINGAGENTS,,2017/9/18,2017/10/27,2017/10/31,Delay in shipping of the drug.,2017/9/18,2017/11/16,No
27719,271152,Shortage,LEVATE,BIOMED PHARMA,Amitriptyline Hydrochloride Tablets 50 mg,,,100,,Actual shortage,,,,,2014/10/23,,,Other (Please describe in comments),2017/11/1,2017/11/1,No
27733,306320,Shortage,LEVATE,BIOMED PHARMA,Amitriptyline Hydrochloride Tablets 25 mg,,,100,,Actual shortage,,,,,2014/10/23,,,Other (Please describe in comments),2017/11/1,2017/11/1,No
27744,405612,Shortage,LEVATE,BIOMED PHARMA,Amitriptyline Hydrochloride Tablets 75 mg,,,100,,Actual shortage,,,,,2014/10/23,,,Other (Please describe in comments),2017/11/1,2017/11/1,No
26818,293911,Shortage,LEVATE,BIOMED PHARMA,Amitriptyline Hydrochloride,,,100,,Actual shortage,,,,2014/10/23,2014/10/23,,,Other (Please describe in comments),2017/10/24,2017/10/26,No
25856,2353342,Shortage,LEVETIRACETAM,SANIS HEALTH INC,LEVETIRACETAM,LEVETIRACETAM,250MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017/10/20,,2017/11/10,2017/11/9,Other (Please describe in comments),2017/10/13,2017/11/10,No
28226,2442566,Shortage,LEVETIRACETAM,SIVEM PHARMACEUTICALS ULC,LEVETIRACETAM,LEVETIRACETAM,750MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017/11/13,2017/11/8,2018/4/27,2018/4/27,Other (Please describe in comments),2017/11/6,2018/4/30,No
27549,2353350,Shortage,LEVETIRACETAM,SANIS HEALTH INC,LEVETIRACETAM TAB,LEVETIRACETAM,500MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017/11/7,,2017/11/30,2017/11/9,Other (Please describe in comments),2017/10/31,2017/11/10,No
30910,2353369,Shortage,LEVETIRACETAM,SANIS HEALTH INC,LEVETIRACETAM TABS,LEVETIRACETAM,750MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017/12/4,,2017/12/29,2017/12/15,Other (Please describe in comments),2017/11/28,2017/12/16,No
26763,2314932,Shortage,LEVOFLOXACIN IN 5% DEXTROSE INJECTION,PFIZER CANADA INC,LEVOFLOXACIN,LEVOFLOXACIN,5MG,24 X 50 mL,INTRAVENOUS,Resolved,SOLUTION,J01MA,QUINOLONE ANTIBACTERIALS,,2017/10/31,,2018/2/2,Disruption of the manufacture of the drug.,2017/10/23,2018/2/3,No
26767,2314932,Shortage,LEVOFLOXACIN IN 5% DEXTROSE INJECTION,PFIZER CANADA INC,LEVOFLOXACIN,LEVOFLOXACIN,5MG,24 X 150 mL,INTRAVENOUS,Resolved,SOLUTION,J01MA,QUINOLONE ANTIBACTERIALS,,2017/10/20,,2017/12/20,Disruption of the manufacture of the drug.,2017/10/23,2017/12/21,No
1184,2314932,Shortage,LEVOFLOXACIN IN 5% DEXTROSE INJECTION,HOSPIRA HEALTHCARE CORPORATION,Levofloxacin,LEVOFLOXACIN,5MG,250mg / 50mL x 24  &  500mg/100mL x 24  &  750mg/150mL x24,INTRAVENOUS,Resolved,SOLUTION,J01MA,QUINOLONE ANTIBACTERIALS,,2015/11/9,2017/6/14,2017/6/14,Disruption of the manufacture of the drug.,2017/3/13,2017/6/15,No
26807,2314932,Shortage,LEVOFLOXACIN IN 5% DEXTROSE INJECTION,PFIZER CANADA INC,LEVOFLOXACIN,LEVOFLOXACIN,5MG,24 X 100 mL,INTRAVENOUS,Resolved,SOLUTION,J01MA,QUINOLONE ANTIBACTERIALS,,2017/10/20,2017/12/7,2017/12/7,Disruption of the manufacture of the drug.,2017/10/24,2017/12/8,No
1369,2241981,Shortage,LEVOPHED 1.0 MG/ML,HOSPIRA HEALTHCARE CORPORATION,Levophed,NOREPINEPHRINE,1MG,4 mg/4 mL x 10,INTRAVENOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017/3/8,2017/5/29,2017/5/29,Shortage of an active ingredient.,2017/3/13,2017/6/1,No
14743,2241981,Shortage,LEVOPHED 1.0 MG/ML,HOSPIRA HEALTHCARE CORPORATION,LEVOPHED,NOREPINEPHRINE,1MG,10x4ML,INTRAVENOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017/8/21,,2018/6/6,Other (Please describe in comments),2017/7/5,2018/6/7,No
12390,2161923,Shortage,LIDEX,VALEANT CANADA LP/VALEANT CANADA S.E.C.,LIDEX,FLUOCINONIDE,0.05%,na,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2017/6/9,,2017/7/21,Other (Please describe in comments),2017/6/9,2017/7/22,No
3278,2161974,Shortage,LIDEX,VALEANT CANADA LP/VALEANT CANADA S.E.C.,LIDEX,FLUOCINONIDE,0.05%,60G,TOPICAL,Resolved,GEL,D07AC,"CORTICOSTEROIDS, PLAIN",,2016/12/1,2017/4/7,2017/4/7,Disruption of the manufacture of the drug.,2017/3/17,2017/4/8,No
34258,2436221,Shortage,"LIDOCAINE 2% AND EPINEPHRINE 1:100,000 INJECTION",TELIGENT OU,LIDOCAINE AND EPINEPHRINE INJECTION,LIDOCAINE HYDROCHLORIDE EPINEPHRINE,20MG 0.01MG,20 ML,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017/12/8,2018/2/1,2018/2/1,Demand increase for the drug.,2017/12/22,2018/2/15,No
2508,1901958,Shortage,LIDOCAINE HYDROCHLORIDE 1% AND EPINEPHRINE 1:100 000 INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE,LIDOCAINE HYDROCHLORIDE EPINEPHRINE,10MG 10MCG,25x20mL VIAL,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017/3/14,,2018/4/27,Disruption of the manufacture of the drug.,2017/3/14,2018/4/30,No
14509,1901915,Shortage,LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:100 000 INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE,LIDOCAINE HYDROCHLORIDE EPINEPHRINE,20MG 10MCG,25x20mL VIAL/AMPOULE,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017/5/16,,2018/4/3,Disruption of the manufacture of the drug.,2017/7/3,2018/4/4,No
1479,2439468,Shortage,LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:200000 INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,Lidocaine with Epinephrine,LIDOCAINE HYDROCHLORIDE EPINEPHRINE,20MG 0.005MG,20mL x 5,"BLOCK/INFILTRATION
EPIDURAL",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017/2/2,,2017/3/13,Shortage of an inactive ingredient or component.,2017/3/13,2017/6/29,No
2503,2439468,Shortage,LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:200000 INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE,LIDOCAINE HYDROCHLORIDE EPINEPHRINE,20MG 0.005MG,5x20mL VIAL / AMPOULE,"BLOCK/INFILTRATION
EPIDURAL",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017/2/6,,2018/5/30,Disruption of the manufacture of the drug.,2017/3/14,2018/5/31,No
14747,884154,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP 1%,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE HYDROCHLORIDE,LIDOCAINE HYDROCHLORIDE,10MG,10x2ml,BLOCK/INFILTRATION,Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018/4/16,,,2017/9/30,Other (Please describe in comments),2017/7/5,2017/11/24,No
14750,884154,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP 1%,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE HYDROCHLORIDE,LIDOCAINE HYDROCHLORIDE,10MG,5x5ml,BLOCK/INFILTRATION,Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018/6/15,,,2017/9/30,Other (Please describe in comments),2017/7/5,2017/11/24,No
1295,1901982,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP 2%,HOSPIRA HEALTHCARE CORPORATION,Lidocaine,LIDOCAINE HYDROCHLORIDE,20MG,5mL * 10,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2016/11/2,,2019/3/25,Other (Please describe in comments),2017/3/13,2019/3/28,No
30523,1901982,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP 2%,HOSPIRA HEALTHCARE CORPORATION,Lidocaine HCL 2%,LIDOCAINE HYDROCHLORIDE,20MG,25x20mL PVL,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017/12/29,,2018/1/19,Disruption of the manufacture of the drug.,2017/11/23,2018/2/7,No
1029,2167603,Shortage,LIDODAN JELLY 2%(SINGLE USE SYRINGE),ODAN LABORATORIES LTD,"Lidocaine Hydrochloride Jelly, USP",LIDOCAINE HYDROCHLORIDE,2%,10 mL,TOPICAL,Actual shortage,JELLY,D04AB,"ANTIPRURITICS,INCL ANTIHIST,ANESTHET,ETC.",,2016/6/21,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1711,2402637,Shortage,LINEZOLID INJECTION,TEVA CANADA LIMITED,LINEZOLID,LINEZOLID,2MG,10,INTRAVENOUS,Resolved,SOLUTION,J01XX,OTHER ANTIBACTERIALS,,2016/11/1,,2017/9/3,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
13392,2269074,Shortage,LIPIDIL EZ,BGP PHARMA ULC,LIPIDIL EZ,FENOFIBRATE,48MG,3x10,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",2019/1/17,2019/1/17,2019/9/5,2019/10/7,Delay in shipping of the drug.,2017/6/20,2019/10/8,No
3707,2269082,Shortage,LIPIDIL EZ,BGP PHARMA ULC,Lipidil,FENOFIBRATE,145MG,3 times 10,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2017/4/24,,2017/6/14,Requirements related to complying with good manufacturing practices.,2017/3/20,2017/6/15,No
26008,2269074,Shortage,LIPIDIL EZ,BGP PHARMA ULC,LIPIDIL EZ,FENOFIBRATE,48MG,3x10,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2017/10/26,,2017/11/6,Disruption of the manufacture of the drug.,2017/10/16,2017/11/7,No
15035,2241602,Shortage,LIPIDIL SUPRA,BGP PHARMA ULC,LIPIDIL SUPRA,FENOFIBRATE,160MG,3x10,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2017/9/8,,2018/1/10,Requirements related to complying with good manufacturing practices.,2017/7/10,2018/1/11,No
11363,2373955,Shortage,LODALIS,VALEANT CANADA LP/VALEANT CANADA S.E.C.,LODALIS,Colesevelam hydrochloride,625MG,NA,ORAL,Resolved,TABLET,C10AC,"LIPID MODIFYING AGENTS, PLAIN",,2017/5/26,2017/6/1,2017/6/1,Other (Please describe in comments),2017/5/26,2017/6/2,No
14416,36323,Shortage,LOMOTIL,PFIZER CANADA INC,Lomotil,ATROPINE SULFATE DIPHENOXYLATE HYDROCHLORIDE,.025MG 2.5MG,250's,ORAL,Avoided shortage,TABLET,A07DA,ANTIPROPULSIVES,2017/8/25,,2017/8/25,2017/8/14,Disruption of the manufacture of the drug.,2017/6/29,2017/8/15,No
11438,397431,Shortage,LOPRESOR 100MG,NOVARTIS PHARMACEUTICALS CANADA INC,LOPRESOR 100MG TABS 100'S,METOPROLOL TARTRATE,100MG,1 X 100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/5/31,2017/7/20,2018/5/31,2017/7/20,Disruption of the manufacture of the drug.,2017/5/29,2018/1/9,No
27902,397423,Shortage,LOPRESOR 50MG,NOVARTIS PHARMACEUTICALS CANADA INC,LOPRESOR 50 MG TABS 100'S,METOPROLOL TARTRATE,50MG,100's,ORAL,Avoided shortage,TABLET,C07AB,BETA BLOCKING AGENTS,2017/12/20,2017/12/17,,2017/12/17,Disruption of the manufacture of the drug.,2017/11/2,2018/1/9,No
31273,658855,Shortage,LOPRESOR SR 100MG,NOVARTIS PHARMACEUTICALS CANADA INC,LOPRESOR SR 100MG 100'S,METOPROLOL TARTRATE,100MG,100'S,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C07AB,BETA BLOCKING AGENTS,2018/2/6,2018/2/1,2018/6/26,2018/6/27,Disruption of the manufacture of the drug.,2017/11/30,2018/6/28,No
17964,2351072,Shortage,LORAZEPAM,SANIS HEALTH INC,LORAZEPAM TAB,LORAZEPAM,0.5MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2016/11/3,,2018/1/11,Disruption of the manufacture of the drug.,2017/8/2,2020/2/27,No
30518,2388669,Shortage,LORAZEPAM INJECTION USP,PFIZER CANADA INC,LORAZEPAM,LORAZEPAM,4MG,10x1mL GVL,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,N05BA,ANXIOLYTICS,,2017/12/15,,2018/1/5,Demand increase for the drug.,2017/11/23,2018/2/7,No
6750,2388669,Shortage,LORAZEPAM INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,LORAZEPAM,LORAZEPAM,4MG,10 x 1mL Vial,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,N05BA,ANXIOLYTICS,2017/4/28,,2017/10/31,2017/10/30,Disruption of the manufacture of the drug.,2017/4/13,2017/11/6,No
24761,2394375,Shortage,LOSARTAN,PRO DOC LIMITEE,LOSARTAN,LOSARTAN POTASSIUM,50MG,30-100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/10/6,,,Other (Please describe in comments),2017/10/6,2018/9/21,No
28089,2388790,Shortage,LOSARTAN,SIVEM PHARMACEUTICALS ULC,LOSARTAN,LOSARTAN POTASSIUM,25MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017/11/13,2017/11/6,2018/4/3,2018/4/2,Delay in shipping of the drug.,2017/11/6,2018/4/3,No
10654,2388979,Shortage,LOSARTAN HCT,SIVEM PHARMACEUTICALS ULC,LOSARTAN HCT,HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM,12.5MG 100MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2017/5/18,,2017/6/6,2017/6/4,Demand increase for the drug.,2017/5/18,2017/11/3,No
25154,2394405,Shortage,LOSARTAN-HCTZ,PRO DOC LIMITEE,LOSARTAN-HCTZ,HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM,12.5MG 100MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/10/10,,,Other (Please describe in comments),2017/10/10,2018/9/21,No
28269,2394413,Shortage,LOSARTAN-HCTZ,PRO DOC LIMITEE,LOSARTAN-HCTZ,HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM,25MG 100MG,30-100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/11/6,,,Other (Please describe in comments),2017/11/6,2018/9/21,No
6449,2435853,Shortage,LOTEMAX GEL,BAUSCH & LOMB INC,LOTEMAX GEL,LOTEPREDNOL ETABONATE,0.50%,5,OPHTHALMIC,Resolved,GEL,S01BA,ANTIINFLAMMATORY AGENTS,,2018/4/11,,2018/5/30,Other (Please describe in comments),2017/4/11,2018/6/8,No
6446,2421941,Shortage,LOTEMAX OINTMENT,BAUSCH & LOMB INC,LOTEMAX OINTMENT,LOTEPREDNOL ETABONATE,0.50%,3.5,OPHTHALMIC,Resolved,OINTMENT,S01BA,ANTIINFLAMMATORY AGENTS,2017/7/1,,2017/7/8,2018/3/1,Other (Please describe in comments),2017/4/11,2018/3/13,No
25088,611174,Shortage,LOTRIDERM CREAM,MERCK CANADA INC,Clotrimazole and Betamethasone Dipropionate Cream,BETAMETHASONE CLOTRIMAZOLE,0.05% 1%,50,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,2017/10/16,2017/10/11,2017/11/17,2017/11/15,Delay in shipping of the drug.,2017/10/10,2017/11/16,No
11522,611174,Shortage,LOTRIDERM CREAM,MERCK CANADA INC,Clotrimazole and Betamethasone Dipropionate Cream,BETAMETHASONE CLOTRIMAZOLE,0.05% 1%,15g,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,2017/6/6,2017/6/1,2017/9/22,2017/9/22,Delay in shipping of the drug.,2017/5/30,2017/9/23,No
30269,611174,Shortage,LOTRIDERM CREAM,MERCK CANADA INC,Clotrimazole and Betamethasone Dipropionate Cream,BETAMETHASONE CLOTRIMAZOLE,0.05% 1%,50g,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,2017/11/23,2017/11/23,2017/12/4,2017/12/4,Delay in shipping of the drug.,2017/11/23,2017/12/5,No
7803,611174,Shortage,LOTRIDERM CREAM,MERCK CANADA INC,Clotrimazole and Betamethasone Dipropionate Cream,BETAMETHASONE CLOTRIMAZOLE,0.05% 1%,50g,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,2017/5/8,2017/5/11,2017/9/22,2017/9/25,Delay in shipping of the drug.,2017/4/24,2017/9/26,No
28284,611174,Shortage,LOTRIDERM CREAM,MERCK CANADA INC,Clotrimazole and Betamethasone Dipropionate Cream,BETAMETHASONE CLOTRIMAZOLE,0.05% 1%,15g,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,2017/11/13,2017/11/9,2017/12/4,2017/12/4,Delay in shipping of the drug.,2017/11/6,2017/12/5,No
2476,2242692,Shortage,LOVENOX HP,SANOFI-AVENTIS CANADA INC,Lovenox HP 120mg,ENOXAPARIN SODIUM,120MG,10,SUBCUTANEOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,,2017/3/3,2017/4/14,2017/3/28,Other (Please describe in comments),2017/3/14,2017/3/29,No
5736,2245860,Shortage,LUMIGAN,ALLERGAN INC,"Lumigan 0,03% 3 mL",BIMATOPROST,0.03%,3ML,OPHTHALMIC,Actual shortage,SOLUTION,S01EE,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2011/4/1,,,Other (Please describe in comments),2017/4/5,2017/10/5,No
2113,2242934,Shortage,LUSTRA-AF,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Lustra-AF,OCTINOXATE HYDROQUINONE AVOBENZONE,7.5% 4% 3%,28.4 g,TOPICAL,Resolved,CREAM,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,2015/1/1,2015/1/1,,2015/6/30,Disruption of the manufacture of the drug.,2017/3/14,2019/8/19,No
4514,2046202,Shortage,LUTREPULSE,FERRING INC,LUTREPULSE,GONADORELIN ACETATE,3.2MG,3 VIALS 3.2 MG LUTREPULSE FOR INJECTION,"INTRAVENOUS
SUBCUTANEOUS",Actual shortage,POWDER FOR SOLUTION,H01CA,HYPOTHALAMIC HORMONES,2017/3/28,2017/3/28,,,Other (Please describe in comments),2017/3/28,2020/3/19,No
4516,2046202,Shortage,LUTREPULSE,FERRING INC,LUTREPULSE,GONADORELIN ACETATE,3.2MG,3 VIALS 3.2 MG LUTREPULSE FOR INJECTION,"INTRAVENOUS
SUBCUTANEOUS",Resolved,POWDER FOR SOLUTION,H01CA,HYPOTHALAMIC HORMONES,,2017/3/28,,2019/1/10,Other (Please describe in comments),2017/3/28,2019/1/11,No
32677,2269066,Shortage,LUVERIS,EMD SERONO A DIVISION OF EMD INC CANADA,Lutropin Alpha for injection,LUTROPIN ALFA,75UNIT,1 x 75 IU vial,SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,G03GA,GONADOTROPHINS AND OTHER OVULATION STIMULANTS,2017/12/13,,2017/12/22,2017/12/20,Demand increase for the drug.,2017/12/13,2017/12/21,No
29285,1919342,Shortage,LUVOX,BGP PHARMA ULC,LUVOX,FLUVOXAMINE MALEATE,50MG,2x15,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018/3/16,2018/4/13,2018/4/13,Demand increase for the drug.,2017/11/15,2018/4/16,No
30124,1919369,Shortage,LUVOX,BGP PHARMA ULC,LUVOX,FLUVOXAMINE MALEATE,100MG,2x15,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/11/22,2018/4/20,2018/4/27,Demand increase for the drug.,2017/11/22,2018/4/28,No
24209,2236996,Shortage,LYDERM OINTMENT 0.05%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Lyderm Ointment,FLUOCINONIDE,0.05%,60 g,TOPICAL,Resolved,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",,2018/5/23,2018/6/15,2018/6/15,Disruption of the manufacture of the drug.,2017/10/3,2018/6/18,No
34025,2019965,Shortage,M-ESLON,ETHYPHARM INC,morphine sulfate,MORPHINE SULFATE,100MG,Blister pack of 20 capsules,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N02AA,OPIOIDS,2017/12/20,2017/12/20,2018/1/5,2018/1/24,Delay in shipping of the drug.,2017/12/20,2018/1/25,No
4420,466085,Shortage,M-M-R II,MERCK CANADA INC,"(measles, mumps and rubella virus vaccine, live, attenuated) Lyophilized powder for injection",MEASLES VIRUS VACCINE LIVE ATTENUATED; MUMPS VIRUS VACCINE LIVE ATTENUATED (JERYL LYNN STRAIN); RUBELLA VIRUS VACCINE LIVE ATTENUATED (WISTAR RA27/3 STRAIN),0.5 mL dose after reconstitution Measles: ≥1000 CCID50 Mumps: ≥5000 CCID50 Rubella: ≥1000 CCID50,10x1dose,Subcutaneous,Resolved,Powder For Solution,J07BD,VIRAL VACCINES,2017/5/10,2017/5/11,2017/5/20,2017/5/12,Requirements related to complying with good manufacturing practices.,2017/3/27,2017/5/15,No
18919,466085,Shortage,M-M-R II,MERCK CANADA INC,"(measles, mumps and rubella virus vaccine, live, attenuated) Lyophilized powder for injection",MUMPS VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED,5000UNIT 1000UNIT 1000UNIT,0.5ML 10X1DOSE VIAL,SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,J07BD,VIRAL VACCINES,2017/9/27,2017/9/27,2017/10/6,2017/10/2,Delay in shipping of the drug.,2017/8/11,2017/10/3,No
14319,2063662,Shortage,MACROBID,ALLERGAN PHARMA CO.,Macrobid,NITROFURANTOIN,100MG,100 tabs,ORAL,Resolved,CAPSULE,J01XE,OTHER ANTIBACTERIALS,2017/7/25,,2017/8/4,2017/8/4,Other (Please describe in comments),2017/6/29,2017/10/4,No
2563,1927639,Shortage,MAJEPTIL TAB 10MG,ERFA CANADA 2012 INC,Majeptil,Majeptil,10 mg,bottle of 100,Oral,Resolved,tablets,N05AB,ANTIPSYCHOTICS,2013/6/11,2013/6/11,,2018/3/14,Shortage of an active ingredient.,2017/3/14,2018/12/11,No
2448,499013,Shortage,MANDELAMINE,ERFA CANADA 2012 INC,"Methenamine Mandelate,USP",Methenamine Mandelate,500 mg,bottle,Oral,Actual shortage,tablet,J01XX,OTHER ANTIBACTERIALS,2018/1/27,2018/1/27,,,Disruption of the manufacture of the drug.,2017/3/14,2019/11/7,No
16626,38024,Shortage,MANNITOL 25%,HOSPIRA HEALTHCARE CORPORATION,Mannitol,MANNITOL,250MG,25x50mL,INTRAVENOUS,Resolved,SOLUTION,B05BC,I.V. SOLUTIONS,,2017/11/28,,2018/2/22,Disruption of the manufacture of the drug.,2017/7/21,2018/2/23,No
12565,2429861,Shortage,MAR-AMITRIPTYLINE,MARCAN PHARMACEUTICALS INC,MAR-Amitriptyline,AMITRIPTYLINE HYDROCHLORIDE,10MG,100 Tablet,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017/6/1,2017/6/1,2018/9/30,2018/8/24,Delay in shipping of the drug.,2017/6/12,2018/8/25,No
12568,2429861,Shortage,MAR-AMITRIPTYLINE,MARCAN PHARMACEUTICALS INC,MAR-Amitriptyline,AMITRIPTYLINE HYDROCHLORIDE,10MG,1000 Tablet,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017/6/1,2017/6/1,2018/9/30,2018/8/24,Delay in shipping of the drug.,2017/6/12,2018/8/25,No
31323,2429888,Shortage,MAR-AMITRIPTYLINE,MARCAN PHARMACEUTICALS INC,MAR-Amitriptyline,AMITRIPTYLINE HYDROCHLORIDE,25MG,1000 Tablet,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017/11/1,2017/11/1,2018/9/5,2018/9/5,Delay in shipping of the drug.,2017/11/30,2018/9/6,No
959,2429918,Shortage,MAR-AMITRIPTYLINE,MARCAN PHARMACEUTICALS INC,MAR-Amitriptyline,AMITRIPTYLINE HYDROCHLORIDE,75MG,100 Tablet,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017/3/13,,2017/7/15,2017/7/14,Delay in shipping of the drug.,2017/3/13,2017/7/15,No
962,2429896,Shortage,MAR-AMITRIPTYLINE,MARCAN PHARMACEUTICALS INC,MAR-Amitriptyline,AMITRIPTYLINE HYDROCHLORIDE,50MG,1000 Tablet,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017/3/13,,2017/7/15,2017/8/28,Delay in shipping of the drug.,2017/3/13,2017/8/29,No
967,2429896,Shortage,MAR-AMITRIPTYLINE,MARCAN PHARMACEUTICALS INC,MAR-Amitriptyline,AMITRIPTYLINE HYDROCHLORIDE,50MG,100 Tablet,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017/3/13,,2017/7/15,2017/8/28,Delay in shipping of the drug.,2017/3/13,2017/8/29,No
971,2429888,Shortage,MAR-AMITRIPTYLINE,MARCAN PHARMACEUTICALS INC,MAR-Amitriptyline,AMITRIPTYLINE HYDROCHLORIDE,25MG,1000 Tablet,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017/3/13,,2017/7/15,2017/7/14,Delay in shipping of the drug.,2017/3/13,2017/7/15,No
978,2429888,Shortage,MAR-AMITRIPTYLINE,MARCAN PHARMACEUTICALS INC,MAR-Amitriptyline,AMITRIPTYLINE HYDROCHLORIDE,25MG,100 Tablet,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017/3/13,,2017/7/15,2017/7/14,Delay in shipping of the drug.,2017/3/13,2017/7/15,No
954,2379562,Shortage,MAR-ANASTROZOLE,MARCAN PHARMACEUTICALS INC,MAR-Anastrozole,ANASTROZOLE,1MG,30 Tablet,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,2018/1/15,2017/11/30,,2019/1/1,Delay in shipping of the drug.,2017/3/13,2019/4/23,No
31328,2452324,Shortage,MAR-AZITHROMYCIN,MARCAN PHARMACEUTICALS INC,MAR-Azithromycin,AZITHROMYCIN,250MG,100 Tablet,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2017/11/30,2017/11/30,,2019/5/17,Delay in shipping of the drug.,2017/11/30,2019/5/22,No
12571,2420058,Shortage,MAR-CELECOXIB,MARCAN PHARMACEUTICALS INC,MAR-Celecoxib,CELECOXIB,100MG,100 Capsule,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/6/1,2017/6/1,2017/10/31,2017/11/15,Delay in shipping of the drug.,2017/6/12,2017/11/23,No
12576,2420058,Shortage,MAR-CELECOXIB,MARCAN PHARMACEUTICALS INC,MAR-Celecoxib,CELECOXIB,100MG,500 Capsule,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/6/1,2017/6/1,2017/10/30,2017/11/15,Delay in shipping of the drug.,2017/6/12,2017/11/23,No
31334,2427133,Shortage,MAR-CETIRIZINE,MARCAN PHARMACEUTICALS INC,MAR-Cetirizine,CETIRIZINE HYDROCHLORIDE,10MG,100 Tablet,ORAL,Resolved,TABLET,R06AE,ANTIHISTAMINES FOR SYSTEMIC USE,2017/11/1,2017/11/1,,2020/3/24,Delay in shipping of the drug.,2017/11/30,2020/3/25,No
31338,2427141,Shortage,MAR-CETIRIZINE,MARCAN PHARMACEUTICALS INC,MAR-Cetirizine,CETIRIZINE HYDROCHLORIDE,20MG,500 Tablet,ORAL,Resolved,TABLET,R06AE,ANTIHISTAMINES FOR SYSTEMIC USE,2017/11/1,2017/11/1,2018/10/1,2018/6/5,Delay in shipping of the drug.,2017/11/30,2018/6/6,No
32927,2427141,Shortage,MAR-CETIRIZINE,MARCAN PHARMACEUTICALS INC,MAR-Cetirizine,CETIRIZINE HYDROCHLORIDE,20MG,100 Tablet,ORAL,Resolved,TABLET,R06AE,ANTIHISTAMINES FOR SYSTEMIC USE,2018/1/1,2018/1/1,2018/10/1,2018/6/5,Delay in shipping of the drug.,2017/12/14,2018/7/5,No
31341,2371871,Shortage,MAR-CITALOPRAM,MARCAN PHARMACEUTICALS INC,MAR-Citalopram,CITALOPRAM,10MG,100 Tablet,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/10/2,2017/10/2,2018/5/15,2018/4/2,Delay in shipping of the drug.,2017/11/30,2018/4/3,No
937,2422255,Shortage,MAR-CLOPIDOGREL,MARCAN PHARMACEUTICALS INC,MAR-Clopidogrel,CLOPIDOGREL,75MG,500 Tablet,ORAL,Resolved,TABLET,B01AC,ANTITHROMBOTIC AGENTS,2017/3/13,,2017/7/1,2017/6/15,Delay in shipping of the drug.,2017/3/13,2017/6/16,No
944,2422255,Shortage,MAR-CLOPIDOGREL,MARCAN PHARMACEUTICALS INC,MAR-Clopidogrel,CLOPIDOGREL,75MG,30 Tablet,ORAL,Resolved,TABLET,B01AC,ANTITHROMBOTIC AGENTS,2017/3/13,,2017/7/1,2017/6/15,Delay in shipping of the drug.,2017/3/13,2017/6/16,No
947,2422255,Shortage,MAR-CLOPIDOGREL,MARCAN PHARMACEUTICALS INC,MAR-Clopidogrel,CLOPIDOGREL,75MG,100 Tablet,ORAL,Resolved,TABLET,B01AC,ANTITHROMBOTIC AGENTS,2017/3/13,,2017/7/1,2017/6/15,Delay in shipping of the drug.,2017/3/13,2017/6/16,No
931,2402092,Shortage,MAR-DONEPEZIL,MARCAN PHARMACEUTICALS INC,MAR-Donepezil,DONEPEZIL HYDROCHLORIDE,5MG,30 Tablet,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,2017/3/13,2017/3/13,,2017/3/13,Delay in shipping of the drug.,2017/3/13,2021/10/26,No
934,2402106,Shortage,MAR-DONEPEZIL,MARCAN PHARMACEUTICALS INC,MAR-Donepezil,DONEPEZIL HYDROCHLORIDE,10MG,30 Tablet,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,2017/3/13,2017/3/13,,2017/3/13,Delay in shipping of the drug.,2017/3/13,2021/10/26,No
31353,2446081,Shortage,MAR-DULOXETINE,MARCAN PHARMACEUTICALS INC,MAR-Duloxetine,DULOXETINE,30MG,100 Capsule,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017/9/1,2017/9/1,,2019/5/14,Delay in shipping of the drug.,2017/11/30,2019/5/22,No
31356,2446081,Shortage,MAR-DULOXETINE,MARCAN PHARMACEUTICALS INC,MAR-Duloxetine,DULOXETINE,30MG,500 Capsule,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017/9/1,2017/9/1,,2017/9/1,Delay in shipping of the drug.,2017/11/30,2021/10/26,No
31359,2446103,Shortage,MAR-DULOXETINE,MARCAN PHARMACEUTICALS INC,MAR-Duloxetine,DULOXETINE,60MG,100 Capsule,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017/9/1,2017/9/1,,2019/5/14,Delay in shipping of the drug.,2017/11/30,2019/5/22,No
31362,2446103,Shortage,MAR-DULOXETINE,MARCAN PHARMACEUTICALS INC,MAR-Duloxetine,DULOXETINE,60MG,500 Capsule,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017/9/1,2017/9/1,,2019/5/14,Delay in shipping of the drug.,2017/11/30,2019/5/22,No
919,2423502,Shortage,MAR-ESCITALOPRAM,MARCAN PHARMACEUTICALS INC,MAR-Escitalopram,ESCITALOPRAM,20MG,500 Tablet,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/3/13,,,2017/6/1,Delay in shipping of the drug.,2017/3/13,2018/7/6,No
925,2423502,Shortage,MAR-ESCITALOPRAM,MARCAN PHARMACEUTICALS INC,MAR-Escitalopram,ESCITALOPRAM,20MG,100 Tablet,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/3/13,,2017/7/1,2017/6/1,Delay in shipping of the drug.,2017/3/13,2017/6/12,No
904,2392917,Shortage,MAR-FLUOXETINE,MARCAN PHARMACEUTICALS INC,MAR-Fluoxetine,FLUOXETINE,20MG,500 Capsule,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017/3/13,2017/4/1,,2017/4/1,Delay in shipping of the drug.,2017/3/13,2021/10/26,No
910,2392917,Shortage,MAR-FLUOXETINE,MARCAN PHARMACEUTICALS INC,MAR-Fluoxetine,FLUOXETINE,20MG,100 Capsule,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017/3/13,2017/4/1,,2017/4/1,Delay in shipping of the drug.,2017/3/13,2021/10/26,No
914,2392909,Shortage,MAR-FLUOXETINE,MARCAN PHARMACEUTICALS INC,MAR-Fluoxetine,FLUOXETINE,10MG,100 Capsule,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017/3/13,2017/4/1,,2017/4/1,Delay in shipping of the drug.,2017/3/13,2021/10/26,No
30475,2391473,Shortage,MAR-GABAPENTIN,MARCAN PHARMACEUTICALS INC,MAR-Gabapentin,GABAPENTIN,100MG,100 Capsule,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/9/10,2017/9/10,2018/5/15,2018/4/24,Delay in shipping of the drug.,2017/11/23,2018/7/6,No
30478,2391481,Shortage,MAR-GABAPENTIN,MARCAN PHARMACEUTICALS INC,MAR-Gabapentin,GABAPENTIN,300MG,100 Capsule,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/9/10,2017/9/10,2018/5/15,2018/4/24,Delay in shipping of the drug.,2017/11/23,2018/4/25,No
30481,2391481,Shortage,MAR-GABAPENTIN,MARCAN PHARMACEUTICALS INC,MAR-Gabapentin,GABAPENTIN,300MG,500 Capsule,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/9/10,2017/9/10,2018/5/15,2018/4/24,Delay in shipping of the drug.,2017/11/23,2018/4/25,No
30484,2391503,Shortage,MAR-GABAPENTIN,MARCAN PHARMACEUTICALS INC,MAR-Gabapentin,GABAPENTIN,400MG,100 Capsule,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/9/10,2017/9/10,,2018/4/24,Delay in shipping of the drug.,2017/11/23,2018/7/6,No
30487,2391503,Shortage,MAR-GABAPENTIN,MARCAN PHARMACEUTICALS INC,MAR-Gabapentin,GABAPENTIN,400MG,500 Capsule,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/9/10,2017/9/10,2018/7/27,2018/7/27,Delay in shipping of the drug.,2017/11/23,2018/7/28,No
899,2391473,Shortage,MAR-GABAPENTIN,MARCAN PHARMACEUTICALS INC,MAR-Gabapentin,GABAPENTIN,100MG,500 Capsule,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/3/13,2017/4/1,2018/5/1,2018/4/24,Delay in shipping of the drug.,2017/3/13,2018/4/25,No
880,2420821,Shortage,MAR-GALANTAMINE ER,MARCAN PHARMACEUTICALS INC,MAR-Galantamine,GALANTAMINE,8MG,30 Capsule,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,2017/3/13,2017/4/1,,2017/4/1,Delay in shipping of the drug.,2017/3/13,2021/10/26,No
887,2420856,Shortage,MAR-GALANTAMINE ER,MARCAN PHARMACEUTICALS INC,MAR-Galantamine,GALANTAMINE,24MG,30 Capsules,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,2017/3/13,2017/4/1,,2017/4/1,Delay in shipping of the drug.,2017/3/13,2021/10/26,No
894,2420848,Shortage,MAR-GALANTAMINE ER,MARCAN PHARMACEUTICALS INC,MAR-Galantamine,GALANTAMINE,16MG,30 Capsule,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,2017/3/13,2017/4/1,,2017/4/1,Delay in shipping of the drug.,2017/3/13,2021/10/26,No
859,2378639,Shortage,MAR-METFORMIN,MARCAN PHARMACEUTICALS INC,MAR-Metformin,METFORMIN HYDROCHLORIDE,850MG,100 Tablet,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017/3/13,2017/3/13,,2017/3/13,Delay in shipping of the drug.,2017/3/13,2021/10/26,No
865,2378620,Shortage,MAR-METFORMIN,MARCAN PHARMACEUTICALS INC,MAR-Metformin,METFORMIN HYDROCHLORIDE,500MG,500 Tablet,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017/3/13,,2017/10/1,2017/6/1,Delay in shipping of the drug.,2017/3/13,2017/6/12,No
868,2378620,Shortage,MAR-METFORMIN,MARCAN PHARMACEUTICALS INC,MAR-Metformin,METFORMIN HYDROCHLORIDE,500MG,100 Tablet,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017/3/13,2017/3/13,,2017/3/13,Delay in shipping of the drug.,2017/3/13,2021/10/26,No
31377,2378620,Shortage,MAR-METFORMIN,MARCAN PHARMACEUTICALS INC,MAR-Metformin,METFORMIN HYDROCHLORIDE,500MG,500 Tablet,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017/11/30,2017/11/30,,2017/11/30,Delay in shipping of the drug.,2017/11/30,2021/10/26,No
841,2399873,Shortage,MAR-MONTELUKAST,MARCAN PHARMACEUTICALS INC,MAR-Montelukast,MONTELUKAST,5MG,30 Tablet,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017/3/13,2017/4/1,2018/11/12,2018/11/12,Delay in shipping of the drug.,2017/3/13,2018/11/13,No
844,2399865,Shortage,MAR-MONTELUKAST,MARCAN PHARMACEUTICALS INC,MAR-Montelukast,MONTELUKAST,4MG,30 Tablet,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017/3/13,2017/4/1,2018/11/12,2018/11/12,Delay in shipping of the drug.,2017/3/13,2018/11/13,No
852,2399997,Shortage,MAR-MONTELUKAST,MARCAN PHARMACEUTICALS INC,MAR-Montelukast,MONTELUKAST,10MG,30 Tablet,ORAL,Resolved,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2019/11/10,2019/11/10,2020/1/8,2020/1/8,Delay in shipping of the drug.,2017/3/13,2020/1/9,No
32948,2421232,Shortage,MAR-OLANZAPINE,MARCAN PHARMACEUTICALS INC,Mar-Olanzapine,OLANZAPINE,2.5MG,100 Tablet,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018/1/1,2018/1/1,2018/10/12,2018/10/12,Delay in shipping of the drug.,2017/12/14,2018/10/15,No
32955,2421240,Shortage,MAR-OLANZAPINE,MARCAN PHARMACEUTICALS INC,Mar-Olanzapine,OLANZAPINE,5MG,100 Tablet,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018/1/1,2018/1/1,2018/10/12,2018/10/12,Delay in shipping of the drug.,2017/12/14,2018/10/15,No
32961,2421259,Shortage,MAR-OLANZAPINE,MARCAN PHARMACEUTICALS INC,Mar-Olanzapine,OLANZAPINE,7.5MG,100 Tablet,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018/1/1,2018/1/1,2018/10/12,2018/10/12,Delay in shipping of the drug.,2017/12/14,2018/10/15,No
32969,2421267,Shortage,MAR-OLANZAPINE,MARCAN PHARMACEUTICALS INC,Mar-Olanzapine,OLANZAPINE,10MG,100 Tablet,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018/1/1,2018/1/1,2018/10/12,2018/10/12,Delay in shipping of the drug.,2017/12/14,2018/10/15,No
32978,2421275,Shortage,MAR-OLANZAPINE,MARCAN PHARMACEUTICALS INC,Mar-Olanzapine,OLANZAPINE,15MG,100 Tablet,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018/1/1,2018/1/1,2018/10/12,2018/10/12,Delay in shipping of the drug.,2017/12/14,2018/10/15,No
31349,2389126,Shortage,MAR-OLANZAPINE ODT,MARCAN PHARMACEUTICALS INC,MAR-Olanzapine ODT,OLANZAPINE,20MG,30 Tablet,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2017/11/15,2017/11/15,,2019/10/1,Delay in shipping of the drug.,2017/11/30,2021/10/26,No
31331,2371731,Shortage,MAR-ONDANSETRON,MARCAN PHARMACEUTICALS INC,Mar-Ondansetron,ONDANSETRON,4MG,10 Tablet,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,2017/11/30,2017/11/30,2018/5/1,2018/4/27,Delay in shipping of the drug.,2017/11/30,2018/4/28,No
12548,2416565,Shortage,MAR-PANTOPRAZOLE,MARCAN PHARMACEUTICALS INC,MAR-Pantoprazole,PANTOPRAZOLE,40MG,100 Tablet,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/6/1,2017/6/1,2017/10/15,2017/11/1,Delay in shipping of the drug.,2017/6/12,2017/11/23,No
838,2416565,Shortage,MAR-PANTOPRAZOLE,MARCAN PHARMACEUTICALS INC,MAR-Pantoprazole,PANTOPRAZOLE,40MG,500 Tablet,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/3/13,2017/3/13,2017/10/15,2017/11/1,Delay in shipping of the drug.,2017/3/13,2017/11/23,No
30490,2417529,Shortage,MAR-PREGABALIN,MARCAN PHARMACEUTICALS INC,MAR-Pregabalin,PREGABALIN,25MG,100 Capsule,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2017/10/1,2017/10/1,,,Delay in shipping of the drug.,2017/11/23,2018/7/5,No
30493,2417529,Shortage,MAR-PREGABALIN,MARCAN PHARMACEUTICALS INC,MAR-Pregabalin,PREGABALIN,25MG,500 Capsule,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2017/10/1,2017/10/1,,,Delay in shipping of the drug.,2017/11/23,2018/7/5,No
30496,2417545,Shortage,MAR-PREGABALIN,MARCAN PHARMACEUTICALS INC,MAR-Pregabalin,PREGABALIN,75MG,100 Capsule,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2017/10/1,2017/10/1,,,Delay in shipping of the drug.,2017/11/23,2018/7/5,No
12579,2417537,Shortage,MAR-PREGABALIN,MARCAN PHARMACEUTICALS INC,MAR-Pregabalin,PREGABALIN,50MG,100 Capsule,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2017/6/1,2017/6/1,,,Delay in shipping of the drug.,2017/6/12,2018/7/5,No
30499,2417545,Shortage,MAR-PREGABALIN,MARCAN PHARMACEUTICALS INC,MAR-Pregabalin,PREGABALIN,75MG,500 Capsule,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2017/10/1,2017/10/1,,,Delay in shipping of the drug.,2017/11/23,2018/7/5,No
12582,2417537,Shortage,MAR-PREGABALIN,MARCAN PHARMACEUTICALS INC,MAR-Pregabalin,PREGABALIN,50MG,500 Capsule,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2017/6/1,2017/6/1,,,Delay in shipping of the drug.,2017/6/12,2018/7/5,No
30502,2417561,Shortage,MAR-PREGABALIN,MARCAN PHARMACEUTICALS INC,MAR-Pregabalin,PREGABALIN,150MG,100 Capsule,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2017/10/1,2017/10/1,,,Delay in shipping of the drug.,2017/11/23,2018/7/5,No
30505,2417561,Shortage,MAR-PREGABALIN,MARCAN PHARMACEUTICALS INC,MAR-Pregabalin,PREGABALIN,150MG,500 Capsule,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2017/10/1,2017/10/1,,,Delay in shipping of the drug.,2017/11/23,2018/7/5,No
811,2399857,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,MAR-Quetiapine,QUETIAPINE,300MG,500 Tablet,ORAL,Actual shortage,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2017/3/13,2017/4/1,,,Delay in shipping of the drug.,2017/3/13,2018/12/20,No
814,2399857,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,MAR-Quetiapine,QUETIAPINE,300MG,100 Tablet,ORAL,Resolved,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2017/3/13,2017/4/1,2018/3/15,2018/1/24,Delay in shipping of the drug.,2017/3/13,2018/1/25,No
817,2399849,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,MAR-Quetiapine,QUETIAPINE,200MG,500 Tablet,ORAL,Resolved,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2017/3/13,2017/4/1,2018/4/15,2018/1/24,Delay in shipping of the drug.,2017/3/13,2018/1/25,No
820,2399849,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,MAR-Quetiapine,QUETIAPINE,200MG,100 Tablet,ORAL,Resolved,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2017/3/13,2017/4/1,2018/3/1,2018/1/24,Delay in shipping of the drug.,2017/3/13,2018/1/25,No
823,2399830,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,MAR-Quetiapine,QUETIAPINE,100MG,500 Tablet,ORAL,Resolved,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2017/3/13,2017/4/1,2018/3/15,2018/1/10,Delay in shipping of the drug.,2017/3/13,2018/1/11,No
826,2399830,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,MAR-Quetiapine,QUETIAPINE,100MG,100 Tablet,ORAL,Resolved,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2017/3/13,2017/4/1,2018/3/15,2018/1/10,Delay in shipping of the drug.,2017/3/13,2018/1/11,No
830,2399822,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,MAR-Quetiapine,QUETIAPINE,25MG,500 Tablet,ORAL,Resolved,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2017/3/13,2017/4/1,,2018/2/7,Delay in shipping of the drug.,2017/3/13,2018/7/6,No
835,2399822,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,MAR-Quetiapine,QUETIAPINE,25MG,100 Tablet,ORAL,Resolved,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2017/3/13,2017/4/1,,2018/2/7,Delay in shipping of the drug.,2017/3/13,2018/7/6,No
796,2420503,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,MAR-Ramipril,RAMIPRIL,15.0MG,30 Capsule,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/3/13,,2017/10/1,2017/10/1,Delay in shipping of the drug.,2017/3/13,2017/10/6,No
799,2420503,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,MAR-Ramipril,RAMIPRIL,15.0MG,100 Capsule,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/3/13,,2017/8/1,2017/10/1,Delay in shipping of the drug.,2017/3/13,2017/10/6,No
12585,2420465,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,MAR-Ramipril,RAMIPRIL,2.5MG,30 CAPSULE,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/6/1,2017/6/1,2018/5/1,2018/4/9,Delay in shipping of the drug.,2017/6/12,2018/4/10,No
12588,2420465,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,MAR-Ramipril,RAMIPRIL,2.5MG,100 Capsule,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/6/1,2017/6/1,2018/5/1,2018/4/9,Delay in shipping of the drug.,2017/6/12,2018/4/10,No
12591,2420481,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,MAR-Ramipril,RAMIPRIL,10.0MG,100 Capsule,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/6/1,2017/6/1,2018/6/15,2018/6/5,Delay in shipping of the drug.,2017/6/12,2018/6/6,No
12201,2420457,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,MAR-Ramipril,RAMIPRIL,1.25MG,30 CAPSULE,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/5/1,2017/5/1,,2018/1/5,Delay in shipping of the drug.,2017/6/7,2018/7/6,No
793,2371812,Shortage,MAR-RISPERIDONE,MARCAN PHARMACEUTICALS INC,MAR-Risperidone,RISPERIDONE,4.0MG,100 Tablet,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2017/3/13,2017/4/1,2018/8/20,2018/8/20,Delay in shipping of the drug.,2017/3/13,2018/8/21,No
772,2413051,Shortage,MAR-ROSUVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Rosuvastatin,ROSUVASTATIN,5MG,100 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/3/13,2017/4/1,,,Delay in shipping of the drug.,2017/3/13,2018/12/20,No
775,2413108,Shortage,MAR-ROSUVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Rosuvastatin,ROSUVASTATIN,40MG,500 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/3/13,2017/4/1,,,Delay in shipping of the drug.,2017/3/13,2018/12/20,No
778,2413108,Shortage,MAR-ROSUVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Rosuvastatin,ROSUVASTATIN,40MG,100 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/3/13,2017/4/1,,,Delay in shipping of the drug.,2017/3/13,2018/12/20,No
781,2413086,Shortage,MAR-ROSUVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Rosuvastatin,ROSUVASTATIN,20MG,500 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/3/13,2017/4/1,,,Delay in shipping of the drug.,2017/3/13,2018/12/20,No
784,2413086,Shortage,MAR-ROSUVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Rosuvastatin,ROSUVASTATIN,20MG,100 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/3/13,2017/4/1,,,Delay in shipping of the drug.,2017/3/13,2018/12/20,No
787,2413078,Shortage,MAR-ROSUVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Rosuvastatin,ROSUVASTATIN,10MG,500 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/3/13,2017/4/1,,,Delay in shipping of the drug.,2017/3/13,2018/12/20,No
790,2413078,Shortage,MAR-ROSUVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Rosuvastatin,ROSUVASTATIN,10MG,100 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/3/13,2017/4/1,,,Delay in shipping of the drug.,2017/3/13,2018/12/20,No
763,2399423,Shortage,MAR-SERTRALINE,MARCAN PHARMACEUTICALS INC,MAR-Sertraline,SERTRALINE,50MG,100 Capsule,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017/3/13,,2017/11/1,2017/7/7,Delay in shipping of the drug.,2017/3/13,2018/5/14,No
766,2399431,Shortage,MAR-SERTRALINE,MARCAN PHARMACEUTICALS INC,MAR-Sertraline,SERTRALINE,100MG,100 Capsule,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017/3/13,,2017/8/1,2017/7/7,Delay in shipping of the drug.,2017/3/13,2017/7/8,No
757,2375079,Shortage,MAR-SIMVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Simvastatin,SIMVASTATIN,80MG,100 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/3/13,2017/4/1,,,Delay in shipping of the drug.,2017/3/13,2018/12/20,No
760,2375036,Shortage,MAR-SIMVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Simvastatin,SIMVASTATIN,5MG,100 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/3/13,2017/4/1,,,Delay in shipping of the drug.,2017/3/13,2018/12/20,No
31365,2452286,Shortage,MAR-TADALAFIL,MARCAN PHARMACEUTICALS INC,MAR-Tadalafil,TADALAFIL,2.5MG,28 Tablet,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/11/30,2017/11/30,,,Delay in shipping of the drug.,2017/11/30,2018/7/5,No
31368,2452278,Shortage,MAR-TADALAFIL,MARCAN PHARMACEUTICALS INC,MAR-Tadalafil,TADALAFIL,5MG,28 Tablet,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/11/30,2017/11/30,,2018/7/12,Delay in shipping of the drug.,2017/11/30,2018/7/13,No
31371,2452251,Shortage,MAR-TADALAFIL,MARCAN PHARMACEUTICALS INC,MAR-Tadalafil,TADALAFIL,10MG,4 Tablet,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/11/30,2017/11/30,2018/7/12,2018/7/12,Delay in shipping of the drug.,2017/11/30,2018/7/13,No
31374,2452243,Shortage,MAR-TADALAFIL,MARCAN PHARMACEUTICALS INC,MAR-Tadalafil,TADALAFIL,20MG,4 Tablet,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/11/30,2017/11/30,,2018/7/12,Delay in shipping of the drug.,2017/11/30,2018/7/13,No
12594,2388324,Shortage,MAR-TRAMADOL/ACET,MARCAN PHARMACEUTICALS INC,MAR-TRAMADOL/ACET,TRAMADOL HYDROCHLORIDE ACETAMINOPHEN,37.5MG 325MG,60 Tablet,ORAL,Resolved,TABLET,N02AJ,OPIOIDS,2017/6/1,2017/6/1,2017/12/1,2017/11/1,Delay in shipping of the drug.,2017/6/12,2017/11/23,No
754,2441586,Shortage,MAR-VALACYCLOVIR,MARCAN PHARMACEUTICALS INC,MAR-Valacyclovir,VALACYCLOVIR,500MG,100 Tablet,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017/3/13,,2017/10/1,2017/6/1,Delay in shipping of the drug.,2017/3/13,2017/6/12,No
751,2399458,Shortage,MAR-ZOLMITRIPTAN,MARCAN PHARMACEUTICALS INC,MAR-Zolmitriptan,ZOLMITRIPTAN,2.5MG,6 Tablet,ORAL,Actual shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2017/3/13,2017/4/1,,,Delay in shipping of the drug.,2017/3/13,2018/12/20,No
32859,2305909,Shortage,MARCAINE,PFIZER CANADA INC,MARCAINE 0.5%,BUPIVACAINE HYDROCHLORIDE,5.0MG,1 x 50mL,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018/3/30,,2019/5/29,Disruption of the manufacture of the drug.,2017/12/14,2019/5/30,No
32865,2241919,Shortage,MARCAINE,PFIZER CANADA INC,MARCAINE 0.5%,BUPIVACAINE HYDROCHLORIDE,5.0MG,10 x 10ML,"BLOCK/INFILTRATION
EPIDURAL",Actual shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018/2/21,,,Disruption of the manufacture of the drug.,2017/12/14,2019/6/12,No
14769,2241919,Shortage,MARCAINE,PFIZER CANADA INC,MARCAINE,BUPIVACAINE HYDROCHLORIDE,5.0MG,10x20ml,"BLOCK/INFILTRATION
EPIDURAL",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017/9/21,,,2017/9/30,Other (Please describe in comments),2017/7/5,2017/12/19,No
30195,2305895,Shortage,MARCAINE,PFIZER CANADA INC,MARCAINE 0.25%,BUPIVACAINE HYDROCHLORIDE,2.5MG,1x50mL GVL,BLOCK/INFILTRATION,Actual shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018/1/31,,,Disruption of the manufacture of the drug.,2017/11/22,2018/2/8,No
14762,2305895,Shortage,MARCAINE 0.25%,HOSPIRA HEALTHCARE CORPORATION,MARCAINE,BUPIVACAINE HYDROCHLORIDE,2.5MG,1x50ml,BLOCK/INFILTRATION,Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017/11/3,,,2017/9/30,Other (Please describe in comments),2017/7/5,2017/11/23,No
14772,2305909,Shortage,MARCAINE 0.50%,HOSPIRA HEALTHCARE CORPORATION,MARCAINE,BUPIVACAINE HYDROCHLORIDE,5.0MG,1x50ml,BLOCK/INFILTRATION,Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018/5/11,,,2017/9/30,Other (Please describe in comments),2017/7/5,2017/11/24,No
14755,2241918,Shortage,MARCAINE 2.5 MG/ML,HOSPIRA HEALTHCARE CORPORATION,MARCAINE,BUPIVACAINE HYDROCHLORIDE,2.5MG,10x10ml,"BLOCK/INFILTRATION
EPIDURAL",Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018/3/27,,,2017/9/30,Other (Please describe in comments),2017/7/5,2017/11/23,No
14759,2241918,Shortage,MARCAINE 2.5 MG/ML,HOSPIRA HEALTHCARE CORPORATION,MARCAINE,BUPIVACAINE HYDROCHLORIDE,2.5MG,10x20ml,"BLOCK/INFILTRATION
EPIDURAL",Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017/12/10,,,2017/9/30,Other (Please describe in comments),2017/7/5,2017/11/23,No
14766,2241919,Shortage,MARCAINE 5 MG/ML,HOSPIRA HEALTHCARE CORPORATION,MARCAINE,BUPIVACAINE HYDROCHLORIDE,5.0MG,10x10ml,"BLOCK/INFILTRATION
EPIDURAL",Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018/2/5,,,2017/9/30,Other (Please describe in comments),2017/7/5,2017/11/23,No
14776,2241917,Shortage,MARCAINE 7.5 MG/ML,HOSPIRA HEALTHCARE CORPORATION,MARCAINE,BUPIVACAINE HYDROCHLORIDE,7.5MG,10x20ml,"EPIDURAL
RETROBULBAR",Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017/12/4,,,2017/9/30,Other (Please describe in comments),2017/7/5,2017/11/24,No
27179,2241915,Shortage,MARCAINE E,PFIZER CANADA INC,MARCAINE E 0.25%,BUPIVACAINE HYDROCHLORIDE EPINEPHRINE BITARTRATE,2.5MG 9.1MCG,10x20mL,"BLOCK/INFILTRATION
EPIDURAL",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017/11/29,,2018/10/16,Disruption of the manufacture of the drug.,2017/10/26,2018/10/17,No
32862,2241916,Shortage,MARCAINE E,PFIZER CANADA INC,MARCAINE E 0.5%,BUPIVACAINE HYDROCHLORIDE EPINEPHRINE BITARTRATE,5.0MG 9.1MCG,10 X 20ML,"BLOCK/INFILTRATION
EPIDURAL",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018/1/31,,2018/7/23,Disruption of the manufacture of the drug.,2017/12/14,2018/7/24,No
14779,2241915,Shortage,MARCAINE E 2.5 MG/ML,HOSPIRA HEALTHCARE CORPORATION,MARCAINE,BUPIVACAINE HYDROCHLORIDE EPINEPHRINE BITARTRATE,2.5MG 9.1MCG,10x20ml,"BLOCK/INFILTRATION
EPIDURAL",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017/9/6,,,2017/9/30,Other (Please describe in comments),2017/7/5,2017/11/24,No
14782,2241916,Shortage,MARCAINE E 5.0 MG/ML,HOSPIRA HEALTHCARE CORPORATION,MARCAINE,BUPIVACAINE HYDROCHLORIDE EPINEPHRINE BITARTRATE,5.0MG 9.1MCG,10x20ml,"BLOCK/INFILTRATION
EPIDURAL",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017/7/5,,,2017/9/30,Other (Please describe in comments),2017/7/5,2017/11/24,No
32462,2042487,Shortage,MARVELON 21,MERCK CANADA INC,"desogestrel and ethinyl estradiol tablets,",ETHINYL ESTRADIOL DESOGESTREL,0.03MG 0.15MG,21,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2018/2/15,2018/2/16,2018/3/5,2018/2/21,Delay in shipping of the drug.,2017/12/11,2018/2/22,No
31821,2239267,Shortage,MAVIK,BGP PHARMA ULC,MAVIK,TRANDOLAPRIL,4MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/12/13,,2017/12/14,Delay in shipping of the drug.,2017/12/5,2017/12/15,No
209,2231457,Shortage,MAVIK,BGP PHARMA ULC,Trandolapril,Trandolapril,0.5MG,100,ORAL,Resolved,Capsule,C09AA,"ACE INHIBITORS, PLAIN",,2016/11/8,,2017/4/3,Requirements related to complying with good manufacturing practices.,2017/3/10,2017/4/4,No
214,2231459,Shortage,MAVIK,BGP PHARMA ULC,Trandolapril,TRANDOLAPRIL,1MG,100,ORAL,Avoided shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2018/11/22,,2018/11/30,2018/11/7,Delay in shipping of the drug.,2017/3/10,2018/11/8,No
1344,2240519,Shortage,MAXALT RPD,MERCK CANADA INC,rizatriptan benzoate wafers,RIZATRIPTAN,10MG,12,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2017/3/10,2017/3/10,2017/3/15,2017/3/15,Delay in shipping of the drug.,2017/3/13,2017/3/16,No
17417,42579,Shortage,MAXIDEX,NOVARTIS PHARMACEUTICALS CANADA INC,MAXIDEX OINTMENT 3.5MG,DEXAMETHASONE,0.10%,3.5 MG,OPHTHALMIC,Resolved,OINTMENT,S01BA,ANTIINFLAMMATORY AGENTS,,2017/7/23,2017/9/11,2017/9/7,Demand increase for the drug.,2017/7/27,2017/9/8,No
20976,358177,Shortage,MAXITROL,NOVARTIS PHARMACEUTICALS CANADA INC,MAXITROL OINT 3.5G,DEXAMETHASONE POLYMYXIN B SULFATE NEOMYCIN,1MG 6000UNIT 3.5MG,3.5G,OPHTHALMIC,Resolved,OINTMENT,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,,2017/8/28,2017/9/11,2017/9/13,Delay in shipping of the drug.,2017/9/5,2017/9/14,No
27751,504742,Shortage,MAZEPINE,BIOMED PHARMA,Carbamazepine Tablets 200 mg,,,100,,Actual shortage,,,,,2014/10/22,,,Other (Please describe in comments),2017/11/1,2017/11/1,No
25157,2253550,Shortage,MEDROXY-2.5,PRO DOC LIMITEE,MEDROXY-2.5,MEDROXYPROGESTERONE ACETATE,2.5MG,500,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,,2017/10/10,,2017/11/7,Delay in shipping of the drug.,2017/10/10,2017/11/8,No
6731,2279924,Shortage,MENACTRA,SANOFI PASTEUR LIMITED,"Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine","MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP A  MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP C MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP W 135  MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP Y",4.0 μG 4.0 μG 4.0 μG 4.0 μG,5 x 0.5 mL vials,INTRAMUSCULAR,Resolved,Solution,J07AH,BACTERIAL VACCINES,2017/11/22,2017/11/22,2018/1/15,2018/1/18,Disruption of the manufacture of the drug.,2017/4/13,2018/1/22,No
1394,1959018,Shortage,MENOMUNE-A/C/Y/W-135,SANOFI PASTEUR LIMITED,"Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined","MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A	 MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C	 MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135	 MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y",50 MCG / 0.5 ML 50 MCG / 0.5 ML 50 MCG / 0.5 ML 50 MCG / 0.5 ML,"1 x 0.5 mL vial plus 1 x 0.6 mL diluent / 1 flacon de 1 dose de 0,5 mL et 1 flacon de 0,6 mL de diluant",Subcutaneous,Resolved,"Kit,  Powder For Solution",J07AH,BACTERIAL VACCINES,2015/2/13,2015/2/13,,2017/3/29,Disruption of the manufacture of the drug.,2017/3/13,2017/3/30,No
29459,2347393,Shortage,MENVEO,GLAXOSMITHKLINE INC,"Meningococcal (Groups A, C, W-135 and Y) Oligosaccharide CRM197 Conjugate Vaccine",MENINGOCOCCAL GROUP C OLIGOSACCHARIDE CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN MENINGOCOCCAL GROUP A OLIGOSACCHARIDE MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE MENINGOCOCCAL GROUP W-135 OLIGOSACCHARIDE,5MCG 47MCG 10MCG 5MCG 5MCG,1 dose,INTRAMUSCULAR,Resolved,"SOLUTION
POWDER FOR SOLUTION",J07AH,BACTERIAL VACCINES,,2017/12/6,2018/1/18,2018/1/17,Delay in shipping of the drug.,2017/11/16,2018/1/19,No
21863,2218488,Shortage,MERREM,ASTRAZENECA CANADA INC,Meropenem,MEROPENEM,500MG,20 mL vial,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DH,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/10/10,,2018/8/28,Other (Please describe in comments),2017/9/11,2018/8/29,No
20374,2218496,Shortage,MERREM,ASTRAZENECA CANADA INC,Meropenem,MEROPENEM,1G,30 mL vial,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DH,OTHER BETA-LACTAM ANTIBACTERIALS,,2017/8/29,,2018/8/28,Other (Please describe in comments),2017/8/25,2018/8/29,No
28733,2247698,Shortage,METADOL,PALADIN LABS INC,Mathadone,METHADONE HYDROCHLORIDE,1MG,100tabs,ORAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2017/11/13,,2018/2/26,Disruption of the manufacture of the drug.,2017/11/9,2018/2/27,No
3471,2247698,Shortage,METADOL,PALADIN LABS INC,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,1MG,100 TABS,ORAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2017/3/1,2017/3/24,2017/3/24,Disruption of the manufacture of the drug.,2017/3/20,2017/3/27,No
30614,2247700,Shortage,METADOL,PALADIN LABS INC,Methadone,METHADONE HYDROCHLORIDE,10MG,100tabs,ORAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2017/11/22,,2018/1/31,Disruption of the manufacture of the drug.,2017/11/24,2018/2/1,No
11570,2245882,Shortage,METHAZOLAMIDE,AA PHARMA INC,Methazolamide,METHAZOLAMIDE,50MG,100 BTL,ORAL,Resolved,TABLET,S01EC,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2017/5/30,,2017/6/2,Disruption of the manufacture of the drug.,2017/5/30,2017/6/3,No
2010,2245882,Shortage,METHAZOLAMIDE,AA PHARMA INC,METHAZOLAMIDE,METHAZOLAMIDE,50 MG,100 Bottle,Oral,Resolved,Tablet,S01EC,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2016/3/3,2017/7/21,2017/5/29,Shortage of an active ingredient.,2017/3/13,2017/5/30,No
2612,2398427,Shortage,METHOTREXATE INJECTION USP,SANDOZ CANADA INCORPORATED,METHOTREXATE,METHOTREXATE,25MG,2mL fiole/vial,"INTRA-ARTERIAL
INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,L01BA,ANTIMETABOLITES,2017/3/14,,2017/8/28,2017/8/25,Other (Please describe in comments),2017/3/14,2017/10/18,No
17472,2182777,Shortage,METHOTREXATE INJECTION USP,PFIZER CANADA INC,Methotrexate,METHOTREXATE,25MG,1x20mL,"INTRA-ARTERIAL
INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,L01BA,ANTIMETABOLITES,2017/10/2,,2017/10/16,2017/10/2,Disruption of the manufacture of the drug.,2017/7/28,2017/10/13,No
31057,2398427,Shortage,METHOTREXATE INJECTION USP,SANDOZ CANADA INCORPORATED,METHOTREXATE,METHOTREXATE,25MG,1 VIAL,"INTRA-ARTERIAL
INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,L01BA,ANTIMETABOLITES,,2017/11/23,2017/12/22,2017/12/20,Delay in shipping of the drug.,2017/11/29,2018/1/8,No
12127,2398427,Shortage,METHOTREXATE INJECTION USP,SANDOZ CANADA INCORPORATED,METHOTREXATE,METHOTREXATE,25MG,20ML VIAL,"INTRA-ARTERIAL
INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,L01BA,ANTIMETABOLITES,,2017/4/28,2017/8/28,2017/7/11,Requirements related to complying with good manufacturing practices.,2017/6/6,2017/7/12,No
32130,2182777,Shortage,METHOTREXATE INJECTION USP,PFIZER CANADA INC,METHOTREXATE,METHOTREXATE,25MG,5 x 2mL,"INTRA-ARTERIAL
INTRAMUSCULAR
INTRAVENOUS",Avoided shortage,SOLUTION,L01BA,ANTIMETABOLITES,2018/3/30,,,2018/2/22,Disruption of the manufacture of the drug.,2017/12/8,2018/2/23,No
18320,2398427,Shortage,METHOTREXATE INJECTION USP,SANDOZ CANADA INCORPORATED,METHOTREXATE,METHOTREXATE,25MG,20ML VIAL,"INTRA-ARTERIAL
INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,L01BA,ANTIMETABOLITES,,2017/8/3,2017/8/31,2017/8/25,Demand increase for the drug.,2017/8/7,2017/10/18,No
14494,2182777,Shortage,METHOTREXATE INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,METHOTREXATE,METHOTREXATE,25MG,5x2mL VIAL/AMPOULE,"INTRA-ARTERIAL
INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,L01BA,ANTIMETABOLITES,2017/7/31,2017/9/1,2017/10/16,2017/9/6,Disruption of the manufacture of the drug.,2017/7/3,2017/10/13,No
28847,2182971,Shortage,METHOTREXATE INJECTION USP,PFIZER CANADA INC,Methotrexate,METHOTREXATE,25MG,1 x 20 mL,INTRAVENOUS,Resolved,SOLUTION,L01BA,ANTIMETABOLITES,,2018/1/24,,2018/4/19,Disruption of the manufacture of the drug.,2017/11/10,2018/4/20,No
28851,2182971,Shortage,METHOTREXATE INJECTION USP,PFIZER CANADA INC,Methotrexate,METHOTREXATE,25MG,Each - 40 mL,INTRAVENOUS,Resolved,SOLUTION,L01BA,ANTIMETABOLITES,,2017/12/22,,2018/4/3,Disruption of the manufacture of the drug.,2017/11/10,2018/4/4,No
3262,2327236,Shortage,"METHOTREXATE INJECTION, BP",ACCORD HEALTHCARE INC,METHOTREXATE,METHOTREXATE,25MG,20 ML VIAL OF 500 MG    |    FLACON DE 20 ML DE 500 MG,"INTRA-ARTERIAL
INTRAMUSCULAR
INTRATHECAL
INTRAVENOUS",Resolved,SOLUTION,L01BA,ANTIMETABOLITES,2016/12/13,2016/12/13,2017/4/19,2017/4/7,Disruption of the manufacture of the drug.,2017/3/17,2017/4/8,No
3115,2099705,Shortage,METHOTREXATE SODIUM INJECTION,TEVA CANADA LIMITED,METHOTREXATE,METHOTREXATE,25MG,20ML,"INTRA-ARTERIAL
INTRAMUSCULAR
INTRATHECAL
INTRAVENOUS",Resolved,SOLUTION,L01BA,ANTIMETABOLITES,,2017/3/17,2017/4/28,2017/5/4,Disruption of the manufacture of the drug.,2017/3/17,2017/5/10,No
19756,2182750,Shortage,"METHOTREXATE TABLETS, USP",HOSPIRA HEALTHCARE CORPORATION,Methotrexate,METHOTREXATE,10MG,1x100,ORAL,Resolved,TABLET,L01BA,ANTIMETABOLITES,2017/8/16,,2017/9/26,2017/9/25,Delay in shipping of the drug.,2017/8/17,2017/9/26,No
8017,1966375,Shortage,METHOXISAL-C 1/2,TEVA CANADA LIMITED,METHOXISAL,ACETYLSALICYLIC ACID METHOCARBAMOL CODEINE PHOSPHATE,325MG 400MG 32.4MG,100,ORAL,Actual shortage,TABLET,N02AA,OPIOIDS,,2013/3/1,,,Requirements related to complying with good manufacturing practices.,2017/4/25,2017/10/5,No
8033,1966375,Shortage,METHOXISAL-C 1/2,TEVA CANADA LIMITED,METHOXISAL,ACETYLSALICYLIC ACID METHOCARBAMOL CODEINE PHOSPHATE,325MG 400MG 32.4MG,24,ORAL,Actual shortage,TABLET,N02AA,OPIOIDS,,2013/12/1,,,Requirements related to complying with good manufacturing practices.,2017/4/25,2017/10/5,No
8041,1966367,Shortage,METHOXISAL-C 1/4,TEVA CANADA LIMITED,METHOXISAL,ACETYLSALICYLIC ACID METHOCARBAMOL CODEINE PHOSPHATE,325MG 400MG 16.2MG,24,ORAL,Actual shortage,TABLET,N02AA,OPIOIDS,,2013/12/1,,,Requirements related to complying with good manufacturing practices.,2017/4/25,2017/10/5,No
8044,1941895,Shortage,METHOXISAL-C 1/8,TEVA CANADA LIMITED,METHOXISAL,ACETYLSALICYLIC ACID METHOCARBAMOL CODEINE PHOSPHATE,325MG 400MG 8MG,18,ORAL,Actual shortage,TABLET,N02AA,OPIOIDS,,2013/12/1,,,Requirements related to complying with good manufacturing practices.,2017/4/25,2017/10/5,No
21610,2326248,Shortage,METHYLPHENIDATE,PRO DOC LIMITEE,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,10MG,500,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018/2/28,,2018/4/11,Delay in shipping of the drug.,2017/9/8,2018/4/12,No
12264,2326221,Shortage,METHYLPHENIDATE,PRO DOC LIMITEE,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,5MG,100,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018/10/2,,2018/10/25,Delay in shipping of the drug.,2017/6/7,2018/10/26,No
21236,2326256,Shortage,METHYLPHENIDATE,PRO DOC LIMITEE,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,20MG,100,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018/6/26,,2018/8/3,Delay in shipping of the drug.,2017/9/7,2018/8/4,No
1714,2241229,Shortage,METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,TEVA CANADA LIMITED,METHYLPREDNISOLONE SODIUM SUCCINATE,METHYLPREDNISOLONE,1G,10,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2016/2/29,2022/12/1,2021/9/10,Shortage of an inactive ingredient or component.,2017/3/13,2021/9/23,No
1720,2231894,Shortage,METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,TEVA CANADA LIMITED,METHYLPREDNISOLONE SODIUM SUCCINATE,METHYLPREDNISOLONE,125MG,10,"INTRAMUSCULAR
INTRAVENOUS",Actual shortage,POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2016/2/29,2022/12/1,,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
1724,2231893,Shortage,METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,TEVA CANADA LIMITED,METHYLPREDNISOLONE,METHYLPREDNISOLONE,40MG,10,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2016/2/29,2022/12/1,2021/9/10,Disruption of the manufacture of the drug.,2017/3/13,2021/9/23,No
1729,2231895,Shortage,METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,TEVA CANADA LIMITED,METHYLPREDNISOLONE,METHYLPREDNISOLONE,500MG,5,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2016/2/29,2022/12/1,2021/9/10,Disruption of the manufacture of the drug.,2017/3/13,2021/9/23,No
13916,2230431,Shortage,METONIA,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,METONIA 5mg TABS 100,METOCLOPRAMIDE HYDROCHLORIDE,5MG,100,ORAL,Resolved,TABLET,A03FA,PROPULSIVES,2017/9/11,2017/9/11,2017/9/25,2017/9/21,Disruption of the manufacture of the drug.,2017/6/26,2017/9/22,No
3764,2230432,Shortage,METONIA,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,METONIA 10mg TABS 100,METOCLOPRAMIDE HYDROCHLORIDE,10MG,100,ORAL,Actual shortage,TABLET,A03FA,PROPULSIVES,2016/11/1,2016/11/1,,,Disruption of the manufacture of the drug.,2017/3/21,2017/10/5,No
3767,2230432,Shortage,METONIA,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,METONIA 10mg TABS 500,METOCLOPRAMIDE HYDROCHLORIDE,10MG,500,ORAL,Actual shortage,TABLET,A03FA,PROPULSIVES,2016/11/1,2016/11/1,,,Disruption of the manufacture of the drug.,2017/3/21,2017/10/5,No
7155,2230433,Shortage,METONIA,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,METONIA 1mg/mL SOL 500mL,METOCLOPRAMIDE HYDROCHLORIDE,1MG,500mL,ORAL,Resolved,SOLUTION,A03FA,PROPULSIVES,,2017/4/18,2017/5/31,2017/6/4,Demand increase for the drug.,2017/4/18,2017/6/5,No
28664,2230431,Shortage,METONIA,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,METONIA 5mg TABS 100,METOCLOPRAMIDE HYDROCHLORIDE,5MG,100,ORAL,Avoided shortage,TABLET,A03FA,PROPULSIVES,2017/12/24,,2017/12/28,2017/12/4,Delay in shipping of the drug.,2017/11/8,2017/12/4,No
2327,2351412,Shortage,METOPROLOL SR,PRO DOC LIMITEE,METOPROLOL SR,METOPROLOL TARTRATE,200MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C07AB,BETA BLOCKING AGENTS,,2017/3/14,,2018/5/30,Other (Please describe in comments),2017/3/14,2018/5/31,No
32573,2442124,Shortage,METOPROLOL-L,SIVEM PHARMACEUTICALS ULC,METOPROLOL-L,METOPROLOL TARTRATE,50MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/12/25,2017/12/23,2018/5/18,2018/5/18,Other (Please describe in comments),2017/12/12,2018/5/19,No
30931,2240769,Shortage,MICARDIS 40MG TAB,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,MICARDIS,TELMISARTAN,40MG,28s,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017/11/28,2017/11/28,2017/12/8,2018/1/19,Delay in shipping of the drug.,2017/11/28,2018/1/20,No
22237,2240769,Shortage,MICARDIS 40MG TAB,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Micardis,TELMISARTAN,40MG,28s,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017/9/22,,2018/1/22,2017/11/13,Disruption of the manufacture of the drug.,2017/9/18,2017/11/17,No
2600,1974548,Shortage,MICRO I,SANDOZ CANADA INCORPORATED,MICRO I,Iodide (as sodium iodide),100MCG/ML 10X10MLV,100MCG/ML 10X10MLV,INJECTION,Resolved,LIQUID IN VAIL,A12,OTHER MINERAL SUPPLEMENTS,,2017/3/14,2017/7/18,2017/7/21,Disruption of the manufacture of the drug.,2017/3/14,2017/10/25,No
2592,2091100,Shortage,MICRO PLUS 6   (PEDIATRIC),SANDOZ CANADA INCORPORATED,MICRO+6 PED INJ,MANGANESE CHROMIUM SELENIUM ZINC COPPER IODINE,0.1MG 4MCG 20MCG 3MG 0.4MG 60MCG,10X10MLV,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,,2017/3/14,2017/4/7,2017/3/21,Disruption of the manufacture of the drug.,2017/3/14,2017/3/21,No
14850,2423766,Shortage,MIDAZOLAM INJECTION,PFIZER CANADA INC,Midazolam,MIDAZOLAM,5MG,10,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,2017/7/14,,2017/10/20,2017/10/5,Demand increase for the drug.,2017/7/6,2017/10/6,No
26124,2423766,Shortage,MIDAZOLAM INJECTION,PFIZER CANADA INC,MIDAZOLAM,MIDAZOLAM,5MG,5 x 10ML,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2017/10/31,,2018/1/12,Disruption of the manufacture of the drug.,2017/10/17,2018/2/7,No
34133,2242904,Shortage,MIDAZOLAM INJECTION,FRESENIUS KABI CANADA LTD,Midazolam for Injection,MIDAZOLAM,1MG,5mL,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2017/12/14,2018/3/29,2018/3/29,Disruption of the manufacture of the drug.,2017/12/22,2018/3/30,No
30645,2423766,Shortage,MIDAZOLAM INJECTION,PFIZER CANADA INC,MIDAZOLAM,MIDAZOLAM,5MG,10x1mL PVL,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2018/1/19,,2018/4/27,Disruption of the manufacture of the drug.,2017/11/24,2018/4/30,No
30191,2423758,Shortage,MIDAZOLAM INJECTION,PFIZER CANADA INC,MIDAZOLAM,MIDAZOLAM,1MG,10x5mL PVL,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2018/2/20,,2018/4/27,Disruption of the manufacture of the drug.,2017/11/22,2018/4/30,No
2045,2423766,Shortage,MIDAZOLAM INJECTION,PFIZER CANADA INC,MIDAZOLAM,MIDAZOLAM,5MG,10 x 1ML,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2016/12/6,2017/3/22,2017/3/29,Delay in shipping of the drug.,2017/3/14,2017/3/30,No
34093,2382342,Shortage,MIDAZOLAM INJECTION USP,PFIZER CANADA INC,Midazolam,MIDAZOLAM,1MG,10 x 2mL GVL,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2017/12/22,,2018/2/28,Disruption of the manufacture of the drug.,2017/12/21,2018/3/1,No
14497,2382377,Shortage,MIDAZOLAM INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,MIDAZOLAM,MIDAZOLAM,1MG,VIAL/AMPOULE,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2017/7/7,,2018/5/24,Disruption of the manufacture of the drug.,2017/7/3,2018/7/26,No
14500,2382350,Shortage,MIDAZOLAM INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,MIDAZOLAM,MIDAZOLAM,5MG,VIAL/AMPOULE,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2017/6/15,,2018/1/12,Disruption of the manufacture of the drug.,2017/7/3,2018/2/7,No
14503,2382385,Shortage,MIDAZOLAM INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,MIDAZOLAM,MIDAZOLAM,5MG,VIAL/AMPOULE,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2017/8/2,,2018/4/23,Disruption of the manufacture of the drug.,2017/7/3,2018/4/24,No
30648,2382342,Shortage,MIDAZOLAM INJECTION USP,PFIZER CANADA INC,MIDAZOLAM,MIDAZOLAM,1MG,10x5mL GVL,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2018/2/7,,2018/5/7,Disruption of the manufacture of the drug.,2017/11/24,2018/5/8,No
25869,2278685,Shortage,MIDODRINE,AA PHARMA INC,MIDODRINE,MIDODRINE HYDROCHLORIDE,5.0MG,100BTL,ORAL,Resolved,TABLET,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2018/7/26,2018/12/17,2018/12/17,Disruption of the manufacture of the drug.,2017/10/13,2018/12/18,No
24363,2278677,Shortage,MIDODRINE,AA PHARMA INC,MIDODRINE,MIDODRINE HYDROCHLORIDE,2.5MG,100BTL,ORAL,Resolved,TABLET,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017/10/4,2017/10/30,2017/10/12,Disruption of the manufacture of the drug.,2017/10/4,2017/10/13,No
10043,2278677,Shortage,MIDODRINE,AA PHARMA INC,MIDODRINE,MIDODRINE HYDROCHLORIDE,2.5MG,100 BTL,ORAL,Resolved,TABLET,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017/5/10,2017/5/16,2017/5/16,Demand increase for the drug.,2017/5/11,2017/5/17,No
4521,2278685,Shortage,MIDODRINE,AA PHARMA INC,MIDODRINE,MIDODRINE HYDROCHLORIDE,5.0MG,100 Bottle,ORAL,Resolved,TABLET,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017/3/28,2017/4/17,2017/4/13,Demand increase for the drug.,2017/3/29,2017/4/14,No
3800,2278677,Shortage,MIDODRINE,AA PHARMA INC,MIDODRINE,MIDODRINE HYDROCHLORIDE,2.5MG,100 Bottle,ORAL,Resolved,TABLET,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017/3/21,2017/4/17,2017/4/13,Demand increase for the drug.,2017/3/21,2017/4/14,No
20581,2444038,Shortage,MIFEGYMISO,LINEPHARMA INTERNATIONAL LIMITED,Mifepristone / Misoprostol,MISOPROSTOL MIFEPRISTONE,200MCG 200MG,Combipack,"BUCCAL
ORAL",Resolved,"KIT
TABLET",G03XB,OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM,2017/8/29,2017/8/29,2017/10/16,2017/10/13,Demand increase for the drug.,2017/8/29,2017/10/16,No
15501,2444038,Shortage,MIFEGYMISO,LINEPHARMA INTERNATIONAL LIMITED,Mifepristone / Misoprostol,MISOPROSTOL MIFEPRISTONE,200MCG 200MG,Combipack (1 box of 1 tablet of mifepristone 200 mg tablet + 1 box of 4 tablets of 200 µg misoprostol),"BUCCAL
ORAL",Resolved,"KIT
TABLET",G03XB,OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM,2017/7/10,2017/7/10,2017/7/18,2017/10/13,Delay in shipping of the drug.,2017/7/12,2017/11/10,No
26866,2444038,Shortage,MIFEGYMISO,LINEPHARMA INTERNATIONAL LIMITED,Mifepristone / Misoprostol,MISOPROSTOL MIFEPRISTONE,200MCG 200MG,Combipack,"BUCCAL
ORAL",Resolved,"KIT
TABLET",G03XB,OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM,,2017/10/24,2017/12/31,2018/1/9,Other (Please describe in comments),2017/10/24,2018/1/11,No
2996,2244622,Shortage,MILRINONE LACTATE INJECTION,FRESENIUS KABI CANADA LTD,Milrinone Lactate Injection 1 mg/mL SD Vial 20 mL,MILRINONE,1.0MG,20mL,INTRAVENOUS,Resolved,SOLUTION,C01CE,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2017/3/20,,,2017/4/7,Disruption of the manufacture of the drug.,2017/3/15,2017/4/8,No
19855,2042320,Shortage,MIN-OVRAL 21,PFIZER CANADA INC,Min-Ovral,ETHINYL ESTRADIOL LEVONORGESTREL,30MCG 150MCG,21's,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2017/8/16,,2017/8/30,2017/8/30,Disruption of the manufacture of the drug.,2017/8/18,2017/8/31,No
22094,2287226,Shortage,MINOCYCLINE,SANIS HEALTH INC,MINOCYCLINE CAPS,MINOCYCLINE,50MG,100,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,2017/9/30,2017/9/7,,2018/7/16,Disruption of the manufacture of the drug.,2017/9/14,2019/1/22,No
22098,2287234,Shortage,MINOCYCLINE,SANIS HEALTH INC,MINOCYCLINE CAPS,MINOCYCLINE,100MG,100,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,2017/9/30,2017/9/8,,2018/7/16,Disruption of the manufacture of the drug.,2017/9/14,2019/1/22,No
1601,2228319,Shortage,MINOX - LIQ TOP 20MG/ML,LABORATOIRE RIVA INC,Minoxidil Topical Solution USP,MINOXIDIL,20MG,60 ml,TOPICAL,Actual shortage,SOLUTION,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,2014/4/11,2014/4/11,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
30002,2362651,Shortage,MINT-AMLODIPINE,MINT PHARMACEUTICALS INC,Amlodipine,AMLODIPINE,5MG,250 Count bottles,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017/11/21,2017/11/21,2018/1/12,2018/1/10,Shortage of an inactive ingredient or component.,2017/11/21,2018/1/11,No
27176,2423243,Shortage,MINT-EZETIMIBE,MINT PHARMACEUTICALS INC,Ezetimibe,EZETIMIBE,10MG,Bottles of 100,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017/7/24,,2017/11/10,Shortage of an inactive ingredient or component.,2017/10/26,2017/11/11,No
32263,2457954,Shortage,MINT-LEVOCARB,MINT PHARMACEUTICALS INC,Levodopa/Carbidopa,CARBIDOPA LEVODOPA,10MG 100MG,100 count bottles,ORAL,Actual shortage,TABLET,N04BA,DOPAMINERGIC AGENTS,,2017/12/8,,,Requirements related to complying with good manufacturing practices.,2017/12/8,2017/12/9,No
32270,2457962,Shortage,MINT-LEVOCARB,MINT PHARMACEUTICALS INC,Levodopa/Carbidopa,CARBIDOPA LEVODOPA,25MG 100MG,100 count bottles,ORAL,Actual shortage,TABLET,N04BA,DOPAMINERGIC AGENTS,,2017/12/8,,,Requirements related to complying with good manufacturing practices.,2017/12/8,2017/12/9,No
32274,2457970,Shortage,MINT-LEVOCARB,MINT PHARMACEUTICALS INC,Levodopa/Carbidopa,CARBIDOPA LEVODOPA,25MG 250MG,100 count bottles,ORAL,Actual shortage,TABLET,N04BA,DOPAMINERGIC AGENTS,,2017/12/8,,,Requirements related to complying with good manufacturing practices.,2017/12/8,2017/12/9,No
27164,2305259,Shortage,MINT-ONDANSETRON,MINT PHARMACEUTICALS INC,Ondansetron,ONDANSETRON,4MG,Bottles of 30,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017/7/14,,2018/3/9,Disruption of the manufacture of the drug.,2017/10/26,2018/3/10,No
27173,2305267,Shortage,MINT-ONDANSETRON,MINT PHARMACEUTICALS INC,Ondansetron,ONDANSETRON,8MG,Bottles of 30,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017/7/14,,2017/11/21,Disruption of the manufacture of the drug.,2017/10/26,2017/11/22,No
27153,2317451,Shortage,MINT-PRAVASTATIN,MINT PHARMACEUTICALS INC,Pravastatin,,,Bottles of 100,,Resolved,,,,,2017/6/30,,2018/1/30,Shortage of an inactive ingredient or component.,2017/10/26,2018/1/31,No
27157,2317478,Shortage,MINT-PRAVASTATIN,MINT PHARMACEUTICALS INC,Pravastatin,,,Bottles of 100,,Resolved,,,,,2017/6/30,,2018/1/30,Shortage of an inactive ingredient or component.,2017/10/26,2018/1/31,No
27161,2317486,Shortage,MINT-PRAVASTATIN,MINT PHARMACEUTICALS INC,Pravastatin,,,Bottles of 100,,Resolved,,,,,2017/6/30,,2018/1/30,Shortage of an inactive ingredient or component.,2017/10/26,2018/1/31,No
28570,2315653,Shortage,MINT-TOPIRAMATE,MINT PHARMACEUTICALS INC,Mint- Topiramate,TOPIRAMATE,100MG,Bottles of 100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/11/7,2017/12/15,2017/12/15,Delay in shipping of the drug.,2017/11/7,2018/1/4,No
6443,2133326,Shortage,MIOCHOL E,BAUSCH & LOMB INC,MIOCHOL E,ACETYLCHOLINE CHLORIDE,10MG,10,OPHTHALMIC,Resolved,POWDER FOR SOLUTION,S01EB,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,2017/5/15,,2017/5/22,2017/7/14,Other (Please describe in comments),2017/4/11,2017/7/15,No
12384,42544,Shortage,MIOSTAT OPHTHALMIC LIQ 0.01%,ALCON CANADA INC,"Carbachol Intraocular Solution, USP",CARBACHOL,0.01%,1.5mL,INTRAOCULAR,Resolved,SOLUTION,S01EB,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,2017/6/9,2017/6/9,2017/7/7,2017/6/20,Disruption of the manufacture of the drug.,2017/6/9,2017/6/21,No
18180,2241594,Shortage,MIRAPEX,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Mirapex,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,90s,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017/8/8,,2017/9/11,2017/8/30,Disruption of the manufacture of the drug.,2017/8/3,2017/8/31,No
4326,2241594,Shortage,MIRAPEX,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Mirapex,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,90,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2017/3/20,2017/4/4,2017/4/5,Disruption of the manufacture of the drug.,2017/3/26,2017/4/6,No
1148,2244614,Shortage,MITOXANTRONE INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,MITOXANTRONE,MITOXANTRONE HYDROCHLORIDE,2mg,20mg/10mL x 1,Intravenous / Intraveineux,Resolved,Solution,L01DB,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,,2015/8/21,2017/9/25,2017/9/15,Disruption of the manufacture of the drug.,2017/3/13,2017/9/25,No
4323,2242785,Shortage,MOBICOX,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Mobicox,MELOXICAM,7.5MG,100,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/4/3,,2017/5/19,2017/5/9,Disruption of the manufacture of the drug.,2017/3/25,2017/5/10,No
89,755575,Shortage,MODECATE CONCENTRATE,BRISTOL-MYERS SQUIBB CANADA,Fluphenazine Decanoate,FLUPHENAZINE DECANOATE,100mg,5amp x 1ml,IV,Avoided shortage,Liquid,N05AB,ANTIPSYCHOTICS,2017/5/31,,,2017/5/19,Shortage of an active ingredient.,2017/3/10,2017/7/4,No
3020,803499,Shortage,MODULON,APTALIS PHARMA CANADA ULC,TRIMEBUTINE MALEATE,TRIMEBUTINE MALEATE,200MG,100,ORAL,Resolved,TABLET,A03AA,DRUGS FOR FUNCTIONAL BOWEL DISORDERS,2017/5/5,2017/5/10,2017/7/14,2017/7/14,Shortage of an inactive ingredient or component.,2017/3/16,2017/7/15,No
8420,511536,Shortage,MOGADON,AA PHARMA INC,Mogadon,NITRAZEPAM,10MG,100 BTL,ORAL,Resolved,TABLET,N05CD,HYPNOTICS AND SEDATIVES,2017/5/1,,,2017/5/31,Disruption of the manufacture of the drug.,2017/4/28,2017/6/1,No
14576,2379325,Shortage,MONTELUKAST,SANIS HEALTH INC,MONTELUKAST TABS,MONTELUKAST,5MG,30's,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2017/7/4,2017/7/31,2017/7/21,Other (Please describe in comments),2017/7/4,2017/7/24,No
26211,2410303,Shortage,MOVISSE,MYLAN PHARMACEUTICALS ULC,MOVISSE,NORETHINDRONE,0.35MG,28BL,ORAL,Avoided shortage,TABLET,G03AC,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2018/2/15,,,2018/2/9,Delay in shipping of the drug.,2017/10/18,2018/2/9,No
555,2415380,Shortage,MYA,APOTEX INC,MYA,DROSPIRENONE ETHINYL ESTRADIOL,3.00MG 0.02MG,28 BLS,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2017/3/9,,2020/9/1,Disruption of the manufacture of the drug.,2017/3/11,2020/9/4,No
20979,465763,Shortage,MYDFRIN,NOVARTIS PHARMACEUTICALS CANADA INC,MYDFRIN 2.4% SOLN 5ML,PHENYLEPHRINE HYDROCHLORIDE,2.50%,5 ML,OPHTHALMIC,Resolved,LIQUID,S01FB,MYDRIATICSAND CYCLOPLEGICS,,2017/8/30,,2017/9/12,Other (Please describe in comments),2017/9/5,2017/9/18,No
23160,2245372,Shortage,MYL-PROPAFENONE,MYLAN PHARMACEUTICALS ULC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,150MG,100BT,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",,2017/9/20,,2018/2/16,Delay in shipping of the drug.,2017/9/22,2018/3/2,No
23163,2245373,Shortage,MYL-PROPAFENONE,MYLAN PHARMACEUTICALS ULC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,300MG,100BT,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",,2017/9/20,,2018/2/16,Delay in shipping of the drug.,2017/9/22,2018/3/2,No
5931,2392577,Shortage,MYL-SILDENAFIL,MYLAN PHARMACEUTICALS ULC,SILDENAFIL,SILDENAFIL,25MG,4BL,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/7/16,,,2017/10/2,Delay in shipping of the drug.,2017/4/7,2017/10/3,No
6976,2392593,Shortage,MYL-SILDENAFIL,MYLAN PHARMACEUTICALS ULC,SILDENAFIL,SILDENAFIL,100MG,"4BL, 30BT",ORAL,Avoided shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/8/2,2017/5/1,,2017/7/12,Disruption of the manufacture of the drug.,2017/4/13,2017/7/17,No
5307,2392585,Shortage,MYL-SILDENAFIL,MYLAN PHARMACEUTICALS ULC,Sildenafil,SILDENAFIL,50MG,4BL,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018/5/1,2018/5/1,,2018/5/1,Delay in shipping of the drug.,2017/4/4,2018/8/23,No
5941,2237721,Shortage,MYLAN-ACEBUTOLOL,MYLAN PHARMACEUTICALS ULC,ACEBUTOLOL,ACEBUTOLOL,100MG,"100BT, 500BT",ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018/3/23,2018/3/2,,2018/7/3,Delay in shipping of the drug.,2017/4/7,2018/7/4,No
30377,2237722,Shortage,MYLAN-ACEBUTOLOL,MYLAN PHARMACEUTICALS ULC,ACEBUTOLOL,ACEBUTOLOL,200MG,"100BT, 500BT",ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018/2/9,2018/2/12,,2018/7/3,Disruption of the manufacture of the drug.,2017/11/23,2018/7/4,No
5922,2237886,Shortage,MYLAN-ACEBUTOLOL (TYPE S),MYLAN PHARMACEUTICALS ULC,ACEBUTOLOL (TYPE S),ACEBUTOLOL,200MG,500BT,ORAL,Avoided shortage,TABLET,C07AB,BETA BLOCKING AGENTS,2017/9/21,,,2017/8/23,Delay in shipping of the drug.,2017/4/7,2017/8/24,No
5962,2237887,Shortage,MYLAN-ACEBUTOLOL (TYPE S),MYLAN PHARMACEUTICALS ULC,ACEBUTOLOL (TYPE S),ACEBUTOLOL,400MG,100BT,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/10/16,2017/10/17,,2017/11/1,Delay in shipping of the drug.,2017/4/7,2017/11/2,No
5987,2237885,Shortage,MYLAN-ACEBUTOLOL (TYPE S),MYLAN PHARMACEUTICALS ULC,MYLAN-ACEBUTOLOL (TYPE S),ACEBUTOLOL,100MG,500BT,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018/1/15,2017/12/27,,2018/2/1,Delay in shipping of the drug.,2017/4/7,2018/2/2,No
28169,2242463,Shortage,MYLAN-ACYCLOVIR,MYLAN PHARMACEUTICALS ULC,ACYCLOVIR,ACYCLOVIR,400MG,100BT,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/11/6,2018/9/21,2018/9/20,Delay in shipping of the drug.,2017/11/6,2018/9/21,No
29231,2242464,Shortage,MYLAN-ACYCLOVIR,MYLAN PHARMACEUTICALS ULC,ACYCLOVIR,ACYCLOVIR,800MG,100BT,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/11/14,2018/9/21,2018/9/20,Delay in shipping of the drug.,2017/11/15,2018/9/21,No
27117,2242784,Shortage,MYLAN-ACYCLOVIR,MYLAN PHARMACEUTICALS ULC,ACYCLOVIR,ACYCLOVIR,200MG,100BT,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2018/4/24,2018/4/27,2018/5/25,2018/5/23,Delay in shipping of the drug.,2017/10/26,2018/5/24,No
5984,2286335,Shortage,MYLAN-ALENDRONATE,MYLAN PHARMACEUTICALS ULC,ALENDRONATE,ALENDRONIC ACID,70MG,4 BL,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2018/7/3,2018/7/3,,2018/7/3,Delay in shipping of the drug.,2017/4/7,2018/7/5,No
27110,2398443,Shortage,MYLAN-ALMOTRIPTAN,MYLAN PHARMACEUTICALS ULC,ALMOTRIPTAN,ALMOTRIPTAN,12.5MG,6BL,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2018/3/5,2018/3/7,2019/1/18,2019/1/21,Delay in shipping of the drug.,2017/10/26,2019/1/22,No
6973,2137542,Shortage,MYLAN-ALPRAZOLAM,MYLAN PHARMACEUTICALS ULC,ALPRAZOLAM,ALPRAZOLAM,0.5MG,"1000BT, 100BT",ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,2018/7/3,2018/7/3,,2018/7/3,Delay in shipping of the drug.,2017/4/13,2018/7/5,No
5966,2137534,Shortage,MYLAN-ALPRAZOLAM,MYLAN PHARMACEUTICALS ULC,MYLAN-ALPRAZOLAM,ALPRAZOLAM,0.25MG,"100 BT, 1000BT",ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,2017/12/1,,,2017/12/1,Delay in shipping of the drug.,2017/4/7,2017/12/2,No
5326,2229813,Shortage,MYLAN-ALPRAZOLAM,MYLAN PHARMACEUTICALS ULC,ALPRAZOLAM,ALPRAZOLAM,1MG,100BT,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,2017/8/3,,,2017/8/23,Delay in shipping of the drug.,2017/4/4,2017/8/24,No
5046,2240604,Shortage,MYLAN-AMIODARONE,MYLAN PHARMACEUTICALS ULC,AMIODARONE,AMIODARONE HYDROCHLORIDE,200MG,100,ORAL,Avoided shortage,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",2017/6/6,,,2017/5/1,Shortage of an active ingredient.,2017/3/31,2017/5/4,No
5335,2240604,Shortage,MYLAN-AMIODARONE,MYLAN PHARMACEUTICALS ULC,AMIODARONE,AMIODARONE HYDROCHLORIDE,200MG,100BT,ORAL,Resolved,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",,2017/7/4,,2017/9/22,Delay in shipping of the drug.,2017/4/4,2018/7/3,No
4090,2240604,Shortage,MYLAN-AMIODARONE,MYLAN PHARMACEUTICALS ULC,Amiodarone,AMIODARONE HYDROCHLORIDE,200MG,100BT,ORAL,Avoided shortage,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",2017/6/4,,,2017/5/1,Shortage of an active ingredient.,2017/3/23,2017/5/4,No
28029,2272121,Shortage,MYLAN-AMLODIPINE,MYLAN PHARMACEUTICALS ULC,AMLODIPINE,AMLODIPINE,10.0MG,"100BT, 500BT",ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2018/1/31,2018/1/31,2018/2/9,2018/2/9,Delay in shipping of the drug.,2017/11/3,2018/2/10,No
28616,2272113,Shortage,MYLAN-AMLODIPINE,MYLAN PHARMACEUTICALS ULC,AMLODIPINE,AMLODIPINE,5.0MG,"100BT, 500BT",ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2018/1/29,2018/1/22,2018/2/9,2018/2/9,Delay in shipping of the drug.,2017/11/8,2018/2/10,No
5972,2238172,Shortage,MYLAN-AMOXICILLIN,MYLAN PHARMACEUTICALS ULC,AMOXICILLIN,AMOXICILLIN,500MG,"100BT, 500BT",ORAL,Resolved,CAPSULE,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2018/2/7,,2019/9/30,Disruption of the manufacture of the drug.,2017/4/7,2019/10/3,No
125,2146894,Shortage,MYLAN-ATENOLOL,MYLAN PHARMACEUTICALS ULC,ATENOLOL,ATENOLOL,50MG,"100BT, 500BT",ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018/7/3,2018/7/3,,2018/7/3,Disruption of the manufacture of the drug.,2017/3/10,2018/7/5,No
10711,2303647,Shortage,MYLAN-ATENOLOL,MYLAN PHARMACEUTICALS ULC,ATENOLOL,ATENOLOL,25MG,100BT,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018/5/25,2018/5/25,,2018/6/7,Disruption of the manufacture of the drug.,2017/5/19,2018/6/8,No
5005,2378957,Shortage,MYLAN-ATOMOXETINE,MYLAN PHARMACEUTICALS ULC,ATOMOXETINE,ATOMOXETINE,40MG,100BT,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018/7/3,2018/5/1,,2018/7/3,Other (Please describe in comments),2017/3/31,2018/7/4,No
155,2378965,Shortage,MYLAN-ATOMOXETINE,MYLAN PHARMACEUTICALS ULC,ATOMOXETINE,ATOMOXETINE,60MG,100BT,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018/7/3,2018/5/1,,2018/7/3,Other (Please describe in comments),2017/3/10,2018/7/4,No
229,2378981,Shortage,MYLAN-ATOMOXETINE,MYLAN PHARMACEUTICALS ULC,Atomoxetine,ATOMOXETINE,100MG,100s,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018/5/1,,2018/7/3,Other (Please describe in comments),2017/3/10,2018/7/4,No
19456,2392976,Shortage,MYLAN-ATORVASTATIN,MYLAN PHARMACEUTICALS ULC,ATORVASTATIN,ATORVASTATIN,80MG,"90BT, 500BT",ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018/10/20,,2018/10/26,2018/10/23,Disruption of the manufacture of the drug.,2017/8/15,2018/10/24,No
11785,2392968,Shortage,MYLAN-ATORVASTATIN,MYLAN PHARMACEUTICALS ULC,ATORVASTATIN,ATORVASTATIN,40MG,"90BT, 500BT",ORAL,Avoided shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018/10/16,,2018/10/19,2018/10/15,Disruption of the manufacture of the drug.,2017/6/2,2018/10/16,No
25898,2392941,Shortage,MYLAN-ATORVASTATIN,MYLAN PHARMACEUTICALS ULC,ATORVASTATIN,ATORVASTATIN,20MG,"90BT, 500BT",ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018/10/15,,2018/10/19,2018/10/15,Disruption of the manufacture of the drug.,2017/10/13,2018/10/16,No
10714,2392976,Shortage,MYLAN-ATORVASTATIN,MYLAN PHARMACEUTICALS ULC,ATORVASTATIN,ATORVASTATIN,80MG,90BT,ORAL,Avoided shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/8/17,,,2017/7/24,Requirements related to complying with good manufacturing practices.,2017/5/19,2017/7/25,No
20553,2402165,Shortage,MYLAN-ATOVAQUONE/PROGUANIL,MYLAN PHARMACEUTICALS ULC,ATOVAQUONE/PROGUANIL,PROGUANIL HYDROCHLORIDE ATOVAQUONE,100MG 250MG,100BT,ORAL,Resolved,TABLET,P01BB,ANTIMALARIALS,2018/12/6,2018/12/10,2018/12/21,2018/12/18,Disruption of the manufacture of the drug.,2017/8/29,2018/12/19,No
5928,2231491,Shortage,MYLAN-AZATHIOPRINE,MYLAN PHARMACEUTICALS ULC,AZATHIOPRINE,AZATHIOPRINE,50MG,100,ORAL,Resolved,TABLET,L04AX,IMMUNOSUPPRESSANTS,2017/11/1,,,2017/11/1,Delay in shipping of the drug.,2017/4/7,2017/11/2,No
30365,2278359,Shortage,MYLAN-AZITHROMYCIN,MYLAN PHARMACEUTICALS ULC,AZITHROMYCIN,AZITHROMYCIN,250MG,"6BL, 30BT",ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2018/2/2,,2018/3/1,Disruption of the manufacture of the drug.,2017/11/23,2018/3/2,No
3931,2088401,Shortage,MYLAN-BACLOFEN,MYLAN PHARMACEUTICALS ULC,BACLOFEN,BACLOFEN,20MG,100BT,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",2017/12/13,2017/12/13,2018/3/30,2018/3/23,Delay in shipping of the drug.,2017/3/22,2018/3/24,No
27072,2088398,Shortage,MYLAN-BACLOFEN,MYLAN PHARMACEUTICALS ULC,BACLOFEN,BACLOFEN,10MG,"100BT, 500BT",ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",2018/1/2,2017/12/29,2018/1/10,2018/1/8,Delay in shipping of the drug.,2017/10/26,2018/1/9,No
14271,2172712,Shortage,MYLAN-BECLO AQ,MYLAN PHARMACEUTICALS ULC,BECLO AQ,BECLOMETHASONE DIPROPIONATE,50MCG,22s,NASAL,Resolved,"METERED-DOSE AEROSOL
SUSPENSION",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,2018/11/7,2018/11/7,2019/2/28,2019/3/8,Delay in shipping of the drug.,2017/6/28,2019/3/9,No
6985,2384418,Shortage,MYLAN-BISOPROLOL,MYLAN PHARMACEUTICALS ULC,BISOPROLOL,BISOPROLOL FUMARATE,5MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/4/11,,2017/7/12,Disruption of the manufacture of the drug.,2017/4/13,2017/7/17,No
9101,2384418,Shortage,MYLAN-BISOPROLOL,MYLAN PHARMACEUTICALS ULC,BISOPROLOL,BISOPROLOL FUMARATE,5MG,100BT,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/5/1,,2017/7/12,Disruption of the manufacture of the drug.,2017/5/5,2017/7/17,No
5313,2384426,Shortage,MYLAN-BISOPROLOL,MYLAN PHARMACEUTICALS ULC,Bisoprolol,BISOPROLOL FUMARATE,10MG,100BT,ORAL,Avoided shortage,TABLET,C07AB,BETA BLOCKING AGENTS,2017/7/28,,,2017/7/12,Disruption of the manufacture of the drug.,2017/4/4,2017/7/17,No
23157,2383497,Shortage,MYLAN-BOSENTAN,MYLAN PHARMACEUTICALS ULC,BOSENTAN,BOSENTAN,62.5MG,56BL,ORAL,Resolved,TABLET,C02KX,OTHER ANTIHYPERTENSIVES,,2017/9/20,,2017/9/22,Disruption of the manufacture of the drug.,2017/9/22,2018/7/3,No
22010,2383500,Shortage,MYLAN-BOSENTAN,MYLAN PHARMACEUTICALS ULC,BOSENTAN,BOSENTAN,125.0MG,56BL,ORAL,Resolved,TABLET,C02KX,OTHER ANTIHYPERTENSIVES,,2017/9/11,,2017/9/22,Disruption of the manufacture of the drug.,2017/9/13,2017/9/23,No
23166,2230648,Shortage,MYLAN-BUDESONIDE AQ,MYLAN PHARMACEUTICALS ULC,BUDESONIDE AQ,BUDESONIDE,100MCG,165,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,2018/4/16,2018/4/16,2020/1/30,2020/1/20,Delay in shipping of the drug.,2017/9/22,2020/1/21,No
23169,2241003,Shortage,MYLAN-BUDESONIDE AQ,MYLAN PHARMACEUTICALS ULC,BUDESONIDE AQ,BUDESONIDE,64MCG,120,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,2018/10/30,2018/11/5,2020/3/3,2020/3/3,Delay in shipping of the drug.,2017/9/22,2020/3/4,No
3089,2408104,Shortage,MYLAN-BUPRENORPHINE/NALOXONE,MYLAN PHARMACEUTICALS ULC,BUPRENORPHINE/NALOXONE,BUPRENORPHINE NALOXONE,8MG 2MG,100BT,SUBLINGUAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2017/3/14,,2019/9/17,Delay in shipping of the drug.,2017/3/16,2019/9/18,No
3922,2408090,Shortage,MYLAN-BUPRENORPHINE/NALOXONE,MYLAN PHARMACEUTICALS ULC,Buprenorphine/Naloxone,BUPRENORPHINE NALOXONE,2MG 0.5MG,100s,SUBLINGUAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2017/3/20,,2017/4/11,Delay in shipping of the drug.,2017/3/22,2017/4/12,No
7392,2408090,Shortage,MYLAN-BUPRENORPHINE/NALOXONE,MYLAN PHARMACEUTICALS ULC,BUPRENORPHINE/NALOXONE,BUPRENORPHINE NALOXONE,2MG 0.5MG,100BT,SUBLINGUAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,2018/7/3,2018/6/26,,2019/9/17,Disruption of the manufacture of the drug.,2017/4/20,2019/9/18,No
3941,2382075,Shortage,MYLAN-BUPROPION XL,MYLAN PHARMACEUTICALS ULC,BUPROPION XL,BUPROPION HYDROCHLORIDE,150MG,"90BT, 500BT",ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,2018/5/18,2018/5/4,2019/9/30,2019/6/18,Disruption of the manufacture of the drug.,2017/3/22,2019/6/19,No
3944,2382083,Shortage,MYLAN-BUPROPION XL,MYLAN PHARMACEUTICALS ULC,BUPROPION XL,BUPROPION HYDROCHLORIDE,300MG,"90BT, 500BT",ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,2018/5/24,2018/5/25,2019/9/30,2019/6/18,Disruption of the manufacture of the drug.,2017/3/22,2019/6/19,No
128,2382075,Shortage,MYLAN-BUPROPION XL,MYLAN PHARMACEUTICALS ULC,Bupropion Once-Daily,BUPROPION HYDROCHLORIDE,150MG,90,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2017/1/25,,2017/3/23,Demand increase for the drug.,2017/3/10,2017/3/24,No
131,2382083,Shortage,MYLAN-BUPROPION XL,MYLAN PHARMACEUTICALS ULC,Bupropion Once-Daily,BUPROPION HYDROCHLORIDE,300MG,90,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2017/1/25,,2017/3/23,Demand increase for the drug.,2017/3/10,2017/3/24,No
5028,2382075,Shortage,MYLAN-BUPROPION XL,MYLAN PHARMACEUTICALS ULC,BUPROPION XL,BUPROPION HYDROCHLORIDE,150MG,90BT,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2017/8/9,2017/9/30,2017/8/16,Requirements related to complying with good manufacturing practices.,2017/3/31,2017/8/17,No
5034,2382083,Shortage,MYLAN-BUPROPION XL,MYLAN PHARMACEUTICALS ULC,BUPROPION XL,BUPROPION HYDROCHLORIDE,300MG,90,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,2017/4/17,,2017/6/6,2017/6/20,Requirements related to complying with good manufacturing practices.,2017/3/31,2017/6/22,No
7131,2382083,Shortage,MYLAN-BUPROPION XL,MYLAN PHARMACEUTICALS ULC,BUPROPION XL,BUPROPION HYDROCHLORIDE,300MG,90,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2017/4/22,,2017/5/1,Shortage of an active ingredient.,2017/4/17,2017/5/2,No
14695,2379147,Shortage,MYLAN-CANDESARTAN,MYLAN PHARMACEUTICALS ULC,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,100BT,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018/4/18,2018/4/18,,2018/7/3,Delay in shipping of the drug.,2017/7/5,2018/7/5,No
16246,2379155,Shortage,MYLAN-CANDESARTAN,MYLAN PHARMACEUTICALS ULC,CANDESARTAN,CANDESARTAN CILEXETIL,32MG,100BT,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018/5/7,2018/5/8,,2018/7/3,Delay in shipping of the drug.,2017/7/18,2018/7/5,No
13190,2379120,Shortage,MYLAN-CANDESARTAN,MYLAN PHARMACEUTICALS ULC,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,100BT,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018/1/22,2018/1/24,,2018/7/3,Delay in shipping of the drug.,2017/6/16,2018/7/4,No
5042,2379139,Shortage,MYLAN-CANDESARTAN,MYLAN PHARMACEUTICALS ULC,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/5/15,2018/8/10,2018/8/10,Disruption of the manufacture of the drug.,2017/3/31,2018/8/11,No
9261,2347512,Shortage,MYLAN-CARVEDILOL,MYLAN PHARMACEUTICALS ULC,CARVEDILOL,CARVEDILOL,3.125MG,100,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,2017/12/1,,,2017/12/1,Disruption of the manufacture of the drug.,2017/5/5,2017/12/2,No
9271,2347520,Shortage,MYLAN-CARVEDILOL,MYLAN PHARMACEUTICALS ULC,CARVEDILOL,CARVEDILOL,6.25MG,100,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,2017/12/1,,,2017/12/1,Disruption of the manufacture of the drug.,2017/5/5,2017/12/2,No
9276,2347555,Shortage,MYLAN-CARVEDILOL,MYLAN PHARMACEUTICALS ULC,CARVEDILOL,CARVEDILOL,12.5MG,100,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,2017/12/1,,,2017/12/1,Disruption of the manufacture of the drug.,2017/5/5,2017/12/2,No
6989,2347571,Shortage,MYLAN-CARVEDILOL,MYLAN PHARMACEUTICALS ULC,CARVEDILOL,CARVEDILOL,25MG,100BT,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2017/4/11,,2017/7/12,Disruption of the manufacture of the drug.,2017/4/13,2017/7/17,No
9105,2347571,Shortage,MYLAN-CARVEDILOL,MYLAN PHARMACEUTICALS ULC,CARVEDILOL,CARVEDILOL,25MG,100BT,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2017/5/1,,2017/7/12,Disruption of the manufacture of the drug.,2017/5/5,2017/7/17,No
134,2423278,Shortage,MYLAN-CELECOXIB,MYLAN PHARMACEUTICALS ULC,CELECOXIB,CELECOXIB,100MG,"100BT, 500BT",ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018/7/3,2018/5/1,,2018/7/3,Other (Please describe in comments),2017/3/10,2018/7/4,No
137,2423278,Shortage,MYLAN-CELECOXIB,MYLAN PHARMACEUTICALS ULC,Celecoxib,CELECOXIB,100MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2016/12/29,2016/12/29,2017/4/15,2017/3/13,Demand increase for the drug.,2017/3/10,2017/3/14,No
140,2399881,Shortage,MYLAN-CELECOXIB,MYLAN PHARMACEUTICALS ULC,Celecoxib,CELECOXIB,200MG,100 BT,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018/7/3,2018/7/3,,2018/7/3,Disruption of the manufacture of the drug.,2017/3/10,2018/7/5,No
5009,2423278,Shortage,MYLAN-CELECOXIB,MYLAN PHARMACEUTICALS ULC,Celecoxib,CELECOXIB,100MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/3/28,,2017/4/20,Demand increase for the drug.,2017/3/31,2017/4/21,No
16933,2283786,Shortage,MYLAN-CILAZAPRIL,MYLAN PHARMACEUTICALS ULC,CILAZAPRIL,CILAZAPRIL,2.5MG,100BT,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017/11/2,,2017/11/10,2017/11/3,Disruption of the manufacture of the drug.,2017/7/25,2017/11/4,No
10054,2283778,Shortage,MYLAN-CILAZAPRIL,MYLAN PHARMACEUTICALS ULC,CILAZAPRIL,CILAZAPRIL,1MG,100,ORAL,Avoided shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018/8/29,,2018/8/30,2018/8/21,Delay in shipping of the drug.,2017/5/11,2018/8/21,No
21588,2283794,Shortage,MYLAN-CILAZAPRIL,MYLAN PHARMACEUTICALS ULC,CILAZAPRIL,CILAZAPRIL,5.0MG,100BT,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018/4/27,2018/8/30,2018/8/30,Delay in shipping of the drug.,2017/9/8,2018/8/31,No
7404,2283778,Shortage,MYLAN-CILAZAPRIL,MYLAN PHARMACEUTICALS ULC,CILAZAPRIL,CILAZAPRIL,1MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/5/8,,2017/5/15,Delay in shipping of the drug.,2017/4/20,2017/5/16,No
6993,2227460,Shortage,MYLAN-CIMETIDINE,MYLAN PHARMACEUTICALS ULC,CIMETIDINE,CIMETIDINE,600MG,100BT,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/4/11,,2017/9/7,Disruption of the manufacture of the drug.,2017/4/13,2017/9/8,No
9108,2227460,Shortage,MYLAN-CIMETIDINE,MYLAN PHARMACEUTICALS ULC,CIMETIDINE,CIMETIDINE,600MG,500BT,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/5/1,,2017/9/7,Disruption of the manufacture of the drug.,2017/5/5,2017/9/8,No
21591,2434547,Shortage,MYLAN-CINACALCET,MYLAN PHARMACEUTICALS ULC,CINACALCET,CINACALCET,60MG,30BT,ORAL,Resolved,TABLET,H05BX,ANTI-PARATHYROID HORMONES,2018/12/5,2018/12/5,2019/2/8,2018/12/18,Delay in shipping of the drug.,2017/9/8,2018/12/19,No
23807,2434539,Shortage,MYLAN-CINACALCET,MYLAN PHARMACEUTICALS ULC,CINACALCET,CINACALCET,30MG,30BT,ORAL,Resolved,TABLET,H05BX,ANTI-PARATHYROID HORMONES,2018/12/5,2018/12/5,,2019/1/15,Delay in shipping of the drug.,2017/9/28,2019/1/16,No
9111,2245649,Shortage,MYLAN-CIPROFLOXACIN,MYLAN PHARMACEUTICALS ULC,CIPROFLOXACIN,CIPROFLOXACIN,750MG,100,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2017/5/1,,2017/12/1,Disruption of the manufacture of the drug.,2017/5/5,2017/12/2,No
232,2246594,Shortage,MYLAN-CITALOPRAM,MYLAN PHARMACEUTICALS ULC,Citalopram,CITALOPRAM,20MG,"100 BT, 500 BT",ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018/7/3,2018/7/3,,2018/7/3,Disruption of the manufacture of the drug.,2017/3/10,2018/7/5,No
6999,2248856,Shortage,MYLAN-CLARITHROMYCIN,MYLAN PHARMACEUTICALS ULC,CLARITHROMYCIN,CLARITHROMYCIN,250MG,100BT,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/4/11,,2017/7/12,Disruption of the manufacture of the drug.,2017/4/13,2017/7/17,No
7005,2248857,Shortage,MYLAN-CLARITHROMYCIN,MYLAN PHARMACEUTICALS ULC,CLARITHROMYCIN,CLARITHROMYCIN,500MG,100BT,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/4/11,,2017/7/12,Disruption of the manufacture of the drug.,2017/4/13,2017/7/17,No
9115,2248856,Shortage,MYLAN-CLARITHROMYCIN,MYLAN PHARMACEUTICALS ULC,CLARITHROMYCIN,CLARITHROMYCIN,250MG,100BT,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/5/1,,2017/7/12,Disruption of the manufacture of the drug.,2017/5/5,2017/7/17,No
9118,2248857,Shortage,MYLAN-CLARITHROMYCIN,MYLAN PHARMACEUTICALS ULC,CLARITHROMYCIN,CLARITHROMYCIN,500MG,100BT,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/5/1,,2017/7/12,Disruption of the manufacture of the drug.,2017/5/5,2017/7/17,No
9036,2258331,Shortage,MYLAN-CLINDAMYCIN,MYLAN PHARMACEUTICALS ULC,CLINDAMYCIN,CLINDAMYCIN,150MG,100BT,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2018/5/1,,2018/7/3,Other (Please describe in comments),2017/5/4,2018/7/4,No
5012,2258358,Shortage,MYLAN-CLINDAMYCIN,MYLAN PHARMACEUTICALS ULC,CLINDAMYCIN,CLINDAMYCIN,300MG,100BT,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2018/5/1,,2018/7/3,Other (Please describe in comments),2017/3/31,2018/7/4,No
18684,2216213,Shortage,MYLAN-CLOBETASOL SCALP APPLICATION,MYLAN PHARMACEUTICALS ULC,CLOBETASOL SCALP APPLICATION,CLOBETASOL PROPIONATE,0.05%,1,TOPICAL,Resolved,LOTION,D07AD,"CORTICOSTEROIDS, PLAIN",2017/11/28,2017/11/28,2018/2/23,2018/2/22,Delay in shipping of the drug.,2017/8/10,2018/2/23,No
31518,2230950,Shortage,MYLAN-CLONAZEPAM,MYLAN PHARMACEUTICALS ULC,CLONAZEPAM,CLONAZEPAM,0.5MG,"100BT, 500BT",ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2017/12/1,,,2017/12/1,Disruption of the manufacture of the drug.,2017/12/1,2017/12/2,No
9300,2230951,Shortage,MYLAN-CLONAZEPAM,MYLAN PHARMACEUTICALS ULC,CLONAZEPAM,CLONAZEPAM,2MG,"100BT, 500BT",ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2018/4/2,,,2018/4/2,Disruption of the manufacture of the drug.,2017/5/5,2018/4/3,No
30326,2351536,Shortage,MYLAN-CLOPIDOGREL,MYLAN PHARMACEUTICALS ULC,MYLAN-CLOPIDOGREL,CLOPIDOGREL,75MG,"100BT, 500BT",ORAL,Resolved,TABLET,B01AC,ANTITHROMBOTIC AGENTS,2018/3/1,,,2018/3/1,Disruption of the manufacture of the drug.,2017/11/23,2018/5/2,No
2465,2231353,Shortage,MYLAN-CYCLOBENZAPRINE,MYLAN PHARMACEUTICALS ULC,Cyclobenzaprine,CYCLOBENZAPRINE HYDROCHLORIDE,10MG,500,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2018/2/20,,2018/6/7,Disruption of the manufacture of the drug.,2017/3/14,2018/6/8,No
10066,2359480,Shortage,MYLAN-DONEPEZIL,MYLAN PHARMACEUTICALS ULC,DONEPEZIL,DONEPEZIL HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,2018/3/1,,,2018/3/1,Disruption of the manufacture of the drug.,2017/5/11,2018/3/2,No
9303,2359472,Shortage,MYLAN-DONEPEZIL,MYLAN PHARMACEUTICALS ULC,DONEPEZIL,DONEPEZIL HYDROCHLORIDE,5MG,100BT,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,2018/5/1,2018/5/2,,2018/5/2,Disruption of the manufacture of the drug.,2017/5/5,2018/5/18,No
23172,2443902,Shortage,MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL,MYLAN PHARMACEUTICALS ULC,EMTRICITABINE/TENOFOVIR DISOPROXIL,TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE,300MG 200MG,30BT,ORAL,Avoided shortage,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,2018/12/19,,2019/1/11,2018/12/18,Delay in shipping of the drug.,2017/9/22,2018/12/19,No
5954,2390337,Shortage,MYLAN-ENTACAPONE,MYLAN PHARMACEUTICALS ULC,ENTACAPONE,ENTACAPONE,200MG,100BT,ORAL,Avoided shortage,TABLET,N04BX,DOPAMINERGIC AGENTS,2017/8/19,,,2017/4/11,Delay in shipping of the drug.,2017/4/7,2017/4/13,No
9306,2390337,Shortage,MYLAN-ENTACAPONE,MYLAN PHARMACEUTICALS ULC,ENTACAPONE,ENTACAPONE,200MG,100BT,ORAL,Resolved,TABLET,N04BX,DOPAMINERGIC AGENTS,2017/11/1,,,2017/11/1,Disruption of the manufacture of the drug.,2017/5/5,2017/11/2,No
25885,2309467,Shortage,MYLAN-ESCITALOPRAM,MYLAN PHARMACEUTICALS ULC,ESCITALOPRAM,ESCITALOPRAM,10MG,100 BT,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/11/3,2017/12/22,2017/12/20,Delay in shipping of the drug.,2017/10/13,2017/12/21,No
17756,2309475,Shortage,MYLAN-ESCITALOPRAM,MYLAN PHARMACEUTICALS ULC,ESCITALOPRAM,ESCITALOPRAM,20MG,100BT,ORAL,Avoided shortage,TABLET,N06AB,ANTIDEPRESSANTS,2018/7/23,,2018/7/27,2018/7/5,Delay in shipping of the drug.,2017/8/1,2018/7/5,No
33989,2383047,Shortage,MYLAN-ESOMEPRAZOLE,MYLAN PHARMACEUTICALS ULC,ESOMEPRAZOLE,ESOMEPRAZOLE,40MG,100 BT,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018/2/12,2018/1/12,2018/3/2,2018/2/28,Delay in shipping of the drug.,2017/12/20,2018/3/1,No
5341,2196026,Shortage,MYLAN-FAMOTIDINE,MYLAN PHARMACEUTICALS ULC,FAMOTIDINE,FAMOTIDINE,40MG,100BT,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018/1/8,2018/1/3,2018/2/1,2018/2/1,Delay in shipping of the drug.,2017/4/4,2018/2/15,No
5332,2240210,Shortage,MYLAN-FENOFIBRATE MICRO,MYLAN PHARMACEUTICALS ULC,FENOFIBRATE MICRO,FENOFIBRATE,200MG,100BT,ORAL,Avoided shortage,CAPSULE,C10AB,"LIPID MODIFYING AGENTS, PLAIN",2017/7/16,,,2017/7/12,Disruption of the manufacture of the drug.,2017/4/4,2017/7/17,No
4126,2396718,Shortage,MYLAN-FENTANYL MATRIX PATCH,MYLAN PHARMACEUTICALS ULC,FENTANYL MATRIX PATCH 25 MCG,FENTANYL,25MCG,5,TRANSDERMAL,Avoided shortage,PATCH,N02AB,OPIOIDS,2017/8/29,,2017/9/15,2017/8/14,Delay in shipping of the drug.,2017/3/24,2017/8/16,No
10059,2396742,Shortage,MYLAN-FENTANYL MATRIX PATCH,MYLAN PHARMACEUTICALS ULC,FENTANYL MATRIX PATCH,FENTANYL,100MCG,5,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,,2017/5/8,,2017/5/31,Delay in shipping of the drug.,2017/5/11,2017/6/2,No
16249,2396726,Shortage,MYLAN-FENTANYL MATRIX PATCH,MYLAN PHARMACEUTICALS ULC,FENTANYL MATRIX PATCH,FENTANYL,50MCG,5,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,,2018/11/19,,2018/12/31,Delay in shipping of the drug.,2017/7/18,2019/1/3,No
152,2396696,Shortage,MYLAN-FENTANYL MATRIX PATCH,MYLAN PHARMACEUTICALS ULC,Fentanyl Patch,FENTANYL,12MCG,5,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,,2018/7/27,2018/8/3,2018/8/1,Delay in shipping of the drug.,2017/3/10,2018/8/2,No
180,2396734,Shortage,MYLAN-FENTANYL MATRIX PATCH,MYLAN PHARMACEUTICALS ULC,FENTANYL MATRIX PATCH 75 MCG,FENTANYL,75MCG,5,TRANSDERMAL,Avoided shortage,PATCH,N02AB,OPIOIDS,2017/9/3,,2017/9/15,2017/8/14,Delay in shipping of the drug.,2017/3/10,2017/8/16,No
7011,2262401,Shortage,MYLAN-FOSINOPRIL,MYLAN PHARMACEUTICALS ULC,FOSINOPRIL,FOSINOPRIL SODIUM,10MG,100BT,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/4/11,,2017/7/12,Disruption of the manufacture of the drug.,2017/4/13,2017/7/17,No
9124,2262401,Shortage,MYLAN-FOSINOPRIL,MYLAN PHARMACEUTICALS ULC,FOSINOPRIL,FOSINOPRIL SODIUM,10MG,100BT,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/5/1,,2017/7/12,Disruption of the manufacture of the drug.,2017/5/5,2017/7/17,No
5316,2262428,Shortage,MYLAN-FOSINOPRIL,MYLAN PHARMACEUTICALS ULC,FOSINOPRIL,FOSINOPRIL SODIUM,20MG,100BT,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017/5/8,2017/7/6,,2017/7/12,Delay in shipping of the drug.,2017/4/4,2017/7/17,No
5976,2248261,Shortage,MYLAN-GABAPENTIN,MYLAN PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,400MG,500BT,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/12/1,,,2017/12/1,Delay in shipping of the drug.,2017/4/7,2017/12/2,No
7014,2248260,Shortage,MYLAN-GABAPENTIN,MYLAN PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,300MG,500BT,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/4/11,,2017/8/23,Disruption of the manufacture of the drug.,2017/4/13,2017/8/24,No
7017,2397471,Shortage,MYLAN-GABAPENTIN,MYLAN PHARMACEUTICALS ULC,MYLAN-GABAPENTIN,GABAPENTIN,600MG,100BT,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/4/11,,2017/8/23,Disruption of the manufacture of the drug.,2017/4/13,2017/8/24,No
7020,2397498,Shortage,MYLAN-GABAPENTIN,MYLAN PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,800MG,100BT,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/4/11,,2017/8/23,Disruption of the manufacture of the drug.,2017/4/13,2017/8/24,No
5301,2248259,Shortage,MYLAN-GABAPENTIN,MYLAN PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,100MG,500BT,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/4/11,2017/7/6,,2017/8/23,Delay in shipping of the drug.,2017/4/4,2017/8/24,No
5322,2248260,Shortage,MYLAN-GABAPENTIN,MYLAN PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,300MG,100BT,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/8/22,,,2017/8/23,Delay in shipping of the drug.,2017/4/4,2017/8/24,No
5913,2229519,Shortage,MYLAN-GLICLAZIDE,MYLAN PHARMACEUTICALS ULC,Gliclazide,GLICLAZIDE,80MG,"100BT, 60BL",ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017/12/1,,,2017/12/1,Delay in shipping of the drug.,2017/4/7,2017/12/2,No
5925,2252600,Shortage,MYLAN-HYDROXYCHLOROQUINE,MYLAN PHARMACEUTICALS ULC,HYDROXYCHLOROQUINE,HYDROXYCHLOROQUINE SULFATE,200MG,100BT,ORAL,Resolved,TABLET,P01BA,ANTIMALARIALS,2018/7/3,2018/7/3,,2018/7/3,Disruption of the manufacture of the drug.,2017/4/7,2018/7/5,No
3372,2242920,Shortage,MYLAN-HYDROXYUREA,MYLAN PHARMACEUTICALS ULC,HYDROXYUREA,HYDROXYUREA,500MG,100BT,ORAL,Resolved,CAPSULE,L01XX,OTHER ANTINEOPLASTIC AGENTS,2017/7/21,2017/7/24,2018/2/26,2018/2/27,Disruption of the manufacture of the drug.,2017/3/17,2018/2/28,No
7289,2153483,Shortage,MYLAN-INDAPAMIDE,MYLAN PHARMACEUTICALS ULC,INDAPAMIDE,INDAPAMIDE,2.5MG,100BT,ORAL,Avoided shortage,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",2018/2/1,,2018/2/9,2018/1/25,Delay in shipping of the drug.,2017/4/19,2018/1/26,No
189,2240067,Shortage,MYLAN-INDAPAMIDE,MYLAN PHARMACEUTICALS ULC,INDAPAMIDE,INDAPAMIDE,1.25MG,100BT,ORAL,Resolved,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",2018/12/18,,2019/2/8,2019/1/17,Delay in shipping of the drug.,2017/3/10,2019/1/18,No
191,2240067,Shortage,MYLAN-INDAPAMIDE,MYLAN PHARMACEUTICALS ULC,Indapamide,INDAPAMIDE,1.25MG,100BT,ORAL,Resolved,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",,2016/9/9,,2017/3/14,Requirements related to complying with good manufacturing practices.,2017/3/10,2017/3/15,No
194,2153483,Shortage,MYLAN-INDAPAMIDE,MYLAN PHARMACEUTICALS ULC,Indapamide,Indapamide,2.5mg,100BT,Oral,Resolved,Tablet,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",,2016/9/22,,2017/3/29,Demand increase for the drug.,2017/3/10,2017/3/31,No
4073,2153483,Shortage,MYLAN-INDAPAMIDE,MYLAN PHARMACEUTICALS ULC,Indapamide,INDAPAMIDE,2.5MG,100BT,ORAL,Resolved,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",2017/4/1,,,2017/4/3,Demand increase for the drug.,2017/3/23,2017/4/4,No
30371,2239131,Shortage,MYLAN-IPRATROPIUM SOLUTION,MYLAN PHARMACEUTICALS ULC,IPRATROPIUM SOLUTION,IPRATROPIUM BROMIDE,0.25MG,20ML,INHALATION,Resolved,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2018/7/2,2018/7/3,,2018/7/3,Disruption of the manufacture of the drug.,2017/11/23,2018/7/5,No
9217,2347296,Shortage,MYLAN-IRBESARTAN,MYLAN PHARMACEUTICALS ULC,IRBESARTAN,IRBESARTAN,75MG,90,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018/7/3,2018/7/3,,2018/7/3,Disruption of the manufacture of the drug.,2017/5/5,2018/7/5,No
9203,2347318,Shortage,MYLAN-IRBESARTAN,MYLAN PHARMACEUTICALS ULC,IRBESARTAN,IRBESARTAN,150MG,90,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018/7/3,2018/7/3,2018/8/10,2018/8/10,Disruption of the manufacture of the drug.,2017/5/5,2018/8/11,No
9210,2347326,Shortage,MYLAN-IRBESARTAN,MYLAN PHARMACEUTICALS ULC,IRBESARTAN,IRBESARTAN,300MG,90BT,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017/7/19,,,2017/10/2,Disruption of the manufacture of the drug.,2017/5/5,2017/10/3,No
11782,2265516,Shortage,MYLAN-LAMOTRIGINE,MYLAN PHARMACEUTICALS ULC,LAMOTRIGINE,LAMOTRIGINE,150MG,100BT,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2018/1/23,2018/1/22,2018/3/19,2018/3/19,Requirements related to complying with good manufacturing practices.,2017/6/2,2018/3/20,No
14700,2353830,Shortage,MYLAN-LANSOPRAZOLE,MYLAN PHARMACEUTICALS ULC,LANSOPRAZOLE,LANSOPRAZOLE,15MG,100BT,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018/8/10,2018/8/7,2018/8/30,2018/8/14,Delay in shipping of the drug.,2017/7/5,2018/8/15,No
29854,2353849,Shortage,MYLAN-LANSOPRAZOLE,MYLAN PHARMACEUTICALS ULC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,100BT,ORAL,Avoided shortage,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018/3/16,,,2018/3/2,Delay in shipping of the drug.,2017/11/20,2018/3/2,No
9222,2274868,Shortage,MYLAN-LISINOPRIL,MYLAN PHARMACEUTICALS ULC,LISINOPRIL,LISINOPRIL,20MG,100BT,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018/4/2,,,2018/4/2,Disruption of the manufacture of the drug.,2017/5/5,2018/4/3,No
7024,2274841,Shortage,MYLAN-LISINOPRIL,MYLAN PHARMACEUTICALS ULC,LISINOPRIL,LISINOPRIL,10MG,100BT,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/4/11,,2017/7/12,Disruption of the manufacture of the drug.,2017/4/13,2017/7/17,No
7028,2274833,Shortage,MYLAN-LISINOPRIL,MYLAN PHARMACEUTICALS ULC,LISINOPRIL,LISINOPRIL,5MG,100BT,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/4/11,,2017/7/12,Disruption of the manufacture of the drug.,2017/4/13,2017/7/17,No
3335,2368277,Shortage,MYLAN-LOSARTAN,MYLAN PHARMACEUTICALS ULC,Losartan,LOSARTAN POTASSIUM,25MG,"100BT, 30 BL",ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018/7/3,2018/7/3,2018/8/10,2018/8/10,Disruption of the manufacture of the drug.,2017/3/17,2018/8/11,No
3354,2368285,Shortage,MYLAN-LOSARTAN,MYLAN PHARMACEUTICALS ULC,Losartan,LOSARTAN POTASSIUM,50MG,"30BL, 100BT",ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018/7/3,2018/7/3,2018/8/10,2018/8/10,Disruption of the manufacture of the drug.,2017/3/17,2018/8/11,No
7031,2378086,Shortage,MYLAN-LOSARTAN HCTZ,MYLAN PHARMACEUTICALS ULC,LOSARTAN HCTZ,HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM,12.5MG 100MG,"30BL, 100BT",ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018/5/1,2018/5/1,,2018/5/1,Disruption of the manufacture of the drug.,2017/4/13,2018/8/23,No
7034,2378094,Shortage,MYLAN-LOSARTAN HCTZ,MYLAN PHARMACEUTICALS ULC,LOSARTAN HCTZ,HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM,25MG 100MG,"100BT, 30BL",ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018/5/1,2018/5/1,,2018/5/1,Disruption of the manufacture of the drug.,2017/4/13,2018/8/23,No
7037,2378078,Shortage,MYLAN-LOSARTAN HCTZ,MYLAN PHARMACEUTICALS ULC,LOSARTAN HCTZ,HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM,12.5MG 50MG,"100BT, 30BL",ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018/5/1,2018/5/1,,2018/5/1,Disruption of the manufacture of the drug.,2017/4/13,2018/8/23,No
7040,2243127,Shortage,MYLAN-LOVASTATIN,MYLAN PHARMACEUTICALS ULC,LOVASTATIN,LOVASTATIN,20MG,100BT,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/4/11,,2017/7/12,Disruption of the manufacture of the drug.,2017/4/13,2017/7/17,No
7043,2243129,Shortage,MYLAN-LOVASTATIN,MYLAN PHARMACEUTICALS ULC,MYLAN-LOVASTATIN,LOVASTATIN,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/4/11,,2017/7/12,Disruption of the manufacture of the drug.,2017/4/13,2017/7/17,No
10070,2255995,Shortage,MYLAN-MELOXICAM,MYLAN PHARMACEUTICALS ULC,MELOXICAM,MELOXICAM,15MG,100,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018/6/1,2018/6/1,,2018/6/7,Disruption of the manufacture of the drug.,2017/5/11,2018/6/8,No
3935,2148765,Shortage,MYLAN-METFORMIN,MYLAN PHARMACEUTICALS ULC,METFORMIN,METFORMIN HYDROCHLORIDE,500MG,"100BT, 360BT, 500BT",ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018/7/3,2018/7/3,,2018/7/3,Disruption of the manufacture of the drug.,2017/3/22,2018/7/5,No
5016,2148765,Shortage,MYLAN-METFORMIN,MYLAN PHARMACEUTICALS ULC,METFORMIN,METFORMIN HYDROCHLORIDE,500MG,100,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/3/16,,2017/9/21,Disruption of the manufacture of the drug.,2017/3/31,2017/9/22,No
5020,2229656,Shortage,MYLAN-METFORMIN,MYLAN PHARMACEUTICALS ULC,METFORMIN,METFORMIN HYDROCHLORIDE,850MG,100BT,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/3/20,2017/9/30,2017/9/21,Delay in shipping of the drug.,2017/3/31,2017/9/22,No
5025,2229656,Shortage,MYLAN-METFORMIN,MYLAN PHARMACEUTICALS ULC,METFORMIN,METFORMIN HYDROCHLORIDE,850MG,"100BT, 500BT",ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018/7/3,2018/7/3,,2018/7/3,Disruption of the manufacture of the drug.,2017/3/31,2018/7/5,No
5919,2230736,Shortage,MYLAN-MINOCYCLINE,MYLAN PHARMACEUTICALS ULC,MINOCYCLINE,MINOCYCLINE,100MG,250BT,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,2017/8/11,2017/10/2,,2019/9/17,Disruption of the manufacture of the drug.,2017/4/7,2019/9/18,No
5934,2230735,Shortage,MYLAN-MINOCYCLINE,MYLAN PHARMACEUTICALS ULC,MINOCYCLINE,MINOCYCLINE,50MG,250BT,ORAL,Avoided shortage,CAPSULE,J01AA,TETRACYCLINES,2017/7/26,,,2017/4/11,Delay in shipping of the drug.,2017/4/7,2017/4/13,No
7046,2230736,Shortage,MYLAN-MINOCYCLINE,MYLAN PHARMACEUTICALS ULC,MINOCYCLINE,MINOCYCLINE,100MG,100BT,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,2017/6/13,2017/10/2,,2019/9/17,Disruption of the manufacture of the drug.,2017/4/13,2019/9/18,No
7049,2230735,Shortage,MYLAN-MINOCYCLINE,MYLAN PHARMACEUTICALS ULC,MINOCYCLINE,MINOCYCLINE,50MG,"100BT, 250BT",ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,2018/7/3,2018/7/3,,2019/9/17,Disruption of the manufacture of the drug.,2017/4/13,2019/9/18,No
15646,2256126,Shortage,MYLAN-MIRTAZAPINE,MYLAN PHARMACEUTICALS ULC,MIRTAZAPINE,MIRTAZAPINE,45MG,100BT,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2017/8/12,2017/7/31,2017/10/6,2017/10/10,Delay in shipping of the drug.,2017/7/13,2017/10/11,No
197,2256096,Shortage,MYLAN-MIRTAZAPINE,MYLAN PHARMACEUTICALS ULC,MIRTAZAPINE,MIRTAZAPINE,15MG,100BT,ORAL,Avoided shortage,TABLET,N06AX,ANTIDEPRESSANTS,2018/9/17,,2018/9/30,2018/9/12,Delay in shipping of the drug.,2017/3/10,2018/9/13,No
9241,2380757,Shortage,MYLAN-MONTELUKAST,MYLAN PHARMACEUTICALS ULC,MONTELUKAST,MONTELUKAST,5MG,30BL,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2018/2/1,,,2018/2/1,Disruption of the manufacture of the drug.,2017/5/5,2018/2/15,No
5946,2368226,Shortage,MYLAN-MONTELUKAST,MYLAN PHARMACEUTICALS ULC,MYLAN-MONTELUKAST,MONTELUKAST,10MG,100,ORAL,Avoided shortage,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017/7/13,,,2017/5/1,Delay in shipping of the drug.,2017/4/7,2017/5/5,No
7052,2380749,Shortage,MYLAN-MONTELUKAST,MYLAN PHARMACEUTICALS ULC,MONTELUKAST,MONTELUKAST,4MG,30BL,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2017/4/11,,2017/9/7,Disruption of the manufacture of the drug.,2017/4/13,2017/9/8,No
7055,2368226,Shortage,MYLAN-MONTELUKAST,MYLAN PHARMACEUTICALS ULC,MONTELUKAST,MONTELUKAST,10MG,"30BL, 100BT",ORAL,Resolved,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017/12/1,,2017/12/1,2017/12/1,Disruption of the manufacture of the drug.,2017/4/13,2017/12/8,No
5916,2243432,Shortage,MYLAN-NAPROXEN EC,MYLAN PHARMACEUTICALS ULC,Naproxen,NAPROXEN,375MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018/7/3,2018/7/3,,2018/7/10,Disruption of the manufacture of the drug.,2017/4/7,2018/7/11,No
34097,2241024,Shortage,MYLAN-NAPROXEN EC,MYLAN PHARMACEUTICALS ULC,NAPROXEN EC,NAPROXEN,500MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/12/20,,2018/7/10,Disruption of the manufacture of the drug.,2017/12/21,2018/7/11,No
13528,2443449,Shortage,MYLAN-NAPROXEN/ESOMEPRAZOLE MR,MYLAN PHARMACEUTICALS ULC,NAPROXEN/ESOMEPRAZOLE MR,ESOMEPRAZOLE NAPROXEN,20MG 500MG,60BT,ORAL,Resolved,TABLET (IMMEDIATE AND DELAYED-RELEASE),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2019/5/15,,2019/5/22,2019/5/22,Delay in shipping of the drug.,2017/6/21,2019/5/23,No
13532,2458608,Shortage,MYLAN-NAPROXEN/ESOMEPRAZOLE MR,MYLAN PHARMACEUTICALS ULC,NAPROXEN/ESOMEPRAZOLE MR,ESOMEPRAZOLE NAPROXEN,20MG 375MG,60BT,ORAL,Resolved,TABLET (IMMEDIATE AND DELAYED-RELEASE),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/6/20,2018/2/2,2018/2/2,Disruption of the manufacture of the drug.,2017/6/21,2018/2/3,No
7414,2387727,Shortage,MYLAN-NEVIRAPINE,MYLAN PHARMACEUTICALS ULC,NEVIRAPINE,NEVIRAPINE,200MG,60,ORAL,Resolved,TABLET,J05AG,DIRECT ACTING ANTIVIRALS,,2018/5/31,2018/8/30,2018/8/27,Delay in shipping of the drug.,2017/4/20,2018/8/28,No
33010,2321149,Shortage,MYLAN-NIFEDIPINE EXTENDED RELEASE,MYLAN PHARMACEUTICALS ULC,NIFEDIPINE,NIFEDIPINE,60MG,100 BT,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2018/10/15,2018/10/15,2020/1/5,2020/1/8,Delay in shipping of the drug.,2017/12/14,2020/1/9,No
11406,2407442,Shortage,MYLAN-NITRO PATCH 0.2,MYLAN PHARMACEUTICALS ULC,NITRO PATCH 0.2,NITROGLYCERIN,20.7MG,30,TRANSDERMAL,Resolved,PATCH (EXTENDED RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2017/10/12,2017/10/27,2017/10/18,Disruption of the manufacture of the drug.,2017/5/26,2017/10/19,No
16239,2407450,Shortage,MYLAN-NITRO PATCH 0.4,MYLAN PHARMACEUTICALS ULC,NITRO PATCH 0.4,NITROGLYCERIN,41.4MG,30,TRANSDERMAL,Resolved,PATCH (EXTENDED RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2017/8/9,2017/8/9,2017/8/11,2017/8/14,Delay in shipping of the drug.,2017/7/18,2017/8/16,No
4086,2407469,Shortage,MYLAN-NITRO PATCH 0.6,MYLAN PHARMACEUTICALS ULC,NITRO PATCH 0.6,NITROGLYCERIN,62.2MG,30,TRANSDERMAL,Avoided shortage,PATCH (EXTENDED RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2018/1/26,,,2017/12/20,Demand increase for the drug.,2017/3/23,2017/12/20,No
4080,2407477,Shortage,MYLAN-NITRO PATCH 0.8,MYLAN PHARMACEUTICALS ULC,Nitro Patch,NITROGLYCERIN,82.9MG,30,TRANSDERMAL,Avoided shortage,PATCH (EXTENDED RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2017/4/20,,,2017/3/27,Delay in shipping of the drug.,2017/3/23,2017/3/29,No
7417,2407477,Shortage,MYLAN-NITRO PATCH 0.8,MYLAN PHARMACEUTICALS ULC,NITRO PATCH 0.8,NITROGLYCERIN,82.9MG,30,TRANSDERMAL,Resolved,PATCH (EXTENDED RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2017/4/29,,,2017/6/7,Delay in shipping of the drug.,2017/4/20,2017/6/16,No
15649,2243588,Shortage,MYLAN-NITRO SUBLINGUAL SPRAY,MYLAN PHARMACEUTICALS ULC,NITRO SUBLINGUAL SPRAY,NITROGLYCERIN,0.4MG,1BT,SUBLINGUAL,Resolved,METERED-DOSE AEROSOL,C01DA,VASODILATORS USED IN CARDIAC DISEASES,2018/4/18,2018/4/18,2018/5/22,2018/5/22,Delay in shipping of the drug.,2017/7/13,2018/5/23,No
9154,2382717,Shortage,MYLAN-OLANZAPINE ODT,MYLAN PHARMACEUTICALS ULC,OLANZAPINE ODT,OLANZAPINE,10MG,30BL,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017/5/1,,2017/7/12,Disruption of the manufacture of the drug.,2017/5/5,2017/7/17,No
9158,2382725,Shortage,MYLAN-OLANZAPINE ODT,MYLAN PHARMACEUTICALS ULC,OLANZAPINE ODT,OLANZAPINE,15MG,30BL,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017/5/1,,2017/7/12,Disruption of the manufacture of the drug.,2017/5/5,2017/7/17,No
9162,2382733,Shortage,MYLAN-OLANZAPINE ODT,MYLAN PHARMACEUTICALS ULC,OLANZAPINE ODT,OLANZAPINE,20MG,30BL,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017/5/1,,2017/7/12,Disruption of the manufacture of the drug.,2017/5/5,2017/7/17,No
9165,2382709,Shortage,MYLAN-OLANZAPINE ODT,MYLAN PHARMACEUTICALS ULC,OLANZAPINE ODT,OLANZAPINE,5MG,30BL,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017/5/1,,2017/7/12,Disruption of the manufacture of the drug.,2017/5/5,2017/7/17,No
19496,2329433,Shortage,MYLAN-OMEPRAZOLE,MYLAN PHARMACEUTICALS ULC,OMEPRAZOLE,OMEPRAZOLE,20MG,"100BT, 500BT",ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/9/8,2017/9/11,,2018/12/20,Disruption of the manufacture of the drug.,2017/8/15,2020/4/22,No
235,2329425,Shortage,MYLAN-OMEPRAZOLE,MYLAN PHARMACEUTICALS ULC,OMEPRAZOLE,OMEPRAZOLE,10MG,30BT,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018/5/1,,2018/8/16,Other (Please describe in comments),2017/3/10,2018/8/27,No
200,2299585,Shortage,MYLAN-PANTOPRAZOLE,MYLAN PHARMACEUTICALS ULC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,"500BT, 100BT",ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018/7/3,2018/7/3,,2018/7/3,Disruption of the manufacture of the drug.,2017/3/10,2018/7/5,No
33019,2408570,Shortage,MYLAN-PANTOPRAZOLE T,MYLAN PHARMACEUTICALS ULC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,100 BT,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018/10/19,2018/10/19,2019/5/15,2019/5/28,Delay in shipping of the drug.,2017/12/14,2019/5/29,No
10722,2298279,Shortage,MYLAN-PIOGLITAZONE,MYLAN PHARMACEUTICALS ULC,PIOGLITAZONE,PIOGLITAZONE,15MG,90BT,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018/7/3,2018/7/3,,2018/7/3,Disruption of the manufacture of the drug.,2017/5/19,2018/7/5,No
10725,2298295,Shortage,MYLAN-PIOGLITAZONE,MYLAN PHARMACEUTICALS ULC,PIOGLITAZONE,PIOGLITAZONE,45MG,90BT,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018/7/3,2018/7/3,,2018/7/3,Delay in shipping of the drug.,2017/5/19,2018/7/5,No
9179,2257092,Shortage,MYLAN-PRAVASTATIN,MYLAN PHARMACEUTICALS ULC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,100BT,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/5/1,,2017/7/12,Disruption of the manufacture of the drug.,2017/5/5,2017/7/17,No
9182,2257106,Shortage,MYLAN-PRAVASTATIN,MYLAN PHARMACEUTICALS ULC,PRAVASTATIN,PRAVASTATIN SODIUM,20MG,100BT,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/7/15,,,2017/9/7,Disruption of the manufacture of the drug.,2017/5/5,2017/9/8,No
9185,2257114,Shortage,MYLAN-PRAVASTATIN,MYLAN PHARMACEUTICALS ULC,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100BT,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/5/1,,2017/7/12,Disruption of the manufacture of the drug.,2017/5/5,2017/7/17,No
9016,2408392,Shortage,MYLAN-RABEPRAZOLE,MYLAN PHARMACEUTICALS ULC,RABEPRAZOLE,RABEPRAZOLE SODIUM,10MG,100BT,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/12/1,,,2017/12/1,Disruption of the manufacture of the drug.,2017/5/4,2017/12/2,No
9188,2408406,Shortage,MYLAN-RABEPRAZOLE,MYLAN PHARMACEUTICALS ULC,RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,100BT,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/5/1,,2017/7/12,Disruption of the manufacture of the drug.,2017/5/5,2017/7/17,No
27146,2390299,Shortage,MYLAN-RILUZOLE,MYLAN PHARMACEUTICALS ULC,RILUZOLE,RILUZOLE,50MG,60BT,ORAL,Resolved,TABLET,N07XX,OTHER NERVOUS SYSTEM DRUGS,2018/1/31,2018/1/31,2018/3/9,2018/3/9,Delay in shipping of the drug.,2017/10/26,2018/3/10,No
9368,2397773,Shortage,MYLAN-RISEDRONATE,MYLAN PHARMACEUTICALS ULC,RISEDRONATE,RISEDRONATE SODIUM,150MG,1BL,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/5/1,,2017/7/12,Disruption of the manufacture of the drug.,2017/5/5,2017/7/17,No
5310,2357984,Shortage,MYLAN-RISEDRONATE,MYLAN PHARMACEUTICALS ULC,Risedronate,RISEDRONATE SODIUM,35MG,4BL,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017/11/1,,,2017/11/1,Delay in shipping of the drug.,2017/4/4,2017/11/2,No
5329,2357984,Shortage,MYLAN-RISEDRONATE,MYLAN PHARMACEUTICALS ULC,Risedronate,RISEDRONATE SODIUM,35MG,30BT,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017/11/1,,,2017/11/1,Delay in shipping of the drug.,2017/4/4,2017/11/2,No
3368,2282291,Shortage,MYLAN-RISPERIDONE,MYLAN PHARMACEUTICALS ULC,Risperidone,RISPERIDONE,4.0MG,100s,ORAL,Avoided shortage,TABLET,N05AX,ANTIPSYCHOTICS,2017/5/13,,,2017/3/29,Requirements related to complying with good manufacturing practices.,2017/3/17,2017/3/29,No
5951,2282240,Shortage,MYLAN-RISPERIDONE,MYLAN PHARMACEUTICALS ULC,RISPERIDONE,RISPERIDONE,0.25MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2018/2/1,,,2018/2/1,Delay in shipping of the drug.,2017/4/7,2018/2/15,No
26702,2282259,Shortage,MYLAN-RISPERIDONE,MYLAN PHARMACEUTICALS ULC,RISPERIDONE,RISPERIDONE,0.50MG,100BT,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2018/2/1,,,2018/2/1,Disruption of the manufacture of the drug.,2017/10/23,2018/2/15,No
9045,2282283,Shortage,MYLAN-RISPERIDONE,MYLAN PHARMACEUTICALS ULC,RISPERIDONE,RISPERIDONE,3.0MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2017/7/11,,,2017/10/2,Delay in shipping of the drug.,2017/5/4,2017/10/3,No
5319,2282267,Shortage,MYLAN-RISPERIDONE,MYLAN PHARMACEUTICALS ULC,RISPERIDONE,RISPERIDONE,1.0MG,100BT,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2017/6/10,2017/7/6,,2017/9/7,Delay in shipping of the drug.,2017/4/4,2017/9/8,No
5338,2282275,Shortage,MYLAN-RISPERIDONE,MYLAN PHARMACEUTICALS ULC,RISPERIDONE,RISPERIDONE,2.0MG,100BT,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2017/6/11,2017/7/6,,2017/10/2,Delay in shipping of the drug.,2017/4/4,2017/10/4,No
8719,2413523,Shortage,MYLAN-RISPERIDONE ODT,MYLAN PHARMACEUTICALS ULC,RISPERIDONE ODT,RISPERIDONE,4MG,100BT,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AX,ANTIPSYCHOTICS,,2017/5/2,,2021/11/15,Requirements related to complying with good manufacturing practices.,2017/5/2,2021/11/23,No
3346,2413507,Shortage,MYLAN-RISPERIDONE ODT,MYLAN PHARMACEUTICALS ULC,RISPERIDONE ODT,RISPERIDONE,2MG,100BT,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AX,ANTIPSYCHOTICS,,2017/3/31,,2021/11/15,Requirements related to complying with good manufacturing practices.,2017/3/17,2021/11/23,No
3360,2413485,Shortage,MYLAN-RISPERIDONE ODT,MYLAN PHARMACEUTICALS ULC,RISPERIDONE ODT,RISPERIDONE,0.5MG,100BT,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AX,ANTIPSYCHOTICS,,2017/4/24,,2021/11/15,Requirements related to complying with good manufacturing practices.,2017/3/17,2021/11/23,No
8764,2413515,Shortage,MYLAN-RISPERIDONE ODT,MYLAN PHARMACEUTICALS ULC,RISPERIDONE ODT,RISPERIDONE,3MG,100BT,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AX,ANTIPSYCHOTICS,,2018/5/2,,2021/11/15,Requirements related to complying with good manufacturing practices.,2017/5/3,2021/11/23,No
206,2413493,Shortage,MYLAN-RISPERIDONE ODT,MYLAN PHARMACEUTICALS ULC,RISPERIDONE ODT,RISPERIDONE,1MG,100BT,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AX,ANTIPSYCHOTICS,,2017/1/23,,2021/11/15,Requirements related to complying with good manufacturing practices.,2017/3/10,2021/11/23,No
20575,2379201,Shortage,MYLAN-RIZATRIPTAN ODT,MYLAN PHARMACEUTICALS ULC,RIZATRIPTAN ODT,RIZATRIPTAN,10MG,6BL,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2017/9/8,2017/9/11,2017/9/29,2017/9/29,Disruption of the manufacture of the drug.,2017/8/29,2017/9/30,No
20578,2379198,Shortage,MYLAN-RIZATRIPTAN ODT,MYLAN PHARMACEUTICALS ULC,RIZATRIPTAN ODT,RIZATRIPTAN,5MG,6BL,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2017/9/8,2017/9/11,2017/9/29,2017/9/29,Disruption of the manufacture of the drug.,2017/8/29,2017/9/30,No
30347,2381273,Shortage,MYLAN-ROSUVASTATIN,MYLAN PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,10MG,"30BL, 100BT, 500BT",ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018/4/2,,,2018/4/2,Disruption of the manufacture of the drug.,2017/11/23,2018/4/3,No
30353,2381303,Shortage,MYLAN-ROSUVASTATIN,MYLAN PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,40MG,"30BL, 100BT",ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018/5/1,2018/5/1,,2018/5/10,Disruption of the manufacture of the drug.,2017/11/23,2018/6/5,No
30392,2381281,Shortage,MYLAN-ROSUVASTATIN,MYLAN PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,20MG,"30BL, 100BT, 500BT",ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018/7/3,2018/7/3,,2018/7/3,Disruption of the manufacture of the drug.,2017/11/23,2018/7/5,No
212,2381265,Shortage,MYLAN-ROSUVASTATIN,MYLAN PHARMACEUTICALS ULC,Rosuvastatin,ROSUVASTATIN,5MG,"100BT, 500 BT, 30 BL",ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018/7/3,2018/7/3,,2018/7/3,Disruption of the manufacture of the drug.,2017/3/10,2018/7/5,No
5304,2231036,Shortage,MYLAN-SELEGILINE,MYLAN PHARMACEUTICALS ULC,SELEGILINE,SELEGILINE HYDROCHLORIDE,5MG,60BT,ORAL,Avoided shortage,TABLET,N04BD,DOPAMINERGIC AGENTS,2017/7/18,,,2017/7/12,Delay in shipping of the drug.,2017/4/4,2017/7/17,No
5979,2242520,Shortage,MYLAN-SERTRALINE,MYLAN PHARMACEUTICALS ULC,SERTRALINE,SERTRALINE,50MG,"100BT, 500BT",ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2018/3/1,,,2018/3/1,Disruption of the manufacture of the drug.,2017/4/7,2018/3/2,No
30359,2242521,Shortage,MYLAN-SERTRALINE,MYLAN PHARMACEUTICALS ULC,SERTRALINE,SERTRALINE,100MG,100BT,ORAL,Avoided shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,2018/7/2,2018/1/25,,2018/2/1,Disruption of the manufacture of the drug.,2017/11/23,2018/2/15,No
30402,2242519,Shortage,MYLAN-SERTRALINE,MYLAN PHARMACEUTICALS ULC,SERTRALINE,SERTRALINE,25MG,100BT,ORAL,Avoided shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,2018/8/1,,,2018/2/1,Disruption of the manufacture of the drug.,2017/11/23,2018/2/15,No
17769,2246584,Shortage,MYLAN-SIMVASTATIN,MYLAN PHARMACEUTICALS ULC,SIMVASTATIN,SIMVASTATIN,40MG,100BT,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018/7/3,2018/7/3,,2019/9/17,Disruption of the manufacture of the drug.,2017/8/1,2019/9/18,No
17773,2246585,Shortage,MYLAN-SIMVASTATIN,MYLAN PHARMACEUTICALS ULC,SIMVASTATIN,SIMVASTATIN,80MG,100BT,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018/7/3,2018/7/3,,2019/9/17,Disruption of the manufacture of the drug.,2017/8/1,2019/9/18,No
28044,2268922,Shortage,MYLAN-SUMATRIPTAN,MYLAN PHARMACEUTICALS ULC,SUMATRIPTAN,SUMATRIPTAN,100MG,6BL,ORAL,Avoided shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2018/5/14,,,2018/5/2,Delay in shipping of the drug.,2017/11/3,2018/5/3,No
18688,2410621,Shortage,MYLAN-TADALAFIL,MYLAN PHARMACEUTICALS ULC,TADALAFIL,TADALAFIL,2.5MG,28BL,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018/9/10,2018/9/10,2018/12/14,2018/12/18,Delay in shipping of the drug.,2017/8/10,2018/12/19,No
11788,2410664,Shortage,MYLAN-TADALAFIL,MYLAN PHARMACEUTICALS ULC,TADALAFIL,TADALAFIL,20MG,4BL,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018/12/18,2018/12/18,2019/8/30,2019/8/22,Delay in shipping of the drug.,2017/6/2,2019/8/23,No
25895,2404192,Shortage,MYLAN-TOLTERODINE ER,MYLAN PHARMACEUTICALS ULC,TOLTERODINE ER,TOLTERODINE TARTRATE,4MG,"30BT, 100BT",ORAL,Resolved,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/11/16,2017/11/13,,2022/2/14,Disruption of the manufacture of the drug.,2017/10/13,2022/2/15,No
17787,2404184,Shortage,MYLAN-TOLTERODINE ER,MYLAN PHARMACEUTICALS ULC,TOLTERODINE ER,TOLTERODINE TARTRATE,2MG,"100BT, 30BT",ORAL,Resolved,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/10/10,2017/10/10,,2022/2/14,Disruption of the manufacture of the drug.,2017/8/1,2022/2/15,No
9019,2383527,Shortage,MYLAN-VALSARTAN,MYLAN PHARMACEUTICALS ULC,VALSARTAN,VALSARTAN,40MG,100BT,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018/7/3,2018/7/3,,2018/7/3,Disruption of the manufacture of the drug.,2017/5/4,2018/7/5,No
9049,2383551,Shortage,MYLAN-VALSARTAN,MYLAN PHARMACEUTICALS ULC,VALSARTAN,VALSARTAN,320MG,100BT,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018/7/3,2018/7/3,,2018/7/3,Delay in shipping of the drug.,2017/5/4,2018/7/5,No
26715,2383543,Shortage,MYLAN-VALSARTAN,MYLAN PHARMACEUTICALS ULC,VALSARTAN,VALSARTAN,160MG,100BT,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017/11/1,,,2017/11/1,Disruption of the manufacture of the drug.,2017/10/23,2017/11/2,No
9198,2383535,Shortage,MYLAN-VALSARTAN,MYLAN PHARMACEUTICALS ULC,VALSARTAN,VALSARTAN,80MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018/7/3,2018/7/3,,2018/7/3,Disruption of the manufacture of the drug.,2017/5/5,2018/7/5,No
5909,2310295,Shortage,MYLAN-VENLAFAXINE XR,MYLAN PHARMACEUTICALS ULC,VENLAFAXINE XR,VENLAFAXINE,150MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2018/7/3,2018/6/26,,2018/7/3,Disruption of the manufacture of the drug.,2017/4/7,2018/7/4,No
5990,2310287,Shortage,MYLAN-VENLAFAXINE XR,MYLAN PHARMACEUTICALS ULC,VENLAFAXINE XR,VENLAFAXINE,75MG,100BT,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2018/1/15,2018/1/4,,2018/2/1,Disruption of the manufacture of the drug.,2017/4/7,2018/2/15,No
9195,2310279,Shortage,MYLAN-VENLAFAXINE XR,MYLAN PHARMACEUTICALS ULC,VENLAFAXINE XR,VENLAFAXINE,37.5MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2017/10/22,2017/10/2,,2018/2/1,Disruption of the manufacture of the drug.,2017/5/5,2018/2/15,No
28047,2237922,Shortage,MYLAN-VERAPAMIL,MYLAN PHARMACEUTICALS ULC,VERAPAMIL,VERAPAMIL HYDROCHLORIDE,120MG,100BT,ORAL,Resolved,TABLET,C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2018/5/24,2018/5/25,2018/7/20,2018/7/18,Delay in shipping of the drug.,2017/11/3,2018/7/19,No
30729,2450496,Shortage,MYLAN-VERAPAMIL SR,MYLAN PHARMACEUTICALS ULC,VERAPAMIL SR,VERAPAMIL HYDROCHLORIDE,240MG,"100BT, 500BT",ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2018/10/15,2018/10/15,2020/6/16,2020/6/16,Delay in shipping of the drug.,2017/11/27,2020/6/17,No
17759,2450488,Shortage,MYLAN-VERAPAMIL SR,MYLAN PHARMACEUTICALS ULC,VERAPAMIL SR,VERAPAMIL HYDROCHLORIDE,180MG,100BT,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2018/9/6,2018/9/6,2020/6/29,2020/6/16,Delay in shipping of the drug.,2017/8/1,2020/6/17,No
17818,2387158,Shortage,MYLAN-ZOLMITRIPTAN ODT,MYLAN PHARMACEUTICALS ULC,ZOLMITRIPTAN ODT,ZOLMITRIPTAN,2.5MG,6BL,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2018/6/22,2018/7/3,,2018/7/3,Disruption of the manufacture of the drug.,2017/8/1,2018/7/5,No
2364,2238596,Shortage,MYLAN-ZOPICLONE,MYLAN PHARMACEUTICALS ULC,Zopiclone,ZOPICLONE,7.5MG,"500BT, 100BT",ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,2018/7/3,2018/7/3,,2018/7/3,Disruption of the manufacture of the drug.,2017/3/14,2018/7/5,No
32195,2296616,Shortage,MYLAN-ZOPICLONE,MYLAN PHARMACEUTICALS ULC,ZOPICLONE,ZOPICLONE,5MG,100BT,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,2018/1/4,2018/1/4,,2018/5/1,Delay in shipping of the drug.,2017/12/8,2018/6/6,No
14864,1927620,Shortage,MYOCHRYSINE,SANOFI-AVENTIS CANADA INC,Myochrysine,GOLD SODIUM THIOMALATE,10MG,5,INTRAMUSCULAR,Resolved,SOLUTION,M01CB,SPECIFIC ANTIRHEUMATIC AGENTS,2017/7/7,2017/7/7,,2017/8/3,Other (Please describe in comments),2017/7/6,2017/8/4,No
29269,1927612,Shortage,MYOCHRYSINE,SANOFI-AVENTIS CANADA INC,Myochrisine 25mg/1ml,GOLD SODIUM THIOMALATE,25MG,5,INTRAMUSCULAR,Resolved,SOLUTION,M01CB,SPECIFIC ANTIRHEUMATIC AGENTS,2017/11/24,2017/12/1,2019/9/30,2019/6/4,Shortage of an active ingredient.,2017/11/15,2019/6/10,No
29274,1927604,Shortage,MYOCHRYSINE,SANOFI-AVENTIS CANADA INC,Myochrisine 50mg/1ml,GOLD SODIUM THIOMALATE,50MG,5,INTRAMUSCULAR,Resolved,SOLUTION,M01CB,SPECIFIC ANTIRHEUMATIC AGENTS,2017/11/24,2017/12/1,2019/9/30,2019/6/4,Shortage of an active ingredient.,2017/11/15,2019/6/10,No
1555,2239030,Shortage,NADRYL 50MG,LABORATOIRE RIVA INC,Diphenhydramine Hydrochloride tablets USP,DIPHENHYDRAMINE HYDROCHLORIDE,50MG,100,ORAL,Actual shortage,TABLET,R06AA,ANTIHISTAMINES FOR SYSTEMIC USE,2014/4/11,2014/4/11,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
3820,2148706,Shortage,NALOXONE HCL INJECTION - 0.4MG/ML USP,SANDOZ CANADA INCORPORATED,NALOXONE,NALOXONE HYDROCHLORIDE,0.4MG,10ML VIAL,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,LIQUID,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,2017/3/27,,2017/6/16,2017/4/11,Demand increase for the drug.,2017/3/22,2017/4/12,No
3823,2148706,Shortage,NALOXONE HCL INJECTION - 0.4MG/ML USP,SANDOZ CANADA INCORPORATED,NALOXONE,NALOXONE HYDROCHLORIDE,0.4MG,10 X 1ML AMPOULES,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Avoided shortage,LIQUID,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,2017/5/12,2017/4/11,2017/6/16,2017/5/8,Demand increase for the drug.,2017/3/22,2017/6/26,No
2609,2148714,Shortage,NALOXONE HCL INJECTION - 1MG/ML USP,SANDOZ CANADA INCORPORATED,NALOXONE,NALOXONE,1mg/mL,10x2mL fioles/vials,INTRA,Resolved,INJ,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,,2017/2/9,2017/4/28,2017/4/28,Demand increase for the drug.,2017/3/14,2017/6/26,No
28244,887056,Shortage,NAPROXEN-NA,PRO DOC LIMITEE,NAPROXEN-NA,NAPROXEN SODIUM,275MG,100,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/11/6,,2018/7/26,Delay in shipping of the drug.,2017/11/6,2018/7/27,No
6195,2153386,Shortage,NAPROXEN-NA DF -TAB 550MG,PRO DOC LIMITEE,NAPROXEN-NA DF,NAPROXEN SODIUM,550MG,100,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/4/25,,2017/12/12,Delay in shipping of the drug.,2017/4/7,2017/12/13,No
32096,2229415,Shortage,NAROPIN,ASPEN PHARMACARE CANADA INC.,Naropin® 5mg/mL 5x20mL SU Polyamp® Duofit®,ROPIVACAINE HYDROCHLORIDE,5MG,5,"EPIDURAL
BLOCK/INFILTRATION",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017/12/4,2018/4/27,2018/4/20,Demand increase for the drug.,2017/12/8,2018/4/23,No
22243,2229418,Shortage,NAROPIN,ASPEN PHARMACARE CANADA INC.,Naropin® 10mg/mL 5x10mL SU Polyamp® Duofit®,ROPIVACAINE HYDROCHLORIDE,10MG,5 PP Amps,EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017/9/18,2017/10/2,2017/10/12,Demand increase for the drug.,2017/9/18,2017/10/13,No
28503,24449,Shortage,NAVANE CAP 5MG,ERFA CANADA 2012 INC,TIOTIXENE,,,100 TABLETS,,Resolved,,,,2017/11/7,2017/11/7,,2017/12/12,Disruption of the manufacture of the drug.,2017/11/7,2018/3/14,No
2728,587818,Shortage,NERISONE OILY CREAM,GLAXOSMITHKLINE INC,Diflucortolone valerate oily cream,Diflucortolone valerate,0.10%,30g,Topical,Resolved,Oily Cream,D07AC,"CORTICOSTEROIDS, PLAIN",,2016/9/1,,2017/4/20,Other (Please describe in comments),2017/3/14,2020/2/27,No
2731,587818,Shortage,NERISONE OILY CREAM,GLAXOSMITHKLINE INC,Diflucortolone valerate oily cream,Diflucortolone valerate,0.10%,60 g,Topical,Resolved,Oily Cream,D07AC,"CORTICOSTEROIDS, PLAIN",,2016/9/12,,2017/4/20,Other (Please describe in comments),2017/3/14,2020/2/27,No
25921,2239717,Shortage,NEURONTIN 600MG,PFIZER CANADA INC,NEURONTIN,GABAPENTIN,600MG,100's,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/12/29,,2018/1/31,Disruption of the manufacture of the drug.,2017/10/13,2018/2/1,No
33933,2084260,Shortage,NEURONTIN CAP 100MG,PFIZER CANADA INC,NEURONTIN,GABAPENTIN,100MG,100's,ORAL,Avoided shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2018/2/14,,,2018/2/6,Disruption of the manufacture of the drug.,2017/12/20,2018/2/7,No
34010,2084279,Shortage,NEURONTIN CAP 300MG,PFIZER CANADA INC,NEURONTIN,GABAPENTIN,300MG,100's,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2018/1/2,,2018/1/29,Disruption of the manufacture of the drug.,2017/12/20,2018/1/30,No
27757,2084287,Shortage,NEURONTIN CAP 400MG,PFIZER CANADA INC,NEURONTIN,GABAPENTIN,400MG,100 capsules,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/12/19,,2018/2/7,Disruption of the manufacture of the drug.,2017/11/1,2018/2/8,No
4036,2262347,Shortage,NIASPAN,SUNOVION PHARMACEUTICALS CANADA INC,Extended-release niacin,NICOTINIC ACID,500MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C10AD,"LIPID MODIFYING AGENTS, PLAIN",2016/9/28,,,2017/3/31,Other (Please describe in comments),2017/3/23,2017/10/5,No
4039,2262339,Shortage,NIASPAN,SUNOVION PHARMACEUTICALS CANADA INC,Extended-release niacin,NICOTINIC ACID,1000MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C10AD,"LIPID MODIFYING AGENTS, PLAIN",2016/9/28,,,2017/6/30,Other (Please describe in comments),2017/3/23,2017/10/5,No
4050,2309262,Shortage,NIASPAN FCT,SUNOVION PHARMACEUTICALS CANADA INC,Extended-release niacin,NICOTINIC ACID,750MG,90,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C10AD,"LIPID MODIFYING AGENTS, PLAIN",2016/9/28,,,2017/5/31,Other (Please describe in comments),2017/3/23,2017/10/5,No
19676,2309289,Shortage,NIASPAN FCT,SUNOVION PHARMACEUTICALS CANADA INC,Extended-release niacin,NICOTINIC ACID,1000MG,90,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C10AD,"LIPID MODIFYING AGENTS, PLAIN",,2017/12/5,,2019/7/22,Other (Please describe in comments),2017/8/17,2019/7/29,No
12393,2125226,Shortage,NIDAGEL VAGINAL GEL 0.75%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,NIDAGEL VAGINAL GEL 0.75%,METRONIDAZOLE,0.75%,NA,VAGINAL,Resolved,GEL,G01AF,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",,2017/6/9,,2017/9/28,Other (Please describe in comments),2017/6/9,2017/9/29,No
11727,2125226,Shortage,NIDAGEL VAGINAL GEL 0.75%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,NIDAGEL VAGINAL GEL 0.75%,METRONIDAZOLE,0.75%,NA,VAGINAL,Resolved,GEL,G01AF,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",2017/6/9,,,2017/9/28,Delay in shipping of the drug.,2017/6/2,2017/9/29,No
16633,2421658,Shortage,NIFEDIPINE ER,PRO DOC LIMITEE,NIFEDIPINE ER 60 MG,NIFEDIPINE,60MG,30-100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/7/20,,2017/10/2,Delay in shipping of the drug.,2017/7/21,2018/10/5,No
21244,2421631,Shortage,NIFEDIPINE ER,PRO DOC LIMITEE,NIFEDIPINE,NIFEDIPINE,30MG,30-100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018/7/11,,2018/10/5,Delay in shipping of the drug.,2017/9/7,2018/10/6,No
26475,779806,Shortage,NIODAN 500 MG TIME RELEASE TABLETS,ODAN LABORATORIES LTD,Niacin Time Release Tablets,NICOTINIC ACID,500MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C04AC,PERIPHERALVASODILATORS,,2018/6/29,,2018/7/3,Disruption of the manufacture of the drug.,2017/10/20,2018/7/4,No
2013,312738,Shortage,NITROFURANTOIN,AA PHARMA INC,NITROFURANTOIN,NITROFURANTOIN,100MG,100 Bottle,ORAL,Resolved,TABLET,J01XE,OTHER ANTIBACTERIALS,,2015/9/23,2017/5/15,2017/5/12,Shortage of an active ingredient.,2017/3/13,2017/5/13,No
2016,319511,Shortage,NITROFURANTOIN,AA PHARMA INC,NITROFURANTOIN,NITROFURANTOIN,50MG,100 Bottle,ORAL,Resolved,TABLET,J01XE,OTHER ANTIBACTERIALS,,2015/9/23,2017/5/15,2017/5/12,Shortage of an active ingredient.,2017/3/13,2017/5/13,No
2906,2223740,Shortage,NORPROLAC,FERRING INC,NORPROLAC,QUINAGOLIDE HYDROCHLORIDE,25mcg,3,Oral,Resolved,Tablet,G02CB,OTHER GYNECOLOGICALS,,2016/7/1,,2018/8/20,Other (Please describe in comments),2017/3/15,2018/8/21,No
2909,2223759,Shortage,NORPROLAC,FERRING INC,NORPROLAC,QUINAGOLIDE,0.05MG,3,ORAL,Resolved,TABLET,G02CB,OTHER GYNECOLOGICALS,,2016/7/1,,2018/8/20,Other (Please describe in comments),2017/3/15,2018/8/21,No
5165,216666,Shortage,NOVASEN,TEVA CANADA LIMITED,ACETYLSALICYLIC ACID,ACETYLSALICYLIC ACID,325MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,,2017/4/3,2017/5/17,2017/5/17,Disruption of the manufacture of the drug.,2017/4/3,2017/5/23,No
8068,2309556,Shortage,NOVO-CYPROTERONE/ETHINYL ESTRADIOL,TEVA CANADA LIMITED,CYPROTERONE/ETHINYL ESTRADIOL,ETHINYL ESTRADIOL CYPROTERONE ACETATE,0.035MG 2MG,21,ORAL,Resolved,TABLET,G03HB,ANTIANDROGENS,,2017/4/21,2017/5/30,2017/8/1,Disruption of the manufacture of the drug.,2017/4/25,2017/9/19,No
159,738824,Shortage,NOVO-HYDROXYZIN,TEVA CANADA LIMITED,Hydroxyzine,HYDROXYZINE HYDROCHLORIDE,10MG,100,ORAL,Actual shortage,CAPSULE,N05BB,ANXIOLYTICS,,2014/3/26,,,Disruption of the manufacture of the drug.,2017/3/10,2017/10/5,No
1013,738832,Shortage,NOVO-HYDROXYZIN,TEVA CANADA LIMITED,HYDROXYZINE HYDROCHLORIDE,HYDROXYZINE HYDROCHLORIDE,25MG,100,ORAL,Actual shortage,CAPSULE,N05BB,ANXIOLYTICS,,2014/3/26,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1017,738840,Shortage,NOVO-HYDROXYZIN,TEVA CANADA LIMITED,HYDROXYZINE HYDROCHLORIDE,HYDROXYZINE HYDROCHLORIDE,50MG,100,ORAL,Actual shortage,CAPSULE,N05BB,ANXIOLYTICS,,2014/12/12,2022/12/1,,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
2278,2364883,Shortage,NOVO-MYCOPHENOLATE,TEVA CANADA LIMITED,MYCOPHENOLATE,MYCOPHENOLATE MOFETIL,250MG,100,ORAL,Resolved,CAPSULE,L04AA,IMMUNOSUPPRESSANTS,,2017/3/1,2017/4/3,2017/4/15,Delay in shipping of the drug.,2017/3/14,2017/4/25,No
18692,1927698,Shortage,NOZINAN INJ 25MG/ML,SANOFI-AVENTIS CANADA INC,Nozinan solution injectable 25 mg/ml,METHOTRIMEPRAZINE,25MG,10,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,N05AA,ANTIPSYCHOTICS,2017/9/15,,2017/11/3,2017/11/9,Other (Please describe in comments),2017/8/10,2017/11/10,No
25117,2415577,Shortage,NUCYNTA EXTENDED-RELEASE,ENDO VENTURES LTD,Nucynta,Tapentadol,50MG,60 Tabs,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,2017/12/30,2018/2/1,2018/3/5,2018/2/27,Disruption of the manufacture of the drug.,2017/10/10,2018/5/17,No
25122,2415585,Shortage,NUCYNTA EXTENDED-RELEASE,ENDO VENTURES LTD,Nucynta,Tapentadol,100MG,60 Tabs,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,2017/12/30,,,2017/12/30,Disruption of the manufacture of the drug.,2017/10/10,2018/5/17,No
25129,2415593,Shortage,NUCYNTA EXTENDED-RELEASE,ENDO VENTURES LTD,Nucynta,Tapentadol,150MG,60 Tabs,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,2017/12/30,,2017/12/6,2017/12/6,Disruption of the manufacture of the drug.,2017/10/10,2017/12/6,No
25134,2415607,Shortage,NUCYNTA EXTENDED-RELEASE,ENDO VENTURES LTD,Nucynta,Tapentadol,200MG,60 Tabs,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,2018/2/27,,,2018/2/27,Disruption of the manufacture of the drug.,2017/10/10,2018/5/17,No
25141,2415615,Shortage,NUCYNTA EXTENDED-RELEASE,ENDO VENTURES LTD,Nucynta,Tapentadol,250MG,60 Tabs,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,2018/1/15,,2018/2/19,2017/12/6,Disruption of the manufacture of the drug.,2017/10/10,2017/12/6,No
25102,2378272,Shortage,NUCYNTA IR,ENDO VENTURES LTD,Nucynta,Tapentadol,50MG,100 Tabs,ORAL,Avoided shortage,TABLET (IMMEDIATE RELEASE),N02AX,OPIOIDS,2017/12/30,,,2017/12/6,Disruption of the manufacture of the drug.,2017/10/10,2017/12/6,No
25108,2378280,Shortage,NUCYNTA IR,ENDO VENTURES LTD,Nucynta,Tapentadol,75MG,100 Tabs,ORAL,Resolved,TABLET (IMMEDIATE RELEASE),N02AX,OPIOIDS,2017/11/21,,,2017/12/19,Disruption of the manufacture of the drug.,2017/10/10,2017/12/20,No
25111,2378299,Shortage,NUCYNTA IR,ENDO VENTURES LTD,Nucynta,Tapentadol,100MG,100 Tabs,ORAL,Avoided shortage,TABLET (IMMEDIATE RELEASE),N02AX,OPIOIDS,2017/12/30,,,2017/12/4,Disruption of the manufacture of the drug.,2017/10/10,2017/12/4,No
22305,2253186,Shortage,NUVARING,MERCK CANADA INC,etonogestrel / ethinyl estradiol slow release vaginal ring,ETHINYL ESTRADIOL ETONOGESTREL,2.6MG 11.4MG,3,VAGINAL,Resolved,RING (SLOW-RELEASE),G02BB,CONTRACEPTIVES FOR TOPICAL USE,2017/9/25,2017/9/26,2017/10/11,2017/10/6,Delay in shipping of the drug.,2017/9/18,2017/10/7,No
4417,2253186,Shortage,NUVARING,MERCK CANADA INC,etonogestrel / ethinyl estradiol slow release vaginal ring,ETHINYL ESTRADIOL ETONOGESTREL,2.6MG 11.4MG,1,VAGINAL,Avoided shortage,RING (SLOW-RELEASE),G02BB,CONTRACEPTIVES FOR TOPICAL USE,2017/3/30,,2017/3/31,2017/3/29,Delay in shipping of the drug.,2017/3/27,2017/10/11,No
5234,716871,Shortage,NYADERM CRM 100000UNIT/GM,TARO PHARMACEUTICALS INC,NYSTATIN,NYSTATIN,100000UNIT,454 GRAM,TOPICAL,Resolved,CREAM,D01AA,ANTIFUNGALS FOR TOPICAL USE,,2018/5/23,2018/7/6,2018/6/15,Disruption of the manufacture of the drug.,2017/4/3,2018/6/18,No
5242,716871,Shortage,NYADERM CRM 100000UNIT/GM,TARO PHARMACEUTICALS INC,NYSTATIN,NYSTATIN,100000UNIT,30 GRAM,TOPICAL,Resolved,CREAM,D01AA,ANTIFUNGALS FOR TOPICAL USE,,2017/3/29,2017/4/28,2017/4/24,Disruption of the manufacture of the drug.,2017/4/3,2017/4/25,No
186,716901,Shortage,NYADERM VAG CRM 25000UNIT/GM,TARO PHARMACEUTICALS INC,NYSTATIN,NYSTATIN,25000UNIT,120 GRAM,VAGINAL,Resolved,CREAM,G01AA,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",,2017/11/2,2018/1/15,2018/1/15,Disruption of the manufacture of the drug.,2017/3/10,2018/1/18,No
1341,622893,Shortage,ODAN BALANCED SALT SOLUTION,ODAN LABORATORIES LTD,Sterile Physiological Irrigating Solution,SODIUM CITRATE SODIUM ACETATE MAGNESIUM CHLORIDE CALCIUM CHLORIDE POTASSIUM CHLORIDE SODIUM CHLORIDE,1.7MG 3.9MG 0.3MG 0.48MG 0.75MG 6.4MG,250 mL; 500 mL,IRRIGATION,Actual shortage,SOLUTION,B05CB,IRRIGATING SOLUTIONS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1032,626562,Shortage,ODAN-AKWA TEARS,ODAN LABORATORIES LTD,Lubricant Ophthalmic Ointment,PETROLATUM LANOLIN MINERAL OIL,55% 2% 42.5%,3.5 g,OPHTHALMIC,Actual shortage,OINTMENT,S01XA,OTHER OPHTHALMOLOGICALS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1355,622907,Shortage,ODAN-ATROPINE,ODAN LABORATORIES LTD,Atropine Sulfate & Hydroxyethyl Cellulose Ophthalmic Solution,Atropine Sulfate Hydroxyethyl Cellulose,1% 0.35%,5 mL,Ophthalmic,Actual shortage,Solution,S01FA,MYDRIATICSAND CYCLOPLEGICS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1293,627720,Shortage,ODAN-CHLORAMPHENICOL,ODAN LABORATORIES LTD,"Chloramphenicol Ophthalmic Ointment, USP",CHLORAMPHENICOL,10MG,3.5 g,OPHTHALMIC,Actual shortage,OINTMENT,S01AA,ANTIINFECTIVES,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1327,622958,Shortage,ODAN-CHLORAMPHENICOL,ODAN LABORATORIES LTD,"Chloramphenicol Ophthalmic Solution, USP",CHLORAMPHENICOL,0.5MG,15 mL,OPHTHALMIC,Actual shortage,LIQUID,S01AA,ANTIINFECTIVES,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
965,630640,Shortage,ODAN-CIDE,ODAN LABORATORIES LTD,"Sulfacetamide Sodium and Prednisolone Acetate Ophthalmic Suspension, USP",PREDNISOLONE ACETATE SULFACETAMIDE SODIUM,5MG 100MG,5 mL; 15 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1254,626627,Shortage,ODAN-CYCLOPENTOLATE,ODAN LABORATORIES LTD,"Cyclopentolate Hydrochloride Ophthalmic Solution, USP",CYCLOPENTOLATE HYDROCHLORIDE,1%,15 mL,OPHTHALMIC,Resolved,SOLUTION,S01FA,MYDRIATICSAND CYCLOPLEGICS,,2016/4/15,,2021/5/11,Disruption of the manufacture of the drug.,2017/3/13,2021/7/6,No
1265,626635,Shortage,ODAN-CYCLOPENTOLATE,ODAN LABORATORIES LTD,"Cyclopentolate Hydrochloride Ophthalmic Solution, USP",CYCLOPENTOLATE HYDROCHLORIDE,0.50%,15 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01FA,MYDRIATICSAND CYCLOPLEGICS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1224,627763,Shortage,ODAN-DEXAMETHASONE,ODAN LABORATORIES LTD,Dexamethasone Sodium Phosphate Ophthalmic/Otic Solution,DEXAMETHASONE SODIUM PHOSPHATE,0.10%,5 mL,"OPHTHALMIC
OTIC",Actual shortage,SOLUTION,S03BA,CORTICOSTEROIDS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
24007,641324,Shortage,ODAN-ERYTHROMYCIN,ODAN LABORATORIES LTD,"Erythromycin Ophthalmic Ointment, USP",ERYTHROMYCIN,5MG,3.5 g,OPHTHALMIC,Resolved,OINTMENT,S01AA,ANTIINFECTIVES,2017/9/29,2017/9/29,2017/12/29,2017/12/20,Shortage of an active ingredient.,2017/9/29,2017/12/21,No
34046,641324,Shortage,ODAN-ERYTHROMYCIN,ODAN LABORATORIES LTD,"Erythromycin Ophthalmic Ointment, USP",ERYTHROMYCIN,5MG,50 x 1g,OPHTHALMIC,Actual shortage,OINTMENT,S01AA,ANTIINFECTIVES,,2017/9/29,,,Disruption of the manufacture of the drug.,2017/12/20,2018/6/8,No
1169,629707,Shortage,ODAN-FLUORACAINE,ODAN LABORATORIES LTD,"Fluorescein Sodium & Proparacaine Hydrochloride Ophthalmic Solution, USP",PROXYMETACAINE HYDROCHLORIDE FLUORESCEIN SODIUM,0.5% 0.25%,5 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01JA,DIAGNOSTICAGENTS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1130,622877,Shortage,ODAN-FLUORESCEIN,ODAN LABORATORIES LTD,"Fluorescein Injection, USP",FLUORESCEIN SODIUM,250MG,2 mL,INTRAVENOUS,Actual shortage,LIQUID,V04,OTHER DIAGNOSTIC AGENTS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1151,622869,Shortage,ODAN-FLUORESCEIN,ODAN LABORATORIES LTD,"Fluorescein Injection, USP",FLUORESCEIN SODIUM,100MG,5 mL,INTRAVENOUS,Actual shortage,SOLUTION,V04,OTHER DIAGNOSTIC AGENTS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1113,687812,Shortage,ODAN-FLUORETS,ODAN LABORATORIES LTD,"Fluorescein Sodium Ophthalmic Strips, USP",FLUORESCEIN SODIUM,1MG,100 strips,OPHTHALMIC,Actual shortage,STRIP,S01JA,DIAGNOSTICAGENTS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1047,832162,Shortage,ODAN-GENTAMICIN,ODAN LABORATORIES LTD,"Gentamicin Sulfate Ophthalmic Solution, USP",Gentamicin Sulfate,0.30%,5 mL,Ophthalmic,Actual shortage,Solution,S01AA,ANTIINFECTIVES,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1050,1989073,Shortage,ODAN-GENTAMICIN,ODAN LABORATORIES LTD,"Gentamicin Sulfate Ophthalmic Ointment, USP",GENTAMICIN SULFATE,5MG,3.5 g,OPHTHALMIC,Actual shortage,OINTMENT,S01AA,ANTIINFECTIVES,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1022,626570,Shortage,ODAN-NAPHAZOLINE,ODAN LABORATORIES LTD,"Naphazoline Hydrochloride Ophthalmic Solution, USP",NAPHAZOLINE HYDROCHLORIDE,0.10%,15 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01GA,DECONGESTANTS AND ANTIALLERGICS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
995,622915,Shortage,ODAN-PHENYLEPHRINE,ODAN LABORATORIES LTD,"Phenylephrine Hydrochloride Ophthalmic Solution, USP",PHENYLEPHRINE HYDROCHLORIDE,2.50%,15 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01FB,MYDRIATICSAND CYCLOPLEGICS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
976,627755,Shortage,ODAN-PILOCARPINE,ODAN LABORATORIES LTD,"Pilocarpine Hydrochloride Ophthalmic Solution, USP",PILOCARPINE HYDROCHLORIDE,4%,15 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01EB,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
985,627747,Shortage,ODAN-PILOCARPINE,ODAN LABORATORIES LTD,"Pilocarpine Hydrochloride Ophthalmic Solution, USP",PILOCARPINE HYDROCHLORIDE,2%,15 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01EB,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
991,627739,Shortage,ODAN-PILOCARPINE,ODAN LABORATORIES LTD,"Pilocarpine Hydrochloride Ophthalmic Solution, USP",Pilocarpine Hydrochloride,1%,15 mL,Ophthalmic,Actual shortage,Solution,S01EB,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
923,622974,Shortage,ODAN-PROPARACAINE,ODAN LABORATORIES LTD,"Proparacaine Hydrochloride Ophthalmic Solution, USP",PROXYMETACAINE HYDROCHLORIDE,0.50%,15 mL,"OPHTHALMIC
TOPICAL",Actual shortage,SOLUTION,S01HA,LOCAL ANESTHETICS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
917,832170,Shortage,ODAN-ROSE,ODAN LABORATORIES LTD,Rose Bengal Ophthalmic Solution,Rose Bengal,1%,5 mL,Ophthalmic,Actual shortage,Liquid,S01JA,DIAGNOSTICAGENTS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1044,635065,Shortage,ODAN-SPOR,ODAN LABORATORIES LTD,"Neomycin and Polymycin B Sulfates & Gramicidin Ophthalmic Solution, USP",POLYMYXIN B SULFATE GRAMICIDIN NEOMYCIN,10000UNIT .025MG 1.75MG,10 mL,OPHTHALMIC,Actual shortage,LIQUID,S01AA,ANTIINFECTIVES,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1041,626600,Shortage,ODAN-SPOR-HC,ODAN LABORATORIES LTD,"Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension, USP",Hydrocortisone Neomycin Sulfate Polymyxin B Sulfate,"10 mg/mL 3.5 mg/mL 10,000 unit/mL",10 mL,Otic,Actual shortage,Suspension,S02CA,CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
896,622966,Shortage,ODAN-SULFACETAMIDE,ODAN LABORATORIES LTD,"Sulfacetamide Sodium Ophthalmic Solution, USP",SULFACETAMIDE SODIUM,10%,15 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01AB,ANTIINFECTIVES,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
876,2010240,Shortage,ODAN-TIMOLOL,ODAN LABORATORIES LTD,"Timolol Maleate Ophthalmic Solution, USP",TIMOLOL MALEATE,0.50%,5 mL; 10 mL; 15 mL,OPHTHALMIC,Actual shortage,LIQUID,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
890,2010259,Shortage,ODAN-TIMOLOL,ODAN LABORATORIES LTD,"Timolol Maleate Ophthalmic Solution, USP",TIMOLOL MALEATE,0.25%,5 mL; 10 mL; 15 mL,OPHTHALMIC,Actual shortage,LIQUID,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1239,626597,Shortage,ODAN-TROL,ODAN LABORATORIES LTD,"Neomycin and Polymycin B Sulfates & Dexamethasone Ophthalmic Suspension, USP",DEXAMETHASONE POLYMYXIN B SULFATE NEOMYCIN SULFATE,1MG 10000UNIT 3.5MG,5 mL,OPHTHALMIC,Actual shortage,SUSPENSION,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
857,622885,Shortage,ODAN-TROPICAMIDE,ODAN LABORATORIES LTD,"Tropicamide Ophthalmic Solution, USP",TROPICAMIDE,1%,15 mL,OPHTHALMIC,Resolved,SOLUTION,S01FA,MYDRIATICSAND CYCLOPLEGICS,,2016/4/15,,2021/10/14,Disruption of the manufacture of the drug.,2017/3/13,2021/10/15,No
870,627704,Shortage,ODAN-TROPICAMIDE,ODAN LABORATORIES LTD,"Tropicamide Ophthalmic Solution, USP",TROPICAMIDE,0.50%,15 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01FA,MYDRIATICSAND CYCLOPLEGICS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1004,626643,Shortage,ODAN-VERNACON,ODAN LABORATORIES LTD,Pheniramine Maleate and Phenylephrine Hydrochloride Ophthalmic Solution,PHENYLEPHRINE HYDROCHLORIDE PHENIRAMINE MALEATE,0.125% 0.5%,15 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01GA,DECONGESTANTS AND ANTIALLERGICS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
11488,2416522,Shortage,OLANZAPINE FOR INJECTION,SANDOZ CANADA INCORPORATED,OLANZAPINE,OLANZAPINE,10MG,1 VIAL,INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,N05AH,ANTIPSYCHOTICS,2017/6/12,,2017/8/18,2017/8/18,Delay in shipping of the drug.,2017/5/30,2017/10/18,No
30725,2352974,Shortage,OLANZAPINE ODT,SANIS HEALTH INC,OLANZAPINE ODT,OLANZAPINE,5MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2018/2/5,2018/2/5,2018/11/30,2018/12/10,Disruption of the manufacture of the drug.,2017/11/27,2018/12/11,No
2320,2425114,Shortage,OLANZAPINE ODT,PRO DOC LIMITEE,OLANZAPINE ODT,OLANZAPINE,20MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2018/8/29,,2018/11/2,Delay in shipping of the drug.,2017/3/14,2018/11/3,No
12095,2352990,Shortage,OLANZAPINE ODT,SANIS HEALTH INC,OLANZAPINE ODT TABS,OLANZAPINE,15MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2017/6/12,2017/7/7,,2018/7/10,Delay in shipping of the drug.,2017/6/6,2018/9/28,No
28887,2343681,Shortage,OLANZAPINE ODT,SIVEM PHARMACEUTICALS ULC,OLANZAPINE ODT,OLANZAPINE,15MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2017/12/25,2017/12/4,,2018/7/2,Other (Please describe in comments),2017/11/10,2018/7/31,No
28890,2343703,Shortage,OLANZAPINE ODT,SIVEM PHARMACEUTICALS ULC,OLANZAPINE ODT,OLANZAPINE,20MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2018/2/16,2018/2/7,,2018/7/2,Other (Please describe in comments),2017/11/10,2018/7/31,No
21989,2352990,Shortage,OLANZAPINE ODT,SANIS HEALTH INC,OLANZAPINE ODT TABS,OLANZAPINE,15MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2017/6/12,2017/7/7,,2018/7/10,Disruption of the manufacture of the drug.,2017/9/13,2018/9/28,No
21992,2352982,Shortage,OLANZAPINE ODT,SANIS HEALTH INC,OLANZAPINE ODT TABS,OLANZAPINE,10MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2017/9/13,2017/9/22,2018/10/31,2018/11/15,Disruption of the manufacture of the drug.,2017/9/13,2018/11/16,No
18869,890960,Shortage,OLESTYR,PHARMASCIENCE INC,OLESTYR,CHOLESTYRAMINE RESIN,4G,30 X 4,ORAL,Resolved,POWDER FOR SUSPENSION,C10AC,"LIPID MODIFYING AGENTS, PLAIN",2017/8/1,2017/8/1,2017/12/27,2018/1/24,Disruption of the manufacture of the drug.,2017/8/11,2018/1/26,No
21691,890960,Shortage,OLESTYR,PHARMASCIENCE INC,OLESTYR,CHOLESTYRAMINE RESIN,4G,30 X 4,ORAL,Resolved,POWDER FOR SUSPENSION,C10AC,"LIPID MODIFYING AGENTS, PLAIN",2017/9/26,2017/9/26,,2017/12/14,Disruption of the manufacture of the drug.,2017/9/8,2017/12/15,No
15024,2352516,Shortage,OLIMEL 4.4% E,BAXTER CORPORATION,OLIMEL 4.4% E,HISTIDINE TRYPTOPHAN SODIUM ACETATE TRIHYDRATE ALANINE SOYBEAN OIL DEXTROSE SODIUM GLYCEROPHOSPHATE MAGNESIUM CHLORIDE CALCIUM CHLORIDE POTASSIUM CHLORIDE OLIVE OIL METHIONINE GLYCINE GLUTAMIC ACID L-TYROSINE L-PROLINE L-ARGININE L-VALINE L-ASPARTIC ACID L-THREONINE L-PHENYLALANINE L-LEUCINE L-ISOLEUCINE LYSINE SERINE,2.64G 0.74G 1.50G 6.41G 8G 154G 3.67G 0.81G 0.52G 2.24G 32G 2.21G 3.07G 2.21G 0.11G 2.64G 4.34G 2.83G 1.28G 2.21G 3.07G 3.07G 2.21G 3.48G 1.75G,1000mL,INTRAVENOUS,Resolved,EMULSION,B05BA,I.V. SOLUTIONS,2017/7/7,2017/7/7,2017/8/15,2017/8/15,Demand increase for the drug.,2017/7/10,2017/8/16,No
22577,2319616,Shortage,OLMETEC PLUS,MERCK CANADA INC,Olmesartan medoxomil and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL,12.5MG 20MG,30 Tablets,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2017/10/9,2017/10/3,2018/1/12,2018/1/11,Other (Please describe in comments),2017/9/19,2018/1/12,No
22580,2319624,Shortage,OLMETEC PLUS,MERCK CANADA INC,Olmesartan medoxomil and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL,12.5MG 40MG,30 Tablets,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2017/10/9,2017/9/25,2018/3/9,2018/3/9,Other (Please describe in comments),2017/9/19,2018/3/10,No
22583,2319632,Shortage,OLMETEC PLUS,MERCK CANADA INC,Olmesartan medoxomil and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL,25MG 40MG,30 Tablets,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2017/10/9,2017/10/2,2018/1/12,2018/1/11,Other (Please describe in comments),2017/9/19,2018/1/12,No
21295,2438968,Shortage,OMEP,SANDOZ CANADA INCORPORATED,OMEP,OMEPRAZOLE,20MG,2X7BL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/9/1,2017/10/23,2017/10/12,Demand increase for the drug.,2017/9/7,2017/10/25,No
2668,2438968,Shortage,OMEP,SANDOZ CANADA INCORPORATED,OMEP,OMEPRAZOLE,20MG,2x7/Bl,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/3/14,2017/5/22,2017/5/15,Disruption of the manufacture of the drug.,2017/3/14,2017/5/17,No
11803,2421402,Shortage,ONDANSETRON,SANIS HEALTH INC,ONDANSETRON,ONDANSETRON,4MG,30,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017/6/5,2017/10/20,2017/10/4,Disruption of the manufacture of the drug.,2017/6/5,2017/10/10,No
11806,2421410,Shortage,ONDANSETRON,SANIS HEALTH INC,ONDANSETRON TABS,ONDANSETRON,8MG,30,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017/6/5,2017/10/20,2017/10/4,Disruption of the manufacture of the drug.,2017/6/5,2017/10/10,No
3230,2421402,Shortage,ONDANSETRON,SANIS HEALTH INC,ONDANSETRON TABS,ONDANSETRON,4MG,30,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,2017/3/31,2017/3/31,2017/7/30,2017/10/4,Other (Please describe in comments),2017/3/17,2017/10/10,No
3239,2421410,Shortage,ONDANSETRON,SANIS HEALTH INC,ONDANSETRON TABS,ONDANSETRON,8MG,30,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,2017/3/31,2017/3/31,2017/7/30,2017/10/4,Other (Please describe in comments),2017/3/17,2017/10/10,No
7880,2291967,Shortage,ONDANSETRON,AA PHARMA INC,ONDANSETRON,ONDANSETRON,4MG,50 ML,ORAL,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017/9/1,2018/3/19,2018/3/13,Demand increase for the drug.,2017/4/25,2018/3/14,No
21979,2421402,Shortage,ONDANSETRON,SANIS HEALTH INC,ONDANSETRON TAB,ONDANSETRON,4MG,30,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017/9/13,2017/10/20,2017/10/4,Disruption of the manufacture of the drug.,2017/9/13,2017/10/5,No
21982,2421410,Shortage,ONDANSETRON,SANIS HEALTH INC,ONDANSETRON TABS,ONDANSETRON,8MG,30,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017/9/13,2017/10/20,2017/10/4,Disruption of the manufacture of the drug.,2017/9/13,2017/10/5,No
2019,2291967,Shortage,ONDANSETRON,AA PHARMA INC,ONDANSETRON,ONDANSETRON,4MG,50 ML,ORAL,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017/2/28,2017/3/24,2017/3/29,Other (Please describe in comments),2017/3/13,2017/3/31,No
18328,2274418,Shortage,ONDANSETRON HYDROCHLORIDE DIHYDRATE INJECTION,SANDOZ CANADA INCORPORATED,ONDANSETRON,ONDANSETRON,2MG,5 X 2ML AMPS,INTRAVENOUS,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,2017/8/7,,2017/9/15,2017/8/22,Delay in shipping of the drug.,2017/8/7,2017/10/19,No
1746,2265532,Shortage,ONDANSETRON INJECTION,TEVA CANADA LIMITED,ONDANSETRON,ONDANSETRON,2MG,20ML,INTRAVENOUS,Actual shortage,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2016/2/29,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1754,2265524,Shortage,ONDANSETRON INJECTION,TEVA CANADA LIMITED,ONDANSETRON,ONDANSETRON,2MG,2ML,INTRAVENOUS,Actual shortage,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2016/2/29,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
16268,2279436,Shortage,ONDANSETRON INJECTION USP     -(WITH PRESERVATIVE),SANDOZ CANADA INCORPORATED,ONDANSETRON,ONDANSETRON,2MG,20ML VIAL,INTRAVENOUS,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,2017/7/21,,2017/7/31,2017/8/4,Demand increase for the drug.,2017/7/18,2017/10/19,No
18325,2279436,Shortage,ONDANSETRON INJECTION USP     -(WITH PRESERVATIVE),SANDOZ CANADA INCORPORATED,ONDANSETRON,ONDANSETRON,2MG,20ML VIAL,INTRAVENOUS,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017/7/25,2017/8/18,2017/8/18,Delay in shipping of the drug.,2017/8/7,2017/10/19,No
4133,2390051,Shortage,"ONDANSETRON INJECTION, USP",MYLAN PHARMACEUTICALS ULC,"ONDANSETRON INJECTION, USP",ONDANSETRON,2MG,20ML 1VL,INTRAVENOUS,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017/9/17,2018/10/30,2018/10/19,Disruption of the manufacture of the drug.,2017/3/24,2018/10/20,No
13614,2390019,Shortage,"ONDANSETRON INJECTION, USP",MYLAN PHARMACEUTICALS ULC,"ONDANSETRON INJECTION, USP",ONDANSETRON,2MG,2ML 5VL,INTRAVENOUS,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2018/9/17,2018/10/30,2018/10/19,Disruption of the manufacture of the drug.,2017/6/22,2018/10/20,No
13535,2390019,Shortage,"ONDANSETRON INJECTION, USP",MYLAN PHARMACEUTICALS ULC,"ONDANSETRON INJECTION, USP",ONDANSETRON,2MG,"4ML 5VL, 2ML 5VL",INTRAVENOUS,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2018/9/17,2018/10/30,2018/10/19,Disruption of the manufacture of the drug.,2017/6/21,2018/10/20,No
4083,2390019,Shortage,"ONDANSETRON INJECTION, USP",MYLAN PHARMACEUTICALS ULC,Ondansetron,ONDANSETRON,2MG,2ML 5VL,INTRAVENOUS,Avoided shortage,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,2017/5/10,,,2017/5/1,Delay in shipping of the drug.,2017/3/23,2017/5/3,No
5605,2389983,Shortage,ONDISSOLVE ODF,TAKEDA CANADA INC,ondansetron,ONDANSETRON,4MG,Carton of 10 orally disintegrating films,ORAL,Resolved,"FILM, SOLUBLE",A04AA,ANTIEMETICS AND ANTINAUSEANTS,2017/4/17,,2017/4/28,2017/5/10,Demand increase for the drug.,2017/4/5,2017/5/11,No
26749,2326663,Shortage,ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP,LABORATOIRES STERIGEN INC,Erythromycin ophthalmic ointment USP,ERYTHROMYCIN,5MG,3.5g,OPHTHALMIC,Resolved,OINTMENT,S01AA,ANTIINFECTIVES,,2018/2/8,2018/9/21,2018/9/20,Other (Please describe in comments),2017/10/23,2018/9/21,No
9975,2326663,Shortage,ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP,LABORATOIRES STERIGEN INC,Erythromycin Ophthalmic Ointment USP,ERYTHROMYCIN,5MG,1 g,OPHTHALMIC,Resolved,OINTMENT,S01AA,ANTIINFECTIVES,,2017/3/9,2021/12/15,2021/12/15,Disruption of the manufacture of the drug.,2017/5/10,2021/12/16,No
9978,2326663,Shortage,ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP,LABORATOIRES STERIGEN INC,Erythromycin Ophthalmic Ointment USP,ERYTHROMYCIN,5MG,3.5 g,OPHTHALMIC,Resolved,OINTMENT,S01AA,ANTIINFECTIVES,,2017/4/20,2017/8/31,2017/8/24,Demand increase for the drug.,2017/5/10,2017/9/6,No
28908,2467135,Shortage,ONIVYDE,BAXALTA CANADA CORPORATION,Irinotecan Liposome for Injection,IRINOTECAN HYDROCHLORIDE,43MG,Vials of 43g/10ML,INTRAVENOUS,Resolved,SUSPENSION,L01XX,OTHER ANTINEOPLASTIC AGENTS,2017/11/7,2017/11/8,2017/12/11,2017/12/6,Demand increase for the drug.,2017/11/10,2017/12/7,No
2024,313815,Shortage,ORAP,AA PHARMA INC,ORAP,PIMOZIDE,2 MG,100 Bottle,Oral,Resolved,Tablet,N05AG,ANTIPSYCHOTICS,,2015/4/15,,2017/7/28,Other (Please describe in comments),2017/3/14,2020/8/6,No
2027,313823,Shortage,ORAP,AA PHARMA INC,ORAP,PIMOZIDE,4MG,100 Bottle,ORAL,Resolved,TABLET,N05AG,ANTIPSYCHOTICS,,2015/4/15,,2017/7/28,Other (Please describe in comments),2017/3/14,2020/8/6,No
12499,2236783,Shortage,ORCIPRENALINE,AA PHARMA INC,ORCIPRENALINE,ORCIPRENALINE SULFATE,2MG,250 ML,ORAL,Resolved,SYRUP,R03CB,ADRENERGICS FOR SYSTEMIC USE,,2018/3/26,,2018/4/4,Disruption of the manufacture of the drug.,2017/6/12,2019/1/11,No
17164,2245641,Shortage,ORGALUTRAN,MERCK CANADA INC,Ganirelix Acetate Injection,GANIRELIX,250MCG,0.5ML SYRINGE,SUBCUTANEOUS,Resolved,SOLUTION,H01CC,HYPOTHALAMIC HORMONES,,2017/8/9,2017/9/29,2017/9/28,Delay in shipping of the drug.,2017/7/25,2017/9/29,No
25320,2245641,Shortage,ORGALUTRAN,MERCK CANADA INC,Ganirelix Acetate Injection,GANIRELIX,250MCG,0.5ML,SUBCUTANEOUS,Avoided shortage,SOLUTION,H01CC,HYPOTHALAMIC HORMONES,2017/11/8,,2017/11/10,2017/11/7,Delay in shipping of the drug.,2017/10/11,2017/11/7,No
19750,2444763,Shortage,OXALIPLATIN,PFIZER CANADA INC,Oxaliplatin,OXALIPLATIN,5MG,1x20mL,INTRAVENOUS,Avoided shortage,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,2017/9/30,,2017/10/31,2017/9/20,Demand increase for the drug.,2017/8/17,2017/9/29,No
19647,2444763,Shortage,OXALIPLATIN,PFIZER CANADA INC,Oxaliplatin,OXALIPLATIN,5MG,1x40mL,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,2017/8/18,,2017/9/30,2017/9/20,Demand increase for the drug.,2017/8/16,2017/9/29,No
4033,2444763,Shortage,OXALIPLATIN,HOSPIRA HEALTHCARE CORPORATION,OXALIPLATIN,OXALIPLATIN,5MG,10ML VIAL / FLACON,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,2017/4/13,,2017/6/20,2017/6/20,Disruption of the manufacture of the drug.,2017/3/23,2017/6/21,No
2606,2436957,Shortage,OXALIPLATIN INJECTION,SANDOZ CANADA INCORPORATED,OXALIPLATIN,OXALIPLATIN,5MG,40mL fiole/vial,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2017/1/20,2017/4/17,2017/4/11,Delay in shipping of the drug.,2017/3/14,2017/4/12,No
15454,2436957,Shortage,OXALIPLATIN INJECTION,SANDOZ CANADA INCORPORATED,OXALIPLATIN,OXALIPLATIN,5MG,10ML VIAL,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2017/7/11,2017/7/31,2017/7/28,Delay in shipping of the drug.,2017/7/11,2017/8/2,No
10599,2436957,Shortage,OXALIPLATIN INJECTION,SANDOZ CANADA INCORPORATED,Oxaliplatin Injection,OXALIPLATIN,5MG,20mLV,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2017/5/17,2017/7/28,2017/7/28,Other (Please describe in comments),2017/5/17,2017/8/2,No
10602,2436957,Shortage,OXALIPLATIN INJECTION,SANDOZ CANADA INCORPORATED,Oxaliplatin Injection,OXALIPLATIN,5MG,40mLV,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2017/5/17,2017/7/28,2017/9/1,Other (Please describe in comments),2017/5/17,2017/10/25,No
27761,414247,Shortage,OXPAM,BIOMED PHARMA,Oxazepam Tablets 10 mg,,,100,,Actual shortage,,,,,2014/10/23,,,Other (Please describe in comments),2017/11/1,2017/11/1,No
27764,414247,Shortage,OXPAM,BIOMED PHARMA,Oxazepam Tablets 10 mg,,,1000,,Actual shortage,,,,,2014/10/23,,,Other (Please describe in comments),2017/11/1,2017/11/1,No
27869,414255,Shortage,OXPAM,BIOMED PHARMA,Oxazepam Tablets 15 mg,,,100,,Actual shortage,,,,,2014/10/23,,,Other (Please describe in comments),2017/11/2,2017/11/2,No
27872,414255,Shortage,OXPAM,BIOMED PHARMA,Oxazepam Tablets 15 mg,,,1000,,Actual shortage,,,,,2014/10/23,,,Other (Please describe in comments),2017/11/2,2017/11/2,No
27875,414263,Shortage,OXPAM,BIOMED PHARMA,Oxazepam Tablets 30 mg,,,100,,Actual shortage,,,,,2014/10/23,,,Other (Please describe in comments),2017/11/2,2017/11/2,No
27878,414263,Shortage,OXPAM,BIOMED PHARMA,Oxazepam Tablets 30 mg,,,1000,,Actual shortage,,,,,2014/10/23,,,Other (Please describe in comments),2017/11/2,2017/11/2,No
33667,2350238,Shortage,OXYBUTYNIN,SANIS HEALTH INC,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,5MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/12/18,2019/2/5,2019/2/5,Other (Please describe in comments),2017/12/18,2019/2/6,No
30915,2350238,Shortage,OXYBUTYNIN,SANIS HEALTH INC,OXYBUTYNIN TABS,OXYBUTYNIN CHLORIDE,5MG,500,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/11/28,,2019/2/5,Other (Please describe in comments),2017/11/28,2019/2/6,No
3981,2220636,Shortage,OXYBUTYNINE-5  -  TAB 5MG,PRO DOC LIMITEE,OXYBUTYNINE,OXYBUTYNIN CHLORIDE,5MG,500,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/6/27,,2018/5/30,Other (Please describe in comments),2017/3/22,2018/5/31,No
21169,497398,Shortage,OXYTOCIN INJECTION 10UNIT/ML,HOSPIRA HEALTHCARE CORPORATION,Oxytocin,OXYTOCIN,10UNIT,25x5mL AMP,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,H01BB,POSTERIOR PITUITARY LOBE HORMONES,,2017/11/2,,2018/2/16,Disruption of the manufacture of the drug.,2017/9/6,2018/2/17,No
21174,497398,Shortage,OXYTOCIN INJECTION 10UNIT/ML,HOSPIRA HEALTHCARE CORPORATION,OXYTOCIN,OXYTOCIN,10UNIT,50x1mL AMP,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,H01BB,POSTERIOR PITUITARY LOBE HORMONES,,2017/12/7,,2018/2/16,Disruption of the manufacture of the drug.,2017/9/6,2018/2/17,No
8223,2320010,Shortage,PACLITAXEL FOR INJECTION USP,STERIMAX INC,PACLITAXEL FOR INJECTION USP,PACLITAXEL,6MG,1 VIAL,INTRAVENOUS,Actual shortage,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2014/9/29,,,Other (Please describe in comments),2017/4/27,2017/10/5,No
15457,2320150,Shortage,PACLITAXEL INJECTION USP,SANDOZ CANADA INCORPORATED,PACLITAXEL,PACLITAXEL,6MG,50ML VIAL,INTRAVENOUS,Resolved,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2017/7/19,,2017/7/31,2017/7/28,Demand increase for the drug.,2017/7/11,2017/8/2,No
15460,2320150,Shortage,PACLITAXEL INJECTION USP,SANDOZ CANADA INCORPORATED,PACLITAXEL,PACLITAXEL,6MG,5 X 5ML VIAL,INTRAVENOUS,Resolved,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2017/7/11,,2017/8/18,2017/8/18,Requirements related to complying with good manufacturing practices.,2017/7/11,2017/10/25,No
18335,2320150,Shortage,PACLITAXEL INJECTION USP,SANDOZ CANADA INCORPORATED,PACLITAXEL,PACLITAXEL,6MG,16.7 ML VIAL,INTRAVENOUS,Resolved,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2017/7/21,2017/8/18,2017/8/18,Delay in shipping of the drug.,2017/8/7,2017/10/25,No
4361,2239170,Shortage,PAL-TIZANIDINE,PALADIN LABS INC,ZANAFLEX,TIZANIDINE,4MG,150 TABS,ORAL,Actual shortage,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2012/10/3,,,Other (Please describe in comments),2017/3/27,2017/10/5,No
2163,2249669,Shortage,PAMIDRONATE DISODIUM OMEGA 3 MG/ML,OMEGA LABORATORIES LTD,Pamidrontae Disodium for Injection 30mg/10mL,PAMIDRONATE DISODIUM,3.0MG,10mL vial,INTRAVENOUS,Actual shortage,SOLUTION,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2013/1/1,,,Disruption of the manufacture of the drug.,2017/3/14,2017/10/5,No
2460,1926306,Shortage,PANECTYL TAB 2.5MG,ERFA CANADA 2012 INC,Trimeprazine  Tartrate,Trimeprazine  Tartrate,2.5 mg,bottle of 100,Oral,Resolved,tablet,R06AD,ANTIHISTAMINES FOR SYSTEMIC USE,2014/11/1,2014/11/1,2017/6/16,2017/5/15,Disruption of the manufacture of the drug.,2017/3/14,2017/12/12,No
3325,2431327,Shortage,PANTOPRAZOLE,LABORATOIRE RIVA INC,Pantoprazole 40mg,PANTOPRAZOLE,40MG,30,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/3/17,2017/3/17,,2017/9/19,Disruption of the manufacture of the drug.,2017/3/17,2021/12/2,No
2603,2306727,Shortage,PANTOPRAZOLE SODIUM FOR INJECTION,SANDOZ CANADA INCORPORATED,PANTOPRAZOLE,PANTOPRAZOLE,40MG,10 fioles/vials,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/1/23,2017/1/23,2017/3/31,2017/3/24,Delay in shipping of the drug.,2017/3/14,2017/3/28,No
11491,2306727,Shortage,PANTOPRAZOLE SODIUM FOR INJECTION,SANDOZ CANADA INCORPORATED,PANTOPRAZOLE,PANTOPRAZOLE,40MG,10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/6/5,,2017/7/28,2017/7/17,Requirements related to complying with good manufacturing practices.,2017/5/30,2017/7/18,No
3265,1919598,Shortage,PARNATE,GLAXOSMITHKLINE INC,Tranylcypromine sulfate tablet,TRANYLCYPROMINE,10MG,100's,ORAL,Avoided shortage,TABLET,N06AF,ANTIDEPRESSANTS,2017/4/17,,,2017/4/12,Demand increase for the drug.,2017/3/17,2017/4/12,No
15631,2248503,Shortage,PAXIL CR,GLAXOSMITHKLINE INC,paroxetine controlled release tablets,PAROXETINE,12.5MG,30's,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AB,ANTIDEPRESSANTS,,2017/8/7,2017/8/17,2017/8/18,Shortage of an inactive ingredient or component.,2017/7/12,2017/8/19,No
13661,2248504,Shortage,PAXIL CR,GLAXOSMITHKLINE INC,paroxetine controlled release tablets,PAROXETINE,25MG,30's,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AB,ANTIDEPRESSANTS,,2017/7/31,2017/8/17,2017/8/14,Disruption of the manufacture of the drug.,2017/6/22,2017/8/16,No
7145,2022826,Shortage,PDP-AMANTADINE HYDROCHLORIDE SYRUP,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pms-AMANTADINE HCL 10mg/1mL SYRUP 500mL,AMANTADINE HYDROCHLORIDE,10MG,500mL,ORAL,Resolved,SYRUP,N04BB,DOPAMINERGIC AGENTS,,2017/4/18,2017/5/24,2017/5/24,Demand increase for the drug.,2017/4/18,2017/6/5,No
17424,426857,Shortage,PDP-BENZTROPINE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-BENZTROPINE 2mg TABS 1000,BENZTROPINE MESYLATE,2MG,1000,ORAL,Actual shortage,TABLET,N04AC,ANTICHOLINERGIC AGENTS,2017/9/26,2017/9/12,,,Disruption of the manufacture of the drug.,2017/7/28,2018/12/20,No
20812,706531,Shortage,PDP-BENZTROPINE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-BENZTROPINE 1mg TABS 1000,BENZTROPINE MESYLATE,1MG,1000,ORAL,Avoided shortage,TABLET,N04AC,ANTICHOLINERGIC AGENTS,2017/10/31,,2017/10/31,2017/10/30,Disruption of the manufacture of the drug.,2017/9/1,2017/10/30,No
24098,2229315,Shortage,PDP-DESONIDE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-DESONIDE 0.05% CR 15g,DESONIDE,0.05%,15g,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",2017/10/2,2017/10/2,2018/1/25,2018/1/18,Demand increase for the drug.,2017/10/2,2018/1/18,No
5442,2229323,Shortage,PDP-DESONIDE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-DESONIDE 0.05% OINTMENT 60g,DESONIDE,0.05%,60g OINT,TOPICAL,Resolved,OINTMENT,D07AB,"CORTICOSTEROIDS, PLAIN",2017/5/12,2017/5/16,2018/1/29,2018/1/23,Disruption of the manufacture of the drug.,2017/4/4,2018/1/25,No
10466,2229315,Shortage,PDP-DESONIDE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-DESONIDE 0.05% CR 60g,DESONIDE,0.05%,60g,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",2017/6/6,2017/6/12,2018/1/19,2018/1/18,Delay in shipping of the drug.,2017/5/16,2018/1/19,No
7150,2229315,Shortage,PDP-DESONIDE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-DESONIDE 0.05% CR 15g,DESONIDE,0.05%,15g CR,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",2017/9/11,2017/9/11,2017/10/4,2017/9/28,Disruption of the manufacture of the drug.,2017/4/18,2017/10/5,No
52,1912755,Shortage,PDP-ERYTHROMYCIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,ERYTHROMYCIN OPHTALMIC OINTMENT,ERYTHROMYCIN,5MG,50x1g,OPHTHALMIC,Avoided shortage,OINTMENT,S01AA,ANTIINFECTIVES,2017/8/31,2017/8/31,2017/9/1,2017/8/4,Disruption of the manufacture of the drug.,2017/3/10,2017/10/5,No
19373,1912755,Shortage,PDP-ERYTHROMYCIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-ERYTHROMYCIN 5mg/g OINT OPH 50X1g U,ERYTHROMYCIN,5MG,50X1G,OPHTHALMIC,Resolved,OINTMENT,S01AA,ANTIINFECTIVES,2017/9/20,2017/9/25,2017/10/9,2017/10/11,Disruption of the manufacture of the drug.,2017/8/15,2017/10/12,No
29874,1912755,Shortage,PDP-ERYTHROMYCIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-ERYTHROMYCIN 5mg/g OINT OPH 50X1g UD,ERYTHROMYCIN,5MG,1x50g,OPHTHALMIC,Resolved,OINTMENT,S01AA,ANTIINFECTIVES,2017/12/15,,2017/12/21,2017/12/15,Delay in shipping of the drug.,2017/11/20,2017/12/16,No
58,2324253,Shortage,PDP-HYDROCODONE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,HYDROCODONE,HYDROCODONE BITARTRATE,1MG,500 ML,ORAL,Resolved,SYRUP,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,,2017/3/6,,2017/3/24,Demand increase for the drug.,2017/3/10,2017/4/4,No
5436,2324253,Shortage,PDP-HYDROCODONE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-HYDROCODONE BITAR 1mg/mL SYR 500mL,HYDROCODONE BITARTRATE,1MG,500mL,ORAL,Resolved,SYRUP,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,,2017/6/12,2017/6/15,2017/6/19,Demand increase for the drug.,2017/4/4,2017/6/20,No
19367,2324253,Shortage,PDP-HYDROCODONE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-HYDROCODONE BITAR 1mg/mL SYR 500mL,HYDROCODONE BITARTRATE,1MG,500mL,ORAL,Resolved,SYRUP,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,,2017/8/14,2017/9/1,2017/9/1,Disruption of the manufacture of the drug.,2017/8/15,2017/9/2,No
27609,2324253,Shortage,PDP-HYDROCODONE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-HYDROCODONE BITAR 1mg/mL SYR 500mL,HYDROCODONE BITARTRATE,1MG,500ML,ORAL,Resolved,SYRUP,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,2017/10/30,2017/10/30,2017/12/28,2018/1/3,Disruption of the manufacture of the drug.,2017/10/31,2018/1/8,No
31685,577804,Shortage,PDP-ISONIAZID,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-ISONIAZID 300mg TABS 100,ISONIAZID,300MG,100,ORAL,Resolved,TABLET,J04AC,DRUGS FOR TREATMENT OF TUBERCULOSIS,2017/12/13,2017/12/18,2018/1/15,2018/1/16,Demand increase for the drug.,2017/12/4,2018/1/18,No
17427,587362,Shortage,PDP-PROCYCLIDINE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-PROCYCLIDINE 2.5mg/5mL 500mL,PROCYCLIDINE HYDROCHLORIDE,2.5MG,500ml,ORAL,Actual shortage,ELIXIR,N04AA,ANTICHOLINERGIC AGENTS,2017/11/16,2017/11/1,,,Disruption of the manufacture of the drug.,2017/7/28,2018/12/20,No
17430,587354,Shortage,PDP-PROCYCLIDINE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-PROCYCLIDINE 5mg TABS 100,PROCYCLIDINE HYDROCHLORIDE,5MG,100,ORAL,Actual shortage,TABLET,N04AA,ANTICHOLINERGIC AGENTS,2017/8/1,2017/7/21,,,Other (Please describe in comments),2017/7/28,2018/9/4,No
8754,649392,Shortage,PDP-PROCYCLIDINE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-PROCYCLIDINE 2.5mg TABS 100,PROCYCLIDINE HYDROCHLORIDE,2.5MG,100,ORAL,Resolved,TABLET,N04AA,ANTICHOLINERGIC AGENTS,2017/6/6,2017/6/6,,2017/6/6,Requirements related to complying with good manufacturing practices.,2017/5/3,2017/9/13,No
17527,649392,Shortage,PDP-PROCYCLIDINE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-PROCYCLIDINE 2.5mg TABS 100,PROCYCLIDINE HYDROCHLORIDE,2.5MG,100,ORAL,Actual shortage,TABLET,N04AA,ANTICHOLINERGIC AGENTS,2017/7/31,2017/8/15,,,Disruption of the manufacture of the drug.,2017/7/31,2018/12/20,No
8929,618810,Shortage,PDP-PYRAZINAMIDE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-PYRAZINAMIDE 500mg TABS 100,PYRAZINAMIDE,500MG,100,ORAL,Resolved,TABLET,J04AK,DRUGS FOR TREATMENT OF TUBERCULOSIS,2017/10/15,,2017/12/17,2017/10/15,Disruption of the manufacture of the drug.,2017/5/4,2017/10/16,No
4467,2243167,Shortage,PEDIACEL,SANOFI PASTEUR LIMITED,Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine and Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate),INACTIVATED POLIOMYELITIS VACCINE INACTIVATED POLIOMYELITIS VACCINE INACTIVATED POLIOMYELITIS VACCINE PERTACTIN FIMBRIAE FILAMENTOUS HAEMAGGLUTININ PERTUSSIS TOXOID TETANUS PROTEIN HAEMOPHILUS INFLUENZAE TYPE B-PRP TETANUS TOXOID DIPHTHERIA TOXOID,32UNIT 8UNIT 40UNIT 3MCG 5MCG 20MCG 20MCG 30MCG 10MCG 5LF 15LF,"5 x 0.5 mL vials / 5 fioles de 0,5 mL",INTRAMUSCULAR,Resolved,SUSPENSION,J07CA,"BACTERIAL AND VIRAL VACCINES, COMBINED",2017/3/28,2017/3/28,,2018/2/1,Delay in shipping of the drug.,2017/3/28,2018/2/11,No
27673,2230619,Shortage,PEDIAPRED,SANOFI-AVENTIS CANADA INC,Pediapred oral liquid,PREDNISOLONE,5MG,120ml,ORAL,Resolved,SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017/11/1,2017/11/30,2017/11/28,Demand increase for the drug.,2017/11/1,2017/12/1,No
15623,2220261,Shortage,"PENICILLIN G SODIUM FOR INJECTION, USP",FRESENIUS KABI CANADA LTD,PENICILLIN G SODIUM,PENICILLIN G,1000000UNIT,1 million unit SD vial,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,J01CE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017/7/12,,2018/3/6,Disruption of the manufacture of the drug.,2017/7/12,2018/3/7,No
1764,1930672,Shortage,"PENICILLIN G SODIUM FOR INJECTION, USP",TEVA CANADA LIMITED,PENICILLIN G SODIUM,PENICILLIN G SODIUM,1000000UNIT,10,"INTRAMUSCULAR
INTRAVENOUS",Actual shortage,POWDER FOR SOLUTION,J01CE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2016/1/25,2022/12/31,,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
1772,1930680,Shortage,"PENICILLIN G SODIUM FOR INJECTION, USP",TEVA CANADA LIMITED,PENICILLIN G SODIUM,PENICILLIN G SODIUM,10000000UNIT,10,"INTRAMUSCULAR
INTRAVENOUS",Actual shortage,POWDER FOR SOLUTION,J01CE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2016/1/25,2022/12/31,,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
1781,883751,Shortage,"PENICILLIN G SODIUM FOR INJECTION, USP",TEVA CANADA LIMITED,PENICILLIN G SODIUM,PENICILLIN G SODIUM,5000,10,INJECTION,Actual shortage,LIQUID,J01CE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2016/1/25,2022/12/31,,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
13439,2240433,Shortage,PERICHLOR,PHARMASCIENCE INC,PERICHLOR ORAL RINSE 0.12% 475mL,CHLORHEXIDINE GLUCONATE,0.12%,475 ml,BUCCAL,Resolved,LIQUID,A01AB,STOMATOLOGICAL PREPARATIONS,,2017/6/19,2017/9/1,2017/9/1,Disruption of the manufacture of the drug.,2017/6/20,2017/9/2,No
20055,2247104,Shortage,PERIOSTAT,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PERIOSTAT 20mg CAPS 60,DOXYCYCLINE,20MG,60,ORAL,Resolved,CAPSULE,A01AB,STOMATOLOGICAL PREPARATIONS,2017/11/6,2017/11/3,2017/12/19,2017/12/15,Disruption of the manufacture of the drug.,2017/8/22,2017/12/18,No
28695,637734,Shortage,PERSANTINE,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Persantine,DIPYRIDAMOLE,5MG,5 X 10ML,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,2017/11/13,2017/11/28,2018/1/30,2018/2/2,Demand increase for the drug.,2017/11/9,2018/2/3,No
2212,637734,Shortage,PERSANTINE,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,PERSANTINE,DIPYRIDAMOLE,5MG,5 x 10ml,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,,2017/2/20,2017/3/31,2017/3/20,Demand increase for the drug.,2017/3/14,2017/3/21,No
19911,637734,Shortage,PERSANTINE,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,PERSANTINE,DIPYRIDAMOLE,5MG,Amps,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,2017/8/20,2017/8/20,2017/8/25,2017/9/1,Delay in shipping of the drug.,2017/8/21,2017/9/4,No
12502,637734,Shortage,PERSANTINE,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,PERSANTINE,DIPYRIDAMOLE,5MG,5 x 10ml,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,2017/6/19,,2017/7/7,2017/7/7,Demand increase for the drug.,2017/6/12,2017/7/9,No
22240,637734,Shortage,PERSANTINE,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,PERSANTINE,DIPYRIDAMOLE,5MG,5's,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,,2017/9/18,2017/10/23,2017/10/5,Demand increase for the drug.,2017/9/18,2017/10/5,No
12625,2229777,Shortage,PHARIXIA,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHARIXIA 0.15% ORAL RINSE 250 mL,BENZYDAMINE HYDROCHLORIDE,1.5MG,250ml,"BUCCAL
ORAL",Resolved,"SOLUTION
MOUTHWASH/GARGLE",A01AD,STOMATOLOGICAL PREPARATIONS,,2017/6/9,,2017/6/19,Disruption of the manufacture of the drug.,2017/6/13,2017/6/20,No
30810,2229777,Shortage,PHARIXIA,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHARIXIA 0.15% ORAL RINSE 250 mL,BENZYDAMINE HYDROCHLORIDE,1.5MG,250ml,BUCCAL,Resolved,MOUTHWASH/GARGLE,A01AD,STOMATOLOGICAL PREPARATIONS,2017/11/29,2017/12/1,2017/12/29,2017/12/15,Delay in shipping of the drug.,2017/11/27,2017/12/18,No
20060,2229777,Shortage,PHARIXIA,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHARIXIA,BENZYDAMINE HYDROCHLORIDE,1.5MG,250Ml,"BUCCAL
ORAL",Resolved,"SOLUTION
MOUTHWASH/GARGLE",A01AD,STOMATOLOGICAL PREPARATIONS,2017/9/1,2017/9/5,2017/9/20,2017/9/22,Disruption of the manufacture of the drug.,2017/8/22,2017/9/25,No
1985,2371499,Shortage,PHARMA-D 10000 IU,PHARMASCIENCE INC,Vitamin D,VITAMIN D3,10000UNIT,100,ORAL,Resolved,CAPSULE,A11CC,"VIT A AND D, INCL COMBINATIONS OF THE TWO",,2015/11/6,,2020/6/5,Other (Please describe in comments),2017/3/13,2020/6/9,No
1989,2371499,Shortage,PHARMA-D 10000 IU,PHARMASCIENCE INC,Vitamin D,VITAMIN D3,10000UNIT,500,ORAL,Resolved,CAPSULE,A11CC,"VIT A AND D, INCL COMBINATIONS OF THE TWO",,2016/2/3,,2020/6/5,Other (Please describe in comments),2017/3/13,2020/6/9,No
32173,2247383,Shortage,PHARMA-LACTULOSE,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,500,ORAL,Resolved,SOLUTION,A06AD,DRUGS FOR CONSTIPATION,,2017/12/8,2017/12/15,2017/12/12,Disruption of the manufacture of the drug.,2017/12/8,2017/12/15,No
11154,1948911,Shortage,PHARMALGEN HONEY BEE VENOM,ALK ABELLO A/S,Allergenic Extract,APIS MELLIFERA VENOM PROTEIN EXTRACT,120MCG,10mL,"INTRADERMAL
SUBCUTANEOUS",Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016/11/1,2016/12/1,,,Requirements related to complying with good manufacturing practices.,2017/5/24,2017/10/5,No
11159,1948903,Shortage,PHARMALGEN HONEY BEE VENOM,ALK ABELLO A/S,Allergenic Extract,APIS MELLIFERA VENOM PROTEIN EXTRACT,1.1MG,30mL,"INTRADERMAL
SUBCUTANEOUS",Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016/11/1,2016/12/1,,,Requirements related to complying with good manufacturing practices.,2017/5/24,2017/10/5,No
11164,1948881,Shortage,PHARMALGEN MIXED VESPID VENOM PROTEIN,ALK ABELLO A/S,Allergenic Extract,WHITE FACED HORNET VENOM PROTEIN YELLOW JACKET VENOM PROTEIN YELLOW HORNET VENOM PROTEIN,120MCG 120MCG 120MCG,10mL,"INTRADERMAL
SUBCUTANEOUS",Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016/11/1,2016/12/1,,,Requirements related to complying with good manufacturing practices.,2017/5/24,2017/10/5,No
11169,1948873,Shortage,PHARMALGEN MIXED VESPID VENOM PROTEIN,ALK ABELLO A/S,Allergenic Extract,WHITE FACED HORNET VENOM PROTEIN YELLOW JACKET VENOM PROTEIN YELLOW HORNET VENOM PROTEIN,120MCG 120MCG 120MCG,30mL,"INTRADERMAL
SUBCUTANEOUS",Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016/11/1,2016/12/1,,,Requirements related to complying with good manufacturing practices.,2017/5/24,2017/10/5,No
11173,1948970,Shortage,PHARMALGEN WASP VENOM PROTEIN,ALK ABELLO A/S,Allergenic Extract,POLISTES SPP VENOM PROTEIN EXTRACT,1.1MG,30mL,"INTRADERMAL
SUBCUTANEOUS",Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016/11/1,2016/12/1,,,Requirements related to complying with good manufacturing practices.,2017/5/24,2017/10/5,No
11179,1948989,Shortage,PHARMALGEN WASP VENOM PROTEIN,ALK ABELLO A/S,Allergenic Extract,POLISTES SPP VENOM PROTEIN EXTRACT,120MCG,10mL,"INTRADERMAL
SUBCUTANEOUS",Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016/11/1,2016/12/1,,,Requirements related to complying with good manufacturing practices.,2017/5/24,2017/10/5,No
11191,1949004,Shortage,PHARMALGEN WHITE FACED HORNET VENOM,ALK ABELLO A/S,Allergenic Extract,DOLICHOVESPULA MACULATA VENOM PROTEIN EXTRACT,120MCG,10mL,"INTRADERMAL
SUBCUTANEOUS",Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016/11/1,2016/12/1,,,Requirements related to complying with good manufacturing practices.,2017/5/24,2017/10/5,No
11194,1948997,Shortage,PHARMALGEN WHITE FACED HORNET VENOM PROTEIN,ALK ABELLO A/S,Allergenic Extract,DOLICHOVESPULA MACULATA VENOM PROTEIN EXTRACT,1.1MG,30mL,"INTRADERMAL
SUBCUTANEOUS",Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016/11/1,2016/12/1,,,Requirements related to complying with good manufacturing practices.,2017/5/24,2017/10/5,No
11197,1948938,Shortage,PHARMALGEN YELLOW HORNET VENOM,ALK ABELLO A/S,Allergenic Extract,DOLICHOVESPULA ARENARIA VENOM PROTEIN EXTRACT,1.1MG,30mL,"INTRADERMAL
SUBCUTANEOUS",Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016/11/1,2016/12/1,,,Requirements related to complying with good manufacturing practices.,2017/5/24,2017/10/5,No
11204,1948946,Shortage,PHARMALGEN YELLOW HORNET VENOM PROTEIN,ALK ABELLO A/S,Allergenic Extract,DOLICHOVESPULA ARENARIA VENOM PROTEIN EXTRACT,120MCG,10mL,"INTRADERMAL
SUBCUTANEOUS",Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016/11/1,2016/12/1,,,Requirements related to complying with good manufacturing practices.,2017/5/24,2017/10/5,No
11209,1948954,Shortage,PHARMALGEN YELLOW JACKET VENOM PROTEIN,ALK ABELLO A/S,Allergenic Extract,VESPULA SPP VENOM PROTEIN EXTRACT,1.1MG,30mL,"INTRADERMAL
SUBCUTANEOUS",Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016/11/1,2016/12/1,,,Requirements related to complying with good manufacturing practices.,2017/5/24,2017/10/5,No
11213,1948962,Shortage,PHARMALGEN YELLOW JACKET VENOM PROTEIN,ALK ABELLO A/S,Allergenic Extract,VESPULA SPP VENOM PROTEIN EXTRACT,120MCG,10mL,"INTRADERMAL
SUBCUTANEOUS",Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016/11/1,2016/12/1,,,Requirements related to complying with good manufacturing practices.,2017/5/24,2017/10/5,No
22039,178802,Shortage,PHENOBARB,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHENOBARB 30mg TABS 500,PHENOBARBITAL,30MG,500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,2017/9/5,2017/9/5,2017/10/15,2017/10/11,Disruption of the manufacture of the drug.,2017/9/13,2017/10/12,No
22341,178799,Shortage,PHENOBARB,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHENOBARB 15mg TABS 500,PHENOBARBITAL,15MG,500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,2017/9/18,2017/9/18,2017/10/15,2017/10/11,Delay in shipping of the drug.,2017/9/18,2017/10/12,No
17293,178810,Shortage,PHENOBARB,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHENOBARB 60mg TABS 500,PHENOBARBITAL,60MG,500,ORAL,Avoided shortage,TABLET,N03AA,ANTIEPILEPTICS,2017/8/1,2017/8/1,2017/8/7,2017/7/31,Disruption of the manufacture of the drug.,2017/7/26,2017/10/5,No
4011,178829,Shortage,PHENOBARB,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHENOBARB 100mg TABS 500,PHENOBARBITAL,100MG,500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,2017/10/22,,2017/10/22,2017/10/23,Disruption of the manufacture of the drug.,2017/3/23,2017/10/23,No
31677,178799,Shortage,PHENOBARB,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHENOBARB 15mg TABS 500,PHENOBARBITAL,15MG,500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,2018/1/22,2018/1/22,2018/3/1,2018/3/1,Shortage of an active ingredient.,2017/12/4,2018/3/1,No
31680,178802,Shortage,PHENOBARB,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHENOBARB 30mg TABS 500,PHENOBARBITAL,30MG,500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,2017/12/22,2017/12/22,2018/3/1,2018/3/1,Delay in shipping of the drug.,2017/12/4,2018/3/1,No
2586,2304090,Shortage,"PHENOBARBITAL SODIUM INJECTION, USP",SANDOZ CANADA INCORPORATED,PHENOBARBITAL Na Inj 1,PHENOBARBITAL SODIUM,120MG,10x1mL Amp,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,N03AA,ANTIEPILEPTICS,2017/4/7,,2017/7/17,2017/7/3,Delay in shipping of the drug.,2017/3/14,2017/7/5,No
15463,2304082,Shortage,"PHENOBARBITAL SODIUM INJECTION, USP",SANDOZ CANADA INCORPORATED,PHENOBARBITAL,PHENOBARBITAL SODIUM,30MG,10 X 1ML AMPOULE,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,N03AA,ANTIEPILEPTICS,2017/7/21,2017/7/17,2017/10/27,2017/10/24,Demand increase for the drug.,2017/7/11,2017/10/27,No
31386,2431378,Shortage,"PHENYTOIN SODIUM INJECTION, USP",STERIMAX INC,Phenytoin Sodium Injection USP,PHENYTOIN SODIUM,50MG,25 vials,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,N03AB,ANTIEPILEPTICS,,2017/11/30,2017/12/11,2017/12/13,Delay in shipping of the drug.,2017/11/30,2017/12/14,No
8200,2402483,Shortage,"PILOCARPINE HYDROCHLORIDE TABLETS, USP",STERIMAX INC,"PILOCARPINE HYDROCHLORIDE TABLETS, USP",PILOCARPINE HYDROCHLORIDE,5MG,100 Tabs,ORAL,Actual shortage,TABLET,N07AX,PARASYMPATHOMIMETICS,,2015/4/16,,,Other (Please describe in comments),2017/4/27,2017/10/5,No
1811,2370166,Shortage,PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION,TEVA CANADA LIMITED,PIPERCILLIN/TAZOBACTAM,PIPERACILLIN TAZOBACTAM,3G 0.375G,10,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",2017/1/15,,,2018/2/28,Disruption of the manufacture of the drug.,2017/3/13,2018/3/1,No
29438,2370174,Shortage,PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION,TEVA CANADA LIMITED,PIPERACILLIN/TAZOBACTAM,PIPERACILLIN TAZOBACTAM,4G 0.5G,10,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017/11/16,,,Disruption of the manufacture of the drug.,2017/11/16,2018/10/11,No
30515,2377748,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,STERIMAX INC,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,PIPERACILLIN TAZOBACTAM,12G 1.5G,1 VIAL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017/11/23,2018/1/8,2018/1/26,Delay in shipping of the drug.,2017/11/23,2018/1/27,No
577,2308452,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,APOTEX INC,PIPERACILLIN - TAZOBACTUM,PIPERACILLIN TAZOBACTAM,3.0G 0.375G,30 ML,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2016/9/7,,,Disruption of the manufacture of the drug.,2017/3/11,2018/9/12,No
580,2308460,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,APOTEX INC,PIPERACILLIN - TAZOBACTUM,PIPERACILLIN TAZOBACTAM,4.0G 0.5G,48 ML,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2016/9/7,,,Disruption of the manufacture of the drug.,2017/3/11,2017/10/5,No
583,2308444,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,APOTEX INC,PIPERACILLIN - TAZOBACTUM,PIPERACILLIN TAZOBACTAM,2G 0.25G,30 ML,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2014/10/1,,,Disruption of the manufacture of the drug.,2017/3/11,2018/9/12,No
8297,2362619,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,STERIMAX INC,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,PIPERACILLIN TAZOBACTAM,2.00G 0.25G,10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2016/5/25,,2018/4/13,Other (Please describe in comments),2017/4/27,2018/4/17,No
31390,2362627,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,STERIMAX INC,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,PIPERACILLIN TAZOBACTAM,3.000G 0.375G,10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017/11/30,2018/1/8,2018/1/15,Other (Please describe in comments),2017/11/30,2018/1/16,No
31394,2362635,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,STERIMAX INC,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,PIPERACILLIN TAZOBACTAM,4.0G 0.5G,10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2018/5/3,2018/6/4,2018/5/30,Other (Please describe in comments),2017/11/30,2018/5/31,No
2570,2299658,Shortage,PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION,SANDOZ CANADA INCORPORATED,PIPERACILLIN-TAZO,PIPERACILLIN TAZOBACTAM,4G 0.5G,10x4.5g fioles/vials,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",2017/3/14,,2017/4/28,2017/5/2,Shortage of an active ingredient.,2017/3/14,2017/10/25,No
30892,2299658,Shortage,PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION,SANDOZ CANADA INCORPORATED,PIPERACILLIN-TAZOBACTAM,PIPERACILLIN TAZOBACTAM,4G 0.5G,10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017/11/24,2018/7/20,2018/8/10,Shortage of an active ingredient.,2017/11/28,2018/8/13,No
30895,2330547,Shortage,PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION,SANDOZ CANADA INCORPORATED,PIPERACILLIN-TAZOBACTAM,PIPERACILLIN TAZOBACTAM,12G 1.5G,1 VIAL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",2017/11/30,2017/12/15,2018/5/11,2018/5/4,Shortage of an active ingredient.,2017/11/28,2018/5/23,No
4586,2299631,Shortage,PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION,SANDOZ CANADA INCORPORATED,TAZOCIN,PIPERACILLIN TAZOBACTAM,3G 0.375G,10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017/3/27,2017/4/28,2017/5/12,Delay in shipping of the drug.,2017/3/29,2017/5/17,No
8581,1946897,Shortage,PMS DEXAMETHASONE ELIXIR 0.5MG/5ML,PHARMASCIENCE INC,DEXAMETHASONE,DEXAMETHASONE,0.5MG,100 mL,ORAL,Resolved,LIQUID,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017/5/1,2017/6/30,2017/7/6,Disruption of the manufacture of the drug.,2017/5/2,2017/7/7,No
21509,1964976,Shortage,PMS DEXAMETHASONE TAB 0.5MG USP,PHARMASCIENCE INC,DEXAMETHASONE,DEXAMETHASONE,0.5MG,100,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017/9/4,2018/1/30,2018/2/8,Disruption of the manufacture of the drug.,2017/9/7,2018/2/12,No
8576,1964976,Shortage,PMS DEXAMETHASONE TAB 0.5MG USP,PHARMASCIENCE INC,DEXAMETHASONE,DEXAMETHASONE,0.5MG,100,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017/5/1,2017/5/16,2017/5/31,Disruption of the manufacture of the drug.,2017/5/2,2017/6/1,No
8931,664553,Shortage,PMS DOCUSATE-CALCIUM CAP 240MG USP,PHARMASCIENCE INC,DOCUSATE CALCIUM,DOCUSATE CALCIUM,240MG,30,ORAL,Resolved,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,2017/5/22,2017/5/22,,2020/6/5,Disruption of the manufacture of the drug.,2017/5/4,2020/6/8,No
17060,1916394,Shortage,PMS HYDROMORPHONE SUPPOSITOIRE 3MG,PHARMASCIENCE INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,3MG,10,RECTAL,Resolved,SUPPOSITORY,N02AA,OPIOIDS,,2017/7/1,,2020/6/5,Disruption of the manufacture of the drug.,2017/7/25,2020/6/8,No
22820,1937235,Shortage,PMS TRAZODONE HCL TAB 100MG,PHARMASCIENCE INC,TRAZADONE,TRAZODONE HYDROCHLORIDE,100MG,500,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017/9/15,,2020/6/9,Other (Please describe in comments),2017/9/19,2020/6/10,No
17097,1937235,Shortage,PMS TRAZODONE HCL TAB 100MG,PHARMASCIENCE INC,TRAZADONE,TRAZODONE HYDROCHLORIDE,100MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017/7/1,,2018/5/4,Disruption of the manufacture of the drug.,2017/7/25,2018/5/5,No
7527,1937227,Shortage,PMS TRAZODONE HCL TAB 50MG,PHARMASCIENCE INC,TRAZADONE,TRAZODONE HYDROCHLORIDE,50MG,500,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017/4/20,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/20,2020/6/10,No
5531,1937227,Shortage,PMS TRAZODONE HCL TAB 50MG,PHARMASCIENCE INC,TRAZADONE,TRAZODONE HYDROCHLORIDE,50MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017/3/23,2018/11/25,2018/11/28,Shortage of an inactive ingredient or component.,2017/4/4,2018/11/29,No
5534,1937227,Shortage,PMS TRAZODONE HCL TAB 50MG,PHARMASCIENCE INC,TRAZADONE,TRAZODONE HYDROCHLORIDE,50MG,250,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017/3/23,,2020/6/5,Shortage of an inactive ingredient or component.,2017/4/4,2020/6/8,No
25829,2458381,Shortage,PMS-ABACAVIR-LAMIVUDINE,PHARMASCIENCE INC,ABACAVIR/LAMIVUDINE,ABACAVIR LAMIVUDINE,600MG 300MG,30,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2017/10/1,,2018/10/2,Disruption of the manufacture of the drug.,2017/10/12,2018/10/3,No
25731,816027,Shortage,PMS-ACETAMINOPHEN W CODEINE ELIXIR,PHARMASCIENCE INC,ACET CODEINE,ACETAMINOPHEN CODEINE PHOSPHATE,160MG 8MG,90,ORAL,Resolved,ELIXIR,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,,2017/10/1,2017/11/15,2017/12/4,Disruption of the manufacture of the drug.,2017/10/12,2017/12/8,No
28780,2284006,Shortage,PMS-ALENDRONATE-FC,PHARMASCIENCE INC,ALENDRONATE,ALENDRONIC ACID,70MG,30,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/11/10,2018/3/2,2018/3/6,Delay in shipping of the drug.,2017/11/9,2018/3/7,No
25734,2284006,Shortage,PMS-ALENDRONATE-FC,PHARMASCIENCE INC,ALENDRONATE,ALENDRONIC ACID,70MG,4,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/10/1,2018/4/2,2018/3/6,Disruption of the manufacture of the drug.,2017/10/12,2018/3/7,No
30,1990403,Shortage,PMS-AMANTADINE HYDROCHLORIDE CAP 100MG,PHARMASCIENCE INC,pms-AMANTADINE HCHL CAPSULES,AMANTADINE HYDROCHLORIDE,100MG,100 CAPS,ORAL,Resolved,CAPSULES,N04BB,DOPAMINERGIC AGENTS,2016/11/18,2016/11/19,2018/2/9,2018/2/9,Disruption of the manufacture of the drug.,2017/3/10,2018/2/10,No
13090,2292173,Shortage,PMS-AMIODARONE,PHARMASCIENCE INC,AMIODARONE,AMIODARONE HYDROCHLORIDE,100MG,100,ORAL,Resolved,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",2017/6/25,2017/6/25,2017/7/14,2017/7/14,Demand increase for the drug.,2017/6/16,2017/10/11,No
28783,2242472,Shortage,PMS-AMIODARONE,PHARMASCIENCE INC,AMIODARONE,AMIODARONE HYDROCHLORIDE,200MG,100,ORAL,Resolved,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",,2017/11/10,2018/4/27,2018/5/4,Disruption of the manufacture of the drug.,2017/11/9,2018/5/5,No
7322,2242472,Shortage,PMS-AMIODARONE,PHARMASCIENCE INC,AMIODARONE,AMIODARONE HYDROCHLORIDE,200MG,100,ORAL,Resolved,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",2017/7/10,2017/7/10,2017/7/10,2017/7/10,Disruption of the manufacture of the drug.,2017/4/20,2017/10/11,No
18853,2242472,Shortage,PMS-AMIODARONE,PHARMASCIENCE INC,AMIODARONE,AMIODARONE HYDROCHLORIDE,200MG,100,ORAL,Resolved,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",,2017/8/11,2017/9/4,2017/9/15,Disruption of the manufacture of the drug.,2017/8/11,2017/9/19,No
27323,2292173,Shortage,PMS-AMIODARONE,PHARMASCIENCE INC,AMIODARONE,AMIODARONE HYDROCHLORIDE,100MG,100,ORAL,Resolved,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",,2017/10/9,2018/4/26,2018/5/4,Disruption of the manufacture of the drug.,2017/10/27,2018/5/5,No
22725,2292173,Shortage,PMS-AMIODARONE,PHARMASCIENCE INC,AMIODARONE,AMIODARONE HYDROCHLORIDE,100MG,100,ORAL,Resolved,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",,2017/9/18,2017/9/29,2017/9/29,Disruption of the manufacture of the drug.,2017/9/19,2017/10/11,No
27326,654507,Shortage,PMS-AMITRIPTYLINE,PHARMASCIENCE INC,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,50MG,1000,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2017/10/27,2017/11/23,2017/11/14,Disruption of the manufacture of the drug.,2017/10/27,2017/11/17,No
12208,654523,Shortage,PMS-AMITRIPTYLINE TABLETS 10MG,PHARMASCIENCE INC,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,10MG,1000,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2017/6/6,,2017/7/23,Disruption of the manufacture of the drug.,2017/6/7,2017/7/24,No
18856,654515,Shortage,PMS-AMITRIPTYLINE TABLETS 25MG,PHARMASCIENCE INC,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,25MG,1000,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017/8/23,2017/8/23,2017/12/20,2017/12/15,Disruption of the manufacture of the drug.,2017/8/11,2017/12/18,No
21489,654515,Shortage,PMS-AMITRIPTYLINE TABLETS 25MG,PHARMASCIENCE INC,AMYTRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,25MG,100,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017/10/6,2017/10/6,2017/11/28,2017/11/14,Disruption of the manufacture of the drug.,2017/9/7,2017/11/17,No
21492,654507,Shortage,PMS-AMITRIPTYLINE TABLETS 50MG,PHARMASCIENCE INC,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,50MG,100,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017/11/13,,2017/12/5,2017/11/14,Disruption of the manufacture of the drug.,2017/9/7,2017/11/17,No
4987,2295148,Shortage,PMS-AMLODIPINE,PHARMASCIENCE INC,AMLODIPINE,AMLODIPINE,2.5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/3/23,,2019/11/13,Disruption of the manufacture of the drug.,2017/3/31,2019/11/14,No
6014,2295148,Shortage,PMS-AMLODIPINE,PHARMASCIENCE INC,AMLODIPINE,AMLODIPINE,2.5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/4/5,2017/9/12,2017/9/12,Disruption of the manufacture of the drug.,2017/4/7,2017/10/11,No
1717,2284073,Shortage,PMS-AMLODIPINE,PHARMASCIENCE INC,Amlodipine,AMLODIPINE,10.0MG,500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/3/20,,2019/3/28,Disruption of the manufacture of the drug.,2017/3/13,2019/3/29,No
1492,2284065,Shortage,PMS-AMLODIPINE,PHARMASCIENCE INC,Amlodipine,AMLODIPINE,5.0MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/3/1,,2019/3/28,Disruption of the manufacture of the drug.,2017/3/13,2019/3/29,No
1512,2284065,Shortage,PMS-AMLODIPINE,PHARMASCIENCE INC,Amlodipine,AMLODIPINE,5.0MG,500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017/3/20,2017/3/20,,2019/3/28,Disruption of the manufacture of the drug.,2017/3/13,2019/3/29,No
1532,2284073,Shortage,PMS-AMLODIPINE,PHARMASCIENCE INC,Amlodipine,AMLODIPINE,10.0MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/3/1,,2019/3/28,Disruption of the manufacture of the drug.,2017/3/13,2019/3/29,No
1726,2404222,Shortage,PMS-AMLODIPINE-ATORVASTATIN,PHARMASCIENCE INC,Amlodipine-Atorvastatin,AMLODIPINE ATORVASTATIN,5MG 10MG,100,ORAL,Resolved,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",,2015/7/7,,2020/4/1,Disruption of the manufacture of the drug.,2017/3/13,2020/4/2,No
1741,2404249,Shortage,PMS-AMLODIPINE-ATORVASTATIN,PHARMASCIENCE INC,Amlodipine- Atorvastatin,AMLODIPINE ATORVASTATIN,10MG 10MG,100,ORAL,Resolved,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",,2015/7/7,,2020/4/1,Disruption of the manufacture of the drug.,2017/3/13,2020/4/2,No
1758,2404257,Shortage,PMS-AMLODIPINE-ATORVASTATIN,PHARMASCIENCE INC,Amlodipine Atorvastatin,AMLODIPINE ATORVASTATIN,10MG 20MG,100,ORAL,Resolved,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",,2015/7/7,,2020/4/1,Disruption of the manufacture of the drug.,2017/3/13,2020/4/2,No
17013,2230245,Shortage,PMS-AMOXICILLIN,PHARMASCIENCE INC,AMOXICILLIN,AMOXICILLIN,125MG,100 mL,ORAL,Resolved,POWDER FOR SUSPENSION,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017/7/1,2017/9/18,2017/10/10,Disruption of the manufacture of the drug.,2017/7/25,2017/10/11,No
6098,2440385,Shortage,PMS-AMPHETAMINES XR,PHARMASCIENCE INC,AMPHETAMINES XR,DEXTROAMPHETAMINE SACCHARATE DEXTROAMPHETAMINE SULFATE AMPHETAMINE ASPARTATE MONOHYDRATE AMPHETAMINE SULFATE,3.75MG 3.75MG 3.75MG 3.75MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/4/5,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/7,2020/6/10,No
32023,2274949,Shortage,PMS-ANAGRELIDE,PHARMASCIENCE INC,ANAGRELIDE,ANAGRELIDE,0.5MG,100,ORAL,Resolved,CAPSULE,L01XX,OTHER ANTINEOPLASTIC AGENTS,2017/12/10,2017/12/15,2018/8/3,2018/8/23,Disruption of the manufacture of the drug.,2017/12/7,2018/8/24,No
11294,2237600,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,50MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/6/29,2017/6/29,2018/5/15,2018/4/17,Shortage of an active ingredient.,2017/5/25,2018/4/19,No
32032,2246581,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,25MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/12/9,2017/12/15,2018/5/14,2018/5/4,Disruption of the manufacture of the drug.,2017/12/7,2018/5/5,No
13097,2237601,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,100MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/10/16,2017/11/8,2018/4/17,2018/5/4,Shortage of an active ingredient.,2017/6/16,2018/5/5,No
28786,2246581,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,25MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/11/10,2018/4/13,2018/4/17,Disruption of the manufacture of the drug.,2017/11/9,2018/4/19,No
7333,2237601,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,100MG,3X10,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/4/20,2017/11/20,2017/7/18,Disruption of the manufacture of the drug.,2017/4/20,2017/7/19,No
8899,2237600,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,50MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/6/18,,2017/11/15,2017/6/18,Disruption of the manufacture of the drug.,2017/5/4,2017/7/19,No
22729,2237600,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,50MG,30,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/9/18,,2018/5/4,Disruption of the manufacture of the drug.,2017/9/19,2018/5/5,No
15085,2237601,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,100MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/10/16,2017/11/8,2018/6/14,2018/5/15,Shortage of an active ingredient.,2017/7/11,2018/5/18,No
15088,2237601,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,100MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/8/26,2017/7/19,2018/4/10,2018/4/17,Shortage of an active ingredient.,2017/7/11,2018/4/19,No
15091,2246581,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,25MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/9/14,2017/10/11,2018/5/12,2018/4/17,Shortage of an active ingredient.,2017/7/11,2018/4/19,No
15094,2237600,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,50MG,30,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/8/2,2017/8/2,2018/3/1,2017/12/4,Shortage of an active ingredient.,2017/7/11,2017/12/8,No
4156,2381060,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,Atomoxetine,ATOMOXETINE,60MG,100,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2017/8/17,2017/8/17,2018/1/28,2018/2/8,Disruption of the manufacture of the drug.,2017/3/24,2018/2/12,No
4165,2381060,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,Atomoxetine,ATOMOXETINE,60MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/3/23,,2017/7/23,Disruption of the manufacture of the drug.,2017/3/24,2017/7/24,No
8533,2381052,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMOXETINE,ATOMOXETINE,40MG,100,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2017/6/26,2017/6/26,2018/1/30,2018/2/8,Disruption of the manufacture of the drug.,2017/5/2,2018/2/12,No
8543,2381052,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMEXETINE,ATOMOXETINE,40MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2017/7/11,2017/7/11,2018/2/20,2018/2/19,Disruption of the manufacture of the drug.,2017/5/2,2018/2/20,No
8903,2381044,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMOXETINE,ATOMOXETINE,25MG,100,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2017/7/6,2017/7/6,2018/1/28,2018/2/8,Shortage of an inactive ingredient or component.,2017/5/4,2018/2/12,No
22732,2381036,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMOXETINE,ATOMOXETINE,18MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/9/18,,2018/5/4,Disruption of the manufacture of the drug.,2017/9/19,2018/5/5,No
22735,2381060,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMOXETINE,ATOMOXETINE,60MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/9/18,,2018/5/4,Disruption of the manufacture of the drug.,2017/9/19,2018/5/5,No
6101,2381044,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMOXETINE,ATOMOXETINE,25MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/4/5,2018/2/19,2018/2/19,Disruption of the manufacture of the drug.,2017/4/7,2018/2/20,No
33117,2399385,Shortage,PMS-ATORVASTATIN,PHARMASCIENCE INC,ATORVASTATIN,ATORVASTATIN,20MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018/1/1,2018/1/24,2018/2/5,2018/2/8,Disruption of the manufacture of the drug.,2017/12/15,2018/2/12,No
22738,2399407,Shortage,PMS-ATORVASTATIN,PHARMASCIENCE INC,ATORVASTATIN,ATORVASTATIN,80MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/9/18,2017/9/25,2017/10/10,Disruption of the manufacture of the drug.,2017/9/19,2017/10/11,No
4168,2261634,Shortage,PMS-AZITHROMYCIN,PHARMASCIENCE INC,AZITHROMYCIN,AZITHROMYCIN,250MG,6,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/3/23,2018/1/8,2017/10/24,Disruption of the manufacture of the drug.,2017/3/24,2017/10/26,No
10081,2418460,Shortage,PMS-AZITHROMYCIN,PHARMASCIENCE INC,AZITHROMYCIN,AZITHROMYCIN,200MG,5 mL,ORAL,Resolved,POWDER FOR SUSPENSION,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/5/1,,2020/6/5,Other (Please describe in comments),2017/5/11,2020/6/9,No
17017,2261634,Shortage,PMS-AZITHROMYCIN,PHARMASCIENCE INC,AZITHROMYCIN,AZITHROMYCIN,250MG,100,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/7/1,2017/11/10,2017/9/15,Disruption of the manufacture of the drug.,2017/7/25,2017/9/19,No
27329,2261634,Shortage,PMS-AZITHROMYCIN,PHARMASCIENCE INC,AZITHROMYCIN,AZITHROMYCIN,250MG,100,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/10/9,2018/1/10,2018/1/24,Disruption of the manufacture of the drug.,2017/10/27,2018/1/26,No
8912,2418460,Shortage,PMS-AZITHROMYCIN,PHARMASCIENCE INC,AZITHROMYCIN,AZITHROMYCIN,200MG,5 mL,ORAL,Resolved,POWDER FOR SUSPENSION,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/5/1,,2020/6/5,Other (Please describe in comments),2017/5/4,2020/6/9,No
22741,2261642,Shortage,PMS-AZITHROMYCIN,PHARMASCIENCE INC,AZITHROMYCIN,AZITHROMYCIN,600MG,30,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/9/18,,2018/10/2,Disruption of the manufacture of the drug.,2017/9/19,2018/10/3,No
5457,2063735,Shortage,PMS-BACLOFEN,PHARMASCIENCE INC,BACLOFEN,BACLOFEN,10MG,100,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2017/3/30,,2017/7/23,Disruption of the manufacture of the drug.,2017/4/4,2017/7/24,No
10086,2063735,Shortage,PMS-BACLOFEN,PHARMASCIENCE INC,BACLOFEN,BACLOFEN,10MG,500,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",2017/5/1,2017/5/1,2017/7/23,2017/7/23,Disruption of the manufacture of the drug.,2017/5/11,2017/10/11,No
25740,2063735,Shortage,PMS-BACLOFEN,PHARMASCIENCE INC,BACLOFEN,BACLOFEN,10MG,500,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2017/10/1,2018/1/9,2018/1/24,Disruption of the manufacture of the drug.,2017/10/12,2018/1/26,No
27336,2063743,Shortage,PMS-BACLOFEN TAB 20MG,PHARMASCIENCE INC,BACLOFEN,BACLOFEN,20MG,100,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2017/10/9,2018/2/12,2018/2/16,Disruption of the manufacture of the drug.,2017/10/27,2018/2/17,No
25826,2330237,Shortage,PMS-BETAHISTINE,PHARMASCIENCE INC,BETAHISTINE,BETAHISTINE HYDROCHLORIDE,24MG,100,ORAL,Resolved,TABLET,N07CA,ANTIVERTIGO PREPARATIONS,,2017/10/1,2017/11/17,2017/11/14,Disruption of the manufacture of the drug.,2017/10/12,2017/11/17,No
7338,2275589,Shortage,PMS-BICALUTAMIDE,PHARMASCIENCE INC,BICALUTAMIDE,BICALUTAMIDE,50MG,100,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,2017/8/17,2017/8/17,2018/6/20,2018/6/26,Disruption of the manufacture of the drug.,2017/4/20,2018/6/29,No
6105,2275589,Shortage,PMS-BICALUTAMIDE,PHARMASCIENCE INC,BICALUTAMIDE,BICALUTAMIDE,50MG,30,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017/5/17,2018/5/30,2018/6/6,Disruption of the manufacture of the drug.,2017/4/7,2018/6/7,No
8919,582883,Shortage,PMS-BISACODYL,PHARMASCIENCE INC,BISACODYL,BISACODYL,10MG,100,RECTAL,Resolved,SUPPOSITORY,A06AB,DRUGS FOR CONSTIPATION,2017/7/17,2017/7/17,,2020/6/9,Other (Please describe in comments),2017/5/4,2020/6/10,No
32035,2383020,Shortage,PMS-BOSENTAN,PHARMASCIENCE INC,BOSENTAN,BOSENTAN,125MG,60,ORAL,Resolved,TABLET,C02KX,OTHER ANTIHYPERTENSIVES,,2017/12/7,2018/2/16,2018/2/16,Disruption of the manufacture of the drug.,2017/12/7,2018/2/17,No
1774,2246284,Shortage,PMS-BRIMONIDINE,PHARMASCIENCE INC,Brimonidine,BRIMONIDINE TARTRATE,0.20%,5 ml & 10 ml,OPHTHALMIC,Resolved,SOLUTION,S01EA,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2013/7/23,,2020/4/1,Other (Please describe in comments),2017/3/13,2020/4/2,No
2352,2424851,Shortage,PMS-BUPRENORPHINE-NALOXONE,PHARMASCIENCE INC,PMS - BUPRENORPHINE NALOXONE,BUPRENORPHINE NALOXONE,2MG 0.5MG,30,SUBLINGUAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,2017/9/30,,2017/11/30,2017/11/22,Disruption of the manufacture of the drug.,2017/3/14,2017/11/23,No
17805,2424878,Shortage,PMS-BUPRENORPHINE-NALOXONE,PHARMASCIENCE INC,BUPRENORPHINE/NALOXONE,BUPRENORPHINE NALOXONE,8MG 2MG,30,SUBLINGUAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2017/8/1,2017/11/30,2017/11/22,Disruption of the manufacture of the drug.,2017/8/1,2017/11/23,No
18860,2230942,Shortage,PMS-BUSPIRONE,PHARMASCIENCE INC,BUSPIRONE,BUSPIRONE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N05BE,ANXIOLYTICS,,2017/8/10,,2018/5/4,Disruption of the manufacture of the drug.,2017/8/11,2018/5/5,No
8925,2230942,Shortage,PMS-BUSPIRONE,PHARMASCIENCE INC,BUSPIRONE,BUSPIRONE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N05BE,ANXIOLYTICS,2017/6/12,,2017/7/9,2017/7/9,Disruption of the manufacture of the drug.,2017/5/4,2017/7/19,No
25743,2391198,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/10/1,2018/4/13,2018/4/17,Disruption of the manufacture of the drug.,2017/10/12,2018/4/19,No
25746,2391201,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,PMS-CANDESARTAN,CANDESARTAN CILEXETIL,16MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/10/1,2018/1/26,2018/2/16,Disruption of the manufacture of the drug.,2017/10/12,2018/2/17,No
22744,2391201,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/9/19,2018/4/24,2018/4/17,Disruption of the manufacture of the drug.,2017/9/19,2018/4/19,No
4171,2391295,Shortage,PMS-CANDESARTAN HCTZ,PHARMASCIENCE INC,CANDESARTAN-HCTZ,HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL,12.5MG 16.0MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/3/23,2017/4/5,2017/4/5,Disruption of the manufacture of the drug.,2017/3/24,2017/4/7,No
17024,2391295,Shortage,PMS-CANDESARTAN HCTZ,PHARMASCIENCE INC,CANDESARTAN-HCTZ,HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL,12.5MG 16.0MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/7/1,2018/1/5,2018/1/24,Disruption of the manufacture of the drug.,2017/7/25,2018/1/26,No
6111,2231544,Shortage,PMS-CARBAMAZEPINE-CR,PHARMASCIENCE INC,CARBAMEZAPINE,CARBAMAZEPINE,400MG,100,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),N03AF,ANTIEPILEPTICS,2017/7/24,2017/5/9,,2017/5/9,Disruption of the manufacture of the drug.,2017/4/7,2017/10/11,No
32038,2355442,Shortage,PMS-CELECOXIB,PHARMASCIENCE INC,CELECOXIB,CELECOXIB,100MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/12/7,2018/3/15,2018/2/21,Disruption of the manufacture of the drug.,2017/12/7,2018/2/22,No
25753,2355450,Shortage,PMS-CELECOXIB,PHARMASCIENCE INC,CELECOXIB,CELECOXIB,200MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/10/1,2018/3/19,2018/2/21,Disruption of the manufacture of the drug.,2017/10/12,2018/2/22,No
18863,2355442,Shortage,PMS-CELECOXIB,PHARMASCIENCE INC,CELECOXIB,CELECOXIB,100MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/8/18,,2017/10/2,2017/10/9,Disruption of the manufacture of the drug.,2017/8/11,2017/10/11,No
22747,2355442,Shortage,PMS-CELECOXIB,PHARMASCIENCE INC,CELECOXIB,CELECOXIB,100MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/9/19,2018/3/15,2018/2/21,Disruption of the manufacture of the drug.,2017/9/19,2018/2/22,No
22750,2315963,Shortage,PMS-CETIRIZINE,PHARMASCIENCE INC,CETIRIZINE,CETIRIZINE HYDROCHLORIDE,20MG,100,ORAL,Resolved,TABLET,R06AE,ANTIHISTAMINES FOR SYSTEMIC USE,,2017/9/18,2017/11/21,2017/12/4,Disruption of the manufacture of the drug.,2017/9/19,2017/12/8,No
1816,2280469,Shortage,PMS-CILAZAPRIL,PHARMASCIENCE INC,Cilazapril,CILAZAPRIL,5.0MG,100 & 500,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2016/1/18,,2020/4/1,Other (Please describe in comments),2017/3/13,2020/4/2,No
1822,2280450,Shortage,PMS-CILAZAPRIL,PHARMASCIENCE INC,Cilazapril,CILAZAPRIL,2.5MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2016/1/25,,2020/4/1,Other (Please describe in comments),2017/3/13,2020/4/2,No
1827,2280442,Shortage,PMS-CILAZAPRIL,PHARMASCIENCE INC,Cilazapril,CILAZAPRIL,1.0MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2016/2/8,,2020/4/1,Other (Please describe in comments),2017/3/13,2020/4/2,No
29500,2270609,Shortage,PMS-CITALOPRAM,PHARMASCIENCE INC,CITALOPRAM,CITALOPRAM,10MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/11/16,2017/11/27,2017/12/12,Disruption of the manufacture of the drug.,2017/11/17,2017/12/15,No
17028,2248010,Shortage,PMS-CITALOPRAM,PHARMASCIENCE INC,CITALOPRAM,CITALOPRAM,20MG,500,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/7/1,,2017/12/14,Disruption of the manufacture of the drug.,2017/7/25,2017/12/15,No
7347,2248011,Shortage,PMS-CITALOPRAM,PHARMASCIENCE INC,CITALOPRAM,CITALOPRAM,40MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/4/20,,2018/5/4,Disruption of the manufacture of the drug.,2017/4/20,2018/5/5,No
21496,2248010,Shortage,PMS-CITALOPRAM,PHARMASCIENCE INC,CITALOPRAM,CITALOPRAM,20MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/9/15,2017/9/15,,2017/12/14,Disruption of the manufacture of the drug.,2017/9/7,2017/12/15,No
21499,2248010,Shortage,PMS-CITALOPRAM,PHARMASCIENCE INC,CITALOPRAM,CITALOPRAM,20MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/9/23,2017/9/23,,2017/12/14,Disruption of the manufacture of the drug.,2017/9/7,2017/12/15,No
21503,2248011,Shortage,PMS-CITALOPRAM,PHARMASCIENCE INC,CITALOPRAM,CITALOPRAM,40MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/9/1,2018/2/26,2018/2/16,Disruption of the manufacture of the drug.,2017/9/7,2018/2/17,No
13694,2247574,Shortage,PMS-CLARITHROMYCIN,PHARMASCIENCE INC,CLARITHROMYCIN,CLARITHROMYCIN,500MG,250,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2017/7/17,2017/7/17,2018/1/29,2018/2/8,Disruption of the manufacture of the drug.,2017/6/23,2018/2/12,No
17031,2247574,Shortage,PMS-CLARITHROMYCIN,PHARMASCIENCE INC,CLARITHROMYCIN,CLARITHROMYCIN,500MG,100,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/7/1,2018/1/29,2018/2/8,Disruption of the manufacture of the drug.,2017/7/25,2018/2/12,No
1833,2244474,Shortage,PMS-CLOBAZAM,PHARMASCIENCE INC,Clobazam,CLOBAZAM,10MG,30,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2014/4/4,,2020/6/5,Disruption of the manufacture of the drug.,2017/3/13,2020/6/9,No
25727,2048701,Shortage,PMS-CLONAZEPAM TAB 0.5MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,0.5MG,500,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2017/10/1,2018/3/15,2018/3/6,Demand increase for the drug.,2017/10/12,2018/3/7,No
31649,2048701,Shortage,PMS-CLONAZEPAM TAB 0.5MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,0.5MG,100,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2017/12/1,2018/3/6,2018/3/6,Disruption of the manufacture of the drug.,2017/12/4,2018/3/7,No
8555,2048728,Shortage,PMS-CLONAZEPAM TAB 1.0MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,1MG,100,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2017/7/29,2017/7/29,2017/10/25,2017/10/10,Disruption of the manufacture of the drug.,2017/5/2,2017/10/11,No
8564,2048728,Shortage,PMS-CLONAZEPAM TAB 1.0MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,1MG,500,ORAL,Avoided shortage,TABLET,N03AE,ANTIEPILEPTICS,2017/7/13,2017/7/13,,2017/5/31,Disruption of the manufacture of the drug.,2017/5/2,2017/10/12,No
28789,2048728,Shortage,PMS-CLONAZEPAM TAB 1.0MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,1MG,100,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2017/11/10,2018/2/20,2018/3/19,Disruption of the manufacture of the drug.,2017/11/9,2018/3/20,No
13697,2048728,Shortage,PMS-CLONAZEPAM TAB 1.0MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,1MG,500,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2017/7/25,2017/7/25,2017/10/12,2017/10/10,Disruption of the manufacture of the drug.,2017/6/23,2017/10/11,No
29506,2048736,Shortage,PMS-CLONAZEPAM TAB 2MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,2MG,100,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2017/11/16,2017/12/18,2017/12/15,Disruption of the manufacture of the drug.,2017/11/17,2017/12/18,No
31652,2048736,Shortage,PMS-CLONAZEPAM TAB 2MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,2MG,500,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2017/12/1,2017/12/18,2017/12/15,Disruption of the manufacture of the drug.,2017/12/4,2017/12/18,No
8550,2179660,Shortage,PMS-CLONAZEPAM- TAB 0.25MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,0.25MG,100,ORAL,Avoided shortage,TABLET,N03AE,ANTIEPILEPTICS,2017/6/19,2017/6/19,2017/8/21,2017/5/23,Disruption of the manufacture of the drug.,2017/5/2,2017/10/12,No
22753,2179660,Shortage,PMS-CLONAZEPAM- TAB 0.25MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,0.25MG,100,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2017/9/15,2018/4/30,2018/4/17,Disruption of the manufacture of the drug.,2017/9/19,2018/4/19,No
21506,2207818,Shortage,PMS-CLONAZEPAM-R TAB 0.5MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,0.5MG,100,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2017/9/4,2017/10/11,2017/10/10,Disruption of the manufacture of the drug.,2017/9/7,2017/10/11,No
13700,2207818,Shortage,PMS-CLONAZEPAM-R TAB 0.5MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,0.5MG,500,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2017/7/6,2017/7/6,,2017/10/10,Disruption of the manufacture of the drug.,2017/6/23,2017/10/11,No
8573,2402181,Shortage,PMS-COLCHICINE,PHARMASCIENCE INC,COLCHICINE,COLCHICINE,0.6MG,100,ORAL,Resolved,TABLET,M04AC,ANTIGOUT PREPARATIONS,2017/5/5,2017/5/5,2019/11/18,2019/12/20,Shortage of an active ingredient.,2017/5/2,2019/12/24,No
13100,2212048,Shortage,PMS-CYCLOBENZAPRINE - TAB 10MG,PHARMASCIENCE INC,CYCLOBENZAPRINE,CYCLOBENZAPRINE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",2017/6/17,2017/6/17,2017/7/11,2017/7/11,Disruption of the manufacture of the drug.,2017/6/16,2017/10/13,No
28792,2212048,Shortage,PMS-CYCLOBENZAPRINE - TAB 10MG,PHARMASCIENCE INC,CYCLOBENZAPRINE,CYCLOBENZAPRINE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",2017/11/13,2017/12/15,2018/4/26,2018/5/4,Disruption of the manufacture of the drug.,2017/11/9,2018/5/5,No
15097,2212048,Shortage,PMS-CYCLOBENZAPRINE - TAB 10MG,PHARMASCIENCE INC,CYCLOBENZAPRINE,CYCLOBENZAPRINE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",2017/9/11,2017/9/11,2018/4/26,2018/4/17,Disruption of the manufacture of the drug.,2017/7/11,2018/4/19,No
15100,2212048,Shortage,PMS-CYCLOBENZAPRINE - TAB 10MG,PHARMASCIENCE INC,CYCLOBENZAPRINE,CYCLOBENZAPRINE HYDROCHLORIDE,10MG,500,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",2018/6/9,2018/5/4,,2020/6/9,Disruption of the manufacture of the drug.,2017/7/11,2020/6/10,No
4178,2406772,Shortage,PMS-CYTARABINE,PHARMASCIENCE INC,CYTARABINE,CYTARABINE,100MG,20ml,"INTRATHECAL
INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,L01BC,ANTIMETABOLITES,,2017/3/23,,2020/6/9,Disruption of the manufacture of the drug.,2017/3/24,2020/6/10,No
7353,2406772,Shortage,PMS-CYTARABINE,PHARMASCIENCE INC,CYTARABINE,CYTARABINE,100MG,20,"INTRATHECAL
INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,L01BC,ANTIMETABOLITES,,2017/4/19,2017/6/2,2017/6/8,Disruption of the manufacture of the drug.,2017/4/20,2017/6/9,No
4181,2304376,Shortage,PMS-DESMOPRESSIN,PHARMASCIENCE INC,DESMOPRESSIN,DESMOPRESSIN ACETATE,0.2MG,100,ORAL,Resolved,TABLET,H01BA,POSTERIOR PITUITARY LOBE HORMONES,2017/8/28,2017/8/28,,2020/6/9,Disruption of the manufacture of the drug.,2017/3/24,2020/6/10,No
22756,2279363,Shortage,PMS-DEXAMETHASONE,PHARMASCIENCE INC,DEXAMETHASONE,DEXAMETHASONE,2MG,100,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017/9/18,2018/4/7,2018/4/17,Disruption of the manufacture of the drug.,2017/9/19,2018/4/19,No
4184,783900,Shortage,PMS-DEXAMETHASONE SOD PHOSPHATE INJ 10MG/ML,PHARMASCIENCE INC,DEXAMETHASONE,DEXAMETHASONE PHOSPHATE,10MG,10ml,"INTRAMUSCULAR
INTRAVENOUS",Resolved,LIQUID,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017/9/29,2017/10/24,2017/10/24,Disruption of the manufacture of the drug.,2017/3/24,2017/11/20,No
5467,783900,Shortage,PMS-DEXAMETHASONE SOD PHOSPHATE INJ 10MG/ML,PHARMASCIENCE INC,DEXAMETHASONE,DEXAMETHASONE PHOSPHATE,10MG,10ml,"INTRAMUSCULAR
INTRAVENOUS",Resolved,LIQUID,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017/3/23,2017/4/25,2017/4/25,Disruption of the manufacture of the drug.,2017/4/4,2017/11/20,No
7356,783900,Shortage,PMS-DEXAMETHASONE SOD PHOSPHATE INJ 10MG/ML,PHARMASCIENCE INC,DEXAMETHASONE,DEXAMETHASONE PHOSPHATE,10MG,10 ML,"INTRAMUSCULAR
INTRAVENOUS",Resolved,LIQUID,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017/4/19,2017/12/18,2018/1/12,Disruption of the manufacture of the drug.,2017/4/20,2018/1/13,No
6117,783900,Shortage,PMS-DEXAMETHASONE SOD PHOSPHATE INJ 10MG/ML,PHARMASCIENCE INC,DEXAMETHASONE,DEXAMETHASONE PHOSPHATE,10MG,10 ML,"INTRAMUSCULAR
INTRAVENOUS",Resolved,LIQUID,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017/4/5,2017/5/29,2017/5/29,Disruption of the manufacture of the drug.,2017/4/7,2017/11/20,No
21517,2247492,Shortage,PMS-DIAZEPAM,PHARMASCIENCE INC,DIAZEPAM,DIAZEPAM,10MG,500,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/9/1,,2020/6/5,Other (Please describe in comments),2017/9/7,2020/6/9,No
21523,2247491,Shortage,PMS-DIAZEPAM,PHARMASCIENCE INC,DIAZEPAM,DIAZEPAM,5MG,500,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/9/1,,2020/6/5,Other (Please describe in comments),2017/9/7,2020/6/9,No
21512,891797,Shortage,PMS-DIAZEPAM SOLUTION 1MG/ML,PHARMASCIENCE INC,DIAZEPAM,DIAZEPAM,1MG,500,ORAL,Resolved,SOLUTION,N05BA,ANXIOLYTICS,,2017/9/1,,2020/6/5,Other (Please describe in comments),2017/9/7,2020/6/9,No
15104,2302624,Shortage,PMS-DICLOFENAC,PHARMASCIENCE INC,DICLOFENAC,DICLOFENAC SODIUM,50MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/10/7,2017/10/7,2018/5/4,2018/5/15,Disruption of the manufacture of the drug.,2017/7/11,2018/5/18,No
10665,2239753,Shortage,PMS-DICLOFENAC K,PHARMASCIENCE INC,DICLOFENAC,DICLOFENAC POTASSIUM,50MG,100,ORAL,Resolved,TABLET,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/6/30,,2017/7/21,2017/7/18,Disruption of the manufacture of the drug.,2017/5/18,2017/7/19,No
32041,2231504,Shortage,PMS-DICLOFENAC-SR,PHARMASCIENCE INC,DICLOFENAC,DICLOFENAC SODIUM,75MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/12/17,2017/12/18,2018/4/23,2018/4/17,Disruption of the manufacture of the drug.,2017/12/7,2018/4/19,No
15107,2355760,Shortage,PMS-DILTIAZEM CD,PHARMASCIENCE INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2017/7/19,2017/12/18,,2020/6/5,Disruption of the manufacture of the drug.,2017/7/11,2020/6/9,No
15110,2355760,Shortage,PMS-DILTIAZEM CD,PHARMASCIENCE INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,180MG,500,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/7/3,,2020/6/5,Disruption of the manufacture of the drug.,2017/7/11,2020/6/9,No
21526,2355760,Shortage,PMS-DILTIAZEM CD,PHARMASCIENCE INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/9/4,,2018/3/6,Other (Please describe in comments),2017/9/7,2018/3/7,No
21529,2355760,Shortage,PMS-DILTIAZEM CD,PHARMASCIENCE INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,180MG,500,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/9/4,,2020/6/5,Other (Please describe in comments),2017/9/7,2020/6/9,No
4187,2355752,Shortage,PMS-DILTIAZEM CD,PHARMASCIENCE INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,120MG,500,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/3/23,,2020/6/5,Disruption of the manufacture of the drug.,2017/3/24,2020/6/9,No
4190,2355779,Shortage,PMS-DILTIAZEM CD,PHARMASCIENCE INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,240MG,100,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/3/23,,2020/6/5,Disruption of the manufacture of the drug.,2017/3/24,2020/6/9,No
4193,2355779,Shortage,PMS-DILTIAZEM CD,PHARMASCIENCE INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,240MG,500,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/3/23,,2020/6/5,Disruption of the manufacture of the drug.,2017/3/24,2020/6/9,No
4196,2355760,Shortage,PMS-DILTIAZEM CD,PHARMASCIENCE INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/3/23,2017/4/17,2017/3/30,Shortage of an inactive ingredient or component.,2017/3/24,2017/3/31,No
10677,2355752,Shortage,PMS-DILTIAZEM CD,PHARMASCIENCE INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,120MG,100,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2017/8/28,2017/8/28,,2020/6/5,Delay in shipping of the drug.,2017/5/18,2020/6/9,No
17035,703494,Shortage,PMS-DOCUSATE SODIUM,PHARMASCIENCE INC,DOCUSATE SODIUM,DOCUSATE SODIUM,100MG,1000,ORAL,Resolved,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,,2017/7/1,2018/2/20,2018/2/19,Delay in shipping of the drug.,2017/7/25,2018/2/20,No
27339,848417,Shortage,PMS-DOCUSATE SODIUM,PHARMASCIENCE INC,DOCUSATE SODIUM,DOCUSATE SODIUM,50MG,90,ORAL,Resolved,SYRUP,A06AA,DRUGS FOR CONSTIPATION,2017/11/28,2017/12/18,,2020/6/9,Disruption of the manufacture of the drug.,2017/10/27,2020/6/10,No
8584,880140,Shortage,PMS-DOCUSATE SODIUM DROPS 10MG/ML,PHARMASCIENCE INC,DOCUSATE,DOCUSATE SODIUM,10MG,BOTTLE 500mL,ORAL,Resolved,DROPS,A06AA,DRUGS FOR CONSTIPATION,,2017/5/1,,2020/6/9,Disruption of the manufacture of the drug.,2017/5/2,2020/6/10,No
6120,2442426,Shortage,PMS-DORZOLAMIDE-TIMOLOL,PHARMASCIENCE INC,DORZOLAMIDE TIMOLOL,TIMOLOL DORZOLAMIDE,5MG 20MG,10ML,OPHTHALMIC,Resolved,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2017/5/1,,2020/6/5,Disruption of the manufacture of the drug.,2017/4/7,2020/6/9,No
32166,2406187,Shortage,PMS-DOXYLAMINE-PYRIDOXINE,PHARMASCIENCE INC,DOXYLAMINE-PRIDOXINE,DOXYLAMINE SUCCINATE PYRIDOXINE HYDROCHLORIDE,10MG 10MG,30,ORAL,Resolved,TABLET (DELAYED-RELEASE),R06AA,ANTIHISTAMINES FOR SYSTEMIC USE,2018/1/2,2018/1/24,2018/9/13,2018/9/16,Disruption of the manufacture of the drug.,2017/12/8,2018/9/17,No
15114,2429446,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOXETINE,DULOXETINE,30MG,30,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017/8/15,2017/8/15,2018/1/10,2017/12/15,Disruption of the manufacture of the drug.,2017/7/11,2017/12/18,No
15119,2429454,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOXETINE,DULOXETINE,60MG,30,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2017/7/3,,2017/8/3,Disruption of the manufacture of the drug.,2017/7/11,2017/8/11,No
15122,2429454,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOEXTINE,DULOXETINE,60MG,100,ORAL,Avoided shortage,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017/9/14,2017/9/14,2017/9/20,2017/7/7,Disruption of the manufacture of the drug.,2017/7/11,2017/10/12,No
21533,2429454,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOXETINE,DULOXETINE,60MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017/9/14,2017/9/14,2018/2/28,2018/3/23,Disruption of the manufacture of the drug.,2017/9/7,2018/3/24,No
11297,2429446,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOXETINE,DULOXETINE,30MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017/6/14,2017/6/14,2017/8/7,2017/12/15,Disruption of the manufacture of the drug.,2017/5/25,2017/12/18,No
13103,2429446,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOXETINE,DULOXETINE,30MG,30,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017/8/12,2017/8/12,2017/10/12,2017/12/15,Disruption of the manufacture of the drug.,2017/6/16,2017/12/18,No
13106,2429454,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOXETINE,DULOXETINE,60MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017/9/6,2017/12/15,2017/9/20,2018/3/1,Disruption of the manufacture of the drug.,2017/6/16,2018/3/2,No
17038,2429454,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOXETINE,DULOXETINE,60MG,30,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017/11/7,2017/12/15,2018/3/29,2018/2/21,Disruption of the manufacture of the drug.,2017/7/25,2018/2/22,No
13109,2393220,Shortage,PMS-DUTASTERIDE,PHARMASCIENCE INC,DUTASTERIDE,DUTASTERIDE,0.5MG,30,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2017/7/24,2017/7/24,2017/8/21,2017/12/15,Disruption of the manufacture of the drug.,2017/6/16,2017/12/18,No
17043,2393220,Shortage,PMS-DUTASTERIDE,PHARMASCIENCE INC,DUTASTERIDE,DUTASTERIDE,0.5MG,30,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/7/1,2022/6/1,2022/7/19,Disruption of the manufacture of the drug.,2017/7/25,2022/12/9,No
1837,2434350,Shortage,PMS-ELETRIPTAN,PHARMASCIENCE INC,Eletriptan,ELETRIPTAN,40MG,30,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2015/8/13,,2020/6/5,Disruption of the manufacture of the drug.,2017/3/13,2020/6/9,No
1844,2434350,Shortage,PMS-ELETRIPTAN,PHARMASCIENCE INC,Eletriptan,ELETRIPTAN,40MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2015/6/1,,2020/6/5,Disruption of the manufacture of the drug.,2017/3/13,2020/6/9,No
1853,2434342,Shortage,PMS-ELETRIPTAN,PHARMASCIENCE INC,Eletriptan,ELETRIPTAN,20MG,30,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2016/6/3,,2020/6/9,Disruption of the manufacture of the drug.,2017/3/13,2020/6/10,No
8590,2434342,Shortage,PMS-ELETRIPTAN,PHARMASCIENCE INC,ELETRIPTAN,ELETRIPTAN,20MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2017/7/13,2017/7/13,,2020/6/9,Disruption of the manufacture of the drug.,2017/5/2,2020/6/10,No
1860,2300095,Shortage,PMS-ENALAPRIL,PHARMASCIENCE INC,Enalapril,ENALAPRIL SODIUM,8MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2015/7/20,,2020/4/1,Other (Please describe in comments),2017/3/13,2020/4/2,No
1869,2300095,Shortage,PMS-ENALAPRIL,PHARMASCIENCE INC,ENALAPRIL,ENALAPRIL SODIUM,8MG,500,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2015/9/23,,2020/4/1,Other (Please describe in comments),2017/3/13,2020/4/2,No
1875,2300079,Shortage,PMS-ENALAPRIL,PHARMASCIENCE INC,Enalapril,ENALAPRIL SODIUM,2.0MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2015/9/23,,2020/4/1,Demand increase for the drug.,2017/3/13,2020/4/2,No
5472,2430576,Shortage,PMS-ENTECAVIR,PHARMASCIENCE INC,ENTECAVIR,ENTECAVIR,0.5MG,30,ORAL,Resolved,TABLET,J05AF,DIRECT ACTING ANTIVIRALS,,2017/3/31,2017/10/18,2017/10/17,Disruption of the manufacture of the drug.,2017/4/4,2017/10/26,No
6123,2454386,Shortage,PMS-ERLOTINIB,PHARMASCIENCE INC,ERLOTINIB,ERLOTINIB,100MG,30,ORAL,Resolved,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,2017/7/14,2017/7/14,,2018/5/4,Shortage of an active ingredient.,2017/4/7,2018/5/5,No
6325,2303949,Shortage,PMS-ESCITALOPRAM,PHARMASCIENCE INC,ESCITALOPRAM,ESCITALOPRAM,10MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/4/9,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/10,2020/6/10,No
6328,2303949,Shortage,PMS-ESCITALOPRAM,PHARMASCIENCE INC,ESCITALOPRAM,ESCITALOPRAM,10MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/4/9,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/10,2020/6/10,No
6331,2303965,Shortage,PMS-ESCITALOPRAM,PHARMASCIENCE INC,ESCITALOPRAM,ESCITALOPRAM,20MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/4/9,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/10,2020/6/10,No
6334,2303965,Shortage,PMS-ESCITALOPRAM,PHARMASCIENCE INC,ESCITALOPRAM,ESCITALOPRAM,20MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/4/9,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/10,2020/6/10,No
32044,2416409,Shortage,PMS-EZETIMIBE,PHARMASCIENCE INC,EZETIMIBE,EZETIMIBE,10MG,100,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017/12/7,2018/3/1,2018/2/21,Disruption of the manufacture of the drug.,2017/12/7,2018/2/22,No
32047,2278081,Shortage,PMS-FAMCICLOVIR,PHARMASCIENCE INC,FAMCICLOVIR,FAMCICLOVIR,125MG,10,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019/7/30,,2020/6/9,Disruption of the manufacture of the drug.,2017/12/7,2020/6/10,No
4199,2278111,Shortage,PMS-FAMCICLOVIR,PHARMASCIENCE INC,FAMCICLOVIR,FAMCICLOVIR,500MG,21,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/3/23,2017/4/10,2017/4/10,Disruption of the manufacture of the drug.,2017/3/24,2017/4/13,No
28797,2278111,Shortage,PMS-FAMCICLOVIR,PHARMASCIENCE INC,FAMCICLOVIR,FAMCICLOVIR,500MG,21,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/11/10,,2020/6/9,Disruption of the manufacture of the drug.,2017/11/9,2020/6/10,No
12211,2278103,Shortage,PMS-FAMCICLOVIR,PHARMASCIENCE INC,FAMCICLOVIR,FAMCICLOVIR,250MG,30,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017/6/26,2017/6/26,2017/9/29,2017/9/29,Disruption of the manufacture of the drug.,2017/6/7,2017/10/11,No
22760,2278111,Shortage,PMS-FAMCICLOVIR,PHARMASCIENCE INC,FAMCICLOVIR,FAMCICLOVIR,500MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/9/15,,2020/6/9,Disruption of the manufacture of the drug.,2017/9/19,2020/6/10,No
6126,2278103,Shortage,PMS-FAMCICLOVIR,PHARMASCIENCE INC,FAMCICLOVIR,FAMCICLOVIR,250MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017/4/12,2017/4/12,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/7,2020/6/10,No
25764,2341387,Shortage,PMS-FENTANYL MTX,PHARMASCIENCE INC,FENTANYL MTX,FENTANYL,25MCG,5,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,,2017/10/1,,2018/5/4,Disruption of the manufacture of the drug.,2017/10/12,2018/5/5,No
25767,2341395,Shortage,PMS-FENTANYL MTX,PHARMASCIENCE INC,FENTANYL,FENTANYL,50MCG,5,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,,2017/10/1,,2018/5/4,Disruption of the manufacture of the drug.,2017/10/12,2018/5/5,No
25770,2341409,Shortage,PMS-FENTANYL MTX,PHARMASCIENCE INC,FENTANYL,FENTANYL,75MCG,5,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,,2017/10/1,,2018/5/4,Disruption of the manufacture of the drug.,2017/10/12,2018/5/5,No
4202,2320169,Shortage,PMS-FINASTERIDE,PHARMASCIENCE INC,FINASTERIDE,FINASTERIDE,1MG,30,ORAL,Resolved,TABLET,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,,2017/3/23,,2018/5/4,Shortage of an active ingredient.,2017/3/24,2018/5/5,No
4205,2320169,Shortage,PMS-FINASTERIDE,PHARMASCIENCE INC,FINASTERIDE,FINASTERIDE,1MG,100,ORAL,Resolved,TABLET,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,,2017/3/23,2018/5/4,2018/5/15,Shortage of an active ingredient.,2017/3/24,2018/5/18,No
4208,2310112,Shortage,PMS-FINASTERIDE,PHARMASCIENCE INC,FINASTERIDE,FINASTERIDE,5MG,100,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/3/23,2018/10/15,2018/10/17,Disruption of the manufacture of the drug.,2017/3/24,2018/10/18,No
7361,2310112,Shortage,PMS-FINASTERIDE,PHARMASCIENCE INC,FINASTERIDE,FINASTERIDE,5MG,30,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/4/19,2017/7/5,2017/7/23,Disruption of the manufacture of the drug.,2017/4/20,2017/7/25,No
1890,2282348,Shortage,PMS-FLUCONAZOLE,PHARMASCIENCE INC,Fluconazole,FLUCONAZOLE,150MG,1,ORAL,Resolved,CAPSULE,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2015/8/14,,2020/4/1,Requirements related to complying with good manufacturing practices.,2017/3/13,2020/4/2,No
21536,2177587,Shortage,PMS-FLUOXETINE - CAP 20MG,PHARMASCIENCE INC,FLUOXETINE,FLUOXETINE,20MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017/10/20,,2017/11/7,2017/11/14,Disruption of the manufacture of the drug.,2017/9/7,2017/11/17,No
32050,2177587,Shortage,PMS-FLUOXETINE - CAP 20MG,PHARMASCIENCE INC,FLUOXETINE,FLUOXETINE,20MG,500,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017/12/18,2017/12/19,2018/2/20,2018/2/19,Disruption of the manufacture of the drug.,2017/12/7,2018/2/20,No
21539,2243448,Shortage,PMS-GABAPENTIN,PHARMASCIENCE INC,GABAPENTIN,GABAPENTIN,400MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/9/4,2018/4/2,2018/3/6,Disruption of the manufacture of the drug.,2017/9/7,2018/3/7,No
21542,2255898,Shortage,PMS-GABAPENTIN,PHARMASCIENCE INC,GABAPENTIN,GABAPENTIN,600MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/9/4,,2020/6/9,Other (Please describe in comments),2017/9/7,2020/6/10,No
17046,2243446,Shortage,PMS-GABAPENTIN,PHARMASCIENCE INC,GABAPENTIN,GABAPENTIN,100MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/7/1,2017/10/30,2017/10/20,Disruption of the manufacture of the drug.,2017/7/25,2017/10/26,No
17049,2243446,Shortage,PMS-GABAPENTIN,PHARMASCIENCE INC,GABAPENTIN,GABAPENTIN,100MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/7/1,2018/1/29,2018/2/8,Disruption of the manufacture of the drug.,2017/7/25,2018/2/12,No
17053,2243447,Shortage,PMS-GABAPENTIN,PHARMASCIENCE INC,GABAPENTIN,GABAPENTIN,300MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/7/30,2017/7/30,2017/11/28,2017/11/14,Disruption of the manufacture of the drug.,2017/7/25,2017/11/17,No
17057,2255901,Shortage,PMS-GABAPENTIN,PHARMASCIENCE INC,GABAPENTIN,GABAPENTIN,800MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/7/1,,2020/6/9,Disruption of the manufacture of the drug.,2017/7/25,2020/6/10,No
25773,2243448,Shortage,PMS-GABAPENTIN,PHARMASCIENCE INC,GABAPENTIN,GABAPENTIN,400MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/10/1,2018/1/29,2018/2/8,Disruption of the manufacture of the drug.,2017/10/12,2018/2/12,No
12214,2243448,Shortage,PMS-GABAPENTIN,PHARMASCIENCE INC,GABAPENTIN,GABAPENTIN,400MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/6/6,,2017/6/14,Disruption of the manufacture of the drug.,2017/6/7,2017/6/16,No
21545,2398389,Shortage,PMS-GALANTAMINE ER,PHARMASCIENCE INC,GALANTAMINE ER,GALANTAMINE,16MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2017/9/4,2018/2/15,2018/2/8,Disruption of the manufacture of the drug.,2017/9/7,2018/2/12,No
21548,2398389,Shortage,PMS-GALANTAMINE ER,PHARMASCIENCE INC,GALANTAMINE ER,GALANTAMINE,16MG,30,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2017/9/4,2018/2/15,2018/2/8,Disruption of the manufacture of the drug.,2017/9/7,2018/2/12,No
13703,2398370,Shortage,PMS-GALANTAMINE ER,PHARMASCIENCE INC,GALANTAMINE ER,GALANTAMINE,8MG,30,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,2017/7/24,2017/9/20,2018/2/16,2018/2/16,Disruption of the manufacture of the drug.,2017/6/23,2018/2/17,No
25776,2398397,Shortage,PMS-GALANTAMINE ER,PHARMASCIENCE INC,GALANTAMINE ER,GALANTAMINE,24MG,30,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2017/10/1,2018/4/6,2018/4/17,Disruption of the manufacture of the drug.,2017/10/12,2018/4/19,No
7364,2398389,Shortage,PMS-GALANTAMINE ER,PHARMASCIENCE INC,GALANTAMINE,GALANTAMINE,16MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,2017/7/17,,2017/9/19,2017/7/23,Disruption of the manufacture of the drug.,2017/4/20,2017/7/25,No
7367,2398397,Shortage,PMS-GALANTAMINE ER,PHARMASCIENCE INC,GALANTAMINE,GALANTAMINE,24MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,2017/7/24,2017/7/24,2018/2/15,2018/2/8,Disruption of the manufacture of the drug.,2017/4/20,2018/2/12,No
6129,2398370,Shortage,PMS-GALANTAMINE ER,PHARMASCIENCE INC,GALANTAMINE ER,GALANTAMINE,8MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2017/4/6,2018/2/16,2018/2/16,Disruption of the manufacture of the drug.,2017/4/7,2018/2/17,No
12217,2236734,Shortage,PMS-GLYBURIDE,PHARMASCIENCE INC,GLYBURIDE,GLYBURIDE,5MG,30,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/6/6,,2020/6/9,Other (Please describe in comments),2017/6/7,2020/6/10,No
8935,2236734,Shortage,PMS-GLYBURIDE,PHARMASCIENCE INC,GLYBURIDE,GLYBURIDE,5MG,100,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/5/3,,2020/6/9,Other (Please describe in comments),2017/5/4,2020/6/10,No
25780,2247386,Shortage,PMS-HYDROCHLOROTHIAZIDE,PHARMASCIENCE INC,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,25MG,1000,ORAL,Resolved,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",,2017/10/1,,2018/5/4,Disruption of the manufacture of the drug.,2017/10/12,2018/5/5,No
8944,2274086,Shortage,PMS-HYDROCHLOROTHIAZIDE,PHARMASCIENCE INC,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,12.5MG,500,ORAL,Resolved,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",,2017/5/1,2017/11/17,2017/11/14,Disruption of the manufacture of the drug.,2017/5/4,2017/11/17,No
22168,885444,Shortage,PMS-HYDROMORPHONE TAB 1MG,PHARMASCIENCE INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,1MG,100,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017/9/14,2017/9/25,2017/9/25,Disruption of the manufacture of the drug.,2017/9/15,2017/10/11,No
22171,885436,Shortage,PMS-HYDROMORPHONE TAB 2MG,PHARMASCIENCE INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,2MG,100,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017/9/14,2017/10/31,2017/12/4,Disruption of the manufacture of the drug.,2017/9/15,2017/12/8,No
22763,885436,Shortage,PMS-HYDROMORPHONE TAB 2MG,PHARMASCIENCE INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,2MG,100,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017/9/18,2017/11/3,2017/12/4,Disruption of the manufacture of the drug.,2017/9/19,2017/12/8,No
22163,885401,Shortage,PMS-HYDROMORPHONE TAB 4MG,PHARMASCIENCE INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,4MG,100,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017/9/14,2017/9/29,2017/10/10,Disruption of the manufacture of the drug.,2017/9/15,2017/10/11,No
7370,2431122,Shortage,PMS-IMATINIB,PHARMASCIENCE INC,IMATINIB,IMATINIB,400MG,30,ORAL,Resolved,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,2017/5/20,2017/7/30,,2020/6/9,Demand increase for the drug.,2017/4/20,2020/6/10,No
5476,2231245,Shortage,PMS-IPRATROPIUM,PHARMASCIENCE INC,IPRATROPIUM,IPRATROPIUM BROMIDE,250MCG,10 X 2 mL,INHALATION,Resolved,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2017/8/16,2017/8/16,2017/10/31,2017/12/4,Demand increase for the drug.,2017/4/4,2017/12/7,No
10097,2231244,Shortage,PMS-IPRATROPIUM,PHARMASCIENCE INC,IPRAPROTIUM,IPRATROPIUM BROMIDE,250MCG,15g,INHALATION,Resolved,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2017/6/12,,,2017/6/14,Shortage of an inactive ingredient or component.,2017/5/11,2017/6/16,No
13706,2231244,Shortage,PMS-IPRATROPIUM,PHARMASCIENCE INC,IPRATROPIUM,IPRATROPIUM BROMIDE,250MCG,20 X 1mL,INHALATION,Avoided shortage,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2018/1/1,,2018/1/1,2017/12/31,Disruption of the manufacture of the drug.,2017/6/23,2018/1/12,No
25783,2231135,Shortage,PMS-IPRATROPIUM,PHARMASCIENCE INC,IPRATROPIUM,IPRATROPIUM BROMIDE,125MCG,120,INHALATION,Resolved,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017/10/1,2017/10/17,2017/10/24,Disruption of the manufacture of the drug.,2017/10/12,2017/10/26,No
12220,2231135,Shortage,PMS-IPRATROPIUM,PHARMASCIENCE INC,IPRATROPIUM,IPRATROPIUM BROMIDE,125MCG,20x2ml,INHALATION,Resolved,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2017/8/24,,2017/9/25,2017/9/25,Demand increase for the drug.,2017/6/7,2017/9/26,No
21551,2317079,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,150MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017/9/23,2017/9/23,2017/11/28,2017/10/10,Disruption of the manufacture of the drug.,2017/9/7,2017/10/11,No
21554,2317087,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,300MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017/9/23,2017/9/23,2018/5/10,2018/4/17,Disruption of the manufacture of the drug.,2017/9/7,2018/4/19,No
21558,2317087,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,300MG,500,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017/9/25,2017/9/25,2018/5/10,2018/4/17,Disruption of the manufacture of the drug.,2017/9/7,2018/4/19,No
27343,2317079,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,150MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/10/9,2017/11/27,2017/11/14,Disruption of the manufacture of the drug.,2017/10/27,2017/11/17,No
27346,2317079,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,150MG,500,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/10/27,2018/3/2,2018/3/6,Disruption of the manufacture of the drug.,2017/10/27,2018/3/7,No
21562,2328534,Shortage,PMS-IRBESARTAN-HCTZ,PHARMASCIENCE INC,IRBESARTAN HCTZ,HYDROCHLOROTHIAZIDE IRBESARTAN,25MG 300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/9/1,2018/3/7,2018/3/19,Disruption of the manufacture of the drug.,2017/9/7,2018/3/20,No
4213,2328518,Shortage,PMS-IRBESARTAN-HCTZ,PHARMASCIENCE INC,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE IRBESARTAN,12.5MG 150MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2017/8/28,2017/8/28,,2018/4/26,Disruption of the manufacture of the drug.,2017/3/24,2018/4/27,No
4216,2328526,Shortage,PMS-IRBESARTAN-HCTZ,PHARMASCIENCE INC,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE IRBESARTAN,12.5MG 300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/3/23,2018/2/20,2017/9/15,Disruption of the manufacture of the drug.,2017/3/24,2017/9/19,No
13709,2328534,Shortage,PMS-IRBESARTAN-HCTZ,PHARMASCIENCE INC,IRBESARTAN HCTZ,HYDROCHLOROTHIAZIDE IRBESARTAN,25MG 300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2017/7/8,2017/7/8,2017/7/31,2017/7/31,Disruption of the manufacture of the drug.,2017/6/23,2017/12/18,No
7373,2328534,Shortage,PMS-IRBESARTAN-HCTZ,PHARMASCIENCE INC,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE IRBESARTAN,25MG 300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2017/4/30,,2017/5/31,2017/6/8,Disruption of the manufacture of the drug.,2017/4/20,2017/6/9,No
10100,2301288,Shortage,PMS-ISMN,PHARMASCIENCE INC,ISOSORBIDE,ISOSORBIDE-5-MONONITRATE,60MG,3X10,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2017/5/1,2018/5/30,2018/6/6,Shortage of an inactive ingredient or component.,2017/5/11,2018/6/7,No
4219,2301288,Shortage,PMS-ISMN,PHARMASCIENCE INC,ISOSORBIDE,ISOSORBIDE-5-MONONITRATE,60MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2017/3/23,2018/5/30,2018/5/15,Disruption of the manufacture of the drug.,2017/3/24,2018/5/18,No
11301,703486,Shortage,PMS-LACTULOSE SYR 667MG/ML,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,1L,ORAL,Resolved,SYRUP,A06AD,DRUGS FOR CONSTIPATION,2017/9/25,2017/9/25,,2018/5/4,Disruption of the manufacture of the drug.,2017/5/25,2018/5/5,No
11304,703486,Shortage,PMS-LACTULOSE SYR 667MG/ML,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,15 mL,ORAL,Resolved,SYRUP,A06AD,DRUGS FOR CONSTIPATION,,2017/5/22,,2017/6/14,Disruption of the manufacture of the drug.,2017/5/25,2017/6/16,No
11315,703486,Shortage,PMS-LACTULOSE SYR 667MG/ML,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,30 mL,ORAL,Resolved,SYRUP,A06AD,DRUGS FOR CONSTIPATION,,2017/5/22,,2017/6/14,Disruption of the manufacture of the drug.,2017/5/25,2017/6/16,No
8599,703486,Shortage,PMS-LACTULOSE SYR 667MG/ML,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,BOTTLE,ORAL,Resolved,SYRUP,A06AD,DRUGS FOR CONSTIPATION,2017/5/3,,2017/5/15,2017/5/17,Disruption of the manufacture of the drug.,2017/5/2,2017/5/18,No
25787,703486,Shortage,PMS-LACTULOSE SYR 667MG/ML,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,15mL,ORAL,Resolved,SYRUP,A06AD,DRUGS FOR CONSTIPATION,,2017/10/1,2017/11/7,2017/11/14,Disruption of the manufacture of the drug.,2017/10/12,2017/11/17,No
22766,703486,Shortage,PMS-LACTULOSE SYR 667MG/ML,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,30mL,ORAL,Resolved,SYRUP,A06AD,DRUGS FOR CONSTIPATION,,2017/9/18,2017/10/24,2017/10/23,Disruption of the manufacture of the drug.,2017/9/19,2017/10/26,No
22769,2246897,Shortage,PMS-LAMOTRIGINE,PHARMASCIENCE INC,LAMOTRIGINE,LAMOTRIGINE,25MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/9/15,2017/9/25,2017/9/25,Disruption of the manufacture of the drug.,2017/9/19,2017/10/11,No
1904,2288273,Shortage,PMS-LEFLUNOMIDE,PHARMASCIENCE INC,Leflunomide,LEFLUNOMIDE,20MG,30,ORAL,Resolved,TABLET,L04AA,IMMUNOSUPPRESSANTS,,2015/5/7,,2020/4/1,Other (Please describe in comments),2017/3/13,2020/4/2,No
1907,2288265,Shortage,PMS-LEFLUNOMIDE,PHARMASCIENCE INC,Leflunomide,LEFLUNOMIDE,10MG,30,ORAL,Resolved,TABLET,L04AA,IMMUNOSUPPRESSANTS,,2016/7/6,,2020/4/1,Other (Please describe in comments),2017/3/13,2020/4/2,No
8605,2309114,Shortage,PMS-LETROZOLE,PHARMASCIENCE INC,LETROZOLE,LETROZOLE,2.5MG,30,ORAL,Avoided shortage,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,2017/10/26,,2017/11/11,2017/9/4,Disruption of the manufacture of the drug.,2017/5/2,2017/9/7,No
25790,2309114,Shortage,PMS-LETROZOLE,PHARMASCIENCE INC,LETROZOLE,LETROZOLE,2.5MG,30,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017/10/1,,2018/9/18,Disruption of the manufacture of the drug.,2017/10/12,2018/9/19,No
6349,2421488,Shortage,PMS-LEVOCARB CR,PHARMASCIENCE INC,LEVOCARB CR,CARBIDOPA LEVODOPA,25MG 100MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2017/4/9,,2020/6/5,Disruption of the manufacture of the drug.,2017/4/10,2020/6/9,No
6352,2421496,Shortage,PMS-LEVOCARB CR,PHARMASCIENCE INC,LEVOCARB CR,CARBIDOPA LEVODOPA,50MG 200MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2017/4/9,,2020/6/5,Disruption of the manufacture of the drug.,2017/4/10,2020/6/9,No
8608,811874,Shortage,PMS-LIDOCAINE VISCOUS 2%,PHARMASCIENCE INC,LIDOCAINE,LIDOCAINE HYDROCHLORIDE,2%,50,DENTAL,Resolved,LIQUID,N01BB,"ANESTHETICS, LOCAL",2017/5/1,2017/5/1,,2020/6/9,Disruption of the manufacture of the drug.,2017/5/2,2020/6/10,No
7376,811874,Shortage,PMS-LIDOCAINE VISCOUS 2%,PHARMASCIENCE INC,LIDOCAINE,LIDOCAINE HYDROCHLORIDE,2%,100,DENTAL,Resolved,LIQUID,N01BB,"ANESTHETICS, LOCAL",,2017/4/19,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/20,2020/6/10,No
1910,2292211,Shortage,PMS-LISINOPRIL,PHARMASCIENCE INC,Lisinopril,LISINOPRIL,10MG,"30, 100 & 500",ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2016/1/19,,2020/4/1,Other (Please describe in comments),2017/3/13,2020/4/2,No
4222,2216132,Shortage,PMS-LITHIUM CARBONATE - CAP 150MG,PHARMASCIENCE INC,LITHIUM CARBONATE,LITHIUM CARBONATE,150MG,1000,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2017/3/23,,2017/10/1,Demand increase for the drug.,2017/3/24,2017/10/6,No
22776,2216132,Shortage,PMS-LITHIUM CARBONATE - CAP 150MG,PHARMASCIENCE INC,LITHIUM CARBONATE,LITHIUM CARBONATE,150MG,100,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2017/11/16,2018/4/8,2018/4/17,Disruption of the manufacture of the drug.,2017/9/19,2018/4/19,No
28591,2216140,Shortage,PMS-LITHIUM CARBONATE - CAP 300MG,PHARMASCIENCE INC,LITHIUM CARBONATE,LITHIUM CARBONATE,300MG,100,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2017/11/7,2018/3/5,2018/3/6,Disruption of the manufacture of the drug.,2017/11/8,2018/3/7,No
7380,2216140,Shortage,PMS-LITHIUM CARBONATE - CAP 300MG,PHARMASCIENCE INC,LITHIUM CARBONATE,LITHIUM CARBONATE,300MG,1000,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,2017/8/10,,,2017/10/1,Delay in shipping of the drug.,2017/4/20,2017/10/6,No
22779,2216140,Shortage,PMS-LITHIUM CARBONATE - CAP 300MG,PHARMASCIENCE INC,LITHIUM CARBONATE,LITHIUM CARBONATE,300MG,100,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2017/9/15,2017/11/1,2017/10/12,Disruption of the manufacture of the drug.,2017/9/19,2017/10/13,No
5479,2216159,Shortage,PMS-LITHIUM CARBONATE - CAP 600MG,PHARMASCIENCE INC,LITHIUM CARBONATE,LITHIUM CARBONATE,600MG,100,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2017/3/23,2018/3/18,2018/2/21,Demand increase for the drug.,2017/4/4,2018/2/22,No
7386,2228351,Shortage,PMS-LOPERAMIDE - CAPLET 2MG,PHARMASCIENCE INC,LOPERAMIDE,LOPERAMIDE HYDROCHLORIDE,2MG,100,ORAL,Avoided shortage,TABLET,A07DA,ANTIPROPULSIVES,2017/7/3,2017/7/3,,2017/5/10,Disruption of the manufacture of the drug.,2017/4/20,2017/10/12,No
28832,2016095,Shortage,PMS-LOPERAMIDE HYDROCHLORIDE SOLUTION.2MG/ML,PHARMASCIENCE INC,LOPERAMIDE,LOPERAMIDE HYDROCHLORIDE,0.2MG,230,ORAL,Resolved,SOLUTION,A07DA,ANTIPROPULSIVES,2017/11/16,2017/12/18,2018/1/10,2018/2/8,Disruption of the manufacture of the drug.,2017/11/10,2018/2/12,No
5489,728187,Shortage,PMS-LORAZEPAM TAB 0.5MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,0.5MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/9/23,2018/3/20,2017/12/17,Disruption of the manufacture of the drug.,2017/4/4,2017/12/18,No
5492,728187,Shortage,PMS-LORAZEPAM TAB 0.5MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,0.5MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/9/23,2017/12/18,2017/12/17,Disruption of the manufacture of the drug.,2017/4/4,2017/12/18,No
5495,728187,Shortage,PMS-LORAZEPAM TAB 0.5MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,0.5MG,500,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/3/23,2017/9/18,2017/9/18,Disruption of the manufacture of the drug.,2017/4/4,2017/12/18,No
4234,728187,Shortage,PMS-LORAZEPAM TAB 0.5MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,0.5MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/3/23,2017/9/18,2017/9/18,Disruption of the manufacture of the drug.,2017/3/24,2017/12/18,No
4237,728187,Shortage,PMS-LORAZEPAM TAB 0.5MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,0.5MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/3/23,2017/9/18,2017/9/18,Disruption of the manufacture of the drug.,2017/3/24,2017/12/18,No
4240,728187,Shortage,PMS-LORAZEPAM TAB 0.5MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,0.5MG,500,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/3/23,2017/9/18,2017/9/18,Disruption of the manufacture of the drug.,2017/3/24,2017/12/18,No
7402,728187,Shortage,PMS-LORAZEPAM TAB 0.5MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,0.5MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/4/20,,2018/5/4,Disruption of the manufacture of the drug.,2017/4/20,2018/5/5,No
7411,728187,Shortage,PMS-LORAZEPAM TAB 0.5MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,0.5MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/4/20,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/20,2020/6/10,No
7420,728187,Shortage,PMS-LORAZEPAM TAB 0.5MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,0.5MG,500,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/4/20,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/20,2020/6/10,No
7426,728195,Shortage,PMS-LORAZEPAM TAB 1MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,1MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/4/20,2018/4/10,2017/12/4,Disruption of the manufacture of the drug.,2017/4/20,2017/12/8,No
5498,728195,Shortage,PMS-LORAZEPAM TAB 1MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,1MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/3/23,2017/7/14,2017/7/17,Disruption of the manufacture of the drug.,2017/4/4,2017/12/18,No
5502,728195,Shortage,PMS-LORAZEPAM TAB 1MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,1MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/3/23,2017/7/14,2017/7/14,Disruption of the manufacture of the drug.,2017/4/4,2017/12/18,No
4243,728195,Shortage,PMS-LORAZEPAM TAB 1MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,1MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/3/23,2017/7/14,2017/7/14,Disruption of the manufacture of the drug.,2017/3/24,2017/12/18,No
4246,728195,Shortage,PMS-LORAZEPAM TAB 1MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,1MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/3/23,2017/7/14,2017/7/14,Disruption of the manufacture of the drug.,2017/3/24,2017/12/18,No
7389,728195,Shortage,PMS-LORAZEPAM TAB 1MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,1MG,3000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/4/20,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/20,2020/6/10,No
7423,728195,Shortage,PMS-LORAZEPAM TAB 1MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,1MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/4/20,2018/4/10,2017/12/4,Disruption of the manufacture of the drug.,2017/4/20,2017/12/8,No
5482,728209,Shortage,PMS-LORAZEPAM TAB 2MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,2MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/3/23,2017/9/18,2017/9/18,Disruption of the manufacture of the drug.,2017/4/4,2017/12/18,No
5486,728209,Shortage,PMS-LORAZEPAM TAB 2MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,2MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/3/23,2017/9/18,2017/9/18,Disruption of the manufacture of the drug.,2017/4/4,2017/12/18,No
4228,728209,Shortage,PMS-LORAZEPAM TAB 2MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,2MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/3/23,2017/9/18,2017/9/18,Disruption of the manufacture of the drug.,2017/3/24,2017/12/18,No
4231,728209,Shortage,PMS-LORAZEPAM TAB 2MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,2MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/3/23,2017/9/18,2017/9/18,Disruption of the manufacture of the drug.,2017/3/24,2017/12/18,No
7395,728209,Shortage,PMS-LORAZEPAM TAB 2MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,2MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/4/20,2018/4/7,2018/4/17,Disruption of the manufacture of the drug.,2017/4/20,2018/4/19,No
7399,728209,Shortage,PMS-LORAZEPAM TAB 2MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,2MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/4/20,2018/4/10,2018/4/17,Disruption of the manufacture of the drug.,2017/4/20,2018/4/19,No
7429,2309769,Shortage,PMS-LOSARTAN,PHARMASCIENCE INC,LOSARTAN,LOSARTAN POTASSIUM,50MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017/9/25,2017/9/25,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/20,2020/6/10,No
6133,2309769,Shortage,PMS-LOSARTAN,PHARMASCIENCE INC,LOSARTAN,LOSARTAN POTASSIUM,50MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017/5/17,2017/5/17,2018/4/7,2018/4/17,Disruption of the manufacture of the drug.,2017/4/7,2018/4/19,No
22785,2392232,Shortage,PMS-LOSARTAN-HCTZ,PHARMASCIENCE INC,LOSARTAN HCTZ,HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM,12.5MG 100MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/9/18,2017/9/25,2017/9/25,Disruption of the manufacture of the drug.,2017/9/19,2017/10/11,No
29509,2392232,Shortage,PMS-LOSARTAN-HCTZ,PHARMASCIENCE INC,LOSARTAN HCTZ,HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM,12.5MG 100MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/11/16,2018/3/6,2018/2/21,Disruption of the manufacture of the drug.,2017/11/17,2018/2/22,No
22782,2392232,Shortage,PMS-LOSARTAN-HCTZ,PHARMASCIENCE INC,LOSARTAN HCTZ,HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM,12.5MG 100MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/9/15,2017/10/31,2017/11/15,Disruption of the manufacture of the drug.,2017/9/19,2017/11/17,No
7432,2248268,Shortage,PMS-MELOXICAM,PHARMASCIENCE INC,MELOXICAM,MELOXICAM,15MG,500,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/6/4,2017/6/4,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/20,2020/6/10,No
7435,2248268,Shortage,PMS-MELOXICAM,PHARMASCIENCE INC,MELOXICAM,MELOXICAM,15MG,30,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/6/2,2017/6/2,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/20,2020/6/10,No
7438,2248267,Shortage,PMS-MELOXICAM,PHARMASCIENCE INC,MELOXICAM,MELOXICAM,7.5MG,100,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/8/28,2017/8/28,2018/4/17,2017/10/10,Disruption of the manufacture of the drug.,2017/4/20,2017/10/11,No
32053,2248268,Shortage,PMS-MELOXICAM,PHARMASCIENCE INC,MELOXICAM,MELOXICAM,15MG,100,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/12/31,2018/2/2,2018/2/8,2018/1/30,Disruption of the manufacture of the drug.,2017/12/7,2018/2/2,No
10103,2248267,Shortage,PMS-MELOXICAM,PHARMASCIENCE INC,MELOXICAM,MELOXICAM,7.5MG,3X10,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/7/13,2017/7/13,,2020/6/9,Shortage of an inactive ingredient or component.,2017/5/11,2020/6/10,No
13712,2248267,Shortage,PMS-MELOXICAM,PHARMASCIENCE INC,MELOXICAM,MELOXICAM,7.5MG,3X10,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/7/20,2017/7/20,,2020/6/9,Disruption of the manufacture of the drug.,2017/6/23,2020/6/10,No
25793,2321130,Shortage,PMS-MEMANTINE,PHARMASCIENCE INC,MEMANTINE,MEMANTINE HYDROCHLORIDE,10MG,30,ORAL,Resolved,TABLET,N06DX,ANTI-DEMENTIA DRUGS,,2017/10/1,2018/3/26,2018/3/23,Disruption of the manufacture of the drug.,2017/10/12,2018/3/24,No
22789,2242589,Shortage,PMS-METFORMIN,PHARMASCIENCE INC,METFORMIN,METFORMIN HYDROCHLORIDE,850MG,500,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/9/15,2017/12/7,2017/12/4,Disruption of the manufacture of the drug.,2017/9/19,2017/12/8,No
25796,2242589,Shortage,PMS-METFORMIN,PHARMASCIENCE INC,METFORMIN,METFORMIN HYDROCHLORIDE,850MG,100,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018/1/15,2018/1/24,2018/3/7,2018/2/21,Disruption of the manufacture of the drug.,2017/10/12,2018/2/22,No
32056,2223562,Shortage,PMS-METFORMIN - TAB 500MG,PHARMASCIENCE INC,METFORMIN,METFORMIN HYDROCHLORIDE,500MG,100,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018/1/16,,2018/3/5,2018/1/24,Disruption of the manufacture of the drug.,2017/12/7,2018/1/26,No
21652,2223562,Shortage,PMS-METFORMIN - TAB 500MG,PHARMASCIENCE INC,METFORMIN,METFORMIN HYDROCHLORIDE,500MG,500,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/9/1,2018/1/4,2017/12/4,Disruption of the manufacture of the drug.,2017/9/8,2017/12/8,No
21655,585009,Shortage,PMS-METHYLPHENIDATE,PHARMASCIENCE INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,20MG,100,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/9/4,2017/11/13,2017/11/14,Disruption of the manufacture of the drug.,2017/9/8,2017/11/17,No
4249,2413736,Shortage,PMS-METHYLPHENIDATE ER,PHARMASCIENCE INC,METHYLPHENIDATE ER,METHYLPHENIDATE HYDROCHLORIDE,27MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/3/23,,2020/6/5,Disruption of the manufacture of the drug.,2017/3/24,2020/6/9,No
4252,2413752,Shortage,PMS-METHYLPHENIDATE ER,PHARMASCIENCE INC,METHYLPHENIDATE ER,METHYLPHENIDATE HYDROCHLORIDE,54MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/3/23,,2020/6/5,Disruption of the manufacture of the drug.,2017/3/24,2020/6/9,No
4255,2413728,Shortage,PMS-METHYLPHENIDATE ER,PHARMASCIENCE INC,METHYLPHENIDATE ER,METHYLPHENIDATE HYDROCHLORIDE,18MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/3/23,,2020/6/5,Disruption of the manufacture of the drug.,2017/3/24,2020/6/9,No
6355,2413744,Shortage,PMS-METHYLPHENIDATE ER,PHARMASCIENCE INC,METHYLPHENIDATE ER,METHYLPHENIDATE HYDROCHLORIDE,36MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/4/9,,2020/6/5,Disruption of the manufacture of the drug.,2017/4/10,2020/6/9,No
13112,2230804,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL-L,METOPROLOL TARTRATE,100MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/8/23,,2017/10/13,2017/10/13,Disruption of the manufacture of the drug.,2017/6/16,2017/12/18,No
32059,2230804,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL-L,METOPROLOL TARTRATE,100MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/12/7,2018/1/19,2018/1/24,Disruption of the manufacture of the drug.,2017/12/7,2018/1/26,No
32062,2248855,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL-L,METOPROLOL TARTRATE,25MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017/12/7,2018/4/13,2018/4/17,Disruption of the manufacture of the drug.,2017/12/7,2018/4/19,No
13715,2248855,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL-L,METOPROLOL TARTRATE,25MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/8/31,2017/8/31,,2017/10/10,Disruption of the manufacture of the drug.,2017/6/23,2017/10/11,No
21659,2230804,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL-L,METOPROLOL TARTRATE,100MG,1000,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/9/21,2017/9/21,2018/3/19,2018/3/23,Disruption of the manufacture of the drug.,2017/9/8,2018/3/24,No
21662,2230803,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL-L,METOPROLOL TARTRATE,50MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/11/20,2017/11/20,2018/1/23,2017/12/17,Disruption of the manufacture of the drug.,2017/9/8,2017/12/18,No
21665,2230803,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL-L,METOPROLOL TARTRATE,50MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/11/27,2017/12/18,2018/1/23,2018/3/7,Disruption of the manufacture of the drug.,2017/9/8,2018/3/8,No
28835,2248855,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL-L,METOPROLOL TARTRATE,25MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/11/24,2017/12/18,2018/6/20,2018/6/26,Disruption of the manufacture of the drug.,2017/11/10,2018/6/29,No
12223,2230804,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL-L,METOPROLOL TARTRATE,100MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/8/14,2017/8/14,2018/1/5,2018/1/24,Disruption of the manufacture of the drug.,2017/6/7,2018/1/26,No
8620,783137,Shortage,PMS-METRONIDAZOLE,PHARMASCIENCE INC,METRONIDAZOLE,METRONIDAZOLE,500MG,100,ORAL,Resolved,CAPSULE,J01XD,OTHER ANTIBACTERIALS,,2017/5/1,,2020/6/9,Other (Please describe in comments),2017/5/2,2020/6/10,No
21669,2294427,Shortage,PMS-MINOCYCLINE,PHARMASCIENCE INC,MINOCYCLINE,MINOCYCLINE,100MG,100,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,,2017/9/4,,2020/6/5,Other (Please describe in comments),2017/9/8,2020/6/9,No
7441,2273942,Shortage,PMS-MIRTAZAPINE,PHARMASCIENCE INC,MIRTAZAPINE,MIRTAZAPINE,15MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017/4/20,2018/11/7,2018/11/28,Disruption of the manufacture of the drug.,2017/4/20,2018/11/29,No
21672,2248762,Shortage,PMS-MIRTAZAPINE,PHARMASCIENCE INC,MIRTAZAPINE,MIRTAZAPINE,30MG,30,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2017/9/28,2019/7/30,,2020/6/9,Other (Please describe in comments),2017/9/8,2020/6/10,No
10680,2248762,Shortage,PMS-MIRTAZAPINE,PHARMASCIENCE INC,MIRTAZAPINE,MIRTAZAPINE,30MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2017/7/5,2017/7/5,2019/2/20,2019/2/25,Disruption of the manufacture of the drug.,2017/5/18,2019/2/26,No
32065,2373947,Shortage,PMS-MONTELUKAST FC,PHARMASCIENCE INC,MONTELUKAST,MONTELUKAST,10MG,30,ORAL,Resolved,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2018/2/7,2018/1/30,2018/3/10,2018/3/10,Disruption of the manufacture of the drug.,2017/12/7,2018/3/11,No
18866,2373947,Shortage,PMS-MONTELUKAST FC,PHARMASCIENCE INC,MONTELUKAST,MONTELUKAST,10MG,100,ORAL,Avoided shortage,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017/9/10,,2017/10/20,2017/9/4,Disruption of the manufacture of the drug.,2017/8/11,2017/9/7,No
22792,2432218,Shortage,PMS-MOXIFLOXACIN,PHARMASCIENCE INC,MOXIFLOXACIN,MOXIFLOXACIN,0.50%,3mL,OPHTHALMIC,Resolved,SOLUTION,S01AE,ANTIINFECTIVES,,2017/9/15,2018/5/30,2018/6/6,Disruption of the manufacture of the drug.,2017/9/19,2018/6/7,No
5505,2380900,Shortage,PMS-NABILONE,PHARMASCIENCE INC,NABILONE,NABILONE,0.5MG,100,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2017/3/23,,2019/1/24,Disruption of the manufacture of the drug.,2017/4/4,2019/1/25,No
5508,2380919,Shortage,PMS-NABILONE,PHARMASCIENCE INC,NABILONE,NABILONE,1.0MG,100,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2017/3/23,,2019/1/24,Disruption of the manufacture of the drug.,2017/4/4,2019/1/25,No
21676,2380900,Shortage,PMS-NABILONE,PHARMASCIENCE INC,NABILONE,NABILONE,0.5MG,100,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2017/9/4,,2019/1/24,Disruption of the manufacture of the drug.,2017/9/8,2019/1/25,No
21679,2380919,Shortage,PMS-NABILONE,PHARMASCIENCE INC,NABILONE,NABILONE,1.0MG,100,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2017/9/4,,2019/1/24,Disruption of the manufacture of the drug.,2017/9/8,2019/1/25,No
6142,2017237,Shortage,PMS-NAPROXEN,PHARMASCIENCE INC,NAPROXEN,NAPROXEN,500MG,30,RECTAL,Resolved,SUPPOSITORY,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/4/12,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/7,2020/6/10,No
6145,2294710,Shortage,PMS-NAPROXEN EC,PHARMASCIENCE INC,NAPROZEN,NAPROXEN,500MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/12/1,2017/12/15,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/7,2020/6/10,No
7444,2416301,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE,NIFEDIPINE,60MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/4/19,2017/6/1,2017/6/8,Disruption of the manufacture of the drug.,2017/4/20,2017/6/9,No
15125,2416301,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE ER,NIFEDIPINE,60MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/7/3,2019/12/3,2019/4/19,Demand increase for the drug.,2017/7/11,2019/4/26,No
7447,2418630,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE,NIFEDIPINE,30MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/4/19,2017/7/12,2017/7/12,Disruption of the manufacture of the drug.,2017/4/20,2017/7/19,No
7450,2416301,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE,NIFEDIPINE,60MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017/11/21,2017/11/21,,2017/12/15,Disruption of the manufacture of the drug.,2017/4/20,2017/12/18,No
13115,2416301,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE ER,NIFEDIPINE,60MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/6/1,2017/7/17,2017/7/17,Demand increase for the drug.,2017/6/16,2017/12/18,No
21682,2416301,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE ER,NIFEDIPINE,60MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/9/1,2017/9/26,2017/9/26,Disruption of the manufacture of the drug.,2017/9/8,2017/10/11,No
21688,2418630,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE ER,NIFEDIPINE,30MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017/10/5,2017/10/5,2018/5/30,2018/5/15,Disruption of the manufacture of the drug.,2017/9/8,2018/5/18,No
8948,2418630,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE ER,NIFEDIPINE,30MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017/8/31,2017/8/31,,2018/10/2,Disruption of the manufacture of the drug.,2017/5/4,2018/10/3,No
22795,792667,Shortage,PMS-NYSTATIN SUSPENSION 100000 UNIT/ML,PHARMASCIENCE INC,NYSTATIN,NYSTATIN,100000UNIT,100mL,ORAL,Resolved,SUSPENSION,A07AA,INTESTINALANTIINFECTIVES,,2018/2/2,2018/10/22,2018/11/28,Disruption of the manufacture of the drug.,2017/9/19,2018/11/29,No
13118,792667,Shortage,PMS-NYSTATIN SUSPENSION 100000 UNIT/ML,PHARMASCIENCE INC,NYSTATIN,NYSTATIN,100000UNIT,500 mL,ORAL,Resolved,SUSPENSION,A07AA,INTESTINALANTIINFECTIVES,2017/8/14,,2017/9/4,2017/9/4,Disruption of the manufacture of the drug.,2017/6/16,2017/12/18,No
17063,792667,Shortage,PMS-NYSTATIN SUSPENSION 100000 UNIT/ML,PHARMASCIENCE INC,NYSTATIN,NYSTATIN,100000UNIT,500 mL,ORAL,Resolved,SUSPENSION,A07AA,INTESTINALANTIINFECTIVES,,2017/7/1,,2018/5/4,Disruption of the manufacture of the drug.,2017/7/25,2018/5/5,No
28841,792667,Shortage,PMS-NYSTATIN SUSPENSION 100000 UNIT/ML,PHARMASCIENCE INC,NYSTATIN,NYSTATIN,100000UNIT,90,ORAL,Resolved,SUSPENSION,A07AA,INTESTINALANTIINFECTIVES,,2017/11/10,2018/1/26,2018/2/12,Disruption of the manufacture of the drug.,2017/11/10,2018/2/19,No
29512,2320851,Shortage,PMS-OMEPRAZOLE,PHARMASCIENCE INC,OMEPRAZOLE,OMEPRAZOLE,20MG,500,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/11/16,2017/12/14,,2020/6/5,Disruption of the manufacture of the drug.,2017/11/17,2020/6/8,No
8624,2320851,Shortage,PMS-OMEPRAZOLE,PHARMASCIENCE INC,OMEPRAZOLE,OMEPRAZOLE,20MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/5/1,,2017/6/21,Disruption of the manufacture of the drug.,2017/5/2,2017/6/23,No
15128,2310260,Shortage,PMS-OMEPRAZOLE DR,PHARMASCIENCE INC,OMEPRAZOLE,OMEPRAZOLE,20MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/7/3,2017/11/8,2017/11/8,Disruption of the manufacture of the drug.,2017/7/11,2017/12/18,No
13122,2310260,Shortage,PMS-OMEPRAZOLE DR,PHARMASCIENCE INC,OMEPRAZOLE,OMEPRAZOLE,20MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/6/1,2017/10/20,2017/10/20,Disruption of the manufacture of the drug.,2017/6/16,2017/12/18,No
4259,2310260,Shortage,PMS-OMEPRAZOLE DR,PHARMASCIENCE INC,OMEPRAZOLE,OMEPRAZOLE,20MG,30,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/3/23,,2020/6/5,Disruption of the manufacture of the drug.,2017/3/24,2020/6/9,No
17066,2310260,Shortage,PMS-OMEPRAZOLE DR,PHARMASCIENCE INC,OMEPRAZOLE,OMEPRAZOLE,20MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/7/1,,2020/6/5,Disruption of the manufacture of the drug.,2017/7/25,2020/6/9,No
17069,2310260,Shortage,PMS-OMEPRAZOLE DR,PHARMASCIENCE INC,OMEPRAZOLE,OMEPRAZOLE,20MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/7/1,,2020/6/5,Disruption of the manufacture of the drug.,2017/7/25,2020/6/9,No
32068,2258188,Shortage,PMS-ONDANSETRON,PHARMASCIENCE INC,ONDANSETRON,ONDANSETRON,4MG,100,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,2017/12/20,2017/12/17,2018/7/5,2018/6/26,Disruption of the manufacture of the drug.,2017/12/7,2018/6/29,No
7453,2437074,Shortage,PMS-OXALIPLATIN,PHARMASCIENCE INC,OXALIPLATIN,OXALIPLATIN,5MG,10 ML,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2017/4/19,,2020/6/5,Disruption of the manufacture of the drug.,2017/4/20,2020/6/9,No
7456,2437074,Shortage,PMS-OXALIPLATIN,PHARMASCIENCE INC,OXALIPLATIN,OXALIPLATIN,5MG,20 ML,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2017/4/19,,2020/6/5,Disruption of the manufacture of the drug.,2017/4/20,2020/6/9,No
7459,2437074,Shortage,PMS-OXALIPLATIN,PHARMASCIENCE INC,OXALIPLATIN,OXALIPLATIN,5MG,40 ML,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2017/4/19,,2020/6/5,Disruption of the manufacture of the drug.,2017/4/20,2020/6/9,No
7462,2240550,Shortage,PMS-OXYBUTYNIN,PHARMASCIENCE INC,OXYBUTININ,OXYBUTYNIN CHLORIDE,5MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/4/20,2017/11/30,2017/12/4,Disruption of the manufacture of the drug.,2017/4/20,2017/12/8,No
8627,2223376,Shortage,PMS-OXYBUTYNIN,PHARMASCIENCE INC,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,1MG,1 mg/mL,ORAL,Resolved,SYRUP,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/10/23,2017/12/17,,2018/6/26,Disruption of the manufacture of the drug.,2017/5/2,2018/6/29,No
18874,2240550,Shortage,PMS-OXYBUTYNIN,PHARMASCIENCE INC,OXYBUTININ,OXYBUTYNIN CHLORIDE,5MG,500,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/8/10,2018/7/30,2018/8/23,Disruption of the manufacture of the drug.,2017/8/11,2018/8/24,No
21694,2240549,Shortage,PMS-OXYBUTYNIN,PHARMASCIENCE INC,OXYBUTININ,OXYBUTYNIN CHLORIDE,2.5MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/11/9,2017/12/17,2018/4/10,2018/4/17,Disruption of the manufacture of the drug.,2017/9/8,2018/4/19,No
4262,2319977,Shortage,PMS-OXYCODONE,PHARMASCIENCE INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,5MG,100,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017/3/23,2017/5/3,2017/5/17,Disruption of the manufacture of the drug.,2017/3/24,2017/5/18,No
15131,2309912,Shortage,PMS-OXYCODONE CR,PHARMASCIENCE INC,OXYCODONE CR,OXYCODONE HYDROCHLORIDE,80MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017/7/3,2017/7/31,2017/12/17,Requirements related to complying with good manufacturing practices.,2017/7/11,2017/12/18,No
7465,2309890,Shortage,PMS-OXYCODONE CR,PHARMASCIENCE INC,OCYCODONE,OXYCODONE HYDROCHLORIDE,20MG,100,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,2017/12/15,,2018/2/9,2017/10/30,Delay in shipping of the drug.,2017/4/20,2017/10/27,No
32071,2309882,Shortage,PMS-OXYCODONE CR,PHARMASCIENCE INC,OXYCODONE CR,OXYCODONE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017/12/7,2018/1/5,2018/1/24,Disruption of the manufacture of the drug.,2017/12/7,2018/1/26,No
18877,2309912,Shortage,PMS-OXYCODONE CR,PHARMASCIENCE INC,OXYCODONE CR,OXYCODONE HYDROCHLORIDE,80MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017/8/1,2017/10/31,2017/12/4,Disruption of the manufacture of the drug.,2017/8/11,2017/12/8,No
8952,2309882,Shortage,PMS-OXYCODONE CR,PHARMASCIENCE INC,OXYCODONE CR,OXYCODONE HYDROCHLORIDE,10MG,100,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,2017/10/26,,2017/11/15,2017/9/4,Disruption of the manufacture of the drug.,2017/5/4,2017/9/7,No
15135,2307871,Shortage,PMS-PANTOPRAZOLE,PHARMASCIENCE INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500,ORAL,Avoided shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/8/4,,,2017/7/23,Disruption of the manufacture of the drug.,2017/7/11,2017/7/25,No
7468,2291665,Shortage,PMS-PANTOPRAZOLE,PHARMASCIENCE INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,10 ML,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/7/30,2020/3/26,2020/6/5,Other (Please describe in comments),2017/4/20,2020/6/9,No
7471,2307871,Shortage,PMS-PANTOPRAZOLE,PHARMASCIENCE INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/9/12,2017/9/12,,2018/5/4,Disruption of the manufacture of the drug.,2017/4/20,2018/5/5,No
13125,2307871,Shortage,PMS-PANTOPRAZOLE,PHARMASCIENCE INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/7/3,2017/7/3,2017/10/6,2017/10/6,Disruption of the manufacture of the drug.,2017/6/16,2017/12/18,No
17072,2307871,Shortage,PMS-PANTOPRAZOLE,PHARMASCIENCE INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/8/1,,2018/5/4,Disruption of the manufacture of the drug.,2017/7/25,2018/5/5,No
7474,2247751,Shortage,PMS-PAROXETINE,PHARMASCIENCE INC,PAROXETINE,PAROXETINE,20MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/4/20,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/20,2020/6/10,No
7479,2247752,Shortage,PMS-PAROXETINE,PHARMASCIENCE INC,PAROXETINE,PAROXETINE,30MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/4/20,,2018/5/4,Disruption of the manufacture of the drug.,2017/4/20,2018/5/5,No
16969,2247751,Shortage,PMS-PAROXETINE,PHARMASCIENCE INC,PAROXETINE,PAROXETINE,20MG,500,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2016/2/8,2017/11/22,2017/11/22,Shortage of an active ingredient.,2017/7/25,2017/12/18,No
1913,2247751,Shortage,PMS-PAROXETINE,PHARMASCIENCE INC,Paroxetine,PAROXETINE,20MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2016/2/8,,2018/5/4,Shortage of an active ingredient.,2017/3/13,2018/5/5,No
1916,2247752,Shortage,PMS-PAROXETINE,PHARMASCIENCE INC,Paroxetine,PAROXETINE,30MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2016/2/25,,2020/6/5,Shortage of an active ingredient.,2017/3/13,2020/6/8,No
4265,2247750,Shortage,PMS-PAROXETINE,PHARMASCIENCE INC,PAROXETINE,PAROXETINE,10MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/3/23,,2018/5/4,Shortage of an active ingredient.,2017/3/24,2018/5/5,No
4268,2247750,Shortage,PMS-PAROXETINE,PHARMASCIENCE INC,PAROXETINE,PAROXETINE,10MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/3/23,,2020/6/9,Shortage of an active ingredient.,2017/3/24,2020/6/10,No
13030,2247751,Shortage,PMS-PAROXETINE,PHARMASCIENCE INC,PAROXETINE,PAROXETINE,20MG,500,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/2/8,2018/1/5,2018/5/4,Shortage of an active ingredient.,2017/6/16,2018/5/5,No
32074,2290111,Shortage,PMS-PRAMIPEXOLE,PHARMASCIENCE INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2017/12/7,,2020/6/5,Disruption of the manufacture of the drug.,2017/12/7,2020/6/9,No
32077,2290146,Shortage,PMS-PRAMIPEXOLE,PHARMASCIENCE INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.0MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2017/12/7,,2020/6/5,Disruption of the manufacture of the drug.,2017/12/7,2020/6/9,No
32080,2247656,Shortage,PMS-PRAVASTATIN,PHARMASCIENCE INC,PRAVASTATIN,PRAVASTATIN SODIUM,20MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/12/7,2018/4/10,2018/4/17,Disruption of the manufacture of the drug.,2017/12/7,2018/4/19,No
32083,2247657,Shortage,PMS-PRAVASTATIN,PHARMASCIENCE INC,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/12/7,2018/5/8,2018/5/4,Other (Please describe in comments),2017/12/7,2018/5/5,No
10668,2247657,Shortage,PMS-PRAVASTATIN,PHARMASCIENCE INC,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/8/14,2017/11/7,2017/10/27,Disruption of the manufacture of the drug.,2017/5/18,2017/10/28,No
4271,2247656,Shortage,PMS-PRAVASTATIN,PHARMASCIENCE INC,PRAVASTATIN,PRAVASTATIN SODIUM,20MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/3/23,,2020/6/9,Disruption of the manufacture of the drug.,2017/3/24,2020/6/10,No
4274,2247655,Shortage,PMS-PRAVASTATIN,PHARMASCIENCE INC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/3/23,,2018/6/26,Disruption of the manufacture of the drug.,2017/3/24,2018/6/29,No
4278,2247655,Shortage,PMS-PRAVASTATIN,PHARMASCIENCE INC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/3/23,,2020/6/9,Disruption of the manufacture of the drug.,2017/3/24,2020/6/10,No
21697,2245532,Shortage,PMS-PREDNISOLONE,PHARMASCIENCE INC,PREDNISOLONE,PREDNISOLONE,5MG,120 mL,ORAL,Resolved,SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017/9/1,2017/11/20,2017/12/4,Disruption of the manufacture of the drug.,2017/9/8,2017/12/8,No
6148,2359618,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,50MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/5/3,2017/10/26,2017/10/24,Disruption of the manufacture of the drug.,2017/4/7,2017/10/26,No
15138,2359596,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,25MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/7/3,2017/7/26,2017/9/15,Shortage of an active ingredient.,2017/7/11,2017/9/18,No
11318,2359596,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,25MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/8/10,2017/11/1,2017/10/27,Disruption of the manufacture of the drug.,2017/5/25,2017/10/28,No
7483,2359634,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,150MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/4/22,2017/7/28,2017/7/23,Disruption of the manufacture of the drug.,2017/4/20,2017/7/25,No
7486,2359642,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/5/18,,2017/7/31,2017/9/15,Disruption of the manufacture of the drug.,2017/4/20,2017/9/18,No
7491,2359626,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,75MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/9/17,2017/9/17,2017/10/23,2017/10/10,Disruption of the manufacture of the drug.,2017/4/20,2017/10/11,No
13128,2359596,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,25MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/7/1,2017/7/1,2017/7/13,2017/12/17,Disruption of the manufacture of the drug.,2017/6/16,2017/12/18,No
32086,2359618,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,50MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/12/7,2017/12/27,2018/1/24,Disruption of the manufacture of the drug.,2017/12/7,2018/1/26,No
10106,2359634,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,150MG,3X10,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/5/1,2017/5/19,2017/6/14,Shortage of an inactive ingredient or component.,2017/5/11,2017/6/16,No
13718,2359634,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,150MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/7/15,,2017/8/12,2017/12/18,Disruption of the manufacture of the drug.,2017/6/23,2017/12/19,No
10671,2359618,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,50MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/9/2,2017/9/2,2017/11/27,2017/10/10,Disruption of the manufacture of the drug.,2017/5/18,2017/10/11,No
18880,2359634,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,150MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/8/1,2017/11/30,2017/12/4,Disruption of the manufacture of the drug.,2017/8/11,2017/12/8,No
18883,2359596,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,25MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/8/1,2017/11/2,2017/10/27,Disruption of the manufacture of the drug.,2017/8/11,2017/10/28,No
21700,2398079,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,225MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/9/1,2017/9/19,2017/9/19,Disruption of the manufacture of the drug.,2017/9/8,2017/10/11,No
22798,2296578,Shortage,PMS-QUETIAPINE,PHARMASCIENCE INC,QUETIAPINE,QUETIAPINE,100MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017/10/16,2017/10/27,2017/11/8,Disruption of the manufacture of the drug.,2017/9/19,2017/11/9,No
22802,2361892,Shortage,PMS-QUETIAPINE,PHARMASCIENCE INC,QUETIAPINE,QUETIAPINE,50MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017/9/15,2018/3/5,2018/2/21,Disruption of the manufacture of the drug.,2017/9/19,2018/2/22,No
18886,2296551,Shortage,PMS-QUETIAPINE,PHARMASCIENCE INC,QUETIAPINE,QUETIAPINE,25MG,500,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017/8/1,2017/11/21,2017/10/27,Disruption of the manufacture of the drug.,2017/8/11,2017/10/28,No
21703,2296551,Shortage,PMS-QUETIAPINE,PHARMASCIENCE INC,QUETIAPINE,QUETIAPINE,25MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2017/9/22,2017/9/22,2017/9/28,2017/9/28,Disruption of the manufacture of the drug.,2017/9/8,2017/10/11,No
25801,2296608,Shortage,PMS-QUETIAPINE,PHARMASCIENCE INC,QUETIAPINE,QUETIAPINE,300MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017/10/1,2017/11/10,2017/10/27,Disruption of the manufacture of the drug.,2017/10/12,2017/10/28,No
21706,2296608,Shortage,PMS-QUETIAPINE,PHARMASCIENCE INC,QUTIAPINE,QUETIAPINE,300MG,500,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017/9/1,2018/2/5,2018/2/8,Disruption of the manufacture of the drug.,2017/9/8,2018/2/12,No
1927,2340585,Shortage,PMS-QUINAPRIL,PHARMASCIENCE INC,Quinapril,QUINAPRIL,40MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/7/1,2019/9/21,2019/10/29,Disruption of the manufacture of the drug.,2017/3/13,2019/10/30,No
17075,2340550,Shortage,PMS-QUINAPRIL,PHARMASCIENCE INC,QUINAPRIL,QUINAPRIL,5MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017/10/15,2017/12/15,2019/9/25,2019/11/4,Disruption of the manufacture of the drug.,2017/7/25,2019/11/15,No
25804,2340577,Shortage,PMS-QUINAPRIL,PHARMASCIENCE INC,QUINAPRIL,QUINAPRIL,20MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/10/1,2019/9/20,2019/10/29,Disruption of the manufacture of the drug.,2017/10/12,2019/10/30,No
21709,2340569,Shortage,PMS-QUINAPRIL,PHARMASCIENCE INC,QUINAPRIL,QUINAPRIL,10MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/9/4,2019/9/17,2019/11/4,Disruption of the manufacture of the drug.,2017/9/8,2019/11/15,No
1930,2295369,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,1.25MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/3/1,,2020/4/1,Disruption of the manufacture of the drug.,2017/3/13,2020/4/2,No
1933,2247917,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,2.5MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/4/30,,2020/4/10,Disruption of the manufacture of the drug.,2017/3/13,2020/4/13,No
1936,2247918,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,5MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/3/1,,2020/4/1,Disruption of the manufacture of the drug.,2017/3/13,2020/4/2,No
1939,2247917,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,2.5MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/10/1,2017/10/1,,2020/4/10,Disruption of the manufacture of the drug.,2017/3/13,2020/4/13,No
1942,2247918,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,5MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2019/7/30,,2020/4/10,Disruption of the manufacture of the drug.,2017/3/13,2020/4/13,No
1945,2247918,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,5MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2019/7/30,,2020/4/10,Disruption of the manufacture of the drug.,2017/3/13,2020/4/13,No
1948,2295369,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,1.25MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/3/1,2017/3/1,,2020/6/5,Disruption of the manufacture of the drug.,2017/3/13,2020/6/9,No
1951,2247919,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,10MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/5/1,2017/5/1,,2020/4/10,Disruption of the manufacture of the drug.,2017/3/13,2020/4/13,No
1954,2247919,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,10MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/3/1,,2020/4/1,Disruption of the manufacture of the drug.,2017/3/13,2020/4/2,No
1957,2247919,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,10MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/11/1,2017/11/1,,2020/4/10,Disruption of the manufacture of the drug.,2017/3/13,2020/4/13,No
1960,2247917,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,2.5MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/10/1,2017/10/1,,2020/4/10,Disruption of the manufacture of the drug.,2017/3/13,2020/4/13,No
6298,2342170,Shortage,PMS-RAMIPRIL-HCTZ,PHARMASCIENCE INC,PMS-RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE RAMIPRIL,25.0MG 10.0MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017/4/9,,2018/5/4,Disruption of the manufacture of the drug.,2017/4/10,2018/5/5,No
6303,2342154,Shortage,PMS-RAMIPRIL-HCTZ,PHARMASCIENCE INC,RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE RAMIPRIL,12.5MG 10.0MG,100,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017/4/9,,2018/5/4,Disruption of the manufacture of the drug.,2017/4/10,2018/5/5,No
6306,2342154,Shortage,PMS-RAMIPRIL-HCTZ,PHARMASCIENCE INC,RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE RAMIPRIL,12.5MG 10.0MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017/4/9,,2018/5/4,Disruption of the manufacture of the drug.,2017/4/10,2018/5/5,No
6309,2342170,Shortage,PMS-RAMIPRIL-HCTZ,PHARMASCIENCE INC,RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE RAMIPRIL,25.0MG 10.0MG,100,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017/4/9,,2019/7/10,Disruption of the manufacture of the drug.,2017/4/10,2019/7/11,No
6312,2342138,Shortage,PMS-RAMIPRIL-HCTZ,PHARMASCIENCE INC,RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE RAMIPRIL,12.5MG 2.5MG,100,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017/4/9,,2020/6/5,Disruption of the manufacture of the drug.,2017/4/10,2020/6/9,No
6315,2342146,Shortage,PMS-RAMIPRIL-HCTZ,PHARMASCIENCE INC,RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE RAMIPRIL,12.5MG 5.0MG,100,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017/4/9,,2020/6/5,Disruption of the manufacture of the drug.,2017/4/10,2020/6/9,No
6318,2342146,Shortage,PMS-RAMIPRIL-HCTZ,PHARMASCIENCE INC,RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE RAMIPRIL,12.5MG 5.0MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017/4/9,,2020/6/5,Disruption of the manufacture of the drug.,2017/4/10,2020/6/9,No
6322,2342162,Shortage,PMS-RAMIPRIL-HCTZ,PHARMASCIENCE INC,RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE RAMIPRIL,25.0MG 5.0MG,100,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017/4/9,,2020/6/5,Disruption of the manufacture of the drug.,2017/4/10,2020/6/9,No
15141,2242453,Shortage,PMS-RANITIDINE 150 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,150MG,60,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/7/3,2017/7/18,2017/7/23,Disruption of the manufacture of the drug.,2017/7/11,2017/7/25,No
13131,2242453,Shortage,PMS-RANITIDINE 150 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,150MG,60,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/6/15,,2017/6/21,Disruption of the manufacture of the drug.,2017/6/16,2017/6/23,No
13722,2242453,Shortage,PMS-RANITIDINE 150 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,150MG,500,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/6/30,2017/6/30,2017/7/10,2017/7/10,Disruption of the manufacture of the drug.,2017/6/23,2017/12/19,No
8630,2242453,Shortage,PMS-RANITIDINE 150 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,150MG,500,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/5/1,2017/5/19,2017/6/8,Disruption of the manufacture of the drug.,2017/5/2,2017/6/9,No
17078,2242453,Shortage,PMS-RANITIDINE 150 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,150MG,100,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/7/1,,2018/5/4,Disruption of the manufacture of the drug.,2017/7/25,2018/5/5,No
17081,2242453,Shortage,PMS-RANITIDINE 150 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,150MG,500,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/7/1,,2018/5/4,Disruption of the manufacture of the drug.,2017/7/25,2018/5/5,No
17084,2242453,Shortage,PMS-RANITIDINE 150 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,150MG,60,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/7/1,,2018/5/4,Disruption of the manufacture of the drug.,2017/7/25,2018/5/5,No
22805,2242454,Shortage,PMS-RANITIDINE 300 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,300MG,250,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/9/15,2018/9/10,2018/6/26,Disruption of the manufacture of the drug.,2017/9/19,2018/6/29,No
28844,2242454,Shortage,PMS-RANITIDINE 300 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,300MG,100,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/11/20,2017/11/20,2018/2/5,2017/12/18,Disruption of the manufacture of the drug.,2017/11/10,2018/12/7,No
10109,2302209,Shortage,PMS-RISEDRONATE,PHARMASCIENCE INC,RISEDRONATE,RISEDRONATE SODIUM,35MG,4,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/5/1,2017/12/18,2017/11/14,Disruption of the manufacture of the drug.,2017/5/11,2017/11/17,No
17088,2424177,Shortage,PMS-RISEDRONATE,PHARMASCIENCE INC,RISEDRONATE,RISEDRONATE SODIUM,150MG,30,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/7/1,2017/11/27,2017/11/14,Disruption of the manufacture of the drug.,2017/7/25,2017/11/17,No
12226,2302209,Shortage,PMS-RISEDRONATE,PHARMASCIENCE INC,RISEDRONATE,RISEDRONATE SODIUM,35MG,30,ORAL,Avoided shortage,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017/7/24,,2017/8/28,2017/7/23,Shortage of an active ingredient.,2017/6/7,2017/7/25,No
17091,2424177,Shortage,PMS-RISEDRONATE,PHARMASCIENCE INC,RISEDRONATE,RISEDRONATE SODIUM,150MG,1,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/7/1,2017/11/22,2017/10/27,Disruption of the manufacture of the drug.,2017/7/25,2017/10/28,No
27351,2302209,Shortage,PMS-RISEDRONATE,PHARMASCIENCE INC,RISEDRONATE,RISEDRONATE SODIUM,35MG,100,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/10/9,2017/12/14,2017/11/14,Disruption of the manufacture of the drug.,2017/10/27,2017/11/17,No
8633,2279266,Shortage,PMS-RISPERIDONE,PHARMASCIENCE INC,RISPERIDONE,RISPERIDONE,1MG,1 mg/mL,ORAL,Resolved,SOLUTION,N05AX,ANTIPSYCHOTICS,2017/5/15,,2017/5/29,2017/6/8,Disruption of the manufacture of the drug.,2017/5/2,2017/6/9,No
21712,2252007,Shortage,PMS-RISPERIDONE,PHARMASCIENCE INC,RISPERIDONE,RISPERIDONE,0.25MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017/9/1,2017/10/30,2017/11/14,Disruption of the manufacture of the drug.,2017/9/8,2017/11/17,No
21715,2252031,Shortage,PMS-RISPERIDONE,PHARMASCIENCE INC,RISPERIDONE,RISPERIDONE,2.0MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2017/10/22,2017/10/26,2017/11/24,2017/11/8,Disruption of the manufacture of the drug.,2017/9/8,2017/11/9,No
27354,2252007,Shortage,PMS-RISPERIDONE,PHARMASCIENCE INC,RISPERIDONE,RISPERIDONE,0.25MG,500,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017/10/9,2017/12/7,2017/12/12,Disruption of the manufacture of the drug.,2017/10/27,2017/12/15,No
6337,2291789,Shortage,PMS-RISPERIDONE ODT,PHARMASCIENCE INC,RISPERIDONE ODT,RISPERIDONE,1MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AX,ANTIPSYCHOTICS,,2017/4/9,,2020/6/5,Disruption of the manufacture of the drug.,2017/4/10,2020/6/9,No
6340,2291797,Shortage,PMS-RISPERIDONE ODT,PHARMASCIENCE INC,RISPERIDONE ODT,RISPERIDONE,2MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AX,ANTIPSYCHOTICS,,2017/4/9,,2020/6/5,Disruption of the manufacture of the drug.,2017/4/10,2020/6/9,No
6343,2370697,Shortage,PMS-RISPERIDONE ODT,PHARMASCIENCE INC,RISPERIDONE ODT,RISPERIDONE,3MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AX,ANTIPSYCHOTICS,,2017/4/9,,2020/6/5,Disruption of the manufacture of the drug.,2017/4/10,2020/6/9,No
6346,2370700,Shortage,PMS-RISPERIDONE ODT,PHARMASCIENCE INC,RISPERIDONE ODT,RISPERIDONE,4MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AX,ANTIPSYCHOTICS,,2017/4/9,,2020/6/5,Disruption of the manufacture of the drug.,2017/4/10,2020/6/9,No
1963,2326639,Shortage,PMS-ROPINIROLE,PHARMASCIENCE INC,Ropinirole,ROPINIROLE,5.0MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2015/10/14,,2020/6/5,Other (Please describe in comments),2017/3/13,2020/6/9,No
8961,2378523,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,5MG,3X10,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/5/15,2018/2/23,2018/2/19,Disruption of the manufacture of the drug.,2017/5/4,2018/2/20,No
15144,2378566,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,40MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/8/28,2017/8/28,2018/1/10,2018/1/24,Shortage of an inactive ingredient or component.,2017/7/11,2018/1/26,No
7494,2378531,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,10MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/5/20,2017/9/13,2017/9/13,Disruption of the manufacture of the drug.,2017/4/20,2017/10/11,No
7497,2378558,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,20MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/5/11,2018/1/18,2018/2/19,Disruption of the manufacture of the drug.,2017/4/20,2018/2/20,No
7500,2378558,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,20MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/5/18,2017/5/18,2018/4/29,2018/4/17,Disruption of the manufacture of the drug.,2017/4/20,2018/4/19,No
10112,2378531,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,10MG,4,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/5/25,2017/10/10,2017/10/10,Disruption of the manufacture of the drug.,2017/5/11,2017/10/11,No
10115,2378523,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,5MG,4,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/6/20,2018/1/29,2018/2/8,Disruption of the manufacture of the drug.,2017/5/11,2018/2/12,No
18890,2378566,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,40MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/8/1,2018/1/15,2018/1/24,Disruption of the manufacture of the drug.,2017/8/11,2018/1/26,No
18893,2378523,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,5MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/8/1,2017/11/28,2018/1/25,Disruption of the manufacture of the drug.,2017/8/11,2018/1/26,No
27359,2378531,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,10MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/10/9,2018/6/10,2018/5/15,Disruption of the manufacture of the drug.,2017/10/27,2018/5/18,No
8955,2378531,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,10MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/6/1,2017/7/24,2017/7/23,Disruption of the manufacture of the drug.,2017/5/4,2017/7/25,No
8958,2378558,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,20MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/6/16,2017/6/16,2017/10/26,2017/11/8,Disruption of the manufacture of the drug.,2017/5/4,2017/11/9,No
6152,2208245,Shortage,PMS-SALBUTAMOL,PHARMASCIENCE INC,SALBUTAMOL,SALBUTAMOL,0.5MG,20,INHALATION,Resolved,SOLUTION,R03AC,"ADRENERGICS, INHALANTS",,2017/5/17,2017/7/12,2017/7/23,Delay in shipping of the drug.,2017/4/7,2017/7/25,No
22808,2244840,Shortage,PMS-SERTRALINE,PHARMASCIENCE INC,SERTRALINE,SERTRALINE,100MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017/10/2,2017/10/2,2017/10/21,2017/10/10,Disruption of the manufacture of the drug.,2017/9/19,2017/10/11,No
32134,2244838,Shortage,PMS-SERTRALINE,PHARMASCIENCE INC,SERTRALINE,SERTRALINE,25MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017/12/8,2018/4/1,2018/4/17,Disruption of the manufacture of the drug.,2017/12/8,2018/4/19,No
32139,2244839,Shortage,PMS-SERTRALINE,PHARMASCIENCE INC,SERTRALINE,SERTRALINE,50MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017/12/8,2018/5/13,2018/4/17,Delay in shipping of the drug.,2017/12/8,2018/4/19,No
21718,2244839,Shortage,PMS-SERTRALINE,PHARMASCIENCE INC,SERTRALINE,SERTRALINE,50MG,250,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017/10/16,2017/11/8,,2018/4/18,Disruption of the manufacture of the drug.,2017/9/8,2018/4/19,No
10118,2412179,Shortage,PMS-SILDENAFIL R,PHARMASCIENCE INC,SILDENAFIL,SILDENAFIL,20MG,4,ORAL,Resolved,TABLET,C02,OTHER ANTIHYPERTENSIVES,,2017/9/18,2017/11/20,2017/5/17,Disruption of the manufacture of the drug.,2017/5/11,2017/5/18,No
27364,2412179,Shortage,PMS-SILDENAFIL R,PHARMASCIENCE INC,SILDENAFIL-R,SILDENAFIL,20MG,100,ORAL,Resolved,TABLET,C02KX,OTHER ANTIHYPERTENSIVES,2017/11/1,2017/12/18,2018/3/7,2018/3/6,Disruption of the manufacture of the drug.,2017/10/27,2018/3/7,No
6157,2269252,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,5MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/7/3,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/7,2020/6/10,No
15147,2269279,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,20MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/7/3,,2020/6/5,Disruption of the manufacture of the drug.,2017/7/11,2020/6/8,No
13134,2269279,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,20MG,3x10,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/6/23,2017/6/23,2018/3/7,2017/12/18,Disruption of the manufacture of the drug.,2017/6/16,2017/12/19,No
7503,2269260,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,10MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/7/3,,2020/6/5,Disruption of the manufacture of the drug.,2017/4/20,2020/6/8,No
7507,2269295,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,80MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/6/10,2017/6/10,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/20,2020/6/10,No
10121,2269287,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,40MG,4,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/5/4,2017/5/4,,2020/6/9,Disruption of the manufacture of the drug.,2017/5/11,2020/6/10,No
25807,2269279,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,20MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/10/1,,2020/6/5,Disruption of the manufacture of the drug.,2017/10/12,2020/6/8,No
18896,2269279,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,20MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/8/1,,2020/6/5,Disruption of the manufacture of the drug.,2017/8/11,2020/6/8,No
20468,2046113,Shortage,PMS-SODIUM CROMOGLYCATE,PHARMASCIENCE INC,pms-SOD CROMOGLYCATE 1% NEBUL SOL 50x2mL,CROMOLYN SODIUM,1%,50x2mL,"INHALATION
ORAL",Avoided shortage,SOLUTION,R03BC,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2018/2/26,,2018/3/3,2017/12/11,Disruption of the manufacture of the drug.,2017/8/28,2017/12/12,No
29428,2046113,Shortage,PMS-SODIUM CROMOGLYCATE,PHARMASCIENCE INC,pms-SOD CROMOGLYCATE 1% NEBUL SOL 50x2mL,CROMOLYN SODIUM,1%,50x2mL,"INHALATION
ORAL",Resolved,SOLUTION,R03BC,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2017/11/16,2017/11/16,2018/1/31,2017/12/11,Demand increase for the drug.,2017/11/16,2017/12/12,No
7510,2417731,Shortage,PMS-SOLIFENACIN,PHARMASCIENCE INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,30,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/7/27,2017/7/27,,2018/5/4,Disruption of the manufacture of the drug.,2017/4/20,2018/5/5,No
7514,2417731,Shortage,PMS-SOLIFENACIN,PHARMASCIENCE INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,30,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/4/20,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/20,2020/6/10,No
10124,2417731,Shortage,PMS-SOLIFENACIN,PHARMASCIENCE INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/7/21,2017/7/21,,2018/5/4,Shortage of an inactive ingredient or component.,2017/5/11,2018/5/5,No
21721,2417723,Shortage,PMS-SOLIFENACIN,PHARMASCIENCE INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,5MG,30,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/9/1,2018/4/27,2018/5/4,Disruption of the manufacture of the drug.,2017/9/8,2018/5/5,No
32142,2238327,Shortage,PMS-SOTALOL - 160 MG,PHARMASCIENCE INC,SOTALOL,SOTALOL HYDROCHLORIDE,160MG,100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,2018/1/14,2018/1/24,2018/2/19,2018/2/19,Disruption of the manufacture of the drug.,2017/12/8,2018/2/20,No
8636,2238327,Shortage,PMS-SOTALOL - 160 MG,PHARMASCIENCE INC,SOTALOL,SOTALOL HYDROCHLORIDE,160MG,CAPL 100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,2017/7/4,2017/7/4,2017/12/14,2017/11/14,Disruption of the manufacture of the drug.,2017/5/2,2017/11/17,No
6164,2238326,Shortage,PMS-SOTALOL - 80 MG,PHARMASCIENCE INC,SOTALOL,SOTALOL HYDROCHLORIDE,80MG,100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2017/4/5,2018/2/13,2017/11/8,Delay in shipping of the drug.,2017/4/7,2017/11/10,No
8639,2238326,Shortage,PMS-SOTALOL - 80 MG,PHARMASCIENCE INC,SOTALOL,SOTALOL HYDROCHLORIDE,80MG,CAPL 500,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2017/6/12,,2017/11/21,Disruption of the manufacture of the drug.,2017/5/2,2017/11/22,No
7517,598461,Shortage,PMS-SULFASALAZINE 500MG/TAB USP,PHARMASCIENCE INC,SULFASALAZINE,SULFASALAZINE,500MG,500,ORAL,Resolved,TABLET,A07EC,INTESTINALANTIINFLAMMATORY AGENTS,,2017/4/20,2018/10/15,2018/10/17,Disruption of the manufacture of the drug.,2017/4/20,2018/10/18,No
5511,598461,Shortage,PMS-SULFASALAZINE 500MG/TAB USP,PHARMASCIENCE INC,SULFASALAZINE,SULFASALAZINE,500MG,500,ORAL,Resolved,TABLET,A07EC,INTESTINALANTIINFLAMMATORY AGENTS,,2019/5/8,,2019/7/10,Shortage of an inactive ingredient or component.,2017/4/4,2019/7/11,No
7520,598488,Shortage,PMS-SULFASALAZINE-E.C. TAB 500MG,PHARMASCIENCE INC,SULFASALAZINE,SULFASALAZINE,500MG,500,ORAL,Resolved,TABLET (ENTERIC-COATED),A07EC,INTESTINALANTIINFLAMMATORY AGENTS,,2017/4/19,2017/4/19,2017/4/19,Disruption of the manufacture of the drug.,2017/4/20,2017/4/20,No
7523,598488,Shortage,PMS-SULFASALAZINE-E.C. TAB 500MG,PHARMASCIENCE INC,SULFASALAZINE,SULFASALAZINE,500MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),A07EC,INTESTINALANTIINFLAMMATORY AGENTS,,2017/6/14,2017/8/21,2017/9/4,Disruption of the manufacture of the drug.,2017/4/20,2017/9/7,No
5514,598488,Shortage,PMS-SULFASALAZINE-E.C. TAB 500MG,PHARMASCIENCE INC,SULFASALAZINE,SULFASALAZINE,500MG,500,ORAL,Resolved,TABLET (ENTERIC-COATED),A07EC,INTESTINALANTIINFLAMMATORY AGENTS,,2017/3/23,2017/8/21,2017/9/11,Shortage of an inactive ingredient or component.,2017/4/4,2017/10/5,No
1966,598488,Shortage,PMS-SULFASALAZINE-E.C. TAB 500MG,PHARMASCIENCE INC,Sulfasalazine,SULFASALAZINE,500MG,500,ORAL,Resolved,TABLET (ENTERIC-COATED),A07EC,INTESTINALANTIINFLAMMATORY AGENTS,,2016/8/16,2019/2/10,2019/2/6,Shortage of an active ingredient.,2017/3/13,2019/2/8,No
22811,2256428,Shortage,PMS-SUMATRIPTAN,PHARMASCIENCE INC,SUMATRIPTAN,SUMATRIPTAN,25MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/9/15,2018/1/9,2018/1/24,Disruption of the manufacture of the drug.,2017/9/19,2018/1/26,No
22814,2256436,Shortage,PMS-SUMATRIPTAN,PHARMASCIENCE INC,SUMATRIPTAN,SUMATRIPTAN,50MG,30,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/9/15,,2018/6/26,Disruption of the manufacture of the drug.,2017/9/19,2018/6/29,No
32145,2256444,Shortage,PMS-SUMATRIPTAN,PHARMASCIENCE INC,SUMATRIPTAN,SUMATRIPTAN,100MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2018/1/22,2018/1/18,2018/5/20,2018/5/4,Disruption of the manufacture of the drug.,2017/12/8,2018/5/5,No
18901,2256436,Shortage,PMS-SUMATRIPTAN,PHARMASCIENCE INC,SUMATRIPTAN,SUMATRIPTAN,50MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/8/1,2017/9/29,2017/9/29,Disruption of the manufacture of the drug.,2017/8/11,2017/10/11,No
25816,2256428,Shortage,PMS-SUMATRIPTAN,PHARMASCIENCE INC,SUMATRIPTAN,SUMATRIPTAN,25MG,30,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/10/1,2017/11/6,2017/12/4,Disruption of the manufacture of the drug.,2017/10/12,2017/12/8,No
22817,2409445,Shortage,PMS-TADALAFIL,PHARMASCIENCE INC,TADALAFIL,TADALAFIL,20MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/9/15,2017/10/25,2017/10/23,Disruption of the manufacture of the drug.,2017/9/19,2017/10/26,No
32148,2409445,Shortage,PMS-TADALAFIL,PHARMASCIENCE INC,TADALAFIL,TADALAFIL,20MG,30,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/12/8,2018/4/10,2018/4/17,Other (Please describe in comments),2017/12/8,2018/4/19,No
12231,2409437,Shortage,PMS-TADALAFIL,PHARMASCIENCE INC,TADALAFIL,TADALAFIL,10MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/7/10,2017/7/10,2018/4/10,2018/4/17,Disruption of the manufacture of the drug.,2017/6/7,2018/4/19,No
32151,2243521,Shortage,PMS-TERAZOSIN,PHARMASCIENCE INC,TERAZOSIN,TERAZOSIN,10MG,100,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/12/8,2018/4/30,2018/4/17,Disruption of the manufacture of the drug.,2017/12/8,2018/4/19,No
32154,2243518,Shortage,PMS-TERAZOSIN,PHARMASCIENCE INC,TERAZOSIN,TERAZOSIN,1MG,100,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/12/8,2018/4/30,2018/4/17,Disruption of the manufacture of the drug.,2017/12/8,2018/4/19,No
32157,2243519,Shortage,PMS-TERAZOSIN,PHARMASCIENCE INC,TERAZOSIN,TERAZOSIN,2MG,100,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/12/8,2018/3/21,2018/4/30,Disruption of the manufacture of the drug.,2017/12/8,2018/5/1,No
32160,2243520,Shortage,PMS-TERAZOSIN,PHARMASCIENCE INC,TERAZOSIN,TERAZOSIN,5MG,100,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/12/8,2018/4/30,2018/4/17,Disruption of the manufacture of the drug.,2017/12/8,2018/4/19,No
32163,2322498,Shortage,PMS-TESTOSTERONE,PHARMASCIENCE INC,TESTOSTERONE,TESTOSTERONE UNDECANOATE,40MG,30,ORAL,Resolved,CAPSULE,G03BA,ANDROGENS,2018/1/2,2018/1/24,2018/4/25,2018/4/17,Disruption of the manufacture of the drug.,2017/12/8,2018/4/19,No
17094,2402424,Shortage,PMS-TETRABENAZINE,PHARMASCIENCE INC,TETRABENAZINE,TETRABENAZINE,25MG,100,ORAL,Resolved,TABLET,N07XX,OTHER NERVOUS SYSTEM DRUGS,,2017/7/1,2018/4/4,2018/4/17,Disruption of the manufacture of the drug.,2017/7/25,2018/4/19,No
6174,2262991,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,25MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/4/5,2017/5/18,2017/6/8,Shortage of an active ingredient.,2017/4/7,2017/6/9,No
6181,2262991,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,25MG,500,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/4/5,2017/4/27,2017/4/27,Shortage of an active ingredient.,2017/4/7,2017/12/19,No
5517,2262991,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,25MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/3/23,2017/5/1,2017/12/18,Shortage of an active ingredient.,2017/4/4,2017/12/19,No
5520,2262991,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,25MG,500,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/3/23,2017/4/27,2017/4/27,Shortage of an active ingredient.,2017/4/4,2017/12/19,No
8642,2263009,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,100MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/6/19,2017/11/21,2017/11/14,Shortage of an active ingredient.,2017/5/2,2017/11/17,No
12234,2262991,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,25MG,500,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/6/6,,2018/5/4,Shortage of an active ingredient.,2017/6/7,2018/5/5,No
21724,2262991,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,25MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/9/4,2017/11/1,2017/10/27,Disruption of the manufacture of the drug.,2017/9/8,2017/10/28,No
21727,2312085,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,50MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/9/4,2018/1/30,2018/2/8,Disruption of the manufacture of the drug.,2017/9/8,2018/2/12,No
27368,2263017,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,200MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/10/9,2018/2/22,2018/2/19,Disruption of the manufacture of the drug.,2017/10/27,2018/2/20,No
1969,2406446,Shortage,PMS-TOPOTECAN,PHARMASCIENCE INC,Topotecan,TOPOTECAN,4MG,1,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2015/7/20,,2020/4/1,Other (Please describe in comments),2017/3/13,2020/4/2,No
6186,2401657,Shortage,PMS-TRAMADOL-ACET,PHARMASCIENCE INC,TRAMADOL-ACET,TRAMADOL HYDROCHLORIDE ACETAMINOPHEN,37.5MG 325MG,60,ORAL,Resolved,TABLET,N02AJ,,,2017/3/23,2017/11/2,2017/10/30,Delay in shipping of the drug.,2017/4/7,2017/10/31,No
6189,2401657,Shortage,PMS-TRAMADOL-ACET,PHARMASCIENCE INC,TRAMADOL-ACET,TRAMADOL HYDROCHLORIDE ACETAMINOPHEN,37.5MG 325MG,100,ORAL,Resolved,TABLET,N02AJ,,,2017/3/23,2018/4/4,2017/10/30,Delay in shipping of the drug.,2017/4/7,2017/10/31,No
5523,2401657,Shortage,PMS-TRAMADOL-ACET,PHARMASCIENCE INC,TRAMADOL-ACET,TRAMADOL HYDROCHLORIDE ACETAMINOPHEN,37.5MG 325MG,60,ORAL,Resolved,TABLET,N02AJ,,,2017/3/23,2017/5/1,2017/12/18,Delay in shipping of the drug.,2017/4/4,2017/12/19,No
5528,2401657,Shortage,PMS-TRAMADOL-ACET,PHARMASCIENCE INC,TRAMADOL-ACET,TRAMADOL HYDROCHLORIDE ACETAMINOPHEN,37.5MG 325MG,100,ORAL,Resolved,TABLET,N02AJ,,,2017/3/23,2017/5/1,2017/5/1,Delay in shipping of the drug.,2017/4/4,2017/12/19,No
4284,2401657,Shortage,PMS-TRAMADOL-ACET,PHARMASCIENCE INC,TRAMADOL-ACET,TRAMADOL HYDROCHLORIDE ACETAMINOPHEN,37.5MG 325MG,60,ORAL,Resolved,TABLET,N02AJ,,,2017/3/23,2017/5/1,2017/5/1,Delay in shipping of the drug.,2017/3/24,2017/12/19,No
4288,2401657,Shortage,PMS-TRAMADOL-ACET,PHARMASCIENCE INC,TRAMADOL-ACET,TRAMADOL HYDROCHLORIDE ACETAMINOPHEN,37.5MG 325MG,100,ORAL,Resolved,TABLET,N02AJ,,,2017/3/23,2017/5/1,2017/5/1,Delay in shipping of the drug.,2017/3/24,2017/12/19,No
10683,2237339,Shortage,PMS-TRAZODONE,PHARMASCIENCE INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,75MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2017/7/4,2017/7/4,2018/4/20,2018/4/17,Disruption of the manufacture of the drug.,2017/5/18,2018/4/19,No
13138,2273497,Shortage,PMS-URSODIOL C,PHARMASCIENCE INC,URSODIOL,URSODIOL,250MG,100,ORAL,Resolved,TABLET,A05AA,BILE THERAPY,2017/7/10,2017/7/10,2017/7/28,2017/7/28,Disruption of the manufacture of the drug.,2017/6/16,2017/12/19,No
17100,2273497,Shortage,PMS-URSODIOL C,PHARMASCIENCE INC,URSODIOL,URSODIOL,250MG,100,ORAL,Resolved,TABLET,A05AA,BILE THERAPY,,2017/7/1,,2018/5/4,Disruption of the manufacture of the drug.,2017/7/25,2018/5/5,No
17103,2273500,Shortage,PMS-URSODIOL C,PHARMASCIENCE INC,URSODIOL,URSODIOL,500MG,100,ORAL,Resolved,TABLET,A05AA,BILE THERAPY,,2017/7/1,2017/10/18,2017/10/23,Disruption of the manufacture of the drug.,2017/7/25,2017/10/26,No
21731,2273497,Shortage,PMS-URSODIOL C,PHARMASCIENCE INC,URSODIOL,URSODIOL,250MG,500,ORAL,Resolved,TABLET,A05AA,BILE THERAPY,2017/10/19,2017/11/8,2017/12/22,2017/11/14,Disruption of the manufacture of the drug.,2017/9/8,2017/11/17,No
8967,2381230,Shortage,PMS-VALACYCLOVIR,PHARMASCIENCE INC,VALACYCLOVIR,VALACYCLOVIR,1000MG,21,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017/5/18,,2017/6/16,2017/7/6,Disruption of the manufacture of the drug.,2017/5/4,2017/7/7,No
22824,2381230,Shortage,PMS-VALACYCLOVIR,PHARMASCIENCE INC,VALACYCLOVIR,VALACYCLOVIR,1000MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/9/15,,2017/12/12,Disruption of the manufacture of the drug.,2017/9/19,2017/12/14,No
7532,2298457,Shortage,PMS-VALACYCLOVIR,PHARMASCIENCE INC,VALACYCLOVIR,VALACYCLOVIR,500MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017/5/23,2017/5/23,,2017/10/2,Disruption of the manufacture of the drug.,2017/4/20,2017/10/11,No
10686,2381230,Shortage,PMS-VALACYCLOVIR,PHARMASCIENCE INC,VALACYCLOVIR,VALACYCLOVIR,1000MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017/5/17,,,2017/6/14,Disruption of the manufacture of the drug.,2017/5/18,2017/6/16,No
21734,2230768,Shortage,PMS-VALPROIC ACID,PHARMASCIENCE INC,VALPROIC ACID,VALPROIC ACID,250MG,100,ORAL,Resolved,CAPSULE,N03AG,ANTIEPILEPTICS,,2017/11/8,2018/4/4,2018/4/17,Disruption of the manufacture of the drug.,2017/9/8,2018/4/19,No
6023,2229628,Shortage,PMS-VALPROIC ACID E.C.,PHARMASCIENCE INC,VALPROIC ACID,VALPROIC ACID,500MG,100,ORAL,Resolved,CAPSULE (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2017/4/5,2018/8/30,2018/8/23,Disruption of the manufacture of the drug.,2017/4/7,2018/8/24,No
6027,2229628,Shortage,PMS-VALPROIC ACID E.C.,PHARMASCIENCE INC,VALPROIC ACID,VALPROIC ACID,500MG,500,ORAL,Resolved,CAPSULE (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2017/4/5,,2020/6/9,Disruption of the manufacture of the drug.,2017/4/7,2020/6/10,No
1974,2229628,Shortage,PMS-VALPROIC ACID E.C.,PHARMASCIENCE INC,Valproic Acid,VALPROIC ACID,500MG,500,ORAL,Resolved,CAPSULE (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2016/2/24,2017/3/30,2017/3/30,Requirements related to complying with good manufacturing practices.,2017/3/13,2017/12/19,No
1979,2229628,Shortage,PMS-VALPROIC ACID E.C.,PHARMASCIENCE INC,Valproic Acid,VALPROIC ACID,500MG,100,ORAL,Resolved,CAPSULE (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2016/3/23,2017/3/30,2017/3/30,Requirements related to complying with good manufacturing practices.,2017/3/13,2017/3/31,No
4291,2229628,Shortage,PMS-VALPROIC ACID E.C.,PHARMASCIENCE INC,VALPROIC ACID,VALPROIC ACID,500MG,500,ORAL,Resolved,CAPSULE (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2017/3/23,2017/7/8,2017/7/8,Disruption of the manufacture of the drug.,2017/3/24,2017/12/19,No
1924,2241821,Shortage,PMS-VANCOMYCIN 1 G,PHARMASCIENCE INC,Vancomycin,VANCOMYCIN,1.0G,1g,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2012/3/23,,2020/4/1,Disruption of the manufacture of the drug.,2017/3/13,2020/4/2,No
1921,2241820,Shortage,PMS-VANCOMYCIN 500 MG,PHARMASCIENCE INC,Vancomycin,VANCOMYCIN,500MG,10,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2012/3/23,,2020/4/1,Disruption of the manufacture of the drug.,2017/3/13,2020/4/2,No
6849,2278561,Shortage,PMS-VENLAFAXINE XR,PHARMASCIENCE INC,VENLAFAXINE,VENLAFAXINE,150MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019/12/13,,2022/6/27,Disruption of the manufacture of the drug.,2017/4/13,2022/7/25,No
6852,2278545,Shortage,PMS-VENLAFAXINE XR,PHARMASCIENCE INC,VENLAFAXINE,VENLAFAXINE,37.5MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017/4/10,,2022/6/27,Disruption of the manufacture of the drug.,2017/4/13,2022/7/25,No
6855,2278545,Shortage,PMS-VENLAFAXINE XR,PHARMASCIENCE INC,PMS-VENLAFAXINE,VENLAFAXINE,37.5MG,500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017/4/10,,2019/7/29,Disruption of the manufacture of the drug.,2017/4/13,2019/7/31,No
6859,2278553,Shortage,PMS-VENLAFAXINE XR,PHARMASCIENCE INC,VENLAFAXINE,VENLAFAXINE,75MG,500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019/7/30,,2022/6/27,Disruption of the manufacture of the drug.,2017/4/13,2022/7/25,No
6862,2278561,Shortage,PMS-VENLAFAXINE XR,PHARMASCIENCE INC,VENLAFAXINE,VENLAFAXINE,150MG,500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017/4/10,2022/6/27,2022/6/27,Disruption of the manufacture of the drug.,2017/4/13,2022/7/25,No
6868,2278553,Shortage,PMS-VENLAFAXINE XR,PHARMASCIENCE INC,VENLAFAXINE,VENLAFAXINE,75MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019/7/30,,2022/6/27,Disruption of the manufacture of the drug.,2017/4/13,2022/7/25,No
25819,2237791,Shortage,PMS-VERAPAMIL SR,PHARMASCIENCE INC,VERAPAMIL,VERAPAMIL HYDROCHLORIDE,240MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/10/1,2017/11/2,2017/11/14,Disruption of the manufacture of the drug.,2017/10/12,2017/11/17,No
22828,2324229,Shortage,PMS-ZOLMITRIPTAN,PHARMASCIENCE INC,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,30,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/9/15,2017/11/1,2017/11/8,Disruption of the manufacture of the drug.,2017/9/19,2017/11/9,No
25823,2324229,Shortage,PMS-ZOLMITRIPTAN,PHARMASCIENCE INC,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/10/1,2017/11/6,2017/12/4,Disruption of the manufacture of the drug.,2017/10/12,2017/12/8,No
10674,2324768,Shortage,PMS-ZOLMITRIPTAN ODT,PHARMASCIENCE INC,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2017/7/11,2017/7/11,2018/12/21,2018/12/11,Disruption of the manufacture of the drug.,2017/5/18,2018/12/12,No
21739,2243426,Shortage,PMS-ZOPICLONE,PHARMASCIENCE INC,ZOPICLONE,ZOPICLONE,5MG,100,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,,2017/9/4,,2017/12/7,Disruption of the manufacture of the drug.,2017/9/8,2017/12/14,No
8303,2375893,Shortage,POLYMYXIN B FOR INJECTION USP,STERIMAX INC,POLYMYXIN B FOR INJECTION USP,POLYMYXIN B,50MG,1 VIAL,"INTRAMUSCULAR
INTRATHECAL
INTRAVENOUS
OPHTHALMIC",Actual shortage,POWDER FOR SOLUTION,J01XB,OTHER ANTIBACTERIALS,,2017/1/17,,,Other (Please describe in comments),2017/4/27,2017/10/5,No
29189,1942921,Shortage,POLYTOPIC,SANDOZ CANADA INCORPORATED,POLYTOPIC,BACITRACIN POLYMYXIN B,500UNIT 10000UNIT,15G,TOPICAL,Resolved,OINTMENT,D06AX,ANTIBIOTICS FOR TOPICAL USE,,2017/9/4,,2018/8/8,Requirements related to complying with good manufacturing practices.,2017/11/14,2020/4/1,No
20789,155225,Shortage,PONSTAN,AA PHARMA INC,Ponstan,MEFENAMIC ACID,250MG,100 BTL,ORAL,Resolved,CAPSULE,M01AG,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/9/1,,2020/7/28,Disruption of the manufacture of the drug.,2017/9/1,2020/7/29,No
849,2293404,Shortage,POSANOL,MERCK CANADA INC,Posaconazole Oral Suspension,POSACONAZOLE,40MG/ML,105ML,ORAL,Resolved,ORAL SUSPENSION,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,2016/12/8,2016/12/8,2017/3/24,2017/3/22,Demand increase for the drug.,2017/3/13,2017/3/23,No
9057,786306,Shortage,POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR,BAXTER CORPORATION,40 mmol Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Injection USP,DEXTROSE POTASSIUM CHLORIDE SODIUM CHLORIDE,5G 300MG 900MG,1000mL,INTRAVENOUS,Resolved,SOLUTION,B05BB,I.V. SOLUTIONS,2017/5/1,2017/5/1,2017/9/25,2017/9/25,Delay in shipping of the drug.,2017/5/4,2017/9/26,No
21765,2362597,Shortage,POTASSIUM ACETATE INJECTION USP,OMEGA LABORATORIES LTD,Potassium Acetate,POTASSIUM ACETATE,39.20%,10 x 50mL vial,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2017/10/13,2017/10/5,2017/12/1,2017/11/20,Disruption of the manufacture of the drug.,2017/9/8,2017/11/21,No
10000,2139545,Shortage,"POTASSIUM PHOSPHATES INJECTION, USP",FRESENIUS KABI CANADA LTD,Potassium Phosphate,POTASSIUM PHOSPHATE DIBASIC POTASSIUM PHOSPHATE MONOBASIC,236MG 224MG,50mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2017/5/12,,2017/6/9,2017/5/26,Delay in shipping of the drug.,2017/5/10,2017/5/27,No
28229,2309122,Shortage,PRAMIPEXOLE,SIVEM PHARMACEUTICALS ULC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2017/10/30,2018/11/30,2018/12/3,Other (Please describe in comments),2017/11/6,2018/12/4,No
25160,2325810,Shortage,PRAMIPEXOLE,PRO DOC LIMITEE,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.50MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018/8/21,,2018/12/20,Delay in shipping of the drug.,2017/10/10,2018/12/21,No
28232,2309130,Shortage,PRAMIPEXOLE,SIVEM PHARMACEUTICALS ULC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017/11/10,2017/11/6,2019/1/11,2019/1/11,Other (Please describe in comments),2017/11/6,2019/1/14,No
11376,2367610,Shortage,PRAMIPEXOLE,SANIS HEALTH INC,PRAMIPEXOLE TABS,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017/5/26,2017/5/26,2017/6/16,2017/6/7,Other (Please describe in comments),2017/5/26,2017/6/8,No
29904,2325802,Shortage,PRAMIPEXOLE,PRO DOC LIMITEE,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018/8/3,,2018/12/24,Delay in shipping of the drug.,2017/11/21,2018/12/25,No
28893,2309157,Shortage,PRAMIPEXOLE,SIVEM PHARMACEUTICALS ULC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.5MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017/11/27,2017/12/2,2018/12/4,2018/12/3,Other (Please describe in comments),2017/11/10,2018/12/4,No
28092,2389746,Shortage,PRAVASTATIN,SIVEM PHARMACEUTICALS ULC,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/9/20,2018/3/2,2018/3/9,Other (Please describe in comments),2017/11/6,2018/3/26,No
28267,2403692,Shortage,PREGABALIN,SIVEM PHARMACEUTICALS ULC,PREGABALIN,PREGABALIN,25MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/10/11,2017/12/22,2017/12/22,Other (Please describe in comments),2017/11/6,2018/1/18,No
28273,2403692,Shortage,PREGABALIN,SIVEM PHARMACEUTICALS ULC,PREGABALIN,PREGABALIN,25MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/11/20,2017/12/4,,2018/6/29,Other (Please describe in comments),2017/11/6,2018/6/30,No
28276,2403706,Shortage,PREGABALIN,SIVEM PHARMACEUTICALS ULC,PREGABALIN,PREGABALIN,50MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/10/15,2017/12/22,2017/12/22,Other (Please describe in comments),2017/11/6,2018/1/18,No
32628,2403722,Shortage,PREGABALIN,SIVEM PHARMACEUTICALS ULC,PREGABALIN,PREGABALIN,150MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/12/11,2017/12/22,2017/12/22,Other (Please describe in comments),2017/12/12,2018/1/18,No
28279,2403706,Shortage,PREGABALIN,SIVEM PHARMACEUTICALS ULC,PREGABALIN,PREGABALIN,50MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/12/18,,,2017/12/22,Other (Please describe in comments),2017/11/6,2017/12/23,No
23674,2405547,Shortage,PREGABALIN,SANIS HEALTH INC,PREGABALIN CAP,PREGABALIN,50MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/10/2,,2017/10/23,2017/10/23,Other (Please describe in comments),2017/9/27,2017/10/31,No
20442,2396548,Shortage,PREGABALIN,PRO DOC LIMITEE,PREGABALIN,PREGABALIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/8/28,,2017/8/31,Delay in shipping of the drug.,2017/8/28,2017/9/29,No
18097,2182904,Shortage,PREGNYL,MERCK CANADA INC,chorionic gonadotropin for injection,CHORIONIC GONADOTROPIN WATER,10000UNIT 10ML,10000U VIAL & 10ML SOLVENT,INTRAMUSCULAR,Resolved,"KIT
LIQUID
POWDER FOR SOLUTION",G03GA,GONADOTROPHINS AND OTHER OVULATION STIMULANTS,,2017/8/2,2017/8/18,2017/8/11,Delay in shipping of the drug.,2017/8/2,2017/8/12,No
14413,2043440,Shortage,PREMARIN VAGINAL CREAM,PFIZER CANADA INC,Premarin,CONJUGATED ESTROGENS,0.625MG,Tube 14g,"TOPICAL
VAGINAL",Resolved,CREAM,G03CA,ESTROGENS,2017/6/29,,2017/7/24,2017/7/24,Disruption of the manufacture of the drug.,2017/6/29,2017/7/25,No
22631,2043440,Shortage,PREMARIN VAGINAL CREAM,PFIZER CANADA INC,PREMARIN,CONJUGATED ESTROGENS,0.625MG,14G TUBE,VAGINAL,Resolved,CREAM,G03CA,ESTROGENS,2017/10/9,,2017/11/21,2017/11/21,Disruption of the manufacture of the drug.,2017/9/19,2017/11/22,No
2734,804541,Shortage,PREVEX B CREAM 0.1%,GLAXOSMITHKLINE INC,Betamethasone valerate cream,BETAMETHASONE VALERATE,0.10%,30 g,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2016/7/27,,2017/11/22,Disruption of the manufacture of the drug.,2017/3/14,2020/2/27,No
9580,839396,Shortage,PRINIVIL,MERCK CANADA INC,lisinopril tablets,LISINOPRIL,10MG,28,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017/5/18,2017/5/23,2017/6/1,2017/5/26,Delay in shipping of the drug.,2017/5/8,2017/10/11,No
16777,839396,Shortage,PRINIVIL,MERCK CANADA INC,lisinopril tablets,LISINOPRIL,10MG,28,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017/7/31,2017/8/3,2017/8/18,2017/8/15,Delay in shipping of the drug.,2017/7/24,2017/8/16,No
32398,2427192,Shortage,PRIVA-CETIRIZINE,PHARMAPAR INC,CETIRIZINE,CETIRIZINE HYDROCHLORIDE,20MG,100,ORAL,Resolved,TABLET,R06AE,ANTIHISTAMINES FOR SYSTEMIC USE,2017/12/8,2017/12/8,2019/2/8,2019/2/7,Requirements related to complying with good manufacturing practices.,2017/12/11,2019/2/8,No
27943,2446499,Shortage,PRIVA-IRBESARTAN,PHARMAPAR INC,Priva-IRBESARTAN 75mg,IRBESARTAN,75MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/11/1,2018/4/15,2018/4/9,Shortage of an active ingredient.,2017/11/2,2018/4/10,No
27948,2446693,Shortage,PRIVA-LOSARTAN,PHARMAPAR INC,Priva-LOSARTAN 25mg,LOSARTAN POTASSIUM,25MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/11/1,,,Other (Please describe in comments),2017/11/2,2017/11/2,No
22844,2425378,Shortage,PRIVA-PANTOPRAZOLE,PHARMAPAR INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/7/1,2017/7/1,2017/10/25,2017/10/24,Delay in shipping of the drug.,2017/9/20,2017/10/26,No
22848,2425378,Shortage,PRIVA-PANTOPRAZOLE,PHARMAPAR INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/7/1,2017/7/1,2017/10/6,2017/10/24,Delay in shipping of the drug.,2017/9/20,2017/10/26,No
22864,2447088,Shortage,PRIVA-QUETIAPINE,PHARMAPAR INC,QUETIAPINE,QUETIAPINE,25MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2017/9/15,2017/9/15,2017/12/1,2017/12/1,Delay in shipping of the drug.,2017/9/20,2017/12/4,No
22867,2447096,Shortage,PRIVA-QUETIAPINE,PHARMAPAR INC,QUETIAPINE,QUETIAPINE,100MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,2017/8/24,2017/8/24,,,Delay in shipping of the drug.,2017/9/20,2017/10/26,No
27940,2448807,Shortage,PRIVA-SILDENAFIL,PHARMAPAR INC,Priva-SILDENAFIL 100mg,SILDENAFIL,100MG,1X4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/10/27,2018/2/7,2018/1/24,Delay in shipping of the drug.,2017/11/2,2018/1/25,No
22852,2441861,Shortage,PRIVA-VALACYCLOVIR,PHARMAPAR INC,VALACYCLOVIR,VALACYCLOVIR,500MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2016/12/15,2016/12/15,2018/2/15,2018/1/17,Shortage of an active ingredient.,2017/9/20,2018/2/19,No
7676,2441861,Shortage,PRIVA-VALACYCLOVIR,PHARMAPAR INC,VALACYCLOVIR,VALACYCLOVIR,500MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2016/12/15,2016/12/15,2018/1/18,2018/1/17,Delay in shipping of the drug.,2017/4/24,2018/1/18,No
5295,2310600,Shortage,PRO-AZITHROMYCINE,PRO DOC LIMITEE,AZITHROMYCINE,AZITHROMYCIN,250MG,6,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/4/3,,2017/7/13,Delay in shipping of the drug.,2017/4/4,2017/7/14,No
21223,2311038,Shortage,PRO-BICALUTAMIDE - 50,PRO DOC LIMITEE,BICALUTAMIDE,BICALUTAMIDE,50MG,30,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017/9/5,,2018/5/31,Delay in shipping of the drug.,2017/9/7,2018/6/4,No
22067,2311607,Shortage,PRO-CLONAZEPAM,PRO DOC LIMITEE,CLONAZEPAM,CLONAZEPAM,1MG,500,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2017/9/13,,2017/12/7,Delay in shipping of the drug.,2017/9/13,2017/12/8,No
32848,2311437,Shortage,PRO-ENALAPRIL - 20,PRO DOC LIMITEE,ENALAPRIL,ENALAPRIL MALEATE,20MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/12/14,,2018/1/10,Delay in shipping of the drug.,2017/12/14,2018/1/11,No
32241,2311399,Shortage,PRO-LEVETIRACETAM - 750,PRO DOC LIMITEE,LEVETIRACETAM,LEVETIRACETAM,750MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/12/8,2018/1/3,2017/12/22,Delay in shipping of the drug.,2017/12/8,2017/12/23,No
2324,655643,Shortage,PRO-LORAZEPAM TAB 0.5MG,PRO DOC LIMITEE,LORAZEPAM,LORAZEPAM,0.5MG,500,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018/12/4,,2019/2/7,Delay in shipping of the drug.,2017/3/14,2019/2/8,No
14341,2312778,Shortage,PRO-MIRTAZAPINE,PRO DOC LIMITEE,MIRTAZAPINE,MIRTAZAPINE,15MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017/7/12,,2018/11/20,Delay in shipping of the drug.,2017/6/29,2018/11/21,No
20226,2312727,Shortage,PRO-RISPERIDONE,PRO DOC LIMITEE,PRO-RISPERIDONE,RISPERIDONE,1.0MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017/8/24,,2017/9/21,Delay in shipping of the drug.,2017/8/24,2017/9/22,No
9735,2312735,Shortage,PRO-RISPERIDONE,PRO DOC LIMITEE,RISPERIDONE,RISPERIDONE,2.0MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2017/7/20,,,2017/7/21,Delay in shipping of the drug.,2017/5/9,2017/7/31,No
21239,2312700,Shortage,PRO-RISPERIDONE,PRO DOC LIMITEE,RISPERIDONE,RISPERIDONE,0.25MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017/9/5,,2017/11/8,Delay in shipping of the drug.,2017/9/7,2017/11/9,No
25689,2316528,Shortage,PRO-SOTALOL,PRO DOC LIMITEE,SOTALOL,SOTALOL HYDROCHLORIDE,80MG,100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2017/10/11,,2017/11/24,Delay in shipping of the drug.,2017/10/12,2017/11/25,No
19395,2316536,Shortage,PRO-SOTALOL,PRO DOC LIMITEE,SOTALOL,SOTALOL HYDROCHLORIDE,160MG,100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2017/8/14,2017/12/21,2017/12/19,Delay in shipping of the drug.,2017/8/15,2017/12/20,No
26146,2313650,Shortage,PRO-TOPIRAMATE,PRO DOC LIMITEE,TOPIRAMATE,TOPIRAMATE,25MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/10/17,,2017/11/7,Delay in shipping of the drug.,2017/10/17,2017/11/8,No
30115,2313677,Shortage,PRO-TOPIRAMATE,PRO DOC LIMITEE,TOPIRAMATE,TOPIRAMATE,200MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/11/22,,2018/2/7,Delay in shipping of the drug.,2017/11/22,2018/2/8,No
22984,2313669,Shortage,PRO-TOPIRAMATE,PRO DOC LIMITEE,TOPIRAMATE,TOPIRAMATE,100MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/9/21,,2017/10/10,Delay in shipping of the drug.,2017/9/21,2017/10/12,No
9709,2315173,Shortage,PRO-VALACYCLOVIR,PRO DOC LIMITEE,PRO-VALACYCLOVIR,VALACYCLOVIR,500MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/7/5,,2017/10/5,Delay in shipping of the drug.,2017/5/9,2017/10/6,No
2559,2184486,Shortage,PROCAINAMIDE HYDROCHLORIDE INJ. USP,SANDOZ CANADA INCORPORATED,PROCAINAMIDE,PROCAINAMIDE,100mg/mL,10x10mLV,Intra,Resolved,INJ,C01BA,"ANTIARRHYTHMICS, CLASS I AND III",2017/3/14,,2017/8/18,2017/8/18,Demand increase for the drug.,2017/3/14,2017/10/25,No
3773,638692,Shortage,PROCAN SR,ERFA CANADA 2012 INC,Procainamide,PROCAINAMIDE HYDROCHLORIDE,250MG,bottle of 100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C01BA,"ANTIARRHYTHMICS, CLASS I AND III",2013/9/17,2013/9/17,,,Other (Please describe in comments),2017/3/21,2018/3/14,No
7313,886432,Shortage,PROCHLORAZINE,AA PHARMA INC,PROCHLORAZINE,PROCHLORPERAZINE,10MG,100 Bottle,ORAL,Resolved,TABLET,N05AB,ANTIPSYCHOTICS,2017/4/21,,2017/6/2,2017/5/11,Demand increase for the drug.,2017/4/20,2017/9/5,No
2030,886432,Shortage,PROCHLORAZINE,AA PHARMA INC,PROCHLORAZINE,PROCHLORPERAZINE (PROCHLORPERAZINE MALEATE),10 MG,100 Bottle,Oral,Resolved,Tablet,N05AB,ANTIPSYCHOTICS,,2016/5/4,2017/3/17,2017/3/17,Shortage of an active ingredient.,2017/3/14,2017/3/25,No
2033,886440,Shortage,PROCHLORAZINE,AA PHARMA INC,PROCHLORAZINE,PROCHLORPERAZINE,5MG,100 Bottle,ORAL,Resolved,TABLET,N05AB,ANTIPSYCHOTICS,,2016/5/17,2017/3/17,2017/3/17,Shortage of an active ingredient.,2017/3/14,2017/3/25,No
18028,363014,Shortage,PROCTOFOAM HC,DUCHESNAY INC,Proctofoam HC,PRAMOXINE HYDROCHLORIDE HYDROCORTISONE ACETATE,1% 1%,22.4g,RECTAL,Resolved,AEROSOL,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,,2017/8/17,,2020/8/10,Disruption of the manufacture of the drug.,2017/8/2,2020/8/11,No
5285,2223260,Shortage,PROCTOSEDYL SUPPOSITORIES,APTALIS PHARMA CANADA ULC,PrPROCTOSEDYL® 0.5% Suppositories,DIBUCAINE HYDROCHLORIDE HYDROCORTISONE FRAMYCETIN SULFATE ESCULIN,5MG 5MG 10MG 10MG,12 and 24 suppositories,RECTAL,Resolved,SUPPOSITORY,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,,2013/3/1,,2017/4/5,Other (Please describe in comments),2017/4/4,2019/3/5,No
5778,2241795,Shortage,PROCYTOX TAB 25MG,BAXTER CORPORATION,Cyclophosphamide,CYCLOPHOSPHAMIDE,25MG,25mg tablets,ORAL,Resolved,TABLET,L01AA,ALKYLATINGAGENTS,2017/4/6,2017/4/6,2017/8/28,2017/8/28,Demand increase for the drug.,2017/4/6,2017/8/29,No
31940,503347,Shortage,PROGLYCEM,MERCK CANADA INC,Diazoxide capsules,DIAZOXIDE,100MG,100 caps,ORAL,Resolved,CAPSULE,V03AH,ALL OTHER THERAPEUTIC PRODUCTS,2018/1/2,2017/12/21,2018/1/26,2018/1/24,Delay in shipping of the drug.,2017/12/6,2018/1/25,No
13158,2439123,Shortage,PROLENSA,BAUSCH & LOMB INC,PROLENSA,Bromfenac,0.07%,N/A,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,,2017/6/14,2017/7/1,2017/3/1,Other (Please describe in comments),2017/6/16,2018/3/13,No
11754,2439123,Shortage,PROLENSA,BAUSCH & LOMB INC,Prolensa,Bromfenac,0.07%,n/a,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,2017/4/26,,2017/6/16,2017/6/9,Other (Please describe in comments),2017/6/2,2017/6/16,No
9713,2229736,Shortage,PRONAL TABLETS,PRO DOC LIMITEE,PRONAL,ACETYLSALICYLIC ACID BUTALBITAL CAFFEINE,330MG 50MG 40MG,100,ORAL,Resolved,TABLET,N02BA,OTHER ANALGESICS AND ANTIPYRETICS,,2017/5/24,,2018/5/30,Other (Please describe in comments),2017/5/9,2018/5/31,No
32539,2343061,Shortage,PROPAFENONE,SANIS HEALTH INC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,300MG,100,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",2017/12/12,2017/12/15,2018/3/16,2018/3/7,Delay in shipping of the drug.,2017/12/12,2018/3/8,No
26243,2343053,Shortage,PROPAFENONE,SANIS HEALTH INC,PROPARENONE,PROPAFENONE HYDROCHLORIDE,150MG,100,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",2017/10/27,2017/11/3,2018/3/16,2018/3/7,Disruption of the manufacture of the drug.,2017/10/18,2018/3/8,No
28294,2238213,Shortage,PROPECIA,MERCK CANADA INC,Finasteride tablets,FINASTERIDE,1MG,28 Tabs,ORAL,Resolved,TABLET,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,2018/1/5,2018/1/5,2018/2/16,2018/2/16,Delay in shipping of the drug.,2017/11/6,2018/2/17,No
29055,2399229,Shortage,PROQUAD,MERCK CANADA INC,"measles, mumps, rubella and varicella virus vaccine live Lyophilized powder for injection",MUMPS VIRUS VACCINE LIVE ATTENUATED VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED,4.30Log10 TCID50 3.99Log10 PFU 3.00Log10 TCID50 3.00Log10 TCID50,0.5ML 10 X 1 DOSE VIAL,SUBCUTANEOUS,Avoided shortage,POWDER FOR SOLUTION,J07BD,VIRAL VACCINES,2017/12/1,,2017/12/8,2017/11/30,Delay in shipping of the drug.,2017/11/13,2017/11/30,No
16290,2231674,Shortage,PROTAMINE SULFATE INJECTION USP,SANDOZ CANADA INCORPORATED,PROTAMINE,PROTAMINE SULFATE,10MG,25ML VIAL,INTRAVENOUS,Resolved,SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,2017/7/19,,2017/7/31,2017/7/28,Delay in shipping of the drug.,2017/7/18,2017/8/2,No
23849,729973,Shortage,PROVERA 10MG TABLETS,PFIZER CANADA INC,Provera,MEDROXYPROGESTERONE ACETATE,10MG,100’s,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,2017/10/10,,2017/10/31,2017/10/27,Disruption of the manufacture of the drug.,2017/9/28,2017/10/30,No
1652,466409,Shortage,PULMOPHYLLINE ELX,LABORATOIRE RIVA INC,Theophylline oral solution USP,THEOPHYLLINE,80MG,1,ORAL,Actual shortage,ELIXIR,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2014/4/11,2014/4/11,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1616,513741,Shortage,PULMORPHAN,LABORATOIRE RIVA INC,"Dextromethorpan hydrobromide, guaifenesin, pheniramine maleate and phenylephrine hydrochloride syrup",DEXTROMETHORPHAN HYDROBROMIDE PHENYLEPHRINE HYDROCHLORIDE PHENIRAMINE MALEATE GUAIFENESIN,10MG 3.75MG 7.5MG 50MG,250 ml,ORAL,Actual shortage,SYRUP,R05FA,"COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS",2014/4/11,2014/4/11,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1623,590282,Shortage,PULMORPHAN PEDIATRIQUE,LABORATOIRE RIVA INC,"Dextromethorpan hydrobromide, pheniramine maleate and phenylephrine hydrochloride syrup",DEXTROMETHORPHAN HYDROBROMIDE PHENYLEPHRINE HYDROCHLORIDE PHENIRAMINE MALEATE,5MG 2MG 5MG,175 ml,ORAL,Actual shortage,SYRUP,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,2014/4/11,2014/4/11,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
17167,2243948,Shortage,PUREGON,MERCK CANADA INC,follitropin beta Solution for injection-cartriges,FOLLITROPIN BETA,833UNIT,900IU/1.08ML 1CARTRIDGE,SUBCUTANEOUS,Resolved,SOLUTION,G03GA,GONADOTROPHINS AND OTHER OVULATION STIMULANTS,,2017/7/26,2017/9/29,2017/9/26,Delay in shipping of the drug.,2017/7/25,2017/9/27,No
1586,2242441,Shortage,PUREGON,MERCK CANADA INC,follitropin beta solution for injection (rec FSH),FOLLITROPIN BETA,100UNIT,5,"INTRAMUSCULAR
SUBCUTANEOUS",Resolved,SOLUTION,G03GA,GONADOTROPHINS AND OTHER OVULATION STIMULANTS,2016/10/26,2016/10/26,2017/3/17,2017/3/15,Delay in shipping of the drug.,2017/3/13,2017/3/16,No
16077,2243948,Shortage,PUREGON,MERCK CANADA INC,follitropin beta Solution for injection-cartriges,FOLLITROPIN BETA,833UNIT,600IU/0.72ML,SUBCUTANEOUS,Resolved,SOLUTION,G03GA,GONADOTROPHINS AND OTHER OVULATION STIMULANTS,,2017/7/21,,2017/9/11,Other (Please describe in comments),2017/7/17,2017/9/12,No
2392,476714,Shortage,PYRIDIUM 100MG,ERFA CANADA 2012 INC,"Phenazopyridine Hydrochloride,USP",PHENAZOPYRIDINE HYDROCHLORIDE,100MG,bottle,ORAL,Actual shortage,TABLET,G04BX,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/2/9,2017/2/9,,,Shortage of an active ingredient.,2017/3/14,2017/12/12,No
2378,476722,Shortage,PYRIDIUM 200MG,ERFA CANADA 2012 INC,"Phenazopyridine Hydrochloride,USP",PHENAZOPYRIDINE HYDROCHLORIDE,200MG,bottle,ORAL,Actual shortage,TABLET,G04BX,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/2/9,2017/2/9,,,Shortage of an active ingredient.,2017/3/14,2017/12/12,No
238,2245215,Shortage,"PYRIDOXINE HYDROCHLORIDE INJECTION, USP",MYLAN PHARMACEUTICALS ULC,Pyridoxine,PYRIDOXINE HYDROCHLORIDE,100MG,1VL,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,A11HA,OTHER PLAIN VITAMIN PREPARATIONS,2018/7/3,2018/7/3,,2018/8/3,Disruption of the manufacture of the drug.,2017/3/10,2018/8/7,No
1317,2230946,Shortage,QUADRACEL,SANOFI PASTEUR LIMITED,Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine,"DIPHTHERIA TOXOID FILAMENTOUS HAEMAGGLUTININ FIMBRIAE INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 1 MAHONEY INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 2 MEF1 INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 3 SAUKETT PERTACTIN PERTUSSIS TOXOID	 TETANUS TOXOID",15 LF / 0.5 ML 20 MCG / 0.5 ML 5 MCG / 0.5 ML 8 UNIT / 0.5 ML 3 MCG / 0.5 ML 20 MCG / 0.5 ML 5 LF / 0.5 ML,"5 x 0.5 mL vials / 5 fioles de 0,5 mL",Intramuscular,Resolved,Suspension,J07CA,"BACTERIAL AND VIRAL VACCINES, COMBINED",2015/5/31,,,2017/8/3,Demand increase for the drug.,2017/3/13,2020/7/23,No
8290,2417383,Shortage,QUETIAPINE XR,SIVEM PHARMACEUTICALS ULC,QUETIAPINE XR,QUETIAPINE,300MG,60,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,2017/5/17,,2017/6/15,2017/5/1,Demand increase for the drug.,2017/4/27,2017/5/18,No
32631,2417359,Shortage,QUETIAPINE XR,SIVEM PHARMACEUTICALS ULC,QUETIAPINE XR,QUETIAPINE,50MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017/11/20,,2018/3/16,Other (Please describe in comments),2017/12/12,2018/3/26,No
32634,2417367,Shortage,QUETIAPINE XR,SIVEM PHARMACEUTICALS ULC,QUETIAPINE XR,QUETIAPINE,150MG,60,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,2018/4/19,,,2018/3/16,Other (Please describe in comments),2017/12/12,2018/3/26,No
28287,2417383,Shortage,QUETIAPINE XR,SIVEM PHARMACEUTICALS ULC,QUETIAPINE XR,QUETIAPINE,300MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017/10/23,,2018/3/16,Other (Please describe in comments),2017/11/6,2018/3/26,No
32639,2417375,Shortage,QUETIAPINE XR,SIVEM PHARMACEUTICALS ULC,QUETIAPINE XR,QUETIAPINE,200MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,2018/1/1,2017/12/29,,2018/3/16,Other (Please describe in comments),2017/12/12,2018/3/26,No
32643,2417391,Shortage,QUETIAPINE XR,SIVEM PHARMACEUTICALS ULC,QUETIAPINE XR,QUETIAPINE,400MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,2018/2/12,2018/2/14,,2018/3/16,Other (Please describe in comments),2017/12/12,2018/3/26,No
19405,2417782,Shortage,QUETIAPINE XR,PRO DOC LIMITEE,QUETIAPINE XR,QUETIAPINE,50MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017/8/10,,2017/8/18,Delay in shipping of the drug.,2017/8/15,2017/8/19,No
14344,2415925,Shortage,QUINAPRIL,PRO DOC LIMITEE,QUINAPRIL,QUINAPRIL,10MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/7/27,,2018/7/26,Other (Please describe in comments),2017/6/29,2018/7/27,No
14379,2415917,Shortage,QUINAPRIL,PRO DOC LIMITEE,QUINAPRIL,QUINAPRIL,5MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/8/31,,2018/7/26,Other (Please describe in comments),2017/6/29,2018/7/27,No
14382,2415933,Shortage,QUINAPRIL,PRO DOC LIMITEE,QUINAPRIL,QUINAPRIL,20MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/8/21,,2018/7/26,Other (Please describe in comments),2017/6/29,2018/7/27,No
20068,2415941,Shortage,QUINAPRIL,PRO DOC LIMITEE,QUINAPRIL,QUINAPRIL,40MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/11/29,,2018/7/26,Delay in shipping of the drug.,2017/8/22,2018/7/27,No
34043,695432,Shortage,QUININE - ODAN,ODAN LABORATORIES LTD,"Quinine Sulfate Tablets, USP",QUININE SULFATE,300MG,100,ORAL,Avoided shortage,TABLET,P01BC,ANTIMALARIALS,2018/8/1,,,2018/4/25,Disruption of the manufacture of the drug.,2017/12/20,2018/4/25,No
11354,2242029,Shortage,QVAR,VALEANT CANADA LP/VALEANT CANADA S.E.C.,QVAR,BECLOMETHASONE DIPROPIONATE,50MCG,NA,INHALATION,Resolved,METERED-DOSE AEROSOL,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017/5/26,,2017/6/22,Other (Please describe in comments),2017/5/26,2017/6/23,No
11357,2242030,Shortage,QVAR,VALEANT CANADA LP/VALEANT CANADA S.E.C.,QVAR,BECLOMETHASONE DIPROPIONATE,100MCG,NA,INHALATION,Resolved,METERED-DOSE AEROSOL,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017/5/25,,2017/6/22,Other (Please describe in comments),2017/5/26,2017/6/23,No
3285,2267667,Shortage,RABAVERT,GLAXOSMITHKLINE INC,Rabies vaccine,RABIES VACCINE INACTIVATED,2.5UNIT,1's,INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,J07BG,VIRAL VACCINES,,2017/3/27,2017/8/31,2017/8/30,Demand increase for the drug.,2017/3/17,2017/8/31,No
22150,2299194,Shortage,RALIVIA,VALEANT CANADA LP/VALEANT CANADA S.E.C.,RALIVIA,TRAMADOL HYDROCHLORIDE,100MG,na,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,,2017/9/15,,2017/9/22,Other (Please describe in comments),2017/9/15,2017/9/25,No
22155,2299208,Shortage,RALIVIA,VALEANT CANADA LP/VALEANT CANADA S.E.C.,RALIVIA,TRAMADOL HYDROCHLORIDE,200MG,na,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,,2017/9/15,,2017/9/22,Other (Please describe in comments),2017/9/15,2017/9/25,No
22158,2299216,Shortage,RALIVIA,VALEANT CANADA LP/VALEANT CANADA S.E.C.,RALIVIA,TRAMADOL HYDROCHLORIDE,300MG,na,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,,2017/9/15,,2017/9/22,Other (Please describe in comments),2017/9/15,2017/9/25,No
5632,2287935,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,5MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/5/20,2017/5/20,2018/7/23,2018/7/6,Other (Please describe in comments),2017/4/5,2018/7/10,No
5635,2287935,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,5MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/4/16,2017/4/16,2018/4/27,2018/4/27,Requirements related to complying with good manufacturing practices.,2017/4/5,2018/4/30,No
5638,2287935,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,5MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/4/24,2017/4/24,2018/4/27,2018/4/27,Other (Please describe in comments),2017/4/5,2018/4/30,No
5641,2287943,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,10MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/5/15,2017/5/15,2018/7/23,2018/7/6,Requirements related to complying with good manufacturing practices.,2017/4/5,2018/7/10,No
5644,2287943,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,10MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/4/25,2017/4/25,2018/4/27,2018/4/27,Other (Please describe in comments),2017/4/5,2018/4/30,No
5649,2287943,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,10MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/4/28,2017/4/28,2018/4/27,2018/4/27,Requirements related to complying with good manufacturing practices.,2017/4/5,2018/4/30,No
22588,2255316,Shortage,RAMIPRIL,LABORATOIRE RIVA INC,Ramipril 2.5mg,RAMIPRIL,2.5MG,30UD + 100 + 500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/9/19,2017/9/19,2018/5/31,2018/6/20,Disruption of the manufacture of the drug.,2017/9/19,2018/7/10,No
22591,2255324,Shortage,RAMIPRIL,LABORATOIRE RIVA INC,Ramipril 5mg,RAMIPRIL,5MG,30 UD + 100 + 500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/9/19,2017/9/19,2018/5/31,2018/6/20,Disruption of the manufacture of the drug.,2017/9/19,2018/7/10,No
8432,2299372,Shortage,RAMIPRIL,LABORATOIRE RIVA INC,Ramipril,RAMIPRIL,1.25MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/4/28,2017/4/28,2018/5/31,2018/6/20,Disruption of the manufacture of the drug.,2017/4/28,2018/7/10,No
5620,2308363,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,1.25MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/5/17,2017/5/17,2018/4/27,2018/4/27,Requirements related to complying with good manufacturing practices.,2017/4/5,2018/4/30,No
5623,2287927,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,2.5MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/5/21,2017/5/21,2018/7/2,2018/7/6,Requirements related to complying with good manufacturing practices.,2017/4/5,2018/7/10,No
5626,2287927,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,2.5MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/4/23,2017/4/23,2018/4/27,2018/4/27,Requirements related to complying with good manufacturing practices.,2017/4/5,2018/4/30,No
5629,2287927,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,2.5MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/5/3,2017/5/3,2018/4/27,2018/4/27,Other (Please describe in comments),2017/4/5,2018/4/30,No
9729,2415887,Shortage,RAMIPRIL-HCTZ,PRO DOC LIMITEE,RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE RAMIPRIL,12.5MG 5.0MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017/6/13,,2018/12/21,Other (Please describe in comments),2017/5/9,2018/12/22,No
9732,2415895,Shortage,RAMIPRIL-HCTZ,PRO DOC LIMITEE,RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE RAMIPRIL,12.5MG 10.0MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017/8/8,,2017/8/24,Delay in shipping of the drug.,2017/5/9,2017/10/5,No
25709,2321858,Shortage,RAN-AMLODIPINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-AMLODIPINE,AMLODIPINE,5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2018/7/24,,2018/7/24,2018/8/17,Disruption of the manufacture of the drug.,2017/10/12,2018/8/23,No
33274,2321866,Shortage,RAN-AMLODIPINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-AMLODIPINE,AMLODIPINE,10MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017/12/15,2017/12/15,2018/1/25,2018/8/17,Disruption of the manufacture of the drug.,2017/12/15,2018/8/23,No
12320,2373963,Shortage,RAN-ATENOLOL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ATENOLOL,ATENOLOL,25MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/1/1,2017/1/1,2018/2/23,2018/2/21,Disruption of the manufacture of the drug.,2017/6/8,2019/2/1,No
12326,2267985,Shortage,RAN-ATENOLOL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ATENOLOL,ATENOLOL,50MG,100,ORAL,Avoided shortage,TABLET,C07AB,BETA BLOCKING AGENTS,2017/1/1,2017/8/6,2018/5/31,2017/7/14,Disruption of the manufacture of the drug.,2017/6/8,2019/2/4,No
21964,2267993,Shortage,RAN-ATENOLOL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ATENOLOL,ATENOLOL,100MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018/2/10,2018/2/10,2018/11/9,2018/9/25,Disruption of the manufacture of the drug.,2017/9/12,2019/2/4,No
21955,2303736,Shortage,RAN-CIPROFLOX,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-CIPROFLOX,CIPROFLOXACIN,500MG,100,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,2017/9/12,2017/9/12,2017/9/29,2018/8/17,Disruption of the manufacture of the drug.,2017/9/12,2018/8/23,No
33280,2285622,Shortage,RAN-CITALO,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-CITALO,CITALOPRAM,20MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018/2/10,2018/9/5,2018/11/16,2018/11/16,Delay in shipping of the drug.,2017/12/15,2018/11/21,No
1666,2361434,Shortage,RAN-CLARITHROMYCIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN™-CLARITHROMYCIN,CLARITHROMYCIN,500MG,100,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2017/3/1,,2017/3/16,2017/3/17,Shortage of an active ingredient.,2017/3/13,2017/4/12,No
1432,2379813,Shortage,RAN-CLOPIDOGREL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN™-CLOPIDOGREL,CLOPIDOGREL,75MG,500,ORAL,Resolved,TABLET,B01AC,ANTITHROMBOTIC AGENTS,,2017/2/1,2017/4/21,2018/8/17,Disruption of the manufacture of the drug.,2017/3/13,2018/8/23,No
9843,2425017,Shortage,RAN-CYPROTERONE/ETHINYL ESTRADIOL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-CYPROTERONE/ETHINYL ESTRADIOL,ETHINYL ESTRADIOL CYPROTERONE ACETATE,0.035MG 2.0MG,100,ORAL,Resolved,TABLET,G03HB,ANTIANDROGENS,2017/3/1,2017/3/1,2017/5/28,2017/5/10,Disruption of the manufacture of the drug.,2017/5/10,2019/2/1,No
25749,2268078,Shortage,RAN-DOMPERIDONE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-DOMPERIDONE,DOMPERIDONE,10MG,100,ORAL,Resolved,TABLET,A03FA,PROPULSIVES,2017/10/12,2018/10/29,,2018/12/14,Disruption of the manufacture of the drug.,2017/10/12,2018/12/15,No
1387,2381508,Shortage,RAN-DONEPEZIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN™-DONEPEZIL,DONEPEZIL HYDROCHLORIDE,5MG,500,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2017/2/1,2017/5/10,2017/4/24,Disruption of the manufacture of the drug.,2017/3/13,2019/2/1,No
1399,2381508,Shortage,RAN-DONEPEZIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN™-DONEPEZIL,DONEPEZIL HYDROCHLORIDE,5MG,100,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2017/2/1,2017/5/10,2017/4/10,Disruption of the manufacture of the drug.,2017/3/13,2019/2/1,No
30231,2423979,Shortage,RAN-ESOMEPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ESOMEPRAZOLE,ESOMEPRAZOLE,20MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/11/22,2017/11/22,2018/3/9,2018/8/17,Disruption of the manufacture of the drug.,2017/11/22,2018/8/23,No
9259,2423987,Shortage,RAN-ESOMEPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ESOMEPRAZOLE,ESOMEPRAZOLE,40MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018/11/28,2018/11/28,2020/10/30,2020/10/23,Disruption of the manufacture of the drug.,2017/5/5,2020/10/28,No
25654,2419548,Shortage,RAN-EZETIMIBE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-EZETIMIBE,EZETIMIBE,10MG,500,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2017/10/12,,2017/12/8,2017/12/7,Disruption of the manufacture of the drug.,2017/10/12,2019/2/1,No
10567,2330105,Shortage,RAN-FENTANYL MATRIX PATCH,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-FENTANYL MATRIX PATCH,FENTANYL,12MCG,100,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,2017/5/10,2017/5/10,,2018/8/17,Disruption of the manufacture of the drug.,2017/5/17,2018/8/23,No
3967,2330121,Shortage,RAN-FENTANYL MATRIX PATCH,RANBAXY PHARMACEUTICALS CANADA INC.,Fentanyl Matrix Patch,FENTANYL,50MCG,each,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,2017/3/1,2017/9/6,,2018/8/17,Other (Please describe in comments),2017/3/22,2018/8/23,No
16425,2371820,Shortage,RAN-FINASTERIDE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-FINASTERIDE,FINASTERIDE,5MG,100,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2017/7/19,2017/7/19,,2017/12/1,Disruption of the manufacture of the drug.,2017/7/19,2019/2/4,No
1546,2319063,Shortage,RAN-GABAPENTIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN™-GABAPENTIN,GABAPENTIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/2/1,2017/2/1,2018/9/24,2018/9/12,Disruption of the manufacture of the drug.,2017/3/13,2019/2/1,No
1549,2319071,Shortage,RAN-GABAPENTIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN™-GABAPENTIN,GABAPENTIN,400MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2018/10/29,2018/10/29,2019/1/15,2018/12/3,Disruption of the manufacture of the drug.,2017/3/13,2019/2/4,No
19636,2319055,Shortage,RAN-GABAPENTIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-GABAPENTIN,GABAPENTIN,100MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2018/10/29,2018/10/29,2019/1/15,2018/12/3,Disruption of the manufacture of the drug.,2017/8/16,2019/2/4,No
31236,2406810,Shortage,RAN-IRBESARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-IRBESARTAN,IRBESARTAN,75MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017/11/30,2017/11/30,2017/12/8,2017/12/1,Disruption of the manufacture of the drug.,2017/11/30,2019/2/1,No
31228,2406829,Shortage,RAN-IRBESARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-IRBESARTAN,IRBESARTAN,150MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017/11/30,2017/11/30,2018/3/15,2017/12/4,Disruption of the manufacture of the drug.,2017/11/30,2019/2/1,No
31231,2406837,Shortage,RAN-IRBESARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-IRBESARTAN,IRBESARTAN,300MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017/11/30,2017/11/30,,2019/1/11,Disruption of the manufacture of the drug.,2017/11/30,2019/1/17,No
9987,2402610,Shortage,RAN-LANSOPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-LANSOPRAZOLE,LANSOPRAZOLE,15MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/3/1,2017/3/1,2018/5/15,2018/8/22,Disruption of the manufacture of the drug.,2017/5/10,2019/2/1,No
25712,2402629,Shortage,RAN-LANSOPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-LANSOPRAZOLE,LANSOPRAZOLE,30MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/10/12,2017/11/22,2017/10/27,Disruption of the manufacture of the drug.,2017/10/12,2019/2/1,No
30237,2294230,Shortage,RAN-LISINOPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-LISINOPRIL,LISINOPRIL,5MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017/11/22,2017/11/22,2018/1/26,2018/1/10,Disruption of the manufacture of the drug.,2017/11/22,2019/2/1,No
11133,2402807,Shortage,RAN-MONTELUKAST,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-MONTELUKAST,MONTELUKAST,5MG,30,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2016/10/1,2016/10/1,,2017/11/24,Disruption of the manufacture of the drug.,2017/5/24,2019/2/1,No
11167,2402793,Shortage,RAN-MONTELUKAST,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-MONTELUKAST,MONTELUKAST,4MG,30,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2016/10/1,2016/10/1,,2017/11/24,Disruption of the manufacture of the drug.,2017/5/24,2019/2/1,No
12331,2358093,Shortage,RAN-NABILONE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-NABILONE,NABILONE,1MG,100,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,2017/3/10,2017/3/10,,2017/12/31,Disruption of the manufacture of the drug.,2017/6/8,2019/2/1,No
12334,2358077,Shortage,RAN-NABILONE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-NABILONE,NABILONE,0.25MG,100,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,2017/5/10,2017/5/10,2017/6/10,2017/12/31,Disruption of the manufacture of the drug.,2017/6/8,2019/2/1,No
12342,2358085,Shortage,RAN-NABILONE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-NABILONE,NABILONE,0.5MG,100,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,2017/5/3,2017/5/3,,2017/12/31,Disruption of the manufacture of the drug.,2017/6/8,2019/2/1,No
30228,2414090,Shortage,RAN-OLANZAPINE ODT,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-OLANZAPINE ODT,OLANZAPINE,5MG,100,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2017/11/22,,,2018/8/20,Disruption of the manufacture of the drug.,2017/11/22,2018/8/21,No
27316,2414104,Shortage,RAN-OLANZAPINE ODT,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-OLANZAPINE ODT,OLANZAPINE,10MG,100,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2017/10/27,2017/10/27,2018/10/8,2018/11/20,Disruption of the manufacture of the drug.,2017/10/27,2019/2/4,No
12294,2305046,Shortage,RAN-PANTOPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PANTOPRAZOLE,PANTOPRAZOLE,40MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/2/1,2017/6/16,2018/9/24,2017/6/23,Disruption of the manufacture of the drug.,2017/6/8,2019/2/4,No
12307,2305038,Shortage,RAN-PANTOPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PANTOPRAZOLE,PANTOPRAZOLE,20MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/4/28,2017/4/28,,2018/10/19,Disruption of the manufacture of the drug.,2017/6/8,2019/2/4,No
16334,2284456,Shortage,RAN-PRAVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/7/18,2017/7/18,2018/11/2,2017/7/18,Disruption of the manufacture of the drug.,2017/7/18,2019/2/4,No
9960,2284448,Shortage,RAN-PRAVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PRAVASTATIN,PRAVASTATIN SODIUM,20MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2016/10/1,2016/10/1,,2018/8/17,Disruption of the manufacture of the drug.,2017/5/10,2018/8/23,No
1524,2284421,Shortage,RAN-PRAVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN™-PRAVASTATIN,PRAVASTATIN SODIUM,10MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2016/10/1,,2018/8/17,Disruption of the manufacture of the drug.,2017/3/13,2018/8/23,No
16431,2392801,Shortage,RAN-PREGABALIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PREGABALIN,PREGABALIN,25MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/7/19,2017/7/19,2017/12/1,2018/8/14,Disruption of the manufacture of the drug.,2017/7/19,2018/8/15,No
21937,2392828,Shortage,RAN-PREGABALIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PREGABALIN,PREGABALIN,50MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/9/12,2017/11/6,2018/4/16,2018/8/14,Disruption of the manufacture of the drug.,2017/9/12,2018/8/15,No
21950,2392860,Shortage,RAN-PREGABALIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PREGABALIN,PREGABALIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/9/12,2017/9/12,2018/5/15,2018/8/14,Disruption of the manufacture of the drug.,2017/9/12,2018/8/15,No
21952,2392860,Shortage,RAN-PREGABALIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PREGABALIN,PREGABALIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/9/12,2017/9/12,2018/6/29,2018/8/14,Disruption of the manufacture of the drug.,2017/9/12,2018/8/15,No
33271,2392836,Shortage,RAN-PREGABALIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PREGABALIN,PREGABALIN,75MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017/12/15,2017/12/15,2018/5/22,2018/8/14,Disruption of the manufacture of the drug.,2017/12/15,2018/8/15,No
17139,2397102,Shortage,RAN-QUETIAPINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-QUETIAPINE,QUETIAPINE,100MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018/11/28,2018/11/28,2019/5/31,2019/5/28,Disruption of the manufacture of the drug.,2017/7/25,2019/5/29,No
33277,2397099,Shortage,RAN-QUETIAPINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-QUETIAPINE,QUETIAPINE,25MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018/11/23,2018/11/23,2019/4/26,2019/4/12,Disruption of the manufacture of the drug.,2017/12/15,2019/4/15,No
12297,2298082,Shortage,RAN-RABEPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/4/28,2017/4/28,,2018/8/17,Disruption of the manufacture of the drug.,2017/6/8,2018/8/23,No
12339,2298074,Shortage,RAN-RABEPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RABEPRAZOLE,RABEPRAZOLE SODIUM,10MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018/2/1,2018/2/1,2018/9/3,2018/8/31,Disruption of the manufacture of the drug.,2017/6/8,2019/2/4,No
12303,2310546,Shortage,RAN-RAMIPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RAMIPRIL,RAMIPRIL,10MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/5/2,2017/5/2,,2018/8/17,Disruption of the manufacture of the drug.,2017/6/8,2018/8/23,No
9252,2310511,Shortage,RAN-RAMIPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RAMIPRIL,RAMIPRIL,2.5MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/4/28,2017/4/28,,2018/8/17,Disruption of the manufacture of the drug.,2017/5/5,2018/8/23,No
12346,2310503,Shortage,RAN-RAMIPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RAMIPRIL,RAMIPRIL,1.25MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/2/1,2017/9/18,,2018/8/17,Disruption of the manufacture of the drug.,2017/6/8,2018/8/23,No
16328,2310538,Shortage,RAN-RAMIPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RAMIPRIL,RAMIPRIL,5MG,100,ORAL,Avoided shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017/7/18,2017/7/18,2018/10/8,2017/7/17,Disruption of the manufacture of the drug.,2017/7/18,2019/2/4,No
12300,2336480,Shortage,RAN-RANITIDINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RANITIDINE,RANITIDINE,150MG,100,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/4/28,2017/4/28,,2018/8/17,Disruption of the manufacture of the drug.,2017/6/8,2018/8/23,No
12310,2336502,Shortage,RAN-RANITIDINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RANITIDINE,RANITIDINE,300MG,100,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017/2/2,2017/2/2,,2018/8/17,Disruption of the manufacture of the drug.,2017/6/8,2018/8/23,No
27310,2314053,Shortage,RAN-ROPINIROLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROPINIROLE,ROPINIROLE,1.0MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017/10/27,2017/10/27,,2018/8/17,Disruption of the manufacture of the drug.,2017/10/27,2018/8/23,No
16331,2314037,Shortage,RAN-ROPINIROLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROPINIROLE,ROPINIROLE,0.25MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017/7/18,2017/7/18,,2018/8/17,Disruption of the manufacture of the drug.,2017/7/18,2018/8/23,No
9992,2382644,Shortage,RAN-ROSUVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROSUVASTATIN,ROSUVASTATIN,5MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/3/13,2017/3/13,,2018/11/23,Disruption of the manufacture of the drug.,2017/5/10,2018/11/28,No
9236,2382660,Shortage,RAN-ROSUVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROSUVASTATIN,ROSUVASTATIN,20MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/4/28,2017/4/28,2017/11/22,2017/10/31,Disruption of the manufacture of the drug.,2017/5/5,2019/2/1,No
10530,2382652,Shortage,RAN-ROSUVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROSUVASTATIN,ROSUVASTATIN,10MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/3/13,2017/3/13,2018/11/30,2017/10/31,Disruption of the manufacture of the drug.,2017/5/16,2019/2/4,No
21961,2382679,Shortage,RAN-ROSUVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROSUVASTATIN,ROSUVASTATIN,40MG,100,ORAL,Avoided shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018/11/28,2018/11/28,2018/12/31,2017/10/31,Disruption of the manufacture of the drug.,2017/9/12,2019/2/4,No
30234,2329166,Shortage,RAN-SIMVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-SIMVASTATIN,SIMVASTATIN,20MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/11/22,2017/11/22,,2018/1/31,Disruption of the manufacture of the drug.,2017/11/22,2019/2/1,No
21958,2437996,Shortage,RAN-SOLIFENACIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/9/12,2017/9/12,,2018/2/13,Disruption of the manufacture of the drug.,2017/9/12,2019/2/4,No
31239,2452073,Shortage,RAN-TADALAFIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-TADALAFIL,TADALAFIL,5MG,100,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/11/30,2017/11/30,,2018/7/9,Disruption of the manufacture of the drug.,2017/11/30,2019/2/1,No
31242,2452081,Shortage,RAN-TADALAFIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-TADALAFIL,TADALAFIL,2.5MG,100,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/11/30,2017/11/30,,2018/8/13,Disruption of the manufacture of the drug.,2017/11/30,2019/2/1,No
30240,2452103,Shortage,RAN-TADALAFIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-TADALAFIL,TADALAFIL,10MG,100,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018/2/1,2018/2/1,,2018/8/8,Disruption of the manufacture of the drug.,2017/11/22,2019/2/1,No
9877,2388197,Shortage,RAN-TRAMADOL/ACET,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-TRAMADOL/ACET,TRAMADOL HYDROCHLORIDE ACETAMINOPHEN,37.5MG 325MG,100,ORAL,Resolved,TABLET,N02AJ,,2017/3/1,2017/3/1,2017/6/21,2017/6/21,Disruption of the manufacture of the drug.,2017/5/10,2019/2/1,No
9297,2363119,Shortage,RAN-VALSARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VALSARTAN,VALSARTAN,160MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017/4/28,2017/4/28,,2017/6/2,Disruption of the manufacture of the drug.,2017/5/5,2019/2/4,No
9317,2363100,Shortage,RAN-VALSARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VALSARTAN,VALSARTAN,80MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017/4/28,2017/4/28,,2017/4/28,Disruption of the manufacture of the drug.,2017/5/5,2019/2/4,No
1473,2363119,Shortage,RAN-VALSARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN™-VALSARTAN,VALSARTAN,160MG,500,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018/11/28,2018/11/28,2021/2/28,2021/4/27,Disruption of the manufacture of the drug.,2017/3/13,2021/5/1,No
1500,2363062,Shortage,RAN-VALSARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN™-VALSARTAN,VALSARTAN,40MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/2/1,2017/3/31,2017/3/31,Disruption of the manufacture of the drug.,2017/3/13,2019/2/4,No
1507,2363100,Shortage,RAN-VALSARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN™-VALSARTAN,VALSARTAN,80MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/1/1,,2018/12/11,Disruption of the manufacture of the drug.,2017/3/13,2018/12/12,No
9220,2380099,Shortage,RAN-VENLAFAXINE XR,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VENLAFAXINE XR,VENLAFAXINE,150MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2018/5/25,,,2018/9/21,Disruption of the manufacture of the drug.,2017/5/5,2018/11/28,No
11125,2380080,Shortage,RAN-VENLAFAXINE XR,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VENLAFAXINE XR,VENLAFAXINE,75MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2017/3/27,2017/3/27,,2018/8/17,Disruption of the manufacture of the drug.,2017/5/24,2018/8/23,No
11207,2380072,Shortage,RAN-VENLAFAXINE XR,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VENLAFAXINE XR,VENLAFAXINE,37.5MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2018/11/28,2018/11/28,2019/6/28,2019/7/5,Disruption of the manufacture of the drug.,2017/5/24,2019/7/6,No
19633,2267926,Shortage,RAN-ZOPICLONE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ZOPICLONE,ZOPICLONE,7.5MG,100,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,2017/8/16,2017/8/16,2018/1/25,2018/1/30,Disruption of the manufacture of the drug.,2017/8/16,2019/2/4,No
14189,740748,Shortage,RANITIDINE - 150,PRO DOC LIMITEE,RANITIDINE,RANITIDINE,150MG,60-500,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/8/1,,2017/8/3,Delay in shipping of the drug.,2017/6/28,2017/10/30,No
17351,740756,Shortage,RANITIDINE - 300,PRO DOC LIMITEE,RANITIDINE,RANITIDINE,300MG,100,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/7/24,,2017/8/3,Delay in shipping of the drug.,2017/7/26,2017/8/4,No
27242,2256711,Shortage,RANITIDINE INJECTION USP,SANDOZ CANADA INCORPORATED,RANITIDINE,RANITIDINE,25MG,50ML VIAL,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/9/25,2017/11/17,2017/11/13,Delay in shipping of the drug.,2017/10/27,2017/11/27,No
10880,2247097,Shortage,RATIO-AMCINONIDE,TEVA CANADA LIMITED,AMCINONIDE,AMCINONIDE,0.10%,60ML,TOPICAL,Actual shortage,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2017/5/17,,,Disruption of the manufacture of the drug.,2017/5/23,2017/10/5,No
17796,2247096,Shortage,RATIO-AMCINONIDE,TEVA CANADA LIMITED,AMCINONIDE,AMCINONIDE,0.10%,60G,TOPICAL,Actual shortage,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",,2017/7/30,,,Disruption of the manufacture of the drug.,2017/8/1,2018/12/21,No
17799,2247098,Shortage,RATIO-AMCINONIDE,TEVA CANADA LIMITED,AMCINONIDE,AMCINONIDE,0.10%,60G,TOPICAL,Actual shortage,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2017/7/30,,,Disruption of the manufacture of the drug.,2017/8/1,2018/12/21,No
1797,2171791,Shortage,RATIO-ATENOLOL,TEVA CANADA LIMITED,ATENOLOL,ATENOLOL,50MG,30,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2015/2/11,,2017/12/28,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
1790,2171805,Shortage,RATIO-ATENOLOL,TEVA CANADA LIMITED,ATENOLOL,ATENOLOL,100MG,30,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2015/2/11,,2017/9/30,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
1803,2350327,Shortage,RATIO-ATORVASTATIN,TEVA CANADA LIMITED,ATORVASTATIN,ATORVASTATIN,40MG,30,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2016/6/29,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/10,No
2343,2350335,Shortage,RATIO-ATORVASTATIN,TEVA CANADA LIMITED,ATORVASTATIN,ATORVASTATIN,80MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/4/1,,,Delay in shipping of the drug.,2017/3/14,2018/12/21,No
10883,2350335,Shortage,RATIO-ATORVASTATIN,TEVA CANADA LIMITED,ATORVASTATIN,ATORVASTATIN,80MG,30,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/5/17,,,Requirements related to complying with good manufacturing practices.,2017/5/23,2017/10/5,No
2359,2252325,Shortage,RATIO-CARVEDILOL,TEVA CANADA LIMITED,CARVEDILOL,CARVEDILOL,12.5MG,100,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,2017/3/15,,2017/6/10,2017/5/17,Delay in shipping of the drug.,2017/3/14,2017/5/23,No
2370,1910299,Shortage,RATIO-CLOBETASOL,TEVA CANADA LIMITED,CLOBETASOL,CLOBETASOL PROPIONATE,0.05%,60ML,TOPICAL,Resolved,LOTION,D07AD,"CORTICOSTEROIDS, PLAIN",,2017/3/15,2017/10/30,2017/11/1,Disruption of the manufacture of the drug.,2017/3/14,2017/11/6,No
22942,1910272,Shortage,RATIO-CLOBETASOL,TEVA CANADA LIMITED,CLOBETASOL,CLOBETASOL PROPIONATE,0.05%,50G,TOPICAL,Resolved,CREAM,D07AD,"CORTICOSTEROIDS, PLAIN",,2017/9/20,2017/11/1,2017/11/1,Disruption of the manufacture of the drug.,2017/9/21,2017/11/6,No
167,1910299,Shortage,RATIO-CLOBETASOL,TEVA CANADA LIMITED,Clobetasol,CLOBETASOL PROPIONATE,0.05%,20ML,TOPICAL,Resolved,LOTION,D07AD,"CORTICOSTEROIDS, PLAIN",,2017/2/3,2017/11/7,2017/11/6,Disruption of the manufacture of the drug.,2017/3/10,2017/11/7,No
2374,653217,Shortage,RATIO-ECTOSONE,TEVA CANADA LIMITED,ECTOSONE,BETAMETHASONE,0.10%,30ML,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2017/3/1,2018/1/10,2018/2/15,Disruption of the manufacture of the drug.,2017/3/14,2018/2/21,No
2380,653217,Shortage,RATIO-ECTOSONE,TEVA CANADA LIMITED,ECTOSONE,BETAMETHASONE,0.10%,75ML,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2017/3/1,2018/2/28,2018/3/7,Disruption of the manufacture of the drug.,2017/3/14,2018/3/8,No
22945,653209,Shortage,RATIO-ECTOSONE MILD LOTION 0.05%,TEVA CANADA LIMITED,ECTOSONE,BETAMETHASONE,0.05%,60ML,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2017/9/20,2018/2/9,2018/2/28,Disruption of the manufacture of the drug.,2017/9/21,2018/3/7,No
19304,750050,Shortage,RATIO-ECTOSONE REGULAR LOTION 0.1%,TEVA CANADA LIMITED,ECTOSONE,BETAMETHASONE,0.10%,60ML,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2017/8/11,2017/12/19,2017/12/29,Disruption of the manufacture of the drug.,2017/8/14,2018/1/3,No
3137,2243789,Shortage,RATIO-IPRA SAL UDV,TEVA CANADA LIMITED,IPRATROPIUM/SALBUTAMOL,IPRATROPIUM BROMIDE SALBUTAMOL,0.5MG 2.5MG,20X2.5ML,INHALATION,Resolved,SOLUTION,R03AL,"ADRENERGICS, INHALANTS",,2017/3/17,2017/6/28,2017/7/27,Disruption of the manufacture of the drug.,2017/3/17,2017/7/28,No
10892,2097168,Shortage,RATIO-IPRATROPIUM UDV,TEVA CANADA LIMITED,IPRATROPIUM BROMIDE,IPRATROPIUM BROMIDE,250MCG,20X1ML,INHALATION,Resolved,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017/5/17,2017/7/19,2017/9/1,Demand increase for the drug.,2017/5/23,2017/9/19,No
19308,2316404,Shortage,RATIO-IRBESARTAN,TEVA CANADA LIMITED,IRBESARTAN,IRBESARTAN,150MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/8/11,2017/9/8,2017/9/15,Disruption of the manufacture of the drug.,2017/8/14,2017/9/19,No
9785,2330520,Shortage,RATIO-IRBESARTAN HCTZ,TEVA CANADA LIMITED,IRBESARTAN HCTZ,HYDROCHLOROTHIAZIDE IRBESARTAN,12.5MG 300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/5/4,2017/7/28,2017/9/15,Disruption of the manufacture of the drug.,2017/5/10,2017/9/19,No
17839,2330539,Shortage,RATIO-IRBESARTAN HCTZ,TEVA CANADA LIMITED,IRBESARTAN HCTZ,HYDROCHLOROTHIAZIDE IRBESARTAN,25MG 300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/7/30,2017/9/8,2017/9/15,Disruption of the manufacture of the drug.,2017/8/1,2017/9/19,No
2400,854409,Shortage,RATIO-LACTULOSE,TEVA CANADA LIMITED,LACTULOSE,LACTULOSE,667MG/ML,500ML,ORAL LIQUID,Resolved,BOTTLE,A06AD,DRUGS FOR CONSTIPATION,,2017/7/15,2017/11/13,2017/12/10,Demand increase for the drug.,2017/3/14,2017/12/15,No
3118,653241,Shortage,RATIO-LENOLTEC NO 2,TEVA CANADA LIMITED,LENOLTEC,ACETAMINOPHEN CODEINE PHOSPHATE CAFFEINE,300MG 15MG 15MG,500,ORAL,Resolved,TABLET,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,2017/4/15,,2017/6/30,2017/7/30,Requirements related to complying with good manufacturing practices.,2017/3/17,2017/9/5,No
2986,653276,Shortage,RATIO-LENOLTEC NO 3,TEVA CANADA LIMITED,LENOLTEC,ACETAMINOPHEN CODEINE PHOSPHATE CAFFEINE,300MG 30MG 15MG,500,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017/6/1,2017/11/30,2017/11/30,Requirements related to complying with good manufacturing practices.,2017/3/15,2017/12/15,No
3121,621463,Shortage,RATIO-LENOLTEC NO 4,TEVA CANADA LIMITED,LENOLTEC,ACETAMINOPHEN CODEINE PHOSPHATE,300MG 60MG,100,ORAL,Resolved,TABLET,N02AA,OPIOIDS,2017/5/1,,2017/5/30,2017/7/20,Disruption of the manufacture of the drug.,2017/3/17,2017/9/5,No
5168,2242931,Shortage,RATIO-METFORMIN,TEVA CANADA LIMITED,METFORMIN,METFORMIN HYDROCHLORIDE,850MG,500,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/4/3,2017/9/15,2017/10/6,Disruption of the manufacture of the drug.,2017/4/3,2017/10/10,No
29441,2248130,Shortage,RATIO-MOMETASONE,TEVA CANADA LIMITED,MOMETASONE,MOMETASONE FUROATE,0.10%,50G,TOPICAL,Resolved,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",,2017/11/16,2018/1/12,2018/1/3,Disruption of the manufacture of the drug.,2017/11/16,2018/1/4,No
3145,2194228,Shortage,RATIO-NYSTATIN,TEVA CANADA LIMITED,NYSTATIN,NYSTATIN,100000UNIT,30G,TOPICAL,Resolved,OINTMENT,D01AA,ANTIFUNGALS FOR TOPICAL USE,,2017/3/17,2017/6/30,2017/7/10,Disruption of the manufacture of the drug.,2017/3/17,2017/9/5,No
3148,2194236,Shortage,RATIO-NYSTATIN,TEVA CANADA LIMITED,NYSTATIN,NYSTATIN,100000UNIT,15G,TOPICAL,Resolved,CREAM,D01AA,ANTIFUNGALS FOR TOPICAL USE,,2017/3/17,2017/5/10,2017/4/17,Disruption of the manufacture of the drug.,2017/3/17,2017/4/25,No
2410,2194201,Shortage,RATIO-NYSTATIN,TEVA CANADA LIMITED,NYSTATIN,NYSTATIN,100000UNIT,1L,ORAL,Resolved,DROPS,A07AA,INTESTINALANTIINFECTIVES,,2017/12/15,2018/1/30,2018/3/7,Delay in shipping of the drug.,2017/3/14,2018/3/8,No
1739,2194236,Shortage,RATIO-NYSTATIN,TEVA CANADA LIMITED,NYSTATIN,NYSTATIN,100000UNIT,450GM,TOPICAL,Resolved,CREAM,D01AA,ANTIFUNGALS FOR TOPICAL USE,,2016/11/1,,2019/5/1,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
2975,608165,Shortage,RATIO-OXYCOCET,TEVA CANADA LIMITED,OXYCOCET,ACETAMINOPHEN OXYCODONE HYDROCHLORIDE,325MG 5MG,100,ORAL,Resolved,TABLET,N02AJ,,,2017/6/1,2018/4/30,2018/4/30,Requirements related to complying with good manufacturing practices.,2017/3/15,2018/5/11,No
2978,608165,Shortage,RATIO-OXYCOCET,TEVA CANADA LIMITED,500,ACETAMINOPHEN OXYCODONE HYDROCHLORIDE,325MG 5MG,500,ORAL,Resolved,TABLET,N02AJ,,,2017/6/1,2018/4/30,2018/4/30,Requirements related to complying with good manufacturing practices.,2017/3/15,2018/5/11,No
2983,608165,Shortage,RATIO-OXYCOCET,TEVA CANADA LIMITED,OXYCOCET,ACETAMINOPHEN OXYCODONE HYDROCHLORIDE,325MG 5MG,100 U/D,ORAL,Resolved,TABLET,N02AJ,,,2017/6/1,2018/2/28,2018/2/21,Requirements related to complying with good manufacturing practices.,2017/3/15,2018/2/22,No
2419,2239365,Shortage,RATIO-SALBUTAMOL,TEVA CANADA LIMITED,SALBUTAMOL,SALBUTAMOL,0.5MG,20 x 2.5ML,INHALATION,Resolved,SOLUTION,R03AC,"ADRENERGICS, INHALANTS",,2016/11/1,,2017/6/15,Requirements related to complying with good manufacturing practices.,2017/3/14,2020/2/13,No
17814,2319500,Shortage,RATIO-SILDENAFIL R,TEVA CANADA LIMITED,SILDENAFIL R,SILDENAFIL,20MG,100,ORAL,Resolved,TABLET,C02,OTHER ANTIHYPERTENSIVES,,2017/7/30,2017/8/25,2017/9/15,Disruption of the manufacture of the drug.,2017/8/1,2017/9/19,No
3151,608238,Shortage,RATIO-TECNAL,TEVA CANADA LIMITED,TECNAL,ACETYLSALICYLIC ACID BUTALBITAL CAFFEINE,330MG 50MG 40MG,100,ORAL,Resolved,CAPSULE,N02BA,OTHER ANALGESICS AND ANTIPYRETICS,,2017/12/15,2018/2/28,2018/2/21,Disruption of the manufacture of the drug.,2017/3/17,2018/2/22,No
17822,2245688,Shortage,RATIO-TOPISALIC,TEVA CANADA LIMITED,TOPISALIC,BETAMETHASONE SALICYLIC ACID,0.5MG 20MG,30 ML,TOPICAL,Resolved,LOTION,D07XC,"CORTICOSTEROIDS, OTHER COMBINATIONS",,2017/7/1,2017/10/5,2017/10/6,Requirements related to complying with good manufacturing practices.,2017/8/1,2017/10/10,No
17827,2245688,Shortage,RATIO-TOPISALIC,TEVA CANADA LIMITED,TOPISALIC,BETAMETHASONE SALICYLIC ACID,0.5MG 20MG,60ML,TOPICAL,Resolved,LOTION,D07XC,"CORTICOSTEROIDS, OTHER COMBINATIONS",,2017/7/30,2017/10/10,2017/10/6,Requirements related to complying with good manufacturing practices.,2017/8/1,2017/10/10,No
8055,809187,Shortage,RATIO-TOPISONE,TEVA CANADA LIMITED,TOPISONE,BETAMETHASONE,0.05%,30ML,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2017/4/21,2017/12/19,2017/12/29,Disruption of the manufacture of the drug.,2017/4/25,2018/1/3,No
17832,809187,Shortage,RATIO-TOPISONE,TEVA CANADA LIMITED,TOPISONE,BETAMETHASONE,0.05%,75ML,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2017/7/30,2017/9/30,2017/10/16,Requirements related to complying with good manufacturing practices.,2017/8/1,2017/10/17,No
18922,2245977,Shortage,RECOMBIVAX HB     -(ADULT DIALYSIS-PRESERVATIVE FREE),MERCK CANADA INC,(hepatitis B vaccine [recombinant]),HEPATITIS B SURFACE ANTIGEN,40MCG,40MCG/1ML 1DOSE VIAL,INTRAMUSCULAR,Resolved,SOLUTION,J07BC,VIRAL VACCINES,2017/10/6,2017/10/3,2017/10/30,2017/10/6,Delay in shipping of the drug.,2017/8/12,2017/10/7,No
873,2243676,Shortage,RECOMBIVAX HB     -(PRESERVATIVE FREE),MERCK CANADA INC,(hepatitis B vaccine [recombinant]),HEPATITIS B SURFACE ANTIGEN,10MCG,10MCG/1ML 10X1DOSE VIAL,INTRAMUSCULAR,Resolved,SOLUTION,J07BC,VIRAL VACCINES,2017/8/1,2017/8/4,2022/6/30,2022/6/22,Disruption of the manufacture of the drug.,2017/3/13,2022/6/23,No
15524,2243676,Shortage,RECOMBIVAX HB     -(PRESERVATIVE FREE),MERCK CANADA INC,(hepatitis B vaccine [recombinant]),HEPATITIS B SURFACE ANTIGEN,10MCG,5MCG/0.5ML 1DOSE VIAL (Ped),INTRAMUSCULAR,Resolved,SOLUTION,J07BC,VIRAL VACCINES,2017/8/2,2017/8/2,2017/9/18,2017/8/24,Delay in shipping of the drug.,2017/7/12,2017/10/12,No
23503,2243676,Shortage,RECOMBIVAX HB     -(PRESERVATIVE FREE),MERCK CANADA INC,(hepatitis B vaccine [recombinant]),HEPATITIS B SURFACE ANTIGEN,10MCG,10MCG/1ML  1DOSE VIAL,INTRAMUSCULAR,Resolved,SOLUTION,J07BC,VIRAL VACCINES,2017/9/21,2017/9/21,2021/4/5,2021/3/15,Disruption of the manufacture of the drug.,2017/9/26,2021/3/16,No
1584,662461,Shortage,RECTOGEL HC,LABORATOIRE RIVA INC,"Hydrocortisone acetate, zinc sulfate and  benzocaine ointment",HYDROCORTISONE ACETATE ZINC SULFATE BENZOCAINE,1.0% 0.5% 10%,15g & 30 g,RECTAL,Actual shortage,OINTMENT,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,2014/4/11,2014/4/11,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
949,2224615,Shortage,RELEFACT TRH INJECTION 200MCG/ML,ODAN LABORATORIES LTD,Protirelin Injection i.v.,Protirelin,0.2 mg/mL,1 mL,I.V. injection,Actual shortage,Liquid,V04CJ,OTHER DIAGNOSTIC AGENTS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
12396,2308215,Shortage,RELISTOR,SALIX PHARMACEUTICALS INC,Relistor,METHYLNALTREXONE BROMIDE,20MG,One vial in a carton (each vial contains 12 mg/0.6 mL),SUBCUTANEOUS,Resolved,SOLUTION,A06AH,DRUGS FOR CONSTIPATION,2016/8/1,,2020/8/3,2021/1/18,Disruption of the manufacture of the drug.,2017/6/9,2021/1/25,No
23459,2243910,Shortage,REMERON,MERCK CANADA INC,(mirtazapine) Tablets,MIRTAZAPINE,30MG,30TAB,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2017/10/16,2017/10/16,2017/10/23,2017/10/17,Delay in shipping of the drug.,2017/9/25,2017/10/18,No
26382,2248542,Shortage,REMERON RD,MERCK CANADA INC,(mirtazapine) Orally Disintegrating Tablets,MIRTAZAPINE,15MG,30TAB,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N06AX,ANTIDEPRESSANTS,2017/11/1,2017/11/2,2017/11/10,2017/11/8,Delay in shipping of the drug.,2017/10/19,2017/11/9,No
31785,2248542,Shortage,REMERON RD,MERCK CANADA INC,(mirtazapine) Orally Disintegrating Tablets,MIRTAZAPINE,15MG,30TAB BLIS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N06AX,ANTIDEPRESSANTS,2017/12/4,2017/12/4,2018/2/28,2017/12/6,Disruption of the manufacture of the drug.,2017/12/5,2017/12/7,No
31788,2248544,Shortage,REMERON RD,MERCK CANADA INC,(mirtazapine) Orally Disintegrating Tablets,MIRTAZAPINE,45MG,30TAB BLIS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N06AX,ANTIDEPRESSANTS,2017/12/4,2017/12/4,2018/2/28,2017/12/6,Disruption of the manufacture of the drug.,2017/12/5,2017/12/12,No
23462,2248543,Shortage,REMERON RD,MERCK CANADA INC,(mirtazapine) Orally Disintegrating Tablets,MIRTAZAPINE,30MG,30TAB,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N06AX,ANTIDEPRESSANTS,2017/10/20,2017/10/19,2018/1/12,2018/1/12,Disruption of the manufacture of the drug.,2017/9/25,2018/1/13,No
28242,1963953,Shortage,RESECTISOL (5% MANNITOL IRRIGATION),B. BRAUN MEDICAL INC,Mannitol,MANNITOL,5%,2000mL,IRRIGATION,Actual shortage,LIQUID,B05CX,IRRIGATING SOLUTIONS,,2017/11/3,,,Requirements related to complying with good manufacturing practices.,2017/11/6,2019/11/6,No
19739,443794,Shortage,RETIN-A,VALEANT CANADA LP/VALEANT CANADA S.E.C.,RETIN-A,TRETINOIN,0.05%,na,TOPICAL,Resolved,CREAM,D10AD,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2017/8/15,,2018/3/29,Other (Please describe in comments),2017/8/17,2018/3/30,No
2036,2279401,Shortage,REVATIO,PFIZER CANADA INC,REVATIO,SILDENAFIL,20MG,6x15,ORAL,Resolved,TABLET,C02,OTHER ANTIHYPERTENSIVES,,2017/1/19,2017/3/15,2017/3/17,Disruption of the manufacture of the drug.,2017/3/14,2017/3/18,No
29079,2238998,Shortage,RHO-NITRO PUMPSPRAY,SANDOZ CANADA INCORPORATED,RHO NITRO,NITROGLYCERIN,0.4MG,200 DOSES,SUBLINGUAL,Resolved,METERED-DOSE PUMP,C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2017/10/2,2018/1/31,2018/1/30,Demand increase for the drug.,2017/11/14,2018/2/5,No
5675,2411407,Shortage,RISEDRONATE-35,SIVEM PHARMACEUTICALS ULC,RISEDRONATE-35,RISEDRONATE SODIUM,35MG,4,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/4/4,,2017/5/15,Disruption of the manufacture of the drug.,2017/4/5,2017/5/16,No
26182,2356902,Shortage,RISPERIDONE,SANIS HEALTH INC,RISPERIDONE TAB,RISPERIDONE,1MG,100,ORAL,Avoided shortage,TABLET,N05AX,ANTIPSYCHOTICS,2017/10/27,,2017/11/10,2017/10/24,Other (Please describe in comments),2017/10/18,2017/10/24,No
12261,5614,Shortage,RITALIN 20MG,NOVARTIS PHARMACEUTICALS CANADA INC,RITALIN 20MG TABS 100'S,METHYLPHENIDATE HYDROCHLORIDE,20MG,100'S,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2017/7/10,2017/7/10,2017/8/28,2017/8/22,Delay in shipping of the drug.,2017/6/7,2017/8/31,No
11280,632775,Shortage,RITALIN-SR TAB 20MG,NOVARTIS PHARMACEUTICALS CANADA INC,RITALIN 20MG SR TABS 100'S,METHYLPHENIDATE HYDROCHLORIDE,20MG,100'S,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/5/11,2017/6/26,2017/6/1,Other (Please describe in comments),2017/5/25,2017/6/2,No
3417,2331500,Shortage,RIVA-AMLODIPINE,LABORATOIRE RIVA INC,Amlodipine,AMLODIPINE,10MG,100 & 500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017/4/14,,,2017/5/23,Demand increase for the drug.,2017/3/17,2017/5/24,No
3421,2331489,Shortage,RIVA-AMLODIPINE,LABORATOIRE RIVA INC,Amlodipine,AMLODIPINE,2.5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017/4/14,,,2017/5/23,Demand increase for the drug.,2017/3/17,2017/5/24,No
3424,2331497,Shortage,RIVA-AMLODIPINE,LABORATOIRE RIVA INC,Amlodipine,AMLODIPINE,5MG,100 & 500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017/4/14,,,2017/5/23,Demand increase for the drug.,2017/3/17,2017/5/24,No
33381,2277379,Shortage,RIVA-ATENOLOL,LABORATOIRE RIVA INC,Atenolol 25mg,ATENOLOL,25MG,100 & 500 pack,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/12/18,2017/12/18,2018/5/25,2018/5/25,Disruption of the manufacture of the drug.,2017/12/18,2018/7/10,No
14126,2242094,Shortage,RIVA-ATENOLOL 50 MG,LABORATOIRE RIVA INC,Riva-Atenolol 50mg,ATENOLOL,50MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/7/7,2017/7/14,2018/3/23,2018/3/22,Delay in shipping of the drug.,2017/6/27,2018/3/30,No
29043,2425386,Shortage,RIVA-CELECOX,LABORATOIRE RIVA INC,Celcox 100mg,CELECOXIB,100MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017/11/13,2017/11/13,2017/12/22,2017/12/5,Disruption of the manufacture of the drug.,2017/11/13,2018/1/18,No
28996,2242077,Shortage,RIVA-CLONAZEPAM,LABORATOIRE RIVA INC,Clonazepam 0.5mg,CLONAZEPAM,0.5MG,100 & 500,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2017/11/17,2017/11/17,2018/4/20,2018/4/20,Disruption of the manufacture of the drug.,2017/11/13,2018/5/2,No
12400,2428830,Shortage,RIVA-ESCITALOPRAM,LABORATOIRE RIVA INC,Riva-Escitalopram,ESCITALOPRAM,10MG,30 & 100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/6/9,2017/6/9,2019/1/18,2019/1/18,Disruption of the manufacture of the drug.,2017/6/9,2019/1/19,No
12403,2428857,Shortage,RIVA-ESCITALOPRAM,LABORATOIRE RIVA INC,Riva-Escitalopram,ESCITALOPRAM,20MG,30 & 100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/6/9,2017/6/9,2019/1/18,2019/1/18,Disruption of the manufacture of the drug.,2017/6/9,2019/1/19,No
31757,2303345,Shortage,RIVA-FLUVOX,LABORATOIRE RIVA INC,fluvoxamine 50mg,FLUVOXAMINE MALEATE,50MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/12/4,2017/12/4,2018/2/28,2018/2/23,Demand increase for the drug.,2017/12/5,2018/2/24,No
31661,2303361,Shortage,RIVA-FLUVOX,LABORATOIRE RIVA INC,Fluvoxamine 100mg,FLUVOXAMINE MALEATE,100MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/12/4,2017/12/4,2018/2/28,2018/2/26,Demand increase for the drug.,2017/12/4,2018/3/30,No
26076,2303345,Shortage,RIVA-FLUVOX,LABORATOIRE RIVA INC,Fluvoxamine 50mg,FLUVOXAMINE MALEATE,50MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/10/16,2017/10/16,2017/10/27,2017/10/26,Demand increase for the drug.,2017/10/16,2017/11/1,No
26079,2303361,Shortage,RIVA-FLUVOX,LABORATOIRE RIVA INC,Fluvoxamine 100mg,FLUVOXAMINE MALEATE,100MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017/10/16,2017/10/16,2017/10/27,2017/10/27,Demand increase for the drug.,2017/10/16,2017/11/1,No
1575,2259796,Shortage,RIVA-GABAPENTIN,LABORATOIRE RIVA INC,Gabapentin tablets,GABAPENTIN,600MG,100,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,2014/4/11,2014/4/11,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1580,2259818,Shortage,RIVA-GABAPENTIN,LABORATOIRE RIVA INC,Gabapentin tablets,GABAPENTIN,800MG,100 & 500,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,2014/4/11,2014/4/11,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1593,2247245,Shortage,RIVA-INDAPAMIDE 1.25,LABORATOIRE RIVA INC,Indapamide Tablets USP,INDAPAMIDE,1.25MG,30 & 100,ORAL,Actual shortage,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",2016/6/2,2016/6/2,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1596,2242125,Shortage,RIVA-INDAPAMIDE 2.5 MG,LABORATOIRE RIVA INC,Indapamide Tablets USP,INDAPAMIDE,2.5MG,30 & 100,ORAL,Actual shortage,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",2016/6/2,2016/6/2,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
3672,2315327,Shortage,RIVA-METOPROLOL L,LABORATOIRE RIVA INC,Metoprolol,METOPROLOL TARTRATE,100MG,1000,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/3/20,2017/3/20,,2021/12/1,Disruption of the manufacture of the drug.,2017/3/20,2021/12/2,No
26906,2299364,Shortage,RIVA-OXYBUTYNIN,LABORATOIRE RIVA INC,Oxybutynin 5mg,OXYBUTYNIN CHLORIDE,5MG,100 & 500,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/10/31,2017/11/8,2018/4/20,2018/4/20,Disruption of the manufacture of the drug.,2017/10/24,2018/5/2,No
1629,2270234,Shortage,RIVA-PRAVASTATIN,LABORATOIRE RIVA INC,Pravastatin Sodium Tablets,PRAVASTATIN SODIUM,10MG,30 & 100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2014/4/11,2014/4/11,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1640,2270242,Shortage,RIVA-PRAVASTATIN,LABORATOIRE RIVA INC,Pravastatin Sodium Tablets,PRAVASTATIN SODIUM,20MG,30 & 100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2014/4/11,2014/4/11,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1645,2270250,Shortage,RIVA-PRAVASTATIN,LABORATOIRE RIVA INC,Pravastatin Sodium Tablets,PRAVASTATIN SODIUM,40MG,30 & 100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2014/4/11,2014/4/11,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
8435,2423464,Shortage,RIVA-RIZATRIPTAN ODT,LABORATOIRE RIVA INC,Riva-Rizatriptan ODT,RIZATRIPTAN,10MG,6,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2017/4/28,2017/4/28,,,Disruption of the manufacture of the drug.,2017/4/28,2018/12/21,No
26924,2272172,Shortage,RIVA-SOTALOL,LABORATOIRE RIVA INC,Sotalol 160mg,SOTALOL HYDROCHLORIDE,160MG,100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,2017/9/4,2017/9/4,2018/6/1,2018/5/7,Disruption of the manufacture of the drug.,2017/10/24,2018/5/8,No
27643,2272164,Shortage,RIVA-SOTALOL,LABORATOIRE RIVA INC,Sotalol 80mg,SOTALOL HYDROCHLORIDE,80MG,100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,2017/11/15,2017/11/8,2018/4/13,2018/4/18,Disruption of the manufacture of the drug.,2017/11/1,2018/5/2,No
1662,2248082,Shortage,RIVA-VERAPAMIL SR,LABORATOIRE RIVA INC,Verapamil Hydrochloride,VERAPAMIL HYDROCHLORIDE,240MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2016/10/20,2016/10/20,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1672,2401304,Shortage,RIVA-ZOLMITRIPTAN,LABORATOIRE RIVA INC,Zolmitriptan film-coated tablets,ZOLMITRIPTAN,2.5MG,6 & 30,ORAL,Actual shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2016/10/14,2016/10/14,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1392,2228300,Shortage,RIVANASE AQ.NASAL SPRAY 50MCG/METERED DOSE,LABORATOIRE RIVA INC,Beclometasone dipropionate aqueous suspension,BECLOMETHASONE DIPROPIONATE,50MCG,200,NASAL,Actual shortage,METERED-DOSE AEROSOL,R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,2014/4/11,2014/4/11,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1588,2240112,Shortage,RIVASOL-HC SUPPOSITORIES,LABORATOIRE RIVA INC,Hydrocortisone acetate and zinc sulfate monohydrate suppositories,HYDROCORTISONE ACETATE ZINC SULFATE,10MG 10MG,12,RECTAL,Actual shortage,SUPPOSITORY,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,2014/4/11,2014/4/11,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1410,1940112,Shortage,RIVASONE SCALP LOT 0.1%,LABORATOIRE RIVA INC,Betamethasone lotion,BETAMETHASONE,0.10%,30ml & 75 ml,TOPICAL,Actual shortage,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",2014/4/11,2014/4/11,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
2307,2417014,Shortage,RIVASTIGMINE,PRO DOC LIMITEE,RIVASTIGMINE,RIVASTIGMINE,4.5MG,100,ORAL,Resolved,CAPSULE,N06DA,ANTI-DEMENTIA DRUGS,,2017/3/14,,2017/3/16,Delay in shipping of the drug.,2017/3/14,2017/3/24,No
28573,382825,Shortage,RIVOTRIL 0.5TAB,HOFFMANN-LA ROCHE LIMITED,CLONAZEPAM,CLONAZEPAM,0.5MG,Bottles of 100 tablets,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2017/11/17,2017/11/9,2017/12/13,2017/12/12,Demand increase for the drug.,2017/11/7,2017/12/13,No
5659,2446138,Shortage,RIZATRIPTAN ODT,SIVEM PHARMACEUTICALS ULC,RIZATRIPTAN ODT,RIZATRIPTAN,10MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2017/4/4,2017/4/11,2017/4/11,Demand increase for the drug.,2017/4/5,2017/4/12,No
32648,2446138,Shortage,RIZATRIPTAN ODT,SIVEM PHARMACEUTICALS ULC,RIZATRIPTAN ODT,RIZATRIPTAN,10MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2018/1/22,2018/1/22,2018/2/23,2018/2/23,Other (Please describe in comments),2017/12/12,2018/2/26,No
28900,2446111,Shortage,RIZATRIPTAN ODT,SIVEM PHARMACEUTICALS ULC,RIZATRIPTAN ODT,RIZATRIPTAN,5MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2017/12/4,2017/12/6,2018/2/23,2018/2/23,Other (Please describe in comments),2017/11/10,2018/2/26,No
17458,2415798,Shortage,RIZATRIPTAN RDT,PRO DOC LIMITEE,RIZATRIPTAN RDT,RIZATRIPTAN,5MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2017/7/27,,2017/10/11,Delay in shipping of the drug.,2017/7/28,2017/10/12,No
30511,2318121,Shortage,ROCURONIUM BROMIDE INJECTION,HOSPIRA HEALTHCARE CORPORATION,ROCURONIUM BROMIDE,ROCURONIUM BROMIDE,10MG,10x5mL,INTRAVENOUS,Resolved,LIQUID,M03AC,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",,2017/12/7,,2018/2/9,Disruption of the manufacture of the drug.,2017/11/23,2018/2/10,No
12130,2318415,Shortage,ROCURONIUM BROMIDE INJECTION,SANDOZ CANADA INCORPORATED,ROCURONIUM,ROCURONIUM BROMIDE,10MG,10 X 5ML VIALS,INTRAVENOUS,Resolved,SOLUTION,M03AC,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",2017/6/9,,2017/6/30,2017/7/21,Delay in shipping of the drug.,2017/6/6,2017/10/10,No
11360,393444,Shortage,ROFACT 150MG,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ROFACT 150MG,RIFAMPIN,150MG,NA,ORAL,Resolved,CAPSULE,J04AB,DRUGS FOR TREATMENT OF TUBERCULOSIS,,2017/5/25,2017/6/15,2017/6/15,Other (Please describe in comments),2017/5/26,2017/6/16,No
3290,393444,Shortage,ROFACT 150MG,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ROFACT,RIFAMPIN,150MG,100,ORAL,Resolved,CAPSULE,J04AB,DRUGS FOR TREATMENT OF TUBERCULOSIS,,2017/3/15,2017/4/18,2017/6/15,Disruption of the manufacture of the drug.,2017/3/17,2017/6/16,No
1621,343617,Shortage,ROFACT 300MG,VALEANT CANADA LP/VALEANT CANADA S.E.C.,Rifampin Capsule,RIFAMPIN,300MG,100,ORAL,Resolved,CAPSULE,J04AB,DRUGS FOR TREATMENT OF TUBERCULOSIS,,2017/2/16,2017/4/11,2017/4/11,Disruption of the manufacture of the drug.,2017/3/13,2017/4/12,No
1520,2122073,Shortage,ROLENE CREAM 0.05%,LABORATOIRE RIVA INC,Betamethasone diproprionate cream,BETAMETHASONE DIPROPIONATE,0.05%,50g & 450g,TOPICAL,Actual shortage,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2014/4/11,2014/4/11,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1530,2122065,Shortage,ROLENE LOTION 0.05%,LABORATOIRE RIVA INC,Betamethasone diproprionate lotion,BETAMETHASONE DIPROPIONATE,0.05%,30ml & 75ml,TOPICAL,Actual shortage,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",2014/4/11,2014/4/11,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1537,2122081,Shortage,ROLENE OINTMENT 0.05%,LABORATOIRE RIVA INC,Betamethasone diproprionate ointment,BETAMETHASONE DIPROPIONATE,0.05%,50g & 450g,TOPICAL,Actual shortage,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",2014/4/11,2014/4/11,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
23677,2353040,Shortage,ROPINIROLE,SANIS HEALTH INC,ROPINIROLE TAB,ROPINIROLE,0.25MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017/10/2,,2017/10/16,2017/10/13,Other (Please describe in comments),2017/9/27,2017/10/16,No
29895,2353040,Shortage,ROPINIROLE,SANIS HEALTH INC,ROPINIROLE TABS,ROPINIROLE,0.25MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017/11/21,,2017/12/15,2017/12/15,Other (Please describe in comments),2017/11/21,2017/12/16,No
8417,2347830,Shortage,ROPIVACAINE HYDROCHLORIDE INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,ROPIVACAINE,ROPIVACAINE HYDROCHLORIDE,10MG,10x10mL,"BLOCK/INFILTRATION
EPIDURAL",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017/5/9,,2018/10/1,Disruption of the manufacture of the drug.,2017/4/28,2018/10/2,No
16621,2347822,Shortage,ROPIVACAINE HYDROCHLORIDE INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,Ropivacaine,ROPIVACAINE HYDROCHLORIDE,5MG,10x30mL,"BLOCK/INFILTRATION
EPIDURAL",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017/7/13,,2018/3/7,Disruption of the manufacture of the drug.,2017/7/21,2018/3/8,No
1540,2122049,Shortage,ROSONE CREAM 0.05%,LABORATOIRE RIVA INC,Betamethasone diproprionate cream,BETAMETHASONE DIPROPIONATE,0.05%,50 g & 450 g,TOPICAL,Actual shortage,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2014/4/11,2014/4/11,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
1542,2122030,Shortage,ROSONE LOTION 0.05%,LABORATOIRE RIVA INC,Betamethasone diproprionate lotion,BETAMETHASONE DIPROPIONATE,0.05%,30 ml & 75 ml,TOPICAL,Actual shortage,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",2014/4/11,2014/4/11,,,Delay in shipping of the drug.,2017/3/13,2017/10/5,No
1544,2122057,Shortage,ROSONE OINTMENT 0.05%,LABORATOIRE RIVA INC,Betamethasone diproprionate ointment,BETAMETHASONE DIPROPIONATE,0.05%,50g & 450 g,TOPICAL,Actual shortage,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",2014/4/11,2014/4/11,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
5663,2411636,Shortage,ROSUVASTATIN-10,SIVEM PHARMACEUTICALS ULC,ROSUVASTATIN-10,ROSUVASTATIN,10MG,90,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/4/27,2017/5/10,2017/5/10,Demand increase for the drug.,2017/4/5,2017/5/18,No
8282,2411636,Shortage,ROSUVASTATIN-10,SIVEM PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,10MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/4/27,,2017/5/10,2017/5/10,Demand increase for the drug.,2017/4/27,2017/5/18,No
5666,2411644,Shortage,ROSUVASTATIN-20,SIVEM PHARMACEUTICALS ULC,ROSUVASTATIN-20,ROSUVASTATIN,20MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/4/27,,2017/6/15,2017/5/5,Demand increase for the drug.,2017/4/5,2017/11/3,No
8285,2411652,Shortage,ROSUVASTATIN-40,SIVEM PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017/4/30,,2017/5/10,2017/5/10,Demand increase for the drug.,2017/4/27,2017/5/18,No
3208,2284413,Shortage,ROTATEQ,MERCK CANADA INC,"rotavirus vaccine, live, oral, pentavalent oral solution",HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G1 /G2/G3/G4/P1(8),2ML,1DOSE TUBE,oral,Resolved,Solution,J07BH,VIRAL VACCINES,,2017/8/1,2017/9/18,2017/9/15,Delay in shipping of the drug.,2017/3/17,2017/9/16,No
19341,1927825,Shortage,ROVAMYCINE 250 CAPSULE 750000 UNIT,ODAN LABORATORIES LTD,Spiramycin capsules,SPIRAMYCIN,750000UNIT,50,ORAL,Resolved,CAPSULE,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2018/2/1,2018/1/31,2018/5/18,2018/5/18,Disruption of the manufacture of the drug.,2017/8/14,2018/5/22,No
19338,1927817,Shortage,ROVAMYCINE 500 CAPSULE 1500000 UNIT,ODAN LABORATORIES LTD,Spiramycin capsules,SPIRAMYCIN,1500000UNIT,50,ORAL,Resolved,CAPSULE,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2017/8/14,2017/8/14,,2018/5/22,Disruption of the manufacture of the drug.,2017/8/14,2018/5/23,No
220,603716,Shortage,RYTHMOL,BGP PHARMA ULC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,300MG,100,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",,2016/12/14,,2017/6/20,Requirements related to complying with good manufacturing practices.,2017/3/10,2017/6/23,No
223,603708,Shortage,RYTHMOL,BGP PHARMA ULC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,150MG,100,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",,2017/2/3,,2017/6/20,Requirements related to complying with good manufacturing practices.,2017/3/10,2017/6/23,No
3826,2453258,Shortage,S.O.S. NALOXONE HYDROCHLORIDE INJECTION,SANDOZ CANADA INCORPORATED,NALOXONE,NALOXONE HYDROCHLORIDE,0.4MG,10 X 1ML AMPOULES,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,2017/4/7,,2017/6/16,2017/5/1,Demand increase for the drug.,2017/3/22,2017/6/26,No
20768,2064480,Shortage,SALAZOPYRIN TAB 500MG,PFIZER CANADA INC,Salazopyrin,SULFASALAZINE,500MG,100,ORAL,Resolved,TABLET,A07EC,INTESTINALANTIINFLAMMATORY AGENTS,2017/9/5,,2017/10/16,2017/10/13,Demand increase for the drug.,2017/9/1,2017/10/14,No
19806,511552,Shortage,SANDOMIGRAN DS,PALADIN LABS INC,Sandomigran,PIZOTIFEN,1MG,100 tablets,ORAL,Resolved,TABLET,N02CX,ANTIMIGRAINE PREPARATIONS,2019/4/24,,,2019/4/24,Disruption of the manufacture of the drug.,2017/8/18,2019/4/25,No
29082,2288109,Shortage,SANDOZ ALENDRONATE,SANDOZ CANADA INCORPORATED,ALENDRONATE,ALENDRONIC ACID,70MG,BLISTERS 4'S,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/9/28,2017/11/27,2017/11/24,Delay in shipping of the drug.,2017/11/14,2017/11/27,No
29085,2429160,Shortage,SANDOZ ALENDRONATE/CHOLECALCIFEROL,SANDOZ CANADA INCORPORATED,ALENDRONATE VITAMIN D,ALENDRONIC ACID VITAMIN D3,70MG 5600UNIT,BLISTERS 4'S,ORAL,Resolved,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/11/1,2018/6/8,2018/6/4,Demand increase for the drug.,2017/11/14,2018/7/3,No
14659,2405334,Shortage,SANDOZ ALMOTRIPTAN,SANDOZ CANADA INCORPORATED,ALMOTRIPTAN,ALMOTRIPTAN,12.5MG,BLISTERS OF 6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/7/3,2017/9/20,2017/9/25,Delay in shipping of the drug.,2017/7/5,2017/10/25,No
2857,2284391,Shortage,SANDOZ AMLODIPINE,SANDOZ CANADA INCORPORATED,AMLODIPINE,AMLODIPINE,10MG,500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/3/14,2017/4/7,2017/4/7,Demand increase for the drug.,2017/3/15,2017/4/11,No
2860,2284383,Shortage,SANDOZ AMLODIPINE,SANDOZ CANADA INCORPORATED,AMLODIPINE,AMLODIPINE,5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/3/14,2017/5/1,2017/5/14,Demand increase for the drug.,2017/3/15,2017/5/15,No
2674,2284391,Shortage,SANDOZ AMLODIPINE,SANDOZ CANADA INCORPORATED,AMLODIPINE,AMLODIPINE,10MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/3/14,2017/4/7,2017/5/22,Demand increase for the drug.,2017/3/14,2017/6/26,No
2677,2284383,Shortage,SANDOZ AMLODIPINE,SANDOZ CANADA INCORPORATED,AMLODIPINE,AMLODIPINE,5MG,500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/3/14,2017/4/14,2017/4/11,Demand increase for the drug.,2017/3/14,2017/4/12,No
9451,2457318,Shortage,SANDOZ AMPHETAMINE XR,SANDOZ CANADA INCORPORATED,SANDOZ AMPHETAMINE XR,DEXTROAMPHETAMINE SACCHARATE DEXTROAMPHETAMINE SULFATE AMPHETAMINE ASPARTATE MONOHYDRATE AMPHETAMINE SULFATE,3.75MG 3.75MG 3.75MG 3.75MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/5/5,2017/7/17,2017/7/31,Delay in shipping of the drug.,2017/5/8,2017/9/7,No
16716,2260107,Shortage,SANDOZ ANAGRELIDE,SANDOZ CANADA INCORPORATED,ANAGRELIDE,ANAGRELIDE,0.5MG,100,ORAL,Resolved,CAPSULE,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2017/7/21,2017/8/21,2017/8/11,Delay in shipping of the drug.,2017/7/24,2017/9/6,No
9454,2338467,Shortage,SANDOZ ANASTROZOLE,SANDOZ CANADA INCORPORATED,SANDOZ ANASTAZOLE,ANASTROZOLE,1MG,3X10BP,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017/5/5,,2017/5/12,Delay in shipping of the drug.,2017/5/8,2017/5/15,No
16719,2386437,Shortage,SANDOZ ATOMOXETINE,SANDOZ CANADA INCORPORATED,ATOMOXETINE,ATOMOXETINE,25MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/7/28,2017/11/27,2017/10/27,Demand increase for the drug.,2017/7/24,2017/11/27,No
16722,2386445,Shortage,SANDOZ ATOMOXETINE,SANDOZ CANADA INCORPORATED,ATOMOXETINE,ATOMOXETINE,40MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/7/28,2018/2/5,2018/1/26,Demand increase for the drug.,2017/7/24,2018/2/5,No
16728,2386453,Shortage,SANDOZ ATOMOXETINE,SANDOZ CANADA INCORPORATED,ATOMOXETINE,ATOMOXETINE,60MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/7/28,2018/5/4,2018/4/26,Demand increase for the drug.,2017/7/24,2018/5/3,No
16731,2386461,Shortage,SANDOZ ATOMOXETINE,SANDOZ CANADA INCORPORATED,ATOMOXETINE,ATOMOXETINE,80MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/7/28,2018/2/5,2018/1/26,Demand increase for the drug.,2017/7/24,2018/2/5,No
5558,2386445,Shortage,SANDOZ ATOMOXETINE,SANDOZ CANADA INCORPORATED,ATOMOXETINE,ATOMOXETINE,40MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/3/31,2017/4/24,2017/4/11,Demand increase for the drug.,2017/4/5,2017/4/12,No
5562,2386453,Shortage,SANDOZ ATOMOXETINE,SANDOZ CANADA INCORPORATED,ATOMOXETINE,ATOMOXETINE,60MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/3/31,2017/4/24,2017/4/13,Demand increase for the drug.,2017/4/5,2017/4/18,No
21261,2324970,Shortage,SANDOZ ATORVASTATIN,SANDOZ CANADA INCORPORATED,ATORVASTATIN,ATORVASTATIN,80MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/9/1,2017/9/22,2017/9/22,Demand increase for the drug.,2017/9/7,2017/10/25,No
29088,2324970,Shortage,SANDOZ ATORVASTATIN,SANDOZ CANADA INCORPORATED,ATORVASTATIN,ATORVASTATIN,80MG,100'S,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/10/13,2017/11/27,2017/11/24,Demand increase for the drug.,2017/11/14,2017/11/27,No
9457,2324954,Shortage,SANDOZ ATORVASTATIN,SANDOZ CANADA INCORPORATED,SANDOZ ATORVASTATIN,ATORVASTATIN,20MG,3X10,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/5/5,2017/5/22,2017/5/16,Delay in shipping of the drug.,2017/5/8,2017/6/26,No
9461,2324970,Shortage,SANDOZ ATORVASTATIN,SANDOZ CANADA INCORPORATED,SANDOZ ATORVASTATIN,ATORVASTATIN,80MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/5/5,2017/9/22,2017/9/22,Delay in shipping of the drug.,2017/5/8,2017/10/25,No
29091,2275082,Shortage,SANDOZ BUPROPION SR,SANDOZ CANADA INCORPORATED,BUPROPION,BUPROPION HYDROCHLORIDE,150MG,60'S,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2017/10/23,2017/11/20,2017/11/17,Delay in shipping of the drug.,2017/11/14,2017/11/27,No
21267,2417340,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,32MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/9/1,2017/9/11,2017/9/8,Delay in shipping of the drug.,2017/9/7,2017/9/9,No
21270,2326957,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/9/1,2017/9/18,2017/9/11,Delay in shipping of the drug.,2017/9/7,2017/10/25,No
21274,2326965,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/9/1,2017/9/11,2017/9/11,Delay in shipping of the drug.,2017/9/7,2017/9/12,No
29094,2326957,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,BLISTERS 3 X 10'S,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/10/20,2017/11/20,2017/11/16,Demand increase for the drug.,2017/11/14,2017/11/27,No
5565,2326965,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,500,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/4/3,2017/4/24,2017/5/5,Delay in shipping of the drug.,2017/4/5,2017/5/8,No
29198,2420732,Shortage,SANDOZ CANDESARTAN PLUS,SANDOZ CANADA INCORPORATED,CANDESARTAN HCT,HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL,12.5MG 32MG,100'S,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/11/9,2018/1/11,2018/1/11,Delay in shipping of the drug.,2017/11/14,2018/1/18,No
29201,2420740,Shortage,SANDOZ CANDESARTAN PLUS,SANDOZ CANADA INCORPORATED,CANDESARTAN HCT,HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL,25MG 32MG,100'S,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/11/9,2018/3/2,2018/3/23,Requirements related to complying with good manufacturing practices.,2017/11/14,2018/3/24,No
2863,2421917,Shortage,SANDOZ CAPECITABINE,SANDOZ CANADA INCORPORATED,CAPECITABINE,CAPECITABINE,150MG,60,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,,2017/3/14,2017/11/1,2017/10/30,Disruption of the manufacture of the drug.,2017/3/15,2017/11/6,No
2866,2421925,Shortage,SANDOZ CAPECITABINE,SANDOZ CANADA INCORPORATED,CAPECITABINE,CAPECITABINE,500MG,120,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,,2017/3/14,2017/4/14,2017/4/13,Demand increase for the drug.,2017/3/15,2017/4/18,No
2680,2421925,Shortage,SANDOZ CAPECITABINE,SANDOZ CANADA INCORPORATED,Sandoz CAPECITABINE,CAPECITABINE,500MG,12x10Bl,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,,2017/3/14,2017/4/14,2017/4/13,Disruption of the manufacture of the drug.,2017/3/14,2017/4/18,No
14876,2248170,Shortage,SANDOZ CITALOPRAM,SANDOZ CANADA INCORPORATED,CITALOPRAM,CITALOPRAM,20MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/7/3,2017/8/14,2017/8/21,Demand increase for the drug.,2017/7/6,2017/9/6,No
21277,2247074,Shortage,SANDOZ CYCLOSPORINE,SANDOZ CANADA INCORPORATED,CYCLOSPORINE,CYCLOSPORINE,50MG,3X10,ORAL,Resolved,CAPSULE,L04AD,IMMUNOSUPPRESSANTS,,2017/9/1,2017/9/17,2017/9/30,Delay in shipping of the drug.,2017/9/7,2017/10/18,No
26256,2247074,Shortage,SANDOZ CYCLOSPORINE,SANDOZ CANADA INCORPORATED,CYCLOSPORINE,CYCLOSPORINE,50MG,30,ORAL,Resolved,CAPSULE,L04AD,IMMUNOSUPPRESSANTS,2017/11/15,2017/12/11,2018/1/31,2018/2/1,Delay in shipping of the drug.,2017/10/18,2018/2/5,No
2881,2243340,Shortage,SANDOZ DILTIAZEM CD,SANDOZ CANADA INCORPORATED,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,240MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/3/14,2017/3/31,2017/3/17,Demand increase for the drug.,2017/3/15,2017/3/21,No
2699,2243340,Shortage,SANDOZ DILTIAZEM CD,SANDOZ CANADA INCORPORATED,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,240MG,100/BTL,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/3/14,2017/3/31,2017/3/17,Disruption of the manufacture of the drug.,2017/3/14,2017/3/21,No
14879,2245922,Shortage,SANDOZ DILTIAZEM T,SANDOZ CANADA INCORPORATED,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,360MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/7/3,,2019/9/28,Demand increase for the drug.,2017/7/6,2020/4/1,No
29100,2245919,Shortage,SANDOZ DILTIAZEM T,SANDOZ CANADA INCORPORATED,DILTIAZEM T,DILTIAZEM HYDROCHLORIDE,180MG,100'S,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/10/2,,2021/10/14,Delay in shipping of the drug.,2017/11/14,2021/10/14,No
21281,2367688,Shortage,SANDOZ DONEPEZIL ODT,SANDOZ CANADA INCORPORATED,DONEPEZIL ODT,DONEPEZIL HYDROCHLORIDE,5MG,3X10BL,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N06DA,ANTI-DEMENTIA DRUGS,,2017/9/1,2018/5/11,2018/5/18,Delay in shipping of the drug.,2017/9/7,2018/5/23,No
21357,2344351,Shortage,SANDOZ DORZOLAMIDE/TIMOLOL,SANDOZ CANADA INCORPORATED,DORZOLAMIDE/TIMOLOL,TIMOLOL DORZOLAMIDE,5MG 20MG,10mLbtl,OPHTHALMIC,Resolved,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2017/9/1,2017/9/19,2017/9/12,Delay in shipping of the drug.,2017/9/7,2017/10/25,No
29105,2439948,Shortage,SANDOZ DULOXETINE,SANDOZ CANADA INCORPORATED,DULOXETINE,DULOXETINE,30MG,100'S,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2017/10/25,2017/11/15,2017/11/15,Demand increase for the drug.,2017/11/14,2017/11/27,No
10295,2424444,Shortage,SANDOZ DUTASTERIDE CAPSULE,SANDOZ CANADA INCORPORATED,SANDOZ DUTASTERIDE,DUTASTERIDE,0.5MG,100,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2017/5/12,,2017/6/26,2017/8/18,Demand increase for the drug.,2017/5/15,2017/10/25,No
2884,2424444,Shortage,SANDOZ DUTASTERIDE CAPSULE,SANDOZ CANADA INCORPORATED,DUTASTERIDE,DUTASTERIDE,0.5MG,100,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/3/14,2017/7/24,2017/8/3,Delay in shipping of the drug.,2017/3/15,2017/9/6,No
2702,2424444,Shortage,SANDOZ DUTASTERIDE CAPSULE,SANDOZ CANADA INCORPORATED,DUTASTERIDE,DUTASTERIDE,0.5MG,3x10/Bl,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/3/14,2017/7/24,2017/7/26,Demand increase for the drug.,2017/3/14,2017/9/7,No
29108,2424444,Shortage,SANDOZ DUTASTERIDE CAPSULE,SANDOZ CANADA INCORPORATED,DUTASTERIDE,DUTASTERIDE,0.5MG,100'S,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/10/16,2018/3/2,2018/3/8,Demand increase for the drug.,2017/11/14,2018/4/13,No
29111,2424444,Shortage,SANDOZ DUTASTERIDE CAPSULE,SANDOZ CANADA INCORPORATED,DUTASTERIDE,DUTASTERIDE,0.5MG,30'S,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/9/11,2018/3/9,2018/3/8,Demand increase for the drug.,2017/11/14,2018/4/13,No
5573,2424444,Shortage,SANDOZ DUTASTERIDE CAPSULE,SANDOZ CANADA INCORPORATED,DUTASTERIDE,DUTASTERIDE,0.5MG,30,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/3/31,2017/7/24,2017/7/26,Demand increase for the drug.,2017/4/5,2017/9/6,No
16736,2299976,Shortage,SANDOZ ENALAPRIL,SANDOZ CANADA INCORPORATED,ENALAPRIL,ENALAPRIL SODIUM,16MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/7/21,2017/8/28,2017/8/21,Demand increase for the drug.,2017/7/24,2017/9/6,No
3863,2364077,Shortage,SANDOZ ESCITALOPRAM,SANDOZ CANADA INCORPORATED,ESCITALOPRAM,ESCITALOPRAM,10MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/3/17,2017/4/7,2017/4/13,Demand increase for the drug.,2017/3/22,2017/4/18,No
3866,2364077,Shortage,SANDOZ ESCITALOPRAM,SANDOZ CANADA INCORPORATED,ESCITALOPRAM,ESCITALOPRAM,10MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/3/17,2017/4/7,2017/4/13,Demand increase for the drug.,2017/3/22,2017/4/18,No
3869,2416778,Shortage,SANDOZ EZETIMIBE,SANDOZ CANADA INCORPORATED,EZETIMIBE,EZETIMIBE,10MG,100,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017/3/17,2017/4/7,2017/4/4,Demand increase for the drug.,2017/3/22,2017/4/4,No
5576,2416778,Shortage,SANDOZ EZETIMIBE,SANDOZ CANADA INCORPORATED,EZETIMIBE,EZETIMIBE,10MG,30,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017/3/31,2017/5/29,2017/5/23,Requirements related to complying with good manufacturing practices.,2017/4/5,2017/10/25,No
9467,2278634,Shortage,SANDOZ FAMCICLOVIR,SANDOZ CANADA INCORPORATED,SANDOZ FAMCICLOVIR,FAMCICLOVIR,125MG,1X10,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/5/5,,2017/5/15,Delay in shipping of the drug.,2017/5/8,2017/5/16,No
9470,2278650,Shortage,SANDOZ FAMCICLOVIR,SANDOZ CANADA INCORPORATED,SANDOZ FAMCICLOVIR,FAMCICLOVIR,500MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/5/5,2017/5/15,2017/6/2,Delay in shipping of the drug.,2017/5/8,2017/6/6,No
16739,2288052,Shortage,SANDOZ FENOFIBRATE S,SANDOZ CANADA INCORPORATED,FENOFIBRATE,FENOFIBRATE,160MG,90,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2017/7/21,2017/9/18,2017/8/28,Delay in shipping of the drug.,2017/7/24,2017/9/6,No
13929,2322579,Shortage,SANDOZ FINASTERIDE,SANDOZ CANADA INCORPORATED,FINASTERIDE,FINASTERIDE,5MG,100,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/6/23,2017/7/14,2017/8/11,Delay in shipping of the drug.,2017/6/26,2017/9/7,No
9473,2269589,Shortage,SANDOZ GLIMEPIRIDE,SANDOZ CANADA INCORPORATED,SANDOZ GLIMEPIRIDE,GLIMEPIRIDE,1MG,3X10,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/5/5,2017/7/17,2017/7/6,Delay in shipping of the drug.,2017/5/8,2017/9/6,No
29114,2328461,Shortage,SANDOZ IRBESARTAN,SANDOZ CANADA INCORPORATED,IRBESARTAN,IRBESARTAN,75MG,100'S,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/11/3,2017/11/20,2017/11/22,Delay in shipping of the drug.,2017/11/14,2017/11/27,No
21284,2337444,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN HCT,HYDROCHLOROTHIAZIDE IRBESARTAN,25MG 300MG,500,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/9/1,2017/9/26,2017/9/15,Delay in shipping of the drug.,2017/9/7,2017/10/25,No
2887,2337444,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE IRBESARTAN,25MG 300MG,500,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/3/14,2017/4/28,2017/5/5,Delay in shipping of the drug.,2017/3/15,2017/5/8,No
2705,2337444,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN HCT,HYDROCHLOROTHIAZIDE IRBESARTAN,25MG 300MG,500/Btl,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/3/14,2017/4/30,2017/5/5,Delay in shipping of the drug.,2017/3/14,2017/5/8,No
29117,2461994,Shortage,SANDOZ LEVETIRACETAM,SANDOZ CANADA INCORPORATED,LEVETIRACETAM,LEVETIRACETAM,500MG,100'S,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/10/16,2018/3/5,2018/3/27,Delay in shipping of the drug.,2017/11/14,2018/4/13,No
2890,2289199,Shortage,SANDOZ LISINOPRIL,SANDOZ CANADA INCORPORATED,LISINOPRIL,LISINOPRIL,5MG,30,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/3/14,,2017/4/28,Delay in shipping of the drug.,2017/3/15,2017/4/29,No
2708,2289199,Shortage,SANDOZ LISINOPRIL,SANDOZ CANADA INCORPORATED,LISINOPRIL,LISINOPRIL,5MG,2x15/Bl,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/3/14,2017/4/30,2017/5/5,Delay in shipping of the drug.,2017/3/14,2017/5/8,No
21287,2313340,Shortage,SANDOZ LOSARTAN,SANDOZ CANADA INCORPORATED,LOSARTAN,LOSARTAN POTASSIUM,50MG,3X10BL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/9/1,2017/10/9,2017/10/6,Delay in shipping of the drug.,2017/9/7,2017/10/25,No
16747,2328593,Shortage,SANDOZ MONTELUKAST TABLET,SANDOZ CANADA INCORPORATED,MONTELUKAST,MONTELUKAST,10MG,100,ORAL,Resolved,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2017/7/21,2017/8/7,2017/7/26,Requirements related to complying with good manufacturing practices.,2017/7/24,2017/9/6,No
29186,2411520,Shortage,SANDOZ MOXIFLOXACIN,SANDOZ CANADA INCORPORATED,MOXIFLOXACIN,MOXIFLOXACIN,0.50%,500'S,OPHTHALMIC,Resolved,SOLUTION,S01AE,ANTIINFECTIVES,,2017/9/25,2017/11/20,2017/11/23,Demand increase for the drug.,2017/11/14,2017/11/27,No
10329,2411520,Shortage,SANDOZ MOXIFLOXACIN,SANDOZ CANADA INCORPORATED,SANDOZ MOXIFLOXACIN,MOXIFLOXACIN,0.50%,3ML BTL/BOUT,OPHTHALMIC,Resolved,SOLUTION,S01AE,ANTIINFECTIVES,,2017/5/12,2017/5/22,2017/5/22,Delay in shipping of the drug.,2017/5/15,2017/6/26,No
13932,2327783,Shortage,SANDOZ OLANZAPINE ODT,SANDOZ CANADA INCORPORATED,OLANZAPINE,OLANZAPINE,10MG,3X10 BLISTERS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017/6/23,2017/10/30,2017/10/30,Demand increase for the drug.,2017/6/26,2017/11/6,No
13935,2327791,Shortage,SANDOZ OLANZAPINE ODT,SANDOZ CANADA INCORPORATED,OLANZAPINE,OLANZAPINE,15MG,3X10 BLISTERS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017/6/23,2017/10/30,2017/10/30,Demand increase for the drug.,2017/6/26,2017/11/6,No
13938,2327805,Shortage,SANDOZ OLANZAPINE ODT,SANDOZ CANADA INCORPORATED,OLANZAPINE,OLANZAPINE,20MG,3X10 BLISTERS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017/6/23,2017/10/30,2017/10/30,Demand increase for the drug.,2017/6/26,2017/11/27,No
29204,2443414,Shortage,SANDOZ OLMESARTAN,SANDOZ CANADA INCORPORATED,OLMERSARTAN,OLMESARTAN MEDOXOMIL,20MG,BLISTERS 3 X 10'S,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/11/6,2018/5/11,2018/5/18,Demand increase for the drug.,2017/11/14,2018/5/23,No
21291,2443422,Shortage,SANDOZ OLMESARTAN,SANDOZ CANADA INCORPORATED,OLMESARTAN,OLMESARTAN MEDOXOMIL,40MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/9/1,2017/11/20,2017/10/30,Demand increase for the drug.,2017/9/7,2017/11/13,No
16750,2443422,Shortage,SANDOZ OLMESARTAN,SANDOZ CANADA INCORPORATED,OLMESARTAN,OLMESARTAN MEDOXOMIL,40MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/7/14,2017/8/14,2017/9/4,Demand increase for the drug.,2017/7/24,2017/9/6,No
21353,2420171,Shortage,SANDOZ OLOPATADINE 0.2%,SANDOZ CANADA INCORPORATED,OLOPATADINE 0.2%,OLOPATADINE,0.20%,2.5mLbtl,OPHTHALMIC,Resolved,SOLUTION,S01GX,DECONGESTANTS AND ANTIALLERGICS,,2017/9/1,2017/9/18,2017/10/3,Demand increase for the drug.,2017/9/7,2017/10/25,No
2893,2296446,Shortage,SANDOZ OMEPRAZOLE,SANDOZ CANADA INCORPORATED,OMEPRAZOLE,OMEPRAZOLE,20MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/3/14,2017/4/28,2017/4/28,Demand increase for the drug.,2017/3/15,2017/5/8,No
2711,2296446,Shortage,SANDOZ OMEPRAZOLE,SANDOZ CANADA INCORPORATED,OMEPRAZOLE,OMEPRAZOLE,20MG,100/Btl,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/3/14,2017/4/30,2017/4/30,Delay in shipping of the drug.,2017/3/14,2017/5/8,No
21298,2274310,Shortage,SANDOZ ONDANSETRON,SANDOZ CANADA INCORPORATED,Sandoz ONDANSETRON,ONDANSETRON,4MG,100,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017/9/1,,2017/9/25,Demand increase for the drug.,2017/9/7,2017/9/26,No
21301,2274329,Shortage,SANDOZ ONDANSETRON,SANDOZ CANADA INCORPORATED,ONDANSETRON,ONDANSETRON,8MG,100,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017/9/1,2017/10/30,2017/10/13,Demand increase for the drug.,2017/9/7,2017/11/6,No
10326,2444674,Shortage,SANDOZ ONDANSETRON ODT,SANDOZ CANADA INCORPORATED,SANDOZ ONDANSETRON ODT,ONDANSETRON,4MG,1X10,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017/5/5,2017/7/10,2017/7/10,Delay in shipping of the drug.,2017/5/15,2017/9/7,No
29122,2444682,Shortage,SANDOZ ONDANSETRON ODT,SANDOZ CANADA INCORPORATED,ONDANSETRON,ONDANSETRON,8MG,BLISTERS 10'S,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017/10/3,2017/11/20,2017/11/15,Demand increase for the drug.,2017/11/14,2017/11/27,No
9505,2307898,Shortage,SANDOZ OXYCODONE/ACETAMINOPHEN,SANDOZ CANADA INCORPORATED,sandoz OXYCODONE+ACET,ACETAMINOPHEN OXYCODONE HYDROCHLORIDE,325MG 5MG,100,ORAL,Resolved,TABLET,N02AJ,,,2017/4/28,2017/9/18,2017/10/20,Demand increase for the drug.,2017/5/8,2017/10/25,No
9508,2307898,Shortage,SANDOZ OXYCODONE/ACETAMINOPHEN,SANDOZ CANADA INCORPORATED,SANDOZ OXYCODONE+ACET,ACETAMINOPHEN OXYCODONE HYDROCHLORIDE,325MG 5MG,500,ORAL,Resolved,TABLET,N02AJ,,,2017/4/28,2017/10/16,2017/10/20,Demand increase for the drug.,2017/5/8,2017/10/25,No
21305,2315262,Shortage,SANDOZ PRAMIPEXOLE,SANDOZ CANADA INCORPORATED,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2017/9/1,2018/6/22,2018/6/13,Demand increase for the drug.,2017/9/7,2018/7/3,No
21308,2315270,Shortage,SANDOZ PRAMIPEXOLE,SANDOZ CANADA INCORPORATED,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2017/9/1,2018/6/1,2018/6/13,Demand increase for the drug.,2017/9/7,2018/7/3,No
3872,2390841,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,150MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/3/21,2017/4/14,2017/4/13,Demand increase for the drug.,2017/3/22,2017/4/18,No
3875,2390868,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/3/21,2017/6/23,2017/5/5,Demand increase for the drug.,2017/3/22,2017/5/8,No
21312,2390841,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,150MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/9/1,2018/2/5,2018/2/1,Demand increase for the drug.,2017/9/7,2018/2/5,No
21315,2390817,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,25MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/9/1,2018/3/2,2018/2/22,Demand increase for the drug.,2017/9/7,2018/4/13,No
21319,2390825,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,50MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/9/1,2018/2/5,2018/2/1,Demand increase for the drug.,2017/9/7,2018/2/5,No
2896,2390825,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,50MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/3/14,2017/4/7,2017/4/13,Demand increase for the drug.,2017/3/15,2017/4/18,No
2899,2390833,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,75MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/3/14,2017/3/31,2017/4/13,Demand increase for the drug.,2017/3/15,2017/4/18,No
2714,2390825,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,50MG,100Btl,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/3/14,2017/3/31,2017/4/13,Demand increase for the drug.,2017/3/14,2017/4/18,No
2717,2390833,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,Sandoz PREGABALIN,PREGABALIN,75MG,100Btl,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/3/14,2017/3/31,2017/4/13,Demand increase for the drug.,2017/3/14,2017/4/18,No
29129,2390868,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,300MG,100'S,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/10/30,2018/5/18,2018/5/18,Delay in shipping of the drug.,2017/11/14,2018/5/23,No
29132,2390833,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,75MG,100'S,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/10/30,2018/2/5,2018/2/5,Demand increase for the drug.,2017/11/14,2018/2/6,No
3888,2242527,Shortage,SANDOZ PROCTOMYXIN HC,SANDOZ CANADA INCORPORATED,PROCTOMYXIN,DIBUCAINE HYDROCHLORIDE HYDROCORTISONE FRAMYCETIN SULFATE ESCULIN,5MG 5MG 10MG 10MG,15G,RECTAL,Resolved,OINTMENT,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,,2017/3/21,2017/4/7,2017/4/7,Requirements related to complying with good manufacturing practices.,2017/3/22,2017/5/8,No
3891,2242527,Shortage,SANDOZ PROCTOMYXIN HC,SANDOZ CANADA INCORPORATED,PROCTOMYXIN,DIBUCAINE HYDROCHLORIDE HYDROCORTISONE FRAMYCETIN SULFATE ESCULIN,5MG 5MG 10MG 10MG,30G,RECTAL,Resolved,OINTMENT,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,,2017/3/21,2017/4/7,2017/4/7,Requirements related to complying with good manufacturing practices.,2017/3/22,2017/5/8,No
3885,2242528,Shortage,SANDOZ PROCTOMYXIN HC SUPPOSITORIES,SANDOZ CANADA INCORPORATED,PROCTOMYXIN,DIBUCAINE HYDROCHLORIDE HYDROCORTISONE FRAMYCETIN SULFATE ESCULIN,5MG 5MG 10MG 10MG,12,RECTAL,Resolved,SUPPOSITORY,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,,2017/3/21,2017/4/7,2017/3/23,Disruption of the manufacture of the drug.,2017/3/22,2017/3/28,No
2624,2313995,Shortage,SANDOZ QUETIAPINE,SANDOZ CANADA INCORPORATED,Sandoz QUETIAPINE,QUETIAPINE,25MG,25mg 500/Btl,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017/3/14,2017/4/7,2017/4/12,Demand increase for the drug.,2017/3/14,2017/4/18,No
2629,2313995,Shortage,SANDOZ QUETIAPINE,SANDOZ CANADA INCORPORATED,Sandoz QUETIAPINE,QUETIAPINE,25MG,25mg 500/Btl,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017/3/14,2017/4/30,2017/5/15,Demand increase for the drug.,2017/3/14,2017/5/17,No
29155,2314002,Shortage,SANDOZ QUETIAPINE,SANDOZ CANADA INCORPORATED,QUETIAPINE,QUETIAPINE,100MG,500'S,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017/10/2,2018/6/8,2018/6/15,Delay in shipping of the drug.,2017/11/14,2018/7/3,No
2626,2407698,Shortage,SANDOZ QUETIAPINE XRT,SANDOZ CANADA INCORPORATED,Sandoz QUETIAPINE XRT,QUETIAPINE,150MG,150mg 100/Btl,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017/3/14,2017/8/28,2017/5/16,Demand increase for the drug.,2017/3/14,2017/5/17,No
2632,2407701,Shortage,SANDOZ QUETIAPINE XRT,SANDOZ CANADA INCORPORATED,Sandoz QUETIAPINE XRT,QUETIAPINE,200MG,200mg 100/Btl,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017/3/14,2017/5/1,2017/5/1,Demand increase for the drug.,2017/3/14,2017/5/15,No
21322,2407701,Shortage,SANDOZ QUETIAPINE XRT,SANDOZ CANADA INCORPORATED,QUETIAPINE XRT,QUETIAPINE,200MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017/9/1,2017/12/18,2017/10/24,Demand increase for the drug.,2017/9/7,2017/11/14,No
21328,2407728,Shortage,SANDOZ QUETIAPINE XRT,SANDOZ CANADA INCORPORATED,QUETIAPINE XRT,QUETIAPINE,300MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017/9/1,2017/10/23,2017/10/6,Demand increase for the drug.,2017/9/7,2017/10/25,No
2641,2407728,Shortage,SANDOZ QUETIAPINE XRT,SANDOZ CANADA INCORPORATED,QUETIAPINE XRT,QUETIAPINE,300MG,300mg 100/Btl,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017/3/14,2017/4/30,2017/5/1,Demand increase for the drug.,2017/3/14,2017/5/15,No
21331,2407671,Shortage,SANDOZ QUETIAPINE XRT,SANDOZ CANADA INCORPORATED,QUETIAPINE XRT,QUETIAPINE,50MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017/9/1,2017/9/18,2017/10/6,Demand increase for the drug.,2017/9/7,2017/10/25,No
2645,2407736,Shortage,SANDOZ QUETIAPINE XRT,SANDOZ CANADA INCORPORATED,QUETIAPINE XRT,QUETIAPINE,400MG,400mg 100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017/3/14,2017/5/31,2017/5/1,Demand increase for the drug.,2017/3/14,2017/5/15,No
2648,2407671,Shortage,SANDOZ QUETIAPINE XRT,SANDOZ CANADA INCORPORATED,QUETIAPINE XRT,QUETIAPINE,50MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017/3/14,2017/9/18,2017/10/6,Demand increase for the drug.,2017/3/14,2017/10/25,No
29160,2407728,Shortage,SANDOZ QUETIAPINE XRT,SANDOZ CANADA INCORPORATED,QUETIAPINE,QUETIAPINE,300MG,100'S,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017/10/23,2018/1/15,2017/12/22,Demand increase for the drug.,2017/11/14,2018/1/18,No
21334,2243230,Shortage,SANDOZ RANITIDINE,SANDOZ CANADA INCORPORATED,RANITIDINE,RANITIDINE,300MG,100,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/9/1,2017/11/6,2017/10/6,Demand increase for the drug.,2017/9/7,2017/11/6,No
10310,2357453,Shortage,SANDOZ REPAGLINIDE,SANDOZ CANADA INCORPORATED,SANDOZ REPAGLINIDE,REPAGLINIDE,0.5MG,100,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/5/12,2017/6/19,2017/6/21,Delay in shipping of the drug.,2017/5/15,2017/6/26,No
2651,2357488,Shortage,SANDOZ REPAGLINIDE,SANDOZ CANADA INCORPORATED,REPAGLINIDE,REPAGLINIDE,2MG,100,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017/3/14,2017/4/21,2017/4/28,Demand increase for the drug.,2017/3/14,2017/5/8,No
3878,2324563,Shortage,SANDOZ RIVASTIGMINE,SANDOZ CANADA INCORPORATED,RIVASTIGMINE,RIVASTIGMINE,1.5MG,56,ORAL,Resolved,CAPSULE,N06DA,ANTI-DEMENTIA DRUGS,,2017/3/21,2017/5/22,2017/5/16,Disruption of the manufacture of the drug.,2017/3/22,2017/5/17,No
21337,2338726,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,5MG,2x15BL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/9/1,2017/9/18,2017/9/15,Demand increase for the drug.,2017/9/7,2017/10/25,No
29168,2338734,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,10MG,100'S,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/10/30,2018/3/30,2018/3/23,Demand increase for the drug.,2017/11/14,2018/4/13,No
29171,2338742,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,20MG,100'S,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/11/9,2018/3/9,2018/3/16,Demand increase for the drug.,2017/11/14,2018/3/23,No
29174,2338750,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,40MG,100'S,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/11/1,2018/7/13,2018/7/6,Delay in shipping of the drug.,2017/11/14,2018/7/12,No
29177,2338726,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,5MG,BLISTERS 2 X 15,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/11/1,2017/11/20,2017/11/14,Demand increase for the drug.,2017/11/14,2017/11/27,No
21340,2245159,Shortage,SANDOZ SERTRALINE,SANDOZ CANADA INCORPORATED,SERTRALINE,SERTRALINE,25MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017/9/1,2017/10/9,2017/10/19,Delay in shipping of the drug.,2017/9/7,2017/10/25,No
3882,2399040,Shortage,SANDOZ SOLIFENACIN,SANDOZ CANADA INCORPORATED,SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/3/21,2017/5/15,2017/5/5,Delay in shipping of the drug.,2017/3/22,2017/5/8,No
2654,2263033,Shortage,SANDOZ SUMATRIPTAN,SANDOZ CANADA INCORPORATED,SUMATRIPTAN,SUMATRIPTAN,100MG,1x6bl,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/3/14,2017/6/12,2017/5/12,Demand increase for the drug.,2017/3/14,2017/5/15,No
21350,2319217,Shortage,SANDOZ TAMSULOSIN,SANDOZ CANADA INCORPORATED,TAMSULOSIN SR,TAMSULOSIN HYDROCHLORIDE,0.4MG,100,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/9/1,2017/11/20,2017/11/14,Delay in shipping of the drug.,2017/9/7,2017/11/27,No
21343,2340208,Shortage,SANDOZ TAMSULOSIN CR,SANDOZ CANADA INCORPORATED,TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/9/1,2017/11/6,2017/10/27,Demand increase for the drug.,2017/9/7,2017/10/28,No
21347,2340208,Shortage,SANDOZ TAMSULOSIN CR,SANDOZ CANADA INCORPORATED,Sandoz TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,500,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/9/1,2017/11/6,2017/10/27,Demand increase for the drug.,2017/9/7,2017/10/28,No
10317,2375958,Shortage,SANDOZ TELMISARTAN,SANDOZ CANADA INCORPORATED,SANDOZ TELMISARTAN,TELMISARTAN,40MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/5/5,2017/5/22,2017/5/22,Delay in shipping of the drug.,2017/5/15,2017/6/13,No
2657,2375958,Shortage,SANDOZ TELMISARTAN,SANDOZ CANADA INCORPORATED,TELMISARTAN,TELMISARTAN,40MG,10x3,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/3/14,2017/4/24,2017/5/5,Demand increase for the drug.,2017/3/14,2017/5/8,No
13941,2375958,Shortage,SANDOZ TELMISARTAN,SANDOZ CANADA INCORPORATED,TELMISARTAN,TELMISARTAN,40MG,500,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/6/16,2017/7/26,2017/7/26,Delay in shipping of the drug.,2017/6/26,2017/9/7,No
13944,2393557,Shortage,SANDOZ TELMISARTAN HCT,SANDOZ CANADA INCORPORATED,TELMISARTAN HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE TELMISARTAN,12.5MG 80MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/6/23,2017/7/17,2017/6/27,Demand increase for the drug.,2017/6/26,2017/9/7,No
10333,2166720,Shortage,SANDOZ TIMOLOL,SANDOZ CANADA INCORPORATED,SANDOZ TIMOLOL,TIMOLOL,0.50%,10ML BTL/BOUT,OPHTHALMIC,Resolved,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2017/5/5,2017/5/29,2017/6/5,Delay in shipping of the drug.,2017/5/15,2017/6/26,No
10336,2241755,Shortage,SANDOZ TOBRAMYCIN 0.3%,SANDOZ CANADA INCORPORATED,SANDOZ TOBRAMYCIN,TOBRAMYCIN,0.30%,5ML BTL/BOUT,OPHTHALMIC,Resolved,SOLUTION,S01AA,ANTIINFECTIVES,,2017/5/12,2017/5/22,2017/8/25,Delay in shipping of the drug.,2017/5/15,2017/9/7,No
2660,2413140,Shortage,SANDOZ TOLTERODINE LA,SANDOZ CANADA INCORPORATED,Sandoz TOLTERODINE LA,TOLTERODINE TARTRATE,2MG,30/Btl,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/3/14,2017/3/31,2017/4/13,Disruption of the manufacture of the drug.,2017/3/14,2017/4/18,No
2663,2413159,Shortage,SANDOZ TOLTERODINE LA,SANDOZ CANADA INCORPORATED,TOLTERODINE LA,TOLTERODINE TARTRATE,4MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/3/14,2017/3/31,2017/4/7,Disruption of the manufacture of the drug.,2017/3/14,2017/4/11,No
2666,2413159,Shortage,SANDOZ TOLTERODINE LA,SANDOZ CANADA INCORPORATED,TOLTERODINE LA,TOLTERODINE TARTRATE,4MG,30,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/3/14,2017/3/31,2017/4/7,Disruption of the manufacture of the drug.,2017/3/14,2017/4/11,No
29180,2413159,Shortage,SANDOZ TOLTERODINE LA,SANDOZ CANADA INCORPORATED,TOLTERODINE,TOLTERODINE TARTRATE,4MG,100'S,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/10/23,2017/11/20,2017/11/22,Delay in shipping of the drug.,2017/11/14,2017/11/27,No
29183,2413159,Shortage,SANDOZ TOLTERODINE LA,SANDOZ CANADA INCORPORATED,TOLTERODINE,TOLTERODINE TARTRATE,4MG,30'S,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/11/1,2017/11/20,2017/11/22,Demand increase for the drug.,2017/11/14,2017/11/27,No
29192,2431815,Shortage,SANDOZ TOPIRAMATE TABLETS,SANDOZ CANADA INCORPORATED,TOPIRAMATE,TOPIRAMATE,100MG,100'S,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/11/6,2018/11/9,2018/11/12,Delay in shipping of the drug.,2017/11/14,2018/11/13,No
16757,2431823,Shortage,SANDOZ TOPIRAMATE TABLETS,SANDOZ CANADA INCORPORATED,TOPIRAMATE,TOPIRAMATE,200MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/7/21,2018/11/9,2018/11/12,Delay in shipping of the drug.,2017/7/24,2018/11/13,No
9491,2347091,Shortage,SANDOZ VALACYCLOVIR,SANDOZ CANADA INCORPORATED,SANDOZ VALACYCLOVIR,VALACYCLOVIR,500MG,90,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/5/5,2018/5/4,2018/5/4,Other (Please describe in comments),2017/5/8,2018/5/7,No
9497,2257572,Shortage,SANDOZ ZOPICLONE,SANDOZ CANADA INCORPORATED,SANDOZ ZOPICLONE,ZOPICLONE,5MG,100,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,,2017/5/5,,2017/5/12,Delay in shipping of the drug.,2017/5/8,2017/5/15,No
5569,2261847,Shortage,SANDOZ-CARBAMAZEPINE CR,SANDOZ CANADA INCORPORATED,CARBAMAZEPINE,CARBAMAZEPINE,400MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N03AF,ANTIEPILEPTICS,,2017/3/31,2017/6/19,2017/6/2,Requirements related to complying with good manufacturing practices.,2017/4/5,2017/6/6,No
1099,541869,Shortage,SCOPOLAMINE HYDROBROMIDE INJECTION 0.4MG/ML,HOSPIRA HEALTHCARE CORPORATION,SCOPOLAMINE,SCOPOLAMINE HYDROBROMIDE,0.4mg,0.4mg/mL x 10,"INTRAVENOUS
INTRAMUSCULAR
SUBCUTANEOUS",Resolved,Solution,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2015/7/28,2017/8/11,2017/8/8,Disruption of the manufacture of the drug.,2017/3/13,2017/8/9,No
30651,541869,Shortage,SCOPOLAMINE HYDROBROMIDE INJECTION 0.4MG/ML,HOSPIRA HEALTHCARE CORPORATION,Scopolamine,SCOPOLAMINE HYDROBROMIDE,.4MG,10x1mL AMP,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2017/12/29,,2018/10/23,Other (Please describe in comments),2017/11/24,2018/10/24,No
23832,541877,Shortage,SCOPOLAMINE HYDROBROMIDE INJECTION 0.6MG/ML,HOSPIRA HEALTHCARE CORPORATION,Scopolamine,SCOPOLAMINE HYDROBROMIDE,.6MG,10x1mL,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2017/9/29,,2018/10/23,Other (Please describe in comments),2017/9/28,2018/11/5,No
1123,541877,Shortage,SCOPOLAMINE HYDROBROMIDE INJECTION 0.6MG/ML,HOSPIRA HEALTHCARE CORPORATION,SCOPOLAMINE,SCOPOLAMINE HYDROBROMIDE,.6MG,0.6mg/mL x 10,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2015/7/28,2017/8/31,2017/8/31,Disruption of the manufacture of the drug.,2017/3/13,2017/9/1,No
14873,2442639,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,100MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/7/3,2018/2/26,2018/3/2,Delay in shipping of the drug.,2017/7/6,2018/3/3,No
2869,2442639,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,100MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/3/14,2017/4/21,2017/5/5,Disruption of the manufacture of the drug.,2017/3/15,2017/5/8,No
2872,2442639,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,100MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/3/14,2017/4/21,2017/5/5,Disruption of the manufacture of the drug.,2017/3/15,2017/5/8,No
2875,2442647,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,200MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/3/14,2017/8/18,2017/5/5,Disruption of the manufacture of the drug.,2017/3/15,2017/5/8,No
2878,2442647,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,200MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/3/14,2017/4/21,2017/5/5,Disruption of the manufacture of the drug.,2017/3/15,2017/5/8,No
2683,2442639,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,Sandoz CELECOXIB,CELECOXIB,100MG,100/Btl,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/3/14,2017/4/30,2017/5/5,Demand increase for the drug.,2017/3/14,2017/5/8,No
2685,2442639,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,100MG,500/Btl,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/3/14,2017/4/30,2017/5/5,Demand increase for the drug.,2017/3/14,2017/5/8,No
2693,2442647,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,200MG,100/Btl,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/3/14,2017/8/31,2017/5/5,Demand increase for the drug.,2017/3/14,2017/5/8,No
2696,2442647,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,200MG,500/Btl,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/3/14,2017/4/30,2017/5/5,Demand increase for the drug.,2017/3/14,2017/5/8,No
29097,2442639,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,100MG,100'S,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017/9/19,2018/2/23,2018/2/26,Requirements related to complying with good manufacturing practices.,2017/11/14,2018/3/2,No
1193,695033,Shortage,SELAX SYR 20MG/5ML USP,ODAN LABORATORIES LTD,"Docusate Sodium Syrup, USP",DOCUSATE SODIUM,20MG,250 mL,ORAL,Actual shortage,SYRUP,A06AA,DRUGS FOR CONSTIPATION,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/5,No
26084,1976184,Shortage,SENSORCAINE WITH EPINEPHRINE,ASPEN PHARMACARE CANADA INC.,"Sensorcaine® 0.25% w/epi1:200M, 10x20mL SU Vial",BUPIVACAINE HYDROCHLORIDE EPINEPHRINE,2.5MG 5MCG,10,"BLOCK/INFILTRATION
EPIDURAL",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017/10/20,,2018/2/23,2018/2/21,Other (Please describe in comments),2017/10/16,2018/2/22,No
31985,1976206,Shortage,SENSORCAINE WITH EPINEPHRINE,ASPEN PHARMACARE CANADA INC.,"Sensorcaine® 0.5% w/epi. 1:200M, 10x20mL SU Vial",BUPIVACAINE HYDROCHLORIDE EPINEPHRINE,5MG 5MCG,10 x 20mL,"BLOCK/INFILTRATION
EPIDURAL",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017/12/4,2018/3/5,2018/3/13,Delay in shipping of the drug.,2017/12/7,2018/3/14,No
12813,2431629,Shortage,SEPTA-CITALOPRAM,SEPTA PHARMACEUTICALS INC,Citalopram,CITALOPRAM,10MG,100s,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2017/6/15,,,Other (Please describe in comments),2017/6/15,2018/12/21,No
26238,2424975,Shortage,SEPTA-LOSARTAN,SEPTA PHARMACEUTICALS INC,Losartan 50 mg,LOSARTAN POTASSIUM,50MG,100s,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/10/5,2017/11/5,2017/11/23,Other (Please describe in comments),2017/10/18,2017/11/24,No
30627,2379767,Shortage,SEPTA-METFORMIN,SEPTA PHARMACEUTICALS INC,Metformin,METFORMIN HYDROCHLORIDE,500MG,500s,ORAL,Actual shortage,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017/11/24,2017/11/24,,,Other (Please describe in comments),2017/11/24,2017/11/25,No
14082,2428474,Shortage,SEPTA-ZOLMITRIPTAN-ODT,SEPTA PHARMACEUTICALS INC,Zolmitriptan Orally Disintegrating tablets,ZOLMITRIPTAN,2.5MG,6s,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2017/6/27,,,Disruption of the manufacture of the drug.,2017/6/27,2019/8/1,No
13422,2386909,Shortage,SEPTA-ZOPICLONE,SEPTA PHARMACEUTICALS INC,Zopiclone,ZOPICLONE,5MG,100s,ORAL,Actual shortage,TABLET,N05CF,HYPNOTICS AND SEDATIVES,2017/6/20,2017/6/20,,,Other (Please describe in comments),2017/6/20,2018/12/21,No
13442,2386917,Shortage,SEPTA-ZOPICLONE,SEPTA PHARMACEUTICALS INC,Zopiclone,ZOPICLONE,7.5MG,100s and 500s,ORAL,Actual shortage,TABLET,N05CF,HYPNOTICS AND SEDATIVES,,2017/6/20,,,Other (Please describe in comments),2017/6/20,2018/12/21,No
29395,550086,Shortage,SEPTRA INJECTION,ASPEN PHARMACARE CANADA INC.,Septra® Injection,SULFAMETHOXAZOLE TRIMETHOPRIM,80MG 16MG,10 amps,INTRAVENOUS,Resolved,SOLUTION,J01EE,SULFONAMIDES AND TRIMETHOPRIM,,2017/11/20,2018/1/19,2018/1/17,Delay in shipping of the drug.,2017/11/16,2018/1/18,No
20740,2214261,Shortage,SEREVENT DISKHALER DISK (50MCG/DOSE),GLAXOSMITHKLINE INC,salmeterol xinafoate dry powder for inhalation,SALMETEROL,50MCG,15's,"INHALATION
ORAL",Resolved,POWDER,R03AC,"ADRENERGICS, INHALANTS",,2017/8/30,,2017/9/20,Other (Please describe in comments),2017/8/31,2020/2/27,No
16549,2231129,Shortage,SEREVENT DISKUS (50MCG/DOSE),GLAXOSMITHKLINE INC,salmeterol xinafoate dry powder for inhalation,SALMETEROL,50MCG,1x60 doses,INHALATION,Avoided shortage,POWDER,R03AC,"ADRENERGICS, INHALANTS",2017/8/3,,2017/8/4,2017/7/31,Delay in shipping of the drug.,2017/7/20,2017/8/2,No
2471,2300206,Shortage,SEROQUEL XR,ASTRAZENECA CANADA INC,quetiapine fumarate extended-release tablets,QUETIAPINE,300MG,60 tablets,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,2017/4/24,2017/4/24,2017/4/26,2017/4/26,Demand increase for the drug.,2017/3/14,2017/4/27,No
6371,2300192,Shortage,SEROQUEL XR,ASTRAZENECA CANADA INC,quetiapine fumarate extended-release tablets,QUETIAPINE,200MG,60 tablets,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,2017/4/14,,,2017/5/15,Demand increase for the drug.,2017/4/10,2017/5/16,No
8964,2317583,Shortage,SILDENAFIL,PHARMASCIENCE INC,SILDENAFIL,SILDENAFIL,100MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017/9/15,2017/9/15,2017/10/10,2017/10/10,Disruption of the manufacture of the drug.,2017/5/4,2017/10/11,No
25163,2424312,Shortage,SILDENAFIL,PRO DOC LIMITEE,SILDENAFIL,SILDENAFIL,50MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/10/10,,2018/1/30,Delay in shipping of the drug.,2017/10/10,2018/1/31,No
29727,513997,Shortage,SINEMET 100/25,MERCK CANADA INC,levodopa and carbidopa tablets,CARBIDOPA LEVODOPA,25MG 100MG,100,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,2018/1/11,2018/1/12,2018/2/9,2018/2/9,Delay in shipping of the drug.,2017/11/20,2018/2/10,No
1397,513997,Shortage,SINEMET 100/25,MERCK CANADA INC,"levodopa and carbidopa tablets, USP",CARBIDOPA LEVODOPA,25MG 100MG,100,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,2017/3/13,2017/3/13,2017/3/23,2017/3/20,Delay in shipping of the drug.,2017/3/13,2017/3/21,No
11904,513997,Shortage,SINEMET 100/25,MERCK CANADA INC,levodopa and carbidopa tablets,CARBIDOPA LEVODOPA,25MG 100MG,100,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,2017/6/23,2017/6/22,2017/8/25,2017/7/31,Other (Please describe in comments),2017/6/5,2017/8/4,No
18907,513997,Shortage,SINEMET 100/25,MERCK CANADA INC,Levodopa and Carbidopa Tablets,CARBIDOPA LEVODOPA,25MG 100MG,100,ORAL,Avoided shortage,TABLET,N04BA,DOPAMINERGIC AGENTS,2017/9/7,,2017/9/8,2017/9/5,Other (Please describe in comments),2017/8/11,2017/10/11,No
6943,2028786,Shortage,SINEMET CR 100/25,MERCK CANADA INC,levodopa and carbidopa controlled release tablets,CARBIDOPA LEVODOPA,25MG 100MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,2017/5/3,2017/5/4,2017/5/10,2017/5/5,Demand increase for the drug.,2017/4/13,2017/5/6,No
29730,2028786,Shortage,SINEMET CR 100/25,MERCK CANADA INC,levodopa and carbidopa controlled release tablets,CARBIDOPA LEVODOPA,25MG 100MG,100,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,2018/3/5,,2018/3/6,2018/3/2,Delay in shipping of the drug.,2017/11/20,2018/8/13,No
11901,2028786,Shortage,SINEMET CR 100/25,MERCK CANADA INC,levodopa and carbidopa controlled release tablets,CARBIDOPA LEVODOPA,25MG 100MG,100,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,2017/6/16,,2017/6/21,2017/6/13,Delay in shipping of the drug.,2017/6/5,2017/10/11,No
16782,2028786,Shortage,SINEMET CR 100/25,MERCK CANADA INC,levodopa and carbidopa controlled release tablets,CARBIDOPA LEVODOPA,25MG 100MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,2017/8/7,2017/8/4,2017/8/28,2017/8/28,Other (Please describe in comments),2017/7/24,2017/8/29,No
20658,2028786,Shortage,SINEMET CR 100/25,MERCK CANADA INC,levodopa and carbidopa controlled release tablets,CARBIDOPA LEVODOPA,25MG 100MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,2017/9/21,2017/9/21,2017/10/6,2017/9/21,Other (Please describe in comments),2017/8/30,2017/9/22,No
16790,870935,Shortage,SINEMET CR 200/50,MERCK CANADA INC,levodopa and carbidopa controlledrelease tablets,CARBIDOPA LEVODOPA,50MG 200MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2017/8/2,2017/8/28,2017/8/28,Other (Please describe in comments),2017/7/24,2017/8/29,No
31988,24325,Shortage,SINEQUAN,AA PHARMA INC,SINEQUAN,DOXEPIN,10MG,100BTL,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2017/12/7,2017/12/21,2017/12/21,Disruption of the manufacture of the drug.,2017/12/7,2017/12/22,No
8495,2228599,Shortage,SINOGRAFIN - LIQ IU,BRACCO IMAGING CANADA,SINOGRAFIN,DIATRIZOATE MEGLUMINE MEGLUMINE IODIPAMIDE,52.7% 26.9%,10 X 10ml,INTRAUTERINE,Actual shortage,LIQUID,V08,"X-RAY CONTRAST MEDIA, IODINATED",,2017/5/1,,,Disruption of the manufacture of the drug.,2017/5/1,2018/12/21,No
19809,10383,Shortage,SINTROM,PALADIN LABS INC,Sintrom,ACENOCOUMAROL,1MG,100 Tablets,ORAL,Resolved,TABLET,B01AA,ANTITHROMBOTIC AGENTS,2019/5/31,,,2019/7/31,Disruption of the manufacture of the drug.,2017/8/18,2021/10/7,No
19812,10391,Shortage,SINTROM,PALADIN LABS INC,Sintrom,ACENOCOUMAROL,4MG,100 Tablets,ORAL,Avoided shortage,TABLET,B01AA,ANTITHROMBOTIC AGENTS,2020/6/30,,,2020/5/28,Disruption of the manufacture of the drug.,2017/8/18,2021/10/7,No
27881,554308,Shortage,SLO-POT,BIOMED PHARMA,Slow-Release Potassium Chloride Tablets 600 mg,,,100,,Actual shortage,,,,,2014/10/23,,,Other (Please describe in comments),2017/11/2,2017/11/2,No
27884,554308,Shortage,SLO-POT,BIOMED PHARMA,Slow-Release Potassium Chloride Tablets 600 mg,,,1000,,Actual shortage,,,,,2014/10/23,,,Other (Please describe in comments),2017/11/2,2017/11/2,No
27887,554308,Shortage,SLO-POT,BIOMED PHARMA,Slow-Release Potassium Chloride Tablets 600 mg,,,500,,Actual shortage,,,,,2014/10/23,,,Other (Please describe in comments),2017/11/2,2017/11/2,No
12477,261998,Shortage,SODIUM BICARBONATE INJ 8.4%,HOSPIRA HEALTHCARE CORPORATION,Sodium bicarbonate,SODIUM BICARBONATE,84MG,25 x 50mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2017/6/8,2017/10/16,2017/10/4,Disruption of the manufacture of the drug.,2017/6/9,2017/10/5,No
26272,261998,Shortage,SODIUM BICARBONATE INJECTION USP,PFIZER CANADA INC,Sodium Bicarbonate,SODIUM BICARBONATE,84MG,10x10mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2017/10/23,,2017/10/31,2017/11/2,Disruption of the manufacture of the drug.,2017/10/18,2017/11/6,No
34276,261971,Shortage,SODIUM BICARBONATE INJECTION USP,PFIZER CANADA INC,SODIUM BICARBONATE INJECTION LIFESHIELD 4.2%,SODIUM BICARBONATE,42MG,10x10mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2018/1/19,,2018/2/2,Demand increase for the drug.,2017/12/22,2018/2/7,No
26121,60208,Shortage,SODIUM CHLORIDE 0.9% INJ 900MG/100ML USP,BAXTER CORPORATION,0.9% Sodium Chloride Inj - AVIVA,SODIUM CHLORIDE,900MG,250mL AVIVA,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2018/1/4,2018/1/4,2018/11/27,2018/11/27,Disruption of the manufacture of the drug.,2017/10/17,2018/11/27,No
32177,60208,Shortage,SODIUM CHLORIDE 0.9% INJ 900MG/100ML USP,BAXTER CORPORATION,0.9% Sodium Chloride Inj – AVIVA,SODIUM CHLORIDE,900MG,500mL AVIVA,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2018/1/4,2018/1/4,2018/11/27,2018/11/27,Disruption of the manufacture of the drug.,2017/12/8,2018/11/27,No
19378,60208,Shortage,SODIUM CHLORIDE 0.9% INJ 900MG/100ML USP,BAXTER CORPORATION,"0.9% Sodium Chloride Injection, USP",SODIUM CHLORIDE,900MG,"50mL, 100mL",INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2017/8/15,2017/8/15,2018/2/28,2018/2/28,Disruption of the manufacture of the drug.,2017/8/15,2018/3/1,No
15059,783633,Shortage,SODIUM CHLORIDE 1.6% SOLUTION USP,BAXTER CORPORATION,1.6% Sodium Chloride Solution,SODIUM CHLORIDE,1.6G,"Product Code 4B7871, 2000 mL",IRRIGATION,Resolved,SOLUTION,B05CB,IRRIGATING SOLUTIONS,2017/7/10,2017/7/10,2017/12/18,2017/12/18,Disruption of the manufacture of the drug.,2017/7/10,2017/12/19,No
15056,783625,Shortage,SODIUM CHLORIDE 12% USP,BAXTER CORPORATION,12% Sodium Chloride Solution,SODIUM CHLORIDE,12G,"Product Code 4B7874Q, 150 mL",IRRIGATION,Resolved,LIQUID,B05CB,IRRIGATING SOLUTIONS,2017/7/10,2017/7/10,2017/12/18,2017/12/18,Disruption of the manufacture of the drug.,2017/7/10,2017/12/19,No
2131,402230,Shortage,SODIUM CHLORIDE INJ 23.4%,OMEGA LABORATORIES LTD,Sodium Chloride Injection USP 23.4%,SODIUM CHLORIDE,234MG,30mL vial,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2016/9/19,2017/4/15,2017/3/29,Disruption of the manufacture of the drug.,2017/3/14,2017/6/19,No
2160,2150204,Shortage,SODIUM CHLORIDE INJECTION USP,OMEGA LABORATORIES LTD,Sodium Chloride for Injection USP,SODIUM CHLORIDE,9MG,10mL vial,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2017/4/15,2017/2/9,,2018/5/23,Disruption of the manufacture of the drug.,2017/3/14,2018/6/11,No
30073,37796,Shortage,SODIUM CHLORIDE INJECTION USP,PFIZER CANADA INC,SODIUM CHLORIDE,SODIUM CHLORIDE,9MG,25x10mL,"INTRAMUSCULAR
INTRAPERITONEAL
INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2017/11/24,,2018/11/17,Disruption of the manufacture of the drug.,2017/11/21,2018/11/19,No
14445,2139510,Shortage,"SODIUM CHLORIDE INJECTION, USP",FRESENIUS KABI CANADA LTD,Sodium Chloride Injection,SODIUM CHLORIDE,234MG,200mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2017/7/3,,2017/11/1,2017/10/27,Disruption of the manufacture of the drug.,2017/6/30,2017/10/28,No
14448,2139510,Shortage,"SODIUM CHLORIDE INJECTION, USP",FRESENIUS KABI CANADA LTD,Sodium Chloride Injection,SODIUM CHLORIDE,234MG,30mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2017/7/28,,2017/8/31,2017/8/25,Disruption of the manufacture of the drug.,2017/6/30,2017/8/28,No
10089,786160,Shortage,SODIUM CHLORIDE LIQ IRIGATION 900MG/100ML USP,BAXTER CORPORATION,SODIUM CHLORIDE LIQ IRIGATION 900MG/100ML USP,SODIUM CHLORIDE,900MG,1000mL,IRRIGATION,Resolved,LIQUID,B05CB,IRRIGATING SOLUTIONS,2017/5/11,2017/5/11,2017/9/6,2017/9/6,Disruption of the manufacture of the drug.,2017/5/11,2017/9/7,No
25813,1994344,Shortage,SOFLAX CAPSULES 100MG,PHARMASCIENCE INC,SOFLAX,DOCUSATE SODIUM,100MG,100,ORAL,Resolved,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,,2017/10/1,,2020/6/5,Disruption of the manufacture of the drug.,2017/10/12,2020/6/8,No
25810,2006758,Shortage,SOFLAX SYRUP 4MG/ML,PHARMASCIENCE INC,SOFLAX,DOCUSATE SODIUM,4MG,500mL,ORAL,Resolved,SYRUP,A06AA,DRUGS FOR CONSTIPATION,,2017/10/1,2017/11/27,2017/12/18,Disruption of the manufacture of the drug.,2017/10/12,2017/12/19,No
2489,1988840,Shortage,SOFRA-TULLE DRESSING 1%,ERFA CANADA 2012 INC,Framycetin Sulfate,Framycetin Sulfate,1%,box of 50,to apply,Actual shortage,10/10cm,D09AA,MEDICATED DRESSINGS,2013/10/23,2013/10/23,,,Requirements related to complying with good manufacturing practices.,2017/3/14,2018/3/14,No
2332,1987682,Shortage,SOFRA-TULLE STRIP 1%,ERFA CANADA 2012 INC,"Framycetin Sulfate,BP 1%",FRAMYCETIN SULFATE,1%,box of 10,TOPICAL,Actual shortage,DRESSING,D09AA,MEDICATED DRESSINGS,2017/2/9,2017/2/9,,,Requirements related to complying with good manufacturing practices.,2017/3/14,2018/3/14,No
3060,2224623,Shortage,SOFRACORT STERILE EAR/EYE DROPS,SANOFI-AVENTIS CANADA INC,Sofracort Sterile Ear/Eye Drops,DEXAMETHASONE GRAMICIDIN FRAMYCETIN SULFATE,0.5MG 0.05MG 5MG,8 mL,"OPHTHALMIC
OTIC",Resolved,DROPS,S03CA,CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION,2017/5/15,2017/5/15,2018/12/14,2018/12/18,Other (Please describe in comments),2017/3/16,2019/1/10,No
2954,2224887,Shortage,SOFRAMYCIN EYE DROPS 0.5%,ERFA CANADA 2012 INC,Soframycin Eye Drops,FRAMYCETIN SULFATE,5MG,bottle,OPHTHALMIC,Actual shortage,DROPS,S01AA,ANTIINFECTIVES,2013/6/11,2013/6/11,,,Disruption of the manufacture of the drug.,2017/3/15,2018/3/14,No
2949,2224879,Shortage,SOFRAMYCIN SKIN OINTMENT,ERFA CANADA 2012 INC,Framycetin Sulfate,GRAMICIDIN FRAMYCETIN SULFATE,50MCG 15MG,tube,TOPICAL,Actual shortage,OINTMENT,D06AX,ANTIBIOTICS FOR TOPICAL USE,2013/6/11,2013/6/11,,,Disruption of the manufacture of the drug.,2017/3/15,2018/3/14,No
2579,2224895,Shortage,SOFRAMYCIN STERILE EYE OINTMENT 0.5%,ERFA CANADA 2012 INC,Framycetin Sulfate,FRAMYCETIN SULFATE,5MG,tube,OPHTHALMIC,Actual shortage,OINTMENT,S01AA,ANTIINFECTIVES,2013/6/11,2013/6/11,,,Disruption of the manufacture of the drug.,2017/3/14,2018/3/14,No
20792,30619,Shortage,SOLU-CORTEF 250 MG ACT-O-VIAL,PFIZER CANADA INC,Solu-Cortef,HYDROCORTISONE,250MG,10x2mL,"INTRAMUSCULAR
INTRAVENOUS",Resolved,POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",2017/9/30,,2017/10/11,2017/10/18,Demand increase for the drug.,2017/9/1,2017/10/19,No
6661,769541,Shortage,SOLYSTAT,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,SOLYSTAT ORAL SUSPENSION,SODIUM POLYSTYRENE SULFONATE,250MG,60mL,ORAL,Resolved,SUSPENSION,V03AE,ALL OTHER THERAPEUTIC PRODUCTS,2017/6/6,2017/6/6,2017/6/6,2017/6/6,Disruption of the manufacture of the drug.,2017/4/12,2017/10/5,No
5416,769541,Shortage,SOLYSTAT,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,SOLYSTAT 250mg/mL U.D.SUSP,SODIUM POLYSTYRENE SULFONATE,250MG,60mL,ORAL,Resolved,SUSPENSION,V03AE,ALL OTHER THERAPEUTIC PRODUCTS,2017/6/6,2017/6/6,2017/10/16,2017/10/11,Disruption of the manufacture of the drug.,2017/4/4,2017/10/12,No
5422,769541,Shortage,SOLYSTAT,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,SOLYSTAT 250mg/mL SUSP,SODIUM POLYSTYRENE SULFONATE,250MG,500mL,ORAL,Resolved,SUSPENSION,V03AE,ALL OTHER THERAPEUTIC PRODUCTS,2017/6/13,2017/6/16,2017/10/16,2017/10/11,Disruption of the manufacture of the drug.,2017/4/4,2017/10/12,No
26779,769541,Shortage,SOLYSTAT,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,SOLYSTAT 250mg/mL SUSP 500mL,SODIUM POLYSTYRENE SULFONATE,250MG,500ML,ORAL,Resolved,SUSPENSION,V03AE,ALL OTHER THERAPEUTIC PRODUCTS,2017/12/1,2017/12/1,2018/2/7,2018/2/2,Disruption of the manufacture of the drug.,2017/10/24,2018/2/5,No
29863,769541,Shortage,SOLYSTAT,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,SOLYSTAT 250mg/mL U.D.SUSP 60mL,SODIUM POLYSTYRENE SULFONATE,250MG,60ml,ORAL,Resolved,SUSPENSION,V03AE,ALL OTHER THERAPEUTIC PRODUCTS,2017/12/18,2017/12/1,2018/3/12,2018/3/6,Disruption of the manufacture of the drug.,2017/11/20,2018/3/13,No
27890,414220,Shortage,SOM-PAM,BIOMED PHARMA,Flurazepam Hydrochloride Capsules 15 mg,,,100,,Actual shortage,,,,,2014/10/23,,,Other (Please describe in comments),2017/11/2,2017/11/2,No
27893,414220,Shortage,SOM-PAM,BIOMED PHARMA,Flurazepam Hydrochloride Capsules 15 mg,,,1000,,Actual shortage,,,,,2014/10/23,,,Other (Please describe in comments),2017/11/2,2017/11/2,No
27896,414239,Shortage,SOM-PAM,BIOMED PHARMA,Flurazepam Hydrochloride Capsules 30 mg,,,100,,Actual shortage,,,,,2014/10/23,,,Other (Please describe in comments),2017/11/2,2017/11/2,No
27899,414239,Shortage,SOM-PAM,BIOMED PHARMA,Flurazepam Hydrochloride Capsules 30 mg,,,1000,,Actual shortage,,,,,2014/10/23,,,Other (Please describe in comments),2017/11/2,2017/11/2,No
12119,2448858,Shortage,SOMAVERT,PFIZER CANADA INC,Somavert,PEGVISOMANT,30MG,1 x 1mL pre filled syringe,SUBCUTANEOUS,Resolved,"KIT
POWDER FOR SOLUTION",H01AX,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,,2017/6/5,2017/6/12,2017/6/12,Delay in shipping of the drug.,2017/6/6,2017/6/13,No
3761,2237578,Shortage,SPASMHALT-8,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,SPASMHALT-8 325mgACET/8mgCOD CAPL BL3X9,ACETAMINOPHEN METHOCARBAMOL CODEINE PHOSPHATE,325MG 400MG 8MG,BL3X9,ORAL,Actual shortage,TABLET,M03BA,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2017/3/16,,,Disruption of the manufacture of the drug.,2017/3/21,2018/12/21,No
16413,2360810,Shortage,SPRYCEL,BRISTOL-MYERS SQUIBB CANADA,dasatinib,DASATINIB,80MG,1 BTL X 30,ORAL,Avoided shortage,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,2017/8/4,,2017/8/4,2017/8/3,Demand increase for the drug.,2017/7/19,2017/8/2,No
19877,596965,Shortage,STATEX SUPPOSITORIES 20MG,PALADIN LABS INC,Statex,MORPHINE SULFATE,20MG,Box of 10,RECTAL,Resolved,SUPPOSITORY,N02AA,OPIOIDS,2021/11/30,,,2021/12/14,Disruption of the manufacture of the drug.,2017/8/18,2021/12/15,No
19880,639389,Shortage,STATEX SUPPOSITORIES 30MG,PALADIN LABS INC,Statex,MORPHINE SULFATE,30MG,Box of 10,RECTAL,Actual shortage,SUPPOSITORY,N02AA,OPIOIDS,2021/8/31,,,,Disruption of the manufacture of the drug.,2017/8/18,2021/9/1,No
19848,632228,Shortage,STATEX SUPPOSITORIES 5MG,PALADIN LABS INC,Statex,MORPHINE SULFATE,5MG,Box of 10,RECTAL,Avoided shortage,SUPPOSITORY,N02AA,OPIOIDS,2021/10/30,,,2021/5/13,Disruption of the manufacture of the drug.,2017/8/18,2021/5/13,No
7723,591467,Shortage,STATEX SYRUP 1MG/ML,PALADIN LABS INC,MORPHINE SULFATE 1mg/ml 500ml,MORPHINE SULFATE,1MG,500ml,ORAL,Resolved,SYRUP,N02AA,OPIOIDS,,2017/4/17,,2017/7/11,Demand increase for the drug.,2017/4/24,2017/7/12,No
5251,591467,Shortage,STATEX SYRUP 1MG/ML,PALADIN LABS INC,Morphine Sulfate 1mg/ml 250ml,MORPHINE SULFATE,1MG,250ml,ORAL,Resolved,SYRUP,N02AA,OPIOIDS,2017/4/4,,2017/4/26,2017/6/30,Demand increase for the drug.,2017/4/3,2017/8/18,No
19834,591475,Shortage,STATEX SYRUP 5MG/ML,PALADIN LABS INC,Statex,MORPHINE SULFATE,5MG,250ml,ORAL,Resolved,SYRUP,N02AA,OPIOIDS,,2018/1/9,,2018/1/9,Disruption of the manufacture of the drug.,2017/8/18,2018/1/29,No
5409,594644,Shortage,STATEX TAB 10MG,PALADIN LABS INC,MORPHINE SULFATE 10mg Tablets,MORPHINE SULFATE,10MG,100 tabs/bottle,ORAL,Resolved,TABLET,N02AA,OPIOIDS,2017/4/4,2017/4/4,,2017/5/22,Demand increase for the drug.,2017/4/4,2017/5/23,No
2462,594644,Shortage,STATEX TAB 10MG,PALADIN LABS INC,Morphine Sulfate 10mg tablets,MORPHINE SULFATE,10MG,4x25 Control Pack,ORAL,Resolved,TABLET,N02AA,OPIOIDS,2017/3/13,2017/3/13,2017/5/27,2017/8/23,Demand increase for the drug.,2017/3/14,2017/10/2,No
4018,594644,Shortage,STATEX TAB 10MG,PALADIN LABS INC,Morphine Sulfate 10mg Tablets,MORPHINE SULFATE,10MG,100 tab bottles,ORAL,Resolved,TABLET,N02AA,OPIOIDS,2017/2/1,2017/2/1,2017/3/27,2017/3/31,Disruption of the manufacture of the drug.,2017/3/23,2017/4/3,No
28736,594652,Shortage,STATEX TAB 5MG,PALADIN LABS INC,Morphine,MORPHINE SULFATE,5MG,Control Pack (4x25 tabs),ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017/11/13,,2018/1/30,Disruption of the manufacture of the drug.,2017/11/9,2018/1/31,No
3461,594652,Shortage,STATEX TAB 5MG,PALADIN LABS INC,MORPHINE SULFATE,MORPHINE SULFATE,5MG,100 TABS,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017/3/1,2017/3/24,2017/3/31,Disruption of the manufacture of the drug.,2017/3/20,2017/4/3,No
7067,594652,Shortage,STATEX TAB 5MG,PALADIN LABS INC,Morphine Sulfate 5mg tabs,MORPHINE SULFATE,5MG,100 tab bottles,ORAL,Resolved,TABLET,N02AA,OPIOIDS,2017/4/17,,2017/5/22,2017/5/22,Demand increase for the drug.,2017/4/14,2017/8/17,No
12794,594652,Shortage,STATEX TAB 5MG,PALADIN LABS INC,Morphine Sulfate 5mg,MORPHINE SULFATE,5MG,100 tabs/bottle,ORAL,Resolved,TABLET,N02AA,OPIOIDS,2017/6/14,2017/6/14,2017/6/23,2017/6/23,Demand increase for the drug.,2017/6/15,2017/8/17,No
31270,594636,Shortage,STATEX TABLET 25MG,PALADIN LABS INC,Statex,MORPHINE SULFATE,25MG,100tabs,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017/11/30,,2017/12/22,Disruption of the manufacture of the drug.,2017/11/30,2017/12/29,No
19852,632201,Shortage,STATEX-SUPPOSITORIES 10MG,PALADIN LABS INC,Statex,MORPHINE SULFATE,10MG,Box of 10,RECTAL,Actual shortage,SUPPOSITORY,N02AA,OPIOIDS,,2021/1/7,,,Disruption of the manufacture of the drug.,2017/8/18,2021/1/8,No
28246,1963961,Shortage,STERILE WATER FOR IRRIGATION USP,B. BRAUN MEDICAL INC,Sterile Water,WATER,100%,"500mL, 1000mL, 2000mL, 4000mL",IRRIGATION,Actual shortage,LIQUID,V07AB,ALL OTHER NON-THERAPEUTIC PRODUCTS,,2017/11/3,,,Requirements related to complying with good manufacturing practices.,2017/11/6,2019/11/6,No
14401,2247228,Shortage,STIEPROX SHAMPOO,GLAXOSMITHKLINE INC,ciclopirox olamine shampoo,CICLOPIROX OLAMINE,1.50%,150 mL,TOPICAL,Resolved,SHAMPOO,D01AE,ANTIFUNGALS FOR TOPICAL USE,,2017/6/28,,2017/6/30,Delay in shipping of the drug.,2017/6/29,2017/7/4,No
24049,2370433,Shortage,SUBLINOX,VALEANT CANADA LP/VALEANT CANADA S.E.C.,SUBLINOX,ZOLPIDEM TARTRATE,10MG,N/A,SUBLINGUAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05CF,HYPNOTICS AND SEDATIVES,2017/10/21,,2017/11/3,2017/11/10,Other (Please describe in comments),2017/10/2,2017/11/13,No
13600,441767,Shortage,SULFINPYRAZONE,AA PHARMA INC,Sulfinpyrazone,SULFINPYRAZONE,200MG,100 Bottle,ORAL,Resolved,TABLET,M04AB,ANTIGOUT PREPARATIONS,,2017/6/22,2017/7/17,2017/7/6,Disruption of the manufacture of the drug.,2017/6/22,2017/9/5,No
15472,2452294,Shortage,SUNVEPRA,BRISTOL-MYERS SQUIBB CANADA,Asunaprevir,ASUNAPREVIR,100MG,1 BTL x 56,ORAL,Resolved,CAPSULE,J05AE,DIRECT ACTING ANTIVIRALS,2017/7/24,2017/7/21,2017/11/30,2017/10/16,Other (Please describe in comments),2017/7/11,2017/10/17,No
30258,2227428,Shortage,SUPRANE,BAXTER CORPORATION,"Desflurane, USP",DESFLURANE,100%,"240mL bottle,   6 units/Case",INHALATION,Resolved,LIQUID,N01AB,"ANESTHETICS, GENERAL",2017/11/22,2017/11/22,2017/12/15,2017/12/15,Delay in shipping of the drug.,2017/11/23,2017/12/16,No
10149,2225166,Shortage,SUPREFACT,SANOFI-AVENTIS CANADA INC,Suprefact Inj. M.D. 1mg/ml - vials,BUSERELIN,1MG,2 X 5.5ml,SUBCUTANEOUS,Resolved,SOLUTION,L02AE,HORMONES AND RELATED AGENTS,,2017/5/15,2017/6/9,2017/6/5,Other (Please describe in comments),2017/5/12,2017/7/6,No
3283,2162512,Shortage,SYNALAR OINTMENT 0.025%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,SYNALAR,FLUOCINOLONE ACETONIDE,0.03%,60G,TOPICAL,Resolved,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",,2017/1/4,2017/5/15,2017/6/5,Disruption of the manufacture of the drug.,2017/3/17,2017/6/6,No
29739,2172100,Shortage,SYNTHROID,BGP PHARMA ULC,SYNTHROID,LEVOTHYROXINE SODIUM,100MCG,90,ORAL,Avoided shortage,TABLET,H03AA,THYROID PREPARATIONS,2017/11/24,,,2017/11/23,Disruption of the manufacture of the drug.,2017/11/20,2017/11/23,No
29743,2172119,Shortage,SYNTHROID,BGP PHARMA ULC,SYNTHROID,LEVOTHYROXINE SODIUM,125MCG,90,ORAL,Avoided shortage,TABLET,H03AA,THYROID PREPARATIONS,2017/11/24,,,2017/11/23,Disruption of the manufacture of the drug.,2017/11/20,2017/11/23,No
33596,2172119,Shortage,SYNTHROID,BGP PHARMA ULC,SYNTHROID,LEVOTHYROXINE SODIUM,125MCG,90,ORAL,Avoided shortage,TABLET,H03AA,THYROID PREPARATIONS,2017/12/21,,,2017/12/19,Disruption of the manufacture of the drug.,2017/12/18,2017/12/19,No
29798,2172127,Shortage,SYNTHROID,BGP PHARMA ULC,SYNTHROID,LEVOTHYROXINE SODIUM,150MCG,1000,ORAL,Avoided shortage,TABLET,H03AA,THYROID PREPARATIONS,2017/12/4,,,2017/11/23,Disruption of the manufacture of the drug.,2017/11/20,2017/11/23,No
19316,2172151,Shortage,SYNTHROID,BGP PHARMA ULC,SYNTHROID,LEVOTHYROXINE SODIUM,300MCG,90,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,,2018/11/5,,2018/11/9,Requirements related to complying with good manufacturing practices.,2017/8/14,2018/11/10,No
14596,2455366,Shortage,TADALAFIL,PRO DOC LIMITEE,TADALAFIL,TADALAFIL,10MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/7/3,,2017/11/2,Delay in shipping of the drug.,2017/7/4,2017/11/3,No
29195,2455358,Shortage,TADALAFIL,PRO DOC LIMITEE,TADALAFIL,TADALAFIL,5MG,30,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/11/14,,2017/12/6,Delay in shipping of the drug.,2017/11/14,2017/12/7,No
17354,2455374,Shortage,TADALAFIL,PRO DOC LIMITEE,TADALAFIL,TADALAFIL,20MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018/11/2,,2018/12/11,Delay in shipping of the drug.,2017/7/26,2018/12/12,No
14785,2241976,Shortage,TALWIN 30 MG/ML,HOSPIRA HEALTHCARE CORPORATION,TALWIN,PENTAZOCINE,30MG,25x1ml,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Avoided shortage,SOLUTION,N02AD,OPIOIDS,2018/11/23,,,2018/9/4,Other (Please describe in comments),2017/7/5,2018/9/4,No
25166,2413612,Shortage,TAMSULOSIN CR,PRO DOC LIMITEE,TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,30-500,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/10/10,,2017/10/27,Delay in shipping of the drug.,2017/10/10,2017/10/30,No
28095,2429667,Shortage,TAMSULOSIN CR,SIVEM PHARMACEUTICALS ULC,TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,500,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2018/1/4,,2018/1/12,2017/12/29,Delay in shipping of the drug.,2017/11/6,2018/1/18,No
17697,2240946,Shortage,TARKA,BGP PHARMA ULC,TARKA,VERAPAMIL HYDROCHLORIDE TRANDOLAPRIL,240MG 2MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C09BB,"ACE INHIBITORS, COMBINATIONS",,2018/1/30,,2019/11/19,Disruption of the manufacture of the drug.,2017/8/1,2020/2/19,No
31634,2246714,Shortage,TARO-AMCINONIDE,TARO PHARMACEUTICALS INC,TARO AMCINONIDE,AMCINONIDE,0.10%,60G,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2017/12/3,2018/10/19,2018/10/17,Disruption of the manufacture of the drug.,2017/12/4,2018/10/18,No
19790,2365650,Shortage,TARO-ANASTROZOLE,TARO PHARMACEUTICALS INC,TARO ANASTROZOLE,ANASTROZOLE,1MG,3x10BL,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2018/5/23,2019/2/27,2019/2/27,Disruption of the manufacture of the drug.,2017/8/18,2019/3/4,No
31631,2407515,Shortage,TARO-CARBAMAZEPINE,TARO PHARMACEUTICALS INC,TARO CARBAMAZEPINE,CARBAMAZEPINE,200MG,500's,ORAL,Actual shortage,TABLET,N03AF,ANTIEPILEPTICS,,2018/10/29,,,Disruption of the manufacture of the drug.,2017/12/4,2022/12/12,No
22252,2367394,Shortage,TARO-CARBAMAZEPINE,TARO PHARMACEUTICALS INC,TARO CARBAMAZEPINE,CARBAMAZEPINE,100MG,450 ML,ORAL,Resolved,SUSPENSION,N03AF,ANTIEPILEPTICS,,2018/10/29,2018/12/14,2018/11/13,Disruption of the manufacture of the drug.,2017/9/18,2019/2/4,No
7213,2244403,Shortage,TARO-CARBAMAZEPINE CHEWABLE TABLETS 100MG,TARO PHARMACEUTICALS INC,CARBAMAZEPINE,CARBAMAZEPINE,100MG,100 tablets,ORAL,Resolved,TABLET (CHEWABLE),N03AF,ANTIEPILEPTICS,,2017/7/13,2017/8/31,2017/8/23,Disruption of the manufacture of the drug.,2017/4/18,2017/9/6,No
5246,2244404,Shortage,TARO-CARBAMAZEPINE CHEWABLE TABLETS 200MG,TARO PHARMACEUTICALS INC,CARBAMAZEPINE,CARBAMAZEPINE,200MG,100'S,ORAL,Resolved,TABLET (CHEWABLE),N03AF,ANTIEPILEPTICS,,2018/2/1,2018/3/5,2018/2/8,Disruption of the manufacture of the drug.,2017/4/3,2018/2/9,No
15693,2266938,Shortage,TARO-CLINDAMYCIN,TARO PHARMACEUTICALS INC,TARO-CLINDAMYCIN,CLINDAMYCIN,1%,30 ML,TOPICAL,Resolved,SOLUTION,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2017/9/15,2019/4/12,2019/4/8,Disruption of the manufacture of the drug.,2017/7/13,2019/4/9,No
15697,2266938,Shortage,TARO-CLINDAMYCIN,TARO PHARMACEUTICALS INC,TARO-CLINDAMYCIN,CLINDAMYCIN,1%,60 ML,TOPICAL,Resolved,SOLUTION,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2017/9/5,2019/4/12,2019/4/10,Disruption of the manufacture of the drug.,2017/7/13,2019/4/15,No
7217,2440180,Shortage,TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL,TARO PHARMACEUTICALS INC,CLINDAMYCIN/BENZOYL PEROXIDE GEL,BENZOYL PEROXIDE CLINDAMYCIN,5% 1%,45 gram,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,2017/4/25,,2017/8/31,2017/8/25,Disruption of the manufacture of the drug.,2017/4/18,2017/9/6,No
6953,2361698,Shortage,TARO-SUMATRIPTAN,TARO PHARMACEUTICALS INC,SUMATRIPTAN,SUMATRIPTAN,6MG,2x0.5mL,SUBCUTANEOUS,Resolved,SOLUTION,N02CC,ANTIMIGRAINE PREPARATIONS,,2018/5/23,2018/6/7,2018/6/15,Disruption of the manufacture of the drug.,2017/4/13,2018/6/18,No
6914,2443538,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TEMOZOLOMIDE,TEMOZOLOMIDE,140MG,5 blister,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/4/25,,2017/10/9,2017/10/1,Disruption of the manufacture of the drug.,2017/4/13,2017/10/2,No
6928,2443481,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TEMOZOLOMIDE,TEMOZOLOMIDE,20MG,5 blister,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/4/25,,2017/10/9,2017/10/1,Disruption of the manufacture of the drug.,2017/4/13,2017/10/2,No
6935,2443473,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TEMOZOLOMIDE,TEMOZOLOMIDE,5MG,5 blister,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,,2018/1/18,2018/7/7,2018/8/2,Disruption of the manufacture of the drug.,2017/4/13,2018/8/3,No
6938,2443473,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TEMOZOLOMIDE,TEMOZOLOMIDE,5MG,20 blister,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/5/10,,2017/11/30,2017/11/29,Disruption of the manufacture of the drug.,2017/4/13,2017/12/4,No
182,2443554,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TEMOZOLOMIDE,TEMOZOLOMIDE,250MG,5 blister,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,,2018/1/18,2018/7/7,2018/8/2,Disruption of the manufacture of the drug.,2017/3/10,2018/8/3,No
18102,2443481,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TEMOZOLOMIDE,TEMOZOLOMIDE,20MG,20 blister,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,,2017/8/2,2017/10/9,2017/10/1,Disruption of the manufacture of the drug.,2017/8/2,2017/10/2,No
18105,2443511,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TEMOZOLOMIDE,TEMOZOLOMIDE,100MG,5 blister,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,,2018/3/2,2018/4/30,2018/4/26,Disruption of the manufacture of the drug.,2017/8/2,2018/4/27,No
18108,2443511,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TEMOZOLOMIDE,TEMOZOLOMIDE,100MG,20 blister,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,,2017/8/2,2017/10/9,2017/10/1,Disruption of the manufacture of the drug.,2017/8/2,2017/10/2,No
14481,2247651,Shortage,TARO-TERCONAZOLE CREAM,TARO PHARMACEUTICALS INC,TARO-TERCONAZOLE CREAM,TERCONAZOLE,0.40%,45G,VAGINAL,Resolved,CREAM,G01AG,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",,2017/6/30,2017/8/30,2017/8/24,Disruption of the manufacture of the drug.,2017/7/1,2017/9/6,No
177,2415100,Shortage,TARO-ZOLEDRONIC ACID,TARO PHARMACEUTICALS INC,ZOLEDRONIC ACID,ZOLEDRONIC ACID,5MG,100 mL,INTRAVENOUS,Resolved,SOLUTION,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2016/11/1,2018/7/31,2018/8/2,Disruption of the manufacture of the drug.,2017/3/10,2018/8/3,No
170,2415186,Shortage,TARO-ZOLEDRONIC ACID CONCENTRATE,TARO PHARMACEUTICALS INC,Zoledronic Acid for injection,ZOLEDRONIC ACID,4MG,5ml,INTRAVENOUS,Resolved,SOLUTION,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2016/1/1,2016/1/1,2018/2/26,2018/2/8,Disruption of the manufacture of the drug.,2017/3/10,2018/2/9,No
14093,,Shortage,Technetium Tc 99m TSC,,Kit for the Preparation of Technetium Tc 99m Sulfur Colloid Injection,sodium thiosulfate anhydrous,not applicable,5-kit package,Intravenous and oral use,Resolved,Reaction vial - lyophilized form; Components - Solution A and Solution B,V09DB,HEPATIC AND RETICULO ENDOTHELIAL SYSTEM,,2017/6/23,2017/7/17,2017/7/5,Other (Please describe in comments),2017/6/27,2017/7/6,No
30982,2194333,Shortage,TEGRETOL - SUS 100MG/5ML,NOVARTIS PHARMACEUTICALS CANADA INC,TEGRETOL SUSPENSION,CARBAMAZEPINE,100MG,450ML,ORAL,Resolved,SUSPENSION,N03AF,ANTIEPILEPTICS,2017/11/30,,2017/12/15,2017/12/19,Demand increase for the drug.,2017/11/28,2018/1/8,No
27924,773611,Shortage,TEGRETOL CR TAB 200MG,NOVARTIS PHARMACEUTICALS CANADA INC,TEGRETOL CR 200MG TABS 100'S,CARBAMAZEPINE,200MG,100's,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N03AF,ANTIEPILEPTICS,2017/11/28,,2017/12/7,2017/12/7,Delay in shipping of the drug.,2017/11/2,2017/12/13,No
6169,2432900,Shortage,TELMISARTAN,PHARMASCIENCE INC,TELMISARTAN,TELMISARTAN,80MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/4/5,,2017/12/18,Delay in shipping of the drug.,2017/4/7,2017/12/19,No
4281,2432900,Shortage,TELMISARTAN,PHARMASCIENCE INC,TELMISARTAN,TELMISARTAN,80MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/3/23,2017/7/11,2017/7/11,Delay in shipping of the drug.,2017/3/24,2017/12/19,No
5669,2390302,Shortage,TELMISARTAN HCTZ,SIVEM PHARMACEUTICALS ULC,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE TELMISARTAN,12.5MG 80.0MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2017/5/10,,2017/6/15,2017/8/6,Requirements related to complying with good manufacturing practices.,2017/4/5,2017/11/3,No
5672,2390310,Shortage,TELMISARTAN HCTZ,SIVEM PHARMACEUTICALS ULC,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE TELMISARTAN,25.0MG 80.0MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2017/4/27,,2017/5/10,2017/5/10,Requirements related to complying with good manufacturing practices.,2017/4/5,2017/5/18,No
13155,2390302,Shortage,TELMISARTAN HCTZ,SIVEM PHARMACEUTICALS ULC,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE TELMISARTAN,12.5MG 80.0MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/6/16,2017/7/17,2017/8/6,Demand increase for the drug.,2017/6/16,2017/11/3,No
16392,2241093,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,5MG,5 cap sachet,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/8/21,2017/8/17,2017/8/29,2017/8/22,Demand increase for the drug.,2017/7/19,2017/8/23,No
12317,2312794,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,140MG,5 sachets (1capsule/sachet),ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/6/8,2017/6/8,2017/6/16,2017/6/9,Delay in shipping of the drug.,2017/6/8,2017/6/10,No
12322,2241095,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,100MG,20 cap,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/6/8,2017/6/8,2017/6/16,2017/6/19,Delay in shipping of the drug.,2017/6/8,2017/7/11,No
18236,2241095,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,100MG,20 CAP,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/8/3,2017/8/3,2017/8/25,2017/8/21,Demand increase for the drug.,2017/8/3,2017/8/22,No
13376,2241095,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,100MG,5 cap,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/6/20,2017/6/20,2017/8/25,2017/8/22,Demand increase for the drug.,2017/6/20,2017/8/23,No
3677,2312794,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,140MG,5 sachets (1 capsule/sachet ),ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/3/20,2017/3/20,2017/3/31,2017/3/30,Delay in shipping of the drug.,2017/3/20,2017/3/31,No
6257,2241095,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,100MG,20 cap,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/4/17,2017/4/17,2017/6/2,2017/5/23,Delay in shipping of the drug.,2017/4/10,2017/5/24,No
6260,2241094,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,20MG,20 cap,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/4/17,2017/4/17,2017/5/5,2017/4/26,Delay in shipping of the drug.,2017/4/10,2017/4/27,No
20352,2241094,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,20MG,5 CAP,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/9/25,2017/9/12,2017/10/13,2017/10/11,Demand increase for the drug.,2017/8/25,2017/10/12,No
10626,2241096,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,250MG,5 cap,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/5/18,2017/5/22,2017/6/16,2017/6/6,Demand increase for the drug.,2017/5/18,2017/6/7,No
11431,2241093,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,5MG,5 cap sachet,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/5/29,2017/5/29,2017/6/16,2017/6/15,Demand increase for the drug.,2017/5/29,2017/6/16,No
5298,2241095,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,100MG,5 cap,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/4/4,2017/4/4,2017/4/13,2017/4/10,Delay in shipping of the drug.,2017/4/4,2017/4/11,No
2227,2241095,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsule,TEMOZOLOMIDE,100MG,20 sachets (1 capsule/sachet),ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/3/3,2017/3/3,2017/4/7,2017/3/24,Delay in shipping of the drug.,2017/3/14,2017/3/25,No
2246,2312794,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,140MG,5 sachets (1 capsule/sachet ),ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/2/22,2017/2/22,2017/3/17,2017/3/30,Delay in shipping of the drug.,2017/3/14,2017/3/31,No
2252,2241096,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,250MG,5 sachets (1 capsule/sachet),ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/2/16,2017/2/16,2017/3/17,2017/3/24,Delay in shipping of the drug.,2017/3/14,2017/3/29,No
17373,2241095,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,100MG,5 cap,ORAL,Avoided shortage,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/9/28,,2017/9/29,2017/9/27,Demand increase for the drug.,2017/7/27,2017/10/11,No
18402,2241096,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,250MG,5 cap,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017/8/2,2017/8/2,2017/9/29,2017/9/26,Demand increase for the drug.,2017/8/7,2017/9/27,No
15614,2241094,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,20MG,5CAP SACHET,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,,2017/7/4,2017/8/7,2017/7/27,Demand increase for the drug.,2017/7/12,2017/7/28,No
23666,2350505,Shortage,TERAZOSIN,SANIS HEALTH INC,TERAZOSIN TAB,TERAZOSIN,10MG,100,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2017/10/2,,2017/10/31,2017/10/6,Other (Please describe in comments),2017/9/27,2017/10/7,No
17844,2171929,Shortage,TEVA-5 ASA,TEVA CANADA LIMITED,5 ASA,MESALAZINE,400MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),A07EC,INTESTINALANTIINFLAMMATORY AGENTS,,2017/7/30,2018/4/13,2018/4/30,Disruption of the manufacture of the drug.,2017/8/1,2018/5/11,No
29444,2285967,Shortage,TEVA-ACYCLOVIR,TEVA CANADA LIMITED,ACYCLOVIR,ACYCLOVIR,400MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/11/16,2018/11/12,2018/11/8,Demand increase for the drug.,2017/11/16,2018/11/9,No
10886,2261715,Shortage,TEVA-ALENDRONATE,TEVA CANADA LIMITED,ALENDRONATE,ALENDRONIC ACID,70MG,4,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/5/17,2017/6/30,2017/9/1,Disruption of the manufacture of the drug.,2017/5/23,2017/9/19,No
23143,2403633,Shortage,TEVA-ALENDRONATE/CHOLECALCIFEROL,TEVA CANADA LIMITED,ALENDRONATE VIT D,ALENDRONIC ACID VITAMIN D3,70MG 2800UNIT,4,ORAL,Actual shortage,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/10/30,,,Shortage of an active ingredient.,2017/9/22,2018/12/21,No
23146,2403641,Shortage,TEVA-ALENDRONATE/CHOLECALCIFEROL,TEVA CANADA LIMITED,ALENDRONATE VIT  D,ALENDRONIC ACID VITAMIN D3,70MG 5600UNIT,4,ORAL,Actual shortage,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/11/20,,,Shortage of an active ingredient.,2017/9/22,2018/12/21,No
19922,2434849,Shortage,TEVA-ALMOTRIPTAN,TEVA CANADA LIMITED,ALMOTRIPTAN,ALMOTRIPTAN,12.5MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/8/17,2019/8/30,2019/8/28,Requirements related to complying with good manufacturing practices.,2017/8/21,2019/8/29,No
5171,2326043,Shortage,TEVA-AMITRIPTYLINE,TEVA CANADA LIMITED,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,10MG,1000,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2017/12/15,2018/2/15,2018/3/7,Disruption of the manufacture of the drug.,2017/4/3,2018/3/8,No
2427,2326043,Shortage,TEVA-AMITRIPTYLINE,TEVA CANADA LIMITED,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2017/12/15,2018/2/12,2018/3/7,Delay in shipping of the drug.,2017/3/14,2018/3/8,No
2434,2326078,Shortage,TEVA-AMITRIPTYLINE,TEVA CANADA LIMITED,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,50MG,100,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2017/3/1,2017/5/20,2017/5/17,Disruption of the manufacture of the drug.,2017/3/14,2017/5/23,No
2437,2326078,Shortage,TEVA-AMITRIPTYLINE,TEVA CANADA LIMITED,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,50MG,1000,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2017/3/1,2017/5/20,2017/5/17,Disruption of the manufacture of the drug.,2017/3/14,2017/5/23,No
9788,2250497,Shortage,TEVA-AMLODIPINE,TEVA CANADA LIMITED,AMLODIPINE,AMLODIPINE,5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/5/4,2018/1/30,2018/2/28,Shortage of an active ingredient.,2017/5/10,2018/3/13,No
9791,2250497,Shortage,TEVA-AMLODIPINE,TEVA CANADA LIMITED,AMLODIPINE,AMLODIPINE,5MG,500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/5/4,2018/1/30,2018/2/28,Shortage of an active ingredient.,2017/5/10,2018/3/13,No
17847,2250497,Shortage,TEVA-AMLODIPINE,TEVA CANADA LIMITED,AMLODIPINE,AMLODIPINE,5MG,250,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/7/30,2018/1/30,2018/2/28,Shortage of an active ingredient.,2017/8/1,2018/3/13,No
17850,2250500,Shortage,TEVA-AMLODIPINE,TEVA CANADA LIMITED,AMLODIPINE,AMLODIPINE,10MG,250,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/7/30,2018/1/30,2018/2/28,Shortage of an active ingredient.,2017/8/1,2018/3/13,No
19925,2250500,Shortage,TEVA-AMLODIPINE,TEVA CANADA LIMITED,AMLODIPINE,AMLODIPINE,10MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017/8/17,2018/1/30,2018/2/28,Shortage of an active ingredient.,2017/8/21,2018/3/13,No
19928,2443813,Shortage,TEVA-ATAZANAVIR,TEVA CANADA LIMITED,ATAZANAVIR,ATAZANAVIR,200MG,60,ORAL,Resolved,CAPSULE,J05AE,DIRECT ACTING ANTIVIRALS,,2017/8/17,2017/9/15,2017/9/15,Disruption of the manufacture of the drug.,2017/8/21,2017/9/19,No
952,2302926,Shortage,TEVA-ATENOLOL/CHLORTHALIDONE,TEVA CANADA LIMITED,Atenolol Chlorthalidone,CHLORTHALIDONE ATENOLOL,25MG 100MG,100,ORAL,Resolved,TABLET,C07CB,BETA BLOCKING AGENTS AND OTHER DIURETICS,2016/11/1,2016/10/17,,2019/9/30,Disruption of the manufacture of the drug.,2017/3/13,2020/1/21,No
29447,2314592,Shortage,TEVA-ATOMOXETINE,TEVA CANADA LIMITED,ATOMOXETINE,ATOMOXETINE,60MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/11/16,2018/1/17,2018/2/15,Disruption of the manufacture of the drug.,2017/11/16,2018/2/21,No
17853,2314584,Shortage,TEVA-ATOMOXETINE,TEVA CANADA LIMITED,ATOMOXETINE,ATOMOXETINE,40MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017/7/30,2018/1/17,2018/2/15,Disruption of the manufacture of the drug.,2017/8/1,2018/2/21,No
17856,2267845,Shortage,TEVA-AZITHROMYCIN,TEVA CANADA LIMITED,AZITHROMYCIN,AZITHROMYCIN,250MG,6,ORAL,Actual shortage,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/7/30,,,Disruption of the manufacture of the drug.,2017/8/1,2018/12/21,No
17859,2280205,Shortage,TEVA-BETAHISTINE,TEVA CANADA LIMITED,BETAHISTINE,BETAHISTINE HYDROCHLORIDE,24MG,100,ORAL,Resolved,TABLET,N07CA,ANTIVERTIGO PREPARATIONS,,2017/8/1,2017/11/17,2017/10/10,Disruption of the manufacture of the drug.,2017/8/1,2017/10/11,No
19931,2280205,Shortage,TEVA-BETAHISTINE,TEVA CANADA LIMITED,BETAHISTINE,BETAHISTINE HYDROCHLORIDE,24MG,100,ORAL,Resolved,TABLET,N07CA,ANTIVERTIGO PREPARATIONS,,2017/8/17,2017/11/15,2017/10/10,Disruption of the manufacture of the drug.,2017/8/21,2017/10/11,No
29450,2270226,Shortage,TEVA-BICALUTAMIDE,TEVA CANADA LIMITED,BICALUTAMIDE,BICALUTAMIDE,50MG,100,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017/11/16,2018/1/15,2018/3/5,Disruption of the manufacture of the drug.,2017/11/16,2018/3/13,No
5174,2270226,Shortage,TEVA-BICALUTAMIDE,TEVA CANADA LIMITED,BICALUTAMIDE,BICALUTAMIDE,50MG,30,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017/4/3,2017/5/8,2017/5/4,Disruption of the manufacture of the drug.,2017/4/3,2017/5/10,No
202,2267470,Shortage,TEVA-BISOPROLOL,TEVA CANADA LIMITED,BISOPROLOL FUMARATE,BISOPROLOL FUMARATE,5MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017/1/15,,2017/3/10,2017/3/10,Disruption of the manufacture of the drug.,2017/3/10,2017/4/25,No
974,2395568,Shortage,TEVA-CANDESARTAN/HCTZ,TEVA CANADA LIMITED,Hydrochlorothiazide Candesartan Cilexetil,HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL,12.5MG 32MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2016/11/22,2017/3/31,2017/9/1,Disruption of the manufacture of the drug.,2017/3/13,2017/10/10,No
8062,2400030,Shortage,TEVA-CAPECITABINE,TEVA CANADA LIMITED,CAPECITABINE,CAPECITABINE,500MG,120,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,,2017/4/21,2017/5/31,2017/5/17,Disruption of the manufacture of the drug.,2017/4/25,2017/5/23,No
17862,2400022,Shortage,TEVA-CAPECITABINE,TEVA CANADA LIMITED,CAPECITABINE,CAPECITABINE,150MG,PP60,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,,2018/1/3,2018/4/30,2018/4/30,Demand increase for the drug.,2017/8/1,2018/5/11,No
983,782718,Shortage,TEVA-CARBAMAZEPINE,TEVA CANADA LIMITED,Carbamazepine,CARBAMAZEPINE,200MG,100,ORAL,Resolved,TABLET,N03AF,ANTIEPILEPTICS,,2016/11/1,2019/5/30,2019/5/15,Disruption of the manufacture of the drug.,2017/3/13,2019/5/28,No
8065,232823,Shortage,TEVA-CHLORPROMAZINE,TEVA CANADA LIMITED,CHLORPROMAZINE,CHLORPROMAZINE,25.0MG,100,ORAL,Resolved,TABLET,N05AA,ANTIPSYCHOTICS,,2017/4/21,2017/6/20,2017/7/30,Disruption of the manufacture of the drug.,2017/4/25,2017/9/19,No
17871,2441624,Shortage,TEVA-CINACALCET,TEVA CANADA LIMITED,CINACALCET,CINACALCET,30MG,30,ORAL,Resolved,TABLET,H05BX,ANTI-PARATHYROID HORMONES,,2017/8/1,2017/9/30,2017/9/30,Disruption of the manufacture of the drug.,2017/8/1,2017/10/10,No
17874,2293226,Shortage,TEVA-CITALOPRAM,TEVA CANADA LIMITED,CITALOPRAM,CITALOPRAM,40MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/8/1,2017/9/29,2017/9/15,Disruption of the manufacture of the drug.,2017/8/1,2017/9/19,No
19934,2293218,Shortage,TEVA-CITALOPRAM,TEVA CANADA LIMITED,CITALOPRAM,CITALOPRAM,20MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017/8/17,2017/11/15,2017/10/6,Disruption of the manufacture of the drug.,2017/8/21,2017/10/10,No
5177,2241709,Shortage,TEVA-CLINDAMYCIN,TEVA CANADA LIMITED,CLINDAMYCIN,CLINDAMYCIN,150MG,100,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/4/3,2017/5/5,2017/5/4,Demand increase for the drug.,2017/4/3,2017/5/10,No
5180,2241710,Shortage,TEVA-CLINDAMYCIN,TEVA CANADA LIMITED,CLINDAMYCIN,CLINDAMYCIN,300MG,100,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/8/10,2017/10/15,2017/10/20,Demand increase for the drug.,2017/4/3,2017/10/24,No
19683,2239024,Shortage,TEVA-CLONAZEPAM,TEVA CANADA LIMITED,CLONAZEPAM,CLONAZEPAM,0.5MG,100,ORAL,Actual shortage,TABLET,N03AE,ANTIEPILEPTICS,,2017/8/11,,,Shortage of an active ingredient.,2017/8/17,2017/10/11,No
19688,2239024,Shortage,TEVA-CLONAZEPAM,TEVA CANADA LIMITED,CLONAZEPAM,CLONAZEPAM,0.5MG,500,ORAL,Actual shortage,TABLET,N03AE,ANTIEPILEPTICS,,2017/8/11,,,Shortage of an active ingredient.,2017/8/17,2017/10/11,No
19937,337757,Shortage,TEVA-CLOXACILLIN,TEVA CANADA LIMITED,CLOXACILLIN,CLOXACILLIN SODIUM,125MG,100ML,ORAL,Resolved,GRANULES FOR SOLUTION,J01CF,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017/8/17,2017/9/5,2017/9/15,Disruption of the manufacture of the drug.,2017/8/21,2017/9/19,No
5183,2242538,Shortage,TEVA-DILTIAZEM CD,TEVA CANADA LIMITED,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,120MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/4/3,2017/6/19,2017/5/4,Demand increase for the drug.,2017/4/3,2017/5/10,No
5186,2242539,Shortage,TEVA-DILTIAZEM CD,TEVA CANADA LIMITED,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017/4/3,2017/5/15,2017/5/4,Demand increase for the drug.,2017/4/3,2017/5/10,No
17878,2340615,Shortage,TEVA-DONEPEZIL,TEVA CANADA LIMITED,DONEPOZIL,DONEPEZIL HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2018/1/3,2018/4/30,2018/4/30,Delay in shipping of the drug.,2017/8/1,2018/5/11,No
17881,725250,Shortage,TEVA-DOXYCYCLINE,TEVA CANADA LIMITED,DOXYCYCLINE,DOXYCYCLINE,100MG,100,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,,2017/8/1,2017/9/5,2017/9/13,Disruption of the manufacture of the drug.,2017/8/1,2017/9/19,No
17884,725250,Shortage,TEVA-DOXYCYCLINE,TEVA CANADA LIMITED,DOXYCYCLINE,DOXYCYCLINE,100MG,200,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,,2017/8/1,2017/9/1,2017/9/13,Disruption of the manufacture of the drug.,2017/8/1,2017/9/19,No
5189,2408287,Shortage,TEVA-DUTASTERIDE,TEVA CANADA LIMITED,DUTASTERIDE,DUTASTERIDE,0.5MG,30,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/7/30,2018/12/28,2018/12/28,Disruption of the manufacture of the drug.,2017/4/3,2019/1/3,No
5192,2408287,Shortage,TEVA-DUTASTERIDE,TEVA CANADA LIMITED,DUTASTERIDE,DUTASTERIDE,0.5MG,100,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/7/30,2018/12/28,2018/12/28,Disruption of the manufacture of the drug.,2017/4/3,2019/1/3,No
17887,2382105,Shortage,TEVA-ELETRIPTAN,TEVA CANADA LIMITED,ELETRIPTAN,ELETRIPTAN,40MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/8/1,2017/10/1,2017/10/6,Disruption of the manufacture of the drug.,2017/8/1,2017/10/10,No
9796,2354101,Shortage,TEVA-EZETIMIBE,TEVA CANADA LIMITED,EZETIMIBE,EZETIMIBE,10MG,100,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017/5/4,2017/6/5,2017/8/15,Disruption of the manufacture of the drug.,2017/5/10,2017/9/19,No
17890,2354101,Shortage,TEVA-EZETIMIBE,TEVA CANADA LIMITED,EZETIMIBE,EZETIMIBE,10MG,PP30,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017/8/1,2017/10/30,2017/11/1,Disruption of the manufacture of the drug.,2017/8/1,2017/11/6,No
19941,2354101,Shortage,TEVA-EZETIMIBE,TEVA CANADA LIMITED,EZETIMIBE,EZETIMIBE,10MG,500,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017/8/17,2017/9/20,2017/9/15,Disruption of the manufacture of the drug.,2017/8/21,2017/9/19,No
22948,2282968,Shortage,TEVA-FENTANYL,TEVA CANADA LIMITED,FENTANYL,FENTANYL,50MCG,5PK,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,,2017/9/21,2017/11/1,2017/11/6,Disruption of the manufacture of the drug.,2017/9/21,2017/11/7,No
19944,2348500,Shortage,TEVA-FINASTERIDE,TEVA CANADA LIMITED,FINASTERIDE,FINASTERIDE,5MG,100,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017/8/17,2017/9/30,2017/10/6,Demand increase for the drug.,2017/8/21,2017/10/10,No
17893,2236979,Shortage,TEVA-FLUCONAZOLE,TEVA CANADA LIMITED,FLUCONAZOLE,FLUCONAZOLE,100MG,50,ORAL,Actual shortage,TABLET,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2017/8/1,,,Disruption of the manufacture of the drug.,2017/8/1,2018/12/21,No
19947,2216590,Shortage,TEVA-FLUOXETINE,TEVA CANADA LIMITED,FLUOXETINE,FLUOXETINE,20MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017/8/17,2017/10/30,2017/11/1,Shortage of an active ingredient.,2017/8/21,2017/11/6,No
19950,2216590,Shortage,TEVA-FLUOXETINE,TEVA CANADA LIMITED,FLUOXETINE,FLUOXETINE,20MG,500,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017/8/17,2017/10/30,2017/11/1,Shortage of an active ingredient.,2017/8/21,2017/11/6,No
989,2299224,Shortage,TEVA-FLUVASTATIN,TEVA CANADA LIMITED,FLUVASTATIN,FLUVASTATIN,20MG,100,ORAL,Resolved,CAPSULE,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2016/11/1,2016/3/30,2017/3/31,2017/3/31,Disruption of the manufacture of the drug.,2017/3/13,2017/4/3,No
2301,2299232,Shortage,TEVA-FLUVASTATIN,TEVA CANADA LIMITED,FLUVASTATIN,FLUVASTATIN,40MG,100,ORAL,Resolved,CAPSULE,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/3/1,2017/4/17,2017/3/31,Disruption of the manufacture of the drug.,2017/3/14,2017/4/3,No
19955,2247802,Shortage,TEVA-FOSINOPRIL,TEVA CANADA LIMITED,FOSINOPRIL,FOSINOPRIL SODIUM,10MG,30,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/8/20,2017/9/14,2017/9/15,Disruption of the manufacture of the drug.,2017/8/21,2017/9/19,No
19960,2247803,Shortage,TEVA-FOSINOPRIL,TEVA CANADA LIMITED,FOSINOPRIL,FOSINOPRIL SODIUM,20MG,30,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/8/18,2017/9/14,2017/9/15,Shortage of an inactive ingredient or component.,2017/8/21,2017/9/19,No
5197,337730,Shortage,TEVA-FUROSEMIDE,TEVA CANADA LIMITED,FUROSEMIDE,FUROSEMIDE,20MG,100,ORAL,Resolved,TABLET,C03CA,HIGH-CEILING DIURETICS,,2017/4/3,2017/5/15,2017/5/17,Disruption of the manufacture of the drug.,2017/4/3,2017/5/23,No
3124,2244514,Shortage,TEVA-GABAPENTIN,TEVA CANADA LIMITED,GABAPENTIN,GABAPENTIN,300MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/3/17,2017/5/31,2017/4/17,Disruption of the manufacture of the drug.,2017/3/17,2017/4/25,No
10889,2244514,Shortage,TEVA-GABAPENTIN,TEVA CANADA LIMITED,GABAPENTIN,GABAPENTIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/5/17,2017/6/12,2017/9/1,Disruption of the manufacture of the drug.,2017/5/23,2017/9/19,No
1841,363677,Shortage,TEVA-HALOPERIDOL,TEVA CANADA LIMITED,HALOPERIDOL,HALOPERIDOL,1MG,100,ORAL,Resolved,TABLET,N05AD,ANTIPSYCHOTICS,,2017/2/1,2017/4/13,2017/4/17,Delay in shipping of the drug.,2017/3/13,2017/4/25,No
3127,363685,Shortage,TEVA-HALOPERIDOL,TEVA CANADA LIMITED,HALOPERIDOL,HALOPERIDOL,0.5MG,100,ORAL,Resolved,TABLET,N05AD,ANTIPSYCHOTICS,,2017/3/17,2017/7/16,2017/3/30,Disruption of the manufacture of the drug.,2017/3/17,2017/4/3,No
997,2319403,Shortage,TEVA-HYDROMORPHONE,TEVA CANADA LIMITED,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,1MG,100,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2014/11/5,,2018/8/31,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
1001,2319411,Shortage,TEVA-HYDROMORPHONE,TEVA CANADA LIMITED,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,2MG,100,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2014/11/5,,2018/8/31,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
1006,2319438,Shortage,TEVA-HYDROMORPHONE,TEVA CANADA LIMITED,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,4MG,100,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2014/11/5,,2018/8/31,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
1009,2319446,Shortage,TEVA-HYDROMORPHONE,TEVA CANADA LIMITED,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,8MG,100,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2014/11/5,,2018/8/31,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
8071,2216221,Shortage,TEVA-IPRATROPIUM STERINEBS,TEVA CANADA LIMITED,IPRATROPIUM,IPRATROPIUM BROMIDE,0.03%,10X2ML,INHALATION,Resolved,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017/4/21,2017/9/30,2017/10/6,Demand increase for the drug.,2017/4/25,2017/10/10,No
5201,2231061,Shortage,TEVA-KETOCONAZOLE,TEVA CANADA LIMITED,KETOCONAZOLE,KETOCONAZOLE,200MG,100,ORAL,Resolved,TABLET,J02AB,ANTIMYCOTICS FOR SYSTEMIC USE,,2017/4/3,2017/5/25,2017/6/30,Disruption of the manufacture of the drug.,2017/4/3,2017/9/6,No
19964,2331551,Shortage,TEVA-LACTULOSE,TEVA CANADA LIMITED,LACTULOSE,LACTULOSE,667MG,20,ORAL,Resolved,SOLUTION,A06AD,DRUGS FOR CONSTIPATION,,2017/8/20,2017/9/30,2017/10/6,Disruption of the manufacture of the drug.,2017/8/21,2017/10/10,No
5204,2248233,Shortage,TEVA-LAMOTRIGINE,TEVA CANADA LIMITED,LAMOTRIGINE,LAMOTRIGINE,100MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017/4/3,2017/5/3,2017/5/4,Disruption of the manufacture of the drug.,2017/4/3,2017/5/10,No
19968,2343657,Shortage,TEVA-LETROZOLE,TEVA CANADA LIMITED,LETROZOLE,LETROZOLE,2.5MG,30,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017/8/18,2017/9/15,2017/9/15,Disruption of the manufacture of the drug.,2017/8/21,2017/9/19,No
19973,2244496,Shortage,TEVA-LEVOCARBIDOPA,TEVA CANADA LIMITED,LEVOCARBIDOPA,CARBIDOPA LEVODOPA,25MG 250MG,100,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,,2017/12/29,2018/6/5,2018/2/21,Disruption of the manufacture of the drug.,2017/8/21,2018/2/22,No
5207,2244495,Shortage,TEVA-LEVOCARBIDOPA,TEVA CANADA LIMITED,LEVOCARBIDOPA,CARBIDOPA LEVODOPA,25MG 100MG,100,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,,2017/8/27,2017/11/6,2017/11/6,Demand increase for the drug.,2017/4/3,2017/11/7,No
17896,2244496,Shortage,TEVA-LEVOCARBIDOPA,TEVA CANADA LIMITED,LEVOCARBIDOPA,CARBIDOPA LEVODOPA,25MG 250MG,500,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,,2018/1/3,2018/6/5,2018/2/21,Disruption of the manufacture of the drug.,2017/8/1,2018/2/22,No
2297,2244495,Shortage,TEVA-LEVOCARBIDOPA,TEVA CANADA LIMITED,LEVOCARBIDOPA,CARBIDOPA LEVODOPA,25MG 100MG,500,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,,2017/6/30,2017/11/6,2017/11/6,Delay in shipping of the drug.,2017/3/14,2017/11/7,No
2310,2285096,Shortage,TEVA-LISINOPRIL (TYPE P),TEVA CANADA LIMITED,LISINOPRIL P,LISINOPRIL,20MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/4/3,2017/6/6,2017/7/3,Disruption of the manufacture of the drug.,2017/3/14,2017/7/27,No
2312,2285061,Shortage,TEVA-LISINOPRIL (TYPE P),TEVA CANADA LIMITED,LISINOPRIL P,LISINOPRIL,5MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017/4/1,,2017/4/27,2017/5/4,Delay in shipping of the drug.,2017/3/14,2017/5/10,No
1026,711101,Shortage,TEVA-LORAZEPAM,TEVA CANADA LIMITED,TEVA-LORAZEPAM,LORAZEPAM,0.5MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2016/10/18,,2019/4/1,Disruption of the manufacture of the drug.,2017/3/13,2019/4/11,No
1035,637742,Shortage,TEVA-LORAZEPAM,TEVA CANADA LIMITED,LORAZEPAM,LORAZEPAM,1MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2016/10/18,,2019/4/1,Disruption of the manufacture of the drug.,2017/3/13,2019/4/11,No
2292,711101,Shortage,TEVA-LORAZEPAM,TEVA CANADA LIMITED,LORAZEPAM,LORAZEPAM,0.5MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017/3/14,2017/6/15,2017/6/30,Demand increase for the drug.,2017/3/14,2017/7/27,No
3130,2221306,Shortage,TEVA-MEDROXYPROGESTERONE,TEVA CANADA LIMITED,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,10MG,100,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,,2017/3/17,2017/6/4,2017/6/4,Disruption of the manufacture of the drug.,2017/3/17,2017/10/10,No
5213,2221284,Shortage,TEVA-MEDROXYPROGESTERONE,TEVA CANADA LIMITED,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,2.5MG,100,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,,2017/12/15,2018/1/29,2018/2/15,Disruption of the manufacture of the drug.,2017/4/3,2018/2/21,No
30668,2315068,Shortage,TEVA-METHYLPHENIDATE ER-C,TEVA CANADA LIMITED,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,18MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018/1/30,2018/1/30,,,Disruption of the manufacture of the drug.,2017/11/24,2020/1/21,No
30685,2315076,Shortage,TEVA-METHYLPHENIDATE ER-C,TEVA CANADA LIMITED,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,27MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018/1/30,2018/1/30,,,Disruption of the manufacture of the drug.,2017/11/24,2020/1/21,No
30688,2315084,Shortage,TEVA-METHYLPHENIDATE ER-C,TEVA CANADA LIMITED,MTHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,36MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018/1/30,2018/1/30,,,Disruption of the manufacture of the drug.,2017/11/24,2020/1/21,No
30691,2315092,Shortage,TEVA-METHYLPHENIDATE ER-C,TEVA CANADA LIMITED,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,54MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018/1/30,2018/1/30,,,Disruption of the manufacture of the drug.,2017/11/24,2020/1/21,No
19978,2230360,Shortage,TEVA-MEXILETINE,TEVA CANADA LIMITED,MEXILETINE,MEXILETINE HYDROCHLORIDE,200MG,100,ORAL,Resolved,CAPSULE,C01BB,"ANTIARRHYTHMICS, CLASS I AND III",,2017/8/21,2018/1/15,2018/2/15,Demand increase for the drug.,2017/8/21,2018/2/21,No
29453,2230359,Shortage,TEVA-MEXILETINE,TEVA CANADA LIMITED,MEXILETINE,MEXILETINE HYDROCHLORIDE,100MG,100,ORAL,Resolved,CAPSULE,C01BB,"ANTIARRHYTHMICS, CLASS I AND III",,2017/11/16,2018/1/15,2018/2/15,Disruption of the manufacture of the drug.,2017/11/16,2018/2/21,No
5216,2375702,Shortage,TEVA-MOXIFLOXACIN,TEVA CANADA LIMITED,MOXIFLOXACIN,MOXIFLOXACIN,400MG,30,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2017/4/3,2017/6/5,2017/6/5,Disruption of the manufacture of the drug.,2017/4/3,2017/10/10,No
2218,2384892,Shortage,TEVA-NABILONE,TEVA CANADA LIMITED,NABILONE,NABILONE,1.0MG,50,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,2018/2/15,2018/2/15,2018/7/15,2018/8/30,Demand increase for the drug.,2017/3/14,2018/9/13,No
2256,2384884,Shortage,TEVA-NABILONE,TEVA CANADA LIMITED,NABILONE,NABILONE,0.5MG,50,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,2018/2/15,2018/2/15,2018/7/15,2018/8/30,Demand increase for the drug.,2017/3/14,2018/9/13,No
17899,2392925,Shortage,TEVA-NABILONE,TEVA CANADA LIMITED,NABILONE,NABILONE,0.25MG,50,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,2018/2/18,2018/2/18,2018/6/30,2018/6/30,Demand increase for the drug.,2017/8/1,2018/7/3,No
1038,2314290,Shortage,TEVA-NARATRIPTAN,TEVA CANADA LIMITED,NARATRIPTAN,NARATRIPTAN,1MG,8,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2015/10/15,2018/2/28,2018/3/13,Disruption of the manufacture of the drug.,2017/3/13,2018/3/14,No
1137,2314304,Shortage,TEVA-NARATRIPTAN,TEVA CANADA LIMITED,NARATRIPTAM HCL,NARATRIPTAN,2.5MG,8,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2015/10/15,2018/2/28,2018/3/13,Disruption of the manufacture of the drug.,2017/3/13,2018/3/14,No
1143,2237682,Shortage,TEVA-NORFLOXACIN,TEVA CANADA LIMITED,NORFLOXACIN,NORFLOXACIN,400MG,100,ORAL,Actual shortage,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2015/12/22,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/11,No
24103,2230394,Shortage,TEVA-OXYBUTYNIN,TEVA CANADA LIMITED,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,5MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/11/1,2019/2/1,2019/1/31,Demand increase for the drug.,2017/10/2,2019/2/1,No
24106,2230394,Shortage,TEVA-OXYBUTYNIN,TEVA CANADA LIMITED,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,5MG,500,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/11/1,2019/2/1,2019/1/31,Demand increase for the drug.,2017/10/2,2019/2/1,No
1153,2248556,Shortage,TEVA-PAROXETINE,TEVA CANADA LIMITED,PAROXETINE,PAROXETINE,10MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2015/10/5,2017/6/30,2017/8/1,Disruption of the manufacture of the drug.,2017/3/13,2017/10/10,No
1161,2248556,Shortage,TEVA-PAROXETINE,TEVA CANADA LIMITED,PAROXETINE,PAROXETINE,10MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2015/10/5,2017/6/30,2017/8/1,Disruption of the manufacture of the drug.,2017/3/13,2017/10/10,No
1167,2248556,Shortage,TEVA-PAROXETINE,TEVA CANADA LIMITED,PAROXETINE,PAROXETINE,10MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2015/10/5,2017/6/30,2017/8/1,Disruption of the manufacture of the drug.,2017/3/13,2017/10/10,No
1175,2248557,Shortage,TEVA-PAROXETINE,TEVA CANADA LIMITED,PAROXETINE,PAROXETINE,20MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2015/10/5,2017/6/30,2017/8/1,Disruption of the manufacture of the drug.,2017/3/13,2017/10/10,No
1179,2248557,Shortage,TEVA-PAROXETINE,TEVA CANADA LIMITED,PAROXETINE,PAROXETINE,20MG,500,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2015/10/5,2017/6/30,2017/8/1,Disruption of the manufacture of the drug.,2017/3/13,2017/10/10,No
1191,2248557,Shortage,TEVA-PAROXETINE,TEVA CANADA LIMITED,PAROXETINE,PAROXETINE,20MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2015/10/5,2017/6/30,2017/8/1,Disruption of the manufacture of the drug.,2017/3/13,2017/10/10,No
1454,2248558,Shortage,TEVA-PAROXETINE,TEVA CANADA LIMITED,PAROXETINE,PAROXETINE,30MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2015/10/5,2017/6/30,2017/8/1,Disruption of the manufacture of the drug.,2017/3/13,2017/10/10,No
1199,2248558,Shortage,TEVA-PAROXETINE,TEVA CANADA LIMITED,PAROXETINE,PAROXETINE,30MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2015/10/5,2017/6/30,2017/8/1,Disruption of the manufacture of the drug.,2017/3/13,2017/10/10,No
1204,2248558,Shortage,TEVA-PAROXETINE,TEVA CANADA LIMITED,PAROXETINE,PAROXETINE,30MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2015/10/5,2017/6/30,2017/8/1,Disruption of the manufacture of the drug.,2017/3/13,2017/10/10,No
9799,2247010,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/9/1,2018/1/26,2018/2/5,Disruption of the manufacture of the drug.,2017/5/10,2018/2/21,No
5219,2247009,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,PRAVASTATIN,PRAVASTATIN SODIUM,20MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/9/6,2017/12/22,2018/2/1,Disruption of the manufacture of the drug.,2017/4/3,2018/2/21,No
10896,2247009,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,PRAVASTATIN,PRAVASTATIN SODIUM,20MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/8/15,2018/1/26,2018/2/5,Disruption of the manufacture of the drug.,2017/5/23,2018/2/21,No
10899,2247010,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/5/17,2018/1/26,2018/2/5,Disruption of the manufacture of the drug.,2017/5/23,2018/2/21,No
1784,2247008,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/11/6,2018/1/30,2017/12/15,Delay in shipping of the drug.,2017/3/13,2017/12/16,No
1787,2247008,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/11/6,2017/12/30,2018/2/28,Delay in shipping of the drug.,2017/3/13,2018/3/13,No
29456,2361159,Shortage,TEVA-PREGABALIN,TEVA CANADA LIMITED,PREGABALIN,PREGABALIN,25MG,60,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017/11/16,2018/1/19,2018/2/15,Disruption of the manufacture of the drug.,2017/11/16,2018/2/21,No
17983,2439913,Shortage,TEVA-PROGESTERONE,TEVA CANADA LIMITED,PROGESTERONE,PROGESTERONE,100MG,PP 30,ORAL,Resolved,CAPSULE,G03DA,PROGESTOGENS,,2017/8/1,2017/9/30,2017/10/6,Disruption of the manufacture of the drug.,2017/8/2,2017/10/10,No
17976,740675,Shortage,TEVA-PROPRANOLOL,TEVA CANADA LIMITED,PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,20MG,100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2017/8/30,,2021/10/12,Disruption of the manufacture of the drug.,2017/8/2,2021/10/14,No
17979,740675,Shortage,TEVA-PROPRANOLOL,TEVA CANADA LIMITED,PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,20MG,500,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2017/8/30,,2021/10/12,Disruption of the manufacture of the drug.,2017/8/2,2021/10/14,No
5223,2395479,Shortage,TEVA-QUETIAPINE XR,TEVA CANADA LIMITED,QUETIAPINE XR,QUETIAPINE,300MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017/11/1,2018/1/26,2018/2/15,Disruption of the manufacture of the drug.,2017/4/3,2018/2/21,No
1748,2395452,Shortage,TEVA-QUETIAPINE XR,TEVA CANADA LIMITED,QUETIAPINE XR,QUETIAPINE,150MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,2017/4/15,,2017/5/26,2017/5/26,Disruption of the manufacture of the drug.,2017/3/13,2017/10/10,No
1760,2395487,Shortage,TEVA-QUETIAPINE XR,TEVA CANADA LIMITED,QUETIAPINE XR,QUETIAPINE,400MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017/8/30,2017/9/29,2017/10/10,Disruption of the manufacture of the drug.,2017/3/13,2017/10/11,No
1769,2395460,Shortage,TEVA-QUETIAPINE XR,TEVA CANADA LIMITED,QUETIAPINE XR,QUETIAPINE,200MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017/12/15,2018/1/26,2018/2/15,Disruption of the manufacture of the drug.,2017/3/13,2018/2/21,No
1778,2395444,Shortage,TEVA-QUETIAPINE XR,TEVA CANADA LIMITED,QUETIAPINE XR,QUETIAPINE,50MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017/8/30,2017/10/6,2017/10/6,Disruption of the manufacture of the drug.,2017/3/13,2017/10/10,No
3133,2296640,Shortage,TEVA-RABEPRAZOLE EC,TEVA CANADA LIMITED,RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/3/17,2017/11/30,2017/10/10,Disruption of the manufacture of the drug.,2017/3/17,2017/10/11,No
19981,2247946,Shortage,TEVA-RAMIPRIL,TEVA CANADA LIMITED,RAMIPRIL,RAMIPRIL,5MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/8/20,2017/11/30,2018/1/3,Demand increase for the drug.,2017/8/21,2018/1/4,No
19984,2247946,Shortage,TEVA-RAMIPRIL,TEVA CANADA LIMITED,RAMIPRIL,RAMIPRIL,5MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/8/21,2018/4/30,2018/4/30,Demand increase for the drug.,2017/8/21,2018/5/11,No
17987,2247945,Shortage,TEVA-RAMIPRIL,TEVA CANADA LIMITED,RAMIPRIL,RAMIPRIL,2.5MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/8/1,2017/11/30,2017/12/20,Disruption of the manufacture of the drug.,2017/8/2,2018/1/3,No
9802,2247945,Shortage,TEVA-RAMIPRIL,TEVA CANADA LIMITED,RAMIPRIL,RAMIPRIL,2.5MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/5/4,2017/11/30,2017/12/29,Disruption of the manufacture of the drug.,2017/5/10,2018/1/3,No
17994,2247947,Shortage,TEVA-RAMIPRIL,TEVA CANADA LIMITED,RAMIPRIL,RAMIPRIL,10MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/8/1,2017/11/30,2017/12/29,Disruption of the manufacture of the drug.,2017/8/2,2018/1/3,No
17997,2247947,Shortage,TEVA-RAMIPRIL,TEVA CANADA LIMITED,RAMIPRIL,RAMIPRIL,10MG,PP 30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017/8/1,2017/11/30,2018/1/3,Disruption of the manufacture of the drug.,2017/8/2,2018/1/4,No
1510,828564,Shortage,TEVA-RANITIDINE,TEVA CANADA LIMITED,RANITIDINE,RANITIDINE,150MG,60,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2016/7/16,,2017/4/7,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
1522,828556,Shortage,TEVA-RANITIDINE,TEVA CANADA LIMITED,RANITIDINE,RANITIDINE,300MG,100,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2016/4/29,,2017/4/7,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
1534,828556,Shortage,TEVA-RANITIDINE,TEVA CANADA LIMITED,RANITIDINE,RANITIDINE,300MG,500,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2016/4/29,,2017/4/7,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
10902,2418444,Shortage,TEVA-RASAGILINE,TEVA CANADA LIMITED,RASAGILINE,RASAGILINE,1MG,30,ORAL,Resolved,TABLET,N04BD,DOPAMINERGIC AGENTS,,2017/5/17,2017/6/30,2017/7/30,Disruption of the manufacture of the drug.,2017/5/23,2017/9/19,No
1607,2413809,Shortage,TEVA-RISEDRONATE,TEVA CANADA LIMITED,RISEDRONATE,RISEDRONATE SODIUM,150MG,3,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017/2/1,2017/4/7,2017/5/1,Delay in shipping of the drug.,2017/3/13,2017/10/10,No
1566,2264188,Shortage,TEVA-RISPERIDONE,TEVA CANADA LIMITED,RISPERIDONE,RISPERIDONE,0.5MG,100,ORAL,Actual shortage,TABLET,N05AX,ANTIPSYCHOTICS,,2016/11/1,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/11,No
9805,2396688,Shortage,TEVA-RIZATRIPTAN ODT,TEVA CANADA LIMITED,RIZATRIPTAN,RIZATRIPTAN,10MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2017/5/4,2017/6/29,2017/8/1,Disruption of the manufacture of the drug.,2017/5/10,2017/9/19,No
10907,2308738,Shortage,TEVA-SILDENAFIL,TEVA CANADA LIMITED,SILDENAFIL,SILDENAFIL,25MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/5/17,2017/6/17,2017/7/15,Disruption of the manufacture of the drug.,2017/5/23,2017/9/19,No
18004,2250160,Shortage,TEVA-SIMVASTATIN,TEVA CANADA LIMITED,SIMVASTATIN,SIMVASTATIN,20MG,PP 30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/8/1,,2017/8/25,Disruption of the manufacture of the drug.,2017/8/2,2017/8/26,No
18014,2250187,Shortage,TEVA-SIMVASTATIN,TEVA CANADA LIMITED,SIMVASTATIN,SIMVASTATIN,80MG,PP 30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017/8/1,2017/8/25,2017/9/15,Disruption of the manufacture of the drug.,2017/8/2,2017/9/19,No
18017,2397919,Shortage,TEVA-SOLIFENACIN,TEVA CANADA LIMITED,SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,30,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017/8/2,2017/10/20,2017/9/18,Disruption of the manufacture of the drug.,2017/8/2,2017/9/19,No
1560,613223,Shortage,TEVA-SPIRONOLACTONE,TEVA CANADA LIMITED,TEVA-SPIRONOLACTONE 100MG TABLETS 100,SPIRONOLACTONE,100MG,100,ORAL,Resolved,TABLET,C03DA,POTASSIUM-SPARING AGENTS,,2017/3/1,,2020/2/12,Shortage of an inactive ingredient or component.,2017/3/13,2020/2/13,No
1568,613215,Shortage,TEVA-SPIRONOLACTONE,TEVA CANADA LIMITED,TEVA-SPIRONOLACTONE 25MG TABLETS 500,SPIRONOLACTONE,25MG,500,ORAL,Resolved,TABLET,C03DA,POTASSIUM-SPARING AGENTS,,2017/7/1,2017/9/30,2017/10/10,Shortage of an inactive ingredient or component.,2017/3/13,2017/10/11,No
18025,613223,Shortage,TEVA-SPIRONOLACTONE,TEVA CANADA LIMITED,SPIRONOLACTONE,SPIRONOLACTONE,100MG,100,ORAL,Resolved,TABLET,C03DA,POTASSIUM-SPARING AGENTS,,2018/1/3,2018/1/19,2018/2/15,Disruption of the manufacture of the drug.,2017/8/2,2018/2/21,No
18021,613231,Shortage,TEVA-SPIRONOLACTONE/HCTZ,TEVA CANADA LIMITED,SPIRONOLACTONE/HCTZ,HYDROCHLOROTHIAZIDE SPIRONOLACTONE,25MG 25MG,100,ORAL,Resolved,TABLET,C03EA,DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB,,2017/8/1,2017/10/30,2017/11/6,Disruption of the manufacture of the drug.,2017/8/2,2017/11/7,No
18030,2286815,Shortage,TEVA-SUMATRIPTAN DF,TEVA CANADA LIMITED,SUMATRIPTAN,SUMATRIPTAN,25MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/8/2,2017/8/22,2017/9/15,Disruption of the manufacture of the drug.,2017/8/2,2017/9/19,No
5226,851973,Shortage,TEVA-TAMOXIFEN,TEVA CANADA LIMITED,TAMOXIFEN,TAMOXIFEN,20MG,100,ORAL,Resolved,TABLET,L02BA,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017/4/3,2017/5/8,2017/5/4,Disruption of the manufacture of the drug.,2017/4/3,2017/5/10,No
5229,2330288,Shortage,TEVA-TELMISARTAN HCTZ,TEVA CANADA LIMITED,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE TELMISARTAN,12.5MG 80MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/4/3,2017/6/16,2017/7/30,Disruption of the manufacture of the drug.,2017/4/3,2017/9/19,No
1619,2230808,Shortage,TEVA-TERAZOSIN,TEVA CANADA LIMITED,TERAZOSIN,TERAZOSIN,10MG,100,ORAL,Actual shortage,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2014/3/7,2022/12/1,,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
1635,2230805,Shortage,TEVA-TERAZOSIN,TEVA CANADA LIMITED,TERAZOSIN,TERAZOSIN HCL,1MG,100,ORAL,Actual shortage,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2014/3/7,2022/12/1,,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
1643,2230807,Shortage,TEVA-TERAZOSIN,TEVA CANADA LIMITED,TERAZOSIN,TERAZOSIN,5MG,100,ORAL,Actual shortage,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2014/3/7,2022/12/1,,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
1655,2240346,Shortage,TEVA-TERBINAFINE,TEVA CANADA LIMITED,TERBINAFINE,TERBINAFINE,250MG,28,ORAL,Actual shortage,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,,2016/10/18,,,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
10911,2389622,Shortage,TEVA-TOBRAMYCIN,TEVA CANADA LIMITED,TOBRAMYCIN,TOBRAMYCIN,60MG,5,INHALATION,Resolved,SOLUTION,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,,2017/12/29,2018/7/6,2018/7/12,Disruption of the manufacture of the drug.,2017/5/23,2018/7/30,No
1659,2412063,Shortage,TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION,TEVA CANADA LIMITED,TRAVAPROST,TRAVOPROST,0.00%,2.5ML,OPHTHALMIC,Resolved,SOLUTION,S01EE,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2016/2/29,,2019/11/30,Disruption of the manufacture of the drug.,2017/3/13,2020/1/21,No
1664,2412063,Shortage,TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION,TEVA CANADA LIMITED,TRAVAPROST,TRAVOPROST,0.00%,5ML,OPHTHALMIC,Resolved,SOLUTION,S01EE,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2016/2/29,,2019/11/30,Disruption of the manufacture of the drug.,2017/3/13,2020/1/21,No
1582,510637,Shortage,TEVA-TRIMEL,TEVA CANADA LIMITED,SULFAMETHOXAZOLE/TRIMETHOPRIM,SULFAMETHOXAZOLE TRIMETHOPRIM,400MG 80MG,100,ORAL,Resolved,TABLET,J01EE,SULFONAMIDES AND TRIMETHOPRIM,,2016/11/23,,2018/8/31,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
1591,726540,Shortage,TEVA-TRIMEL,TEVA CANADA LIMITED,SULFAMETHOXAZOLE TRIMETHOPRIM,SULFAMETHOXAZOLE TRIMETHOPRIM,40MG 8MG,100ML,ORAL,Actual shortage,SUSPENSION,J01EE,SULFONAMIDES AND TRIMETHOPRIM,,2017/2/1,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/13,No
1609,726540,Shortage,TEVA-TRIMEL,TEVA CANADA LIMITED,SULFAMETHOXAZOLE TRIMETHOPRIM,SULFAMETHOXAZOLE TRIMETHOPRIM,40MG 8MG,400ML,ORAL,Actual shortage,SUSPENSION,J01EE,SULFONAMIDES AND TRIMETHOPRIM,,2017/3/1,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/13,No
18033,2413825,Shortage,TEVA-VALGANCICLOVIR,TEVA CANADA LIMITED,VALGANCICLOVIR,VALGANCICLOVIR,450MG,60,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/8/1,2018/2/16,2018/2/28,Demand increase for the drug.,2017/8/2,2018/3/13,No
1552,2357003,Shortage,TEVA-VALSARTAN/HCTZ,TEVA CANADA LIMITED,TEVA-VALSARTAN/HCTZ 160/12.5MG TAB PP 30,HYDROCHLOROTHIAZIDE VALSARTAN,12.5MG 160MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/5/20,2017/9/20,2017/9/30,Delay in shipping of the drug.,2017/3/13,2017/10/10,No
8074,2357038,Shortage,TEVA-VALSARTAN/HCTZ,TEVA CANADA LIMITED,VALSARTAN/HCTZ,HYDROCHLOROTHIAZIDE VALSARTAN,12.5MG 320MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/4/21,2018/1/30,2018/2/15,Disruption of the manufacture of the drug.,2017/4/25,2018/2/21,No
1226,2357046,Shortage,TEVA-VALSARTAN/HCTZ,TEVA CANADA LIMITED,TEVA-VALSARTAN/HCTZ,HYDROCHLOROTHIAZIDE VALSARTAN,25MG 320MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017/2/1,2018/4/30,2018/4/30,Delay in shipping of the drug.,2017/3/13,2018/5/11,No
1674,2342545,Shortage,TEVA-ZOLMITRIPTAN OD,TEVA CANADA LIMITED,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2016/11/22,,2020/2/12,Disruption of the manufacture of the drug.,2017/3/13,2020/2/13,No
29736,2240432,Shortage,TEVETEN,BGP PHARMA ULC,TEVETEN,EPROSARTAN,400MG,2x14,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017/12/4,,2018/1/5,Delay in shipping of the drug.,2017/11/20,2018/1/6,No
14396,,Shortage,Thallous Chloride TI 201 Injection,,Thallous Chloride TI 201 Injection,Thallous Chloride (TI 201),1 mCi/mL,glass vial,Intravenous,Resolved,Solution,V09GX,Cardiovascular system,,2017/6/27,2017/6/30,2017/6/30,Requirements related to complying with good manufacturing practices.,2017/6/29,2017/7/4,No
5691,23965,Shortage,THYROID TAB 125MG,ERFA CANADA 2012 INC,Natural Desiccated Thyroid,THYROID,125MG,100,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,,2018/5/28,2018/6/15,2018/6/12,Other (Please describe in comments),2017/4/5,2018/6/13,No
6389,23949,Shortage,THYROID TAB 30MG,ERFA CANADA 2012 INC,Natural Desiccated Thyroid,THYROID,30MG,bottle of 100,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,,2018/5/28,2018/6/29,2018/7/18,Demand increase for the drug.,2017/4/11,2018/7/25,No
6882,23957,Shortage,THYROID TAB 60MG,ERFA CANADA 2012 INC,Natural Desiccated Thyroid,THYROID,60MG,100,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,,2018/5/28,2018/10/29,2018/11/14,Demand increase for the drug.,2017/4/13,2018/11/15,No
17414,778915,Shortage,TOBRADEX,NOVARTIS PHARMACEUTICALS CANADA INC,TOBRADEX OINT 3.5G,DEXAMETHASONE TOBRAMYCIN,0.1% 0.3%,1,OPHTHALMIC,Resolved,OINTMENT,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,,2017/7/20,2017/9/12,2017/9/12,Demand increase for the drug.,2017/7/27,2017/9/13,No
13861,778915,Shortage,TOBRADEX,NOVARTIS PHARMACEUTICALS CANADA INC,TOBRADEX OINT 3.5G,DEXAMETHASONE TOBRAMYCIN,0.1% 0.3%,1,OPHTHALMIC,Resolved,OINTMENT,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,,2017/6/1,2017/7/4,2017/7/10,Delay in shipping of the drug.,2017/6/23,2017/7/11,No
22359,778915,Shortage,TOBRADEX,NOVARTIS PHARMACEUTICALS CANADA INC,TOBRADEX OINTMENT 3.5G,DEXAMETHASONE TOBRAMYCIN,0.1% 0.3%,3.5g,OPHTHALMIC,Resolved,OINTMENT,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,,2017/9/14,2017/10/25,2017/10/26,Demand increase for the drug.,2017/9/18,2017/11/2,No
20969,778907,Shortage,TOBRADEX,NOVARTIS PHARMACEUTICALS CANADA INC,TOBRADEX SUSP 5ML,DEXAMETHASONE TOBRAMYCIN,0.1% 0.3%,5ML,OPHTHALMIC,Resolved,SUSPENSION,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,,2017/8/25,2017/9/11,2017/9/13,Demand increase for the drug.,2017/9/5,2017/9/14,No
2553,2443368,Shortage,TOBRAMYCIN INHALATION SOLUTION,SANDOZ CANADA INCORPORATED,TOBRAMYCIN,TOBRAMYCIN,300MG,5mL x 56 Amp,INHALATION,Resolved,SOLUTION,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,,2017/2/6,2017/4/14,2017/5/15,Requirements related to complying with good manufacturing practices.,2017/3/14,2017/5/17,No
6979,2382814,Shortage,"TOBRAMYCIN INJECTION, USP",MYLAN PHARMACEUTICALS ULC,"TOBRAMYCIN INJECTION, USP",TOBRAMYCIN,40MG,2ML 10VL,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,,2017/5/1,,2022/1/6,Delay in shipping of the drug.,2017/4/13,2022/1/12,No
6982,2382814,Shortage,"TOBRAMYCIN INJECTION, USP",MYLAN PHARMACEUTICALS ULC,"TOBRAMYCIN INJECTION, USP",TOBRAMYCIN,40MG,30ML 1VL,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,,2017/5/1,,2022/1/6,Delay in shipping of the drug.,2017/4/13,2022/1/12,No
226,2382814,Shortage,"TOBRAMYCIN INJECTION, USP",MYLAN PHARMACEUTICALS ULC,Tobramycin,TOBRAMYCIN,40MG,10VL,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,,2016/12/13,2017/7/15,2017/3/13,Delay in shipping of the drug.,2017/3/10,2017/3/14,No
20963,513962,Shortage,TOBREX,NOVARTIS PHARMACEUTICALS CANADA INC,TOBREX 0.3% SOLN 5ML,TOBRAMYCIN,0.30%,5 ml,OPHTHALMIC,Resolved,SOLUTION,S01AA,ANTIINFECTIVES,,2017/7/20,2017/9/12,2017/9/13,Demand increase for the drug.,2017/9/5,2017/9/14,No
2,2242320,Shortage,TOLOXIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,TOLOXIN 0.05mg/mL ORAL SOL 115mL,DIGOXIN,0.05MG,115 mL,ORAL,Resolved,SOLUTION,C01AA,CARDIAC GLYCOSIDES,2017/2/23,2017/2/23,2017/3/23,2017/3/23,Disruption of the manufacture of the drug.,2017/3/10,2017/10/5,No
6423,2335700,Shortage,TOLOXIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,TOLOXIN 0.0625mg TABS 250,DIGOXIN,0.0625MG,250,ORAL,Avoided shortage,TABLET,C01AA,CARDIAC GLYCOSIDES,2017/12/3,,2018/1/5,2017/9/1,Disruption of the manufacture of the drug.,2017/4/11,2017/9/1,No
34333,2242320,Shortage,TOLOXIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,TOLOXIN 0.05mg/mL ORAL SOL 115mL,DIGOXIN,0.05MG,115ml,ORAL,Avoided shortage,SOLUTION,C01AA,CARDIAC GLYCOSIDES,2018/2/19,,2018/2/19,2018/2/12,Disruption of the manufacture of the drug.,2017/12/22,2018/2/13,No
5439,2335719,Shortage,TOLOXIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,TOLOXIN 0.125mg TABS 250,DIGOXIN,0.125MG,250 Tabs,ORAL,Resolved,TABLET,C01AA,CARDIAC GLYCOSIDES,2017/9/27,2017/9/29,2018/1/4,2017/12/20,Delay in shipping of the drug.,2017/4/4,2017/12/21,No
26035,2335700,Shortage,TOLOXIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,TOLOXIN 0.0625mg TABS 250,DIGOXIN,0.0625MG,250,ORAL,Resolved,TABLET,C01AA,CARDIAC GLYCOSIDES,2017/11/24,2017/11/24,2017/12/29,2017/12/20,Delay in shipping of the drug.,2017/10/16,2017/12/21,No
2496,2229566,Shortage,TOMUDEX,HOSPIRA HEALTHCARE CORPORATION,Raltitrexed powder,TOMUDEX,2MG,VIAL / AMPOULE,INTRAVENOUS / INTRAVEINEUSE,Resolved,SOLUTION,L01BA,ANTIMETABOLITES,2017/4/14,,2017/5/25,2017/5/25,Disruption of the manufacture of the drug.,2017/3/14,2017/6/1,No
4347,816132,Shortage,TOPACTIN CREAM 0.05% U.S.P.,PALADIN LABS INC,FLUOCINONIDE,FLUOCINONIDE,0.05%,450g,TOPICAL,Actual shortage,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2014/1/1,,,Other (Please describe in comments),2017/3/27,2017/10/13,No
4350,2240269,Shortage,TOPACTIN EMOLLIENT CREAM 0.05%,PALADIN LABS INC,FLUOCINONIDE,FLUOCINONIDE,0.5MG,60G/225G,TOPICAL,Actual shortage,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2014/1/1,,,Other (Please describe in comments),2017/3/27,2017/10/13,No
4344,749834,Shortage,TOPIDERM HC 2%,PALADIN LABS INC,HYDROCORTISONE ACETAT,HYDROCORTISONE ACETATE,2%,30gr AND 225gr,TOPICAL,Resolved,CREAM,D07AA,"CORTICOSTEROIDS, PLAIN",2016/7/31,2016/7/31,,2017/5/10,Other (Please describe in comments),2017/3/27,2020/6/17,No
13152,2389460,Shortage,TOPIRAMATE,SIVEM PHARMACEUTICALS ULC,TOPIRAMATE,TOPIRAMATE,25MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017/6/16,,2017/7/10,2017/10/1,Demand increase for the drug.,2017/6/16,2017/11/3,No
32651,2389487,Shortage,TOPIRAMATE,SIVEM PHARMACEUTICALS ULC,TOPIRAMATE,TOPIRAMATE,100MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2018/1/1,2017/12/28,2018/5/18,2018/5/18,Other (Please describe in comments),2017/12/12,2018/5/19,No
21797,2395746,Shortage,TOPIRAMATE TABLETS,ACCORD HEALTHCARE INC,TOPIRAMATE,TOPIRAMATE,100MG,100 TABS PER BOTTLE     |     BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017/8/25,2017/8/25,2017/11/3,2017/11/1,Disruption of the manufacture of the drug.,2017/9/8,2017/11/13,No
21800,2395754,Shortage,TOPIRAMATE TABLETS,ACCORD HEALTHCARE INC,TOPIRAMATE,TOPIRAMATE,200MG,100 TABS PER BOTTLE     |     BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017/8/15,2017/8/15,2017/11/10,2017/11/1,Disruption of the manufacture of the drug.,2017/9/8,2017/11/13,No
21803,2395738,Shortage,TOPIRAMATE TABLETS,ACCORD HEALTHCARE INC,TOPIRAMATE,TOPIRAMATE,25MG,100 TABS PER BOTTLE     |     BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017/8/24,2017/8/24,2017/11/3,2017/11/1,Disruption of the manufacture of the drug.,2017/9/8,2017/11/13,No
3269,2395738,Shortage,TOPIRAMATE TABLETS,ACCORD HEALTHCARE INC,TOPIRANATE,TOPIRAMATE,25MG,BOTTLE OF 100 TABS   |    BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2016/12/28,2016/12/28,2017/7/21,2017/7/24,Disruption of the manufacture of the drug.,2017/3/17,2017/7/26,No
14854,2379422,Shortage,TOPOTECAN HYDROCHLORIDE FOR INJECTION,PFIZER CANADA INC,Topotecan,TOPOTECAN,1MG,5 x 4mL,INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,2017/7/12,,2017/8/30,2017/8/29,Demand increase for the drug.,2017/7/6,2017/8/30,No
28645,2379422,Shortage,TOPOTECAN HYDROCHLORIDE FOR INJECTION,PFIZER CANADA INC,TOPOTECAN,TOPOTECAN,1MG,5x4mL,INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,2017/11/7,,2017/11/22,2017/11/20,Disruption of the manufacture of the drug.,2017/11/8,2017/11/21,No
2550,2390981,Shortage,TOPOTECAN INJECTION,SANDOZ CANADA INCORPORATED,Topotecan HCl,TOPOTECAN,1MG,5x4mL fiole/vial,INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2016/12/13,2017/7/28,2017/7/28,Demand increase for the drug.,2017/3/14,2017/8/7,No
21742,590215,Shortage,TPN ELECTROLYTES,PFIZER CANADA INC,TPN ELECTROLYTES,SODIUM ACETATE MAGNESIUM CHLORIDE CALCIUM CHLORIDE POTASSIUM CHLORIDE SODIUM CHLORIDE,121MG 25.4MG 16.55MG 74.55MG 16.05MG,25x20mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2018/1/26,,2018/7/16,Disruption of the manufacture of the drug.,2017/9/8,2018/7/17,No
16543,2370921,Shortage,TRAJENTA,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Trajenta,LINAGLIPTIN,5MG,30's,ORAL,Resolved,TABLET,A10BH,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017/7/21,,2017/7/31,2017/7/31,Disruption of the manufacture of the drug.,2017/7/20,2017/8/1,No
28642,2370921,Shortage,TRAJENTA,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Trajenta,LINAGLIPTIN,5MG,90's,ORAL,Resolved,TABLET,A10BH,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017/11/10,2017/11/14,2017/11/21,2017/12/21,Disruption of the manufacture of the drug.,2017/11/8,2017/12/22,No
31060,2246365,Shortage,TRANEXAMIC ACID INJECTION BP,SANDOZ CANADA INCORPORATED,TRANEXAMIC ACID,TRANEXAMIC ACID,100MG,10 X 10ML VIALS,INTRAVENOUS,Resolved,SOLUTION,B02AA,ANTIFIBRINOLYTICS,,2017/11/24,2017/12/29,2017/12/22,Delay in shipping of the drug.,2017/11/29,2018/1/8,No
3779,2186845,Shortage,TRASYLOL,NORDIC GROUP B.V.,APROTININ (BOVINE),APROTININ,10000UNIT,"50 ML VIAL (500,000 KIU); 200 ML VIAL (2,000,000 KIU)",INTRAVENOUS,Actual shortage,SOLUTION,B02AB,ANTIFIBRINOLYTICS,,2014/10/30,,,Other (Please describe in comments),2017/3/21,2017/10/13,No
6201,2164361,Shortage,TRAZODONE - 100 - TAB 100MG,PRO DOC LIMITEE,TRAZODONE,TRAZODONE HYDROCHLORIDE,100MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2018/7/24,,2018/9/27,Delay in shipping of the drug.,2017/4/7,2018/9/28,No
6204,2164388,Shortage,TRAZODONE-150 D - TAB 150MG,PRO DOC LIMITEE,TRAZODONE,TRAZODONE HYDROCHLORIDE,150MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2018/11/12,,2019/1/11,Delay in shipping of the drug.,2017/4/7,2019/1/12,No
6198,2164353,Shortage,TRAZODONE-50 - TAB 50MG,PRO DOC LIMITEE,TRAZODONE,TRAZODONE HYDROCHLORIDE,50MG,250,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2018/4/17,,2018/8/28,Delay in shipping of the drug.,2017/4/7,2018/8/29,No
12719,716960,Shortage,TRIADERM CRM 0.1%,TARO PHARMACEUTICALS INC,TRIADERM CRM 0.1%,TRIAMCINOLONE ACETONIDE,0.10%,500G,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",,2018/10/15,2018/10/26,2018/10/29,Disruption of the manufacture of the drug.,2017/6/13,2018/10/30,No
8423,808571,Shortage,TRIAZOLAM,AA PHARMA INC,Triazolam,TRIAZOLAM,0.25MG,7 x 10 blister,ORAL,Resolved,TABLET,N05CD,HYPNOTICS AND SEDATIVES,,2017/5/19,2017/8/15,2017/7/25,Disruption of the manufacture of the drug.,2017/4/28,2017/7/26,No
6723,2296381,Shortage,TRIDURAL,PALADIN LABS INC,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,100MG,100 Tabs,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,2017/4/13,2017/4/13,2017/5/10,2017/5/9,Delay in shipping of the drug.,2017/4/13,2017/5/10,No
8351,2296411,Shortage,TRIDURAL,PALADIN LABS INC,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,300MG,100 Tabs,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,2017/5/1,2017/5/2,2017/5/12,2017/5/10,Delay in shipping of the drug.,2017/4/28,2017/5/11,No
4147,740802,Shortage,TRIMIPRAMINE,AA PHARMA INC,TRIMIPRAMINE,TRIMIPRAMINE,25MG,500 BOTTLE,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2016/8/19,,2017/3/28,Disruption of the manufacture of the drug.,2017/3/24,2017/3/28,No
15753,2407833,Shortage,TRISENOX,LUNDBECK CANADA INC,Arsenic Trioxide for Injection,ARSENIC TRIOXIDE,1MG,10 mg/10mL ampoule,INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,2017/9/8,2017/9/8,2018/7/20,2018/7/24,Disruption of the manufacture of the drug.,2017/7/14,2018/7/30,No
4030,2269090,Shortage,TRUSOPT,PURDUE PHARMA,Trusopt,DORZOLAMIDE,2%,60 x 0.2mL pipettes,OPHTHALMIC,Resolved,SOLUTION,S01EC,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,2017/2/23,2017/2/23,2017/4/7,2017/4/6,Demand increase for the drug.,2017/3/23,2017/4/7,No
26489,654531,Shortage,TRYPTAN TAB 1000MG,VALEANT CANADA LP/VALEANT CANADA S.E.C.,TRYPTAN TAB 1000MG,TRYPTOPHAN,1G,na,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2017/10/20,,2017/11/17,2017/11/23,Other (Please describe in comments),2017/10/20,2017/11/24,No
14058,317268,Shortage,TUBERSOL,SANOFI PASTEUR LIMITED,Tuberculin Purified Protein Derivative (Mantoux),PURIFIED PROTEIN DERIVATIVE OF TUBERCULIN,5TUB,5 mL multidose vial (5 TU per test) / Flacon multidose de 5 mL (5 UT par épreuve),INTRADERMAL,Resolved,SOLUTION,V04CF,OTHER DIAGNOSTIC AGENTS,,2017/6/22,2017/7/12,2017/7/12,Other (Please describe in comments),2017/6/27,2017/7/13,No
3086,1916963,Shortage,TUSSIONEX,SANOFI-AVENTIS CANADA INC,TUSSIONEX 5-10MG TABLETS,HYDROCODONE PHENYLTOLOXAMINE,5MG 10MG,100'S,ORAL,Resolved,TABLET (EXTENDED-RELEASE),R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,,2017/1/6,,2017/8/3,Other (Please describe in comments),2017/3/16,2017/8/22,No
1213,720208,Shortage,TUSSODAN DM SYRUP,ODAN LABORATORIES LTD,Cough Syrup,DEXTROMETHORPHAN HYDROBROMIDE PSEUDOEPHEDRINE HYDROCHLORIDE,15MG 30MG,250 mL,ORAL,Actual shortage,SYRUP,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,,2016/4/15,,,Disruption of the manufacture of the drug.,2017/3/13,2017/10/13,No
11383,2230578,Shortage,TWINRIX,GLAXOSMITHKLINE INC,Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine,"HEPATITIS A VACCINE, INACTIVATED HEPATITIS B SURFACE ANTIGEN",720UNIT 20MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2017/5/24,2017/7/11,2017/7/10,Demand increase for the drug.,2017/5/26,2017/7/19,No
16553,2230578,Shortage,TWINRIX,GLAXOSMITHKLINE INC,Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine,"HEPATITIS A VACCINE, INACTIVATED HEPATITIS B SURFACE ANTIGEN",720UNIT 20MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2017/7/18,2017/12/7,2017/12/4,Delay in shipping of the drug.,2017/7/20,2017/12/6,No
19518,2237548,Shortage,TWINRIX JUNIOR,GLAXOSMITHKLINE INC,Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine,"HEPATITIS A VACCINE, INACTIVATED HEPATITIS B SURFACE ANTIGEN",360UNIT 10MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2017/8/10,2017/11/16,2017/10/10,Delay in shipping of the drug.,2017/8/16,2017/10/11,No
28016,2237548,Shortage,TWINRIX JUNIOR,GLAXOSMITHKLINE INC,Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine,"HEPATITIS A VACCINE, INACTIVATED HEPATITIS B SURFACE ANTIGEN",360UNIT 10MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2017/11/8,2017/12/7,2017/12/4,Demand increase for the drug.,2017/11/3,2017/12/6,No
2737,2242727,Shortage,TYPHERIX,GLAXOSMITHKLINE INC,SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE,SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE,25MCG,1's,INTRAMUSCULAR,Resolved,LIQUID,J07AP,BACTERIAL VACCINES,,2016/5/5,,2017/12/21,Disruption of the manufacture of the drug.,2017/3/14,2020/2/27,No
19508,2130955,Shortage,TYPHIM VI,SANOFI PASTEUR LIMITED,Salmonella typhi Vi Capsular Polysaccharide Vaccine,SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE,25MCG,10 mL multidose vial (20 Doses),INTRAMUSCULAR,Resolved,SOLUTION,J07AP,BACTERIAL VACCINES,2017/8/15,2017/8/15,2018/1/31,2018/2/9,Disruption of the manufacture of the drug.,2017/8/15,2018/2/10,No
19511,2130955,Shortage,TYPHIM VI,SANOFI PASTEUR LIMITED,Salmonella typhi Vi Capsular Polysaccharide Vaccine,SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE,25MCG,1 x 0.5 mL (single dose) syringe,INTRAMUSCULAR,Resolved,SOLUTION,J07AP,BACTERIAL VACCINES,2017/8/15,2017/8/15,2018/1/15,2018/2/1,Disruption of the manufacture of the drug.,2017/8/15,2018/2/9,No
3770,2130955,Shortage,TYPHIM VI,SANOFI PASTEUR LIMITED,Salmonella typhi Vi Capsular Polysaccharide Vaccine,SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE,25MCG,"1 x 0.5 mL (single dose) syringe / 1 seringue de 0,5 mL (dose unique)",INTRAMUSCULAR,Resolved,SOLUTION,J07AP,BACTERIAL VACCINES,2017/3/21,,2017/4/15,2017/3/29,Delay in shipping of the drug.,2017/3/21,2017/3/30,No
3775,2130955,Shortage,TYPHIM VI,SANOFI PASTEUR LIMITED,Salmonella typhi Vi Capsular Polysaccharide Vaccine,SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE,25MCG,10 mL multidose vial (20 Doses) / Fiole multidose de 10 mL,INTRAMUSCULAR,Resolved,SOLUTION,J07AP,BACTERIAL VACCINES,2017/3/21,,2017/4/15,2017/3/29,Disruption of the manufacture of the drug.,2017/3/21,2017/3/30,No
5957,1962701,Shortage,ULTRAVATE CREAM,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ULTRAVATE CREAM,HALOBETASOL PROPIONATE,0.05%,50G,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2017/8/30,,,2017/9/15,Other (Please describe in comments),2017/4/7,2017/9/16,No
4355,728179,Shortage,URISPAS TAB 200MG,PALADIN LABS INC,FLAVOXATE HYDROCHLORIDE,FLAVOXATE HYDROCHLORIDE,200MG,100 TABS,ORAL,Actual shortage,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2008/3/19,,,Other (Please describe in comments),2017/3/27,2017/10/13,No
27905,263893,Shortage,UROZIDE,BIOMED PHARMA,Hydrochlorothiazide Tablets 25 mg,,,100,,Actual shortage,,,,,2014/10/24,2025/2/1,,Other (Please describe in comments),2017/11/2,2018/2/15,No
27908,263907,Shortage,UROZIDE,BIOMED PHARMA,Hydrochlorothiazide Tablets 50 mg,,,100,,Actual shortage,,,,,2014/10/23,,,Other (Please describe in comments),2017/11/2,2017/11/2,No
27911,263907,Shortage,UROZIDE,BIOMED PHARMA,Hydrochlorothiazide Tablets 50 mg,,,1000,,Actual shortage,,,,,2014/10/23,,,Other (Please describe in comments),2017/11/2,2017/11/2,No
27914,263907,Shortage,UROZIDE,BIOMED PHARMA,Hydrochlorothiazide Tablets 50 mg,,,500,,Actual shortage,,,,,2014/10/23,,,Other (Please describe in comments),2017/11/2,2017/11/2,No
27917,405620,Shortage,UROZIDE,BIOMED PHARMA,Hydrochlorothiazide Tablets 100 mg,,,100,,Actual shortage,,,,,2014/10/23,,,Other (Please describe in comments),2017/11/2,2017/11/2,No
30985,2426900,Shortage,URSODIOL TABLETS USP,GLENMARK PHARMACEUTICALS CANADA INC.,Ursodiol,URSODIOL,250MG,100,ORAL,Resolved,TABLET,A05AA,BILE THERAPY,2017/11/29,2017/11/29,2017/12/15,2018/1/1,Demand increase for the drug.,2017/11/28,2018/1/2,No
30989,2426919,Shortage,URSODIOL TABLETS USP,GLENMARK PHARMACEUTICALS CANADA INC.,Ursodiol,URSODIOL,500MG,100,ORAL,Resolved,TABLET,A05AA,BILE THERAPY,2017/11/29,2017/11/29,2017/12/15,2018/1/1,Demand increase for the drug.,2017/11/28,2018/1/2,No
22147,2413639,Shortage,VAL-BACLOFEN INTRATHECAL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,VAL-BACLOFEN INTRATHECAL,BACLOFEN,0.5MG,na,INTRATHECAL,Resolved,SOLUTION,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2017/9/15,,2017/9/19,Other (Please describe in comments),2017/9/15,2017/9/20,No
12947,2405830,Shortage,VAL-VANCOMYCIN,VALEANT CANADA LP/VALEANT CANADA S.E.C.,VAL-VANCOMYCIN,VANCOMYCIN,10G,na,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2017/6/15,2017/6/27,2017/8/16,Other (Please describe in comments),2017/6/16,2017/8/17,No
13162,2442000,Shortage,VALACYCLOVIR,SIVEM PHARMACEUTICALS ULC,VALACYCLOVIR,VALACYCLOVIR,500MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/6/5,2018/5/18,2018/5/18,Disruption of the manufacture of the drug.,2017/6/16,2018/5/19,No
13165,2442019,Shortage,VALACYCLOVIR,SIVEM PHARMACEUTICALS ULC,VALACYCLOVIR,VALACYCLOVIR,1000MG,21,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017/7/3,,2017/12/11,Disruption of the manufacture of the drug.,2017/6/16,2017/12/12,No
3272,177016,Shortage,VALISONE-G CREAM,VALEANT CANADA LP/VALEANT CANADA S.E.C.,VALISONE-G CREAM,BETAMETHASONE GENTAMICIN,0.1% 0.1%,30g,TOPICAL,Resolved,CREAM,D07CC,"CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",,2017/3/16,,2017/4/23,Other (Please describe in comments),2017/3/17,2017/4/24,No
10019,2219492,Shortage,VALTREX,GLAXOSMITHKLINE INC,valacyclovir caplets,VALACYCLOVIR,500MG,30's,ORAL,Avoided shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017/6/26,,2017/7/18,2017/5/31,Disruption of the manufacture of the drug.,2017/5/11,2017/5/31,No
7168,2394634,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",SANDOZ CANADA INCORPORATED,Vancocyn,VANCOMYCIN,1G,10 x 1G vials,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2017/4/17,2017/4/28,2017/5/15,Requirements related to complying with good manufacturing practices.,2017/4/18,2017/5/17,No
24841,2407930,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",MYLAN PHARMACEUTICALS ULC,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",VANCOMYCIN,5G,1VL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2017/10/4,,2018/6/7,Disruption of the manufacture of the drug.,2017/10/10,2018/6/8,No
29772,2407922,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",MYLAN PHARMACEUTICALS ULC,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",VANCOMYCIN,1G,10VL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2017/11/17,,2018/6/7,Delay in shipping of the drug.,2017/11/20,2018/6/8,No
29777,2407914,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",MYLAN PHARMACEUTICALS ULC,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",VANCOMYCIN,500MG,10VL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2017/11/17,,2018/6/7,Delay in shipping of the drug.,2017/11/20,2018/6/8,No
31063,2394634,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",SANDOZ CANADA INCORPORATED,VANCOMYCIN,VANCOMYCIN,1G,10 X 1G VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2017/11/28,2017/12/22,2018/1/3,Requirements related to complying with good manufacturing practices.,2017/11/29,2018/1/8,No
31066,2394626,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",SANDOZ CANADA INCORPORATED,VANCOMYCIN,VANCOMYCIN,500MG,10 X 500MG VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2017/11/28,2017/12/22,2018/1/3,Requirements related to complying with good manufacturing practices.,2017/11/29,2018/1/8,No
15466,2394626,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",SANDOZ CANADA INCORPORATED,VANCOMYCIN,VANCOMYCIN,500MG,10VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,2017/7/19,,2017/8/18,2017/8/18,Demand increase for the drug.,2017/7/11,2017/10/25,No
10648,2378345,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",HOSPIRA HEALTHCARE CORPORATION,Vancomycin HCL,VANCOMYCIN,10G,1 x 10g,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,2017/6/1,,,2017/10/20,Other (Please describe in comments),2017/5/18,2017/10/21,No
14506,2230192,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",HOSPIRA HEALTHCARE CORPORATION,VANCOMYCIN,VANCOMYCIN,1000MG,10x1g  VIAL/AMPOULES,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2017/6/14,2017/9/22,2017/9/22,Disruption of the manufacture of the drug.,2017/7/3,2017/9/25,No
14789,2378337,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",HOSPIRA HEALTHCARE CORPORATION,VANCOMYCIN HYDROCHLORIDE,VANCOMYCIN,5G,1x5g,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2017/9/6,,,Other (Please describe in comments),2017/7/5,2018/12/22,No
2539,2394650,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",SANDOZ CANADA INCORPORATED,VANCOMYCIN HYDROCHLORIDE,VANCOMYCIN,10G,10g 1 fiole/vial,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,2017/3/14,2017/3/17,,,Shortage of an active ingredient.,2017/3/14,2018/12/22,No
6249,2229702,Shortage,VAQTA,MERCK CANADA INC,"hepatitis A vaccine, purified inactivated Suspension for injection","HEPATITIS A VACCINE, INACTIVATED",50UNIT,vial (fiole),INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2017/6/19,2017/8/31,2017/8/2,Demand increase for the drug.,2017/4/10,2017/8/3,No
32720,2229702,Shortage,VAQTA,MERCK CANADA INC,"hepatitis A vaccine, purified inactivated Suspension for injection","HEPATITIS A VACCINE, INACTIVATED",50UNIT,50U/1ML 1DOSE VIAL (ADULT),INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,2018/2/2,2018/1/11,2018/3/26,2018/3/26,Delay in shipping of the drug.,2017/12/13,2018/3/27,No
30754,657298,Shortage,VASERETIC,MERCK CANADA INC,Enalapril and Hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE ENALAPRIL SODIUM,25MG 8MG,28,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",2017/12/8,2017/12/6,2017/12/20,2017/12/20,Delay in shipping of the drug.,2017/11/27,2017/12/21,No
10855,657298,Shortage,VASERETIC,MERCK CANADA INC,Enalapril and Hydrochlorothiazide Tablets,HYDROCHLOROTHIAZIDE ENALAPRIL SODIUM,25MG 8MG,28,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",2017/6/5,2017/5/26,2017/6/9,2017/6/6,Delay in shipping of the drug.,2017/5/23,2017/6/7,No
3988,2139502,Shortage,VASOPRESSIN INJECTION,FRESENIUS KABI CANADA LTD,"Vasopressin Injection, USP 20 units/mL MD Vial 1 mL",VASOPRESSIN,20UNIT,1mL,"INTRAMUSCULAR
SUBCUTANEOUS",Resolved,SOLUTION,H01BA,POSTERIOR PITUITARY LOBE HORMONES,,2017/2/16,2017/4/20,2017/4/20,Demand increase for the drug.,2017/3/22,2017/4/21,No
15469,2247938,Shortage,VASOPRESSIN INJECTION USP,SANDOZ CANADA INCORPORATED,VASOPRESSIN,VASOPRESSIN,20UNIT,5ML VIAL,"INTRAMUSCULAR
SUBCUTANEOUS",Resolved,SOLUTION,H01BA,POSTERIOR PITUITARY LOBE HORMONES,2017/7/11,,2017/7/31,2017/7/28,Delay in shipping of the drug.,2017/7/11,2017/8/2,No
2530,2247938,Shortage,VASOPRESSIN INJECTION USP,SANDOZ CANADA INCORPORATED,VASOPRESSIN INJECTION USP,VASOPRESSIN,20UNIT,5mL fioles/vials,"INTRAMUSCULAR
SUBCUTANEOUS",Resolved,SOLUTION,H01BA,POSTERIOR PITUITARY LOBE HORMONES,,2016/11/7,2017/7/28,2017/7/3,Requirements related to complying with good manufacturing practices.,2017/3/14,2017/7/5,No
10860,670928,Shortage,VASOTEC,MERCK CANADA INC,Enalapril tablets,ENALAPRIL SODIUM,16MG,28,ORAL,Avoided shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017/5/31,,2017/5/30,2017/5/30,Delay in shipping of the drug.,2017/5/23,2017/10/11,No
19917,708879,Shortage,VASOTEC,MERCK CANADA INC,Enalapril Tablets,ENALAPRIL SODIUM,4MG,28,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017/8/17,2017/9/1,2017/8/31,Delay in shipping of the drug.,2017/8/21,2017/9/1,No
6676,2339250,Shortage,VENLAFAXINE XR,PRO DOC LIMITEE,VENLAFAXINE XR,VENLAFAXINE,75MG,500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017/4/12,,2017/6/5,Delay in shipping of the drug.,2017/4/12,2017/6/6,No
6996,2339242,Shortage,VENLAFAXINE XR,PRO DOC LIMITEE,VENLAFAXINE XR,VENLAFAXINE,37.5MG,100-500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017/5/9,,2017/7/6,Delay in shipping of the drug.,2017/4/13,2017/7/7,No
7002,2339269,Shortage,VENLAFAXINE XR,PRO DOC LIMITEE,VENLAFAXINE XR,VENLAFAXINE,150MG,100-500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017/5/31,,2017/5/31,Delay in shipping of the drug.,2017/4/13,2018/1/4,No
16556,2243115,Shortage,VENTOLIN DISKUS,GLAXOSMITHKLINE INC,salbutamol sulfate dry powder for inhalation,SALBUTAMOL,200MCG,1x60 doses,INHALATION,Resolved,POWDER,R03AC,"ADRENERGICS, INHALANTS",,2017/8/8,2017/8/25,2017/8/16,Delay in shipping of the drug.,2017/7/20,2017/8/16,No
24661,2213451,Shortage,VENTOLIN I.V. INFUSION SOLUTION 5.0MG SALBUTAMOL IN 5ML (1000MCG/ML),GLAXOSMITHKLINE INC,salbutamol sulfate for injection,SALBUTAMOL,1MG,5 x 5mL,INTRAVENOUS,Resolved,SOLUTION,R03CC,ADRENERGICS FOR SYSTEMIC USE,,2017/10/3,2017/11/17,2017/11/14,Demand increase for the drug.,2017/10/6,2017/11/16,No
2740,2213419,Shortage,VENTOLIN NEBULES P.F. - 2.5MG/2.5ML,GLAXOSMITHKLINE INC,Salbutamol sulfate solution,SALBUTAMOL,2.5MG,20's,INHALATION,Resolved,SOLUTION,R03AC,"ADRENERGICS, INHALANTS",,2016/12/8,,2017/3/21,Demand increase for the drug.,2017/3/14,2017/3/22,No
26397,2213486,Shortage,VENTOLIN RESPIRATOR SOLUTION,GLAXOSMITHKLINE INC,salbutamol sulfate solution,SALBUTAMOL,5MG,10ML,INHALATION,Avoided shortage,SOLUTION,R03AC,"ADRENERGICS, INHALANTS",2017/11/30,,2017/11/30,2017/11/28,Demand increase for the drug.,2017/10/19,2017/11/29,No
10074,2256487,Shortage,VFEND FOR INJECTION,PFIZER CANADA INC,VFEND,VORICONAZOLE,200MG,each,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,2017/5/31,,2017/8/18,2017/8/18,Disruption of the manufacture of the drug.,2017/5/11,2017/8/19,No
7883,717029,Shortage,VIADERM KC ONT,TARO PHARMACEUTICALS INC,VIADERM K.C OINTMENT,TRIAMCINOLONE ACETONIDE NYSTATIN GRAMICIDIN NEOMYCIN,1MG 100000UNIT 0.25MG 2.5MG,15 GRAM,TOPICAL,Resolved,OINTMENT,D07CB,"CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",,2017/4/24,2017/4/28,2017/4/28,Disruption of the manufacture of the drug.,2017/4/25,2017/4/29,No
7886,717029,Shortage,VIADERM KC ONT,TARO PHARMACEUTICALS INC,VIADERM K.C. OINT,TRIAMCINOLONE ACETONIDE NYSTATIN GRAMICIDIN NEOMYCIN,1MG 100000UNIT 0.25MG 2.5MG,30 GRAM,TOPICAL,Resolved,OINTMENT,D07CB,"CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",,2017/4/24,2017/4/28,2017/4/28,Disruption of the manufacture of the drug.,2017/4/25,2017/4/29,No
11840,2244598,Shortage,VIDEX EC,BRISTOL-MYERS SQUIBB CANADA,Didanosine,DIDANOSINE,250MG,1 BTL X 30,ORAL,Avoided shortage,CAPSULE (ENTERIC-COATED),J05AF,DIRECT ACTING ANTIVIRALS,2017/7/10,,,2017/7/4,Demand increase for the drug.,2017/6/5,2017/7/4,No
33098,2265990,Shortage,VINORELBINE INJECTION,FRESENIUS KABI CANADA LTD,"Vinorelbine Injection, USP 10 mg/mL",VINORELBINE,10MG,5mL SD Vial,INTRAVENOUS,Resolved,SOLUTION,L01CA,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2017/12/14,,,2018/1/17,Disruption of the manufacture of the drug.,2017/12/15,2020/1/16,No
33103,2265990,Shortage,VINORELBINE INJECTION,FRESENIUS KABI CANADA LTD,"Vinorelbine Injection, USP 10 mg/mL",VINORELBINE,10MG,1mL SD Vial,INTRAVENOUS,Resolved,SOLUTION,L01CA,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2017/12/14,,,2017/12/31,Disruption of the manufacture of the drug.,2017/12/15,2020/1/16,No
11676,2265990,Shortage,VINORELBINE INJECTION,FRESENIUS KABI CANADA LTD,VINORELBINE INJECTION,VINORELBINE,10MG,5mL,INTRAVENOUS,Resolved,SOLUTION,L01CA,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2017/6/19,,2017/7/14,2017/7/10,Delay in shipping of the drug.,2017/6/1,2017/7/11,No
14599,2257777,Shortage,VINORELBINE TARTRATE FOR INJECTION,HOSPIRA HEALTHCARE CORPORATION,VINORELBINE,VINORELBINE,10MG,1x5 ml,INTRAVENOUS,Resolved,SOLUTION,L01CA,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2017/7/7,,2017/10/18,2017/10/17,Disruption of the manufacture of the drug.,2017/7/4,2017/10/18,No
17779,2271214,Shortage,VINORELBINE TARTRATE FOR INJECTION,TEVA CANADA LIMITED,VINORELBINE,VINORELBINE,10MG,5ML,INTRAVENOUS,Resolved,SOLUTION,L01CA,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2017/7/30,2018/4/30,2018/5/1,Shortage of an active ingredient.,2017/8/1,2018/5/8,No
17556,2257777,Shortage,VINORELBINE TARTRATE FOR INJECTION,HOSPIRA HEALTHCARE CORPORATION,Vinorelbine,VINORELBINE,10MG,1x1mL,INTRAVENOUS,Resolved,SOLUTION,L01CA,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2017/10/18,,2018/8/14,Other (Please describe in comments),2017/7/31,2018/8/15,No
31951,2257777,Shortage,VINORELBINE TARTRATE FOR INJECTION,PFIZER CANADA INC,VINORELBINE,VINORELBINE,10MG,1x5mL,INTRAVENOUS,Resolved,SOLUTION,L01CA,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2018/6/15,,,2018/8/14,Other (Please describe in comments),2017/12/6,2018/8/15,No
5969,687456,Shortage,VIROPTIC,VALEANT CANADA LP/VALEANT CANADA S.E.C.,VIROPTIC,TRIFLURIDINE,1%,OPHTHALMIC,OPHTHALMIC,Resolved,SOLUTION,S01AD,ANTIINFECTIVES,2017/6/14,,,2022/1/25,Other (Please describe in comments),2017/4/7,2022/1/26,No
12940,687456,Shortage,VIROPTIC,VALEANT CANADA LP/VALEANT CANADA S.E.C.,VIROPTIC,TRIFLURIDINE,1%,na,OPHTHALMIC,Resolved,SOLUTION,S01AD,ANTIINFECTIVES,,2017/6/14,,2017/10/24,Other (Please describe in comments),2017/6/16,2017/10/25,No
33333,521515,Shortage,VITAMIN B12,SANDOZ CANADA INCORPORATED,CYANOCOBALAMIN,VITAMIN B12,1MG,30ML VIAL,"INTRAMUSCULAR
SUBCUTANEOUS",Resolved,LIQUID,B03BA,VITAMIN B12 AND FOLIC ACID,,2017/11/29,2018/1/31,2018/2/2,Delay in shipping of the drug.,2017/12/16,2018/2/5,No
27102,2245214,Shortage,VITAMIN C,MYLAN PHARMACEUTICALS ULC,VITAMIN C,VITAMIN C,500MG,50ML 1 VIAL,"INTRAMUSCULAR
INTRAVENOUS
SUBCUTANEOUS",Resolved,SOLUTION,A11GA,"ASCORBIC ACID (VIT C), INCL COMBINATIONS",2018/5/16,2018/5/4,2018/7/27,2018/7/20,Delay in shipping of the drug.,2017/10/26,2018/7/21,No
1300,2248361,Shortage,VIVAXIM,SANOFI PASTEUR LIMITED,Combined purified Vi polysaccharide typhoid and inactivated hepatitis A vaccine,"SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE HEPATITIS A VACCINE, INACTIVATED",25MCG 160UNIT,"1 x 1.0 mL (single dose) dual chamber syringe / 1 seringue (dose unique) à double compartiment de 1,0 mL",INTRAMUSCULAR,Resolved,"SOLUTION
SUSPENSION",J07CA,"BACTERIAL AND VIRAL VACCINES, COMBINED",2016/11/16,2016/11/16,2019/1/31,2019/9/5,Disruption of the manufacture of the drug.,2017/3/13,2019/9/6,No
29497,885975,Shortage,VIVOTIF,PAXVAX BERNA GMBH,Typhoid vaccine live oral attenuated Ty21a vaccine,TYPHOID VACCINE,10B,Single foil blister with 4 enteric-coated capsules,ORAL,Resolved,CAPSULE (ENTERIC-COATED),J07AP,BACTERIAL VACCINES,,2017/11/17,2017/12/22,2017/12/11,Demand increase for the drug.,2017/11/17,2017/12/12,No
31276,1940414,Shortage,VOLTAREN OPHTHA,NOVARTIS PHARMACEUTICALS CANADA INC,VOLTAREN,DICLOFENAC SODIUM,0.10%,2 X 5ML,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,2017/12/4,2017/12/11,2018/1/30,2018/1/17,Disruption of the manufacture of the drug.,2017/11/30,2018/1/18,No
5797,2439603,Shortage,VYVANSE,SHIRE PHARMA CANADA ULC,Lisdexamfetamine,LISDEXAMFETAMINE DIMESYLATE,10MG,Bottles of 100 capsules,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2017/4/4,2017/4/4,2017/4/11,2017/4/12,Demand increase for the drug.,2017/4/6,2017/4/13,No
30976,2453703,Shortage,WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE,JAMP PHARMA CORPORATION,Acetaminophen/Codeine/Caffeine,ACETAMINOPHEN CODEINE PHOSPHATE CAFFEINE,300MG 8MG 15MG,100,ORAL,Actual shortage,TABLET,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,,2017/11/27,2020/12/31,,Disruption of the manufacture of the drug.,2017/11/28,2019/3/1,No
31152,38245,Shortage,WATER FOR INJECTION STERILE USP,HOSPIRA HEALTHCARE CORPORATION,Sterile Water for Injection,WATER,100%,1000ML,INTRAVENOUS,Resolved,LIQUID,V07AB,ALL OTHER NON-THERAPEUTIC PRODUCTS,2017/12/20,,2018/1/8,2018/1/31,Disruption of the manufacture of the drug.,2017/11/29,2018/2/27,No
23233,2404044,Shortage,XERESE,VALEANT CANADA LP/VALEANT CANADA S.E.C.,XERESE,ACYCLOVIR HYDROCORTISONE,5% 1%,n/a,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,2017/10/31,,2018/2/28,2018/2/12,Other (Please describe in comments),2017/9/25,2018/2/13,No
3303,2404044,Shortage,XERESE,VALEANT CANADA LP/VALEANT CANADA S.E.C.,XERESE,ACYCLOVIR HYDROCORTISONE,5% 1%,5G,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,2017/4/24,,2017/5/22,2017/5/24,Disruption of the manufacture of the drug.,2017/3/17,2017/5/25,No
5445,2230837,Shortage,XYLAC,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,XYLAC 5mg TABS 100,LOXAPINE,5MG,100 Tabs,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,2017/6/26,2017/6/26,,,Disruption of the manufacture of the drug.,2017/4/4,2018/12/22,No
5448,2230840,Shortage,XYLAC,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,XYLAC 50mg TABS 100,LOXAPINE,50MG,100 Tabs,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2017/4/5,,,Disruption of the manufacture of the drug.,2017/4/4,2018/12/22,No
12630,2242868,Shortage,XYLAC,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,XYLAC 2.5mg TABS 100,LOXAPINE,2.5MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2017/8/16,2017/8/16,2017/8/16,2017/8/16,Delay in shipping of the drug.,2017/6/13,2017/10/5,No
17288,2230839,Shortage,XYLAC,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,XYLAC 25mg TABS 100,LOXAPINE,25MG,100,ORAL,Avoided shortage,TABLET,N05AH,ANTIPSYCHOTICS,2017/9/2,2017/9/2,2017/9/7,2017/9/1,Disruption of the manufacture of the drug.,2017/7/26,2017/10/5,No
19370,2242868,Shortage,XYLAC,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,XYLAC 2.5mg TABS 100,LOXAPINE,2.5MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2017/8/30,2017/8/30,2017/9/1,2017/9/1,Disruption of the manufacture of the drug.,2017/8/15,2017/10/5,No
32105,2372983,Shortage,XYLOCAINE 0.5%,ASPEN PHARMACARE CANADA INC.,Xylocaine® 0.5% Plain 10x20mL SU Vial,LIDOCAINE HYDROCHLORIDE,5MG,10 vials,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017/12/15,,,2017/12/18,Other (Please describe in comments),2017/12/8,2017/12/19,No
32099,1732,Shortage,XYLOCAINE 1%,ASPEN PHARMACARE CANADA INC.,Xylocaine® 1% Plain 50x5mL SU Polyamp® Duofit®,LIDOCAINE HYDROCHLORIDE,10MG,50x5mL,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017/12/19,2018/2/23,2018/2/26,Delay in shipping of the drug.,2017/12/8,2018/9/4,No
27313,1732,Shortage,XYLOCAINE 1%,ASPEN PHARMACARE CANADA INC.,Xylocaine® 1% Plain 50x10mL SU Polyamp® Duofit®,LIDOCAINE HYDROCHLORIDE,10MG,50x10mL,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017/10/30,2018/3/16,2018/3/29,Other (Please describe in comments),2017/10/27,2018/9/4,No
26087,1791,Shortage,XYLOCAINE 1% W EPINEPHRINE 1:100000,ASPEN PHARMACARE CANADA INC.,Xylocaine® 1% w/epi.1:100M 10x20mL MD Vial,LIDOCAINE HYDROCHLORIDE EPINEPHRINE,10MG 0.01MG,10,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017/10/27,,2018/2/19,2018/2/26,Other (Please describe in comments),2017/10/16,2018/2/27,No
29702,1805,Shortage,XYLOCAINE 1% W EPINEPHRINE 1:200000,ASPEN PHARMACARE CANADA INC.,Xylocaine® 1% w/epi.1:200M 10x20mL MD Vial,LIDOCAINE HYDROCHLORIDE EPINEPHRINE,10MG 5MCG,10 vials,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017/11/15,2018/6/1,2018/6/1,Delay in shipping of the drug.,2017/11/20,2018/9/4,No
31972,36641,Shortage,XYLOCAINE 2%,ASPEN PHARMACARE CANADA INC.,Xylocaine® 2% Plain 50x10mL SU Polyamp® Duofit®,LIDOCAINE HYDROCHLORIDE,20MG,50x10mL,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017/12/6,2018/7/2,2018/7/9,Delay in shipping of the drug.,2017/12/7,2018/7/11,No
29705,2373130,Shortage,XYLOCAINE 2% WITH EPINEPHRINE 1:200000,ASPEN PHARMACARE CANADA INC.,Xylocaine® 2% w/epi.1:200M 10x20mL MD Vial,LIDOCAINE HYDROCHLORIDE EPINEPHRINE,20MG 0.005MG,10 vials,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017/11/15,2018/8/31,2018/8/31,Delay in shipping of the drug.,2017/11/20,2018/9/4,No
32102,2003767,Shortage,XYLOCAINE ENDOTRACHEAL,ASPEN PHARMACARE CANADA INC.,"Xylocaine® Endo Spray 10mg, 1x50mL Bottle",LIDOCAINE,100MG,1 bottle,ORAL,Resolved,SOLUTION,R02AD,THROAT PREPARATIONS,,2017/10/23,,2018/1/5,Other (Please describe in comments),2017/12/8,2018/1/11,No
1053,1686,Shortage,XYLOCAINE VISCOUS 2%,ASTRAZENECA CANADA INC,lidocaine hydrochloride solution,LIDOCAINE HYDROCHLORIDE,20MG,1x100mL,"ORAL
TOPICAL",Resolved,LIQUID,N01BB,"ANESTHETICS, LOCAL",2016/7/7,2016/7/7,,2018/9/24,Shortage of an inactive ingredient or component.,2017/3/13,2018/9/25,No
1247,428833,Shortage,YF-VAX (YELLOW FEVER VACCINE),SANOFI PASTEUR LIMITED,Yellow Fever Vaccine,Yellow fever virus strain 17D-204,109648PFU,"5 x 0.5 mL dose vials with diluent / 5 fioles de 1 dose de 0,5 mL avec diluant",INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,J07BL,VIRAL VACCINES,,2020/1/31,2020/9/30,2020/8/21,Other (Please describe in comments),2017/3/13,2020/8/22,No
558,2410788,Shortage,ZAMINE 21,APOTEX INC,ZAMINE,DROSPIRENONE ETHINYL ESTRADIOL,3.0MG 0.030MG,21 BLS,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2017/3/9,,2020/9/1,Disruption of the manufacture of the drug.,2017/3/11,2020/9/4,No
561,2410796,Shortage,ZAMINE 28,APOTEX INC,ZAMINE,DROSPIRENONE ETHINYL ESTRADIOL,3.0MG 0.030MG,28 BLS,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2017/3/9,,2020/9/1,Disruption of the manufacture of the drug.,2017/3/11,2020/9/4,No
2745,2212331,Shortage,ZANTAC,GLAXOSMITHKLINE INC,Ranitidine tablets,RANITIDINE,150MG,100's,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2016/10/4,,2017/9/14,Shortage of an active ingredient.,2017/3/14,2020/2/27,No
2748,2212331,Shortage,ZANTAC,GLAXOSMITHKLINE INC,Ranitidine tablets,RANITIDINE,150MG,500's,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2016/11/8,,2017/9/14,Shortage of an active ingredient.,2017/3/15,2020/2/27,No
2751,2212366,Shortage,ZANTAC,GLAXOSMITHKLINE INC,Ranitidine injection,RANITIDINE,25MG,2mL x 10's,"INTRAMUSCULAR
INTRAVENOUS",Resolved,SOLUTION,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2016/4/25,,2018/8/31,Shortage of an active ingredient.,2017/3/15,2020/2/27,No
2761,2212358,Shortage,ZANTAC,GLAXOSMITHKLINE INC,Ranitidine tablets,RANITIDINE,300MG,60's,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017/4/19,,2017/9/14,Disruption of the manufacture of the drug.,2017/3/15,2020/2/27,No
3193,2108208,Shortage,ZEMURON,MERCK CANADA INC,ZEMURON Solution for Injection,ROCURONIUM BROMIDE,10MG,10 x 5 mL vials,INTRAVENOUS,Avoided shortage,SOLUTION,M03AC,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",2017/7/31,,,2017/7/14,Other (Please describe in comments),2017/3/17,2017/7/17,No
11366,2361752,Shortage,ZENHALE,MERCK CANADA INC,mometasone furoate & formoterol fumarate dihydrate inhalation aerosol,FORMOTEROL FUMARATE DIHYDRATE MOMETASONE FUROATE,5MCG 100MCG,60 & 120 dose,INHALATION,Resolved,"AEROSOL, METERED DOSE",R03AK,"ADRENERGICS, INHALANTS",,2017/5/23,2017/6/5,2017/6/6,Other (Please describe in comments),2017/5/26,2017/6/7,No
11369,2361760,Shortage,ZENHALE,MERCK CANADA INC,mometasone furoate & formoterol fumarate dihydrate inhalation aerosol,FORMOTEROL FUMARATE DIHYDRATE MOMETASONE FUROATE,5MCG 200MCG,60 & 120 dose,INHALATION,Resolved,"AEROSOL, METERED DOSE",R03AK,"ADRENERGICS, INHALANTS",,2017/5/23,2017/6/5,2017/6/6,Other (Please describe in comments),2017/5/26,2017/6/7,No
26770,2361760,Shortage,ZENHALE,MERCK CANADA INC,mometasone furoate & formoterol fumarate dihydrate inhalation aerosol,FORMOTEROL FUMARATE DIHYDRATE MOMETASONE FUROATE,5MCG 200MCG,60DOSE,INHALATION,Resolved,"AEROSOL, METERED DOSE",R03AK,"ADRENERGICS, INHALANTS",2017/12/18,2017/12/18,2018/2/9,2018/1/30,Disruption of the manufacture of the drug.,2017/10/23,2018/1/31,No
5540,2361760,Shortage,ZENHALE,MERCK CANADA INC,mometasone furoate & formoterol fumarate dihydrate inhalation aerosol,FORMOTEROL FUMARATE DIHYDRATE MOMETASONE FUROATE,5MCG 200MCG,120dose,INHALATION,Resolved,"AEROSOL, METERED DOSE",R03AK,"ADRENERGICS, INHALANTS",2017/4/10,2017/4/10,2017/4/12,2017/4/10,Delay in shipping of the drug.,2017/4/4,2017/10/10,No
2050,2153440,Shortage,ZINECARD,PFIZER CANADA INC,ZINECARD,DEXRAZOXANE,500MG,1 EACH / CHAQUE,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,V03AF,ALL OTHER THERAPEUTIC PRODUCTS,,2016/12/15,,,Disruption of the manufacture of the drug.,2017/3/14,2020/3/3,No
1360,2223716,Shortage,ZITHROMAX - PWS ORL 100MG/5ML,PFIZER CANADA INC,ZITHROMAX,AZITHROMYCIN,100MG,BOTTLE/BOUTEILLE,ORAL,Resolved,POWDER FOR SUSPENSION,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017/1/20,2017/4/21,2017/4/20,Disruption of the manufacture of the drug.,2017/3/13,2017/4/21,No
33938,2223716,Shortage,ZITHROMAX - PWS ORL 100MG/5ML,PFIZER CANADA INC,Zithromax,AZITHROMYCIN,100MG,300mg/15mL,ORAL,Resolved,POWDER FOR SUSPENSION,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2018/4/20,,2018/11/1,Disruption of the manufacture of the drug.,2017/12/20,2018/11/2,No
2513,2401606,Shortage,ZOLEDRONIC ACID - Z,SANDOZ CANADA INCORPORATED,ZOLEDRONIC ACID,ZOLEDRONIC ACID,4MG,5mL fioles/vials,INTRAVENOUS,Resolved,SOLUTION,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017/3/14,2017/3/17,2017/3/31,2017/5/15,Requirements related to complying with good manufacturing practices.,2017/3/14,2017/5/17,No
9738,2379929,Shortage,ZOLMITRIPTAN,PRO DOC LIMITEE,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017/7/14,,2017/12/6,Delay in shipping of the drug.,2017/5/9,2017/12/7,No
15518,2379988,Shortage,ZOLMITRIPTAN ODT,PRO DOC LIMITEE,ZOLMITRIPTAN ODT,ZOLMITRIPTAN,2.5MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2017/7/12,,2019/1/9,Delay in shipping of the drug.,2017/7/12,2019/1/10,No
5237,2375516,Shortage,ZOSTAVAX II,MERCK CANADA INC,"(zoster vaccine live, attenuated [Oka/Merck], refrigerator-stable) powder for suspension for injection",VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED,19400PFU,1 Dose Vial,SUBCUTANEOUS,Avoided shortage,POWDER FOR SUSPENSION,J07BK,VIRAL VACCINES,2017/5/25,,2017/6/16,2017/5/17,Demand increase for the drug.,2017/4/3,2017/5/17,No
3200,2354772,Shortage,ZUACTA,SANOFI-AVENTIS CANADA INC,ZUACTA,ZUCAPSAICIN,0.08%,30G & 60G TUBES,TOPICAL,Resolved,CREAM,M02AB,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,,2016/3/29,,2020/7/17,Other (Please describe in comments),2017/3/17,2020/7/30,No
8343,2340445,Shortage,ZYCLARA,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ZYCLARA,IMIQUIMOD,3.75%,TOPICAL,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,2017/5/3,,2017/5/10,2017/5/10,Delay in shipping of the drug.,2017/4/28,2017/5/12,No
21685,2340445,Shortage,ZYCLARA,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ZYCLARA,IMIQUIMOD,3.75%,na,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,,2017/9/8,2017/9/22,2017/9/22,Other (Please describe in comments),2017/9/8,2017/9/25,No
18241,2257270,Shortage,ZYMAR,ALLERGAN INC,ZYMAR 1mL,GATIFLOXACIN,0.30%,1 mL,OPHTHALMIC,Resolved,SOLUTION,S01AE,ANTIINFECTIVES,2017/8/3,2017/8/3,2017/9/18,2017/10/6,Disruption of the manufacture of the drug.,2017/8/3,2017/10/13,No
33440,2257270,Shortage,ZYMAR,ALLERGAN INC,ZYMAR 1mL,GATIFLOXACIN,0.30%,5mL,OPHTHALMIC,Resolved,SOLUTION,S01AE,ANTIINFECTIVES,2019/9/16,2019/9/16,2019/9/20,2019/9/18,Disruption of the manufacture of the drug.,2017/12/18,2019/9/19,No
14132,2243684,Shortage,ZYVOXAM 600 MG,PFIZER CANADA INC,Zyvoxam,LINEZOLID,600MG,20,ORAL,Avoided shortage,TABLET,J01XX,OTHER ANTIBACTERIALS,2017/7/28,,2017/7/24,2017/7/24,Disruption of the manufacture of the drug.,2017/6/27,2017/7/24,No
